data_2m5s_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m5s _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.45 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 23.7 p . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.448 0.166 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 61.3 52.13 53.63 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.302 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.445 HG21 ' O ' ' A' ' 263' ' ' ALA . 58.7 mt -103.37 148.39 8.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 34.5 p -97.2 150.58 20.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.603 0.716 . . . . 0.0 111.992 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.61 HG12 ' O ' ' A' ' 335' ' ' ALA . 9.8 p -63.92 151.45 8.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.025 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.9 t -115.34 81.68 1.62 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.899 0.381 . . . . 0.0 110.006 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 102.48 165.09 26.37 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.838 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -101.88 136.44 41.71 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.472 ' OE1' ' HA ' ' A' ' 259' ' ' VAL . 3.9 pt20 -144.14 139.46 28.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.247 0.546 . . . . 0.0 111.475 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 28.1 t -145.98 103.39 3.74 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.384 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -102.39 150.63 23.15 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 320' ' ' LEU . 45.9 mmtm -119.68 131.91 24.22 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.223 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 N--CA 1.462 -0.376 0 C-N-CA 122.603 2.202 . . . . 0.0 111.863 178.972 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.86 0.362 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -117.27 115.83 26.05 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.082 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.2 m -87.36 100.3 12.62 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.107 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.472 ' HA ' ' OE1' ' A' ' 234' ' ' GLN . 2.5 t -83.1 122.27 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.414 -172.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 25.0 m -96.13 105.81 17.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.834 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.405 HD22 HG22 ' A' ' 230' ' ' VAL . 21.0 mt -123.7 165.95 16.37 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.968 -175.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.9 t -60.11 -54.66 43.27 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.445 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.27 139.44 40.95 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.166 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 11.6 p -132.48 24.55 4.43 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.98 0.895 . . . . 0.0 108.867 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.4 m -78.23 139.26 38.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.865 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.77 -9.02 55.12 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -175.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 61.6 mtt -94.13 148.97 21.66 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 24.8 pttm -139.11 163.56 32.1 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -57.52 135.95 56.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.86 0.362 . . . . 0.0 110.935 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 82.71 19.03 64.46 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.801 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 268' ' ' LYS . 0.6 OUTLIER -94.21 174.2 7.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.791 0.329 . . . . 0.0 110.178 -178.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 0.1 OUTLIER -114.8 116.72 29.07 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.69 -178.269 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.413 HD12 HG22 ' A' ' 308' ' ' ILE . 17.1 pt -122.31 139.93 47.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.898 0.38 . . . . 0.0 110.238 175.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 72.9 p -119.75 145.05 46.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.011 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -107.0 111.4 23.87 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.19 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.18 113.3 4.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.071 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.26 -34.25 5.4 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 96.6 t -87.9 118.81 34.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -149.44 172.07 15.55 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.214 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -83.47 150.29 26.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.611 0.719 . . . . 0.0 112.364 -169.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.418 HD11 ' HB2' ' A' ' 315' ' ' LEU . 40.3 mt . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.965 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 120.651 0.262 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -57.97 113.32 1.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.291 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 9.5 p -96.77 105.39 17.5 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.052 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -116.93 147.83 41.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.741 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.8 t -94.94 124.48 39.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.747 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.427 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.9 p -75.15 140.98 16.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.323 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 37.9 t -103.33 -38.04 5.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.861 0.363 . . . . 0.0 110.83 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -158.82 136.75 10.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 0.0 111.026 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.25 106.58 17.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.53 -59.3 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.912 -171.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -112.9 -3.7 14.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.852 0.358 . . . . 0.0 111.445 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 71.24 12.46 72.38 Favored Glycine 0 CA--C 1.517 0.216 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -172.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 16.7 p -147.92 19.49 1.13 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.425 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.4 t-160 -169.98 113.15 0.48 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.056 -167.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.0 166.11 13.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -175.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.95 119.05 28.44 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.232 0.539 . . . . 0.0 109.996 171.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.413 HG22 HD12 ' A' ' 273' ' ' ILE . 36.6 pt -113.61 171.1 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.572 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 10.3 t -155.08 144.94 15.57 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -71.75 -179.91 24.16 Favored 'Cis proline' 0 CA--C 1.532 0.382 0 C-N-CA 124.215 -1.16 . . . . 0.0 113.048 -1.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -87.1 126.9 61.29 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.675 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.93 121.8 8.45 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.586 2.191 . . . . 0.0 112.328 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.471 HG21 ' HA ' ' A' ' 328' ' ' ALA . 0.9 OUTLIER -130.78 128.55 63.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.741 178.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -85.95 139.1 31.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.158 -174.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . 0.454 ' O ' HD12 ' A' ' 315' ' ' LEU . 3.0 tm? -80.73 -27.05 36.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.986 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -77.7 -10.48 59.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.443 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -83.02 116.02 22.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.037 0.446 . . . . 0.0 110.335 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.3 m -82.68 0.22 4.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.643 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 13.8 m -71.1 -19.18 62.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.609 0.242 . . . . 0.0 111.437 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 0.8 OUTLIER -94.94 168.77 10.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.147 0.498 . . . . 0.0 111.858 -177.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 15.2 t -87.45 152.28 52.01 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.906 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -40.73 -45.3 4.76 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.381 2.721 . . . . 0.0 113.781 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 323' ' ' GLU . 3.0 mp0 -51.33 -45.68 62.36 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.225 0.536 . . . . 0.0 110.855 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . 0.491 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 13.7 mm100 -64.76 -25.23 67.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.28 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -65.33 -31.09 72.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.93 0.395 . . . . 0.0 110.53 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.45 74.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.373 175.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -85.53 -10.28 56.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.15 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.471 ' HA ' HG21 ' A' ' 313' ' ' VAL . . . -63.08 135.08 57.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.638 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -119.51 -30.24 4.9 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 34.3 m -112.91 165.69 7.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.044 0.45 . . . . 0.0 111.399 -177.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -78.71 -44.89 22.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.528 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.3 t -130.9 145.91 52.16 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.126 0.489 . . . . 0.0 110.97 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 38.4 m -74.18 169.02 18.42 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.727 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.8 tp -75.86 102.98 5.73 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.61 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -91.66 166.19 12.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.994 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.42 62.19 4.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.09 0.472 . . . . 0.0 111.778 -173.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -176.94 30.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.491 171.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.2 mmt -101.47 134.38 44.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.342 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -90.15 132.85 35.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.009 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 22.8 t -108.3 108.56 25.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.717 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . 0.45 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 64.1 t30 -123.6 132.5 53.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.074 -175.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 47.6 mt -76.59 129.94 36.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.125 0.488 . . . . 0.0 110.295 173.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 45.4 mt . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.803 178.837 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.604 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 19.4 p . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.26 0.076 . . . . 0.0 111.061 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.64 49.66 76.16 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.754 177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.505 HG21 ' O ' ' A' ' 263' ' ' ALA . 57.7 mt -102.75 141.76 18.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 29.7 p -97.44 153.13 18.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.532 0.682 . . . . 0.0 111.839 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 335' ' ' ALA . 8.7 p -58.92 151.5 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.289 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 10.2 t -105.33 73.51 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.992 0.425 . . . . 0.0 110.095 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 97.19 158.58 31.06 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.093 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -72.61 116.96 13.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.731 0.3 . . . . 0.0 110.401 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.404 ' O ' ' HB3' ' A' ' 334' ' ' LEU . 6.2 tp-100 -129.37 127.09 40.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.148 0.499 . . . . 0.0 110.589 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.2 p -118.5 125.38 49.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.105 0.478 . . . . 0.0 109.819 177.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.465 ' CD2' ' HG2' ' A' ' 312' ' ' PRO . 70.1 m-85 -81.23 131.86 35.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.602 -174.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -129.52 111.11 17.71 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -175.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.448 -1.15 0 C-N-CA 122.67 2.247 . . . . 0.0 111.024 169.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.956 0.408 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -106.5 117.19 33.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.071 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -92.1 101.82 14.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.107 0.48 . . . . 0.0 110.542 -178.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.448 ' HB ' HG22 ' A' ' 306' ' ' VAL . 3.3 t -83.2 118.99 31.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.517 -172.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 20.5 m -90.78 108.54 19.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.186 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 20.7 mt -127.11 165.06 20.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.065 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 20.8 m -58.59 -55.68 31.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.398 0.618 . . . . 0.0 109.543 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.505 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -138.2 141.16 40.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.511 ' HB ' ' SD ' ' A' ' 267' ' ' MET . 9.3 p -126.42 24.69 6.69 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.057 0.932 . . . . 0.0 108.766 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 17.0 m -71.59 138.8 49.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.372 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 105.76 -11.26 45.76 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' MET . . . . . 0.545 ' SD ' HG13 ' A' ' 306' ' ' VAL . 63.3 mtt -95.18 142.83 27.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -154.17 140.36 18.5 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.461 ' HA ' HG12 ' A' ' 297' ' ' VAL . 30.0 ptt180 -44.17 118.01 1.38 Allowed 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.977 0.798 . . . . 0.0 112.607 -171.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.47 -10.63 19.4 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.467 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.464 ' N ' HG13 ' A' ' 297' ' ' VAL . 1.5 p30 -82.84 -177.2 6.66 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.552 0.692 . . . . 0.0 112.175 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -124.97 117.73 24.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.973 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 308' ' ' ILE . 37.5 pt -111.12 139.3 35.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.038 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.493 ' OG ' HG23 ' A' ' 294' ' ' THR . 3.0 m -125.34 129.51 50.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.508 -174.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -97.27 110.92 23.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.303 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.12 121.42 20.19 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.011 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.36 -27.93 9.58 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.77 131.28 50.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -141.84 157.73 44.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.786 0.327 . . . . 0.0 110.902 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -83.97 149.33 26.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.082 -174.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.391 176.574 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 C--O 1.235 0.33 0 CA-C-O 120.695 0.283 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -71.29 85.87 0.79 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.9 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.493 HG23 ' OG ' ' A' ' 274' ' ' SER . 22.2 p -96.79 122.18 39.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.233 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -124.11 153.65 41.15 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.97 0.414 . . . . 0.0 110.796 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.5 m -90.61 125.83 35.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.579 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 271' ' ' ASP . 4.8 p -67.03 134.45 30.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.034 0.445 . . . . 0.0 109.86 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 99.7 t -101.39 -53.05 7.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.744 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.401 ' CZ ' ' HA ' ' A' ' 301' ' ' VAL . 2.7 tmt_? -157.1 131.11 8.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.032 0.444 . . . . 0.0 110.843 -177.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 99.2 t -84.63 114.44 24.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.478 174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 299' ' ' ARG . 46.1 t -76.54 -59.15 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.644 -174.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -128.26 -7.72 5.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.445 0.64 . . . . 0.0 110.989 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.4 14.15 76.98 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 23.7 p -137.3 6.91 2.83 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 172.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.406 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.7 t-160 -164.14 119.64 1.55 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.456 -169.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.83 161.83 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -176.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -119.8 128.85 54.09 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 172.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.462 HG23 ' HA ' ' A' ' 297' ' ' VAL . 26.8 pt -133.94 171.64 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.102 0.477 . . . . 0.0 111.848 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 8.5 t -152.35 143.35 15.71 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.191 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.38 -179.96 27.88 Favored 'Cis proline' 0 CA--C 1.53 0.302 0 C-N-CA 123.752 -1.353 . . . . 0.0 112.939 -0.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.511 ' HB2' ' HZ2' ' A' ' 311' ' ' LYS . 2.6 ttmp? -92.26 123.67 61.8 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.167 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . 0.465 ' HG2' ' CD2' ' A' ' 236' ' ' PHE . 38.2 Cg_endo -70.48 109.46 2.45 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.49 2.127 . . . . 0.0 112.404 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 46.7 t -117.42 129.65 73.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.893 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -87.12 132.73 33.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.27 0.557 . . . . 0.0 111.473 -175.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -68.96 -26.99 65.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.205 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -98.27 19.48 14.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.719 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . 0.475 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 11.2 t70 -72.96 130.22 39.87 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.17 -16.61 10.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -174.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 18.9 t -90.76 -36.07 14.5 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -169.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.475 ' HG ' ' OD1' ' A' ' 317' ' ' ASP . 0.5 OUTLIER -71.15 175.92 4.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.526 0.679 . . . . 0.0 112.783 -175.3 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 13.5 m -103.13 158.53 31.58 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.21 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -39.7 -52.39 2.63 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.087 3.192 . . . . 0.0 114.756 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -58.54 -34.28 70.83 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -71.63 -26.46 62.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.788 0.328 . . . . 0.0 110.658 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -69.23 -22.97 63.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.975 0.416 . . . . 0.0 110.611 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -70.9 -34.3 71.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.29 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -86.24 -0.25 55.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.171 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -64.7 144.02 57.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.072 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -137.03 -9.26 1.78 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 32.5 m -123.4 155.25 29.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -84.88 -25.57 27.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 6.8 t -134.11 140.76 46.82 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.078 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 14.6 p -79.36 173.49 12.52 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 234' ' ' GLN . 19.1 tp -73.95 102.22 4.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.608 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -90.82 164.15 14.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.254 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . 0.408 ' HA ' ' CG1' ' A' ' 230' ' ' VAL . 23.8 t0 -77.89 60.57 2.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.181 0.515 . . . . 0.0 111.693 -173.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -178.23 29.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.473 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.5 mmt -98.17 134.37 41.32 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.228 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -94.48 131.14 40.5 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.79 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.0 t -104.75 114.05 43.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.048 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . 0.604 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 63.2 t30 -130.83 150.86 51.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.4 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 27.6 mt -102.84 130.73 52.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.115 0.483 . . . . 0.0 111.419 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 46.3 mt . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.192 173.804 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 33.8 p . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 111.231 0.086 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.13 48.39 86.16 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.644 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.466 HG13 ' HE1' ' A' ' 267' ' ' MET . 27.3 mm -100.87 143.75 13.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.836 -0.182 . . . . 0.0 110.733 -174.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 18.9 p -119.79 167.76 11.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.181 0.515 . . . . 0.0 111.417 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.559 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.9 p -85.38 150.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.835 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.3 t -107.11 60.04 0.62 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.155 0.503 . . . . 0.0 110.37 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 102.67 159.71 25.78 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.591 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 334' ' ' LEU . . . -70.81 131.12 43.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.929 0.395 . . . . 0.0 110.649 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -133.96 126.35 30.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.106 -175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 27.1 p -110.07 142.64 41.25 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.786 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.539 ' O ' HG13 ' A' ' 313' ' ' VAL . 98.7 m-85 -124.97 130.6 52.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.241 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -129.61 139.27 35.17 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.05 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.403 ' HD3' HG11 ' A' ' 313' ' ' VAL . 94.8 Cg_endo . . . . . 0 N--CA 1.453 -0.908 0 C-N-CA 122.763 2.309 . . . . 0.0 112.151 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.419 ' HB1' ' HD2' ' A' ' 312' ' ' PRO . . . -121.24 114.97 22.14 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.664 0.269 . . . . 0.0 110.773 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -87.09 97.59 10.82 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.236 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -85.17 126.81 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.333 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 40.4 m -96.53 109.15 21.79 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 173.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 22.2 mt -122.43 172.52 8.28 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.7 m -58.87 -57.4 13.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.241 0.543 . . . . 0.0 109.754 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.461 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -137.2 135.98 37.76 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.956 178.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 8.2 p -130.79 23.88 5.01 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.544 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 89.7 m -82.89 137.05 34.39 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.87 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 112.54 -29.5 8.2 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -171.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' MET . . . . . 0.466 ' HE1' HG13 ' A' ' 228' ' ' ILE . 1.9 mpt? -69.66 155.42 40.53 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 170.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -154.43 143.43 21.06 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.438 ' HA ' HG11 ' A' ' 297' ' ' VAL . 37.4 ptt180 -52.32 114.21 1.28 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.23 0.538 . . . . 0.0 111.06 -174.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 113.78 -2.7 24.51 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.903 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.421 ' OD1' HG23 ' A' ' 273' ' ' ILE . 0.6 OUTLIER -83.6 175.1 9.99 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 117.1 0.45 . . . . 0.0 111.052 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -126.47 117.39 22.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.245 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.421 HG23 ' OD1' ' A' ' 271' ' ' ASP . 40.8 pt -112.13 140.28 32.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.188 0.518 . . . . 0.0 110.356 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.503 ' OG ' HG21 ' A' ' 294' ' ' THR . 2.7 m -120.5 137.48 54.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.987 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -101.24 111.35 23.54 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.68 116.34 9.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.023 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.27 -36.19 4.27 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 85.2 t -86.47 114.54 26.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 172.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -136.25 158.17 45.05 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.633 -172.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.469 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 66.7 m-85 -76.18 133.93 40.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.344 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--N 1.322 -0.611 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.663 -179.927 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.469 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -73.6 106.96 5.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.982 -176.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.503 HG21 ' OG ' ' A' ' 274' ' ' SER . 67.0 p -97.34 133.62 41.71 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.97 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -131.33 148.89 52.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.941 0.401 . . . . 0.0 110.579 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.1 m -92.29 129.95 38.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.087 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.464 ' HA ' HG22 ' A' ' 308' ' ' ILE . 4.0 p -72.4 143.72 13.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.795 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 62.0 t -105.41 -38.95 4.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.682 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -162.66 136.35 6.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.654 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 58.7 t -86.53 110.45 20.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 169.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 24.3 t -77.32 -56.83 6.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.732 -171.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -127.49 13.92 7.06 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.618 -173.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 59.55 13.84 25.39 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-O 121.438 0.466 . . . . 0.0 112.055 -174.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.3 p -150.27 19.49 0.85 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.458 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.3 t-160 -169.03 115.84 0.62 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.817 -1.538 . . . . 0.0 108.074 -166.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.5 m -119.43 163.42 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.313 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -124.44 116.38 22.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.143 0.496 . . . . 0.0 109.674 169.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.464 HG22 ' HA ' ' A' ' 297' ' ' VAL . 24.2 pt -115.87 169.83 6.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.104 -177.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 6.3 t -154.32 145.21 16.22 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.24 179.7 22.57 Favored 'Cis proline' 0 C--N 1.346 0.403 0 C-N-CA 124.038 -1.234 . . . . 0.0 113.238 1.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 236' ' ' PHE . 31.7 tttp -83.53 119.11 73.28 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.255 -177.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 19.9 Cg_endo -62.29 109.11 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.51 2.14 . . . . 0.0 112.091 178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 236' ' ' PHE . 8.9 m -127.81 128.33 69.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.324 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -87.34 136.16 33.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.953 -173.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 43.9 tp -80.62 -28.81 36.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.512 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -85.91 13.53 7.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.334 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -76.02 117.78 18.1 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 29.5 m -82.87 1.17 3.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.743 -175.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 16.1 m -94.51 -27.95 15.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.69 0.281 . . . . 0.0 111.107 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CB ' ' A' ' 324' ' ' GLN . 1.6 pp -79.38 174.27 11.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.061 0.457 . . . . 0.0 111.291 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.499 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.6 m -116.36 168.37 8.79 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.16 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 29.3 Cg_exo -39.62 -49.1 3.38 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.793 2.995 . . . . 0.0 114.925 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -61.53 -36.94 82.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.039 0.447 . . . . 0.0 111.297 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . 0.481 ' CB ' ' HB2' ' A' ' 320' ' ' LEU . 15.5 mm-40 -68.84 -30.4 68.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.603 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -62.86 -25.58 68.35 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.216 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.78 -34.05 69.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.128 0.489 . . . . 0.0 110.298 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -76.05 -30.67 58.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.297 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.526 ' HA ' HG21 ' A' ' 313' ' ' VAL . . . -59.26 139.69 56.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.08 -175.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -135.13 -33.36 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.822 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 27.6 m -101.35 171.24 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.969 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -75.33 -57.18 4.05 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.739 -176.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.8 t -139.41 164.1 30.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.666 0.269 . . . . 0.0 110.358 -175.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.6 p -73.91 164.48 26.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.743 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 233' ' ' ALA . 25.6 tp -67.43 104.27 1.5 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.254 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.559 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -87.07 -174.35 4.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.598 -178.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -80.99 157.31 25.55 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.579 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 59.33 39.08 22.75 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.864 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.9 mmt -103.78 130.17 51.27 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -81.69 137.81 35.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.214 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 22.0 t -111.18 110.06 30.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -123.29 144.21 49.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.638 -173.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 55.6 mt -96.84 127.56 48.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.31 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.415 -178.238 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 32.2 p . . . . . 0 CA--C 1.533 0.294 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -82.14 76.06 2.26 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.083 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 40.1 mt -95.82 153.51 3.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 3.2 p -96.6 151.69 19.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.485 0.659 . . . . 0.0 112.211 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 335' ' ' ALA . 4.2 p -64.5 151.01 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.638 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.1 t -105.52 76.77 1.23 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.61 165.16 40.73 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.059 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.44 122.8 18.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.953 0.406 . . . . 0.0 110.596 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.44 ' NE2' ' HB ' ' A' ' 260' ' ' THR . 86.1 mm-40 -110.0 126.91 54.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.235 0.54 . . . . 0.0 110.496 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.4 p -137.21 112.17 8.97 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.76 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 234' ' ' GLN . 40.9 m-85 -116.95 132.41 56.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.86 0.362 . . . . 0.0 110.926 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -115.94 131.55 23.67 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.367 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 N--CA 1.458 -0.565 0 C-N-CA 122.381 2.054 . . . . 0.0 111.512 177.209 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 121.0 0.428 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -100.41 115.97 31.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.616 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -85.83 97.78 10.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.978 179.459 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.0 t -81.98 114.18 22.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.977 -173.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' THR . . . . . 0.44 ' HB ' ' NE2' ' A' ' 234' ' ' GLN . 17.5 m -86.42 107.19 17.93 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.985 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 21.0 mt -122.12 167.12 13.53 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.8 m -55.86 -54.6 42.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.372 0.606 . . . . 0.0 109.65 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -138.4 146.83 42.68 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 24.3 p -133.6 31.38 3.7 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.889 0.852 . . . . 0.0 108.904 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.9 m -80.24 152.7 28.95 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.65 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 90.36 -28.73 7.19 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 52.7 mtt -78.2 135.62 37.65 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.503 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 3.2 ptpp? -134.36 163.53 29.46 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -52.85 126.58 20.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.941 0.4 . . . . 0.0 111.147 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 95.21 18.82 32.43 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.098 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.503 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 66.5 m-20 -100.77 161.39 13.63 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 117.349 0.574 . . . . 0.0 110.892 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.472 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 12.0 tppt? -106.53 117.53 34.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.782 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.41 HD12 HG22 ' A' ' 308' ' ' ILE . 36.5 pt -112.25 139.74 35.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.128 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 32.6 p -113.06 134.35 54.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.317 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -100.06 111.55 23.84 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.932 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.96 130.73 46.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.837 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 89.43 -35.51 3.7 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.082 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.6 124.23 35.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -143.01 159.91 41.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.879 0.371 . . . . 0.0 111.183 -175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.425 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 80.7 m-85 -78.66 156.3 29.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.478 -173.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 91.5 mt . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.291 177.104 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 . . . . . 0 C--O 1.233 0.189 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.425 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -65.17 108.93 2.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.123 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.472 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 4.4 p -103.54 110.99 23.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.142 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -115.79 157.68 24.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.158 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 27.8 t -96.89 127.24 42.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.471 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.405 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.1 p -82.85 131.23 34.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.169 0.509 . . . . 0.0 110.228 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 39.2 t -92.21 -36.08 7.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.193 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -162.67 144.1 10.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.228 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.24 114.71 28.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 16.8 t -77.83 -52.29 16.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.976 -172.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -125.11 3.16 7.93 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -172.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 65.22 13.98 58.73 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.295 -171.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -151.9 20.57 0.69 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.0 t-160 -171.43 114.94 0.39 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 113.821 -1.536 . . . . 0.0 108.296 -164.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.6 m -118.84 160.66 18.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -176.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -118.03 120.5 37.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.081 0.467 . . . . 0.0 109.984 173.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.41 HG22 HD12 ' A' ' 273' ' ' ILE . 31.0 pt -118.56 164.47 14.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.273 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' THR . . . . . 0.403 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 8.8 t -154.11 140.91 13.15 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.141 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.403 ' C ' ' HA ' ' A' ' 309' ' ' THR . 15.5 Cg_exo -69.02 177.2 27.69 Favored 'Cis proline' 0 C--N 1.347 0.492 0 C-N-CA 123.932 -1.278 . . . . 0.0 112.567 -0.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -90.42 124.88 61.62 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.731 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.06 109.38 2.16 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.789 2.326 . . . . 0.0 112.467 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.435 ' CG2' ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -112.69 130.83 65.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.897 176.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -81.93 126.97 32.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.173 0.511 . . . . 0.0 111.133 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.2 -31.58 70.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.61 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -82.55 3.61 27.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.588 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . 0.446 ' OD2' ' HG ' ' A' ' 320' ' ' LEU . 20.2 t70 -72.96 123.11 22.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.888 0.375 . . . . 0.0 110.119 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.51 2.11 4.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 29.1 t -93.93 -31.27 14.36 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -173.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.463 HD11 ' HG2' ' A' ' 325' ' ' ARG . 0.4 OUTLIER -84.09 155.17 22.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.595 0.712 . . . . 0.0 112.492 -177.163 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.486 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 47.1 t -80.12 154.92 75.02 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.919 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.486 ' HD2' ' OG ' ' A' ' 321' ' ' SER . 41.3 Cg_exo -36.13 -52.65 1.05 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 124.087 3.191 . . . . 0.0 114.291 177.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.28 -38.84 84.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.815 0.34 . . . . 0.0 111.122 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 15.3 mm100 -64.65 -26.72 68.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.637 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.463 ' HG2' HD11 ' A' ' 320' ' ' LEU . 88.2 mtt180 -73.33 -19.23 61.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.912 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -78.83 -25.42 44.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.987 175.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -88.69 -11.63 44.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.536 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.435 ' HA ' ' CG2' ' A' ' 313' ' ' VAL . . . -66.76 121.65 15.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.782 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . 0.474 ' OD1' HG11 ' A' ' 330' ' ' VAL . 3.2 p30 -102.35 -27.45 12.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.823 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.474 HG11 ' OD1' ' A' ' 329' ' ' ASN . 36.0 m -113.85 168.08 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.998 0.427 . . . . 0.0 110.995 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -88.48 -41.43 12.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.328 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.5 t -123.64 145.36 49.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.252 0.548 . . . . 0.0 110.853 -174.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 7.5 p -73.0 162.57 29.33 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.339 172.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 40.6 tp -71.57 104.16 3.22 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.532 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -80.01 178.0 8.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.639 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -81.01 153.45 27.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.551 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 66.41 34.51 6.21 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 124.083 0.864 . . . . 0.0 111.897 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' MET . . . . . 0.44 ' H ' HG11 ' A' ' 230' ' ' VAL . 78.5 mmm -106.55 149.8 26.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -94.32 140.25 30.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.031 0.443 . . . . 0.0 111.588 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 41.7 t -125.28 120.35 57.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -138.51 148.21 44.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.711 0.291 . . . . 0.0 111.218 -174.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 60.5 mt -87.92 122.57 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.005 0.431 . . . . 0.0 110.585 174.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 47.8 mt . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.281 178.754 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.543 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 22.2 p . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 120.386 0.136 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.99 48.01 88.18 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.569 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 263' ' ' ALA . 71.3 mt -102.25 143.7 14.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 17.5 p -96.84 150.21 20.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.703 0.763 . . . . 0.0 112.243 -173.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 335' ' ' ALA . 8.9 p -62.77 151.26 8.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.469 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 70.9 m -102.2 72.52 1.3 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.95 0.405 . . . . 0.0 110.724 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 99.09 164.86 29.95 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.377 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -88.93 138.53 31.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.618 0.246 . . . . 0.0 110.436 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -153.58 147.32 25.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.143 0.497 . . . . 0.0 110.849 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 50.7 p -119.06 124.23 46.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.224 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -81.36 146.91 30.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.129 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -141.76 116.57 6.9 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.112 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 N--CA 1.45 -1.058 0 C-N-CA 122.476 2.117 . . . . 0.0 110.436 166.791 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.543 ' O ' ' HE3' ' A' ' 311' ' ' LYS . 40.9 m-85 . . . . . 0 C--O 1.23 0.045 0 CA-C-O 120.823 0.344 . . . . 0.0 111.455 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -130.98 138.52 49.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.662 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 4.0 m -101.54 114.41 28.42 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.417 ' HB ' HG21 ' A' ' 306' ' ' VAL . 2.7 t -95.42 125.02 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.234 -174.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 28.3 m -98.74 111.55 23.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.022 177.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 14.7 mt -130.59 169.34 15.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.455 -174.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.5 m -62.5 -55.38 28.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.492 0.663 . . . . 0.0 109.829 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -137.6 135.04 36.24 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.194 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.4 p -127.45 26.64 5.95 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 172.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 37.8 m -74.5 140.67 44.69 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.129 -1.851 . . . . 0.0 110.548 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 94.32 -11.93 69.68 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 66.0 mtt -86.09 145.2 27.15 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 25.2 pttm -136.22 155.23 50.42 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -57.34 128.48 37.22 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.92 18.47 34.38 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.447 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.456 ' H ' HG11 ' A' ' 297' ' ' VAL . 0.6 OUTLIER -101.28 178.02 4.77 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.473 ' HD3' ' HB ' ' A' ' 294' ' ' THR . 2.3 tmmm? -130.75 116.21 17.69 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.172 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 37.7 pt -112.48 151.42 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.936 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.406 ' OG ' HG23 ' A' ' 294' ' ' THR . 18.5 m -140.41 144.07 35.97 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.395 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.451 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 88.7 m-85 -102.77 111.97 24.54 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.593 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.86 113.02 5.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.431 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.44 -18.19 23.11 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.712 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 59.4 t -110.32 114.08 46.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.465 ' HB3' ' HZ3' ' A' ' 279' ' ' LYS . 0.6 OUTLIER -131.05 159.4 37.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.814 0.34 . . . . 0.0 111.472 -176.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -69.86 161.46 29.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.045 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 87.2 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.916 177.716 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.846 0.355 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.606 ' HB3' ' CE2' ' A' ' 295' ' ' PHE . . . -64.21 86.09 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.734 -176.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.473 ' HB ' ' HD3' ' A' ' 272' ' ' LYS . 43.7 p -87.93 110.37 20.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.526 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.606 ' CE2' ' HB3' ' A' ' 293' ' ' ALA . 64.7 m-85 -119.45 147.49 44.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.037 0.446 . . . . 0.0 111.381 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.7 m -91.89 127.82 37.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.689 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.456 HG11 ' H ' ' A' ' 271' ' ' ASP . 7.5 p -83.29 130.82 35.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.16 0.505 . . . . 0.0 110.289 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 307' ' ' GLU . 12.8 p -95.06 -30.05 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.498 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -163.38 139.84 7.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.11 0.481 . . . . 0.0 111.253 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 72.7 t -97.36 119.51 45.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.88 -59.88 2.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.838 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -129.23 -3.69 4.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.375 0.607 . . . . 0.0 111.091 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.6 14.44 75.91 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.413 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 14.4 p -143.0 16.09 1.92 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 174.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -171.54 116.28 0.4 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.807 -168.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.54 163.55 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.632 -174.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.436 ' O ' HG12 ' A' ' 298' ' ' VAL . 6.7 pt-20 -124.85 123.36 39.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.105 0.478 . . . . 0.0 109.943 172.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.452 HG23 ' HA ' ' A' ' 297' ' ' VAL . 28.4 pt -129.17 175.05 11.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.284 -174.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' THR . . . . . 0.406 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 11.6 t -154.17 145.39 16.46 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 176.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.79 179.36 29.52 Favored 'Cis proline' 0 C--N 1.345 0.393 0 C-N-CA 124.002 -1.249 . . . . 0.0 112.65 -2.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.543 ' HE3' ' O ' ' A' ' 256' ' ' PHE . 30.1 ttmt -84.42 128.84 60.1 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.854 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . 0.494 ' HG3' ' CE2' ' A' ' 295' ' ' PHE . 7.6 Cg_exo -71.28 108.87 2.45 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.448 2.099 . . . . 0.0 112.283 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.462 HG21 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -123.33 129.99 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.546 175.048 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -85.59 131.03 34.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.796 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.29 -32.69 73.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.716 177.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -92.83 24.83 3.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.351 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.27 128.55 34.31 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 29.3 m -84.48 -1.89 6.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -173.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 33.7 t -110.13 -14.34 14.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -173.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.95 167.9 21.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.6 0.714 . . . . 0.0 112.312 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 7.9 t -99.98 154.03 37.45 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.15 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.478 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 67.0 Cg_exo -41.86 -47.81 6.27 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.158 2.572 . . . . 0.0 113.549 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -53.76 -39.94 65.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.186 0.517 . . . . 0.0 110.933 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -72.76 -23.88 60.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.823 -176.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 29.6 mtm180 -66.36 -27.46 67.89 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.942 0.401 . . . . 0.0 110.297 176.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.82 63.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.222 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -96.06 7.57 46.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.939 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.462 ' HA ' HG21 ' A' ' 313' ' ' VAL . . . -58.9 140.09 55.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.898 0.38 . . . . 0.0 110.527 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -123.17 -33.43 3.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.412 -170.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 27.5 m -125.47 169.01 17.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.862 0.363 . . . . 0.0 110.16 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -94.07 -16.87 23.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.809 0.338 . . . . 0.0 110.916 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.0 t -144.62 141.33 29.31 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.894 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 50.1 m -80.18 171.99 14.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.2 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 17.7 tp -68.25 103.89 1.7 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.187 0.518 . . . . 0.0 110.364 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.7 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -81.02 170.82 15.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.917 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -79.31 11.56 2.85 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.373 -171.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -142.85 40.99 1.54 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.025 0.44 . . . . 0.0 110.979 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 21.6 mmt -98.99 133.07 43.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.355 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -94.33 130.6 40.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.822 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 12.2 t -99.78 113.17 34.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.613 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . 0.543 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 57.9 t30 -130.65 139.61 50.36 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.032 -177.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.6 mt -86.93 122.82 39.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.939 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 38.0 mt . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.747 -177.943 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 341' ' ' ASN . 31.0 p . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 121.329 0.585 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -113.94 56.43 0.49 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 263' ' ' ALA . 10.9 mt -92.51 161.2 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.22 -0.49 . . . . 0.0 110.342 -172.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 37.0 p -113.22 157.99 21.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.305 0.574 . . . . 0.0 111.369 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 335' ' ' ALA . 7.2 p -72.07 151.63 8.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.454 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 39.8 t -106.24 95.43 5.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.921 174.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 83.42 165.04 37.42 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.92 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -92.99 126.08 37.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -142.0 129.53 21.39 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.249 0.547 . . . . 0.0 111.357 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 15.5 t -106.42 121.9 45.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.551 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.441 ' O ' HG12 ' A' ' 313' ' ' VAL . 91.2 m-85 -83.89 113.53 21.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.862 0.363 . . . . 0.0 110.596 -176.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -124.04 118.48 26.8 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.528 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo . . . . . 0 C--O 1.233 0.254 0 C-N-CA 122.516 2.144 . . . . 0.0 111.774 177.285 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.876 0.37 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -140.04 120.48 14.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.47 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.0 OUTLIER -90.27 104.24 16.84 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.991 0.424 . . . . 0.0 110.338 -179.466 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.437 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.6 t -88.94 117.9 33.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 -173.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 60.6 m -89.59 107.69 19.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.018 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 18.6 mt -123.6 164.11 19.68 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.68 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 17.2 m -57.52 -52.93 63.38 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.432 0.634 . . . . 0.0 109.681 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.577 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -137.47 146.13 43.9 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 175.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 16.0 p -132.0 29.93 4.34 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.102 0.953 . . . . 0.0 108.569 174.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 18.3 m -73.74 138.97 44.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.291 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 100.15 -1.06 56.15 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.312 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' MET . . . . . 0.414 ' SD ' HG13 ' A' ' 306' ' ' VAL . 54.9 mtt -102.04 142.86 32.65 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 62.0 pttt -143.33 148.18 35.87 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -50.18 122.32 6.68 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.601 0.563 . . . . 0.0 111.876 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 97.45 18.35 28.59 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.678 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 268' ' ' LYS . 1.4 t70 -98.06 -171.02 2.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.98 0.39 . . . . 0.0 110.168 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -135.12 117.06 15.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.872 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 29.6 pt -112.64 140.37 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.421 -0.512 . . . . 0.0 109.974 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 6.8 m -120.86 137.03 54.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.233 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -103.18 111.55 23.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.3 119.03 12.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.365 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.03 -32.14 6.53 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -176.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.475 ' HA ' ' CG2' ' A' ' 332' ' ' THR . 43.7 t -96.73 122.37 48.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -140.12 170.1 16.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.878 0.37 . . . . 0.0 111.379 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -81.18 173.41 12.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.753 -174.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 71.9 mt . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.257 -176.724 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 . . . . . 0 C--O 1.235 0.316 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -52.91 104.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.513 0.508 . . . . 0.0 111.199 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.05 106.48 16.73 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.037 -176.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.498 ' CE2' ' HB3' ' A' ' 293' ' ' ALA . 50.2 m-85 -122.96 154.82 37.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.949 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 31.6 t -91.69 134.84 34.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.303 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.432 HG11 ' H ' ' A' ' 271' ' ' ASP . 11.9 p -87.15 126.74 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.218 0.533 . . . . 0.0 110.171 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.6 t -92.59 -38.77 10.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.581 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -159.13 133.89 8.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 50.3 t -93.8 110.28 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 39.5 t -70.16 -58.28 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.887 -171.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -124.34 -8.92 7.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.257 0.551 . . . . 0.0 111.151 -176.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.9 13.86 76.67 Favored Glycine 0 C--N 1.32 -0.309 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -172.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 29.6 p -138.71 13.2 2.72 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 172.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -166.35 120.65 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.519 -170.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.6 159.81 20.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 -176.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -122.77 115.48 22.11 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.284 0.564 . . . . 0.0 109.724 168.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.407 HG23 ' HA ' ' A' ' 297' ' ' VAL . 30.1 pt -111.83 178.35 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.102 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 15.0 t -153.73 142.73 14.67 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.404 ' HD2' ' CD1' ' A' ' 295' ' ' PHE . 4.8 Cg_exo -82.13 -179.87 25.15 Favored 'Cis proline' 0 C--N 1.344 0.317 0 C-N-CA 124.282 -1.133 . . . . 0.0 112.522 -2.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -77.27 124.42 87.04 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.491 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . 0.484 ' HA ' ' OD1' ' A' ' 329' ' ' ASN . 64.3 Cg_endo -77.94 108.6 2.56 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.374 2.05 . . . . 0.0 112.365 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 236' ' ' PHE . 0.2 OUTLIER -109.49 136.17 46.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -81.47 115.8 20.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.057 0.456 . . . . 0.0 111.106 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.96 -26.54 66.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.528 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.09 12.54 21.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.864 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -85.66 118.63 25.29 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.88 -14.34 11.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.004 0.43 . . . . 0.0 111.221 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.5 t -77.7 -28.28 50.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.47 -174.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 1.8 pp -71.07 172.92 8.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.31 0.576 . . . . 0.0 112.009 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 23.5 m -102.65 162.98 18.53 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.483 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.439 ' O ' ' HG3' ' A' ' 325' ' ' ARG . 85.3 Cg_exo -44.62 -52.21 6.31 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.004 3.136 . . . . 0.0 115.39 -172.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -73.42 -18.13 61.18 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.771 -0.581 . . . . 0.0 111.743 -172.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -73.92 -39.7 63.65 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.224 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 322' ' ' PRO . 0.0 OUTLIER -75.07 -16.29 60.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.121 0.486 . . . . 0.0 110.785 178.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -66.71 -35.48 80.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.551 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -95.43 -0.62 52.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.138 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.432 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -66.19 128.45 36.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.15 0.5 . . . . 0.0 111.266 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . 0.484 ' OD1' ' HA ' ' A' ' 312' ' ' PRO . 10.2 p30 -110.85 -26.85 9.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.699 -176.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 29.2 m -108.54 164.07 5.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.017 0.437 . . . . 0.0 110.834 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -98.86 -5.66 30.54 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.475 ' CG2' ' HA ' ' A' ' 278' ' ' VAL . 8.9 t -146.05 148.11 32.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.059 0.457 . . . . 0.0 110.882 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 59.5 m -81.26 167.33 19.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.492 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 18.7 tp -76.02 102.92 5.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.693 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -80.58 167.63 19.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.297 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -80.68 28.7 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -171.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -153.09 32.23 0.48 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.874 0.368 . . . . 0.0 110.838 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.6 mmt -94.22 129.99 40.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.871 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -85.15 140.69 30.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.618 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 11.2 t -109.46 108.11 24.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.919 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 226' ' ' THR . 6.8 t30 -119.6 132.11 55.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.15 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 4.0 mt -92.72 129.57 43.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.02 0.438 . . . . 0.0 110.591 175.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 50.8 mt . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.807 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 50.96 37.73 36.76 Favored Glycine 0 C--N 1.332 0.361 0 O-C-N 123.331 0.394 . . . . 0.0 113.056 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 263' ' ' ALA . 44.2 mt -82.5 141.7 14.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -176.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 5.4 p -95.29 147.14 23.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.724 0.773 . . . . 0.0 112.131 -171.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 335' ' ' ALA . 9.6 p -57.54 151.37 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.089 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 33.1 t -101.93 47.7 0.89 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.084 0.469 . . . . 0.0 110.427 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 122.57 163.94 12.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.407 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -79.34 123.26 27.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.797 0.332 . . . . 0.0 110.417 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.427 HE22 ' CB ' ' A' ' 260' ' ' THR . 95.1 mt-30 -132.88 131.55 41.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.228 0.537 . . . . 0.0 111.217 -177.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.1 t -131.34 101.93 5.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.558 ' O ' HG12 ' A' ' 313' ' ' VAL . 64.8 m-85 -94.68 137.45 33.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.219 -176.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.68 ' HB3' ' NE2' ' A' ' 324' ' ' GLN . 3.3 mptp? -109.85 146.56 34.36 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.681 -177.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.456 -0.726 0 C-N-CA 122.571 2.181 . . . . 0.0 111.029 170.776 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 120.928 0.394 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -100.55 122.9 44.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.475 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -90.68 101.26 14.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.016 0.436 . . . . 0.0 111.089 179.002 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.6 t -83.15 121.48 36.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.977 -175.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' THR . . . . . 0.427 ' CB ' HE22 ' A' ' 234' ' ' GLN . 29.0 m -94.28 107.02 18.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.312 0.577 . . . . 0.0 109.985 176.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.44 ' HB2' HG21 ' A' ' 264' ' ' THR . 17.8 mt -121.04 163.19 18.71 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.634 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 26.2 m -55.03 -54.0 48.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.172 0.51 . . . . 0.0 109.958 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -137.47 135.45 36.84 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.44 HG21 ' HB2' ' A' ' 261' ' ' LEU . 7.9 p -126.37 29.25 5.82 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.5 m -82.21 139.51 34.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.023 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 96.05 18.48 31.53 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 65.4 mtt -121.45 147.26 45.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.022 -0.589 . . . . 0.0 109.722 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -139.14 169.5 17.66 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.527 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 298' ' ' VAL . 47.6 mtt180 -56.48 128.56 36.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.777 0.323 . . . . 0.0 111.371 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.02 18.57 42.89 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.354 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.438 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 92.0 m-20 -93.78 156.12 16.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.169 0.484 . . . . 0.0 110.302 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -102.9 116.6 32.87 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.423 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 308' ' ' ILE . 28.5 pt -113.51 138.69 42.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.095 176.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 10.5 t -120.19 132.25 55.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.461 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.412 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 92.5 m-85 -94.43 110.33 22.12 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.97 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.44 111.37 8.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.374 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.63 -19.95 20.98 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.577 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 74.7 t -104.44 128.7 57.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 174.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -147.11 159.7 43.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.956 0.407 . . . . 0.0 111.106 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 76.9 m-85 -73.66 166.08 23.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.277 -175.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 89.6 mt . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.489 178.267 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 C--O 1.235 0.327 0 CA-C-O 121.037 0.446 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -68.99 129.99 41.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.762 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 9.3 p -119.74 110.6 16.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.847 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -116.95 151.75 36.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.057 0.455 . . . . 0.0 110.95 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.3 m -98.56 131.08 45.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.713 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.438 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.3 p -79.09 131.33 34.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.263 0.554 . . . . 0.0 110.8 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.551 ' O ' ' HG2' ' A' ' 269' ' ' ARG . 25.6 t -94.61 -24.55 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.532 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.436 ' HB3' ' CD ' ' A' ' 307' ' ' GLU . 12.4 tpt180 -176.85 139.33 0.29 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.369 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 75.6 t -90.59 111.02 22.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 36.9 t -73.27 -55.59 12.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.047 -171.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -128.96 -4.26 5.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.191 0.519 . . . . 0.0 111.463 -176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 80.55 13.32 81.79 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.46 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.3 p -143.51 16.42 1.83 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.513 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.1 t-160 -165.47 118.25 1.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.269 -170.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.5 m -118.95 157.54 20.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -176.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.436 ' CD ' ' HB3' ' A' ' 299' ' ' ARG . 8.8 pt-20 -115.39 121.72 43.66 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 173.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.452 HG22 HD11 ' A' ' 273' ' ' ILE . 30.0 pt -122.45 163.75 20.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.184 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.9 t -149.21 142.28 15.85 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.447 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.05 179.63 28.93 Favored 'Cis proline' 0 C--N 1.345 0.35 0 C-N-CA 123.463 -1.474 . . . . 0.0 112.696 -0.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -83.14 124.45 76.33 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.053 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -72.78 109.2 2.74 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.835 2.357 . . . . 0.0 112.225 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 236' ' ' PHE . 0.0 OUTLIER -118.82 137.3 53.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.642 176.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -81.46 131.15 35.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.285 0.564 . . . . 0.0 110.459 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -73.79 -29.35 62.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.111 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -93.9 24.79 3.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.346 0.593 . . . . 0.0 110.498 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . 0.632 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 14.8 t70 -82.05 121.4 26.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.198 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 13.1 p -84.32 -19.09 9.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.986 0.422 . . . . 0.0 110.996 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 34.2 t -71.72 -46.61 58.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.51 -174.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.632 ' HG ' ' OD1' ' A' ' 317' ' ' ASP . 0.3 OUTLIER -74.82 170.15 16.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.739 0.781 . . . . 0.0 113.066 -175.167 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 41.2 t -83.77 151.59 61.49 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.624 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' A' ' 325' ' ' ARG . 99.9 Cg_exo -45.84 -40.3 19.6 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.183 2.588 . . . . 0.0 113.414 176.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -60.44 -41.53 94.24 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.444 0.64 . . . . 0.0 110.914 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . 0.68 ' NE2' ' HB3' ' A' ' 237' ' ' LYS . 39.2 mt-30 -70.21 -24.44 63.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.037 -177.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.446 ' HD2' ' HA ' ' A' ' 322' ' ' PRO . 90.6 mtt180 -70.34 -26.51 63.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.585 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.5 -29.07 68.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.236 0.541 . . . . 0.0 110.17 176.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -97.38 6.36 48.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.342 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -71.79 150.13 44.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 0.0 110.884 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -126.97 -32.25 2.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.915 0.388 . . . . 0.0 111.387 -174.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.9 m -112.46 155.14 13.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.24 -176.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -83.76 -22.1 32.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.252 0.548 . . . . 0.0 109.99 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 1.4 t -129.46 131.44 46.71 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.606 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.404 ' N ' ' HB1' ' A' ' 314' ' ' ALA . 8.7 p -75.39 168.13 20.58 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.682 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 20.5 tp -70.22 103.73 2.44 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.656 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -80.49 173.14 12.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.294 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.31 10.37 3.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.858 -173.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -143.0 57.85 1.41 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.234 0.54 . . . . 0.0 110.786 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.8 mmt -117.11 136.14 53.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.282 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -96.38 131.93 42.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.903 0.382 . . . . 0.0 110.823 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 38.5 t -103.51 108.2 23.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.669 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -123.11 129.55 51.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.337 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 42.9 mt -80.17 125.14 38.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.525 175.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 78.5 mt . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.853 177.194 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 28.6 p . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 120.866 0.365 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.79 63.96 3.06 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.742 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.521 HD11 ' O ' ' A' ' 263' ' ' ALA . 45.5 mm -98.66 139.58 20.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.583 0.23 . . . . 0.0 111.112 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.3 p -121.72 160.24 24.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.949 0.404 . . . . 0.0 110.581 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 335' ' ' ALA . 9.8 p -78.5 151.04 5.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.345 177.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.8 t -116.73 78.81 1.24 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.234 0.54 . . . . 0.0 109.755 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 110.68 166.33 19.1 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.46 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -97.35 110.12 22.74 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -97.51 127.36 43.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.36 0.6 . . . . 0.0 111.604 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.6 m -127.33 101.2 6.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.101 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.426 ' HB3' ' HE2' ' A' ' 311' ' ' LYS . 94.1 m-85 -85.49 167.92 15.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.497 -174.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -137.65 136.63 20.4 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.496 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.45 -1.076 0 C-N-CA 122.638 2.226 . . . . 0.0 111.686 177.852 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 . . . . . 0 C--O 1.233 0.205 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.75 122.67 43.76 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.825 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -90.96 104.3 16.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.501 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.6 t -86.33 121.96 38.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.441 -173.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 63.3 m -91.12 105.35 17.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.218 0.533 . . . . 0.0 110.202 175.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.474 ' HB2' ' CG2' ' A' ' 264' ' ' THR . 21.7 mt -122.02 162.85 20.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.623 -177.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 8.0 m -59.79 -52.05 67.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.169 0.509 . . . . 0.0 109.875 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.521 ' O ' HD11 ' A' ' 228' ' ' ILE . . . -136.08 125.09 24.29 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.667 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.525 ' HB ' ' SD ' ' A' ' 267' ' ' MET . 6.7 p -124.92 27.07 6.86 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.138 0.971 . . . . 0.0 108.589 174.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 8.3 m -82.89 138.05 34.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.585 177.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 101.7 -14.31 57.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -175.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' MET . . . . . 0.525 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 64.5 mtt -82.82 153.73 25.04 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -153.67 142.61 21.17 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.482 ' HA ' HG11 ' A' ' 297' ' ' VAL . 34.6 ptt180 -50.87 114.03 1.06 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.624 0.578 . . . . 0.0 111.401 -173.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.16 -2.43 22.49 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.74 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.466 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.4 p30 -81.67 -179.25 7.3 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 117.258 0.529 . . . . 0.0 111.243 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -131.93 116.51 17.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.845 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 22.3 pt -114.14 138.9 42.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.148 0.499 . . . . 0.0 110.769 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 13.3 t -118.51 137.07 53.45 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.615 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -103.69 111.36 23.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.037 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.54 118.82 13.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.688 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.99 -13.74 26.56 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.682 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.02 147.94 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -161.24 156.55 24.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.912 0.387 . . . . 0.0 111.48 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -81.15 153.46 27.24 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.465 -171.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.4 HD12 ' HB2' ' A' ' 315' ' ' LEU . 83.7 mt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.213 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 . . . . . 0 C--O 1.233 0.235 0 CA-C-O 121.017 0.437 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -57.71 117.76 4.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.085 -172.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 37.9 p -105.01 113.75 27.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.565 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -110.94 148.44 32.5 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.992 0.425 . . . . 0.0 110.735 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 16.0 m -96.23 127.92 42.67 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.001 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.482 HG11 ' HA ' ' A' ' 269' ' ' ARG . 2.5 p -73.95 140.62 17.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.7 t -104.09 -31.85 2.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.055 0.455 . . . . 0.0 109.88 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.532 ' HD2' ' OE2' ' A' ' 307' ' ' GLU . 1.2 tmt_? -173.47 138.41 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.0 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 79.4 t -90.64 116.8 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 22.2 t -78.01 -58.8 3.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.042 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -116.71 -10.62 11.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.918 0.389 . . . . 0.0 111.864 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 78.53 12.22 84.48 Favored Glycine 0 CA--C 1.517 0.204 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -171.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.8 p -149.92 22.3 0.88 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.449 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 8.5 t-160 -174.08 115.59 0.21 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 113.561 -1.654 . . . . 0.0 107.999 -166.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.23 166.51 13.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.532 ' OE2' ' HD2' ' A' ' 299' ' ' ARG . 10.5 pt-20 -123.79 122.34 37.8 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 169.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.454 HG22 ' HA ' ' A' ' 297' ' ' VAL . 30.0 pt -121.2 170.74 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.51 -174.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' THR . . . . . 0.41 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 11.8 t -152.01 139.93 13.07 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.969 172.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 309' ' ' THR . 61.6 Cg_endo -71.14 179.4 25.39 Favored 'Cis proline' 0 C--N 1.345 0.368 0 C-N-CA 123.846 -1.314 . . . . 0.0 113.209 2.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 236' ' ' PHE . 19.6 ttmt -84.95 126.37 68.17 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.669 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -65.9 108.11 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.316 2.011 . . . . 0.0 111.84 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 329' ' ' ASN . 1.3 m -130.87 129.54 63.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.151 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -93.06 141.5 28.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.433 -173.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . 0.4 ' HB2' HD12 ' A' ' 281' ' ' LEU . 2.8 tm? -75.07 -26.16 59.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.483 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -94.83 26.0 3.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.644 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -83.49 136.56 34.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 27.8 m -83.81 -9.77 11.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 9.6 t -120.22 23.33 11.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.938 0.399 . . . . 0.0 111.626 -171.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.23 168.67 10.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.077 0.465 . . . . 0.0 111.026 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.426 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 51.9 m -112.49 165.25 13.43 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.358 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.44 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 85.5 Cg_exo -45.25 -49.45 10.16 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.517 2.812 . . . . 0.0 114.737 -175.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.2 -28.94 61.51 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.807 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -67.99 -41.13 82.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.663 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.44 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 28.8 ptt180 -69.12 -23.43 63.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.145 0.498 . . . . 0.0 110.17 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -80.68 -10.25 59.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.628 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -118.41 16.52 13.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.783 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -65.1 151.27 46.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.223 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . 0.402 ' H ' HG23 ' A' ' 313' ' ' VAL . 83.3 m-20 -115.21 -39.64 3.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.796 -175.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 30.7 m -118.26 168.28 10.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.22 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -82.31 -49.63 9.83 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.874 0.368 . . . . 0.0 110.798 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 13.5 t -117.79 149.82 40.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.202 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 22.6 p -80.8 171.23 15.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.009 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 20.1 tp -73.75 111.27 8.74 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.624 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -82.0 170.68 15.29 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.137 0.494 . . . . 0.0 111.435 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.07 -8.92 57.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.506 -169.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -138.33 55.36 1.75 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.04 0.448 . . . . 0.0 111.578 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' MET . . . . . 0.494 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 14.5 mmt -102.33 147.57 26.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.162 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -96.14 143.56 27.16 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.68 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.45 ' O ' ' HB ' ' A' ' 228' ' ' ILE . 17.7 t -115.52 126.89 73.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -133.35 136.35 45.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.177 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 25.2 mt -90.1 124.38 42.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.919 0.39 . . . . 0.0 110.324 174.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 45.2 mt . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.212 178.385 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.52 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 23.2 p . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 60.67 39.3 96.41 Favored Glycine 0 CA--C 1.516 0.144 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.313 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.535 HG23 ' O ' ' A' ' 263' ' ' ALA . 71.9 mt -102.95 143.86 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 7.0 p -111.3 151.43 28.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.079 0.466 . . . . 0.0 111.246 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.627 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.5 p -60.75 150.48 6.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.807 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 8.8 t -112.3 82.21 1.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.115 0.484 . . . . 0.0 109.747 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 92.66 149.61 24.99 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.858 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.56 121.75 17.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.837 0.351 . . . . 0.0 110.552 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -113.25 126.96 55.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.203 0.525 . . . . 0.0 110.238 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 20.3 p -127.9 104.0 7.57 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.171 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -81.51 161.51 23.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.789 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -142.02 133.74 13.38 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.601 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.429 ' HD3' HG13 ' A' ' 313' ' ' VAL . 84.7 Cg_endo . . . . . 0 N--CA 1.454 -0.819 0 C-N-CA 122.853 2.368 . . . . 0.0 111.435 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.991 0.424 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -119.86 126.98 52.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.524 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.5 m -93.96 99.19 11.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.01 0.433 . . . . 0.0 110.62 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.438 ' HB ' HG21 ' A' ' 306' ' ' VAL . 2.7 t -83.66 120.16 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.168 -174.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 19.3 m -91.55 105.75 17.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.835 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.404 ' HB2' ' CG2' ' A' ' 264' ' ' THR . 19.9 mt -121.63 169.41 10.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.257 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 6.6 m -63.05 -55.19 27.68 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.535 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -136.62 131.15 33.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.696 178.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.411 ' HB ' ' SD ' ' A' ' 267' ' ' MET . 3.2 p -129.51 27.49 5.27 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 18.4 m -82.69 141.88 32.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.096 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.03 -3.95 60.62 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -174.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' MET . . . . . 0.411 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 89.5 mtp -86.9 152.85 22.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -154.84 140.85 18.34 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.22 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.505 ' HA ' HG11 ' A' ' 297' ' ' VAL . 35.9 ptt180 -52.45 117.82 3.14 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.374 0.606 . . . . 0.0 111.089 -175.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.47 1.12 21.8 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.378 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -84.06 179.68 7.45 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.132 0.466 . . . . 0.0 110.507 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.462 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 5.1 tppp? -137.67 115.94 11.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.827 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.449 HD13 HG21 ' A' ' 308' ' ' ILE . 35.7 pt -112.99 140.0 35.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.206 0.527 . . . . 0.0 110.389 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 17.9 m -131.39 138.73 49.24 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.663 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -100.29 113.5 26.25 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.096 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.94 113.56 2.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.499 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.77 -34.34 5.16 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.932 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.7 t -81.14 127.85 39.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -149.12 161.75 41.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.708 0.289 . . . . 0.0 110.896 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -83.67 158.42 21.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.053 -175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--O 1.235 0.328 0 CA-C-O 121.305 0.574 . . . . 0.0 111.26 -179.607 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -59.78 106.76 0.52 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.957 0.408 . . . . 0.0 111.334 -176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 21.3 p -88.59 115.6 26.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.501 -177.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -121.31 144.31 48.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.367 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 68.4 m -101.32 132.39 46.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.749 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.505 HG11 ' HA ' ' A' ' 269' ' ' ARG . 9.3 p -67.49 140.35 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.126 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.63 -42.65 7.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.111 175.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.408 ' HB3' ' CD ' ' A' ' 307' ' ' GLU . 23.5 tpt180 -157.33 128.06 6.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.85 -178.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 97.8 t -86.3 97.8 6.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 172.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 25.4 t -65.9 -58.74 5.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.691 -173.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -126.66 -8.31 6.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.141 0.496 . . . . 0.0 111.472 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.15 13.81 78.27 Favored Glycine 0 C--N 1.321 -0.252 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.677 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 21.6 p -138.95 10.31 2.6 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 170.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -162.74 116.6 1.71 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.453 -1.249 . . . . 0.0 107.894 -169.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.99 160.29 18.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.674 -172.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.0 pt-20 -121.28 122.58 40.22 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 168.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.449 HG21 HD13 ' A' ' 273' ' ' ILE . 23.4 pt -123.49 169.39 14.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.228 0.537 . . . . 0.0 112.309 -174.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.0 t -145.38 138.83 14.38 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.788 172.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.33 -179.75 24.62 Favored 'Cis proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.759 -1.35 . . . . 0.0 113.313 -1.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.519 ' HZ3' ' HB2' ' A' ' 311' ' ' LYS . 3.3 ttmp? -87.42 125.53 65.29 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.558 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.61 108.85 1.94 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.369 2.046 . . . . 0.0 111.861 175.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.456 ' CG2' ' HA ' ' A' ' 328' ' ' ALA . 1.5 m -136.3 120.86 25.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.454 ' HB1' ' N ' ' A' ' 333' ' ' SER . . . -82.49 134.43 35.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.838 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.9 tm? -75.69 -25.05 56.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.618 176.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -85.9 6.02 30.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.14 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -77.2 126.8 31.53 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.2 m -83.94 2.35 3.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 7.7 m -103.5 23.22 12.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.703 0.287 . . . . 0.0 111.77 -172.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.411 HD13 ' HG2' ' A' ' 325' ' ' ARG . 1.0 OUTLIER -126.18 157.2 38.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.44 0.638 . . . . 0.0 112.25 -179.29 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.483 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 2.8 m -92.25 166.81 16.35 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.554 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 2.3 Cg_endo -42.18 -58.08 1.34 Allowed 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.759 2.973 . . . . 0.0 113.864 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -60.4 -36.88 79.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.137 0.494 . . . . 0.0 111.084 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -63.4 -30.5 71.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.664 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.411 ' HG2' HD13 ' A' ' 320' ' ' LEU . 34.2 mtp85 -61.28 -39.31 89.93 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.226 176.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.04 -26.15 68.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.066 0.46 . . . . 0.0 110.922 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -87.11 -12.88 45.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.232 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.456 ' HA ' ' CG2' ' A' ' 313' ' ' VAL . . . -72.3 151.63 42.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.515 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -137.18 -35.72 0.68 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -173.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.3 m -101.93 167.62 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.852 0.358 . . . . 0.0 111.092 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -83.63 -39.3 20.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.919 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.1 t -126.69 139.54 53.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.673 -177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.454 ' N ' ' HB1' ' A' ' 314' ' ' ALA . 46.3 m -70.42 171.92 9.24 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 20.3 tp -71.24 103.91 2.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.627 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -79.62 172.12 14.22 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.878 -175.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.51 -11.61 60.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.129 -171.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -132.49 71.27 1.47 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.016 0.436 . . . . 0.0 111.223 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' MET . . . . . 0.408 ' H ' HG13 ' A' ' 230' ' ' VAL . 23.5 mmt -121.84 133.84 54.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.666 175.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -85.38 136.54 33.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.906 0.384 . . . . 0.0 111.301 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 17.4 t -101.4 112.82 35.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.703 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . 0.52 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 5.7 t-20 -129.91 138.8 51.1 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.815 0.34 . . . . 0.0 111.382 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 62.3 mt -92.1 125.92 44.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 172.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 40.4 mt . . . . . 0 C--N 1.323 -0.577 0 CA-C-O 120.97 0.414 . . . . 0.0 111.012 -178.38 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 3.8 p . . . . . 0 N--CA 1.448 -0.55 0 CA-C-O 121.146 0.498 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -116.52 37.53 3.35 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.509 HG23 ' O ' ' A' ' 263' ' ' ALA . 37.9 mt -82.28 152.44 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.277 -0.461 . . . . 0.0 109.883 -173.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 22.0 p -114.64 162.59 16.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.454 0.645 . . . . 0.0 111.808 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 335' ' ' ALA . 9.8 p -62.7 151.75 7.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.897 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 16.5 t -116.82 78.9 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.195 0.521 . . . . 0.0 109.615 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 100.82 145.79 17.89 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.904 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.83 111.74 5.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.844 0.354 . . . . 0.0 110.304 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -109.15 127.8 54.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.264 0.554 . . . . 0.0 110.834 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 16.7 p -115.95 143.12 45.88 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.639 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -115.99 154.45 29.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.791 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -143.45 135.56 13.2 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.422 ' HD3' HG12 ' A' ' 313' ' ' VAL . 10.9 Cg_endo . . . . . 0 N--CA 1.454 -0.836 0 C-N-CA 122.892 2.395 . . . . 0.0 110.66 169.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 308' ' ' ILE . 51.7 m-85 . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 120.908 0.385 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -153.57 125.23 7.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.677 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -90.18 104.13 16.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.246 0.546 . . . . 0.0 111.147 178.004 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.8 t -86.61 121.09 37.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.998 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 30.5 m -92.84 109.54 20.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.992 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 17.4 mt -124.54 176.03 6.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.918 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 35.0 t -64.56 -59.66 4.03 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.509 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -137.58 138.7 39.83 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 7.6 p -126.97 28.09 5.86 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.004 0.906 . . . . 0.0 108.914 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 1.3 m -78.81 151.28 32.02 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.981 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 93.11 -22.44 34.57 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 53.8 mtt -79.6 144.67 33.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.562 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 0.3 OUTLIER -137.31 152.48 49.8 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -50.82 126.03 14.87 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.568 0.542 . . . . 0.0 111.474 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.95 19.23 37.35 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.567 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 268' ' ' LYS . 0.8 OUTLIER -98.81 177.39 5.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.973 0.416 . . . . 0.0 110.673 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -122.02 116.34 24.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.908 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 308' ' ' ILE . 40.3 pt -113.19 140.28 34.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.215 177.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -118.24 133.47 55.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.215 -176.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -99.63 110.99 23.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.894 0.378 . . . . 0.0 110.028 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.09 117.81 15.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.531 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.79 -24.41 15.09 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 42.4 t -99.99 133.85 41.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -151.1 160.63 43.77 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 120.993 0.425 . . . . 0.0 111.066 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -78.19 154.33 31.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.369 -169.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 84.4 mt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.388 177.223 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 . . . . . 0 C--O 1.235 0.296 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.412 ' HB3' ' CE2' ' A' ' 295' ' ' PHE . . . -60.33 102.05 0.16 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.26 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 1.2 p -103.44 117.84 35.38 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.245 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 293' ' ' ALA . 85.1 m-85 -124.36 152.59 42.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.13 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.7 m -92.2 125.5 36.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.198 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.454 HG13 ' H ' ' A' ' 271' ' ' ASP . 10.9 p -81.48 130.17 36.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.301 0.572 . . . . 0.0 110.521 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 58.6 t -90.53 -38.7 11.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.548 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -160.41 141.47 12.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.202 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 90.4 t -94.38 107.56 19.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 27.3 t -77.41 -59.17 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.873 -172.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -120.21 -7.58 9.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.384 0.611 . . . . 0.0 111.116 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 79.27 14.18 81.93 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.316 -174.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 25.6 p -137.18 7.55 2.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.155 0.979 . . . . 0.0 108.525 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.557 ' NE2' ' HB ' ' A' ' 258' ' ' THR . 3.5 t-160 -160.88 118.96 2.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.392 -170.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -118.73 155.49 20.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -115.04 115.01 26.14 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 256' ' ' PHE . 25.4 pt -114.2 176.72 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.711 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 5.2 t -154.17 141.53 13.59 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.674 174.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.09 -179.9 28.35 Favored 'Cis proline' 0 C--N 1.346 0.4 0 C-N-CA 123.818 -1.326 . . . . 0.0 112.568 -4.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -81.18 126.11 77.75 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.857 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.49 109.13 2.78 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.43 2.087 . . . . 0.0 111.887 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.524 HG22 ' HA ' ' A' ' 328' ' ' ALA . 0.4 OUTLIER -126.56 134.16 66.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.694 178.425 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -91.85 135.29 34.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.72 -173.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.3 tm? -70.55 -30.24 66.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.834 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -86.2 11.13 12.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.186 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.52 121.91 25.19 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 31.1 m -83.54 1.81 3.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -174.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.2 t -102.56 -6.5 22.76 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.424 -174.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.4 pp -102.82 153.77 19.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.49 0.662 . . . . 0.0 111.684 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 14.8 m -87.51 160.95 46.78 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.004 -177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -39.14 -50.49 2.72 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.923 3.082 . . . . 0.0 114.612 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -58.09 -41.17 82.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.255 0.55 . . . . 0.0 111.333 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 47.9 mt-30 -70.48 -26.31 63.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.711 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -61.04 -35.43 76.89 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 121.018 0.437 . . . . 0.0 110.445 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.89 -28.88 67.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.431 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . 0.445 ' CD2' ' HA ' ' A' ' 324' ' ' GLN . 12.0 m-85 -81.71 -11.05 59.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.824 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' A' ' 313' ' ' VAL . . . -65.59 139.01 58.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.991 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -127.62 -17.07 4.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.882 -175.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 31.5 m -122.11 158.23 25.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.929 0.395 . . . . 0.0 110.113 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -91.16 -7.01 52.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.307 -174.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.7 t -147.72 140.98 25.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.096 0.474 . . . . 0.0 110.824 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 26.9 p -78.28 168.05 20.42 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.316 175.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 19.3 tp -74.11 105.42 5.32 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.628 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -79.82 -178.8 6.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.055 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.06 -7.1 57.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.973 -172.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -133.74 57.83 1.79 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.849 0.357 . . . . 0.0 111.736 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 25.2 mmt -111.78 137.46 49.67 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -92.25 145.46 24.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.778 0.323 . . . . 0.0 111.047 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 19.3 t -118.69 118.2 57.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.866 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -134.73 135.75 42.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.99 0.424 . . . . 0.0 111.557 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 21.1 mt -87.62 127.46 40.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.813 176.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.05 176.303 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.552 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 34.2 p . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 55.65 48.94 68.05 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.834 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 263' ' ' ALA . 57.2 mt -103.07 142.54 16.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 37.1 p -97.82 150.12 21.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.408 0.623 . . . . 0.0 112.261 -173.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.522 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.2 p -61.53 150.93 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.599 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 37.0 m -126.05 84.94 2.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.152 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 113.0 130.56 5.32 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.477 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -79.37 123.43 27.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -142.22 130.33 22.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.223 0.535 . . . . 0.0 111.474 -172.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.9 t -107.98 110.46 22.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.281 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.518 ' O ' HG13 ' A' ' 313' ' ' VAL . 62.4 m-85 -81.05 120.13 24.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.507 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -115.27 127.42 26.83 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.696 -175.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo . . . . . 0 N--CA 1.46 -0.464 0 C-N-CA 122.895 2.396 . . . . 0.0 111.265 173.563 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.438 ' CD2' ' HB ' ' A' ' 309' ' ' THR . 96.7 m-85 . . . . . 0 N--CA 1.456 -0.136 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -136.01 129.31 31.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.479 0.18 . . . . 0.0 110.785 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.5 m -97.88 107.64 20.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.05 0.452 . . . . 0.0 109.984 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.41 120.27 36.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.205 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 60.4 m -91.01 115.33 27.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.823 173.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 17.2 mt -132.24 168.86 17.31 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 5.3 p -60.52 -55.96 27.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.196 0.522 . . . . 0.0 110.136 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -136.75 136.81 39.26 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.146 177.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 15.8 p -132.11 32.75 3.97 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 6.9 m -82.47 149.25 27.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.308 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 93.51 13.37 55.64 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 62.7 mtt -114.02 148.0 37.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.367 -0.417 . . . . 0.0 110.141 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -134.41 156.33 48.73 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -54.15 121.96 9.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.074 0.464 . . . . 0.0 110.762 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 106.75 7.97 33.01 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.862 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.447 ' H ' HG12 ' A' ' 297' ' ' VAL . 80.1 m-20 -90.79 148.54 22.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.419 0.609 . . . . 0.0 110.16 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 4.6 tppp? -96.03 117.67 31.13 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.725 -177.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 38.5 pt -112.58 139.96 34.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 176.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 45.5 m -120.5 136.48 54.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.516 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -100.7 111.46 23.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.871 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -74.15 114.21 12.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.709 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.55 -34.39 5.17 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 86.0 t -90.95 111.71 24.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.503 ' HZ1' ' HB3' ' A' ' 279' ' ' LYS . 0.5 OUTLIER -128.85 170.07 13.82 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.406 -177.109 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -75.95 171.73 13.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.644 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.105 177.881 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -59.18 100.33 0.07 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.882 -174.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.0 p -98.99 99.63 10.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.673 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 293' ' ' ALA . 61.3 m-85 -118.23 142.8 47.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.09 0.472 . . . . 0.0 111.139 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.2 t -89.97 126.27 35.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.494 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 271' ' ' ASP . 11.5 p -69.12 135.13 28.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.122 0.487 . . . . 0.0 110.136 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.24 -32.93 4.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.684 -176.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.579 ' HD2' ' OE2' ' A' ' 307' ' ' GLU . 0.4 OUTLIER -167.85 137.07 2.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.255 -176.129 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 75.3 t -85.02 111.38 20.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 19.2 t -77.76 -53.9 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.646 -173.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -125.89 -11.63 6.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.81 0.338 . . . . 0.0 111.812 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 77.6 12.49 84.45 Favored Glycine 0 CA--C 1.516 0.145 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -170.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.0 p -149.9 22.17 0.88 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 174.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -174.04 112.63 0.18 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 113.378 -1.737 . . . . 0.0 107.991 -163.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.0 OUTLIER -119.43 164.05 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -174.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.579 ' OE2' ' HD2' ' A' ' 299' ' ' ARG . 11.4 pt-20 -125.01 127.01 46.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.218 0.532 . . . . 0.0 110.127 170.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 24.0 pt -120.42 175.79 4.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.884 -177.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' THR . . . . . 0.438 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 14.2 t -154.61 143.53 14.84 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.853 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.98 179.4 31.15 Favored 'Cis proline' 0 C--N 1.346 0.406 0 C-N-CA 123.709 -1.371 . . . . 0.0 112.512 -4.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -76.94 121.68 85.16 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.504 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.09 108.54 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.217 1.944 . . . . 0.0 112.327 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 236' ' ' PHE . 0.1 OUTLIER -109.35 137.67 40.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.121 175.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -81.98 123.25 28.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.095 0.474 . . . . 0.0 110.513 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.5 -29.5 70.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.894 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.45 19.65 4.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.495 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -83.47 119.91 25.26 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.9 m -84.43 0.4 5.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -174.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 37.2 t -95.47 -28.16 15.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.566 0.222 . . . . 0.0 111.404 -174.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.64 160.61 25.0 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.413 0.625 . . . . 0.0 112.41 -175.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.553 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 34.4 t -87.04 157.42 54.15 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.146 -178.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.553 ' HD2' ' OG ' ' A' ' 321' ' ' SER . 2.8 Cg_exo -35.61 -58.01 0.47 Allowed 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 124.764 3.643 . . . . 0.0 115.513 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.64 -25.08 64.65 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.376 -174.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 321' ' ' SER . 8.5 mm100 -61.15 -34.48 75.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.038 0.447 . . . . 0.0 110.116 174.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 322' ' ' PRO . 31.1 mtm180 -64.77 -32.67 74.46 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.724 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -70.62 -24.94 62.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.087 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.77 -2.3 57.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.685 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.424 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -67.81 156.27 37.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.066 0.46 . . . . 0.0 111.022 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -138.42 -20.84 1.05 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.292 -173.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 23.4 m -125.28 160.17 31.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.946 0.403 . . . . 0.0 110.399 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -89.16 -17.14 29.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.527 -175.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 8.8 t -143.42 142.89 31.39 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 22.6 p -75.72 170.33 16.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.736 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 17.0 tp -72.34 103.3 3.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.522 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -81.99 -170.88 3.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.19 -176.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -80.32 -8.5 59.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.013 -175.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -137.42 66.97 1.44 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.0 0.429 . . . . 0.0 111.567 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' MET . . . . . 0.466 ' H ' HG13 ' A' ' 230' ' ' VAL . 23.1 mmt -119.86 132.48 55.58 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -91.25 137.16 32.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.839 0.352 . . . . 0.0 111.007 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 32.7 t -114.25 107.2 22.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.239 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . 0.552 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 64.5 t30 -126.35 145.62 50.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.922 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 22.8 mt -89.56 132.37 34.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 177.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 80.8 mt . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.542 176.566 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 120.343 0.116 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.56 39.77 95.46 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.006 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 263' ' ' ALA . 55.7 mt -103.05 145.28 12.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 36.0 p -99.22 160.79 14.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.417 0.627 . . . . 0.0 112.248 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 335' ' ' ALA . 9.7 p -68.88 152.04 9.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.495 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.1 m -122.08 86.77 2.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.949 0.404 . . . . 0.0 110.7 173.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 102.56 137.2 9.47 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.337 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.54 130.27 42.69 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -132.9 127.14 33.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.165 0.507 . . . . 0.0 111.31 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.8 t -117.26 103.12 9.85 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -80.8 129.1 34.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.319 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -117.19 125.75 27.96 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.052 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 N--CA 1.461 -0.438 0 C-N-CA 123.111 2.541 . . . . 0.0 111.639 176.472 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 . . . . . 0 N--CA 1.45 -0.467 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -109.26 124.03 50.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.951 176.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.7 m -97.47 107.14 19.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.225 0.536 . . . . 0.0 110.275 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -89.0 124.86 42.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.603 -170.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 55.6 m -95.18 114.59 26.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.799 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.403 HD11 HG21 ' A' ' 340' ' ' VAL . 17.4 mt -129.87 170.52 13.8 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -176.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 16.8 m -57.31 -56.93 15.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.389 0.614 . . . . 0.0 109.599 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.599 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -138.52 141.02 39.34 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.776 175.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 11.2 p -130.8 26.49 4.98 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.7 m -80.49 147.5 30.86 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.526 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 95.24 -28.11 12.98 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -177.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 62.1 mtt -71.42 153.47 42.25 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -135.53 151.02 49.92 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.807 0.337 . . . . 0.0 110.58 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -56.39 131.8 49.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.204 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.77 19.14 32.53 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.352 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.417 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 1.8 t70 -103.28 -167.51 1.39 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 117.555 0.677 . . . . 0.0 110.159 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.423 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 3.9 tppp? -129.76 115.7 17.67 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.593 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.417 HG21 ' CG1' ' A' ' 342' ' ' ILE . 20.0 pt -115.06 142.76 26.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.134 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 73.5 p -128.85 143.69 50.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.149 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -105.2 114.02 27.95 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.044 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.82 115.98 3.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.828 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.94 -31.15 6.95 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.105 -177.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 292' ' ' ASP . 48.5 t -84.54 136.08 23.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.586 ' HZ1' ' HB3' ' A' ' 279' ' ' LYS . 0.1 OUTLIER -160.76 156.33 25.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.112 0.482 . . . . 0.0 111.413 -177.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.432 ' HA ' ' O ' ' A' ' 329' ' ' ASN . 63.0 m-85 -76.58 148.63 36.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.372 -170.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.427 HD11 ' HB2' ' A' ' 315' ' ' LEU . 59.5 mt . . . . . 0 CA--C 1.519 -0.214 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.461 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 60.3 m-20 . . . . . 0 CA--C 1.518 -0.26 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -57.07 116.07 3.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.636 -174.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 28.1 p -97.81 129.17 44.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.866 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -130.63 143.14 50.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.783 0.325 . . . . 0.0 110.699 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 62.5 m -78.72 126.96 31.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.101 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.452 ' HA ' HG22 ' A' ' 308' ' ' ILE . 13.5 p -84.06 126.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.262 0.553 . . . . 0.0 110.018 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 44.7 t -84.01 -40.85 16.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.379 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -163.29 142.26 8.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.407 ' CG1' ' HA2' ' A' ' 303' ' ' GLY . 89.6 t -82.59 106.95 13.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 26.7 t -72.82 -58.7 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.945 -170.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -119.59 0.48 11.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.94 0.4 . . . . 0.0 111.331 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . 0.407 ' HA2' ' CG1' ' A' ' 300' ' ' VAL . . . 70.81 12.73 71.25 Favored Glycine 0 C--O 1.23 -0.143 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -173.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 19.4 p -149.31 19.72 0.95 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 174.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.529 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.9 t-160 -170.89 115.46 0.44 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 113.737 -1.574 . . . . 0.0 107.976 -164.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.73 165.04 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.494 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -123.86 122.1 37.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.051 0.453 . . . . 0.0 110.264 172.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 297' ' ' VAL . 28.2 pt -124.03 168.55 16.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.102 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 15.1 t -154.57 145.18 16.05 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -72.29 178.13 32.23 Favored 'Cis proline' 0 C--N 1.344 0.337 0 C-N-CA 124.013 -1.245 . . . . 0.0 112.556 0.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -87.39 123.37 69.83 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.743 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . 0.419 ' HA ' ' OD1' ' A' ' 329' ' ' ASN . 48.7 Cg_endo -71.41 108.94 2.49 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.37 2.046 . . . . 0.0 112.091 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.56 132.0 57.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.713 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -83.09 121.92 27.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.081 0.467 . . . . 0.0 110.448 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . 0.427 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.0 tm? -62.99 -30.2 71.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.725 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -86.39 5.12 36.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.393 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -89.91 111.68 22.8 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 17.9 m -83.61 2.4 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 9.4 t -92.95 29.09 1.91 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.027 0.441 . . . . 0.0 110.832 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 2.5 pp -129.06 171.32 12.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.879 0.371 . . . . 0.0 111.467 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 41.7 t -85.96 149.14 49.85 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.105 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.634 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 1.4 Cg_endo -42.27 -47.29 7.19 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.84 3.027 . . . . 0.0 113.885 -177.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.442 ' O ' ' HD1' ' A' ' 327' ' ' TYR . 58.6 mm-40 -63.16 -23.38 67.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.98 0.419 . . . . 0.0 111.456 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -81.27 -24.34 37.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.784 -174.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 5.3 ptp180 -78.28 -22.31 48.43 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.096 0.474 . . . . 0.0 110.04 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -69.15 -36.03 76.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.183 174.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . 0.442 ' HD1' ' O ' ' A' ' 323' ' ' GLU . 77.8 m-85 -90.05 3.05 54.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.839 178.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -70.26 123.94 22.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.03 0.443 . . . . 0.0 110.022 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 280' ' ' PHE . 26.7 p-10 -109.28 -17.92 13.71 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.506 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.3 m -118.85 159.4 19.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.188 0.518 . . . . 0.0 110.798 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -96.84 -12.04 24.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.164 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.4 t -141.02 148.63 40.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.435 -176.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 7.6 p -85.04 166.27 16.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.694 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.608 HD13 ' SD ' ' A' ' 338' ' ' MET . 21.2 tp -67.74 104.4 1.64 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.669 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -84.04 156.82 22.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.772 -175.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.59 58.08 2.15 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.252 0.549 . . . . 0.0 111.942 -173.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -176.04 27.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.494 172.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' MET . . . . . 0.608 ' SD ' HD13 ' A' ' 334' ' ' LEU . 54.4 mtt -100.06 131.83 45.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -176.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -87.64 140.22 29.74 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.924 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.403 HG21 HD11 ' A' ' 261' ' ' LEU . 9.0 t -99.83 113.5 35.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.537 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -122.56 133.4 54.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.404 -175.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.417 ' CG1' HG21 ' A' ' 273' ' ' ILE . 14.6 mt -99.23 130.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.066 0.46 . . . . 0.0 110.798 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 46.3 mt . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.763 -178.82 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.66 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 41.6 p . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 120.394 0.14 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 58.05 43.11 95.26 Favored Glycine 0 C--N 1.329 0.165 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.24 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.48 HG23 ' O ' ' A' ' 263' ' ' ALA . 68.6 mt -90.66 149.46 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 2.3 p -96.8 157.58 15.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.572 0.701 . . . . 0.0 112.428 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 335' ' ' ALA . 6.8 p -76.16 151.35 6.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.499 -176.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 65.0 m -109.63 83.22 1.72 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.025 0.441 . . . . 0.0 110.385 174.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.7 154.75 28.94 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.341 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -73.05 124.91 26.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.966 0.412 . . . . 0.0 111.008 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -113.25 128.56 56.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.059 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 12.8 t -131.16 119.83 22.45 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.411 ' O ' ' HD3' ' A' ' 237' ' ' LYS . 88.2 m-85 -104.08 143.06 33.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.743 -175.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.411 ' HD3' ' O ' ' A' ' 236' ' ' PHE . 44.7 mmtm -129.41 138.66 33.65 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.631 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.4 ' HD3' ' CG2' ' A' ' 313' ' ' VAL . 82.9 Cg_endo . . . . . 0 N--CA 1.455 -0.764 0 C-N-CA 123.035 2.49 . . . . 0.0 112.166 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.454 ' CD1' ' HB ' ' A' ' 309' ' ' THR . 75.1 m-85 . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 120.935 0.398 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -114.59 121.89 44.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.618 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -89.43 106.38 18.41 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.748 177.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -86.04 118.13 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.402 -172.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 23.2 m -89.32 105.92 18.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.895 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 20.4 mt -122.07 172.08 8.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.735 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 42.2 m -64.57 -53.42 48.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.108 0.48 . . . . 0.0 109.783 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.48 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -137.57 142.93 41.32 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 18.2 p -134.07 30.0 3.68 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.3 m -81.26 134.63 35.63 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.956 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.7 -26.25 14.87 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -176.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -70.67 151.3 45.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -136.38 164.33 28.38 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -64.44 144.66 57.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.694 0.283 . . . . 0.0 110.676 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 77.8 19.02 76.29 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.742 173.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.476 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 1.7 t70 -100.68 -167.1 1.39 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 117.779 0.79 . . . . 0.0 109.907 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.443 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 13.1 tppt? -125.04 115.16 20.09 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.502 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.453 HD13 HG22 ' A' ' 308' ' ' ILE . 32.0 pt -116.93 139.31 44.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.677 177.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 50.1 p -118.9 138.4 52.78 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.559 -178.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -103.23 111.56 24.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.519 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.63 132.37 53.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.688 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 93.45 -34.71 4.46 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 56.4 t -86.0 146.04 6.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.506 ' NZ ' ' HB3' ' A' ' 279' ' ' LYS . 0.0 OUTLIER -162.22 162.21 28.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.75 0.31 . . . . 0.0 111.059 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 96.2 m-85 -73.59 170.3 15.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.63 -174.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.483 178.725 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.448 ' HA ' ' NZ ' ' A' ' 279' ' ' LYS . 64.7 m-20 . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.788 0.328 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -70.46 104.27 2.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.649 -174.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 14.0 p -92.14 103.29 15.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.033 177.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -102.72 154.83 18.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.149 0.5 . . . . 0.0 111.277 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.4 m -89.99 120.89 31.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.088 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.476 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 14.2 p -84.19 139.45 17.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.466 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.2 t -105.76 -42.18 6.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.241 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -156.51 133.74 10.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.027 0.442 . . . . 0.0 111.659 -175.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 87.2 t -81.85 99.47 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 169.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.7 t -70.65 -58.47 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.917 -171.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -120.26 -0.66 10.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.719 0.295 . . . . 0.0 111.576 -174.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 69.31 12.58 66.32 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -172.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 26.6 p -147.4 19.99 1.2 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.524 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 7.1 t-160 -172.74 115.82 0.3 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.194 -164.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.52 166.75 13.62 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -176.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -123.86 126.56 46.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.084 0.469 . . . . 0.0 109.994 169.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.453 HG22 HD13 ' A' ' 273' ' ' ILE . 30.3 pt -123.12 170.04 13.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.997 -177.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' THR . . . . . 0.454 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 13.5 t -154.52 145.12 16.03 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 309' ' ' THR . 58.4 Cg_endo -70.2 176.08 35.36 Favored 'Cis proline' 0 C--N 1.347 0.48 0 C-N-CA 123.835 -1.319 . . . . 0.0 112.879 1.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.423 ' O ' HG22 ' A' ' 313' ' ' VAL . 40.5 tttt -77.14 119.88 79.33 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.807 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.14 107.13 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.157 1.905 . . . . 0.0 111.676 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 328' ' ' ALA . 55.5 t -121.29 119.81 60.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.037 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -85.86 128.53 34.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.073 0.463 . . . . 0.0 111.101 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -70.16 -30.39 67.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.246 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -89.0 23.19 2.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.0 0.429 . . . . 0.0 111.25 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 314' ' ' ALA . 14.6 t70 -100.52 137.49 38.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 30.1 m -84.29 -15.56 11.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 13.1 m -91.03 34.89 0.91 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.016 0.436 . . . . 0.0 111.485 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.486 ' HA ' ' NE2' ' A' ' 324' ' ' GLN . 1.9 pp -126.95 164.18 22.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.092 0.472 . . . . 0.0 111.449 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 65.4 p -99.89 168.59 9.25 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.768 176.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.494 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 86.8 Cg_exo -49.35 -36.07 37.14 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.306 2.004 . . . . 0.0 111.818 172.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.82 -46.3 65.96 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.818 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . 0.486 ' NE2' ' HA ' ' A' ' 320' ' ' LEU . 26.5 mt-30 -69.65 -28.51 65.94 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -175.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.494 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 30.2 ptt180 -72.05 -21.69 61.49 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.324 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -73.4 -27.84 61.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.202 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -94.24 7.97 43.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.82 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.519 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -57.92 142.11 47.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.825 176.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -124.22 -30.02 3.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.2 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 27.7 m -122.4 160.11 24.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.871 0.367 . . . . 0.0 110.293 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -89.04 -20.89 23.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.071 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.1 t -141.6 141.88 33.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.994 0.426 . . . . 0.0 110.481 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 34.8 p -70.27 161.65 29.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.87 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.408 HD23 HG23 ' A' ' 230' ' ' VAL . 48.0 tp -69.47 103.41 2.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.544 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -82.93 170.42 14.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.841 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . 0.407 ' HA ' ' CG1' ' A' ' 230' ' ' VAL . 29.1 t70 -72.26 151.86 42.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.496 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 68.18 39.75 2.3 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.998 0.811 . . . . 0.0 111.608 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 19.9 mmt -110.19 144.42 38.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 176.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.19 138.3 33.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.031 0.443 . . . . 0.0 111.316 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 23.9 t -113.73 110.73 33.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.444 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . 0.66 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 60.5 t30 -130.49 145.16 51.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.936 0.398 . . . . 0.0 111.484 -175.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.404 ' CG1' HG22 ' A' ' 273' ' ' ILE . 61.0 mt -88.06 116.41 29.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.057 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 63.9 mt . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.182 -176.75 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 C--O 1.234 0.27 0 CA-C-O 120.362 0.125 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 63.25 53.1 42.1 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.283 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.493 HD12 ' O ' ' A' ' 263' ' ' ALA . 29.1 mm -102.21 143.02 15.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 20.7 p -131.49 170.21 15.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.087 0.47 . . . . 0.0 110.305 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 335' ' ' ALA . 8.2 p -78.98 150.39 5.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.56 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.7 t -107.03 75.15 1.02 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.193 0.52 . . . . 0.0 109.654 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.83 155.06 29.57 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.042 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -78.01 141.6 38.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.925 0.393 . . . . 0.0 111.208 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -149.54 137.14 20.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.41 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.5 t -110.08 142.04 42.1 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 312' ' ' PRO . 92.5 m-85 -102.64 156.79 17.39 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . 46.9 mmtm -138.34 130.36 15.92 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.657 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 237' ' ' LYS . 22.2 Cg_exo . . . . . 0 C--N 1.344 0.325 0 C-N-CA 122.677 2.252 . . . . 0.0 111.335 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 308' ' ' ILE . 60.5 m-85 . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.746 0.308 . . . . 0.0 110.653 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -120.34 134.37 55.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.735 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -93.91 105.21 17.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.283 0.564 . . . . 0.0 111.231 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.6 t -88.39 122.04 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.056 -175.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 11.9 m -96.51 106.04 18.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.254 0.55 . . . . 0.0 110.053 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.455 ' HB2' HG23 ' A' ' 264' ' ' THR . 22.5 mt -122.18 167.26 13.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.574 -173.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 26.3 p -60.14 -52.42 65.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.529 0.68 . . . . 0.0 109.71 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.493 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.28 132.59 35.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.316 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.455 HG23 ' HB2' ' A' ' 261' ' ' LEU . 7.7 p -128.9 15.29 6.36 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.214 174.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 25.2 m -83.4 144.78 29.39 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.742 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.74 0.73 57.62 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 71.9 mtm -123.22 153.3 40.31 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -142.07 178.99 7.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -63.43 142.22 58.47 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 123.201 0.313 . . . . 0.0 110.545 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 93.52 19.8 34.0 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.688 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.452 ' O ' HG11 ' A' ' 297' ' ' VAL . 7.4 m-20 -116.85 164.78 14.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.546 0.673 . . . . 0.0 111.288 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -106.24 115.94 31.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.336 -177.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.44 HD13 ' CG2' ' A' ' 308' ' ' ILE . 15.6 pt -115.31 140.28 37.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.476 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 54.1 p -128.15 141.06 51.59 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.373 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -100.21 112.64 24.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.051 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.32 120.05 9.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.472 -175.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.49 -35.84 4.75 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.597 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 49.7 t -77.84 124.68 36.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -142.97 161.5 37.94 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.791 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -84.93 142.02 29.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.378 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 79.7 mt . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.112 176.505 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -60.01 98.86 0.06 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.527 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 38.6 p -79.98 124.03 28.34 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.626 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -124.54 146.78 48.81 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.234 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.8 m -86.19 118.29 25.55 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.151 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.452 HG11 ' O ' ' A' ' 271' ' ' ASP . 11.7 p -73.8 123.44 28.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.414 0.626 . . . . 0.0 110.095 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.4 t -94.29 -38.22 9.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.599 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -164.81 133.6 3.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.499 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 79.9 t -90.14 100.89 11.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 167.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.63 -59.4 3.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.737 -172.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -98.67 -12.72 20.76 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.633 -170.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 74.13 13.1 81.4 Favored Glycine 0 CA--C 1.517 0.196 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.08 23.35 0.5 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 171.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.517 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 3.7 t-160 -170.67 115.33 0.46 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 113.813 -1.539 . . . . 0.0 107.533 -171.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.7 155.68 20.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -173.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.1 pt-20 -112.02 121.72 45.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.321 0.581 . . . . 0.0 110.128 172.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 256' ' ' PHE . 29.8 pt -118.19 169.37 8.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.968 -177.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.1 t -145.48 140.47 15.92 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.63 -179.24 26.53 Favored 'Cis proline' 0 C--N 1.345 0.374 0 C-N-CA 123.684 -1.382 . . . . 0.0 112.753 -2.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -75.29 124.12 89.03 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.786 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . 0.422 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 14.1 Cg_exo -68.52 108.24 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.408 2.072 . . . . 0.0 111.99 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.517 HG23 ' HA ' ' A' ' 328' ' ' ALA . 1.2 m -128.21 132.95 67.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.355 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.507 ' O ' HD22 ' A' ' 320' ' ' LEU . . . -95.22 135.71 36.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.906 -172.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.9 tm? -74.19 -24.1 59.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.547 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -82.25 -2.04 51.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.151 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -77.84 113.31 15.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.6 m -82.98 2.59 3.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.972 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 40.1 m -95.2 -27.61 15.44 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -175.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.507 HD22 ' O ' ' A' ' 314' ' ' ALA . 1.3 pp -79.1 152.74 30.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.56 0.695 . . . . 0.0 111.764 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.462 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.3 m -81.33 167.42 31.9 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.74 -173.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.515 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 78.2 Cg_exo -44.81 -52.26 6.4 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.528 2.819 . . . . 0.0 114.183 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -67.22 -30.98 71.05 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.897 -0.502 . . . . 0.0 111.003 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -71.36 -33.78 69.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.433 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 18.0 ptp180 -77.37 -14.98 59.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.214 0.53 . . . . 0.0 110.6 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -72.41 -30.8 64.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.122 171.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -85.93 -7.97 58.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.553 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.517 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -65.09 115.37 5.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.047 0.451 . . . . 0.0 110.908 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -104.13 -28.17 11.63 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.49 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 30.2 m -108.32 165.33 4.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.027 0.441 . . . . 0.0 111.355 -175.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -83.54 -40.08 19.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.438 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.8 t -128.79 144.98 51.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.169 0.509 . . . . 0.0 111.007 -176.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 13.5 p -77.76 173.96 11.52 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.428 174.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 14.5 tp -76.71 105.06 7.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.103 0.478 . . . . 0.0 110.179 -175.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.588 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -80.35 -178.6 6.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.413 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -82.54 -1.13 49.67 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -171.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -139.78 64.95 1.44 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.141 0.496 . . . . 0.0 111.281 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.9 mmt -116.12 130.74 56.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.538 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -84.02 144.16 29.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.997 0.427 . . . . 0.0 111.016 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 21.5 t -113.86 115.4 49.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.481 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -131.58 138.99 49.09 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.799 -176.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 26.7 mt -87.62 125.22 41.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.653 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 49.1 mt . . . . . 0 C--N 1.322 -0.599 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.335 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 25.6 p . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 111.397 0.147 . . . . 0.0 111.397 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 61.96 35.27 91.15 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.506 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 263' ' ' ALA . 53.7 mt -79.88 153.05 4.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 19.6 p -97.2 143.97 27.48 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.612 0.72 . . . . 0.0 112.495 -173.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.611 HG12 ' O ' ' A' ' 335' ' ' ALA . 4.4 p -61.02 151.9 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.024 177.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 7.6 t -110.52 74.56 0.88 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 0.0 110.001 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 98.39 165.22 30.88 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.052 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -87.98 125.79 34.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.802 0.334 . . . . 0.0 110.442 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -120.39 127.04 51.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.04 0.448 . . . . 0.0 111.01 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 38.4 m -104.86 120.78 42.25 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.635 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.442 ' O ' HG13 ' A' ' 313' ' ' VAL . 93.3 m-85 -100.21 122.38 42.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.657 -176.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.416 ' HE2' HD23 ' A' ' 320' ' ' LEU . 32.4 mmtp -124.85 128.28 24.92 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.208 -178.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo . . . . . 0 N--CA 1.463 -0.296 0 C-N-CA 123.091 2.527 . . . . 0.0 111.855 177.503 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.401 ' CD1' ' HB ' ' A' ' 309' ' ' THR . 97.8 m-85 . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 121.073 0.463 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.413 ' HB2' ' HA ' ' A' ' 311' ' ' LYS . . . -146.19 113.79 6.38 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.065 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.3 m -86.4 104.07 15.55 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.338 0.59 . . . . 0.0 110.208 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.1 t -82.83 118.17 30.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.358 -172.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 21.8 m -86.97 105.24 16.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.212 0.529 . . . . 0.0 110.239 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.416 ' HB2' HG22 ' A' ' 264' ' ' THR . 19.5 mt -122.76 161.36 24.1 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.2 m -58.86 -50.5 73.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.255 0.55 . . . . 0.0 109.587 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.543 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -137.89 144.23 41.24 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.416 HG22 ' HB2' ' A' ' 261' ' ' LEU . 16.0 p -131.31 26.59 4.82 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.135 0.969 . . . . 0.0 108.514 174.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 24.9 m -74.57 135.88 42.09 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.972 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 103.34 -12.91 54.96 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -176.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 55.7 mtt -96.41 138.79 33.49 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.589 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 6.6 ptpp? -130.88 156.93 44.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -55.93 114.39 1.9 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.945 0.402 . . . . 0.0 110.623 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 110.83 18.57 8.29 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.487 -176.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.589 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 9.6 m-20 -105.14 158.36 16.63 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 117.039 0.419 . . . . 0.0 110.766 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 15.0 tppt? -103.7 116.32 32.11 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.647 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 30.3 pt -112.74 139.56 37.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.189 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 4.1 m -124.45 130.57 52.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.445 -176.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -94.53 111.88 23.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.447 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.84 116.71 9.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.838 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 107.76 -11.78 38.45 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 39.2 t -111.81 128.9 68.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -135.99 157.97 45.55 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.429 ' HE1' ' CZ ' ' A' ' 295' ' ' PHE . 50.0 m-85 -73.45 165.02 25.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.775 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 C--N 1.327 -0.399 0 CA-C-O 121.221 0.534 . . . . 0.0 110.127 178.286 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 . . . . . 0 C--O 1.233 0.185 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -69.29 76.23 0.37 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.158 0.504 . . . . 0.0 111.117 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.414 HG22 ' OG ' ' A' ' 274' ' ' SER . 65.6 p -86.78 105.18 16.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.411 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 312' ' ' PRO . 61.8 m-85 -115.46 143.72 44.89 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.023 0.439 . . . . 0.0 111.035 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.7 m -86.8 124.58 33.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.957 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 271' ' ' ASP . 8.3 p -83.1 136.06 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.038 0.447 . . . . 0.0 110.239 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 37.8 t -101.61 -29.5 3.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.948 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -163.81 142.04 7.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.582 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 78.8 t -98.14 117.62 43.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 38.9 t -77.89 -58.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.92 -172.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -121.21 2.29 10.33 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -173.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 70.45 13.34 70.88 Favored Glycine 0 CA--C 1.518 0.25 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.9 p -146.41 18.04 1.34 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.421 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.8 t-160 -171.07 113.99 0.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.778 -169.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.35 161.97 16.83 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -173.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -120.78 121.24 37.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.36 0.6 . . . . 0.0 110.739 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 23.3 pt -112.76 174.57 2.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.415 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' THR . . . . . 0.401 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 13.2 t -152.13 141.27 14.13 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.99 -179.79 26.24 Favored 'Cis proline' 0 C--N 1.345 0.349 0 C-N-CA 123.681 -1.383 . . . . 0.0 112.411 0.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.422 ' CG ' ' HB3' ' A' ' 236' ' ' PHE . 23.3 ttmm -74.56 123.12 88.87 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.286 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 295' ' ' PHE . 56.9 Cg_endo -74.46 108.42 2.68 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.115 1.876 . . . . 0.0 112.045 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.527 ' HB ' ' HA ' ' A' ' 328' ' ' ALA . 0.2 OUTLIER -106.54 132.71 53.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.216 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -78.95 116.84 19.52 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 123.53 0.519 . . . . 0.0 110.827 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.0 tm? -64.71 -29.67 70.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.31 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -91.77 15.53 12.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.854 -177.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -90.57 127.26 36.2 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 9.6 p -82.98 -12.53 12.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.989 0.423 . . . . 0.0 111.376 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 5.3 m -93.13 33.71 1.17 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.118 0.485 . . . . 0.0 111.32 -173.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.416 HD23 ' HE2' ' A' ' 237' ' ' LYS . 2.0 pp -132.78 170.91 14.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.745 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 23.3 m -106.23 159.61 29.11 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.341 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -39.97 -48.24 3.79 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.581 2.854 . . . . 0.0 113.913 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -56.28 -41.05 75.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.094 0.473 . . . . 0.0 111.343 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -72.1 -37.67 69.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.777 -175.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -77.05 -16.09 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.936 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -69.22 -30.75 68.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.478 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -96.16 -0.88 49.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.153 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.527 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -61.75 151.24 34.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.19 0.519 . . . . 0.0 111.546 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -138.43 -28.01 0.85 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.141 -171.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 23.4 m -113.89 162.16 12.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -92.51 -14.21 28.72 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.279 -176.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 11.9 t -147.62 148.5 31.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.768 0.318 . . . . 0.0 110.324 -177.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 46.0 m -77.78 158.63 29.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.575 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 41.1 tp -71.31 103.21 2.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.611 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -85.55 -179.24 6.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.407 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . 0.455 ' HA ' ' CG1' ' A' ' 230' ' ' VAL . 33.2 t70 -77.83 159.79 28.74 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.14 -0.224 . . . . 0.0 110.409 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 65.1 40.9 4.82 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.91 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' MET . . . . . 0.48 ' H ' HG11 ' A' ' 230' ' ' VAL . 25.2 mmt -110.28 140.32 44.56 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 176.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -92.21 135.25 34.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.989 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 14.0 t -114.26 105.01 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.902 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . 0.441 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 64.1 t30 -118.77 150.31 40.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.705 0.288 . . . . 0.0 111.003 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 69.3 mt -95.91 123.67 48.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.643 177.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 60.2 mt . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.394 176.314 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.479 ' HG1' ' ND2' ' A' ' 341' ' ' ASN . 17.4 p . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 111.536 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -85.09 57.47 4.99 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 339' ' ' ALA . 31.9 mm -85.78 142.93 12.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 122.282 0.233 . . . . 0.0 110.808 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 12.3 p -118.84 143.22 47.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.089 0.471 . . . . 0.0 110.467 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 335' ' ' ALA . 9.9 p -59.5 149.39 6.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.75 -178.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 25.9 t -113.07 77.91 1.09 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 177.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 90.37 141.71 9.25 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.993 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.68 140.9 55.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.764 0.316 . . . . 0.0 110.927 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -144.76 132.87 21.54 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.544 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.1 t -116.92 114.12 23.4 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 175.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.447 ' O ' HG21 ' A' ' 313' ' ' VAL . 71.5 m-85 -81.15 133.0 35.39 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.343 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -124.09 134.99 25.84 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo . . . . . 0 N--CA 1.459 -0.519 0 C-N-CA 122.757 2.305 . . . . 0.0 111.831 178.272 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 C--O 1.225 -0.236 0 CA-C-O 120.827 0.346 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -146.18 123.37 11.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.677 0.275 . . . . 0.0 110.74 177.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.1 m -94.55 101.45 13.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.892 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.7 t -86.18 120.46 36.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.234 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 30.3 m -92.9 109.73 21.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.917 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 19.2 mt -126.49 171.0 11.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.023 -175.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 16.6 p -62.07 -55.59 27.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.412 0.625 . . . . 0.0 109.77 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -136.85 139.05 41.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.785 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.4 p -131.38 27.55 4.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.793 0.806 . . . . 0.0 109.138 175.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 48.8 m -76.88 140.46 40.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.639 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 101.77 -2.25 52.49 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -173.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 63.3 mtt -108.03 137.27 46.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.813 -0.694 . . . . 0.0 109.299 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -155.0 141.69 18.95 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.501 ' HA ' HG12 ' A' ' 297' ' ' VAL . 29.1 ptt180 -39.34 119.24 0.9 Allowed 'General case' 0 N--CA 1.469 0.51 0 O-C-N 124.01 0.819 . . . . 0.0 112.694 -173.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 116.0 -9.26 18.47 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.564 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.459 ' H ' HG13 ' A' ' 297' ' ' VAL . 2.1 p30 -87.17 -174.82 5.06 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 117.523 0.662 . . . . 0.0 111.307 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 296' ' ' SER . 4.2 tmmm? -140.99 118.45 11.49 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.11 -177.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 34.3 pt -110.55 140.77 28.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.149 0.5 . . . . 0.0 110.095 -177.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 15.0 m -126.35 132.38 51.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.365 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -94.5 111.19 22.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.431 -176.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.7 116.75 7.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.722 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.38 -34.15 5.31 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 98.1 t -94.24 118.82 41.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.493 ' HB3' ' HZ2' ' A' ' 279' ' ' LYS . 0.4 OUTLIER -135.75 171.91 13.78 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.389 -178.093 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -74.66 172.92 11.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.189 -173.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.191 179.939 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.609 ' HB3' ' CE2' ' A' ' 295' ' ' PHE . . . -54.41 98.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.918 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.4 p -91.48 99.1 12.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.052 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.609 ' CE2' ' HB3' ' A' ' 293' ' ' ALA . 43.1 m-85 -118.61 138.63 52.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.919 0.39 . . . . 0.0 110.925 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 272' ' ' LYS . 28.1 t -85.4 138.43 32.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.898 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 269' ' ' ARG . 4.3 p -71.67 137.27 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.966 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.25 -42.18 9.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.939 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -165.1 142.14 5.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.773 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 99.0 t -103.13 119.16 51.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 171.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.07 -58.71 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.01 -174.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -121.6 -9.41 8.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.337 0.589 . . . . 0.0 111.651 -173.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.62 13.98 76.94 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.309 -172.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 55.2 p -140.06 12.14 2.42 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 171.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -163.03 116.05 1.59 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.457 -167.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.41 165.01 15.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 121.194 -0.202 . . . . 0.0 110.577 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 8.0 pt-20 -128.09 123.09 33.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.076 0.465 . . . . 0.0 109.77 170.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.401 HG23 ' HA ' ' A' ' 297' ' ' VAL . 26.6 pt -121.67 176.86 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.314 -175.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.5 t -154.11 144.22 15.59 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.018 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.73 179.37 31.15 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 123.414 -1.494 . . . . 0.0 112.606 -4.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -77.39 121.1 83.94 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.873 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . 0.431 ' HG2' ' CD2' ' A' ' 236' ' ' PHE . 30.5 Cg_endo -68.83 108.38 1.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.067 1.845 . . . . 0.0 111.934 174.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.529 ' HB ' ' HA ' ' A' ' 328' ' ' ALA . 85.8 t -118.02 130.65 72.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.317 178.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -90.42 131.9 35.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.194 0.521 . . . . 0.0 111.459 -176.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.3 tm? -69.46 -29.08 66.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.719 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -97.63 15.17 24.23 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -83.8 128.3 34.43 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.82 0.21 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 18.0 m -105.49 30.84 5.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.224 -0.298 . . . . 0.0 111.757 -174.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 1.7 pp -128.34 159.57 34.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.271 0.557 . . . . 0.0 111.879 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 2.7 t -91.53 152.75 43.82 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.854 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.535 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 50.1 Cg_exo -38.44 -47.99 2.48 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.978 3.118 . . . . 0.0 114.943 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -64.38 -33.58 76.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.828 0.347 . . . . 0.0 111.922 -176.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -68.06 -36.5 79.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.875 0.369 . . . . 0.0 111.243 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 7.4 ptm180 -78.76 -11.16 59.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.315 0.579 . . . . 0.0 110.366 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -74.73 -22.77 58.63 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.617 171.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -99.89 6.19 45.3 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.525 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.529 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -53.61 144.52 17.35 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.648 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -128.63 -34.69 1.98 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.032 -177.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.9 m -113.82 155.27 15.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.364 -178.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -90.97 -8.34 49.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.24 0.543 . . . . 0.0 110.809 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.4 t -148.3 141.28 24.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.881 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 24.1 m -75.38 166.18 24.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.898 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 26.2 tp -71.16 102.97 2.63 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.624 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -93.19 -172.9 3.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -74.35 160.83 30.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.776 0.322 . . . . 0.0 110.427 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 61.18 32.84 19.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.44 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 25.5 mmt -102.48 126.89 49.67 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 228' ' ' ILE . . . -84.47 129.91 34.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.096 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.402 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 16.1 t -104.18 108.42 24.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . 0.479 ' ND2' ' HG1' ' A' ' 226' ' ' THR . 26.1 t-20 -134.11 142.19 47.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.818 0.342 . . . . 0.0 111.908 -171.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 58.5 mt -87.96 127.0 41.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.76 175.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 57.8 mt . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.902 177.489 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 38.9 p . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 110.652 -0.129 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 54.4 56.75 20.28 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.247 -0.502 . . . . 0.0 112.832 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 263' ' ' ALA . 51.1 mt -103.24 150.05 6.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 14.6 p -97.58 153.7 18.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.535 0.683 . . . . 0.0 112.082 -177.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 338' ' ' MET . 7.8 p -65.93 150.4 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.025 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 10.2 t -102.32 66.89 1.01 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.76 158.37 31.87 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.211 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.22 132.54 53.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.017 0.437 . . . . 0.0 111.681 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.571 ' NE2' ' HB ' ' A' ' 260' ' ' THR . 83.6 mm-40 -120.66 127.37 52.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.293 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 11.2 p -129.86 144.77 51.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.14 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -133.81 158.98 41.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.47 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -139.81 126.91 12.61 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.886 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.461 -0.419 0 C-N-CA 122.877 2.385 . . . . 0.0 111.641 175.771 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.459 ' HA ' ' O ' ' A' ' 308' ' ' ILE . 52.0 m-85 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.998 0.428 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -106.49 120.72 42.65 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.171 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.8 m -87.35 97.45 10.81 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.128 0.489 . . . . 0.0 110.899 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.5 t -83.91 125.39 40.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.546 -173.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' THR . . . . . 0.571 ' HB ' ' NE2' ' A' ' 234' ' ' GLN . 13.3 m -97.53 106.97 19.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.187 0.518 . . . . 0.0 109.853 175.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.456 ' HB2' HG22 ' A' ' 264' ' ' THR . 17.4 mt -121.2 163.02 19.15 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -177.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.1 t -56.75 -51.88 67.16 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -137.88 136.95 37.59 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.456 HG22 ' HB2' ' A' ' 261' ' ' LEU . 17.5 p -125.25 24.13 7.47 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 122.005 0.907 . . . . 0.0 108.922 175.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 10.4 m -77.71 145.4 36.6 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.301 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 96.83 -15.9 61.88 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -174.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' MET . . . . . 0.466 ' O ' HG22 ' A' ' 300' ' ' VAL . 54.1 mtt -92.28 132.84 36.37 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -129.75 149.73 51.37 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -49.71 114.07 0.98 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.548 0.69 . . . . 0.0 110.851 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 107.64 11.15 25.58 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.56 -0.745 . . . . 0.0 113.024 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -98.25 147.6 24.46 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 117.757 0.778 . . . . 0.0 110.991 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -94.63 117.53 30.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.334 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 22.7 pt -112.41 139.58 36.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.003 0.43 . . . . 0.0 110.238 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.417 ' HB3' HG21 ' A' ' 294' ' ' THR . 77.9 p -112.61 137.95 50.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.306 -177.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -105.89 119.95 40.49 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.368 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -63.3 136.27 57.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.892 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 81.95 -35.36 2.54 Favored Glycine 0 N--CA 1.454 -0.109 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.667 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 52.3 t -82.36 105.15 11.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.486 ' HB3' ' HZ3' ' A' ' 279' ' ' LYS . 0.5 OUTLIER -128.88 165.02 21.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.968 0.413 . . . . 0.0 111.46 -176.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.541 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 70.8 m-85 -79.26 144.75 34.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.3 -176.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.523 175.846 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 47.7 m-20 . . . . . 0 CA--C 1.518 -0.275 0 CA-C-O 120.735 0.303 . . . . 0.0 110.335 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.551 ' HB3' ' CE2' ' A' ' 295' ' ' PHE . . . -67.62 97.7 0.63 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.57 -175.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.417 HG21 ' HB3' ' A' ' 274' ' ' SER . 30.3 p -100.38 105.0 16.46 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.285 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.551 ' CE2' ' HB3' ' A' ' 293' ' ' ALA . 68.2 m-85 -112.62 145.87 39.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.937 0.399 . . . . 0.0 110.95 -178.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 50.1 m -86.08 124.91 33.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.324 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 11.2 p -69.85 132.61 32.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.062 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.74 -33.94 4.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.951 0.405 . . . . 0.0 110.419 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -157.99 133.46 8.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.071 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 267' ' ' MET . 96.7 t -91.48 101.35 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.6 t -73.77 -59.06 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.686 -171.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -109.39 -11.44 14.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.001 0.429 . . . . 0.0 111.691 -174.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.79 12.98 83.49 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -170.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 5.2 p -147.55 18.09 1.17 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 173.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.468 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.7 t-160 -169.64 114.7 0.54 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.207 -167.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.31 167.91 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -174.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -126.18 119.72 28.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.257 0.551 . . . . 0.0 109.958 169.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 256' ' ' PHE . 27.1 pt -113.99 171.21 4.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.705 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 12.6 t -153.52 145.51 16.93 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.84 179.29 30.99 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.498 -1.459 . . . . 0.0 112.933 -2.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -82.64 121.1 77.75 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.913 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.85 113.28 3.24 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.798 2.332 . . . . 0.0 112.912 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' A' ' 328' ' ' ALA . 0.1 OUTLIER -114.38 139.52 39.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.818 173.915 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -87.07 131.31 34.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.673 -177.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . 0.47 ' O ' HD12 ' A' ' 315' ' ' LEU . 2.7 tm? -65.91 -28.06 68.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.881 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.69 24.97 3.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.198 178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -91.91 122.04 34.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 8.4 p -84.05 -0.99 5.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.246 0.546 . . . . 0.0 111.483 -175.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 33.3 t -93.93 -25.52 17.25 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.069 -0.394 . . . . 0.0 111.474 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.44 HD21 ' O ' ' A' ' 314' ' ' ALA . 1.3 pp -83.7 162.85 20.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.238 0.542 . . . . 0.0 111.533 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.426 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 7.1 m -100.57 167.4 10.93 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.504 -176.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 42.2 Cg_exo -41.13 -51.51 3.85 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.8 3.0 . . . . 0.0 114.787 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.71 -39.28 93.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.002 0.429 . . . . 0.0 111.076 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -64.43 -28.95 70.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.906 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 325' ' ' ARG . 43.3 mtp85 -63.99 -28.73 70.01 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.796 0.331 . . . . 0.0 110.844 175.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -74.88 -19.34 60.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.104 0.478 . . . . 0.0 110.658 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -96.17 -2.78 45.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.444 ' HA ' HG21 ' A' ' 313' ' ' VAL . . . -72.74 106.39 4.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.661 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -98.31 -17.83 18.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.314 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.8 m -116.47 156.68 17.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.175 0.512 . . . . 0.0 110.417 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -82.38 -32.47 29.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.418 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 12.0 t -139.98 154.08 47.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.572 -174.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.2 p -86.95 169.66 12.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.318 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 18.1 tp -71.15 115.5 10.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.192 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.433 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -80.58 -178.92 6.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.32 -177.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -78.97 -9.83 59.64 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -138.7 72.56 1.41 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.924 0.392 . . . . 0.0 111.376 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' MET . . . . . 0.504 ' H ' HG12 ' A' ' 230' ' ' VAL . 21.0 mmt -125.11 146.37 49.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -93.81 139.5 30.78 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.735 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 40.9 t -121.81 119.36 58.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.965 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -135.83 143.9 45.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.967 -176.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 52.7 mt -85.73 121.64 37.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.948 173.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 63.9 mt . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.399 -179.638 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.481 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 19.5 p . . . . . 0 C--O 1.236 0.377 0 N-CA-C 111.459 0.17 . . . . 0.0 111.459 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 58.44 39.91 93.59 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.764 -177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.63 HG21 ' O ' ' A' ' 263' ' ' ALA . 62.2 mt -103.23 146.63 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 21.8 p -108.24 156.08 19.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.398 0.618 . . . . 0.0 111.405 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 335' ' ' ALA . 8.5 p -63.0 151.63 8.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.825 176.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.7 t -105.02 83.73 2.03 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 84.12 165.24 38.68 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.177 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.88 129.81 40.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.792 0.33 . . . . 0.0 110.425 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -123.39 127.4 48.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.049 0.452 . . . . 0.0 110.853 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 21.4 p -127.14 131.58 50.73 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.206 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 312' ' ' PRO . 78.4 m-85 -111.91 142.77 43.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.88 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -133.71 132.75 21.82 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.04 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo . . . . . 0 N--CA 1.452 -0.96 0 C-N-CA 122.689 2.259 . . . . 0.0 111.388 174.228 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.993 0.425 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -146.9 132.67 18.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.897 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -92.03 104.93 17.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.131 0.491 . . . . 0.0 111.131 177.443 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.8 t -85.65 117.45 30.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.495 -174.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 19.4 m -87.22 105.83 17.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.171 0.51 . . . . 0.0 110.195 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.436 ' HB2' ' CG2' ' A' ' 264' ' ' THR . 20.5 mt -122.17 164.92 16.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.652 -177.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.3 t -59.9 -51.8 68.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.171 0.51 . . . . 0.0 109.776 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.63 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.37 131.45 32.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.22 176.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.436 ' CG2' ' HB2' ' A' ' 261' ' ' LEU . 12.8 p -126.0 18.09 7.84 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.774 0.797 . . . . 0.0 109.029 175.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 26.5 m -82.62 148.11 28.17 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.857 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 95.51 -0.18 63.21 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 42.9 mtm -117.07 158.08 24.79 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.43 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 23.4 pttm -139.94 172.45 12.74 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -59.29 121.07 10.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.631 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 103.04 18.85 13.88 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.244 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.43 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 59.8 m-20 -100.62 152.64 20.19 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 117.433 0.616 . . . . 0.0 110.135 178.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -95.07 116.32 28.57 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.97 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 308' ' ' ILE . 15.0 pt -115.84 138.92 44.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.237 176.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 4.5 m -123.92 131.47 53.58 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.832 -178.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -99.26 112.2 24.41 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.964 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.61 115.39 3.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.459 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.27 -34.86 4.95 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.937 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 45.2 t -81.66 142.13 14.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.517 ' NZ ' ' HB3' ' A' ' 279' ' ' LYS . 0.1 OUTLIER -162.13 152.19 16.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.916 0.389 . . . . 0.0 111.276 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -80.85 154.16 27.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.465 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.154 177.008 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -68.0 104.0 1.64 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.367 -175.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 30.3 p -90.88 106.69 18.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.511 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.402 ' CZ ' ' HG3' ' A' ' 312' ' ' PRO . 88.4 m-85 -105.31 149.89 25.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.158 0.504 . . . . 0.0 111.105 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 12.8 m -96.7 119.87 35.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.777 176.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.421 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.5 p -78.71 130.45 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.163 0.506 . . . . 0.0 110.231 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 21.1 t -93.49 -28.09 4.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.392 -178.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -172.88 140.62 0.96 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.63 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 95.7 t -90.31 109.54 20.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 170.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 42.8 t -78.03 -59.0 3.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.294 -172.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -110.33 -10.05 14.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.046 0.45 . . . . 0.0 111.737 -174.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.56 11.95 84.05 Favored Glycine 0 C--N 1.32 -0.343 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 27.9 p -146.01 13.91 1.31 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.6 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 3.7 t-160 -165.16 116.51 1.14 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.357 -167.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.9 m -119.26 162.13 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -176.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.31 120.65 42.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.926 0.393 . . . . 0.0 110.0 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 273' ' ' ILE . 39.8 pt -122.36 176.74 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.092 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.5 t -154.45 145.6 16.46 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.13 -179.99 26.64 Favored 'Cis proline' 0 C--N 1.346 0.428 0 C-N-CA 124.23 -1.154 . . . . 0.0 112.84 -0.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -78.88 113.64 37.12 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.96 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . 0.431 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 23.5 Cg_exo -63.68 107.94 0.81 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.351 2.034 . . . . 0.0 112.365 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.5 t -124.39 126.3 71.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 317' ' ' ASP . . . -83.54 137.44 33.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.569 0.699 . . . . 0.0 111.897 -173.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.0 tm? -77.74 -25.2 49.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.54 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.6 5.2 43.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.426 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . 0.409 ' HB2' ' HB2' ' A' ' 314' ' ' ALA . 12.2 t70 -74.51 120.03 19.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.03 0.443 . . . . 0.0 110.186 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.9 p -84.79 -15.43 10.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.323 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 33.7 m -77.13 -23.93 51.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.498 -174.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 2.0 pp -85.75 164.41 17.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.456 0.646 . . . . 0.0 111.915 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 21.4 m -92.33 159.25 37.5 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.693 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 2.6 Cg_endo -41.34 -51.12 4.22 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 124.276 3.317 . . . . 0.0 114.311 -177.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -65.11 -29.03 69.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.853 0.359 . . . . 0.0 111.257 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 23.5 mt-30 -71.76 -38.52 70.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.089 -178.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -73.73 -19.88 60.67 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.489 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.23 -18.68 64.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.155 0.502 . . . . 0.0 110.023 172.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -112.15 12.03 20.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.084 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -60.54 152.62 25.54 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.927 0.394 . . . . 0.0 110.999 176.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -118.27 -29.73 5.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.663 -175.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.7 m -133.19 170.7 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 121.014 -0.275 . . . . 0.0 110.759 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -84.13 -51.44 7.06 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.594 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 11.4 t -107.27 146.3 31.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.03 0.443 . . . . 0.0 110.778 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.1 p -80.46 157.98 26.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.739 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.9 tp -68.56 101.96 1.38 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.717 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -82.53 165.89 19.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.489 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -76.96 25.41 0.15 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -149.1 30.92 0.77 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.962 0.41 . . . . 0.0 110.842 176.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.8 mmt -88.64 137.82 31.97 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.33 141.45 28.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.742 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 12.4 t -110.07 116.89 53.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.079 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . 0.481 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 27.8 t-20 -127.44 139.8 52.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.162 -177.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 16.3 mt -98.58 131.33 45.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 121.045 0.45 . . . . 0.0 111.125 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 33.5 mt . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.482 176.491 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 54.8 p . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 69.97 31.27 69.71 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.056 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 263' ' ' ALA . 89.0 mt -99.88 144.4 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.451 0.167 . . . . 0.0 110.613 -174.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 21.6 p -105.97 167.28 9.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.042 0.449 . . . . 0.0 111.549 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 335' ' ' ALA . 8.0 p -73.17 151.06 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.711 174.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 8.5 t -116.41 68.26 0.73 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.231 0.539 . . . . 0.0 109.909 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 103.94 141.83 11.41 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.856 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.8 127.6 33.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.919 0.39 . . . . 0.0 110.946 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -123.57 126.04 45.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.119 0.485 . . . . 0.0 110.427 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 5.4 p -111.08 103.36 11.8 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.197 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -81.65 151.76 27.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.337 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -145.03 127.7 8.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.257 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo . . . . . 0 N--CA 1.456 -0.677 0 C-N-CA 122.763 2.309 . . . . 0.0 110.45 169.13 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.409 ' CD1' ' HB ' ' A' ' 309' ' ' THR . 83.6 m-85 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.728 0.299 . . . . 0.0 110.669 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -110.19 135.32 51.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.249 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.3 OUTLIER -103.63 100.39 10.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.08 0.467 . . . . 0.0 110.58 -177.513 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.51 ' HB ' HG23 ' A' ' 306' ' ' VAL . 2.8 t -83.97 124.52 39.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.1 -170.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 21.8 m -93.74 106.21 18.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.259 0.552 . . . . 0.0 110.358 175.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.474 ' HB2' HG21 ' A' ' 264' ' ' THR . 21.8 mt -123.09 164.16 19.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.771 -176.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.7 m -57.48 -53.48 57.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.285 0.565 . . . . 0.0 109.987 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.604 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -136.85 133.53 35.94 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.257 177.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.474 HG21 ' HB2' ' A' ' 261' ' ' LEU . 4.3 p -127.96 17.48 6.73 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 11.4 m -80.32 150.49 29.92 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.772 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 91.72 -3.22 77.91 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.823 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 57.8 mtm -108.79 161.25 15.29 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.42 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 23.1 pttm -132.45 175.45 9.28 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -65.95 136.87 56.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.902 0.382 . . . . 0.0 110.338 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.99 7.6 62.4 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.213 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.42 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 44.3 m-20 -85.25 142.23 29.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.621 0.71 . . . . 0.0 109.903 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 1.3 tpmt? -87.71 115.32 25.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.776 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.428 HD11 HG23 ' A' ' 308' ' ' ILE . 6.8 pt -113.41 139.04 40.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.394 176.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 44.2 t -128.45 132.18 48.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.315 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -101.6 112.03 24.46 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.461 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.02 117.46 7.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.602 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.19 -11.19 26.68 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.458 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.2 133.55 58.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.516 ' HB3' ' HZ2' ' A' ' 279' ' ' LYS . 0.2 OUTLIER -159.16 162.89 36.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.963 0.411 . . . . 0.0 111.602 -178.193 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -81.11 156.66 25.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.266 -174.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 1.4 mm? . . . . . 0 CA--C 1.518 -0.252 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.437 -177.395 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -54.56 123.17 12.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.374 -171.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 14.0 p -99.4 127.0 45.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.888 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 312' ' ' PRO . 86.0 m-85 -127.74 150.4 49.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.598 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 24.1 t -97.4 122.65 40.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.102 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.8 134.91 28.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.08 0.467 . . . . 0.0 109.949 177.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 37.3 t -98.59 -35.21 4.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.725 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -164.63 136.72 4.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 0.0 110.761 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 88.9 t -83.84 109.78 17.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 171.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 42.5 t -74.43 -59.33 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.708 -173.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -120.65 -14.5 8.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.413 0.625 . . . . 0.0 111.101 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 84.08 13.91 73.3 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -169.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 31.9 p -140.92 13.57 2.27 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 171.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 3.6 t-160 -168.71 121.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.038 -170.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 258' ' ' THR . 2.0 m -119.71 162.97 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.654 -175.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -116.69 123.0 46.16 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 170.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.428 HG23 HD11 ' A' ' 273' ' ' ILE . 43.7 pt -122.44 170.69 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.38 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' THR . . . . . 0.409 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 5.1 t -153.41 144.85 16.44 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 172.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.18 179.84 25.69 Favored 'Cis proline' 0 C--N 1.345 0.368 0 C-N-CA 124.061 -1.225 . . . . 0.0 112.817 -1.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -88.97 119.7 69.87 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.977 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 295' ' ' PHE . 38.2 Cg_endo -69.68 116.48 4.57 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.673 2.249 . . . . 0.0 112.527 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.518 ' CG2' ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -124.67 131.79 72.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.524 176.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.503 ' HB3' ' HB2' ' A' ' 317' ' ' ASP . . . -78.96 130.92 36.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.259 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.34 -28.28 66.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.935 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -98.9 25.72 6.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.294 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . 0.503 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 10.0 t70 -78.59 123.55 27.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.2 m -83.5 3.29 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 16.8 m -109.77 18.63 20.0 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.672 0.272 . . . . 0.0 111.287 -174.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.8 pp -127.91 168.58 15.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.083 0.468 . . . . 0.0 111.945 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 4.1 m -102.82 169.97 6.86 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.568 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -47.35 -48.95 13.95 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.234 2.623 . . . . 0.0 113.915 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -65.45 -33.95 77.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.284 0.564 . . . . 0.0 110.554 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 13.0 mm100 -67.44 -42.47 83.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.148 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -71.82 -17.01 62.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.913 0.387 . . . . 0.0 111.167 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.2 -29.16 67.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.067 0.46 . . . . 0.0 110.098 173.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -86.4 -13.17 47.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.827 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.518 ' HA ' ' CG2' ' A' ' 313' ' ' VAL . . . -58.41 143.68 44.48 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.29 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -131.13 -8.95 3.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.049 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.5 174.22 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.046 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -84.88 -45.23 12.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.684 0.278 . . . . 0.0 111.115 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 6.2 t -129.57 144.43 51.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.366 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.496 ' N ' ' HB1' ' A' ' 314' ' ' ALA . 22.5 m -68.22 169.48 10.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 21.4 tp -70.16 102.22 2.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.547 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -90.75 -173.69 3.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.312 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -73.3 158.98 34.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.89 0.376 . . . . 0.0 110.826 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 60.6 39.1 18.26 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.207 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' MET . . . . . 0.427 ' H ' HG12 ' A' ' 230' ' ' VAL . 26.1 mmt -104.6 133.08 50.05 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -89.01 137.6 32.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.066 0.46 . . . . 0.0 111.354 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 12.5 t -103.21 124.35 57.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.565 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -138.24 134.34 34.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.557 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 70.7 mt -88.46 119.72 36.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.917 0.389 . . . . 0.0 110.088 176.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 40.8 mt . . . . . 0 C--N 1.32 -0.697 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.721 -178.273 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 33.7 p . . . . . 0 N--CA 1.446 -0.637 0 CA-C-O 121.191 0.519 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -81.23 67.83 3.55 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 174.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 263' ' ' ALA . 40.0 mm -100.1 145.01 11.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.585 -0.308 . . . . 0.0 110.685 -174.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.2 p -128.16 159.97 33.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.291 0.567 . . . . 0.0 110.681 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.65 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.4 p -84.68 151.88 3.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.537 -175.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 67.8 m -109.14 82.23 1.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.841 0.353 . . . . 0.0 110.408 174.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 93.58 165.22 37.29 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.592 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 334' ' ' LEU . . . -84.22 114.15 21.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.874 0.368 . . . . 0.0 110.15 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -120.61 128.43 53.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.026 -175.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.47 ' HB3' ' HB3' ' A' ' 333' ' ' SER . 26.9 p -145.84 102.08 3.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.4 0.619 . . . . 0.0 110.092 172.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.415 ' C ' ' HD3' ' A' ' 311' ' ' LYS . 79.3 m-85 -95.15 148.15 22.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.927 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 237' ' ' LYS . 12.9 mptt -110.01 146.0 33.25 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.974 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.456 -0.682 0 C-N-CA 122.494 2.129 . . . . 0.0 111.677 174.729 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.429 ' CD2' ' HB ' ' A' ' 309' ' ' THR . 97.2 m-85 . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -105.08 118.24 36.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.611 0.244 . . . . 0.0 111.424 -177.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -87.06 103.48 15.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.177 0.513 . . . . 0.0 110.586 175.399 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -82.22 118.23 29.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.021 -173.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 23.5 m -84.93 105.64 15.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.013 176.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 31.3 mt -126.09 166.45 16.98 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.949 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.4 t -64.59 -52.85 55.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.096 0.474 . . . . 0.0 109.798 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.518 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.69 127.31 27.04 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.802 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 10.6 p -125.22 32.37 5.39 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 173.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 1.4 m -81.31 145.99 30.61 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.163 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 90.28 -2.8 81.63 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.758 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 59.7 mtt -97.79 146.3 25.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -133.05 172.73 12.25 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -59.36 138.49 57.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.034 0.445 . . . . 0.0 111.069 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 88.12 11.83 66.65 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.257 176.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.401 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 53.1 m-20 -90.64 153.84 20.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.555 0.678 . . . . 0.0 110.49 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -103.8 117.67 34.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.824 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 40.4 pt -112.72 139.87 35.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.137 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.464 ' HB3' HG23 ' A' ' 294' ' ' THR . 77.3 p -120.27 133.63 55.43 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.766 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -95.04 110.43 22.35 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.83 118.72 13.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.122 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 108.49 -22.7 26.06 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.62 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 41.2 t -101.32 133.76 43.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -144.25 156.82 44.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.706 0.288 . . . . 0.0 111.131 -174.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.529 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 82.4 m-85 -77.55 169.35 18.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.599 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.686 179.04 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.529 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -71.56 95.48 1.42 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.249 -177.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.464 HG23 ' HB3' ' A' ' 274' ' ' SER . 70.8 p -103.78 126.72 51.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.35 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.414 ' CE2' ' HG3' ' A' ' 312' ' ' PRO . 92.5 m-85 -131.59 155.98 46.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.888 0.375 . . . . 0.0 110.828 -179.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 5.6 m -100.86 129.5 46.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.153 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.401 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 11.9 p -83.17 135.93 23.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.143 0.497 . . . . 0.0 110.462 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 27.9 t -98.48 -28.91 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.704 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 307' ' ' GLU . 27.8 tpt180 -167.17 137.92 3.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.506 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 97.6 t -87.85 111.36 22.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 14.9 t -75.86 -56.43 8.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.869 -170.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -119.3 -6.06 10.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.902 0.382 . . . . 0.0 111.65 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.94 12.16 84.17 Favored Glycine 0 C--N 1.322 -0.202 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -170.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 6.6 p -148.03 19.85 1.11 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.434 ' NE2' ' HB ' ' A' ' 258' ' ' THR . 3.6 t-160 -167.08 116.93 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.052 -1.431 . . . . 0.0 107.965 -170.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -118.64 152.15 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -175.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 299' ' ' ARG . 9.9 pt-20 -110.37 118.07 35.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.079 0.466 . . . . 0.0 110.002 173.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 27.2 pt -120.57 171.06 9.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.531 -177.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' THR . . . . . 0.429 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 7.1 t -148.91 140.32 14.21 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.625 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.4 -179.91 28.49 Favored 'Cis proline' 0 C--N 1.344 0.31 0 C-N-CA 123.906 -1.289 . . . . 0.0 112.375 -2.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.415 ' HD3' ' C ' ' A' ' 236' ' ' PHE . 37.2 ttmt -85.47 125.28 70.0 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.954 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . 0.414 ' HG3' ' CE2' ' A' ' 295' ' ' PHE . 16.1 Cg_exo -67.74 108.97 1.76 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.661 2.241 . . . . 0.0 112.755 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -120.92 131.23 73.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.744 173.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -91.62 141.06 29.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.334 0.588 . . . . 0.0 111.377 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.7 tm? -72.84 -22.89 60.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.567 177.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.4 17.38 14.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.409 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.07 115.26 22.28 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 9.4 p -83.11 -9.68 11.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.005 0.431 . . . . 0.0 111.29 -175.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 15.0 m -82.33 -29.75 30.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.347 -174.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 2.4 pp -84.65 162.62 19.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.4 0.619 . . . . 0.0 112.002 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.458 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 41.9 m -95.93 166.07 15.19 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.076 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 71.3 Cg_exo -43.68 -44.23 11.33 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.554 2.836 . . . . 0.0 114.666 -177.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.27 -33.91 75.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.254 0.55 . . . . 0.0 111.201 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . 0.508 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 46.4 mt-30 -79.86 -36.93 35.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.675 -175.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.44 ' HB3' ' CD1' ' A' ' 320' ' ' LEU . 13.6 ptm180 -73.2 -20.19 60.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.053 0.454 . . . . 0.0 110.161 177.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.01 -29.89 69.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.994 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -101.19 11.37 39.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.378 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.469 ' HA ' ' CG2' ' A' ' 313' ' ' VAL . . . -59.67 149.74 29.65 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.88 0.372 . . . . 0.0 111.212 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -125.95 -36.29 2.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.711 -176.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 30.7 m -110.31 155.19 11.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.229 0.537 . . . . 0.0 111.182 -175.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -85.61 -17.04 37.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.428 -176.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.1 t -144.0 139.74 29.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.225 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.47 ' HB3' ' HB3' ' A' ' 235' ' ' SER . 73.0 m -70.89 163.62 27.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.241 175.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 233' ' ' ALA . 29.0 tp -69.05 104.26 2.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.65 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -78.98 170.23 17.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.699 -175.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -76.44 12.41 1.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -170.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -152.93 65.31 0.78 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.356 0.598 . . . . 0.0 110.347 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' MET . . . . . 0.429 ' H ' HG13 ' A' ' 230' ' ' VAL . 22.2 mmt -114.85 141.95 47.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.255 178.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -90.77 129.62 36.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.528 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 19.2 t -104.19 117.27 49.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -131.57 138.72 48.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.747 0.308 . . . . 0.0 111.185 -174.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 3.3 mt -90.42 133.37 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.137 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 60.4 mt . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.31 178.427 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 53.8 p . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.344 0.592 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -123.39 48.12 0.97 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 175.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 263' ' ' ALA . 17.4 mt -87.26 150.46 3.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -175.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 6.1 p -107.86 166.02 11.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.309 0.576 . . . . 0.0 111.722 -178.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.626 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.7 p -72.82 150.32 8.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.971 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 231' ' ' SER . . . . . 0.477 ' HB2' ' N ' ' A' ' 262' ' ' SER . 7.0 t -110.87 74.48 0.87 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.344 0.592 . . . . 0.0 109.72 177.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 92.8 144.3 14.3 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.996 -178.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.51 126.89 29.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.857 0.361 . . . . 0.0 110.808 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -125.33 126.35 44.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.134 -179.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.9 m -105.65 104.42 14.14 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.693 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -80.52 113.64 18.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.977 -176.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -124.64 121.78 25.76 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.92 0.391 . . . . 0.0 111.763 -174.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo . . . . . 0 N--CA 1.453 -0.893 0 C-N-CA 122.782 2.321 . . . . 0.0 110.997 170.765 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 N--CA 1.454 -0.253 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -101.99 115.69 31.09 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.727 0.299 . . . . 0.0 110.408 178.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.7 OUTLIER -92.78 103.61 15.95 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.164 0.507 . . . . 0.0 109.995 179.639 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.1 t -82.84 117.0 28.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.466 -171.189 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 16.2 m -87.04 105.3 17.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.101 177.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 29.0 mt -125.59 162.73 24.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.13 -176.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 262' ' ' SER . . . . . 0.477 ' N ' ' HB2' ' A' ' 231' ' ' SER . 14.0 m -62.21 -50.2 72.73 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.428 0.632 . . . . 0.0 109.697 179.229 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.567 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -138.13 142.06 40.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.269 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.44 ' HB ' ' SD ' ' A' ' 267' ' ' MET . 19.1 p -129.39 26.86 5.36 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.087 0.946 . . . . 0.0 108.875 174.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 15.5 m -77.71 138.3 38.97 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.343 -1.298 . . . . 0.0 109.513 175.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 104.9 -7.1 44.45 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -172.224 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 267' ' ' MET . . . . . 0.44 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 61.1 mtt -101.5 144.74 29.89 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.389 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -154.89 141.98 19.31 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.464 ' HA ' HG13 ' A' ' 297' ' ' VAL . 24.3 ptt180 -44.46 116.52 1.05 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.96 0.788 . . . . 0.0 112.582 -171.586 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.62 -6.63 20.44 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.426 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.512 ' H ' HG11 ' A' ' 297' ' ' VAL . 1.6 p30 -85.15 -177.9 6.64 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.482 0.641 . . . . 0.0 111.534 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -124.65 117.11 23.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.897 -177.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.417 HD12 HG22 ' A' ' 308' ' ' ILE . 40.8 pt -112.72 139.88 35.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.108 0.48 . . . . 0.0 110.208 177.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.485 ' OG ' HG22 ' A' ' 294' ' ' THR . 4.9 m -127.98 149.28 50.42 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.822 -178.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -113.59 111.85 22.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.424 -178.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.52 115.71 6.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.823 -178.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.32 -25.62 12.2 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.708 -178.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 47.2 t -99.04 115.15 38.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -132.7 162.55 31.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.867 0.365 . . . . 0.0 111.896 -173.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.436 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 60.1 m-85 -80.46 154.16 27.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.86 -175.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.423 HD12 ' HB2' ' A' ' 315' ' ' LEU . 40.2 mt . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.796 179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 C--O 1.234 0.261 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.485 ' HB3' ' CE2' ' A' ' 295' ' ' PHE . . . -70.69 87.9 0.69 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.464 -176.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.485 HG22 ' OG ' ' A' ' 274' ' ' SER . 70.5 p -90.99 112.53 24.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.288 178.416 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 293' ' ' ALA . 68.0 m-85 -123.07 145.43 48.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.931 0.396 . . . . 0.0 110.857 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 11.9 m -80.3 130.0 34.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.696 175.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.512 HG11 ' H ' ' A' ' 271' ' ' ASP . 5.2 p -67.75 132.72 32.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.255 0.55 . . . . 0.0 109.668 179.293 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 84.6 t -94.07 -45.34 13.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.105 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -167.51 139.08 3.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.126 178.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 93.7 t -88.11 108.79 18.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 171.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.0 t -78.54 -59.66 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.971 -173.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -111.91 -8.16 14.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.948 0.404 . . . . 0.0 111.529 -174.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.16 12.85 83.22 Favored Glycine 0 CA--C 1.517 0.193 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -170.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 20.4 p -146.05 16.25 1.37 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 174.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.419 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.2 t-160 -170.73 115.53 0.46 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.384 -168.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.58 161.92 18.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.537 -175.227 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -116.22 129.29 56.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.003 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.488 HG21 ' HA ' ' A' ' 297' ' ' VAL . 27.1 pt -132.07 169.83 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.031 0.443 . . . . 0.0 111.471 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 7.2 t -150.02 143.58 16.78 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.41 177.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -76.44 -179.95 29.0 Favored 'Cis proline' 0 C--N 1.345 0.378 0 C-N-CA 124.129 -1.196 . . . . 0.0 112.419 -3.113 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -87.41 123.35 69.84 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.207 -178.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.15 109.29 2.9 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.593 2.196 . . . . 0.0 112.658 178.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.467 ' CG2' ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -107.06 133.92 50.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.62 175.745 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.442 ' O ' HD22 ' A' ' 320' ' ' LEU . . . -82.84 126.06 32.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.11 0.481 . . . . 0.0 111.409 -178.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . 0.423 ' HB2' HD12 ' A' ' 281' ' ' LEU . 2.7 tm? -68.64 -29.6 68.13 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.968 177.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -79.52 -0.81 34.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.751 -179.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -79.92 122.5 26.76 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.984 0.421 . . . . 0.0 110.622 -178.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 14.2 p -83.96 -16.64 10.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.237 -178.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 24.5 m -74.42 -35.82 63.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.721 -175.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 320' ' ' LEU . 1.7 pp -75.4 152.64 38.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.276 0.56 . . . . 0.0 110.884 178.423 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.462 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.8 m -91.09 170.84 9.06 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.259 -173.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 91.2 Cg_exo -46.98 -50.45 10.89 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 123.446 2.764 . . . . 0.0 114.517 -175.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.35 -28.85 69.98 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.149 -177.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -76.03 -39.65 55.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.631 0.253 . . . . 0.0 111.026 -178.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.431 ' HB3' ' CD1' ' A' ' 320' ' ' LEU . 13.0 ptp180 -73.37 -22.85 60.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.009 0.433 . . . . 0.0 110.538 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.87 -34.21 77.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.217 174.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -96.6 6.23 49.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.185 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.467 ' HA ' ' CG2' ' A' ' 313' ' ' VAL . . . -61.41 135.61 57.75 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.887 0.375 . . . . 0.0 110.753 178.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -108.89 -29.2 8.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.365 -176.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.8 171.53 9.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.946 0.403 . . . . 0.0 111.132 -175.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -88.55 -38.77 14.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.449 -178.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.1 t -128.3 143.17 50.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.909 0.385 . . . . 0.0 110.763 -176.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.432 ' N ' ' HB3' ' A' ' 314' ' ' ALA . 44.1 m -72.29 162.71 29.09 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 172.389 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 23.0 tp -68.66 102.42 1.5 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -177.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.626 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -95.72 -179.24 4.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.269 -178.337 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -67.57 150.45 48.79 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 65.45 45.62 2.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.819 179.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 26.4 mmt -112.0 131.07 55.63 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -87.07 133.6 33.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.604 -176.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 10.3 t -101.83 114.86 42.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.476 177.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -125.85 134.52 51.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.098 -174.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 19.5 mt -93.01 131.43 40.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 174.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 121.022 0.439 . . . . 0.0 110.586 179.758 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 121.222 0.534 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.43 68.1 3.39 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 174.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 340' ' ' VAL . 40.6 mm -100.17 143.45 13.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 122.339 0.256 . . . . 0.0 111.101 -173.356 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 74.4 p -121.89 149.41 43.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.195 0.521 . . . . 0.0 110.506 173.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.653 HG12 ' O ' ' A' ' 335' ' ' ALA . 9.5 p -64.48 152.97 8.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.678 175.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 14.2 t -124.58 88.78 2.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.914 0.388 . . . . 0.0 110.017 175.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 103.4 165.34 25.51 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.038 -178.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -86.52 125.13 33.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.718 0.294 . . . . 0.0 110.428 179.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -120.58 129.51 53.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.929 0.395 . . . . 0.0 110.961 -176.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 25.5 t -153.89 103.04 2.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.899 177.404 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -114.26 141.65 47.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.892 -179.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.429 ' HE3' ' HB3' ' A' ' 320' ' ' LEU . 2.9 mptp? -111.9 145.89 33.66 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.822 -175.544 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.459 -0.539 0 C-N-CA 122.261 1.974 . . . . 0.0 110.846 174.115 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.492 ' CE1' HG22 ' A' ' 298' ' ' VAL . 48.1 m-85 . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 120.744 0.307 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -145.36 118.44 8.85 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.861 176.33 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 3.8 m -83.22 113.01 20.37 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.076 0.465 . . . . 0.0 110.484 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.5 t -98.08 120.5 47.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.427 -173.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 79.5 m -89.64 108.2 19.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.04 0.448 . . . . 0.0 109.958 174.167 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.408 ' HB2' ' CG2' ' A' ' 264' ' ' THR . 23.9 mt -125.04 168.32 13.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.732 -177.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.8 t -64.7 -52.84 55.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.526 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.68 127.24 26.94 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.328 179.426 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.408 ' CG2' ' HB2' ' A' ' 261' ' ' LEU . 11.5 p -125.23 25.5 7.15 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.885 174.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 24.1 m -82.01 145.29 30.32 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.156 175.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.93 -18.17 57.2 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -173.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 59.9 mtt -91.46 138.81 31.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.936 -0.632 . . . . 0.0 109.317 176.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -133.35 153.61 51.43 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -58.13 134.63 56.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.971 0.415 . . . . 0.0 111.366 -175.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 99.6 14.45 34.87 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.296 -177.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.401 ' H ' HG13 ' A' ' 297' ' ' VAL . 0.6 OUTLIER -109.45 175.59 5.39 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.8 0.3 . . . . 0.0 110.224 179.487 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.446 ' HD3' ' HB ' ' A' ' 294' ' ' THR . 5.2 tmmm? -127.09 117.49 22.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.564 -174.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 31.0 pt -111.65 142.57 23.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.906 -177.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 14.8 m -124.55 138.55 54.32 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.507 -178.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -100.87 112.0 24.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.485 -178.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.96 116.56 9.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.97 -178.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.19 -34.22 5.3 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 60.2 t -89.06 122.09 39.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 175.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -139.88 158.38 44.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.043 0.449 . . . . 0.0 111.608 -176.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -73.48 145.41 45.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.155 -173.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 77.2 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.359 176.612 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.547 ' HB3' ' CE2' ' A' ' 295' ' ' PHE . . . -60.39 102.56 0.18 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.526 -170.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.446 ' HB ' ' HD3' ' A' ' 272' ' ' LYS . 19.7 p -95.19 111.19 23.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.603 177.045 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.547 ' CE2' ' HB3' ' A' ' 293' ' ' ALA . 65.1 m-85 -123.68 150.53 44.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.859 0.362 . . . . 0.0 110.897 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 16.2 m -96.06 134.03 39.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.255 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.401 HG13 ' H ' ' A' ' 271' ' ' ASP . 9.5 p -86.98 135.53 24.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.964 0.411 . . . . 0.0 110.359 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.492 HG22 ' CE1' ' A' ' 256' ' ' PHE . 46.0 t -105.48 -31.5 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.274 -176.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -162.27 138.4 7.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.826 0.346 . . . . 0.0 110.593 -178.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 89.3 t -92.4 114.23 28.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.83 -59.29 3.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.842 -172.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.77 -2.47 10.91 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.873 0.368 . . . . 0.0 111.794 -174.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.08 11.71 83.84 Favored Glycine 0 N--CA 1.459 0.2 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -174.075 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 5.9 p -150.75 23.03 0.78 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 173.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.441 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.2 t-160 -167.78 112.75 0.68 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 113.594 -1.639 . . . . 0.0 107.896 -165.454 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.27 169.89 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.559 -174.174 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 10.9 pt-20 -128.22 121.74 30.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.215 0.531 . . . . 0.0 109.931 169.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 22.7 pt -120.98 174.65 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.143 -177.136 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.7 t -155.19 147.06 17.18 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.121 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -69.23 179.94 19.86 Favored 'Cis proline' 0 C--N 1.349 0.567 0 C-N-CA 124.163 -1.182 . . . . 0.0 113.162 -2.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 24.1 ttmm -82.26 124.81 78.02 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.212 -177.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 13.3 Cg_exo -69.25 109.89 2.32 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.84 2.36 . . . . 0.0 112.606 177.106 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.488 ' CG2' ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -126.04 130.69 72.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.905 174.161 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -95.32 143.7 26.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.272 0.558 . . . . 0.0 111.506 -175.431 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -76.43 -26.5 55.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.101 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -98.05 26.0 5.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.647 178.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . 0.481 ' HB2' ' HB1' ' A' ' 314' ' ' ALA . 20.3 t70 -86.14 131.3 34.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.528 -179.412 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 11.3 p -84.49 -18.53 9.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.946 -176.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 19.7 m -91.77 5.11 51.09 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -168.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.429 ' HB3' ' HE3' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -115.67 157.53 24.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.365 0.602 . . . . 0.0 112.056 -179.378 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 16.9 m -86.55 158.47 54.28 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.552 177.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.547 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 61.9 Cg_exo -39.66 -49.78 3.27 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.434 3.423 . . . . 0.0 114.882 -176.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.9 -39.39 85.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.849 0.357 . . . . 0.0 111.68 -177.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -72.71 -29.57 63.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -172.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 9.7 ptm180 -76.14 -18.77 58.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.449 0.642 . . . . 0.0 109.862 178.43 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.79 -21.7 61.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.78 172.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -96.74 1.24 50.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.706 175.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.488 ' HA ' ' CG2' ' A' ' 313' ' ' VAL . . . -59.09 144.43 45.56 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.551 179.412 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -118.17 -27.28 6.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.436 -176.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.8 m -119.31 170.89 8.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.685 0.278 . . . . 0.0 111.218 -177.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -82.71 -53.97 5.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.922 -176.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.4 t -114.91 145.28 42.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.066 0.46 . . . . 0.0 110.876 -171.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.0 m -75.23 154.62 37.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.438 178.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.1 103.34 2.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.653 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -95.76 162.33 13.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.958 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . 0.416 ' HA ' HG13 ' A' ' 230' ' ' VAL . 38.4 t70 -75.21 62.72 1.27 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.097 0.475 . . . . 0.0 112.1 -174.143 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -176.6 33.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.696 171.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 338' ' ' MET . . . . . 0.472 ' H ' HG11 ' A' ' 230' ' ' VAL . 23.9 mmt -104.54 130.7 52.48 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -83.63 135.1 34.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.607 178.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.528 ' O ' ' HB ' ' A' ' 228' ' ' ILE . 22.0 t -112.22 115.05 48.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.525 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -132.6 135.2 45.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.875 0.369 . . . . 0.0 111.6 -174.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 45.8 mt -84.29 123.59 39.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.855 174.072 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . 0.423 HD11 ' HE3' ' A' ' 272' ' ' LYS . 51.3 mt . . . . . 0 C--N 1.32 -0.705 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.846 178.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.415 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 16.3 p . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 111.383 0.142 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 60.45 36.98 92.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.7 -177.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 58.6 mt -91.17 144.04 9.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -176.151 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 13.4 p -96.65 153.26 17.96 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.555 0.693 . . . . 0.0 111.998 -172.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 335' ' ' ALA . 8.6 p -67.06 151.09 10.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.052 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 71.5 m -113.75 82.0 1.62 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.919 0.39 . . . . 0.0 110.463 177.104 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 95.34 147.57 22.85 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.013 -179.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -82.59 139.07 34.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.839 0.352 . . . . 0.0 111.116 -177.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -141.38 135.18 30.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.251 0.548 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.9 p -139.87 103.07 4.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.245 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -115.38 153.95 30.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.352 -177.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -108.63 138.76 20.35 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.077 177.316 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 N--CA 1.462 -0.348 0 C-N-CA 122.677 2.251 . . . . 0.0 112.112 -179.762 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 . . . . . 0 CA--C 1.52 -0.188 0 CA-C-O 120.833 0.349 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.55 124.87 46.7 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.343 178.269 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.3 m -93.37 101.41 13.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.302 0.572 . . . . 0.0 110.363 -179.374 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -82.97 122.92 38.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.146 -173.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 29.8 m -98.01 106.43 18.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.36 0.6 . . . . 0.0 110.299 179.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 16.5 mt -125.08 164.56 19.94 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.727 -174.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 51.1 m -58.54 -54.75 43.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.198 0.523 . . . . 0.0 109.927 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -136.78 130.66 32.25 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.258 178.304 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 10.5 p -126.37 25.94 6.49 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.7 m -79.68 143.13 34.88 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.69 -1.595 . . . . 0.0 109.819 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 99.29 -19.76 52.64 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -175.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 85.2 mtp -75.72 152.56 37.44 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -154.83 147.26 24.03 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -178.232 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.419 ' HA ' HG11 ' A' ' 297' ' ' VAL . 32.1 ptt180 -51.9 114.43 1.3 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.366 0.603 . . . . 0.0 111.15 -176.066 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 116.33 6.13 15.94 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.557 -174.078 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -88.7 179.84 6.16 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 117.094 0.447 . . . . 0.0 110.928 176.067 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.522 ' HB2' ' HZ1' ' A' ' 272' ' ' LYS . 0.2 OUTLIER -141.45 117.18 10.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.647 -178.115 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 21.9 pt -113.22 139.95 35.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.026 0.441 . . . . 0.0 110.876 -178.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 69.9 p -120.88 133.99 55.3 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.706 176.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.437 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 95.5 m-85 -94.11 111.46 23.18 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.179 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.463 ' HA ' ' OD1' ' A' ' 292' ' ' ASP . . . -66.0 111.53 3.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.02 -177.671 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.22 -35.3 4.73 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.7 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 83.9 t -82.62 129.69 37.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 173.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -148.35 160.23 43.21 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.26 -175.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -77.08 150.94 35.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.931 -178.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.765 177.93 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.463 ' OD1' ' HA ' ' A' ' 276' ' ' ALA . 57.3 m-20 . . . . . 0 C--O 1.232 0.166 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -58.66 108.97 0.71 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.607 -175.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.3 p -91.49 118.17 30.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.164 -178.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.67 148.25 48.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.225 177.473 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 25.4 m -98.67 136.73 38.32 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.603 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 269' ' ' ARG . 8.7 p -67.56 142.56 16.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.449 178.566 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.2 t -105.74 -45.03 8.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.742 173.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -154.94 139.36 16.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.637 179.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 77.3 t -86.05 109.23 18.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 171.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 31.9 t -76.45 -58.26 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.821 -172.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -122.58 -2.7 8.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.866 0.365 . . . . 0.0 111.318 -176.085 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 72.18 12.88 76.37 Favored Glycine 0 CA--C 1.518 0.268 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -172.056 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 4.4 p -149.11 21.75 0.97 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.176 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.9 t-160 -173.41 115.73 0.25 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 113.833 -1.531 . . . . 0.0 107.667 -167.326 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.64 162.67 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -173.63 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 10.1 pt-20 -123.19 126.11 46.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.113 0.482 . . . . 0.0 110.189 171.744 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 25.5 pt -125.24 168.8 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.38 -176.031 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 6.0 t -140.59 138.47 18.68 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.802 176.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.04 179.45 25.95 Favored 'Cis proline' 0 C--N 1.344 0.318 0 C-N-CA 123.364 -1.515 . . . . 0.0 112.411 -1.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.518 ' HZ3' ' HB2' ' A' ' 311' ' ' LYS . 3.0 ttmp? -80.12 123.57 83.31 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.384 177.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 15.0 Cg_exo -67.85 113.36 2.97 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.821 2.348 . . . . 0.0 112.647 178.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.449 HG21 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -117.32 128.96 74.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.125 174.817 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -81.19 130.62 35.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.261 0.553 . . . . 0.0 111.201 -178.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . 0.408 HD11 ' O ' ' A' ' 315' ' ' LEU . 3.0 tm? -65.18 -27.06 68.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.052 177.325 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.43 10.94 27.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.567 -178.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.68 128.96 36.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.789 0.328 . . . . 0.0 110.133 178.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.1 p -83.92 -17.89 10.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.93 0.395 . . . . 0.0 111.58 -175.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 12.3 m -79.06 -36.33 41.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.489 -173.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.475 ' CD1' ' HB3' ' A' ' 325' ' ' ARG . 1.5 pp -72.25 162.53 29.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.448 0.642 . . . . 0.0 112.141 -178.522 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.462 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 12.5 m -108.26 173.87 2.78 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.697 -179.009 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 72.8 Cg_exo -44.19 -53.17 4.98 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 123.429 2.753 . . . . 0.0 114.987 -173.172 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -62.96 -39.12 93.72 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.071 -176.425 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -65.38 -41.37 93.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.452 -179.006 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.475 ' HB3' ' CD1' ' A' ' 320' ' ' LEU . 5.4 ppt_? -74.68 -19.0 60.44 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.972 179.132 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.78 -18.39 62.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.202 173.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -103.21 -0.61 30.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.485 176.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.449 ' HA ' HG21 ' A' ' 313' ' ' VAL . . . -62.27 127.33 30.84 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.774 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -106.5 -26.61 11.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.493 -176.001 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 27.0 m -116.29 161.45 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.0 110.858 -177.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -89.18 -16.75 30.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.109 -177.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.3 t -143.01 139.46 30.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.967 0.413 . . . . 0.0 111.002 -178.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.411 ' N ' ' HB2' ' A' ' 314' ' ' ALA . 20.2 m -74.56 174.56 8.83 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.431 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 19.1 tp -78.05 102.89 7.66 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.641 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -84.04 169.29 15.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.147 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -81.36 32.26 0.34 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -171.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.94 48.57 0.39 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.059 0.457 . . . . 0.0 110.841 174.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 338' ' ' MET . . . . . 0.409 ' H ' HG11 ' A' ' 230' ' ' VAL . 26.2 mmt -110.68 137.66 48.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.243 179.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.48 132.58 40.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.946 0.403 . . . . 0.0 110.874 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 31.8 t -102.83 114.36 42.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.897 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . 0.415 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 8.4 t30 -126.07 124.46 40.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.398 -176.32 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 32.3 mt -77.65 128.54 38.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.921 172.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 74.9 mt . . . . . 0 C--N 1.322 -0.62 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.743 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 63.07 33.66 87.86 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.769 -176.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 263' ' ' ALA . 51.4 mt -102.99 149.96 6.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -175.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.88 148.07 32.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.812 0.339 . . . . 0.0 110.487 177.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 335' ' ' ALA . 8.9 p -53.97 151.75 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.589 178.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 231' ' ' SER . . . . . 0.439 ' HB2' ' N ' ' A' ' 262' ' ' SER . 9.4 t -100.79 69.57 1.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.068 0.461 . . . . 0.0 110.026 178.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 89.52 166.16 41.57 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.013 -178.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.11 117.49 10.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.995 0.426 . . . . 0.0 110.756 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -114.77 126.43 54.83 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.967 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 57.2 p -125.27 149.57 47.9 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.152 -178.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -125.75 154.87 41.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.631 -178.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -143.02 138.42 15.77 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.159 177.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.488 ' HD2' ' OE1' ' A' ' 324' ' ' GLN . 5.5 Cg_endo . . . . . 0 N--CA 1.448 -1.166 0 C-N-CA 121.766 1.644 . . . . 0.0 110.602 171.55 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.425 ' CD2' ' HB ' ' A' ' 309' ' ' THR . 78.8 m-85 . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -136.33 132.79 36.11 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.702 0.286 . . . . 0.0 110.771 178.194 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.7 m -98.94 103.05 14.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.109 0.481 . . . . 0.0 110.069 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.51 125.81 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.744 -171.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 23.5 m -93.4 106.15 18.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.193 175.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.417 ' HB2' ' CG2' ' A' ' 264' ' ' THR . 19.6 mt -126.0 160.62 29.56 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -177.388 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 262' ' ' SER . . . . . 0.468 ' O ' HG22 ' A' ' 304' ' ' THR . 15.9 p -61.57 -48.09 82.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.147 0.499 . . . . 0.0 110.127 -178.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.44 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -136.72 138.33 40.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.294 175.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.417 ' CG2' ' HB2' ' A' ' 261' ' ' LEU . 9.4 p -134.61 28.45 3.62 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.503 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.6 m -78.07 145.02 36.07 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.486 -178.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 97.08 -4.12 62.55 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.428 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 62.0 mtt -93.58 158.57 15.63 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 178.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.422 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 25.1 pttm -150.08 163.8 37.24 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.594 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -56.07 123.99 16.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.068 0.461 . . . . 0.0 110.791 -178.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 98.72 18.25 25.89 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.418 178.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.422 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 0.3 OUTLIER -99.1 160.22 14.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.634 0.717 . . . . 0.0 110.127 179.056 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -108.96 117.07 33.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.834 -175.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.405 HD11 HG23 ' A' ' 308' ' ' ILE . 36.8 pt -117.91 140.7 40.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.234 0.54 . . . . 0.0 110.407 177.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 39.0 t -126.97 153.81 45.38 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.371 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -117.46 111.69 19.63 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.08 117.73 5.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.234 -177.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.03 -34.7 5.06 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 96.3 t -88.37 114.44 26.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -137.12 157.15 47.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.962 0.411 . . . . 0.0 111.035 -175.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.408 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 63.0 m-85 -76.6 135.9 39.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.029 -176.239 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 68.9 mt . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.974 175.026 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.646 0.26 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.408 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -49.61 110.07 0.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.621 -175.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 4.9 p -100.49 120.5 40.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.08 -178.249 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -122.44 151.28 41.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.629 -178.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.8 m -98.32 130.59 45.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.211 178.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 14.1 p -80.83 132.08 32.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.322 0.582 . . . . 0.0 110.629 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 37.3 t -91.53 -33.9 5.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.317 -178.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -166.37 139.9 4.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.418 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 57.5 t -88.32 107.36 17.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 169.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 39.9 t -68.59 -54.79 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.874 -172.048 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -128.5 -6.42 5.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.154 0.502 . . . . 0.0 111.514 -174.156 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.04 12.67 80.69 Favored Glycine 0 N--CA 1.457 0.095 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -176.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 304' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 262' ' ' SER . 0.7 OUTLIER -150.65 20.84 0.81 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.229 1.014 . . . . 0.0 108.304 175.03 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -172.02 115.07 0.34 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.35 -171.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.89 162.59 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.514 -172.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -119.79 120.04 35.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.052 0.453 . . . . 0.0 110.014 171.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.405 HG23 HD11 ' A' ' 273' ' ' ILE . 27.6 pt -119.87 171.59 8.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.047 -177.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 309' ' ' THR . . . . . 0.425 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 12.7 t -150.05 142.2 15.51 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.235 175.342 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.18 -179.53 27.42 Favored 'Cis proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.764 -1.348 . . . . 0.0 113.135 -1.563 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -78.85 121.39 83.39 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.161 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.25 109.5 1.78 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.697 2.265 . . . . 0.0 111.902 175.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.3 OUTLIER -130.2 127.3 62.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.58 178.161 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -77.26 129.2 35.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.195 -177.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 44.6 tp -73.86 -26.4 60.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.664 178.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -86.25 3.97 40.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.266 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -65.61 125.09 24.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.119 177.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 31.3 m -84.46 -6.42 10.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 17.3 m -91.49 -29.25 17.11 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.61 0.243 . . . . 0.0 111.248 -173.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 1.7 pp -73.4 167.38 21.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.405 0.622 . . . . 0.0 111.79 -179.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.407 ' H ' ' NE2' ' A' ' 324' ' ' GLN . 5.8 m -99.23 160.96 26.25 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.198 -177.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.435 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 46.5 Cg_exo -39.97 -52.94 2.61 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.578 2.852 . . . . 0.0 114.165 178.438 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -61.37 -34.02 74.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.05 0.453 . . . . 0.0 111.187 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . 0.488 ' OE1' ' HD2' ' A' ' 238' ' ' PRO . 45.7 mt-30 -67.45 -25.07 65.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.025 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 44.8 mtm180 -63.31 -36.05 82.39 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.06 0.457 . . . . 0.0 110.042 175.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -63.54 -31.06 72.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.067 179.25 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -87.51 -10.53 51.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.392 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.465 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -69.79 146.99 51.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.699 0.285 . . . . 0.0 111.267 -177.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . 0.435 ' OD1' HG12 ' A' ' 330' ' ' VAL . 3.3 p30 -134.39 -36.6 0.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -174.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.435 HG12 ' OD1' ' A' ' 329' ' ' ASN . 34.5 m -101.75 170.1 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.935 -178.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -82.89 -47.4 11.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.886 0.374 . . . . 0.0 110.83 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 72.1 p -124.72 141.48 52.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.768 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 34.9 m -70.66 171.81 9.75 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.091 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 20.5 tp -71.72 103.12 2.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.093 0.473 . . . . 0.0 110.065 -175.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.572 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -91.51 -177.89 4.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.331 179.303 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -73.53 151.02 41.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.937 0.399 . . . . 0.0 110.867 -178.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 66.15 29.01 10.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.198 179.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.7 mmt -88.67 127.02 35.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -82.7 130.68 35.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.989 0.423 . . . . 0.0 111.323 -176.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 13.8 t -92.36 120.08 40.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.427 178.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -125.96 128.4 47.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.119 -175.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 9.6 mt -93.6 134.1 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 172.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 69.8 mt . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.145 179.032 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 60.55 54.98 32.6 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.897 -178.253 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 263' ' ' ALA . 55.9 mt -102.11 146.26 10.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 7.7 p -97.7 147.35 24.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.536 0.684 . . . . 0.0 111.903 -177.424 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.638 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.7 p -59.81 150.94 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.708 -178.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.9 t -97.96 74.63 2.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 79.99 158.69 16.89 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.596 179.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.51 146.58 53.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.709 0.29 . . . . 0.0 110.431 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -155.93 136.3 13.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.155 0.503 . . . . 0.0 110.721 -179.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.1 p -118.97 122.1 41.45 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.805 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.53 ' O ' HG13 ' A' ' 313' ' ' VAL . 54.3 m-85 -88.74 147.59 24.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.394 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.43 ' HD2' ' HB3' ' A' ' 320' ' ' LEU . 34.4 mmtp -127.28 139.85 36.3 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.023 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 N--CA 1.453 -0.902 0 C-N-CA 122.922 2.415 . . . . 0.0 110.993 173.27 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.812 0.339 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -140.08 131.63 27.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.192 175.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.3 OUTLIER -101.02 102.6 13.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.093 0.473 . . . . 0.0 110.226 179.862 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.443 ' O ' ' HD2' ' A' ' 305' ' ' HIS . 3.3 t -82.48 120.87 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.059 -172.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 9.6 m -91.2 105.51 17.85 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.197 -179.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 19.3 mt -126.61 163.71 22.85 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -175.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 10.4 t -63.18 -49.17 75.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.191 0.52 . . . . 0.0 109.704 -178.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.452 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -137.08 138.22 40.14 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.333 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 15.8 p -130.51 25.22 5.11 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.84 0.828 . . . . 0.0 109.087 175.626 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.2 m -76.64 147.48 37.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.295 175.134 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.0 -18.82 56.57 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -175.021 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 56.8 mtt -87.03 139.58 30.43 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 11.5 ptmm? -143.75 145.46 32.41 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.035 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -46.34 122.6 4.14 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.921 0.763 . . . . 0.0 112.891 -170.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 98.36 18.85 24.99 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.689 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 268' ' ' LYS . 1.1 t70 -100.08 -176.92 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.926 0.393 . . . . 0.0 110.749 -176.513 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.444 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 3.7 tppp? -122.69 116.27 23.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.225 -175.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 308' ' ' ILE . 17.9 pt -120.21 139.9 46.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 120.916 0.389 . . . . 0.0 110.326 175.652 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 54.8 p -124.1 141.06 52.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.008 179.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -107.47 111.06 23.18 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.874 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.47 119.24 10.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.605 -178.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.26 -34.1 5.35 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.137 -0.554 . . . . 0.0 111.794 -178.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 70.6 t -90.93 137.15 22.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 177.044 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 279' ' ' LYS . 8.3 ptpt -159.97 160.79 33.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.076 0.465 . . . . 0.0 111.548 178.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -78.37 154.25 30.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.729 -172.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 65.8 mt . . . . . 0 C--N 1.325 -0.496 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.456 179.064 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 . . . . . 0 C--O 1.233 0.218 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -59.14 111.19 1.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.048 -172.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.444 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 0.8 OUTLIER -94.3 123.39 37.67 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.795 176.32 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -121.39 148.57 44.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.407 178.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.6 m -91.62 122.22 33.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.722 178.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 271' ' ' ASP . 11.3 p -73.21 121.5 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.388 0.613 . . . . 0.0 110.112 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.2 t -84.53 -41.59 16.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.447 -178.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.516 ' HD2' ' OE2' ' A' ' 307' ' ' GLU . 0.9 OUTLIER -165.55 136.22 3.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.825 -175.749 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 84.4 t -90.17 111.77 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.416 175.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 14.9 t -78.09 -58.94 3.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.78 -173.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -116.87 -3.39 11.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.904 0.383 . . . . 0.0 111.8 -172.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 69.3 12.86 66.75 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -170.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.8 p -145.6 16.79 1.47 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 174.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.443 ' HD2' ' O ' ' A' ' 259' ' ' VAL . 5.6 t-160 -170.89 118.32 0.49 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.631 -1.168 . . . . 0.0 107.865 -170.316 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -118.73 156.97 20.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -173.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.516 ' OE2' ' HD2' ' A' ' 299' ' ' ARG . 10.8 pt-20 -114.26 122.14 45.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.126 0.488 . . . . 0.0 109.864 171.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.435 HG21 HD13 ' A' ' 273' ' ' ILE . 33.6 pt -118.88 175.01 4.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.232 -177.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 15.1 t -154.23 138.34 11.06 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.071 174.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.61 -178.94 25.51 Favored 'Cis proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.909 -1.288 . . . . 0.0 112.806 -1.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 22.0 ttmm -80.24 131.28 62.83 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.044 -179.146 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 3.7 Cg_exo -75.73 108.44 2.69 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.249 1.966 . . . . 0.0 111.496 173.614 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 236' ' ' PHE . 1.0 OUTLIER -126.02 136.58 60.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.106 177.557 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -91.95 138.03 31.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.348 0.594 . . . . 0.0 112.292 -170.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 315' ' ' LEU . 3.3 tm? -80.77 -31.73 35.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.185 178.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -85.38 8.18 19.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.265 -177.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . 0.492 ' OD2' ' HG ' ' A' ' 320' ' ' LEU . 23.5 t70 -83.22 129.52 35.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.203 179.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 11.9 p -84.8 -19.62 8.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.804 0.335 . . . . 0.0 111.268 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 36.8 t -69.66 -42.97 73.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.36 -172.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.492 ' HG ' ' OD2' ' A' ' 317' ' ' ASP . 0.4 OUTLIER -76.92 152.08 35.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.485 0.659 . . . . 0.0 111.165 176.426 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 18.1 m -86.1 163.18 44.02 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.151 -173.526 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 41.6 Cg_exo -37.59 -54.37 1.25 Allowed 'Trans proline' 0 C--N 1.356 0.974 0 C-N-CA 124.306 3.337 . . . . 0.0 114.889 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -64.96 -34.04 77.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.945 0.402 . . . . 0.0 111.235 -176.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -69.18 -32.74 72.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.032 0.444 . . . . 0.0 109.906 177.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.485 ' HG2' HD13 ' A' ' 320' ' ' LEU . 98.2 mtt180 -65.7 -26.71 67.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.744 175.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -72.64 -20.19 61.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.143 0.496 . . . . 0.0 110.609 176.399 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -97.56 -0.36 45.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.738 176.086 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.513 ' HA ' HG22 ' A' ' 313' ' ' VAL . . . -65.8 132.7 49.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.005 0.431 . . . . 0.0 111.078 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . 0.424 ' H ' HG22 ' A' ' 313' ' ' VAL . 91.5 m-20 -108.29 -32.17 7.58 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.901 -172.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.59 172.83 6.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.668 -177.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -86.23 -48.68 8.33 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.647 0.26 . . . . 0.0 111.452 -178.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.7 t -118.32 149.72 40.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.038 0.447 . . . . 0.0 110.875 -175.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 28.7 p -79.75 174.21 11.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.815 176.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.9 tp -78.27 103.7 8.37 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -176.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.638 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.52 174.69 11.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.743 -178.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -81.55 10.41 5.96 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.178 0.806 . . . . 0.0 113.178 -168.254 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -141.01 33.58 1.75 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.915 0.388 . . . . 0.0 111.318 177.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 14.3 mmt -86.19 131.75 34.17 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -86.18 130.87 34.38 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.774 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 18.1 t -104.75 111.64 35.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.829 178.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -126.04 136.65 53.2 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.67 -177.226 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 17.7 mt -85.25 121.15 36.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.924 0.393 . . . . 0.0 110.64 175.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 41.1 mt . . . . . 0 C--N 1.323 -0.575 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.788 175.772 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 29.8 p . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 119.918 -0.087 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 52.76 53.23 34.03 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.644 176.517 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.556 HD11 ' O ' ' A' ' 263' ' ' ALA . 42.6 mm -102.85 140.22 21.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -177.504 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.3 p -121.5 159.34 26.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.957 0.408 . . . . 0.0 110.808 175.18 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.606 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.0 p -80.78 150.4 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.236 177.372 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 75.1 m -116.1 86.26 2.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.219 0.533 . . . . 0.0 110.423 176.004 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 94.51 138.55 9.38 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.398 179.592 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.29 132.09 46.5 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.002 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -141.6 127.36 19.2 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.425 0.631 . . . . 0.0 111.067 -175.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.9 p -117.87 114.61 23.5 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.129 179.095 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -81.1 164.02 22.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.075 -178.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . 44.8 mmtm -135.78 130.76 18.84 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.85 0.357 . . . . 0.0 111.348 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 237' ' ' LYS . 71.7 Cg_endo . . . . . 0 N--CA 1.449 -1.126 0 C-N-CA 122.885 2.39 . . . . 0.0 111.685 177.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.504 ' CE1' HG21 ' A' ' 298' ' ' VAL . 56.7 m-85 . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.004 0.431 . . . . 0.0 110.716 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.17 137.21 38.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.597 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.0 OUTLIER -97.69 107.15 19.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.268 0.556 . . . . 0.0 110.671 -177.889 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.455 ' HB ' HG22 ' A' ' 306' ' ' VAL . 3.1 t -89.41 124.22 42.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.408 -172.765 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 37.5 m -93.63 107.4 19.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.162 177.596 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 27.9 mt -124.64 172.12 9.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.422 -174.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.3 m -64.83 -53.69 42.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.37 0.605 . . . . 0.0 109.871 179.396 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.556 ' O ' HD11 ' A' ' 228' ' ' ILE . . . -135.95 130.56 33.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.391 179.038 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.467 ' HB ' ' CG1' ' A' ' 306' ' ' VAL . 6.9 p -129.59 22.66 5.48 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.867 0.841 . . . . 0.0 108.817 174.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 15.5 m -80.59 145.37 31.77 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.564 176.17 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.99 -9.91 61.81 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -175.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 57.9 mtt -93.88 151.8 19.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.515 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 1.9 ptpp? -147.34 157.15 43.47 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.396 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -52.36 117.23 2.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.152 0.501 . . . . 0.0 110.832 -178.074 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 106.28 18.43 11.17 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.741 -177.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.515 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 7.4 m-20 -99.78 159.16 15.27 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 117.236 0.518 . . . . 0.0 110.167 176.721 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -111.62 116.75 31.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.986 -178.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.421 HD13 HG21 ' A' ' 308' ' ' ILE . 34.6 pt -113.19 140.67 32.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.217 178.609 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 22.0 p -123.14 139.98 53.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.22 178.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.403 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 93.1 m-85 -103.57 111.34 23.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.037 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.2 113.03 4.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.146 -176.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.34 -24.98 12.97 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.641 -178.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 90.6 t -97.5 128.18 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 177.296 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.436 ' HB3' ' HA ' ' A' ' 292' ' ' ASP . 15.0 ptpt -160.46 179.73 8.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.2 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -68.56 174.89 3.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.183 -172.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 75.7 mt . . . . . 0 C--N 1.326 -0.429 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -171.438 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.436 ' HA ' ' HB3' ' A' ' 279' ' ' LYS . 14.9 m-20 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -64.54 105.19 0.91 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.294 -175.19 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 15.8 p -90.93 132.66 35.81 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.597 177.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 312' ' ' PRO . 97.7 m-85 -129.79 150.78 50.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.427 179.305 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 20.1 m -96.65 125.06 40.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.122 178.56 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.407 HG11 ' H ' ' A' ' 271' ' ' ASP . 12.4 p -80.82 138.07 20.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.161 0.505 . . . . 0.0 110.61 -179.484 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.504 HG21 ' CE1' ' A' ' 256' ' ' PHE . 45.3 t -104.75 -29.53 2.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.021 -178.822 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -164.1 137.2 5.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.017 0.437 . . . . 0.0 111.171 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 87.5 t -95.75 112.19 27.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 45.1 t -75.8 -58.79 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.909 -172.251 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -123.35 -3.06 8.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.298 0.57 . . . . 0.0 111.215 -175.753 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 78.37 13.87 82.8 Favored Glycine 0 C--N 1.322 -0.24 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -173.225 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 27.1 p -142.18 14.57 2.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.3 t-160 -164.02 117.45 1.44 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.491 -169.769 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.6 m -118.46 164.67 14.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -175.459 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.2 pt-20 -125.46 123.32 38.98 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 169.478 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 256' ' ' PHE . 23.4 pt -124.44 164.3 23.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.045 -173.092 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 309' ' ' THR . . . . . 0.422 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 8.2 t -135.57 140.19 33.28 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.637 174.693 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.8 179.55 30.17 Favored 'Cis proline' 0 CA--C 1.531 0.355 0 C-N-CA 123.187 -1.589 . . . . 0.0 112.655 -1.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -70.81 119.53 73.59 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.742 177.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . 0.444 ' HD2' ' CB ' ' A' ' 257' ' ' ALA . 38.1 Cg_endo -69.5 108.94 2.14 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.436 2.091 . . . . 0.0 111.65 175.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.488 ' CG2' ' HA ' ' A' ' 328' ' ' ALA . 0.2 OUTLIER -135.43 135.31 51.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.825 -178.497 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -83.4 129.76 35.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.251 -176.516 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . 0.411 ' O ' HD11 ' A' ' 315' ' ' LEU . 3.1 tm? -68.86 -26.07 64.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.45 178.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -99.31 18.3 17.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.103 -179.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . 0.432 ' HB3' ' HG ' ' A' ' 320' ' ' LEU . 9.9 t0 -65.47 130.85 44.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.726 178.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 30.4 m -83.16 1.98 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -173.194 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 14.2 t -125.78 28.34 6.2 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.064 -0.654 . . . . 0.0 112.441 -176.086 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.468 HD12 ' HG2' ' A' ' 325' ' ' ARG . 0.7 OUTLIER -123.54 164.76 18.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.131 0.491 . . . . 0.0 111.551 175.43 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.413 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.3 m -101.92 164.92 14.88 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.678 -179.284 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 86.4 Cg_exo -44.19 -50.18 7.96 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.641 2.894 . . . . 0.0 114.537 -176.623 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -66.34 -27.7 68.09 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -177.383 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -71.6 -28.9 64.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.005 0.431 . . . . 0.0 109.976 177.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.468 ' HG2' HD12 ' A' ' 320' ' ' LEU . 55.8 mtp180 -70.82 -18.93 62.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.434 178.019 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -74.52 -32.7 62.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.288 176.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -85.51 -4.25 59.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.742 177.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.488 ' HA ' ' CG2' ' A' ' 313' ' ' VAL . . . -63.3 159.62 17.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.06 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -138.65 -49.15 0.52 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.831 0.348 . . . . 0.0 111.244 -175.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.2 m -105.72 161.67 5.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.647 -175.963 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -91.78 -5.46 53.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.01 -176.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 8.0 t -147.73 136.3 21.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.527 -176.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.1 p -80.11 163.56 24.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.365 178.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 19.2 tp -70.57 106.09 3.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.968 0.413 . . . . 0.0 110.724 -173.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.606 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -79.53 173.53 12.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.81 -178.449 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -81.05 4.04 21.16 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -166.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -143.62 45.7 1.49 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.064 0.459 . . . . 0.0 111.421 176.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 338' ' ' MET . . . . . 0.42 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 22.8 mmt -92.17 143.56 26.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.214 178.018 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.42 138.45 33.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.422 179.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 19.1 t -112.9 116.96 54.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.14 0.495 . . . . 0.0 109.91 -178.603 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -125.41 138.9 54.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.891 -175.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 21.7 mt -96.65 132.68 40.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.68 0.276 . . . . 0.0 110.452 174.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 54.9 mt . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.193 176.563 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 33.9 p . . . . . 0 N--CA 1.447 -0.58 0 CA-C-O 121.084 0.468 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.0 61.24 0.43 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 177.054 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 263' ' ' ALA . 23.7 mt -102.87 154.24 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.583 0.23 . . . . 0.0 110.841 -174.065 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 18.9 p -114.75 171.25 7.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.142 0.496 . . . . 0.0 111.571 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 335' ' ' ALA . 8.1 p -87.35 150.15 3.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.87 -178.227 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 62.2 m -114.98 91.44 3.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.827 0.346 . . . . 0.0 110.393 175.638 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 90.46 161.41 37.41 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.143 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -83.27 117.73 23.17 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.934 0.397 . . . . 0.0 110.15 178.651 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -109.07 126.37 53.09 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.097 0.475 . . . . 0.0 109.958 179.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 10.2 p -121.29 125.63 47.52 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.618 -178.318 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.576 ' HB2' ' O ' ' A' ' 312' ' ' PRO . 86.2 m-85 -109.08 145.43 35.66 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.899 -179.118 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -133.4 144.27 51.61 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.984 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.411 ' HD2' HE21 ' A' ' 324' ' ' GLN . 59.9 Cg_endo . . . . . 0 N--CA 1.456 -0.713 0 C-N-CA 122.169 1.912 . . . . 0.0 110.863 173.18 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 . . . . . 0 CA--C 1.521 -0.147 0 CA-C-O 120.726 0.298 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -107.59 117.29 33.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.57 178.044 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 4.1 m -89.68 109.19 20.18 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.034 0.445 . . . . 0.0 110.314 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.0 t -92.73 122.27 44.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.593 -172.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 25.2 m -91.33 115.05 27.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.948 175.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 26.0 mt -132.78 172.41 12.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.273 -175.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 14.9 m -62.95 -56.48 16.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.476 0.655 . . . . 0.0 109.503 177.547 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.649 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -136.93 140.99 42.66 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.8 177.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 10.9 p -131.39 23.15 4.77 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.283 1.04 . . . . 0.0 108.205 173.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 7.6 m -77.93 142.64 38.26 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.859 -1.519 . . . . 0.0 109.649 176.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 97.96 -15.16 62.01 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -175.692 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 61.7 mtt -89.15 151.07 22.4 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -135.44 164.24 28.22 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -62.62 140.24 58.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.867 179.237 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.93 19.04 62.03 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.829 173.059 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.45 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 1.2 t70 -105.74 -166.73 1.24 Allowed 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 118.038 0.919 . . . . 0.0 110.458 -178.293 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -125.54 116.28 21.52 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.702 -178.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 19.6 pt -113.69 139.69 37.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.49 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.481 ' OG ' HG22 ' A' ' 294' ' ' THR . 2.9 m -122.19 140.39 52.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.486 -175.117 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -105.97 111.41 24.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.334 178.273 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -71.5 117.93 13.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.27 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.79 -17.55 22.76 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.611 -176.254 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.53 124.24 71.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.465 ' HZ2' ' HB3' ' A' ' 279' ' ' LYS . 1.0 OUTLIER -138.86 165.23 27.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.917 0.389 . . . . 0.0 111.757 -176.042 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -82.57 148.39 28.07 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.323 -176.226 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.714 -176.775 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.771 0.319 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.611 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -66.77 81.84 0.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.316 -177.703 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.481 HG22 ' OG ' ' A' ' 274' ' ' SER . 12.6 p -85.07 89.69 7.68 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.309 177.485 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.611 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 51.1 m-85 -96.03 149.24 21.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.279 0.561 . . . . 0.0 111.364 -176.171 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.9 m -91.51 126.76 36.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.969 -179.458 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.45 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 8.7 p -87.77 141.52 14.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.184 -178.346 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 13.3 p -104.78 -26.01 3.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.714 179.339 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -170.34 146.82 2.94 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.931 0.396 . . . . 0.0 111.086 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.69 121.0 41.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 169.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.22 -58.03 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.932 -172.544 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -129.02 -5.23 5.01 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.285 0.564 . . . . 0.0 111.631 -175.244 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.27 12.01 81.33 Favored Glycine 0 CA--C 1.518 0.247 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -175.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 22.2 p -145.05 16.24 1.55 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 171.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.9 t-160 -169.29 117.92 0.65 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.092 -1.413 . . . . 0.0 107.59 -167.264 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.6 m -119.58 168.57 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 117.706 0.23 . . . . 0.0 110.736 -174.651 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -126.18 118.18 24.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.259 0.552 . . . . 0.0 110.026 171.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 297' ' ' VAL . 35.1 pt -119.84 174.28 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.341 -176.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.2 t -154.65 143.07 14.5 Favored Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.461 176.407 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -76.18 -179.12 25.96 Favored 'Cis proline' 0 C--N 1.345 0.344 0 C-N-CA 124.105 -1.206 . . . . 0.0 112.909 -3.076 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.432 ' HD3' ' HB3' ' A' ' 236' ' ' PHE . 2.5 ttmp? -75.09 132.1 77.46 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.12 -178.093 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . 0.576 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 9.3 Cg_exo -71.82 108.15 2.37 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.326 2.017 . . . . 0.0 111.192 173.381 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 329' ' ' ASN . 4.4 m -130.11 128.01 64.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.788 -177.709 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 317' ' ' ASP . . . -87.66 141.56 28.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.307 0.575 . . . . 0.0 112.238 -172.728 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -81.0 -28.8 35.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.996 -179.305 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -100.31 20.66 14.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.671 -176.336 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 11.6 t70 -83.38 124.08 30.3 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.277 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 9.3 p -82.96 -11.96 12.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.874 0.369 . . . . 0.0 111.608 -175.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 15.7 m -86.66 0.74 53.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.693 -172.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 1.5 pp -106.77 169.83 8.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.829 0.347 . . . . 0.0 111.312 179.508 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 28.2 t -85.88 148.03 47.29 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.539 175.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -42.72 -43.99 8.79 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.112 2.541 . . . . 0.0 113.662 -177.683 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -61.01 -29.99 70.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.958 0.408 . . . . 0.0 111.465 -178.139 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . 0.411 HE21 ' HD2' ' A' ' 238' ' ' PRO . 18.8 mt-30 -71.16 -25.55 62.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.509 -178.582 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -62.67 -34.99 78.24 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.214 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.37 -24.06 65.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.948 178.296 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -103.21 11.82 36.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 177.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -73.89 164.87 26.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.865 178.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . 0.416 ' N ' HG22 ' A' ' 313' ' ' VAL . 50.4 t30 -139.99 -43.53 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.606 -172.655 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.6 m -111.21 175.33 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.698 0.285 . . . . 0.0 111.02 -178.663 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -80.48 -50.22 10.35 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.699 0.285 . . . . 0.0 111.454 -177.112 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.7 t -130.91 151.83 50.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.413 -177.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 49.0 m -71.4 167.47 19.51 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 174.004 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 27.8 tp -70.91 103.71 2.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 110.147 -176.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.517 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -89.76 -170.92 2.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.194 178.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -76.86 162.48 27.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.855 0.36 . . . . 0.0 110.705 -179.336 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 58.31 45.97 16.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.089 178.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 338' ' ' MET . . . . . 0.444 ' H ' HG11 ' A' ' 230' ' ' VAL . 24.8 mmt -114.61 131.04 56.84 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.339 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -85.53 138.98 31.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.008 -179.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 14.2 t -113.12 114.47 47.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.649 178.386 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -132.22 138.49 47.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.808 0.337 . . . . 0.0 111.813 -173.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 21.4 mt -91.6 123.29 43.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.846 174.537 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 59.2 mt . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.282 178.809 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 38.9 p . . . . . 0 N--CA 1.45 -0.435 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.82 50.92 62.45 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.359 178.3 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.485 HD12 ' O ' ' A' ' 263' ' ' ALA . 48.0 mm -89.29 144.35 9.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -178.695 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 23.2 p -122.39 156.66 33.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.297 0.57 . . . . 0.0 111.262 176.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 335' ' ' ALA . 7.1 p -73.84 151.16 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.043 179.395 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.3 t -115.37 64.62 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.208 0.528 . . . . 0.0 109.983 178.124 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 106.11 149.67 17.59 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.323 -179.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -59.37 125.49 23.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.904 0.383 . . . . 0.0 111.127 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 334' ' ' LEU . 26.3 mm-40 -113.24 126.6 55.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.961 0.41 . . . . 0.0 110.269 179.133 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 p -122.97 105.04 9.63 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.131 177.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -89.55 146.78 24.35 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.168 -173.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -144.08 121.12 6.54 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.776 178.719 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo . . . . . 0 N--CA 1.453 -0.893 0 C-N-CA 122.777 2.318 . . . . 0.0 110.694 168.144 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.48 122.57 43.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.556 0.217 . . . . 0.0 111.135 -177.724 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.4 m -96.31 107.38 19.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.044 0.45 . . . . 0.0 110.104 -179.526 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.5 t -92.91 119.32 40.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.767 -171.107 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 18.5 m -89.74 106.19 18.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.18 0.514 . . . . 0.0 109.983 174.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.438 ' HB2' ' CG2' ' A' ' 264' ' ' THR . 30.1 mt -121.29 169.37 10.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.058 -176.142 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 30.2 p -67.53 -48.26 67.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.334 0.588 . . . . 0.0 109.881 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.485 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -135.77 130.3 33.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.472 178.279 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.438 ' CG2' ' HB2' ' A' ' 261' ' ' LEU . 4.8 p -132.47 17.93 4.38 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.314 173.609 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 39.4 m -84.2 147.26 27.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.31 174.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 92.96 -5.48 75.98 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -171.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 70.9 mtp -108.67 138.66 44.63 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -137.7 154.33 49.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.779 0.323 . . . . 0.0 110.547 -178.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -59.61 135.32 57.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.64 -174.503 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 102.86 18.32 15.96 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.728 -0.749 . . . . 0.0 113.027 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.479 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 2.7 t0 -113.82 -169.57 1.54 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 117.369 0.585 . . . . 0.0 109.814 177.314 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.459 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 4.7 tppp? -124.18 116.56 22.91 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.592 -178.125 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.428 HD12 HG21 ' A' ' 308' ' ' ILE . 15.6 pt -117.19 140.48 39.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 120.131 -0.627 . . . . 0.0 109.965 179.106 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 44.2 p -126.21 150.87 48.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.145 -178.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.446 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 89.0 m-85 -111.83 111.32 22.2 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.065 -178.862 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.01 111.98 3.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 -178.032 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 113.67 -35.52 4.48 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -178.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 97.6 t -87.06 110.83 20.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -137.14 179.48 6.36 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.328 -174.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -69.08 172.81 6.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.109 -177.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 73.6 mt . . . . . 0 C--N 1.326 -0.446 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -175.001 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 120.747 0.308 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.441 ' HB2' ' CE2' ' A' ' 295' ' ' PHE . . . -61.31 107.3 0.74 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.006 -177.392 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 61.2 p -95.01 125.35 39.61 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.572 -179.491 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.473 ' CE2' ' HG3' ' A' ' 312' ' ' PRO . 88.1 m-85 -128.18 152.92 47.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.103 0.478 . . . . 0.0 111.132 -179.316 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 41.9 m -92.1 125.79 36.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.312 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.479 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.0 p -76.98 127.74 37.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.085 0.469 . . . . 0.0 110.415 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 23.4 t -100.59 -35.72 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.202 -175.594 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -164.32 142.57 7.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 111.124 -179.107 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 94.5 t -102.69 117.84 48.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 170.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 46.0 t -77.19 -55.7 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.122 -172.369 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -128.49 -1.27 5.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.057 0.456 . . . . 0.0 111.604 -175.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 83.25 14.31 74.68 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.216 -176.501 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 1.8 p -145.97 19.93 1.44 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 171.449 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -165.71 115.75 1.03 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.476 -171.584 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.2 m -119.05 164.89 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 110.235 -0.284 . . . . 0.0 110.235 -174.585 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 10.9 pt-20 -125.48 132.02 52.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.118 0.485 . . . . 0.0 109.9 169.673 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.428 HG21 HD12 ' A' ' 273' ' ' ILE . 21.5 pt -125.38 164.32 24.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.363 -176.347 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.4 t -141.86 141.16 21.26 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.714 175.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.75 -179.61 27.04 Favored 'Cis proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.964 -1.265 . . . . 0.0 112.532 -3.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 31.4 ttmt -86.31 126.25 65.32 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . 0.473 ' HG3' ' CE2' ' A' ' 295' ' ' PHE . 8.7 Cg_exo -70.07 112.14 3.05 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.875 2.384 . . . . 0.0 112.712 178.609 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.479 HG21 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -119.39 128.94 75.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.789 172.661 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.677 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -88.02 138.72 31.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.906 -176.12 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -68.53 -28.63 67.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.689 178.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -92.44 10.03 31.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.755 -179.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 314' ' ' ALA . 9.9 t70 -72.57 122.22 21.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.996 0.426 . . . . 0.0 109.909 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.2 m -84.49 2.32 4.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.225 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.7 p -119.84 29.17 7.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -174.343 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 2.0 pp -128.74 161.22 30.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.061 0.458 . . . . 0.0 111.633 176.418 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 19.7 m -85.24 162.03 50.16 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.323 -177.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.463 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 96.0 Cg_exo -46.0 -46.3 16.21 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.32 2.68 . . . . 0.0 113.927 -177.649 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.23 -33.07 75.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.679 0.276 . . . . 0.0 111.267 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 50.9 mt-30 -69.32 -35.95 76.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.235 -177.052 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 8.0 ptp180 -74.8 -23.54 58.5 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.089 0.471 . . . . 0.0 110.206 178.91 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -72.03 -18.65 61.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.129 175.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -109.21 11.15 25.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.505 175.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.479 ' HA ' HG21 ' A' ' 313' ' ' VAL . . . -67.36 142.44 56.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.514 177.06 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . 0.405 ' OD1' HG12 ' A' ' 330' ' ' VAL . 5.6 p30 -125.39 -20.55 4.76 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -175.424 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.1 m -115.45 155.09 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.728 179.426 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -91.98 -2.48 56.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.781 -174.18 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 14.7 t -162.4 152.79 16.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.803 0.335 . . . . 0.0 110.254 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.0 p -86.88 165.56 15.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.114 179.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 234' ' ' GLN . 18.0 tp -68.27 108.0 3.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -177.483 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.602 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -80.35 -177.92 6.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.286 -177.122 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.48 1.49 29.13 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -172.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -147.87 54.94 1.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.224 0.535 . . . . 0.0 111.395 177.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 338' ' ' MET . . . . . 0.415 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 22.8 mmt -101.33 142.52 32.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.799 176.102 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.64 140.55 30.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.467 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 22.0 t -114.66 120.11 63.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.312 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -136.78 144.26 43.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.85 0.357 . . . . 0.0 111.147 -175.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 31.3 mt -93.86 128.47 45.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.71 178.093 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.566 -179.809 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 29.0 p . . . . . 0 N--CA 1.446 -0.652 0 CA-C-O 121.489 0.661 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -109.8 52.15 0.66 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 173.281 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.546 HG21 ' O ' ' A' ' 263' ' ' ALA . 22.7 mt -93.66 159.07 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.273 -0.463 . . . . 0.0 110.275 -173.0 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 13.3 p -118.23 153.42 33.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.281 0.563 . . . . 0.0 111.332 179.048 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 335' ' ' ALA . 9.3 p -66.74 152.58 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.83 177.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.5 t -114.99 78.92 1.21 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.13 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 101.58 151.07 24.23 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.699 179.574 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -85.63 141.54 29.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.463 0.173 . . . . 0.0 110.609 179.579 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -157.62 150.47 23.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.159 0.504 . . . . 0.0 111.771 -177.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 38.4 p -153.39 102.33 2.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.994 172.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -80.61 143.9 32.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.775 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -107.51 134.46 19.98 Favored Pre-proline 0 C--N 1.323 -0.577 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.264 -177.228 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 N--CA 1.449 -1.113 0 C-N-CA 122.747 2.298 . . . . 0.0 110.647 169.065 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.824 0.345 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.27 132.91 53.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 177.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.4 m -94.85 114.27 26.12 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.041 0.448 . . . . 0.0 110.368 178.52 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.9 t -93.76 122.27 45.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.282 -173.882 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 3.0 m -94.0 106.7 18.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.049 179.527 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 23.1 mt -126.35 168.14 14.56 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.412 -174.026 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.6 t -63.25 -54.87 30.5 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.546 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.09 136.84 38.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.266 178.543 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 15.9 p -129.7 25.27 5.36 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.028 0.918 . . . . 0.0 108.558 175.23 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 17.4 m -82.96 153.44 25.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.284 -1.326 . . . . 0.0 109.712 176.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 90.7 -6.44 82.05 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -174.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 47.8 mtt -104.3 147.45 27.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.828 -0.686 . . . . 0.0 109.314 178.524 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 0.0 OUTLIER -139.62 158.05 44.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.307 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -54.47 132.65 45.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.182 0.515 . . . . 0.0 111.437 -176.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 95.11 19.03 31.98 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.099 -177.271 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 268' ' ' LYS . 1.1 t0 -103.46 169.01 8.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.7 0.286 . . . . 0.0 110.289 -178.284 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -118.5 115.46 24.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.996 -178.137 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.429 HD12 HG23 ' A' ' 308' ' ' ILE . 30.0 pt -112.78 139.74 36.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.039 0.447 . . . . 0.0 110.061 179.52 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.4 ' OG ' HG23 ' A' ' 294' ' ' THR . 7.1 m -124.48 133.47 53.34 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.871 -179.188 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -100.0 111.42 23.72 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.206 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.464 ' HA ' ' OD1' ' A' ' 292' ' ' ASP . . . -66.51 120.54 13.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.342 -179.2 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.95 -25.95 12.2 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -176.591 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.546 ' HA ' ' OG1' ' A' ' 332' ' ' THR . 47.0 t -100.28 119.74 48.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.772 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -136.34 157.48 46.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.035 0.445 . . . . 0.0 111.436 -173.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -72.94 118.87 16.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.245 179.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 331' ' ' ASN . 1.5 pt? . . . . . 0 C--N 1.323 -0.544 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.464 ' OD1' ' HA ' ' A' ' 276' ' ' ALA . 49.4 m-20 . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -65.81 101.14 0.61 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.037 -178.661 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.4 HG23 ' OG ' ' A' ' 274' ' ' SER . 45.4 p -84.05 117.16 23.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.959 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -120.64 148.31 44.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.921 0.391 . . . . 0.0 110.624 177.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 8.5 m -94.88 127.75 41.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.257 -178.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.464 HG12 ' H ' ' A' ' 271' ' ' ASP . 7.4 p -79.9 134.02 28.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.271 0.558 . . . . 0.0 110.286 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.413 ' HB ' ' HG3' ' A' ' 307' ' ' GLU . 61.0 t -95.13 -38.7 9.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.859 -178.927 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -166.82 139.88 3.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.752 0.311 . . . . 0.0 110.235 -179.199 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 86.8 t -83.88 103.75 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.622 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 18.4 t -72.58 -58.21 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.024 -171.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -116.69 -9.98 11.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.98 0.419 . . . . 0.0 111.817 -174.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 78.03 11.39 85.43 Favored Glycine 0 CA--C 1.516 0.136 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -173.378 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 20.3 p -148.98 18.53 0.98 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 173.43 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.524 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.8 t-160 -169.43 113.59 0.53 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.006 -165.079 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.5 m -119.06 163.17 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 121.206 -0.198 . . . . 0.0 110.57 -173.413 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.413 ' HG3' ' HB ' ' A' ' 298' ' ' VAL . 11.5 pt-20 -116.92 128.5 55.29 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 171.255 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.429 HG23 HD12 ' A' ' 273' ' ' ILE . 29.8 pt -126.61 168.15 20.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.123 0.487 . . . . 0.0 111.938 -176.104 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.3 t -146.92 138.57 13.38 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.049 174.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.36 -179.66 27.75 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.815 -1.327 . . . . 0.0 112.721 -1.599 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 38.6 ttmt -79.51 124.07 84.03 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.258 -178.479 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 13.4 Cg_exo -68.86 113.44 3.22 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.972 2.448 . . . . 0.0 112.384 177.416 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.415 HG21 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -123.96 129.28 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.355 176.229 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -86.53 129.34 34.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.876 -177.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.83 -27.49 68.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.719 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -95.75 15.19 20.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -81.96 127.66 33.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.291 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.2 m -84.17 -3.48 7.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -174.027 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 14.7 m -96.82 1.38 50.62 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -174.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.0 OUTLIER -111.18 156.37 21.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.211 0.529 . . . . 0.0 111.403 178.515 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.448 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 16.0 m -94.07 165.7 17.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.11 -175.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 66.6 Cg_exo -42.96 -49.0 7.23 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 123.697 2.932 . . . . 0.0 114.253 -178.627 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -62.53 -39.51 93.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 0.0 110.949 -179.101 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 47.5 mt-30 -67.56 -33.25 74.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.309 179.592 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 321' ' ' SER . 83.2 mtt180 -60.86 -32.6 72.02 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.859 175.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -69.02 -25.11 64.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.677 179.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -95.52 -0.74 51.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 178.51 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.415 ' HA ' HG21 ' A' ' 313' ' ' VAL . . . -73.76 107.4 5.98 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.237 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . 0.493 ' ND2' HG12 ' A' ' 330' ' ' VAL . 5.6 p-10 -92.3 -5.38 52.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.157 -176.004 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.493 HG12 ' ND2' ' A' ' 329' ' ' ASN . 28.1 m -133.21 155.92 41.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.562 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . 0.412 ' HB3' ' HB3' ' A' ' 281' ' ' LEU . 24.9 p-10 -93.99 -26.53 16.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.764 -178.669 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 332' ' ' THR . . . . . 0.546 ' OG1' ' HA ' ' A' ' 278' ' ' VAL . 43.2 p -109.21 139.48 44.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.165 0.507 . . . . 0.0 111.311 -179.033 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 46.9 p -86.57 169.56 12.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.328 176.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.9 tp -74.91 102.22 4.69 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.664 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -82.3 165.86 20.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.961 -179.886 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -78.99 26.27 0.26 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -172.498 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -154.49 41.13 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.01 0.433 . . . . 0.0 110.911 176.111 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 338' ' ' MET . . . . . 0.432 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 23.4 mmt -99.32 149.66 22.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 177.786 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 276' ' ' ALA . . . -99.99 143.88 29.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.949 -179.111 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.5 t -110.91 115.8 50.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.143 -178.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -132.7 137.55 46.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.861 -177.273 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 24.2 mt -97.9 129.5 48.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.718 178.375 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 59.8 mt . . . . . 0 C--N 1.325 -0.484 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.321 178.123 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 46.4 p . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 120.471 0.177 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -73.67 69.45 1.48 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.758 -177.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.498 HG21 ' O ' ' A' ' 263' ' ' ALA . 38.4 mt -102.33 152.6 5.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.477 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -99.86 169.6 9.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.392 0.615 . . . . 0.0 112.315 -177.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 335' ' ' ALA . 10.4 p -81.61 152.08 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.752 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.3 t -104.55 80.77 1.71 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 91.02 165.38 40.07 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.177 -179.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -96.33 136.88 36.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.603 0.239 . . . . 0.0 110.44 179.206 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -149.27 127.16 11.85 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.36 0.6 . . . . 0.0 111.327 179.602 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.486 ' HA ' ' HB3' ' A' ' 333' ' ' SER . 11.6 p -98.14 120.65 38.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.267 177.347 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.86 157.99 25.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.935 -175.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -141.87 132.15 12.77 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.351 -179.498 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.445 ' HD3' HG11 ' A' ' 313' ' ' VAL . 70.6 Cg_endo . . . . . 0 N--CA 1.455 -0.762 0 C-N-CA 122.528 2.152 . . . . 0.0 112.063 178.438 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -113.88 114.36 26.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.307 177.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -84.16 103.02 13.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.432 0.634 . . . . 0.0 111.306 179.012 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.8 t -83.24 124.62 39.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.351 -177.273 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 6.1 m -97.82 105.77 17.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.912 178.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.433 ' HB2' HG21 ' A' ' 264' ' ' THR . 17.4 mt -123.04 165.76 16.26 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.998 -174.537 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.7 m -57.06 -56.71 18.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.434 0.635 . . . . 0.0 109.649 179.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.498 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -138.12 134.63 34.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.874 177.154 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 264' ' ' THR . . . . . 0.433 HG21 ' HB2' ' A' ' 261' ' ' LEU . 6.7 p -123.99 24.71 8.17 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.938 0.875 . . . . 0.0 108.723 175.132 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 44.9 m -75.4 131.79 40.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.16 173.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 110.48 -26.5 13.06 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -171.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -76.53 140.75 41.26 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 172.674 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -154.35 146.11 23.37 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.183 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.452 ' HA ' HG12 ' A' ' 297' ' ' VAL . 29.9 ptt180 -41.9 119.66 1.36 Allowed 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.149 0.906 . . . . 0.0 112.609 -173.334 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 110.33 -9.16 30.9 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.44 176.683 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.43 ' H ' HG13 ' A' ' 297' ' ' VAL . 2.4 p30 -77.06 -178.12 4.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.372 0.606 . . . . 0.0 111.943 -177.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.52 117.08 18.28 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.628 -178.598 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 35.5 pt -112.63 140.23 33.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.156 0.503 . . . . 0.0 110.763 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 22.7 t -121.32 145.29 48.03 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.559 178.49 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -112.33 111.46 22.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.023 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.65 120.24 15.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.591 -178.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.96 -34.24 5.19 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -178.068 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 96.1 t -90.29 115.68 30.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 173.235 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -131.46 151.41 51.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.033 0.444 . . . . 0.0 111.739 -173.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.519 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 77.5 m-85 -70.18 115.45 9.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.462 176.332 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.458 HD23 ' C ' ' A' ' 330' ' ' VAL . 2.3 pt? . . . . . 0 C--N 1.322 -0.611 0 CA-C-O 120.717 0.294 . . . . 0.0 111.114 -175.311 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 . . . . . 0 C--O 1.235 0.311 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.519 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -60.47 127.28 30.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.606 -174.531 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 29.3 p -120.03 122.95 42.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.591 -179.387 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -133.78 152.28 51.83 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 11.9 t -96.28 134.8 38.94 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.41 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 269' ' ' ARG . 4.7 p -69.79 139.98 19.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.145 178.733 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 50.2 t -104.67 -38.4 4.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.151 175.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -163.06 140.74 7.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.615 179.555 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.4 109.18 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.074 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.15 -59.61 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.017 -174.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -111.03 -13.62 14.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.291 0.567 . . . . 0.0 111.57 -175.026 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.22 13.99 77.74 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.255 -174.033 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 40.0 p -136.67 9.86 3.12 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 169.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.484 ' NE2' ' HB ' ' A' ' 258' ' ' THR . 2.2 t-160 -158.18 114.15 2.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.343 -1.299 . . . . 0.0 108.279 -168.749 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.2 m -118.69 150.98 20.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -177.011 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -111.06 117.05 32.24 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.182 0.515 . . . . 0.0 110.092 173.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.429 HG21 ' HA ' ' A' ' 297' ' ' VAL . 24.6 pt -116.67 172.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.069 -179.229 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.9 t -154.53 141.86 13.68 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.324 176.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.98 179.71 29.68 Favored 'Cis proline' 0 CA--C 1.531 0.337 0 C-N-CA 123.487 -1.464 . . . . 0.0 112.838 -3.06 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.524 ' HB2' ' HZ2' ' A' ' 311' ' ' LYS . 3.7 ttmp? -83.87 128.03 64.83 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.58 -177.774 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.97 108.93 2.56 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.379 2.053 . . . . 0.0 111.727 174.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.49 HG21 ' HA ' ' A' ' 328' ' ' ALA . 0.8 OUTLIER -123.99 136.79 59.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.028 -179.063 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -86.88 138.27 31.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.54 0.686 . . . . 0.0 112.285 -173.041 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 315' ' ' LEU . . . . . 0.44 HD23 ' HB2' ' A' ' 325' ' ' ARG . 3.0 tm? -76.58 -33.67 58.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.253 178.594 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -89.2 13.99 11.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.256 -177.305 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . 0.444 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 11.3 t70 -73.13 123.27 23.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.034 179.266 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 11.8 p -83.75 -16.55 10.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.768 -175.825 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 14.4 m -80.61 -33.78 35.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.441 -172.086 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.5 pp -82.93 159.27 22.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.445 0.641 . . . . 0.0 112.084 -177.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.41 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 18.8 m -81.07 163.97 52.75 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.428 -178.5 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 67.2 Cg_exo -43.39 -52.86 4.69 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.503 2.802 . . . . 0.0 114.35 179.763 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.93 -28.54 70.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.09 0.471 . . . . 0.0 111.135 -177.15 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 11.7 mm100 -69.22 -45.98 68.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.72 -179.008 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 325' ' ' ARG . . . . . 0.44 ' HB2' HD23 ' A' ' 315' ' ' LEU . 2.7 ptp180 -70.47 -21.15 62.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.857 0.361 . . . . 0.0 110.677 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -65.18 -28.4 69.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.983 0.421 . . . . 0.0 110.265 173.394 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -94.66 -0.2 54.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.002 179.575 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.49 ' HA ' HG21 ' A' ' 313' ' ' VAL . . . -60.85 149.87 34.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.422 178.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -124.75 -19.45 5.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.643 -176.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.0 m -127.99 163.61 31.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -83.77 -34.14 24.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.636 0.255 . . . . 0.0 111.337 -176.258 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 12.1 t -132.83 146.92 52.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.199 -178.589 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 235' ' ' SER . 30.6 m -82.2 -175.86 5.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.749 -179.416 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.1 tp -75.99 103.81 6.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.134 -176.549 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . 0.621 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -82.01 169.45 16.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.479 179.697 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -79.44 23.25 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -171.277 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -155.42 46.46 0.5 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.96 0.41 . . . . 0.0 110.805 177.323 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.0 mmt -100.07 132.23 45.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.18 178.3 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -88.5 129.31 35.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.817 179.133 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 10.3 t -97.45 147.6 6.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -160.52 138.01 9.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.496 0.189 . . . . 0.0 110.798 176.212 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 47.3 mt -88.76 121.66 39.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.052 0.453 . . . . 0.0 110.672 176.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 61.5 mt . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.714 179.195 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 11.7 t 61.99 31.67 17.95 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.321 0.581 . . . . 0.0 110.41 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 13.9 m -113.67 -32.76 6.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.153 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -77.35 138.11 39.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.396 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.45 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 23.7 p -108.39 -62.61 1.43 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.075 -178.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 61.3 52.13 53.63 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.302 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.445 HG21 ' O ' ' A' ' 263' ' ' ALA . 58.7 mt -103.37 148.39 8.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 34.5 p -97.2 150.58 20.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.603 0.716 . . . . 0.0 111.992 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.61 HG12 ' O ' ' A' ' 335' ' ' ALA . 9.8 p -63.92 151.45 8.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.025 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.9 t -115.34 81.68 1.62 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.899 0.381 . . . . 0.0 110.006 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 102.48 165.09 26.37 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.838 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -101.88 136.44 41.71 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.472 ' OE1' ' HA ' ' A' ' 259' ' ' VAL . 3.9 pt20 -144.14 139.46 28.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.247 0.546 . . . . 0.0 111.475 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 28.1 t -145.98 103.39 3.74 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.384 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -102.39 150.63 23.15 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 320' ' ' LEU . 45.9 mmtm -119.68 131.91 24.22 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.223 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.92 148.77 25.36 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.603 2.202 . . . . 0.0 111.863 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.17 124.64 29.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.228 0.537 . . . . 0.0 109.704 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -87.83 -177.7 5.86 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.397 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -67.4 -40.83 85.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.235 0.541 . . . . 0.0 109.788 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -97.42 103.01 14.91 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.047 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 7.5 mp -83.44 59.07 4.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.283 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -85.83 -55.02 4.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.148 -177.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -73.48 -55.29 6.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.927 0.394 . . . . 0.0 110.339 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -112.74 112.3 23.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.586 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -100.0 44.52 1.62 Allowed Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.028 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -58.45 121.1 10.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.94 0.4 . . . . 0.0 110.426 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -80.94 -37.05 30.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.548 -174.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 34.2 m -79.4 145.76 8.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.933 0.397 . . . . 0.0 110.654 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -105.91 95.67 5.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.025 0.441 . . . . 0.0 109.961 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.76 139.39 16.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.382 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 10.3 t70 57.76 40.97 25.79 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.605 0.717 . . . . 0.0 109.98 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -93.78 -53.65 3.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.332 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -100.15 -23.3 14.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.975 0.416 . . . . 0.0 110.542 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -95.7 144.77 25.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.216 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -117.27 115.83 26.05 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.082 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.2 m -87.36 100.3 12.62 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.107 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.472 ' HA ' ' OE1' ' A' ' 234' ' ' GLN . 2.5 t -83.1 122.27 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.414 -172.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 25.0 m -96.13 105.81 17.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.834 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.405 HD22 HG22 ' A' ' 230' ' ' VAL . 21.0 mt -123.7 165.95 16.37 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.968 -175.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.9 t -60.11 -54.66 43.27 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.445 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.27 139.44 40.95 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.166 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 11.6 p -132.48 24.55 4.43 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.98 0.895 . . . . 0.0 108.867 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.4 m -78.23 139.26 38.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.865 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.77 -9.02 55.12 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -175.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 61.6 mtt -94.13 148.97 21.66 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 24.8 pttm -139.11 163.56 32.1 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -57.52 135.95 56.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.86 0.362 . . . . 0.0 110.935 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 82.71 19.03 64.46 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.801 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 268' ' ' LYS . 0.6 OUTLIER -94.21 174.2 7.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.791 0.329 . . . . 0.0 110.178 -178.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 0.1 OUTLIER -114.8 116.72 29.07 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.69 -178.269 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.413 HD12 HG22 ' A' ' 308' ' ' ILE . 17.1 pt -122.31 139.93 47.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.898 0.38 . . . . 0.0 110.238 175.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 72.9 p -119.75 145.05 46.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.011 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -107.0 111.4 23.87 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.19 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.18 113.3 4.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.071 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.26 -34.25 5.4 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 96.6 t -87.9 118.81 34.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.408 ' HB2' ' OE1' ' A' ' 283' ' ' GLN . 14.6 ptpt -149.44 172.07 15.55 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.214 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -83.47 150.29 26.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.611 0.719 . . . . 0.0 112.364 -169.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.418 HD11 ' HB2' ' A' ' 315' ' ' LEU . 40.3 mt -67.29 124.76 24.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.965 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 112.91 -27.79 9.38 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.176 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.408 ' OE1' ' HB2' ' A' ' 279' ' ' LYS . 97.3 mt-30 -63.85 -48.87 75.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.701 0.286 . . . . 0.0 110.975 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 55.6 mtm -68.96 -20.12 64.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.675 -173.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -71.8 -15.28 62.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.485 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -131.05 -52.06 1.04 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.995 0.426 . . . . 0.0 110.598 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -83.72 107.03 15.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.095 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.14 -41.21 91.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.351 0.596 . . . . 0.0 109.888 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 87.0 mt -97.25 55.51 1.29 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.208 174.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.43 131.9 49.69 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.254 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.27 155.58 34.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.252 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -81.41 166.52 20.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.491 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -57.97 113.32 1.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.291 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 9.5 p -96.77 105.39 17.5 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.052 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -116.93 147.83 41.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.741 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.8 t -94.94 124.48 39.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.747 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.427 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.9 p -75.15 140.98 16.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.323 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 37.9 t -103.33 -38.04 5.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.861 0.363 . . . . 0.0 110.83 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -158.82 136.75 10.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 0.0 111.026 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.25 106.58 17.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.53 -59.3 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.912 -171.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -112.9 -3.7 14.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.852 0.358 . . . . 0.0 111.445 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 71.24 12.46 72.38 Favored Glycine 0 CA--C 1.517 0.216 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -172.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 16.7 p -147.92 19.49 1.13 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.425 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.4 t-160 -169.98 113.15 0.48 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.056 -167.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.0 166.11 13.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -175.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.95 119.05 28.44 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.232 0.539 . . . . 0.0 109.996 171.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.413 HG22 HD12 ' A' ' 273' ' ' ILE . 36.6 pt -113.61 171.1 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.572 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 10.3 t -155.08 144.94 15.57 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -71.75 -179.91 24.16 Favored 'Cis proline' 0 CA--C 1.532 0.382 0 C-N-CA 124.215 -1.16 . . . . 0.0 113.048 -1.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -87.1 126.9 61.29 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.675 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.93 121.8 8.45 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.586 2.191 . . . . 0.0 112.328 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.471 HG21 ' HA ' ' A' ' 328' ' ' ALA . 0.9 OUTLIER -130.78 128.55 63.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.741 178.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -85.95 139.1 31.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.158 -174.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . 0.454 ' O ' HD12 ' A' ' 315' ' ' LEU . 3.0 tm? -80.73 -27.05 36.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.986 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -77.7 -10.48 59.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.443 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -83.02 116.02 22.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.037 0.446 . . . . 0.0 110.335 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.3 m -82.68 0.22 4.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.643 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 13.8 m -71.1 -19.18 62.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.609 0.242 . . . . 0.0 111.437 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 0.8 OUTLIER -94.94 168.77 10.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.147 0.498 . . . . 0.0 111.858 -177.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 15.2 t -87.45 152.28 52.01 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.906 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -40.73 -45.3 4.76 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.381 2.721 . . . . 0.0 113.781 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 323' ' ' GLU . 3.0 mp0 -51.33 -45.68 62.36 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.225 0.536 . . . . 0.0 110.855 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.491 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 13.7 mm100 -64.76 -25.23 67.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.28 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -65.33 -31.09 72.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.93 0.395 . . . . 0.0 110.53 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.45 74.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.373 175.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -85.53 -10.28 56.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.15 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.471 ' HA ' HG21 ' A' ' 313' ' ' VAL . . . -63.08 135.08 57.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.638 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -119.51 -30.24 4.9 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 34.3 m -112.91 165.69 7.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.044 0.45 . . . . 0.0 111.399 -177.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -78.71 -44.89 22.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.528 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.3 t -130.9 145.91 52.16 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.126 0.489 . . . . 0.0 110.97 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 38.4 m -74.18 169.02 18.42 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.727 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.8 tp -75.86 102.98 5.73 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.61 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -91.66 166.19 12.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.994 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.42 62.19 4.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.09 0.472 . . . . 0.0 111.778 -173.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -176.94 30.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.491 171.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.2 mmt -101.47 134.38 44.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.342 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -90.15 132.85 35.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.009 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 22.8 t -108.3 108.56 25.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.717 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . 0.45 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 64.1 t30 -123.6 132.5 53.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.074 -175.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 47.6 mt -76.59 129.94 36.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.125 0.488 . . . . 0.0 110.295 173.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 45.4 mt -82.8 135.57 34.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.803 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -90.91 113.13 25.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.495 0.664 . . . . 0.0 110.607 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.252 1.193 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.827 179.936 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 112.349 -0.3 . . . . 0.0 112.349 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.3 t -152.8 129.83 11.08 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.653 ' HA ' ' ND2' ' A' ' 344' ' ' ASN . 3.2 p -95.5 -8.45 35.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.091 0.472 . . . . 0.0 110.843 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -155.66 98.91 1.97 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.093 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.604 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 19.4 p -80.92 -56.06 4.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.061 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.64 49.66 76.16 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.754 177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.505 HG21 ' O ' ' A' ' 263' ' ' ALA . 57.7 mt -102.75 141.76 18.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 29.7 p -97.44 153.13 18.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.532 0.682 . . . . 0.0 111.839 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 335' ' ' ALA . 8.7 p -58.92 151.5 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.289 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 10.2 t -105.33 73.51 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.992 0.425 . . . . 0.0 110.095 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 97.19 158.58 31.06 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.093 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -72.61 116.96 13.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.731 0.3 . . . . 0.0 110.401 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.404 ' O ' ' HB3' ' A' ' 334' ' ' LEU . 6.2 tp-100 -129.37 127.09 40.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.148 0.499 . . . . 0.0 110.589 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.2 p -118.5 125.38 49.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.105 0.478 . . . . 0.0 109.819 177.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.465 ' CD2' ' HG2' ' A' ' 312' ' ' PRO . 70.1 m-85 -81.23 131.86 35.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.602 -174.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -129.52 111.11 17.71 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -175.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -91.28 119.47 0.59 Allowed 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.67 2.247 . . . . 0.0 111.024 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.5 p -70.6 111.84 4.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.304 0.574 . . . . 0.0 109.966 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -132.88 133.91 43.9 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.787 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 81.2 m95 56.11 41.3 29.7 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.919 0.762 . . . . 0.0 111.354 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -142.94 145.13 32.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.915 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 91.5 mt 68.14 -174.72 0.19 Allowed 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.795 0.684 . . . . 0.0 111.107 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -96.47 -157.93 0.62 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.449 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -60.53 -32.19 71.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.135 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -91.12 111.49 22.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.115 0.483 . . . . 0.0 110.868 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -136.32 -154.05 6.72 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.567 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -71.18 106.86 3.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.791 0.329 . . . . 0.0 110.425 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -118.02 -7.67 10.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.199 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 55.5 t -81.61 -39.45 17.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.71 0.766 . . . . 0.0 110.585 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 253' ' ' ASP . 31.4 p-10 -95.7 161.56 13.98 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.209 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 3.5 t -115.62 45.28 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 122.025 0.916 . . . . 0.0 109.433 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.439 ' HB2' ' ND2' ' A' ' 251' ' ' ASN . 3.0 m-20 -103.18 10.36 37.83 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.15 -178.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -79.88 -52.33 8.02 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -90.71 -64.29 1.15 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.609 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -78.7 153.14 31.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.733 -176.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -106.5 117.19 33.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.071 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -92.1 101.82 14.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.107 0.48 . . . . 0.0 110.542 -178.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.448 ' HB ' HG22 ' A' ' 306' ' ' VAL . 3.3 t -83.2 118.99 31.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.517 -172.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 20.5 m -90.78 108.54 19.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.186 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 20.7 mt -127.11 165.06 20.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.065 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 20.8 m -58.59 -55.68 31.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.398 0.618 . . . . 0.0 109.543 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.505 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -138.2 141.16 40.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.511 ' HB ' ' SD ' ' A' ' 267' ' ' MET . 9.3 p -126.42 24.69 6.69 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.057 0.932 . . . . 0.0 108.766 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 17.0 m -71.59 138.8 49.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.372 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 105.76 -11.26 45.76 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' MET . . . . . 0.545 ' SD ' HG13 ' A' ' 306' ' ' VAL . 63.3 mtt -95.18 142.83 27.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -154.17 140.36 18.5 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.461 ' HA ' HG12 ' A' ' 297' ' ' VAL . 30.0 ptt180 -44.17 118.01 1.38 Allowed 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.977 0.798 . . . . 0.0 112.607 -171.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.47 -10.63 19.4 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.467 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.464 ' N ' HG13 ' A' ' 297' ' ' VAL . 1.5 p30 -82.84 -177.2 6.66 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.552 0.692 . . . . 0.0 112.175 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -124.97 117.73 24.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.973 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 308' ' ' ILE . 37.5 pt -111.12 139.3 35.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.038 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.493 ' OG ' HG23 ' A' ' 294' ' ' THR . 3.0 m -125.34 129.51 50.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.508 -174.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -97.27 110.92 23.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.303 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.12 121.42 20.19 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.011 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.36 -27.93 9.58 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.77 131.28 50.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.434 ' HG3' ' SD ' ' A' ' 284' ' ' MET . 16.2 ptpt -141.84 157.73 44.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.786 0.327 . . . . 0.0 110.902 -175.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -83.97 149.33 26.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.082 -174.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 96.4 mt -79.06 179.01 7.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.391 176.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 82.67 -40.35 2.76 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -90.67 -9.07 48.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.097 0.475 . . . . 0.0 109.937 176.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.434 ' SD ' ' HG3' ' A' ' 279' ' ' LYS . 86.0 mtp -98.42 31.62 2.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.185 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -66.28 -46.96 75.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.203 0.525 . . . . 0.0 109.894 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -138.16 -19.48 1.12 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.167 174.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -86.95 123.58 32.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.501 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.06 -30.51 7.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.798 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.39 46.1 1.19 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.056 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.6 167.63 14.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.128 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -60.36 125.44 23.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.149 0.5 . . . . 0.0 111.021 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -62.17 158.73 16.22 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.295 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -71.29 85.87 0.79 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.9 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.493 HG23 ' OG ' ' A' ' 274' ' ' SER . 22.2 p -96.79 122.18 39.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.233 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -124.11 153.65 41.15 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.97 0.414 . . . . 0.0 110.796 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.5 m -90.61 125.83 35.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.579 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 271' ' ' ASP . 4.8 p -67.03 134.45 30.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.034 0.445 . . . . 0.0 109.86 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 99.7 t -101.39 -53.05 7.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.744 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.401 ' CZ ' ' HA ' ' A' ' 301' ' ' VAL . 2.7 tmt_? -157.1 131.11 8.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.032 0.444 . . . . 0.0 110.843 -177.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 99.2 t -84.63 114.44 24.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.478 174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 299' ' ' ARG . 46.1 t -76.54 -59.15 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.644 -174.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -128.26 -7.72 5.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.445 0.64 . . . . 0.0 110.989 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.4 14.15 76.98 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 23.7 p -137.3 6.91 2.83 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 172.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.406 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.7 t-160 -164.14 119.64 1.55 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.456 -169.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.83 161.83 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -176.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -119.8 128.85 54.09 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 172.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.462 HG23 ' HA ' ' A' ' 297' ' ' VAL . 26.8 pt -133.94 171.64 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.102 0.477 . . . . 0.0 111.848 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 8.5 t -152.35 143.35 15.71 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.191 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.38 -179.96 27.88 Favored 'Cis proline' 0 CA--C 1.53 0.302 0 C-N-CA 123.752 -1.353 . . . . 0.0 112.939 -0.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.511 ' HB2' ' HZ2' ' A' ' 311' ' ' LYS . 2.6 ttmp? -92.26 123.67 61.8 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.167 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.465 ' HG2' ' CD2' ' A' ' 236' ' ' PHE . 38.2 Cg_endo -70.48 109.46 2.45 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.49 2.127 . . . . 0.0 112.404 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 46.7 t -117.42 129.65 73.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.893 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -87.12 132.73 33.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.27 0.557 . . . . 0.0 111.473 -175.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -68.96 -26.99 65.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.205 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -98.27 19.48 14.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.719 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . 0.475 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 11.2 t70 -72.96 130.22 39.87 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.17 -16.61 10.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -174.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 18.9 t -90.76 -36.07 14.5 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -169.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.475 ' HG ' ' OD1' ' A' ' 317' ' ' ASP . 0.5 OUTLIER -71.15 175.92 4.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.526 0.679 . . . . 0.0 112.783 -175.3 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 13.5 m -103.13 158.53 31.58 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.21 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -39.7 -52.39 2.63 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.087 3.192 . . . . 0.0 114.756 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -58.54 -34.28 70.83 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -71.63 -26.46 62.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.788 0.328 . . . . 0.0 110.658 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -69.23 -22.97 63.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.975 0.416 . . . . 0.0 110.611 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -70.9 -34.3 71.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.29 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -86.24 -0.25 55.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.171 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -64.7 144.02 57.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.072 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -137.03 -9.26 1.78 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 32.5 m -123.4 155.25 29.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -84.88 -25.57 27.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 6.8 t -134.11 140.76 46.82 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.078 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 14.6 p -79.36 173.49 12.52 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 234' ' ' GLN . 19.1 tp -73.95 102.22 4.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.608 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -90.82 164.15 14.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.254 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . 0.408 ' HA ' ' CG1' ' A' ' 230' ' ' VAL . 23.8 t0 -77.89 60.57 2.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.181 0.515 . . . . 0.0 111.693 -173.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -178.23 29.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.473 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.5 mmt -98.17 134.37 41.32 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.228 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -94.48 131.14 40.5 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.79 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.0 t -104.75 114.05 43.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.048 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . 0.604 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 63.2 t30 -130.83 150.86 51.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.4 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 27.6 mt -102.84 130.73 52.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.115 0.483 . . . . 0.0 111.419 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 46.3 mt -86.41 116.18 24.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.192 173.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . 0.653 ' ND2' ' HA ' ' A' ' 224' ' ' THR . 40.3 m-80 -101.08 146.88 26.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.932 0.396 . . . . 0.0 111.412 -176.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 89.1 t . . . . . 0 C--O 1.246 0.907 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.048 177.747 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.576 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 43.3 t -91.79 133.17 35.87 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.4 p -82.86 -21.36 34.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.911 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 47.23 70.61 0.39 Allowed 'General case' 0 C--O 1.235 0.317 0 O-C-N 123.76 0.662 . . . . 0.0 112.452 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 33.8 p -106.36 -79.0 0.57 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.231 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.13 48.39 86.16 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.644 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.466 HG13 ' HE1' ' A' ' 267' ' ' MET . 27.3 mm -100.87 143.75 13.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.836 -0.182 . . . . 0.0 110.733 -174.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 18.9 p -119.79 167.76 11.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.181 0.515 . . . . 0.0 111.417 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.559 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.9 p -85.38 150.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.835 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.3 t -107.11 60.04 0.62 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.155 0.503 . . . . 0.0 110.37 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 102.67 159.71 25.78 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.591 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 334' ' ' LEU . . . -70.81 131.12 43.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.929 0.395 . . . . 0.0 110.649 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -133.96 126.35 30.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.106 -175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 27.1 p -110.07 142.64 41.25 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.786 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.539 ' O ' HG13 ' A' ' 313' ' ' VAL . 98.7 m-85 -124.97 130.6 52.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.241 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -129.61 139.27 35.17 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.05 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.498 ' HA ' ' OD1' ' A' ' 254' ' ' ASN . 94.8 Cg_endo -88.84 160.52 6.14 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.763 2.309 . . . . 0.0 112.151 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 47.8 t -79.91 84.94 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.225 0.536 . . . . 0.0 110.212 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -103.61 104.75 14.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.054 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -133.83 134.0 42.29 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.768 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -62.01 124.19 20.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.528 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.09 58.23 1.96 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.528 0.68 . . . . 0.0 111.772 -177.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -72.67 -50.5 24.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.098 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -70.39 -48.62 55.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.329 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -175.34 -44.13 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.229 0.538 . . . . 0.0 110.418 175.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 149.62 144.54 3.96 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.214 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -95.6 75.24 3.25 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.27 0.557 . . . . 0.0 110.533 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -83.14 72.03 10.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.815 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.0 m -80.7 124.08 38.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.116 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -76.56 86.16 3.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.374 0.607 . . . . 0.0 110.633 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 14.6 p -147.25 150.71 14.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.293 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -76.64 60.03 1.61 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.38 0.61 . . . . 0.0 111.092 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.498 ' OD1' ' HA ' ' A' ' 238' ' ' PRO . 28.6 t-20 -87.77 -22.0 24.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.056 -177.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -76.95 -8.78 58.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.634 0.73 . . . . 0.0 109.692 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -110.6 159.33 17.66 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.127 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.419 ' HB1' ' HD2' ' A' ' 312' ' ' PRO . . . -121.24 114.97 22.14 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.664 0.269 . . . . 0.0 110.773 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -87.09 97.59 10.82 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.236 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -85.17 126.81 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.333 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 40.4 m -96.53 109.15 21.79 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 173.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 22.2 mt -122.43 172.52 8.28 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.7 m -58.87 -57.4 13.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.241 0.543 . . . . 0.0 109.754 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.461 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -137.2 135.98 37.76 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.956 178.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 8.2 p -130.79 23.88 5.01 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.544 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 89.7 m -82.89 137.05 34.39 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.87 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 112.54 -29.5 8.2 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -171.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' MET . . . . . 0.466 ' HE1' HG13 ' A' ' 228' ' ' ILE . 1.9 mpt? -69.66 155.42 40.53 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 170.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -154.43 143.43 21.06 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.438 ' HA ' HG11 ' A' ' 297' ' ' VAL . 37.4 ptt180 -52.32 114.21 1.28 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.23 0.538 . . . . 0.0 111.06 -174.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 113.78 -2.7 24.51 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.903 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.421 ' OD1' HG23 ' A' ' 273' ' ' ILE . 0.6 OUTLIER -83.6 175.1 9.99 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 117.1 0.45 . . . . 0.0 111.052 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -126.47 117.39 22.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.245 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.421 HG23 ' OD1' ' A' ' 271' ' ' ASP . 40.8 pt -112.13 140.28 32.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.188 0.518 . . . . 0.0 110.356 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.503 ' OG ' HG21 ' A' ' 294' ' ' THR . 2.7 m -120.5 137.48 54.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.987 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -101.24 111.35 23.54 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.68 116.34 9.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.023 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.27 -36.19 4.27 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 85.2 t -86.47 114.54 26.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 172.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -136.25 158.17 45.05 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.633 -172.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.469 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 66.7 m-85 -76.18 133.93 40.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.344 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 96.3 mt -76.17 154.74 35.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.663 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 102.17 -31.38 8.77 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' A' ' 287' ' ' ASN . 84.6 mm-40 -74.81 -18.49 60.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.472 0.177 . . . . 0.0 111.067 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 74.0 mtm -91.6 10.24 28.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.656 0.265 . . . . 0.0 110.947 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -69.06 -27.75 65.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.058 0.456 . . . . 0.0 110.297 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -148.94 -41.6 0.15 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.739 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 283' ' ' GLN . 91.6 m-20 -70.95 108.25 4.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.973 0.416 . . . . 0.0 110.888 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 39.6 t -70.68 -32.09 48.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.596 0.713 . . . . 0.0 109.323 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.09 51.08 2.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.882 175.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -57.78 127.0 29.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.401 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -61.12 138.09 58.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.081 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -77.42 167.06 22.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.958 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.469 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -73.6 106.96 5.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.982 -176.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.503 HG21 ' OG ' ' A' ' 274' ' ' SER . 67.0 p -97.34 133.62 41.71 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.97 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -131.33 148.89 52.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.941 0.401 . . . . 0.0 110.579 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.1 m -92.29 129.95 38.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.087 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.464 ' HA ' HG22 ' A' ' 308' ' ' ILE . 4.0 p -72.4 143.72 13.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.795 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 62.0 t -105.41 -38.95 4.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.682 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -162.66 136.35 6.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.654 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 58.7 t -86.53 110.45 20.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 169.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 24.3 t -77.32 -56.83 6.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.732 -171.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -127.49 13.92 7.06 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.618 -173.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 59.55 13.84 25.39 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-O 121.438 0.466 . . . . 0.0 112.055 -174.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.3 p -150.27 19.49 0.85 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.458 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.3 t-160 -169.03 115.84 0.62 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.817 -1.538 . . . . 0.0 108.074 -166.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.5 m -119.43 163.42 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.313 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -124.44 116.38 22.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.143 0.496 . . . . 0.0 109.674 169.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.464 HG22 ' HA ' ' A' ' 297' ' ' VAL . 24.2 pt -115.87 169.83 6.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.104 -177.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 6.3 t -154.32 145.21 16.22 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.24 179.7 22.57 Favored 'Cis proline' 0 C--N 1.346 0.403 0 C-N-CA 124.038 -1.234 . . . . 0.0 113.238 1.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 236' ' ' PHE . 31.7 tttp -83.53 119.11 73.28 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.255 -177.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 19.9 Cg_endo -62.29 109.11 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.51 2.14 . . . . 0.0 112.091 178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 236' ' ' PHE . 8.9 m -127.81 128.33 69.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.324 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -87.34 136.16 33.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.953 -173.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 43.9 tp -80.62 -28.81 36.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.512 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -85.91 13.53 7.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.334 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -76.02 117.78 18.1 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 29.5 m -82.87 1.17 3.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.743 -175.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 16.1 m -94.51 -27.95 15.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.69 0.281 . . . . 0.0 111.107 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.481 ' HB2' ' CB ' ' A' ' 324' ' ' GLN . 1.6 pp -79.38 174.27 11.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.061 0.457 . . . . 0.0 111.291 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.499 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.6 m -116.36 168.37 8.79 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.16 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 29.3 Cg_exo -39.62 -49.1 3.38 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.793 2.995 . . . . 0.0 114.925 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -61.53 -36.94 82.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.039 0.447 . . . . 0.0 111.297 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.481 ' CB ' ' HB2' ' A' ' 320' ' ' LEU . 15.5 mm-40 -68.84 -30.4 68.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.603 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -62.86 -25.58 68.35 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.216 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.78 -34.05 69.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.128 0.489 . . . . 0.0 110.298 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -76.05 -30.67 58.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.297 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.526 ' HA ' HG21 ' A' ' 313' ' ' VAL . . . -59.26 139.69 56.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.08 -175.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -135.13 -33.36 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.822 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 27.6 m -101.35 171.24 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.969 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -75.33 -57.18 4.05 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.739 -176.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.8 t -139.41 164.1 30.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.666 0.269 . . . . 0.0 110.358 -175.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.6 p -73.91 164.48 26.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.743 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 233' ' ' ALA . 25.6 tp -67.43 104.27 1.5 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.254 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.559 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -87.07 -174.35 4.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.598 -178.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -80.99 157.31 25.55 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.579 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 59.33 39.08 22.75 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.864 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.9 mmt -103.78 130.17 51.27 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -81.69 137.81 35.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.214 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 22.0 t -111.18 110.06 30.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -123.29 144.21 49.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.638 -173.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 55.6 mt -96.84 127.56 48.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.31 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.6 140.67 53.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.415 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -82.7 77.48 9.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.458 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.36 178.498 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.3 m 60.53 41.75 15.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.161 0.505 . . . . 0.0 111.053 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 86.1 m -68.3 -49.73 58.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.965 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 57.36 75.46 0.37 Allowed 'General case' 0 C--O 1.234 0.256 0 O-C-N 123.489 0.493 . . . . 0.0 110.875 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 32.2 p -73.16 40.32 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.306 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -82.14 76.06 2.26 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.083 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 40.1 mt -95.82 153.51 3.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 3.2 p -96.6 151.69 19.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.485 0.659 . . . . 0.0 112.211 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 335' ' ' ALA . 4.2 p -64.5 151.01 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.638 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.1 t -105.52 76.77 1.23 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.61 165.16 40.73 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.059 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.44 122.8 18.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.953 0.406 . . . . 0.0 110.596 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.44 ' NE2' ' HB ' ' A' ' 260' ' ' THR . 86.1 mm-40 -110.0 126.91 54.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.235 0.54 . . . . 0.0 110.496 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.4 p -137.21 112.17 8.97 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.76 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 234' ' ' GLN . 40.9 m-85 -116.95 132.41 56.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.86 0.362 . . . . 0.0 110.926 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -115.94 131.55 23.67 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.367 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 254' ' ' ASN . 72.9 Cg_endo -79.65 132.07 9.65 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.381 2.054 . . . . 0.0 111.512 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 24.1 t -82.71 83.73 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.242 0.544 . . . . 0.0 109.773 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -100.82 93.51 5.58 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.802 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.415 ' HA ' ' OD1' ' A' ' 244' ' ' ASP . 91.4 m95 67.09 -174.03 0.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.535 -177.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 68.47 122.85 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.121 0.568 . . . . 0.0 110.729 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 6.4 mp 58.37 42.68 21.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.388 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.415 ' OD1' ' HA ' ' A' ' 241' ' ' TRP . 30.3 m-20 -74.18 -19.27 60.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.782 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -88.05 -53.15 4.87 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.39 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -103.76 -20.45 13.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -173.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -81.73 163.42 44.06 Favored Glycine 0 C--N 1.321 -0.266 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.23 -174.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 55.53 58.05 4.86 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.511 0.724 . . . . 0.0 110.967 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -77.84 -42.73 32.63 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.78 177.38 4.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.166 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 8.3 t30 63.49 81.33 0.21 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.474 0.654 . . . . 0.0 110.109 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 12.3 t -81.86 62.91 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.8 0.809 . . . . 0.0 110.083 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.53 42.26 3.0 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.537 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 238' ' ' PRO . 6.0 p30 -72.63 -51.54 19.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.706 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -86.78 -47.27 9.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.817 0.341 . . . . 0.0 110.929 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -78.93 139.08 38.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.505 -176.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -100.41 115.97 31.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.616 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -85.83 97.78 10.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.978 179.459 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.0 t -81.98 114.18 22.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.977 -173.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' THR . . . . . 0.44 ' HB ' ' NE2' ' A' ' 234' ' ' GLN . 17.5 m -86.42 107.19 17.93 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.985 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 21.0 mt -122.12 167.12 13.53 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.8 m -55.86 -54.6 42.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.372 0.606 . . . . 0.0 109.65 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -138.4 146.83 42.68 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 24.3 p -133.6 31.38 3.7 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.889 0.852 . . . . 0.0 108.904 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.9 m -80.24 152.7 28.95 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.65 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 90.36 -28.73 7.19 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 52.7 mtt -78.2 135.62 37.65 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.503 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 3.2 ptpp? -134.36 163.53 29.46 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -52.85 126.58 20.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.941 0.4 . . . . 0.0 111.147 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 95.21 18.82 32.43 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.098 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.503 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 66.5 m-20 -100.77 161.39 13.63 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 117.349 0.574 . . . . 0.0 110.892 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.472 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 12.0 tppt? -106.53 117.53 34.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.782 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.41 HD12 HG22 ' A' ' 308' ' ' ILE . 36.5 pt -112.25 139.74 35.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.128 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 32.6 p -113.06 134.35 54.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.317 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -100.06 111.55 23.84 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.932 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.96 130.73 46.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.837 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 89.43 -35.51 3.7 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.082 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.6 124.23 35.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.488 ' HD2' ' SD ' ' A' ' 284' ' ' MET . 8.6 ptpp? -143.01 159.91 41.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.879 0.371 . . . . 0.0 111.183 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.425 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 80.7 m-85 -78.66 156.3 29.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.478 -173.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.11 143.3 57.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.291 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 107.03 -15.94 39.57 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -91.26 175.16 7.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.488 ' SD ' ' HD2' ' A' ' 279' ' ' LYS . 48.9 mtm 70.76 12.76 7.22 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.425 0.453 . . . . 0.0 111.422 176.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -83.7 -43.16 15.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.313 0.578 . . . . 0.0 109.501 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -166.21 54.19 0.09 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.555 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -153.69 119.47 5.3 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.702 0.763 . . . . 0.0 110.992 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 23.0 t -87.13 -20.92 7.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.181 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 83.9 mt -87.43 42.72 1.06 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.031 175.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.88 132.14 49.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.823 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -79.09 150.76 31.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.346 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -87.3 158.19 19.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.913 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.425 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -65.17 108.93 2.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.123 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.472 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 4.4 p -103.54 110.99 23.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.142 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -115.79 157.68 24.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.158 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 27.8 t -96.89 127.24 42.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.471 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.405 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.1 p -82.85 131.23 34.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.169 0.509 . . . . 0.0 110.228 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 39.2 t -92.21 -36.08 7.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.193 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -162.67 144.1 10.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.228 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.24 114.71 28.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 16.8 t -77.83 -52.29 16.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.976 -172.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -125.11 3.16 7.93 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -172.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 65.22 13.98 58.73 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.295 -171.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -151.9 20.57 0.69 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.0 t-160 -171.43 114.94 0.39 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 113.821 -1.536 . . . . 0.0 108.296 -164.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.6 m -118.84 160.66 18.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -176.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -118.03 120.5 37.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.081 0.467 . . . . 0.0 109.984 173.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.41 HG22 HD12 ' A' ' 273' ' ' ILE . 31.0 pt -118.56 164.47 14.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.273 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' THR . . . . . 0.403 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 8.8 t -154.11 140.91 13.15 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.141 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.403 ' C ' ' HA ' ' A' ' 309' ' ' THR . 15.5 Cg_exo -69.02 177.2 27.69 Favored 'Cis proline' 0 C--N 1.347 0.492 0 C-N-CA 123.932 -1.278 . . . . 0.0 112.567 -0.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -90.42 124.88 61.62 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.731 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.06 109.38 2.16 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.789 2.326 . . . . 0.0 112.467 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.435 ' CG2' ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -112.69 130.83 65.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.897 176.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -81.93 126.97 32.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.173 0.511 . . . . 0.0 111.133 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.2 -31.58 70.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.61 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -82.55 3.61 27.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.588 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . 0.446 ' OD2' ' HG ' ' A' ' 320' ' ' LEU . 20.2 t70 -72.96 123.11 22.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.888 0.375 . . . . 0.0 110.119 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.51 2.11 4.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 29.1 t -93.93 -31.27 14.36 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -173.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.463 HD11 ' HG2' ' A' ' 325' ' ' ARG . 0.4 OUTLIER -84.09 155.17 22.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.595 0.712 . . . . 0.0 112.492 -177.163 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.486 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 47.1 t -80.12 154.92 75.02 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.919 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.486 ' HD2' ' OG ' ' A' ' 321' ' ' SER . 41.3 Cg_exo -36.13 -52.65 1.05 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 124.087 3.191 . . . . 0.0 114.291 177.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.28 -38.84 84.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.815 0.34 . . . . 0.0 111.122 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 15.3 mm100 -64.65 -26.72 68.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.637 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.463 ' HG2' HD11 ' A' ' 320' ' ' LEU . 88.2 mtt180 -73.33 -19.23 61.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.912 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -78.83 -25.42 44.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.987 175.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -88.69 -11.63 44.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.536 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.435 ' HA ' ' CG2' ' A' ' 313' ' ' VAL . . . -66.76 121.65 15.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.782 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . 0.474 ' OD1' HG11 ' A' ' 330' ' ' VAL . 3.2 p30 -102.35 -27.45 12.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.823 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.474 HG11 ' OD1' ' A' ' 329' ' ' ASN . 36.0 m -113.85 168.08 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.998 0.427 . . . . 0.0 110.995 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -88.48 -41.43 12.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.328 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.5 t -123.64 145.36 49.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.252 0.548 . . . . 0.0 110.853 -174.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 7.5 p -73.0 162.57 29.33 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.339 172.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 40.6 tp -71.57 104.16 3.22 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.532 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -80.01 178.0 8.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.639 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -81.01 153.45 27.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.551 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 66.41 34.51 6.21 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 124.083 0.864 . . . . 0.0 111.897 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' MET . . . . . 0.44 ' H ' HG11 ' A' ' 230' ' ' VAL . 78.5 mmm -106.55 149.8 26.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -94.32 140.25 30.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.031 0.443 . . . . 0.0 111.588 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 41.7 t -125.28 120.35 57.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -138.51 148.21 44.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.711 0.291 . . . . 0.0 111.218 -174.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 60.5 mt -87.92 122.57 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.005 0.431 . . . . 0.0 110.585 174.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 47.8 mt -86.35 112.19 21.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.281 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -99.53 89.15 4.06 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.528 -0.749 . . . . 0.0 110.678 -178.538 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.912 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.7 p -86.33 71.57 10.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.191 0.52 . . . . 0.0 111.177 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 16.5 p -100.11 27.04 5.87 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.125 0.488 . . . . 0.0 111.158 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.08 96.43 5.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.785 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.543 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 22.2 p -72.68 -60.57 2.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.033 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.99 48.01 88.18 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.569 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 263' ' ' ALA . 71.3 mt -102.25 143.7 14.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 17.5 p -96.84 150.21 20.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.703 0.763 . . . . 0.0 112.243 -173.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 335' ' ' ALA . 8.9 p -62.77 151.26 8.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.469 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 70.9 m -102.2 72.52 1.3 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.95 0.405 . . . . 0.0 110.724 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 99.09 164.86 29.95 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.377 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -88.93 138.53 31.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.618 0.246 . . . . 0.0 110.436 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -153.58 147.32 25.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.143 0.497 . . . . 0.0 110.849 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 50.7 p -119.06 124.23 46.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.224 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -81.36 146.91 30.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.129 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -141.76 116.57 6.9 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.112 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -92.08 119.33 0.49 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.476 2.117 . . . . 0.0 110.436 166.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 242' ' ' GLN . 7.7 p -88.61 133.99 29.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.101 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -116.35 104.17 11.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.431 -175.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 85.8 m95 69.36 30.63 4.12 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.292 0.637 . . . . 0.0 111.598 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . 0.443 ' HB2' ' CG2' ' A' ' 239' ' ' VAL . 26.7 mt-30 -138.89 124.26 19.3 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 91.9 mt 61.53 21.48 12.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.107 0.48 . . . . 0.0 110.696 -175.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -82.52 -36.96 25.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.364 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -65.06 -46.15 82.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.478 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -137.11 105.76 5.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.063 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 144.09 -58.6 0.53 Allowed Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.549 -0.621 . . . . 0.0 111.549 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -100.61 73.18 1.6 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.188 0.518 . . . . 0.0 109.711 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -90.17 -50.29 6.07 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.681 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.1 m -112.66 161.23 11.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.766 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 69.96 126.56 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.993 0.808 . . . . 0.0 111.202 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 3.8 m -84.98 62.27 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.773 0.797 . . . . 0.0 110.797 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -66.36 -17.31 64.69 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.995 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -75.94 -17.13 59.86 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.728 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -111.73 -32.87 6.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.154 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.543 ' O ' ' HE3' ' A' ' 311' ' ' LYS . 40.9 m-85 -115.01 164.96 13.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.455 -176.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -130.98 138.52 49.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.662 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 4.0 m -101.54 114.41 28.42 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.417 ' HB ' HG21 ' A' ' 306' ' ' VAL . 2.7 t -95.42 125.02 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.234 -174.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 28.3 m -98.74 111.55 23.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.022 177.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 14.7 mt -130.59 169.34 15.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.455 -174.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.5 m -62.5 -55.38 28.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.492 0.663 . . . . 0.0 109.829 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -137.6 135.04 36.24 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.194 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.4 p -127.45 26.64 5.95 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 172.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 37.8 m -74.5 140.67 44.69 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.129 -1.851 . . . . 0.0 110.548 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 94.32 -11.93 69.68 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 66.0 mtt -86.09 145.2 27.15 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 25.2 pttm -136.22 155.23 50.42 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -57.34 128.48 37.22 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.92 18.47 34.38 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.447 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.456 ' H ' HG11 ' A' ' 297' ' ' VAL . 0.6 OUTLIER -101.28 178.02 4.77 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.473 ' HD3' ' HB ' ' A' ' 294' ' ' THR . 2.3 tmmm? -130.75 116.21 17.69 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.172 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 37.7 pt -112.48 151.42 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.936 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.406 ' OG ' HG23 ' A' ' 294' ' ' THR . 18.5 m -140.41 144.07 35.97 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.395 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.451 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 88.7 m-85 -102.77 111.97 24.54 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.593 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.86 113.02 5.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.431 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.44 -18.19 23.11 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.712 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 59.4 t -110.32 114.08 46.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.465 ' HB3' ' HZ3' ' A' ' 279' ' ' LYS . 0.6 OUTLIER -131.05 159.4 37.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.814 0.34 . . . . 0.0 111.472 -176.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -69.86 161.46 29.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.045 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 87.2 mt -77.21 -177.94 4.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.916 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 72.05 16.71 76.78 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.726 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.423 ' OE1' ' HG2' ' A' ' 291' ' ' GLN . 37.2 mt-30 -135.14 -161.78 1.19 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.404 ' HB2' ' O ' ' A' ' 283' ' ' GLN . 69.5 mtp 75.93 -45.84 0.54 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.83 0.706 . . . . 0.0 111.723 173.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.23 -36.46 84.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.463 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -128.34 -43.71 1.44 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.998 0.428 . . . . 0.0 110.337 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -75.45 104.0 5.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.193 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 48.6 t -74.4 -48.55 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.265 0.555 . . . . 0.0 109.645 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 93.0 mt -83.97 55.0 3.11 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.462 ' HB3' ' HD3' ' A' ' 279' ' ' LYS . . . -66.11 125.61 26.04 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.135 -176.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . 0.423 ' HG2' ' OE1' ' A' ' 283' ' ' GLN . 10.7 pt20 -55.58 129.8 40.45 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 123.939 0.774 . . . . 0.0 111.255 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -74.78 168.26 20.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.393 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.606 ' HB3' ' CE2' ' A' ' 295' ' ' PHE . . . -64.21 86.09 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.734 -176.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.473 ' HB ' ' HD3' ' A' ' 272' ' ' LYS . 43.7 p -87.93 110.37 20.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.526 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.606 ' CE2' ' HB3' ' A' ' 293' ' ' ALA . 64.7 m-85 -119.45 147.49 44.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.037 0.446 . . . . 0.0 111.381 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.7 m -91.89 127.82 37.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.689 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.456 HG11 ' H ' ' A' ' 271' ' ' ASP . 7.5 p -83.29 130.82 35.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.16 0.505 . . . . 0.0 110.289 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 307' ' ' GLU . 12.8 p -95.06 -30.05 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.498 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -163.38 139.84 7.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.11 0.481 . . . . 0.0 111.253 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 72.7 t -97.36 119.51 45.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.88 -59.88 2.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.838 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -129.23 -3.69 4.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.375 0.607 . . . . 0.0 111.091 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.6 14.44 75.91 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.413 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 14.4 p -143.0 16.09 1.92 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 174.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -171.54 116.28 0.4 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.807 -168.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.54 163.55 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.632 -174.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.436 ' O ' HG12 ' A' ' 298' ' ' VAL . 6.7 pt-20 -124.85 123.36 39.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.105 0.478 . . . . 0.0 109.943 172.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.452 HG23 ' HA ' ' A' ' 297' ' ' VAL . 28.4 pt -129.17 175.05 11.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.284 -174.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' THR . . . . . 0.406 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 11.6 t -154.17 145.39 16.46 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 176.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.79 179.36 29.52 Favored 'Cis proline' 0 C--N 1.345 0.393 0 C-N-CA 124.002 -1.249 . . . . 0.0 112.65 -2.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.543 ' HE3' ' O ' ' A' ' 256' ' ' PHE . 30.1 ttmt -84.42 128.84 60.1 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.854 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.494 ' HG3' ' CE2' ' A' ' 295' ' ' PHE . 7.6 Cg_exo -71.28 108.87 2.45 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.448 2.099 . . . . 0.0 112.283 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.462 HG21 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -123.33 129.99 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.546 175.048 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -85.59 131.03 34.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.796 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.29 -32.69 73.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.716 177.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -92.83 24.83 3.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.351 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.27 128.55 34.31 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 29.3 m -84.48 -1.89 6.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -173.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 33.7 t -110.13 -14.34 14.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -173.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.95 167.9 21.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.6 0.714 . . . . 0.0 112.312 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 7.9 t -99.98 154.03 37.45 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.15 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.478 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 67.0 Cg_exo -41.86 -47.81 6.27 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.158 2.572 . . . . 0.0 113.549 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -53.76 -39.94 65.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.186 0.517 . . . . 0.0 110.933 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -72.76 -23.88 60.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.823 -176.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 29.6 mtm180 -66.36 -27.46 67.89 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.942 0.401 . . . . 0.0 110.297 176.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.82 63.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.222 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -96.06 7.57 46.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.939 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.462 ' HA ' HG21 ' A' ' 313' ' ' VAL . . . -58.9 140.09 55.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.898 0.38 . . . . 0.0 110.527 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -123.17 -33.43 3.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.412 -170.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 27.5 m -125.47 169.01 17.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.862 0.363 . . . . 0.0 110.16 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -94.07 -16.87 23.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.809 0.338 . . . . 0.0 110.916 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.0 t -144.62 141.33 29.31 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.894 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 50.1 m -80.18 171.99 14.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.2 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 17.7 tp -68.25 103.89 1.7 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.187 0.518 . . . . 0.0 110.364 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.7 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -81.02 170.82 15.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.917 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -79.31 11.56 2.85 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.373 -171.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -142.85 40.99 1.54 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.025 0.44 . . . . 0.0 110.979 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 21.6 mmt -98.99 133.07 43.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.355 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -94.33 130.6 40.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.822 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 12.2 t -99.78 113.17 34.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.613 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . 0.543 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 57.9 t30 -130.65 139.61 50.36 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.032 -177.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.6 mt -86.93 122.82 39.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.939 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 38.0 mt -86.03 118.28 25.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.747 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -95.87 102.48 14.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.715 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.068 -0.967 . . . . 0.0 110.657 -178.947 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.674 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.6 p -76.04 -19.51 58.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.711 0.291 . . . . 0.0 111.464 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 28.4 m -71.27 -30.3 66.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.263 0.554 . . . . 0.0 110.323 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.31 63.03 6.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.499 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 341' ' ' ASN . 31.0 p -130.72 66.02 1.53 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.329 0.585 . . . . 0.0 111.189 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -113.94 56.43 0.49 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 263' ' ' ALA . 10.9 mt -92.51 161.2 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.22 -0.49 . . . . 0.0 110.342 -172.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 37.0 p -113.22 157.99 21.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.305 0.574 . . . . 0.0 111.369 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 335' ' ' ALA . 7.2 p -72.07 151.63 8.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.454 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 39.8 t -106.24 95.43 5.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.921 174.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 83.42 165.04 37.42 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.92 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -92.99 126.08 37.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -142.0 129.53 21.39 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.249 0.547 . . . . 0.0 111.357 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 15.5 t -106.42 121.9 45.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.551 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.441 ' O ' HG12 ' A' ' 313' ' ' VAL . 91.2 m-85 -83.89 113.53 21.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.862 0.363 . . . . 0.0 110.596 -176.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -124.04 118.48 26.8 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.528 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.39 134.97 16.11 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.516 2.144 . . . . 0.0 111.774 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 5.9 p -71.76 95.33 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.804 0.811 . . . . 0.0 110.965 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -125.31 80.8 1.91 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.376 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -141.39 97.46 3.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.148 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -70.07 103.99 2.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.831 0.348 . . . . 0.0 110.209 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 79.7 mt -74.04 -58.11 3.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.91 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -107.93 -92.52 0.41 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.132 174.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -88.6 -40.87 13.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.528 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.526 ' CG ' ' HD2' ' A' ' 249' ' ' LYS . 3.7 p30 -132.93 179.23 6.3 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.093 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -138.09 76.53 0.35 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.442 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 19.2 m120 59.43 52.76 5.6 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 122.746 0.418 . . . . 0.0 110.827 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.526 ' HD2' ' CG ' ' A' ' 246' ' ' ASP . 0.1 OUTLIER -77.56 -18.91 56.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.811 -175.262 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 40.4 t -80.7 -19.93 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.714 0.768 . . . . 0.0 109.571 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -86.28 84.52 7.45 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.265 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 28.1 m -90.37 25.22 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 122.018 0.913 . . . . 0.0 110.392 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -77.62 -15.45 59.2 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.538 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -71.96 -7.69 50.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.292 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.489 ' NE ' ' HA ' ' A' ' 255' ' ' ARG . 3.3 mmp_? -75.8 -15.48 60.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.152 0.501 . . . . 0.0 109.744 174.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -108.68 165.62 11.41 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.353 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -140.04 120.48 14.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.47 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.0 OUTLIER -90.27 104.24 16.84 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.991 0.424 . . . . 0.0 110.338 -179.466 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.437 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.6 t -88.94 117.9 33.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 -173.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 60.6 m -89.59 107.69 19.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.018 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 18.6 mt -123.6 164.11 19.68 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.68 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 17.2 m -57.52 -52.93 63.38 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.432 0.634 . . . . 0.0 109.681 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.577 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -137.47 146.13 43.9 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 175.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 16.0 p -132.0 29.93 4.34 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.102 0.953 . . . . 0.0 108.569 174.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 18.3 m -73.74 138.97 44.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.291 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 100.15 -1.06 56.15 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.312 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' MET . . . . . 0.414 ' SD ' HG13 ' A' ' 306' ' ' VAL . 54.9 mtt -102.04 142.86 32.65 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 62.0 pttt -143.33 148.18 35.87 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -50.18 122.32 6.68 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.601 0.563 . . . . 0.0 111.876 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 97.45 18.35 28.59 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.678 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 268' ' ' LYS . 1.4 t70 -98.06 -171.02 2.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.98 0.39 . . . . 0.0 110.168 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -135.12 117.06 15.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.872 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 29.6 pt -112.64 140.37 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.421 -0.512 . . . . 0.0 109.974 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 6.8 m -120.86 137.03 54.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.233 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -103.18 111.55 23.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.3 119.03 12.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.365 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.03 -32.14 6.53 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -176.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.475 ' HA ' ' CG2' ' A' ' 332' ' ' THR . 43.7 t -96.73 122.37 48.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -140.12 170.1 16.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.878 0.37 . . . . 0.0 111.379 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -81.18 173.41 12.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.753 -174.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 71.9 mt -80.1 71.28 6.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.257 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 143.84 -163.67 27.61 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.97 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 60.86 30.88 19.93 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.053 0.454 . . . . 0.0 110.85 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 65.4 mtm -123.1 -15.87 7.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.916 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.79 -55.9 14.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.239 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -113.95 -24.51 9.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.138 0.494 . . . . 0.0 110.299 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -82.48 105.04 13.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.301 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 19.7 t -74.52 -34.3 35.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.354 0.597 . . . . 0.0 109.454 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 94.9 mt -89.66 61.27 5.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.311 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -61.89 124.51 20.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.407 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -63.5 127.3 30.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.179 0.514 . . . . 0.0 110.264 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -76.0 166.91 22.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.463 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -52.91 104.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.513 0.508 . . . . 0.0 111.199 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.05 106.48 16.73 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.037 -176.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.498 ' CE2' ' HB3' ' A' ' 293' ' ' ALA . 50.2 m-85 -122.96 154.82 37.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.949 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 31.6 t -91.69 134.84 34.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.303 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.432 HG11 ' H ' ' A' ' 271' ' ' ASP . 11.9 p -87.15 126.74 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.218 0.533 . . . . 0.0 110.171 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.6 t -92.59 -38.77 10.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.581 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -159.13 133.89 8.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 50.3 t -93.8 110.28 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 39.5 t -70.16 -58.28 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.887 -171.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -124.34 -8.92 7.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.257 0.551 . . . . 0.0 111.151 -176.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.9 13.86 76.67 Favored Glycine 0 C--N 1.32 -0.309 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -172.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 29.6 p -138.71 13.2 2.72 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 172.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -166.35 120.65 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.519 -170.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.6 159.81 20.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 -176.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -122.77 115.48 22.11 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.284 0.564 . . . . 0.0 109.724 168.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.407 HG23 ' HA ' ' A' ' 297' ' ' VAL . 30.1 pt -111.83 178.35 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.102 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 15.0 t -153.73 142.73 14.67 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.404 ' HD2' ' CD1' ' A' ' 295' ' ' PHE . 4.8 Cg_exo -82.13 -179.87 25.15 Favored 'Cis proline' 0 C--N 1.344 0.317 0 C-N-CA 124.282 -1.133 . . . . 0.0 112.522 -2.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -77.27 124.42 87.04 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.491 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.484 ' HA ' ' OD1' ' A' ' 329' ' ' ASN . 64.3 Cg_endo -77.94 108.6 2.56 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.374 2.05 . . . . 0.0 112.365 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 236' ' ' PHE . 0.2 OUTLIER -109.49 136.17 46.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -81.47 115.8 20.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.057 0.456 . . . . 0.0 111.106 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.96 -26.54 66.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.528 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.09 12.54 21.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.864 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -85.66 118.63 25.29 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.88 -14.34 11.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.004 0.43 . . . . 0.0 111.221 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.5 t -77.7 -28.28 50.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.47 -174.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 1.8 pp -71.07 172.92 8.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.31 0.576 . . . . 0.0 112.009 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 23.5 m -102.65 162.98 18.53 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.483 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.439 ' O ' ' HG3' ' A' ' 325' ' ' ARG . 85.3 Cg_exo -44.62 -52.21 6.31 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.004 3.136 . . . . 0.0 115.39 -172.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -73.42 -18.13 61.18 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.771 -0.581 . . . . 0.0 111.743 -172.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -73.92 -39.7 63.65 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.224 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 322' ' ' PRO . 0.0 OUTLIER -75.07 -16.29 60.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.121 0.486 . . . . 0.0 110.785 178.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -66.71 -35.48 80.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.551 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -95.43 -0.62 52.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.138 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.432 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -66.19 128.45 36.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.15 0.5 . . . . 0.0 111.266 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . 0.484 ' OD1' ' HA ' ' A' ' 312' ' ' PRO . 10.2 p30 -110.85 -26.85 9.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.699 -176.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 29.2 m -108.54 164.07 5.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.017 0.437 . . . . 0.0 110.834 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -98.86 -5.66 30.54 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.475 ' CG2' ' HA ' ' A' ' 278' ' ' VAL . 8.9 t -146.05 148.11 32.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.059 0.457 . . . . 0.0 110.882 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 59.5 m -81.26 167.33 19.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.492 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 18.7 tp -76.02 102.92 5.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.693 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -80.58 167.63 19.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.297 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -80.68 28.7 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -171.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -153.09 32.23 0.48 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.874 0.368 . . . . 0.0 110.838 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.6 mmt -94.22 129.99 40.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.871 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -85.15 140.69 30.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.618 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 11.2 t -109.46 108.11 24.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.919 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 226' ' ' THR . 6.8 t30 -119.6 132.11 55.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.15 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 4.0 mt -92.72 129.57 43.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.02 0.438 . . . . 0.0 110.591 175.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 50.8 mt -76.17 111.1 11.23 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -123.77 144.91 49.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.97 0.414 . . . . 0.0 110.75 -174.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.248 1.015 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.986 -177.317 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.708 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 48.8 m -124.66 165.93 17.03 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 14.9 t -160.06 160.21 32.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.946 0.403 . . . . 0.0 110.366 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -132.05 -172.56 2.91 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 20.1 p -66.81 -77.24 0.07 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.275 176.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 50.96 37.73 36.76 Favored Glycine 0 C--N 1.332 0.361 0 O-C-N 123.331 0.394 . . . . 0.0 113.056 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 263' ' ' ALA . 44.2 mt -82.5 141.7 14.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -176.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 5.4 p -95.29 147.14 23.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.724 0.773 . . . . 0.0 112.131 -171.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 335' ' ' ALA . 9.6 p -57.54 151.37 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.089 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 33.1 t -101.93 47.7 0.89 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.084 0.469 . . . . 0.0 110.427 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 122.57 163.94 12.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.407 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -79.34 123.26 27.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.797 0.332 . . . . 0.0 110.417 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.427 HE22 ' CB ' ' A' ' 260' ' ' THR . 95.1 mt-30 -132.88 131.55 41.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.228 0.537 . . . . 0.0 111.217 -177.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.1 t -131.34 101.93 5.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.558 ' O ' HG12 ' A' ' 313' ' ' VAL . 64.8 m-85 -94.68 137.45 33.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.219 -176.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.68 ' HB3' ' NE2' ' A' ' 324' ' ' GLN . 3.3 mptp? -109.85 146.56 34.36 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.681 -177.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.508 ' HA ' ' OD1' ' A' ' 254' ' ' ASN . 73.5 Cg_endo -80.25 137.24 11.87 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.571 2.181 . . . . 0.0 111.029 170.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.67 109.22 7.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.431 0.634 . . . . 0.0 110.539 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -136.41 129.77 31.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.538 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 28.2 t90 71.74 -53.21 0.69 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.022 0.826 . . . . 0.0 111.492 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -74.8 153.38 38.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.409 ' HG ' ' H ' ' A' ' 247' ' ' GLY . 39.3 tp 58.53 51.37 8.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.403 0.62 . . . . 0.0 110.012 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -75.67 -9.08 58.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.458 -175.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -80.4 -25.91 38.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.881 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -124.47 -59.87 1.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.434 -173.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.409 ' H ' ' HG ' ' A' ' 243' ' ' LEU . . . 60.67 -142.58 48.18 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.961 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -105.12 12.88 31.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.351 0.596 . . . . 0.0 109.772 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -79.08 -33.48 44.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.809 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.09 179.9 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.692 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 62.54 -154.7 0.34 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.45 138.44 22.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 171.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -77.13 110.41 11.78 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.508 ' OD1' ' HA ' ' A' ' 238' ' ' PRO . 20.1 t-20 -71.79 -7.63 49.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.108 -174.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -67.42 -17.19 64.62 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.705 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -107.4 135.58 48.65 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.652 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -100.55 122.9 44.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.475 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -90.68 101.26 14.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.016 0.436 . . . . 0.0 111.089 179.002 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.6 t -83.15 121.48 36.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.977 -175.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' THR . . . . . 0.427 ' CB ' HE22 ' A' ' 234' ' ' GLN . 29.0 m -94.28 107.02 18.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.312 0.577 . . . . 0.0 109.985 176.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.44 ' HB2' HG21 ' A' ' 264' ' ' THR . 17.8 mt -121.04 163.19 18.71 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.634 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 26.2 m -55.03 -54.0 48.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.172 0.51 . . . . 0.0 109.958 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -137.47 135.45 36.84 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.44 HG21 ' HB2' ' A' ' 261' ' ' LEU . 7.9 p -126.37 29.25 5.82 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.5 m -82.21 139.51 34.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.023 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 96.05 18.48 31.53 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 65.4 mtt -121.45 147.26 45.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.022 -0.589 . . . . 0.0 109.722 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -139.14 169.5 17.66 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.527 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 298' ' ' VAL . 47.6 mtt180 -56.48 128.56 36.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.777 0.323 . . . . 0.0 111.371 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.02 18.57 42.89 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.354 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.438 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 92.0 m-20 -93.78 156.12 16.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.169 0.484 . . . . 0.0 110.302 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -102.9 116.6 32.87 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.423 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 308' ' ' ILE . 28.5 pt -113.51 138.69 42.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.095 176.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 10.5 t -120.19 132.25 55.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.461 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.412 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 92.5 m-85 -94.43 110.33 22.12 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.97 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.44 111.37 8.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.374 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.63 -19.95 20.98 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.577 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 74.7 t -104.44 128.7 57.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 174.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -147.11 159.7 43.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.956 0.407 . . . . 0.0 111.106 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 76.9 m-85 -73.66 166.08 23.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.277 -175.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 89.6 mt -61.32 136.86 58.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.489 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 99.23 -22.35 41.23 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.028 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.412 ' OE1' ' HB2' ' A' ' 290' ' ' ALA . 86.0 mm-40 -75.78 128.74 35.8 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 178.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 287' ' ' ASN . 86.1 mtp 69.48 17.54 8.0 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.599 -176.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.38 -36.99 60.83 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -151.85 24.02 0.67 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.923 171.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.489 ' O ' ' HA ' ' A' ' 284' ' ' MET . 9.6 m120 -130.85 96.16 4.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.026 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 83.7 t -62.99 -49.41 83.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.175 0.512 . . . . 0.0 110.219 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 80.5 mt -87.59 61.11 6.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.864 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.412 ' HB2' ' OE1' ' A' ' 283' ' ' GLN . . . -82.78 173.44 11.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.973 -177.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -102.27 137.73 40.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.438 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -76.41 166.74 23.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.465 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -68.99 129.99 41.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.762 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 9.3 p -119.74 110.6 16.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.847 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -116.95 151.75 36.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.057 0.455 . . . . 0.0 110.95 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.3 m -98.56 131.08 45.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.713 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.438 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.3 p -79.09 131.33 34.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.263 0.554 . . . . 0.0 110.8 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.551 ' O ' ' HG2' ' A' ' 269' ' ' ARG . 25.6 t -94.61 -24.55 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.532 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.436 ' HB3' ' CD ' ' A' ' 307' ' ' GLU . 12.4 tpt180 -176.85 139.33 0.29 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.369 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 75.6 t -90.59 111.02 22.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 36.9 t -73.27 -55.59 12.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.047 -171.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -128.96 -4.26 5.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.191 0.519 . . . . 0.0 111.463 -176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 80.55 13.32 81.79 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.46 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.3 p -143.51 16.42 1.83 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.513 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.1 t-160 -165.47 118.25 1.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.269 -170.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.5 m -118.95 157.54 20.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -176.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.436 ' CD ' ' HB3' ' A' ' 299' ' ' ARG . 8.8 pt-20 -115.39 121.72 43.66 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 173.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.452 HG22 HD11 ' A' ' 273' ' ' ILE . 30.0 pt -122.45 163.75 20.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.184 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.9 t -149.21 142.28 15.85 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.447 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.05 179.63 28.93 Favored 'Cis proline' 0 C--N 1.345 0.35 0 C-N-CA 123.463 -1.474 . . . . 0.0 112.696 -0.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -83.14 124.45 76.33 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.053 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -72.78 109.2 2.74 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.835 2.357 . . . . 0.0 112.225 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 236' ' ' PHE . 0.0 OUTLIER -118.82 137.3 53.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.642 176.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -81.46 131.15 35.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.285 0.564 . . . . 0.0 110.459 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -73.79 -29.35 62.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.111 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -93.9 24.79 3.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.346 0.593 . . . . 0.0 110.498 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . 0.632 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 14.8 t70 -82.05 121.4 26.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.198 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 13.1 p -84.32 -19.09 9.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.986 0.422 . . . . 0.0 110.996 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 34.2 t -71.72 -46.61 58.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.51 -174.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.632 ' HG ' ' OD1' ' A' ' 317' ' ' ASP . 0.3 OUTLIER -74.82 170.15 16.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.739 0.781 . . . . 0.0 113.066 -175.167 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 41.2 t -83.77 151.59 61.49 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.624 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' A' ' 325' ' ' ARG . 99.9 Cg_exo -45.84 -40.3 19.6 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.183 2.588 . . . . 0.0 113.414 176.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -60.44 -41.53 94.24 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.444 0.64 . . . . 0.0 110.914 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.68 ' NE2' ' HB3' ' A' ' 237' ' ' LYS . 39.2 mt-30 -70.21 -24.44 63.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.037 -177.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.446 ' HD2' ' HA ' ' A' ' 322' ' ' PRO . 90.6 mtt180 -70.34 -26.51 63.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.585 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.5 -29.07 68.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.236 0.541 . . . . 0.0 110.17 176.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -97.38 6.36 48.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.342 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -71.79 150.13 44.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 0.0 110.884 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -126.97 -32.25 2.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.915 0.388 . . . . 0.0 111.387 -174.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.9 m -112.46 155.14 13.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.24 -176.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -83.76 -22.1 32.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.252 0.548 . . . . 0.0 109.99 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 1.4 t -129.46 131.44 46.71 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.606 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.404 ' N ' ' HB1' ' A' ' 314' ' ' ALA . 8.7 p -75.39 168.13 20.58 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.682 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 20.5 tp -70.22 103.73 2.44 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.656 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -80.49 173.14 12.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.294 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.31 10.37 3.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.858 -173.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -143.0 57.85 1.41 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.234 0.54 . . . . 0.0 110.786 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.8 mmt -117.11 136.14 53.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.282 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -96.38 131.93 42.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.903 0.382 . . . . 0.0 110.823 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 38.5 t -103.51 108.2 23.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.669 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -123.11 129.55 51.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.337 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 42.9 mt -80.17 125.14 38.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.525 175.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 78.5 mt -72.75 112.29 8.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.853 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -88.71 77.94 7.79 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.873 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.34 177.784 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.858 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.1 m -75.46 -42.19 53.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.702 0.287 . . . . 0.0 110.675 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 13.4 t -70.75 149.62 46.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -130.37 112.71 13.54 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.223 0.535 . . . . 0.0 111.066 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 28.6 p -96.18 82.65 3.49 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.972 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.79 63.96 3.06 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.742 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.521 HD11 ' O ' ' A' ' 263' ' ' ALA . 45.5 mm -98.66 139.58 20.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.583 0.23 . . . . 0.0 111.112 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.3 p -121.72 160.24 24.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.949 0.404 . . . . 0.0 110.581 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 335' ' ' ALA . 9.8 p -78.5 151.04 5.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.345 177.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.8 t -116.73 78.81 1.24 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.234 0.54 . . . . 0.0 109.755 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 110.68 166.33 19.1 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.46 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -97.35 110.12 22.74 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -97.51 127.36 43.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.36 0.6 . . . . 0.0 111.604 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.6 m -127.33 101.2 6.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.101 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.426 ' HB3' ' HE2' ' A' ' 311' ' ' LYS . 94.1 m-85 -85.49 167.92 15.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.497 -174.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -137.65 136.63 20.4 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.496 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -89.86 127.97 1.59 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.638 2.226 . . . . 0.0 111.686 177.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 8.0 p -61.77 125.37 17.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.058 0.456 . . . . 0.0 110.359 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -73.58 114.36 11.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.304 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 74.7 m95 72.51 155.62 0.16 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.05 0.844 . . . . 0.0 111.444 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -79.17 133.72 36.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.171 -175.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 87.3 mt -97.03 167.93 10.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.963 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -119.16 -151.29 0.48 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -60.86 -39.74 90.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.253 0.549 . . . . 0.0 110.079 174.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -102.59 179.17 4.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.548 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 116.4 -90.76 0.53 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.772 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -100.85 171.95 7.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.546 0.212 . . . . 0.0 110.61 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -80.19 -39.25 29.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.051 0.453 . . . . 0.0 110.169 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.6 m -73.51 113.89 12.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.431 0.634 . . . . 0.0 110.706 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -103.75 22.26 14.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.575 0.703 . . . . 0.0 110.489 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.0 p -99.18 148.63 6.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.328 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -59.94 118.64 6.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.842 0.353 . . . . 0.0 110.25 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -93.52 2.14 56.53 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.843 -175.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -85.93 -32.71 21.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.134 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -79.45 127.91 32.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.963 173.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.75 122.67 43.76 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.825 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -90.96 104.3 16.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.501 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.6 t -86.33 121.96 38.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.441 -173.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 63.3 m -91.12 105.35 17.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.218 0.533 . . . . 0.0 110.202 175.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.474 ' HB2' ' CG2' ' A' ' 264' ' ' THR . 21.7 mt -122.02 162.85 20.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.623 -177.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 8.0 m -59.79 -52.05 67.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.169 0.509 . . . . 0.0 109.875 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.521 ' O ' HD11 ' A' ' 228' ' ' ILE . . . -136.08 125.09 24.29 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.667 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.525 ' HB ' ' SD ' ' A' ' 267' ' ' MET . 6.7 p -124.92 27.07 6.86 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.138 0.971 . . . . 0.0 108.589 174.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 8.3 m -82.89 138.05 34.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.585 177.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 101.7 -14.31 57.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -175.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' MET . . . . . 0.525 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 64.5 mtt -82.82 153.73 25.04 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -153.67 142.61 21.17 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.482 ' HA ' HG11 ' A' ' 297' ' ' VAL . 34.6 ptt180 -50.87 114.03 1.06 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.624 0.578 . . . . 0.0 111.401 -173.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.16 -2.43 22.49 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.74 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.466 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.4 p30 -81.67 -179.25 7.3 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 117.258 0.529 . . . . 0.0 111.243 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -131.93 116.51 17.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.845 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 22.3 pt -114.14 138.9 42.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.148 0.499 . . . . 0.0 110.769 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 13.3 t -118.51 137.07 53.45 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.615 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -103.69 111.36 23.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.037 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.54 118.82 13.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.688 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.99 -13.74 26.56 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.682 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.02 147.94 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.601 ' HG3' ' SD ' ' A' ' 284' ' ' MET . 11.6 ptpt -161.24 156.55 24.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.912 0.387 . . . . 0.0 111.48 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -81.15 153.46 27.24 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.465 -171.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.4 HD12 ' HB2' ' A' ' 315' ' ' LEU . 83.7 mt -72.07 143.02 49.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.213 175.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 100.22 -39.8 2.63 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.442 ' O ' ' HB3' ' A' ' 287' ' ' ASN . 6.3 tp-100 -76.69 -20.11 56.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.238 0.542 . . . . 0.0 109.649 178.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.601 ' SD ' ' HG3' ' A' ' 279' ' ' LYS . 88.2 mtp -98.03 17.19 18.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.703 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.57 -56.06 4.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.805 0.336 . . . . 0.0 110.94 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -121.59 -29.95 4.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.589 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 283' ' ' GLN . 3.0 t-20 -75.42 108.95 8.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.036 0.446 . . . . 0.0 109.954 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.04 -31.26 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.241 0.543 . . . . 0.0 109.872 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 73.5 mt -91.56 53.93 2.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.509 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.52 124.87 23.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.05 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -59.74 141.86 54.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.096 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -66.02 148.23 52.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.357 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -57.71 117.76 4.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.085 -172.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 37.9 p -105.01 113.75 27.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.565 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -110.94 148.44 32.5 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.992 0.425 . . . . 0.0 110.735 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 16.0 m -96.23 127.92 42.67 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.001 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.482 HG11 ' HA ' ' A' ' 269' ' ' ARG . 2.5 p -73.95 140.62 17.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.7 t -104.09 -31.85 2.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.055 0.455 . . . . 0.0 109.88 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.532 ' HD2' ' OE2' ' A' ' 307' ' ' GLU . 1.2 tmt_? -173.47 138.41 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.0 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 79.4 t -90.64 116.8 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 22.2 t -78.01 -58.8 3.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.042 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -116.71 -10.62 11.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.918 0.389 . . . . 0.0 111.864 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 78.53 12.22 84.48 Favored Glycine 0 CA--C 1.517 0.204 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -171.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.8 p -149.92 22.3 0.88 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.449 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 8.5 t-160 -174.08 115.59 0.21 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 113.561 -1.654 . . . . 0.0 107.999 -166.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.23 166.51 13.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.532 ' OE2' ' HD2' ' A' ' 299' ' ' ARG . 10.5 pt-20 -123.79 122.34 37.8 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 169.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.454 HG22 ' HA ' ' A' ' 297' ' ' VAL . 30.0 pt -121.2 170.74 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.51 -174.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' THR . . . . . 0.41 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 11.8 t -152.01 139.93 13.07 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.969 172.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 309' ' ' THR . 61.6 Cg_endo -71.14 179.4 25.39 Favored 'Cis proline' 0 C--N 1.345 0.368 0 C-N-CA 123.846 -1.314 . . . . 0.0 113.209 2.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 236' ' ' PHE . 19.6 ttmt -84.95 126.37 68.17 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.669 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -65.9 108.11 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.316 2.011 . . . . 0.0 111.84 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 329' ' ' ASN . 1.3 m -130.87 129.54 63.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.151 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -93.06 141.5 28.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.433 -173.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . 0.4 ' HB2' HD12 ' A' ' 281' ' ' LEU . 2.8 tm? -75.07 -26.16 59.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.483 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -94.83 26.0 3.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.644 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -83.49 136.56 34.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 27.8 m -83.81 -9.77 11.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 9.6 t -120.22 23.33 11.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.938 0.399 . . . . 0.0 111.626 -171.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.23 168.67 10.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.077 0.465 . . . . 0.0 111.026 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.426 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 51.9 m -112.49 165.25 13.43 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.358 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.44 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 85.5 Cg_exo -45.25 -49.45 10.16 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.517 2.812 . . . . 0.0 114.737 -175.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.2 -28.94 61.51 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.807 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -67.99 -41.13 82.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.663 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.44 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 28.8 ptt180 -69.12 -23.43 63.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.145 0.498 . . . . 0.0 110.17 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -80.68 -10.25 59.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.628 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -118.41 16.52 13.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.783 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -65.1 151.27 46.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.223 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . 0.402 ' H ' HG23 ' A' ' 313' ' ' VAL . 83.3 m-20 -115.21 -39.64 3.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.796 -175.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 30.7 m -118.26 168.28 10.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.22 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -82.31 -49.63 9.83 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.874 0.368 . . . . 0.0 110.798 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 13.5 t -117.79 149.82 40.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.202 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 22.6 p -80.8 171.23 15.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.009 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 20.1 tp -73.75 111.27 8.74 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.624 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -82.0 170.68 15.29 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.137 0.494 . . . . 0.0 111.435 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.07 -8.92 57.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.506 -169.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -138.33 55.36 1.75 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.04 0.448 . . . . 0.0 111.578 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' MET . . . . . 0.494 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 14.5 mmt -102.33 147.57 26.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.162 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -96.14 143.56 27.16 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.68 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.45 ' O ' ' HB ' ' A' ' 228' ' ' ILE . 17.7 t -115.52 126.89 73.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -133.35 136.35 45.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.177 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 25.2 mt -90.1 124.38 42.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.919 0.39 . . . . 0.0 110.324 174.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 45.2 mt -75.16 113.16 12.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.212 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -75.96 88.59 2.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 175.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.247 0.94 0 CA-C-O 117.642 -1.17 . . . . 0.0 110.409 -178.102 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.63 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 35.4 m -108.09 104.46 13.9 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.769 0.319 . . . . 0.0 110.357 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.433 ' OG1' ' HB2' ' A' ' 344' ' ' ASN . 13.5 p -91.56 1.76 56.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.84 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -76.64 69.9 3.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.203 0.525 . . . . 0.0 110.716 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.52 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 23.2 p -66.95 -59.6 3.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.693 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 60.67 39.3 96.41 Favored Glycine 0 CA--C 1.516 0.144 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.313 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.535 HG23 ' O ' ' A' ' 263' ' ' ALA . 71.9 mt -102.95 143.86 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 7.0 p -111.3 151.43 28.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.079 0.466 . . . . 0.0 111.246 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.627 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.5 p -60.75 150.48 6.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.807 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 8.8 t -112.3 82.21 1.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.115 0.484 . . . . 0.0 109.747 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 92.66 149.61 24.99 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.858 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.56 121.75 17.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.837 0.351 . . . . 0.0 110.552 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -113.25 126.96 55.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.203 0.525 . . . . 0.0 110.238 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 20.3 p -127.9 104.0 7.57 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.171 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -81.51 161.51 23.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.789 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -142.02 133.74 13.38 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.601 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.429 ' HD3' HG13 ' A' ' 313' ' ' VAL . 84.7 Cg_endo -87.76 174.51 4.77 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.853 2.368 . . . . 0.0 111.435 176.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 46.3 t -108.7 96.79 4.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.913 0.387 . . . . 0.0 110.012 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -95.43 -164.39 1.16 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.64 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -79.21 -52.39 8.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.707 0.289 . . . . 0.0 110.753 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . 0.561 ' HB2' ' OE1' ' A' ' 323' ' ' GLU . 26.8 mt-30 -105.89 139.01 41.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.821 0.343 . . . . 0.0 110.62 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.8 35.51 1.6 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.809 -175.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 59.9 -108.67 0.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.465 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -88.63 -47.31 8.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.921 0.391 . . . . 0.0 110.983 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -161.67 155.7 22.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.601 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -146.33 -69.47 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.111 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -83.52 65.5 8.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.469 0.652 . . . . 0.0 111.403 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -74.25 -57.19 4.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.991 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.4 m -86.11 162.79 2.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.083 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -80.15 96.3 6.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.129 0.49 . . . . 0.0 110.966 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 18.1 m -116.4 154.42 17.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.5 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -86.66 129.09 35.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.71 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -67.73 -33.42 74.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.657 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 44.0 mtm-85 -95.2 -49.22 5.59 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -174.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -79.19 147.66 32.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.991 0.424 . . . . 0.0 111.019 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -119.86 126.98 52.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.524 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.5 m -93.96 99.19 11.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.01 0.433 . . . . 0.0 110.62 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.438 ' HB ' HG21 ' A' ' 306' ' ' VAL . 2.7 t -83.66 120.16 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.168 -174.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 19.3 m -91.55 105.75 17.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.835 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.404 ' HB2' ' CG2' ' A' ' 264' ' ' THR . 19.9 mt -121.63 169.41 10.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.257 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 6.6 m -63.05 -55.19 27.68 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.535 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -136.62 131.15 33.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.696 178.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.411 ' HB ' ' SD ' ' A' ' 267' ' ' MET . 3.2 p -129.51 27.49 5.27 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 18.4 m -82.69 141.88 32.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.096 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.03 -3.95 60.62 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -174.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' MET . . . . . 0.411 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 89.5 mtp -86.9 152.85 22.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -154.84 140.85 18.34 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.22 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.505 ' HA ' HG11 ' A' ' 297' ' ' VAL . 35.9 ptt180 -52.45 117.82 3.14 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.374 0.606 . . . . 0.0 111.089 -175.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.47 1.12 21.8 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.378 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -84.06 179.68 7.45 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.132 0.466 . . . . 0.0 110.507 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.462 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 5.1 tppp? -137.67 115.94 11.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.827 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.449 HD13 HG21 ' A' ' 308' ' ' ILE . 35.7 pt -112.99 140.0 35.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.206 0.527 . . . . 0.0 110.389 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 17.9 m -131.39 138.73 49.24 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.663 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -100.29 113.5 26.25 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.096 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.94 113.56 2.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.499 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.77 -34.34 5.16 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.932 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.7 t -81.14 127.85 39.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -149.12 161.75 41.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.708 0.289 . . . . 0.0 110.896 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -83.67 158.42 21.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.053 -175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 95.5 mt -81.65 44.35 0.81 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.305 0.574 . . . . 0.0 111.26 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -144.08 25.8 2.05 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.424 HE21 ' HB2' ' A' ' 290' ' ' ALA . 12.3 mt-30 -130.42 170.86 13.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.272 -0.464 . . . . 0.0 109.815 -175.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 19.1 mmt 62.54 26.54 15.77 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.499 0.499 . . . . 0.0 111.11 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -78.41 -32.62 48.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.205 0.526 . . . . 0.0 109.955 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -155.23 -41.39 0.08 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.441 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -72.6 125.49 27.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.475 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 22.4 t -85.94 -22.09 7.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.186 0.517 . . . . 0.0 109.924 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 86.0 mt -81.42 59.62 4.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.718 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.424 ' HB2' HE21 ' A' ' 283' ' ' GLN . . . -80.14 133.64 36.08 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.136 -176.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -69.56 167.51 16.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.397 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -95.3 166.85 11.69 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 172.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -59.78 106.76 0.52 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.957 0.408 . . . . 0.0 111.334 -176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 21.3 p -88.59 115.6 26.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.501 -177.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -121.31 144.31 48.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.367 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 68.4 m -101.32 132.39 46.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.749 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.505 HG11 ' HA ' ' A' ' 269' ' ' ARG . 9.3 p -67.49 140.35 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.126 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.63 -42.65 7.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.111 175.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.408 ' HB3' ' CD ' ' A' ' 307' ' ' GLU . 23.5 tpt180 -157.33 128.06 6.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.85 -178.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 97.8 t -86.3 97.8 6.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 172.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 25.4 t -65.9 -58.74 5.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.691 -173.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -126.66 -8.31 6.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.141 0.496 . . . . 0.0 111.472 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.15 13.81 78.27 Favored Glycine 0 C--N 1.321 -0.252 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.677 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 21.6 p -138.95 10.31 2.6 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 170.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -162.74 116.6 1.71 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.453 -1.249 . . . . 0.0 107.894 -169.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.99 160.29 18.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.674 -172.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.0 pt-20 -121.28 122.58 40.22 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 168.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.449 HG21 HD13 ' A' ' 273' ' ' ILE . 23.4 pt -123.49 169.39 14.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.228 0.537 . . . . 0.0 112.309 -174.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.0 t -145.38 138.83 14.38 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.788 172.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.33 -179.75 24.62 Favored 'Cis proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.759 -1.35 . . . . 0.0 113.313 -1.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.519 ' HZ3' ' HB2' ' A' ' 311' ' ' LYS . 3.3 ttmp? -87.42 125.53 65.29 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.558 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.61 108.85 1.94 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.369 2.046 . . . . 0.0 111.861 175.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.456 ' CG2' ' HA ' ' A' ' 328' ' ' ALA . 1.5 m -136.3 120.86 25.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.454 ' HB1' ' N ' ' A' ' 333' ' ' SER . . . -82.49 134.43 35.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.838 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.9 tm? -75.69 -25.05 56.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.618 176.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -85.9 6.02 30.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.14 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -77.2 126.8 31.53 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.2 m -83.94 2.35 3.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 7.7 m -103.5 23.22 12.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.703 0.287 . . . . 0.0 111.77 -172.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.411 HD13 ' HG2' ' A' ' 325' ' ' ARG . 1.0 OUTLIER -126.18 157.2 38.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.44 0.638 . . . . 0.0 112.25 -179.29 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.483 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 2.8 m -92.25 166.81 16.35 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.554 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 2.3 Cg_endo -42.18 -58.08 1.34 Allowed 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.759 2.973 . . . . 0.0 113.864 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.561 ' OE1' ' HB2' ' A' ' 242' ' ' GLN . 15.8 mp0 -60.4 -36.88 79.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.137 0.494 . . . . 0.0 111.084 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -63.4 -30.5 71.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.664 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.411 ' HG2' HD13 ' A' ' 320' ' ' LEU . 34.2 mtp85 -61.28 -39.31 89.93 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.226 176.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.04 -26.15 68.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.066 0.46 . . . . 0.0 110.922 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -87.11 -12.88 45.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.232 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.456 ' HA ' ' CG2' ' A' ' 313' ' ' VAL . . . -72.3 151.63 42.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.515 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -137.18 -35.72 0.68 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -173.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.3 m -101.93 167.62 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.852 0.358 . . . . 0.0 111.092 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -83.63 -39.3 20.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.919 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.1 t -126.69 139.54 53.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.673 -177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.454 ' N ' ' HB1' ' A' ' 314' ' ' ALA . 46.3 m -70.42 171.92 9.24 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 20.3 tp -71.24 103.91 2.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.627 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -79.62 172.12 14.22 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.878 -175.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.51 -11.61 60.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.129 -171.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -132.49 71.27 1.47 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.016 0.436 . . . . 0.0 111.223 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' MET . . . . . 0.408 ' H ' HG13 ' A' ' 230' ' ' VAL . 23.5 mmt -121.84 133.84 54.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.666 175.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -85.38 136.54 33.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.906 0.384 . . . . 0.0 111.301 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 17.4 t -101.4 112.82 35.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.703 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . 0.52 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 5.7 t-20 -129.91 138.8 51.1 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.815 0.34 . . . . 0.0 111.382 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 62.3 mt -92.1 125.92 44.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 172.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 40.4 mt -75.75 124.7 27.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.97 0.414 . . . . 0.0 111.012 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . 0.433 ' HB2' ' OG1' ' A' ' 224' ' ' THR . 46.2 t-20 -86.86 81.56 8.11 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.505 -0.759 . . . . 0.0 110.3 -177.7 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.815 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.6 m -75.12 144.77 42.68 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 12.2 m 59.16 69.13 0.74 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.307 0.575 . . . . 0.0 110.213 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.21 106.41 2.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.57 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 3.8 p -129.84 97.92 4.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.27 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -116.52 37.53 3.35 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.509 HG23 ' O ' ' A' ' 263' ' ' ALA . 37.9 mt -82.28 152.44 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.277 -0.461 . . . . 0.0 109.883 -173.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 22.0 p -114.64 162.59 16.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.454 0.645 . . . . 0.0 111.808 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 335' ' ' ALA . 9.8 p -62.7 151.75 7.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.897 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 16.5 t -116.82 78.9 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.195 0.521 . . . . 0.0 109.615 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 100.82 145.79 17.89 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.904 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.83 111.74 5.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.844 0.354 . . . . 0.0 110.304 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -109.15 127.8 54.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.264 0.554 . . . . 0.0 110.834 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 16.7 p -115.95 143.12 45.88 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.639 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -115.99 154.45 29.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.791 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -143.45 135.56 13.2 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.422 ' HD3' HG12 ' A' ' 313' ' ' VAL . 10.9 Cg_endo -91.24 121.0 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.892 2.395 . . . . 0.0 110.66 169.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.458 HG13 ' OD1' ' A' ' 254' ' ' ASN . 8.9 p -62.43 132.21 28.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 121.359 0.6 . . . . 0.0 111.171 -176.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -100.32 -169.34 1.71 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.992 -177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 98.9 m95 72.87 127.09 0.04 OUTLIER 'General case' 0 C--O 1.234 0.274 0 O-C-N 124.013 0.82 . . . . 0.0 111.358 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -68.76 154.89 41.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.491 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 246' ' ' ASP . 1.4 pp -113.14 34.39 4.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.077 0.465 . . . . 0.0 111.488 -173.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -73.66 -54.06 9.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.474 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -87.78 -52.01 5.54 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 243' ' ' LEU . 3.6 p-10 -147.8 159.28 43.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.15 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 179.14 -166.17 35.52 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.998 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -92.35 78.83 5.04 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.042 0.448 . . . . 0.0 110.669 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -81.21 59.41 3.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.455 0.645 . . . . 0.0 110.108 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.4 m -136.65 -169.21 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.959 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . 0.408 HD21 ' N ' ' A' ' 251' ' ' ASN . 0.9 OUTLIER -73.84 72.47 1.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.133 0.492 . . . . 0.0 110.156 176.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.408 ' HB ' ' OD1' ' A' ' 254' ' ' ASN . 15.8 m -77.92 129.46 37.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.698 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -93.76 53.02 1.76 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.343 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.458 ' OD1' HG13 ' A' ' 239' ' ' VAL . 4.0 m-20 -68.28 -49.62 59.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.165 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 255' ' ' ARG . 5.7 tpm_? -79.44 -33.34 42.56 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.48 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 308' ' ' ILE . 51.7 m-85 -99.91 176.95 5.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.171 -172.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -153.57 125.23 7.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.677 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -90.18 104.13 16.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.246 0.546 . . . . 0.0 111.147 178.004 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.8 t -86.61 121.09 37.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.998 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 30.5 m -92.84 109.54 20.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.992 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 17.4 mt -124.54 176.03 6.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.918 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 35.0 t -64.56 -59.66 4.03 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.509 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -137.58 138.7 39.83 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 7.6 p -126.97 28.09 5.86 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.004 0.906 . . . . 0.0 108.914 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 1.3 m -78.81 151.28 32.02 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.981 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 93.11 -22.44 34.57 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 53.8 mtt -79.6 144.67 33.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.562 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 0.3 OUTLIER -137.31 152.48 49.8 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -50.82 126.03 14.87 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.568 0.542 . . . . 0.0 111.474 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.95 19.23 37.35 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.567 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 268' ' ' LYS . 0.8 OUTLIER -98.81 177.39 5.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.973 0.416 . . . . 0.0 110.673 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -122.02 116.34 24.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.908 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 308' ' ' ILE . 40.3 pt -113.19 140.28 34.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.215 177.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -118.24 133.47 55.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.215 -176.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -99.63 110.99 23.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.894 0.378 . . . . 0.0 110.028 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.09 117.81 15.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.531 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.79 -24.41 15.09 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 42.4 t -99.99 133.85 41.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -151.1 160.63 43.77 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 120.993 0.425 . . . . 0.0 111.066 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -78.19 154.33 31.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.369 -169.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 84.4 mt -71.32 141.01 50.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.388 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 94.69 -29.34 9.26 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.528 ' O ' ' HB2' ' A' ' 287' ' ' ASN . 28.6 mm-40 -84.4 8.13 17.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.995 0.426 . . . . 0.0 110.746 -177.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 90.5 mtp -122.77 8.92 9.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.955 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -83.82 -32.77 25.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.144 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -160.26 31.62 0.17 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.419 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 283' ' ' GLN . 17.0 m120 -128.35 103.16 7.0 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.455 -175.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 50.6 t -70.73 -31.36 45.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.341 0.591 . . . . 0.0 109.658 176.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 93.8 mt -89.49 55.58 3.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.032 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.97 112.74 7.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.677 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.57 144.82 54.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.617 -178.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -69.63 154.32 42.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.52 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.412 ' HB3' ' CE2' ' A' ' 295' ' ' PHE . . . -60.33 102.05 0.16 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.26 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 1.2 p -103.44 117.84 35.38 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.245 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 293' ' ' ALA . 85.1 m-85 -124.36 152.59 42.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.13 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.7 m -92.2 125.5 36.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.198 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.454 HG13 ' H ' ' A' ' 271' ' ' ASP . 10.9 p -81.48 130.17 36.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.301 0.572 . . . . 0.0 110.521 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 58.6 t -90.53 -38.7 11.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.548 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -160.41 141.47 12.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.202 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 90.4 t -94.38 107.56 19.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 27.3 t -77.41 -59.17 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.873 -172.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -120.21 -7.58 9.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.384 0.611 . . . . 0.0 111.116 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 79.27 14.18 81.93 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.316 -174.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 25.6 p -137.18 7.55 2.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.155 0.979 . . . . 0.0 108.525 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.557 ' NE2' ' HB ' ' A' ' 258' ' ' THR . 3.5 t-160 -160.88 118.96 2.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.392 -170.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -118.73 155.49 20.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -115.04 115.01 26.14 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 256' ' ' PHE . 25.4 pt -114.2 176.72 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.711 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 5.2 t -154.17 141.53 13.59 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.674 174.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.09 -179.9 28.35 Favored 'Cis proline' 0 C--N 1.346 0.4 0 C-N-CA 123.818 -1.326 . . . . 0.0 112.568 -4.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -81.18 126.11 77.75 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.857 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.49 109.13 2.78 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.43 2.087 . . . . 0.0 111.887 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.524 HG22 ' HA ' ' A' ' 328' ' ' ALA . 0.4 OUTLIER -126.56 134.16 66.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.694 178.425 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -91.85 135.29 34.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.72 -173.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.3 tm? -70.55 -30.24 66.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.834 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -86.2 11.13 12.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.186 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.52 121.91 25.19 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 31.1 m -83.54 1.81 3.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -174.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.2 t -102.56 -6.5 22.76 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.424 -174.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.4 pp -102.82 153.77 19.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.49 0.662 . . . . 0.0 111.684 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 14.8 m -87.51 160.95 46.78 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.004 -177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -39.14 -50.49 2.72 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.923 3.082 . . . . 0.0 114.612 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -58.09 -41.17 82.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.255 0.55 . . . . 0.0 111.333 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 47.9 mt-30 -70.48 -26.31 63.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.711 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -61.04 -35.43 76.89 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 121.018 0.437 . . . . 0.0 110.445 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.89 -28.88 67.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.431 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . 0.445 ' CD2' ' HA ' ' A' ' 324' ' ' GLN . 12.0 m-85 -81.71 -11.05 59.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.824 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' A' ' 313' ' ' VAL . . . -65.59 139.01 58.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.991 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -127.62 -17.07 4.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.882 -175.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 31.5 m -122.11 158.23 25.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.929 0.395 . . . . 0.0 110.113 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -91.16 -7.01 52.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.307 -174.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.7 t -147.72 140.98 25.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.096 0.474 . . . . 0.0 110.824 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 26.9 p -78.28 168.05 20.42 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.316 175.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 19.3 tp -74.11 105.42 5.32 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.628 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -79.82 -178.8 6.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.055 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.06 -7.1 57.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.973 -172.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -133.74 57.83 1.79 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.849 0.357 . . . . 0.0 111.736 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 25.2 mmt -111.78 137.46 49.67 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -92.25 145.46 24.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.778 0.323 . . . . 0.0 111.047 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 19.3 t -118.69 118.2 57.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.866 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -134.73 135.75 42.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.99 0.424 . . . . 0.0 111.557 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 21.1 mt -87.62 127.46 40.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.813 176.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 65.3 mt -75.13 111.19 10.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.05 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -81.52 146.1 30.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.981 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 34.0 t . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.348 -0.834 . . . . 0.0 110.789 -177.376 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.617 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 34.8 t -79.64 -37.33 36.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.922 0.391 . . . . 0.0 110.144 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 20.8 p -82.31 -83.45 0.13 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.865 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 47.73 69.08 0.56 Allowed 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.711 0.632 . . . . 0.0 110.953 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.552 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 34.2 p -75.55 -64.95 0.96 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.441 -174.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 55.65 48.94 68.05 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.834 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 263' ' ' ALA . 57.2 mt -103.07 142.54 16.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 37.1 p -97.82 150.12 21.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.408 0.623 . . . . 0.0 112.261 -173.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.522 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.2 p -61.53 150.93 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.599 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 37.0 m -126.05 84.94 2.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.152 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 113.0 130.56 5.32 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.477 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -79.37 123.43 27.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -142.22 130.33 22.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.223 0.535 . . . . 0.0 111.474 -172.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.9 t -107.98 110.46 22.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.281 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.518 ' O ' HG13 ' A' ' 313' ' ' VAL . 62.4 m-85 -81.05 120.13 24.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.507 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -115.27 127.42 26.83 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.696 -175.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -83.69 -178.02 3.42 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.895 2.396 . . . . 0.0 111.265 173.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 254' ' ' ASN . 7.7 p -112.94 110.56 32.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.263 0.554 . . . . 0.0 110.574 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.18 133.06 49.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.539 174.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -73.78 102.59 4.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.191 0.519 . . . . 0.0 110.281 -175.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -119.5 103.09 9.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.826 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 29.7 tp -84.51 68.95 10.49 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.392 0.615 . . . . 0.0 110.118 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -134.73 -63.36 0.71 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.544 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -87.57 -55.85 3.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.145 0.497 . . . . 0.0 110.404 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -123.95 150.26 44.98 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.94 -6.12 87.13 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.569 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . 0.515 ' HA ' ' OD1' ' A' ' 251' ' ' ASN . 13.1 m120 59.18 39.29 23.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.279 0.562 . . . . 0.0 111.203 176.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -68.52 -63.1 1.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.558 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 5.0 m -132.23 106.23 10.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.309 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . 0.515 ' OD1' ' HA ' ' A' ' 248' ' ' ASN . 11.9 m120 -137.56 52.81 1.88 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.283 -175.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 251' ' ' ASN . 96.1 t 74.13 143.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.351 0 O-C-N 123.683 0.614 . . . . 0.0 110.535 -178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -59.05 104.26 0.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.363 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.403 ' HB3' HG12 ' A' ' 239' ' ' VAL . 9.2 p30 -93.85 -16.06 24.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.291 -174.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -91.69 -6.66 51.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.156 0.503 . . . . 0.0 110.402 177.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.438 ' CD2' ' HB ' ' A' ' 309' ' ' THR . 96.7 m-85 -120.14 160.98 21.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.017 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -136.01 129.31 31.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.479 0.18 . . . . 0.0 110.785 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.5 m -97.88 107.64 20.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.05 0.452 . . . . 0.0 109.984 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.41 120.27 36.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.205 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 60.4 m -91.01 115.33 27.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.823 173.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 17.2 mt -132.24 168.86 17.31 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 5.3 p -60.52 -55.96 27.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.196 0.522 . . . . 0.0 110.136 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.514 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -136.75 136.81 39.26 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.146 177.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 15.8 p -132.11 32.75 3.97 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 6.9 m -82.47 149.25 27.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.308 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 93.51 13.37 55.64 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 62.7 mtt -114.02 148.0 37.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.367 -0.417 . . . . 0.0 110.141 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -134.41 156.33 48.73 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -54.15 121.96 9.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.074 0.464 . . . . 0.0 110.762 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 106.75 7.97 33.01 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.862 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.447 ' H ' HG12 ' A' ' 297' ' ' VAL . 80.1 m-20 -90.79 148.54 22.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.419 0.609 . . . . 0.0 110.16 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 4.6 tppp? -96.03 117.67 31.13 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.725 -177.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 38.5 pt -112.58 139.96 34.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 176.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 45.5 m -120.5 136.48 54.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.516 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -100.7 111.46 23.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.871 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -74.15 114.21 12.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.709 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.55 -34.39 5.17 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 86.0 t -90.95 111.71 24.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.503 ' HZ1' ' HB3' ' A' ' 279' ' ' LYS . 0.5 OUTLIER -128.85 170.07 13.82 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.406 -177.109 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -75.95 171.73 13.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.644 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 89.0 mt -83.33 81.51 8.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.105 177.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 179.89 165.54 33.97 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 61.97 -153.95 0.35 Allowed 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.792 0.348 . . . . 0.0 110.354 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 89.8 mtp 73.67 6.99 5.03 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.203 0.601 . . . . 0.0 111.545 175.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -82.64 -54.19 5.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.11 0.481 . . . . 0.0 110.143 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -133.73 -35.2 0.99 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.851 176.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -70.05 133.33 47.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.788 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.62 -21.64 6.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.491 0.662 . . . . 0.0 110.195 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 94.9 mt -83.85 56.84 3.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.686 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -77.86 111.28 13.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.073 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -50.58 124.61 11.14 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.777 0.673 . . . . 0.0 112.268 -173.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -76.21 166.39 23.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.844 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -59.18 100.33 0.07 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.882 -174.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.0 p -98.99 99.63 10.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.673 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 293' ' ' ALA . 61.3 m-85 -118.23 142.8 47.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.09 0.472 . . . . 0.0 111.139 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.2 t -89.97 126.27 35.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.494 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 271' ' ' ASP . 11.5 p -69.12 135.13 28.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.122 0.487 . . . . 0.0 110.136 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.24 -32.93 4.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.684 -176.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.579 ' HD2' ' OE2' ' A' ' 307' ' ' GLU . 0.4 OUTLIER -167.85 137.07 2.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.255 -176.129 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 75.3 t -85.02 111.38 20.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 19.2 t -77.76 -53.9 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.646 -173.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -125.89 -11.63 6.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.81 0.338 . . . . 0.0 111.812 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 77.6 12.49 84.45 Favored Glycine 0 CA--C 1.516 0.145 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -170.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.0 p -149.9 22.17 0.88 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 174.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -174.04 112.63 0.18 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 113.378 -1.737 . . . . 0.0 107.991 -163.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.0 OUTLIER -119.43 164.05 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -174.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.579 ' OE2' ' HD2' ' A' ' 299' ' ' ARG . 11.4 pt-20 -125.01 127.01 46.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.218 0.532 . . . . 0.0 110.127 170.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 24.0 pt -120.42 175.79 4.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.884 -177.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' THR . . . . . 0.438 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 14.2 t -154.61 143.53 14.84 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.853 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.98 179.4 31.15 Favored 'Cis proline' 0 C--N 1.346 0.406 0 C-N-CA 123.709 -1.371 . . . . 0.0 112.512 -4.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -76.94 121.68 85.16 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.504 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.09 108.54 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.217 1.944 . . . . 0.0 112.327 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 236' ' ' PHE . 0.1 OUTLIER -109.35 137.67 40.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.121 175.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -81.98 123.25 28.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.095 0.474 . . . . 0.0 110.513 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.5 -29.5 70.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.894 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.45 19.65 4.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.495 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -83.47 119.91 25.26 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.9 m -84.43 0.4 5.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -174.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 37.2 t -95.47 -28.16 15.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.566 0.222 . . . . 0.0 111.404 -174.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.64 160.61 25.0 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.413 0.625 . . . . 0.0 112.41 -175.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.553 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 34.4 t -87.04 157.42 54.15 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.146 -178.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.553 ' HD2' ' OG ' ' A' ' 321' ' ' SER . 2.8 Cg_exo -35.61 -58.01 0.47 Allowed 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 124.764 3.643 . . . . 0.0 115.513 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.64 -25.08 64.65 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.376 -174.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 321' ' ' SER . 8.5 mm100 -61.15 -34.48 75.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.038 0.447 . . . . 0.0 110.116 174.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 322' ' ' PRO . 31.1 mtm180 -64.77 -32.67 74.46 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.724 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -70.62 -24.94 62.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.087 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.77 -2.3 57.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.685 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.424 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -67.81 156.27 37.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.066 0.46 . . . . 0.0 111.022 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -138.42 -20.84 1.05 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.292 -173.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 23.4 m -125.28 160.17 31.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.946 0.403 . . . . 0.0 110.399 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -89.16 -17.14 29.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.527 -175.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 8.8 t -143.42 142.89 31.39 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 22.6 p -75.72 170.33 16.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.736 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 17.0 tp -72.34 103.3 3.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.522 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -81.99 -170.88 3.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.19 -176.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -80.32 -8.5 59.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.013 -175.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -137.42 66.97 1.44 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.0 0.429 . . . . 0.0 111.567 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' MET . . . . . 0.466 ' H ' HG13 ' A' ' 230' ' ' VAL . 23.1 mmt -119.86 132.48 55.58 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -91.25 137.16 32.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.839 0.352 . . . . 0.0 111.007 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 32.7 t -114.25 107.2 22.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.239 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . 0.552 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 64.5 t30 -126.35 145.62 50.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.922 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 22.8 mt -89.56 132.37 34.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 177.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 80.8 mt -76.14 118.97 19.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.542 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -125.87 149.41 48.7 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 28.9 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.824 -179.671 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.53 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 42.2 p 49.55 44.77 24.35 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.178 0.591 . . . . 0.0 111.571 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.9 t -159.82 157.72 29.75 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.444 -178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 52.4 64.79 1.72 Allowed 'General case' 0 C--O 1.234 0.287 0 O-C-N 123.575 0.547 . . . . 0.0 111.482 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 24.2 p -72.37 -72.05 0.26 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.172 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.56 39.77 95.46 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.006 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 263' ' ' ALA . 55.7 mt -103.05 145.28 12.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 36.0 p -99.22 160.79 14.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.417 0.627 . . . . 0.0 112.248 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 335' ' ' ALA . 9.7 p -68.88 152.04 9.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.495 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.1 m -122.08 86.77 2.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.949 0.404 . . . . 0.0 110.7 173.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 102.56 137.2 9.47 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.337 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.54 130.27 42.69 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -132.9 127.14 33.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.165 0.507 . . . . 0.0 111.31 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.8 t -117.26 103.12 9.85 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -80.8 129.1 34.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.319 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -117.19 125.75 27.96 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.052 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.488 ' HA ' ' OD1' ' A' ' 254' ' ' ASN . 95.2 Cg_endo -80.32 172.91 13.09 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.111 2.541 . . . . 0.0 111.639 176.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.11 127.14 40.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.092 0.472 . . . . 0.0 110.477 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -73.97 107.21 6.05 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 30.0 m-90 -63.32 -18.85 64.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.067 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -99.97 103.57 15.13 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.0 mp -107.11 -159.4 0.69 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.623 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -78.21 -155.66 0.08 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.429 ' N ' HD21 ' A' ' 245' ' ' ASN . 0.9 OUTLIER -63.67 -32.1 73.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.775 0.322 . . . . 0.0 111.041 -178.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -106.28 107.06 17.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.421 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.67 -173.82 45.59 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.56 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -88.45 129.4 35.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.106 0.479 . . . . 0.0 110.179 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -103.11 -20.83 14.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.25 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 36.0 m -78.62 155.84 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.726 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -89.06 85.26 6.65 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 8.1 p -83.67 131.81 32.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.216 -174.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -80.83 40.56 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.551 0.691 . . . . 0.0 110.501 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.488 ' OD1' ' HA ' ' A' ' 238' ' ' PRO . 11.9 t-20 -77.55 -12.35 59.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.208 -175.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -70.67 -12.15 61.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.766 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -114.47 148.54 37.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.919 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -109.26 124.03 50.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.951 176.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.7 m -97.47 107.14 19.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.225 0.536 . . . . 0.0 110.275 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -89.0 124.86 42.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.603 -170.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 55.6 m -95.18 114.59 26.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.799 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.403 HD11 HG21 ' A' ' 340' ' ' VAL . 17.4 mt -129.87 170.52 13.8 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -176.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 16.8 m -57.31 -56.93 15.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.389 0.614 . . . . 0.0 109.599 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.599 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -138.52 141.02 39.34 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.776 175.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 11.2 p -130.8 26.49 4.98 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.7 m -80.49 147.5 30.86 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.526 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 95.24 -28.11 12.98 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -177.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 62.1 mtt -71.42 153.47 42.25 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -135.53 151.02 49.92 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.807 0.337 . . . . 0.0 110.58 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -56.39 131.8 49.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.204 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.77 19.14 32.53 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.352 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.417 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 1.8 t70 -103.28 -167.51 1.39 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 117.555 0.677 . . . . 0.0 110.159 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.423 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 3.9 tppp? -129.76 115.7 17.67 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.593 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.417 HG21 ' CG1' ' A' ' 342' ' ' ILE . 20.0 pt -115.06 142.76 26.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.134 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 73.5 p -128.85 143.69 50.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.149 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -105.2 114.02 27.95 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.044 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.82 115.98 3.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.828 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.94 -31.15 6.95 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.105 -177.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 292' ' ' ASP . 48.5 t -84.54 136.08 23.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.586 ' HZ1' ' HB3' ' A' ' 279' ' ' LYS . 0.1 OUTLIER -160.76 156.33 25.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.112 0.482 . . . . 0.0 111.413 -177.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.432 ' HA ' ' O ' ' A' ' 329' ' ' ASN . 63.0 m-85 -76.58 148.63 36.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.372 -170.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.427 HD11 ' HB2' ' A' ' 315' ' ' LEU . 59.5 mt -63.34 -34.7 78.28 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.461 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -64.65 -19.1 64.62 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.788 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -112.22 4.48 17.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.661 0.267 . . . . 0.0 110.861 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 90.5 mmm -121.47 22.88 10.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.96 0.41 . . . . 0.0 110.724 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -81.35 -52.05 7.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.176 0.512 . . . . 0.0 110.211 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -130.67 -7.34 4.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.946 175.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -102.7 149.15 24.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.042 178.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.41 -15.56 10.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.726 0.774 . . . . 0.0 109.505 178.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 92.5 mt -88.47 50.71 2.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.973 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.413 ' HB2' ' HD3' ' A' ' 279' ' ' LYS . . . -84.58 124.14 31.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.364 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -60.41 146.14 45.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.083 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 60.3 m-20 -60.05 139.8 57.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.212 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -57.07 116.07 3.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.636 -174.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 28.1 p -97.81 129.17 44.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.866 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -130.63 143.14 50.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.783 0.325 . . . . 0.0 110.699 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 62.5 m -78.72 126.96 31.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.101 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.452 ' HA ' HG22 ' A' ' 308' ' ' ILE . 13.5 p -84.06 126.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.262 0.553 . . . . 0.0 110.018 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 44.7 t -84.01 -40.85 16.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.379 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -163.29 142.26 8.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.407 ' CG1' ' HA2' ' A' ' 303' ' ' GLY . 89.6 t -82.59 106.95 13.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 26.7 t -72.82 -58.7 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.945 -170.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -119.59 0.48 11.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.94 0.4 . . . . 0.0 111.331 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . 0.407 ' HA2' ' CG1' ' A' ' 300' ' ' VAL . . . 70.81 12.73 71.25 Favored Glycine 0 C--O 1.23 -0.143 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -173.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 19.4 p -149.31 19.72 0.95 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 174.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.529 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.9 t-160 -170.89 115.46 0.44 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 113.737 -1.574 . . . . 0.0 107.976 -164.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.73 165.04 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.494 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -123.86 122.1 37.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.051 0.453 . . . . 0.0 110.264 172.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 297' ' ' VAL . 28.2 pt -124.03 168.55 16.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.102 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 15.1 t -154.57 145.18 16.05 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -72.29 178.13 32.23 Favored 'Cis proline' 0 C--N 1.344 0.337 0 C-N-CA 124.013 -1.245 . . . . 0.0 112.556 0.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -87.39 123.37 69.83 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.743 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.419 ' HA ' ' OD1' ' A' ' 329' ' ' ASN . 48.7 Cg_endo -71.41 108.94 2.49 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.37 2.046 . . . . 0.0 112.091 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.56 132.0 57.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.713 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -83.09 121.92 27.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.081 0.467 . . . . 0.0 110.448 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . 0.427 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.0 tm? -62.99 -30.2 71.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.725 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -86.39 5.12 36.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.393 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -89.91 111.68 22.8 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 17.9 m -83.61 2.4 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 9.4 t -92.95 29.09 1.91 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.027 0.441 . . . . 0.0 110.832 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 2.5 pp -129.06 171.32 12.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.879 0.371 . . . . 0.0 111.467 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 41.7 t -85.96 149.14 49.85 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.105 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.634 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 1.4 Cg_endo -42.27 -47.29 7.19 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.84 3.027 . . . . 0.0 113.885 -177.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.442 ' O ' ' HD1' ' A' ' 327' ' ' TYR . 58.6 mm-40 -63.16 -23.38 67.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.98 0.419 . . . . 0.0 111.456 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -81.27 -24.34 37.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.784 -174.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 5.3 ptp180 -78.28 -22.31 48.43 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.096 0.474 . . . . 0.0 110.04 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -69.15 -36.03 76.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.183 174.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . 0.442 ' HD1' ' O ' ' A' ' 323' ' ' GLU . 77.8 m-85 -90.05 3.05 54.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.839 178.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -70.26 123.94 22.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.03 0.443 . . . . 0.0 110.022 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 280' ' ' PHE . 26.7 p-10 -109.28 -17.92 13.71 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.506 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.3 m -118.85 159.4 19.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.188 0.518 . . . . 0.0 110.798 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -96.84 -12.04 24.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.164 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.4 t -141.02 148.63 40.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.435 -176.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 7.6 p -85.04 166.27 16.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.694 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.608 HD13 ' SD ' ' A' ' 338' ' ' MET . 21.2 tp -67.74 104.4 1.64 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.669 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -84.04 156.82 22.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.772 -175.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.59 58.08 2.15 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.252 0.549 . . . . 0.0 111.942 -173.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -176.04 27.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.494 172.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' MET . . . . . 0.608 ' SD ' HD13 ' A' ' 334' ' ' LEU . 54.4 mtt -100.06 131.83 45.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -176.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -87.64 140.22 29.74 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.924 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.403 HG21 HD11 ' A' ' 261' ' ' LEU . 9.0 t -99.83 113.5 35.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.537 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -122.56 133.4 54.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.404 -175.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.417 ' CG1' HG21 ' A' ' 273' ' ' ILE . 14.6 mt -99.23 130.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.066 0.46 . . . . 0.0 110.798 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 46.3 mt -82.7 115.95 21.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.763 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -80.43 100.69 8.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.408 177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 C--O 1.246 0.878 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.31 -177.518 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 112.174 -0.371 . . . . 0.0 112.174 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.445 ' N ' ' HB2' ' A' ' 344' ' ' ASN . 15.7 m -73.68 -61.58 1.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.875 0.369 . . . . 0.0 111.185 -176.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 7.7 m -85.46 -18.6 33.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.856 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 58.32 60.11 2.76 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.532 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.66 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 41.6 p -82.38 -69.9 0.59 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.967 -176.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 58.05 43.11 95.26 Favored Glycine 0 C--N 1.329 0.165 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.24 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.48 HG23 ' O ' ' A' ' 263' ' ' ALA . 68.6 mt -90.66 149.46 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 2.3 p -96.8 157.58 15.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.572 0.701 . . . . 0.0 112.428 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 335' ' ' ALA . 6.8 p -76.16 151.35 6.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.499 -176.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 65.0 m -109.63 83.22 1.72 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.025 0.441 . . . . 0.0 110.385 174.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.7 154.75 28.94 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.341 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -73.05 124.91 26.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.966 0.412 . . . . 0.0 111.008 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -113.25 128.56 56.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.059 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 12.8 t -131.16 119.83 22.45 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.411 ' O ' ' HD3' ' A' ' 237' ' ' LYS . 88.2 m-85 -104.08 143.06 33.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.743 -175.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.411 ' HD3' ' O ' ' A' ' 236' ' ' PHE . 44.7 mmtm -129.41 138.66 33.65 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.631 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.4 ' HD3' ' CG2' ' A' ' 313' ' ' VAL . 82.9 Cg_endo -89.69 135.75 2.52 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.035 2.49 . . . . 0.0 112.166 177.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 84.3 t -73.01 98.21 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.136 0.493 . . . . 0.0 110.788 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -92.97 89.91 6.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.295 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -147.4 -76.72 0.18 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.468 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 58.94 102.69 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.781 0.675 . . . . 0.0 111.177 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 62.2 tp -109.55 -51.55 2.86 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.3 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -143.21 -178.06 5.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.657 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -52.79 -42.61 65.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.239 0.543 . . . . 0.0 110.164 175.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -106.75 146.08 31.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.949 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 158.85 -138.51 5.73 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.069 -1.062 . . . . 0.0 112.975 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -78.8 45.17 0.58 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -119.79 4.08 11.05 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.126 0.489 . . . . 0.0 110.394 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 30.0 m -103.87 155.28 5.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.637 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 65.38 107.57 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.777 0.673 . . . . 0.0 110.66 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 96.1 t 70.8 112.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.779 -175.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.432 ' CB ' ' HB2' ' A' ' 256' ' ' PHE . 60.7 m-20 -60.54 139.97 57.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.152 -173.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.527 ' O ' ' HD2' ' A' ' 311' ' ' LYS . 9.9 m120 -82.61 -46.39 13.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.375 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -91.9 -12.73 32.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.872 -174.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.454 ' CD1' ' HB ' ' A' ' 309' ' ' THR . 75.1 m-85 -115.56 144.68 43.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.393 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -114.59 121.89 44.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.618 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -89.43 106.38 18.41 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.748 177.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -86.04 118.13 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.402 -172.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 23.2 m -89.32 105.92 18.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.895 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 20.4 mt -122.07 172.08 8.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.735 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 42.2 m -64.57 -53.42 48.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.108 0.48 . . . . 0.0 109.783 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.48 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -137.57 142.93 41.32 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 18.2 p -134.07 30.0 3.68 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.3 m -81.26 134.63 35.63 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.956 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.7 -26.25 14.87 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -176.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -70.67 151.3 45.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -136.38 164.33 28.38 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -64.44 144.66 57.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.694 0.283 . . . . 0.0 110.676 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 77.8 19.02 76.29 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.742 173.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.476 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 1.7 t70 -100.68 -167.1 1.39 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 117.779 0.79 . . . . 0.0 109.907 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.443 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 13.1 tppt? -125.04 115.16 20.09 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.502 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.453 HD13 HG22 ' A' ' 308' ' ' ILE . 32.0 pt -116.93 139.31 44.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.677 177.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 50.1 p -118.9 138.4 52.78 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.559 -178.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -103.23 111.56 24.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.519 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.63 132.37 53.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.688 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 93.45 -34.71 4.46 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 56.4 t -86.0 146.04 6.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.578 ' HD2' ' SD ' ' A' ' 284' ' ' MET . 0.0 OUTLIER -162.22 162.21 28.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.75 0.31 . . . . 0.0 111.059 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 96.2 m-85 -73.59 170.3 15.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.63 -174.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.99 141.38 56.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.483 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 102.8 -26.36 24.31 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -173.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -78.14 146.97 34.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.578 ' SD ' ' HD2' ' A' ' 279' ' ' LYS . 94.0 mtp 66.76 20.44 10.65 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.797 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -96.11 -31.73 12.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.543 0.687 . . . . 0.0 109.649 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -161.87 39.94 0.13 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -124.02 100.17 6.61 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.726 -171.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 42.6 t -68.75 -41.54 82.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.02 -0.734 . . . . 0.0 109.02 173.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 74.0 mt -105.68 79.62 1.46 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.655 175.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -90.9 123.49 34.46 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.998 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -68.34 165.8 17.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.695 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.448 ' HA ' ' NZ ' ' A' ' 279' ' ' LYS . 64.7 m-20 -94.72 164.01 13.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.683 -178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -70.46 104.27 2.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.649 -174.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 14.0 p -92.14 103.29 15.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.033 177.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -102.72 154.83 18.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.149 0.5 . . . . 0.0 111.277 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.4 m -89.99 120.89 31.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.088 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.476 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 14.2 p -84.19 139.45 17.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.466 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.2 t -105.76 -42.18 6.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.241 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -156.51 133.74 10.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.027 0.442 . . . . 0.0 111.659 -175.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 87.2 t -81.85 99.47 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 169.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.7 t -70.65 -58.47 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.917 -171.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -120.26 -0.66 10.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.719 0.295 . . . . 0.0 111.576 -174.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 69.31 12.58 66.32 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -172.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 26.6 p -147.4 19.99 1.2 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.524 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 7.1 t-160 -172.74 115.82 0.3 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.194 -164.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.52 166.75 13.62 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -176.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -123.86 126.56 46.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.084 0.469 . . . . 0.0 109.994 169.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.453 HG22 HD13 ' A' ' 273' ' ' ILE . 30.3 pt -123.12 170.04 13.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.997 -177.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' THR . . . . . 0.454 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 13.5 t -154.52 145.12 16.03 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 309' ' ' THR . 58.4 Cg_endo -70.2 176.08 35.36 Favored 'Cis proline' 0 C--N 1.347 0.48 0 C-N-CA 123.835 -1.319 . . . . 0.0 112.879 1.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.527 ' HD2' ' O ' ' A' ' 254' ' ' ASN . 40.5 tttt -77.14 119.88 79.33 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.807 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.14 107.13 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.157 1.905 . . . . 0.0 111.676 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 328' ' ' ALA . 55.5 t -121.29 119.81 60.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.037 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -85.86 128.53 34.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.073 0.463 . . . . 0.0 111.101 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -70.16 -30.39 67.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.246 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -89.0 23.19 2.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.0 0.429 . . . . 0.0 111.25 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 314' ' ' ALA . 14.6 t70 -100.52 137.49 38.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 30.1 m -84.29 -15.56 11.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 13.1 m -91.03 34.89 0.91 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.016 0.436 . . . . 0.0 111.485 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.486 ' HA ' ' NE2' ' A' ' 324' ' ' GLN . 1.9 pp -126.95 164.18 22.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.092 0.472 . . . . 0.0 111.449 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 65.4 p -99.89 168.59 9.25 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.768 176.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.494 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 86.8 Cg_exo -49.35 -36.07 37.14 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.306 2.004 . . . . 0.0 111.818 172.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.82 -46.3 65.96 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.818 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.486 ' NE2' ' HA ' ' A' ' 320' ' ' LEU . 26.5 mt-30 -69.65 -28.51 65.94 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -175.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.494 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 30.2 ptt180 -72.05 -21.69 61.49 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.324 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -73.4 -27.84 61.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.202 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -94.24 7.97 43.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.82 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.519 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -57.92 142.11 47.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.825 176.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -124.22 -30.02 3.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.2 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 27.7 m -122.4 160.11 24.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.871 0.367 . . . . 0.0 110.293 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -89.04 -20.89 23.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.071 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.1 t -141.6 141.88 33.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.994 0.426 . . . . 0.0 110.481 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 34.8 p -70.27 161.65 29.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.87 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.408 HD23 HG23 ' A' ' 230' ' ' VAL . 48.0 tp -69.47 103.41 2.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.544 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -82.93 170.42 14.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.841 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . 0.407 ' HA ' ' CG1' ' A' ' 230' ' ' VAL . 29.1 t70 -72.26 151.86 42.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.496 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 68.18 39.75 2.3 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.998 0.811 . . . . 0.0 111.608 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 19.9 mmt -110.19 144.42 38.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 176.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.19 138.3 33.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.031 0.443 . . . . 0.0 111.316 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 23.9 t -113.73 110.73 33.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.444 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . 0.66 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 60.5 t30 -130.49 145.16 51.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.936 0.398 . . . . 0.0 111.484 -175.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.404 ' CG1' HG22 ' A' ' 273' ' ' ILE . 61.0 mt -88.06 116.41 29.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.057 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 63.9 mt -78.13 154.17 31.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.182 -176.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . 0.445 ' HB2' ' N ' ' A' ' 223' ' ' SER . 7.5 t30 -123.35 128.95 50.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.755 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.55 -0.738 . . . . 0.0 109.939 179.259 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.773 0 N-CA-C 111.956 -0.458 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.4 m 61.51 60.03 1.75 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.41 0.624 . . . . 0.0 111.195 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 11.8 t -156.58 141.82 17.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.384 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 56.3 48.26 17.52 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.233 0.539 . . . . 0.0 110.285 -174.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 20.0 p -69.38 -56.79 6.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.186 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 63.25 53.1 42.1 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.283 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.493 HD12 ' O ' ' A' ' 263' ' ' ALA . 29.1 mm -102.21 143.02 15.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 20.7 p -131.49 170.21 15.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.087 0.47 . . . . 0.0 110.305 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 335' ' ' ALA . 8.2 p -78.98 150.39 5.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.56 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.7 t -107.03 75.15 1.02 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.193 0.52 . . . . 0.0 109.654 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.83 155.06 29.57 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.042 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -78.01 141.6 38.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.925 0.393 . . . . 0.0 111.208 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -149.54 137.14 20.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.41 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.5 t -110.08 142.04 42.1 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 312' ' ' PRO . 92.5 m-85 -102.64 156.79 17.39 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . 46.9 mmtm -138.34 130.36 15.92 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.657 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 237' ' ' LYS . 22.2 Cg_exo -65.16 121.04 8.38 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.677 2.252 . . . . 0.0 111.335 177.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 23.3 t -78.17 84.88 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.418 -176.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -82.44 82.17 7.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.602 176.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 70.03 -60.64 0.48 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 124.046 0.841 . . . . 0.0 110.748 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . 0.605 ' O ' ' HA2' ' A' ' 247' ' ' GLY . 7.5 tp60 61.5 101.62 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.506 0.722 . . . . 0.0 110.9 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.41 77.34 2.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.774 -176.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -79.67 -86.85 0.07 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.618 177.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -89.56 -55.84 3.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.229 0.537 . . . . 0.0 110.047 172.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -127.62 -31.32 2.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.563 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 242' ' ' GLN . . . 137.04 150.5 5.79 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.411 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -108.54 47.49 0.9 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.134 0.493 . . . . 0.0 109.906 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -80.53 -35.8 33.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.534 -174.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.0 t -87.89 -6.9 10.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 122.059 0.933 . . . . 0.0 109.818 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -74.55 113.01 11.3 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.27 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.461 ' O ' ' HD2' ' A' ' 256' ' ' PHE . 28.7 m -88.16 36.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.519 0.676 . . . . 0.0 111.716 -176.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -99.01 15.22 26.49 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.331 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.558 ' O ' ' HE2' ' A' ' 311' ' ' LYS . 58.6 t30 -94.03 -50.43 5.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.943 176.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -68.96 -25.63 64.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.887 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 308' ' ' ILE . 60.5 m-85 -114.66 143.9 44.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.653 -177.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -120.34 134.37 55.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.735 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -93.91 105.21 17.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.283 0.564 . . . . 0.0 111.231 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.6 t -88.39 122.04 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.056 -175.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 11.9 m -96.51 106.04 18.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.254 0.55 . . . . 0.0 110.053 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.455 ' HB2' HG23 ' A' ' 264' ' ' THR . 22.5 mt -122.18 167.26 13.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.574 -173.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 26.3 p -60.14 -52.42 65.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.529 0.68 . . . . 0.0 109.71 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.493 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.28 132.59 35.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.316 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.455 HG23 ' HB2' ' A' ' 261' ' ' LEU . 7.7 p -128.9 15.29 6.36 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.214 174.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 25.2 m -83.4 144.78 29.39 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.742 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.74 0.73 57.62 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 71.9 mtm -123.22 153.3 40.31 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -142.07 178.99 7.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -63.43 142.22 58.47 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 123.201 0.313 . . . . 0.0 110.545 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 93.52 19.8 34.0 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.688 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.452 ' O ' HG11 ' A' ' 297' ' ' VAL . 7.4 m-20 -116.85 164.78 14.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.546 0.673 . . . . 0.0 111.288 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -106.24 115.94 31.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.336 -177.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.44 HD13 ' CG2' ' A' ' 308' ' ' ILE . 15.6 pt -115.31 140.28 37.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.476 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 54.1 p -128.15 141.06 51.59 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.373 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -100.21 112.64 24.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.051 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.32 120.05 9.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.472 -175.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.49 -35.84 4.75 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.597 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 49.7 t -77.84 124.68 36.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -142.97 161.5 37.94 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.791 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -84.93 142.02 29.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.378 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.47 HD22 ' SD ' ' A' ' 284' ' ' MET . 79.7 mt -75.56 164.17 26.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.112 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 100.42 -40.85 2.3 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.965 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -99.43 -7.96 25.39 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.766 -0.255 . . . . 0.0 111.205 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.47 ' SD ' HD22 ' A' ' 281' ' ' LEU . 81.6 mtp -72.14 -26.5 62.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -63.6 -45.19 91.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.846 0.355 . . . . 0.0 111.322 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -95.63 -42.24 8.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.964 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -92.38 91.07 7.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.93 0.395 . . . . 0.0 110.66 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.76 -31.83 55.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.56 38.23 0.78 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.423 174.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -56.55 139.35 49.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.381 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -61.23 148.42 41.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.556 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -69.55 149.58 48.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -60.01 98.86 0.06 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.527 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 38.6 p -79.98 124.03 28.34 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.626 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -124.54 146.78 48.81 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.234 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.8 m -86.19 118.29 25.55 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.151 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.452 HG11 ' O ' ' A' ' 271' ' ' ASP . 11.7 p -73.8 123.44 28.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.414 0.626 . . . . 0.0 110.095 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.4 t -94.29 -38.22 9.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.599 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -164.81 133.6 3.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.499 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 79.9 t -90.14 100.89 11.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 167.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.63 -59.4 3.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.737 -172.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -98.67 -12.72 20.76 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.633 -170.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 74.13 13.1 81.4 Favored Glycine 0 CA--C 1.517 0.196 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.08 23.35 0.5 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 171.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.517 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 3.7 t-160 -170.67 115.33 0.46 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 113.813 -1.539 . . . . 0.0 107.533 -171.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.7 155.68 20.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -173.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.1 pt-20 -112.02 121.72 45.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.321 0.581 . . . . 0.0 110.128 172.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 256' ' ' PHE . 29.8 pt -118.19 169.37 8.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.968 -177.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.1 t -145.48 140.47 15.92 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.63 -179.24 26.53 Favored 'Cis proline' 0 C--N 1.345 0.374 0 C-N-CA 123.684 -1.382 . . . . 0.0 112.753 -2.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.558 ' HE2' ' O ' ' A' ' 254' ' ' ASN . 23.8 ttmm -75.29 124.12 89.03 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.786 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.422 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 14.1 Cg_exo -68.52 108.24 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.408 2.072 . . . . 0.0 111.99 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.517 HG23 ' HA ' ' A' ' 328' ' ' ALA . 1.2 m -128.21 132.95 67.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.355 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.507 ' O ' HD22 ' A' ' 320' ' ' LEU . . . -95.22 135.71 36.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.906 -172.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.9 tm? -74.19 -24.1 59.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.547 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -82.25 -2.04 51.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.151 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -77.84 113.31 15.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.6 m -82.98 2.59 3.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.972 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 40.1 m -95.2 -27.61 15.44 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -175.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.507 HD22 ' O ' ' A' ' 314' ' ' ALA . 1.3 pp -79.1 152.74 30.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.56 0.695 . . . . 0.0 111.764 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.462 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.3 m -81.33 167.42 31.9 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.74 -173.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.515 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 78.2 Cg_exo -44.81 -52.26 6.4 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.528 2.819 . . . . 0.0 114.183 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -67.22 -30.98 71.05 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.897 -0.502 . . . . 0.0 111.003 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -71.36 -33.78 69.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.433 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 18.0 ptp180 -77.37 -14.98 59.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.214 0.53 . . . . 0.0 110.6 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -72.41 -30.8 64.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.122 171.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -85.93 -7.97 58.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.553 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.517 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -65.09 115.37 5.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.047 0.451 . . . . 0.0 110.908 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -104.13 -28.17 11.63 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.49 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 30.2 m -108.32 165.33 4.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.027 0.441 . . . . 0.0 111.355 -175.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -83.54 -40.08 19.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.438 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.8 t -128.79 144.98 51.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.169 0.509 . . . . 0.0 111.007 -176.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 13.5 p -77.76 173.96 11.52 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.428 174.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 14.5 tp -76.71 105.06 7.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.103 0.478 . . . . 0.0 110.179 -175.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.588 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -80.35 -178.6 6.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.413 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -82.54 -1.13 49.67 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -171.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -139.78 64.95 1.44 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.141 0.496 . . . . 0.0 111.281 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.9 mmt -116.12 130.74 56.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.538 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -84.02 144.16 29.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.997 0.427 . . . . 0.0 111.016 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 21.5 t -113.86 115.4 49.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.481 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -131.58 138.99 49.09 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.799 -176.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 26.7 mt -87.62 125.22 41.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.653 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 49.1 mt -85.02 123.06 30.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -74.9 92.1 2.53 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.95 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 6.8 m . . . . . 0 C--O 1.249 1.049 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.924 -179.764 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 25.6 m -106.0 -179.05 3.83 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 15.7 m 65.85 66.98 0.49 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.474 0.654 . . . . 0.0 111.341 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.46 113.09 24.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.577 174.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 25.6 p -71.8 -71.88 0.25 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.397 -176.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 61.96 35.27 91.15 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.506 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 263' ' ' ALA . 53.7 mt -79.88 153.05 4.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 19.6 p -97.2 143.97 27.48 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.612 0.72 . . . . 0.0 112.495 -173.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.611 HG12 ' O ' ' A' ' 335' ' ' ALA . 4.4 p -61.02 151.9 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.024 177.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 7.6 t -110.52 74.56 0.88 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 0.0 110.001 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 98.39 165.22 30.88 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.052 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -87.98 125.79 34.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.802 0.334 . . . . 0.0 110.442 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -120.39 127.04 51.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.04 0.448 . . . . 0.0 111.01 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 38.4 m -104.86 120.78 42.25 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.635 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.442 ' O ' HG13 ' A' ' 313' ' ' VAL . 93.3 m-85 -100.21 122.38 42.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.657 -176.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.416 ' HE2' HD23 ' A' ' 320' ' ' LEU . 32.4 mmtp -124.85 128.28 24.92 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.208 -178.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.77 177.12 8.76 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 123.091 2.527 . . . . 0.0 111.855 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 12.6 p -81.67 129.38 37.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.153 0.501 . . . . 0.0 110.693 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -89.97 125.8 35.51 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.895 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -74.28 91.7 2.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.864 0.364 . . . . 0.0 110.128 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . 0.501 ' O ' ' HA2' ' A' ' 247' ' ' GLY . 1.6 pp0? -152.0 146.0 25.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.005 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.7 pp -133.25 13.33 4.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.817 173.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -84.31 -41.0 17.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.672 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -87.81 -50.07 6.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.089 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -155.51 -68.72 0.12 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.114 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 242' ' ' GLN . . . 154.65 -153.48 24.83 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.929 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -103.88 130.36 51.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.117 0.484 . . . . 0.0 110.563 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -114.16 -46.04 3.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.745 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 24.9 m -69.58 110.96 3.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.678 0.751 . . . . 0.0 111.098 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -129.41 148.67 51.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.192 -176.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.6 t 54.09 53.64 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.991 0.901 . . . . 0.0 109.713 -175.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -165.32 -35.89 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.606 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -77.64 -1.02 28.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -168.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -99.27 -8.38 25.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.978 0.418 . . . . 0.0 110.368 173.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.401 ' CD1' ' HB ' ' A' ' 309' ' ' THR . 97.8 m-85 -134.85 -176.11 4.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.073 0.463 . . . . 0.0 110.448 -177.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.413 ' HB2' ' HA ' ' A' ' 311' ' ' LYS . . . -146.19 113.79 6.38 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.065 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.3 m -86.4 104.07 15.55 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.338 0.59 . . . . 0.0 110.208 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.1 t -82.83 118.17 30.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.358 -172.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 21.8 m -86.97 105.24 16.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.212 0.529 . . . . 0.0 110.239 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.416 ' HB2' HG22 ' A' ' 264' ' ' THR . 19.5 mt -122.76 161.36 24.1 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.2 m -58.86 -50.5 73.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.255 0.55 . . . . 0.0 109.587 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.543 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -137.89 144.23 41.24 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.416 HG22 ' HB2' ' A' ' 261' ' ' LEU . 16.0 p -131.31 26.59 4.82 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.135 0.969 . . . . 0.0 108.514 174.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 24.9 m -74.57 135.88 42.09 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.972 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 103.34 -12.91 54.96 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -176.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 55.7 mtt -96.41 138.79 33.49 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.589 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 6.6 ptpp? -130.88 156.93 44.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -55.93 114.39 1.9 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.945 0.402 . . . . 0.0 110.623 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 110.83 18.57 8.29 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.487 -176.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.589 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 9.6 m-20 -105.14 158.36 16.63 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 117.039 0.419 . . . . 0.0 110.766 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 15.0 tppt? -103.7 116.32 32.11 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.647 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 30.3 pt -112.74 139.56 37.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.189 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 4.1 m -124.45 130.57 52.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.445 -176.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -94.53 111.88 23.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.447 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.84 116.71 9.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.838 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 107.76 -11.78 38.45 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 39.2 t -111.81 128.9 68.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -135.99 157.97 45.55 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.429 ' HE1' ' CZ ' ' A' ' 295' ' ' PHE . 50.0 m-85 -73.45 165.02 25.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.775 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 82.8 mt -67.21 -39.17 86.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.221 0.534 . . . . 0.0 110.127 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -70.11 148.48 46.08 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.718 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.533 ' O ' ' HB2' ' A' ' 287' ' ' ASN . 83.4 mm-40 72.86 23.0 2.94 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.048 0.539 . . . . 0.0 110.703 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 73.2 mtp -113.33 25.45 11.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.018 0.437 . . . . 0.0 110.528 175.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -94.98 -56.29 2.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.929 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -143.93 37.0 1.28 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.182 0.515 . . . . 0.0 109.918 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 283' ' ' GLN . 15.5 m120 -125.12 109.21 12.62 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.517 -175.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 43.1 t -76.27 -35.05 26.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.332 0.587 . . . . 0.0 109.71 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 89.7 mt -91.35 51.85 1.98 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.401 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -61.67 150.33 36.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.361 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -63.63 118.62 8.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.08 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -65.66 166.43 10.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.633 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -69.29 76.23 0.37 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.158 0.504 . . . . 0.0 111.117 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.414 HG22 ' OG ' ' A' ' 274' ' ' SER . 65.6 p -86.78 105.18 16.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.411 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 312' ' ' PRO . 61.8 m-85 -115.46 143.72 44.89 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.023 0.439 . . . . 0.0 111.035 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.7 m -86.8 124.58 33.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.957 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 271' ' ' ASP . 8.3 p -83.1 136.06 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.038 0.447 . . . . 0.0 110.239 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 37.8 t -101.61 -29.5 3.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.948 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -163.81 142.04 7.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.582 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 78.8 t -98.14 117.62 43.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 38.9 t -77.89 -58.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.92 -172.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -121.21 2.29 10.33 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -173.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 70.45 13.34 70.88 Favored Glycine 0 CA--C 1.518 0.25 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.9 p -146.41 18.04 1.34 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.421 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.8 t-160 -171.07 113.99 0.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.778 -169.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.35 161.97 16.83 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -173.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -120.78 121.24 37.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.36 0.6 . . . . 0.0 110.739 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 23.3 pt -112.76 174.57 2.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.415 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' THR . . . . . 0.401 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 13.2 t -152.13 141.27 14.13 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.99 -179.79 26.24 Favored 'Cis proline' 0 C--N 1.345 0.349 0 C-N-CA 123.681 -1.383 . . . . 0.0 112.411 0.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.422 ' CG ' ' HB3' ' A' ' 236' ' ' PHE . 23.3 ttmm -74.56 123.12 88.87 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.286 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 295' ' ' PHE . 56.9 Cg_endo -74.46 108.42 2.68 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.115 1.876 . . . . 0.0 112.045 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.527 ' HB ' ' HA ' ' A' ' 328' ' ' ALA . 0.2 OUTLIER -106.54 132.71 53.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.216 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -78.95 116.84 19.52 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 123.53 0.519 . . . . 0.0 110.827 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.0 tm? -64.71 -29.67 70.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.31 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -91.77 15.53 12.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.854 -177.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -90.57 127.26 36.2 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 9.6 p -82.98 -12.53 12.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.989 0.423 . . . . 0.0 111.376 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 5.3 m -93.13 33.71 1.17 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.118 0.485 . . . . 0.0 111.32 -173.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.416 HD23 ' HE2' ' A' ' 237' ' ' LYS . 2.0 pp -132.78 170.91 14.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.745 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 23.3 m -106.23 159.61 29.11 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.341 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -39.97 -48.24 3.79 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.581 2.854 . . . . 0.0 113.913 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -56.28 -41.05 75.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.094 0.473 . . . . 0.0 111.343 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -72.1 -37.67 69.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.777 -175.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -77.05 -16.09 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.936 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -69.22 -30.75 68.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.478 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -96.16 -0.88 49.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.153 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.527 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -61.75 151.24 34.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.19 0.519 . . . . 0.0 111.546 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -138.43 -28.01 0.85 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.141 -171.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 23.4 m -113.89 162.16 12.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -92.51 -14.21 28.72 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.279 -176.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 11.9 t -147.62 148.5 31.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.768 0.318 . . . . 0.0 110.324 -177.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 46.0 m -77.78 158.63 29.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.575 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 41.1 tp -71.31 103.21 2.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.611 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -85.55 -179.24 6.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.407 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . 0.455 ' HA ' ' CG1' ' A' ' 230' ' ' VAL . 33.2 t70 -77.83 159.79 28.74 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.14 -0.224 . . . . 0.0 110.409 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 65.1 40.9 4.82 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.91 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' MET . . . . . 0.48 ' H ' HG11 ' A' ' 230' ' ' VAL . 25.2 mmt -110.28 140.32 44.56 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 176.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -92.21 135.25 34.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.989 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 14.0 t -114.26 105.01 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.902 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . 0.441 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 64.1 t30 -118.77 150.31 40.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.705 0.288 . . . . 0.0 111.003 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 69.3 mt -95.91 123.67 48.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.643 177.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 60.2 mt -84.26 147.78 27.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.394 176.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -82.86 95.82 8.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.008 0.433 . . . . 0.0 110.181 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.55 -0.738 . . . . 0.0 109.763 179.179 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.536 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 23.3 t -87.42 102.57 14.67 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.161 0.505 . . . . 0.0 110.566 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.8 t -116.04 43.66 2.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.092 0.949 . . . . 0.0 109.247 175.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -65.88 104.0 1.02 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.551 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.479 ' HG1' ' ND2' ' A' ' 341' ' ' ASN . 17.4 p -74.72 73.2 2.03 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.536 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -85.09 57.47 4.99 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 339' ' ' ALA . 31.9 mm -85.78 142.93 12.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 122.282 0.233 . . . . 0.0 110.808 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 12.3 p -118.84 143.22 47.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.089 0.471 . . . . 0.0 110.467 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 335' ' ' ALA . 9.9 p -59.5 149.39 6.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.75 -178.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 25.9 t -113.07 77.91 1.09 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 177.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 90.37 141.71 9.25 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.993 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.68 140.9 55.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.764 0.316 . . . . 0.0 110.927 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -144.76 132.87 21.54 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.544 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.1 t -116.92 114.12 23.4 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 175.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.447 ' O ' HG21 ' A' ' 313' ' ' VAL . 71.5 m-85 -81.15 133.0 35.39 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.343 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -124.09 134.99 25.84 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -86.19 152.88 9.49 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.757 2.305 . . . . 0.0 111.831 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.08 83.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.151 0.5 . . . . 0.0 110.407 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -131.28 81.87 2.01 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.789 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -129.86 -51.94 1.14 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.696 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -151.47 159.77 44.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.07 177.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 79.0 mt -112.76 117.43 32.19 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.94 0.4 . . . . 0.0 110.714 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -77.59 163.23 26.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.017 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -55.85 -40.0 72.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.73 0.3 . . . . 0.0 111.166 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -97.96 17.55 18.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.14 0.495 . . . . 0.0 110.146 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 82.04 -62.12 4.59 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.676 -0.57 . . . . 0.0 111.676 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -164.92 174.15 10.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 249' ' ' LYS . 52.8 tttp -135.44 32.33 3.09 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.682 0.753 . . . . 0.0 109.564 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 28.5 m -134.58 176.6 8.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.624 -176.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -80.41 74.3 7.28 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.14 114.22 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.669 0.747 . . . . 0.0 111.406 -174.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -101.69 31.64 3.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.616 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -62.35 -21.89 65.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.925 -175.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.507 ' NE ' ' HA ' ' A' ' 255' ' ' ARG . 4.9 mmp_? -104.79 -3.45 23.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.516 0.198 . . . . 0.0 111.366 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -122.21 169.94 10.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.827 0.346 . . . . 0.0 110.883 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -146.18 123.37 11.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.677 0.275 . . . . 0.0 110.74 177.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.1 m -94.55 101.45 13.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.892 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.7 t -86.18 120.46 36.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.234 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 30.3 m -92.9 109.73 21.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.917 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 19.2 mt -126.49 171.0 11.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.023 -175.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 16.6 p -62.07 -55.59 27.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.412 0.625 . . . . 0.0 109.77 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -136.85 139.05 41.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.785 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.4 p -131.38 27.55 4.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.793 0.806 . . . . 0.0 109.138 175.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 48.8 m -76.88 140.46 40.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.639 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 101.77 -2.25 52.49 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -173.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 63.3 mtt -108.03 137.27 46.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.813 -0.694 . . . . 0.0 109.299 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -155.0 141.69 18.95 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.501 ' HA ' HG12 ' A' ' 297' ' ' VAL . 29.1 ptt180 -39.34 119.24 0.9 Allowed 'General case' 0 N--CA 1.469 0.51 0 O-C-N 124.01 0.819 . . . . 0.0 112.694 -173.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 116.0 -9.26 18.47 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.564 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.459 ' H ' HG13 ' A' ' 297' ' ' VAL . 2.1 p30 -87.17 -174.82 5.06 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 117.523 0.662 . . . . 0.0 111.307 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 296' ' ' SER . 4.2 tmmm? -140.99 118.45 11.49 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.11 -177.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 34.3 pt -110.55 140.77 28.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.149 0.5 . . . . 0.0 110.095 -177.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 15.0 m -126.35 132.38 51.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.365 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -94.5 111.19 22.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.431 -176.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.7 116.75 7.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.722 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.38 -34.15 5.31 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 98.1 t -94.24 118.82 41.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.493 ' HB3' ' HZ2' ' A' ' 279' ' ' LYS . 0.4 OUTLIER -135.75 171.91 13.78 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.389 -178.093 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -74.66 172.92 11.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.189 -173.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 94.0 mt -75.92 92.74 3.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.191 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 135.95 171.53 12.36 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.724 173.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.466 ' HB3' HD21 ' A' ' 287' ' ' ASN . 76.7 mt-30 59.4 45.54 13.65 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 122.816 0.446 . . . . 0.0 111.298 177.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.415 ' HE3' ' CG ' ' A' ' 331' ' ' ASN . 58.4 mtm -128.78 -6.36 5.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.301 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -70.75 -55.41 8.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.024 0.44 . . . . 0.0 110.607 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -114.84 -28.42 7.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.772 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.466 HD21 ' HB3' ' A' ' 283' ' ' GLN . 50.0 t30 -74.68 109.81 8.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.103 -176.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 31.4 t -82.43 -33.35 11.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.579 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 94.0 mt -82.87 48.53 1.36 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.375 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -77.91 111.26 13.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.397 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -51.34 129.71 25.46 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 123.71 0.631 . . . . 0.0 111.37 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -74.88 168.49 19.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.381 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.609 ' HB3' ' CE2' ' A' ' 295' ' ' PHE . . . -54.41 98.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.918 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.4 p -91.48 99.1 12.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.052 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.609 ' CE2' ' HB3' ' A' ' 293' ' ' ALA . 43.1 m-85 -118.61 138.63 52.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.919 0.39 . . . . 0.0 110.925 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 272' ' ' LYS . 28.1 t -85.4 138.43 32.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.898 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 269' ' ' ARG . 4.3 p -71.67 137.27 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.966 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.25 -42.18 9.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.939 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -165.1 142.14 5.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.773 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 99.0 t -103.13 119.16 51.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 171.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.07 -58.71 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.01 -174.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -121.6 -9.41 8.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.337 0.589 . . . . 0.0 111.651 -173.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.62 13.98 76.94 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.309 -172.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 55.2 p -140.06 12.14 2.42 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 171.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -163.03 116.05 1.59 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.457 -167.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.41 165.01 15.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 121.194 -0.202 . . . . 0.0 110.577 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 8.0 pt-20 -128.09 123.09 33.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.076 0.465 . . . . 0.0 109.77 170.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.401 HG23 ' HA ' ' A' ' 297' ' ' VAL . 26.6 pt -121.67 176.86 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.314 -175.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.5 t -154.11 144.22 15.59 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.018 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.73 179.37 31.15 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 123.414 -1.494 . . . . 0.0 112.606 -4.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -77.39 121.1 83.94 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.873 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.431 ' HG2' ' CD2' ' A' ' 236' ' ' PHE . 30.5 Cg_endo -68.83 108.38 1.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.067 1.845 . . . . 0.0 111.934 174.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.529 ' HB ' ' HA ' ' A' ' 328' ' ' ALA . 85.8 t -118.02 130.65 72.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.317 178.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -90.42 131.9 35.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.194 0.521 . . . . 0.0 111.459 -176.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.3 tm? -69.46 -29.08 66.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.719 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -97.63 15.17 24.23 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -83.8 128.3 34.43 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.82 0.21 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 18.0 m -105.49 30.84 5.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.224 -0.298 . . . . 0.0 111.757 -174.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 1.7 pp -128.34 159.57 34.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.271 0.557 . . . . 0.0 111.879 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 2.7 t -91.53 152.75 43.82 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.854 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.535 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 50.1 Cg_exo -38.44 -47.99 2.48 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.978 3.118 . . . . 0.0 114.943 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -64.38 -33.58 76.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.828 0.347 . . . . 0.0 111.922 -176.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -68.06 -36.5 79.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.875 0.369 . . . . 0.0 111.243 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 7.4 ptm180 -78.76 -11.16 59.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.315 0.579 . . . . 0.0 110.366 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -74.73 -22.77 58.63 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.617 171.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -99.89 6.19 45.3 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.525 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.529 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -53.61 144.52 17.35 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.648 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -128.63 -34.69 1.98 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.032 -177.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.9 m -113.82 155.27 15.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.364 -178.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.415 ' CG ' ' HE3' ' A' ' 284' ' ' MET . 7.8 t30 -90.97 -8.34 49.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.24 0.543 . . . . 0.0 110.809 -175.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.4 t -148.3 141.28 24.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.881 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 24.1 m -75.38 166.18 24.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.898 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 26.2 tp -71.16 102.97 2.63 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.624 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -93.19 -172.9 3.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -74.35 160.83 30.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.776 0.322 . . . . 0.0 110.427 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 61.18 32.84 19.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.44 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 25.5 mmt -102.48 126.89 49.67 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 228' ' ' ILE . . . -84.47 129.91 34.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.096 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.402 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 16.1 t -104.18 108.42 24.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . 0.479 ' ND2' ' HG1' ' A' ' 226' ' ' THR . 26.1 t-20 -134.11 142.19 47.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.818 0.342 . . . . 0.0 111.908 -171.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 58.5 mt -87.96 127.0 41.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.76 175.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 57.8 mt -80.48 111.69 17.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.902 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -102.85 83.64 2.27 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.167 0.508 . . . . 0.0 110.629 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.248 0.977 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.133 176.074 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.851 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 17.9 m -119.57 31.94 6.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.007 0.432 . . . . 0.0 111.059 -176.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 20.4 m -131.92 116.96 17.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.204 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 56.09 70.63 0.62 Allowed 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.568 0.543 . . . . 0.0 110.989 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 38.9 p -81.51 -49.8 10.16 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.652 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 54.4 56.75 20.28 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.247 -0.502 . . . . 0.0 112.832 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 263' ' ' ALA . 51.1 mt -103.24 150.05 6.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 14.6 p -97.58 153.7 18.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.535 0.683 . . . . 0.0 112.082 -177.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 338' ' ' MET . 7.8 p -65.93 150.4 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.025 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 10.2 t -102.32 66.89 1.01 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.76 158.37 31.87 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.211 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.22 132.54 53.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.017 0.437 . . . . 0.0 111.681 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.571 ' NE2' ' HB ' ' A' ' 260' ' ' THR . 83.6 mm-40 -120.66 127.37 52.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.293 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 11.2 p -129.86 144.77 51.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.14 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -133.81 158.98 41.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.47 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -139.81 126.91 12.61 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.886 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -79.73 143.08 16.44 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.877 2.385 . . . . 0.0 111.641 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 59.6 t -81.38 123.61 38.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.77 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -81.92 152.13 26.92 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 18.8 t90 67.43 91.51 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.743 0.652 . . . . 0.0 109.508 -174.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -113.03 167.64 10.36 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.501 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -82.97 -75.94 0.29 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.967 0.413 . . . . 0.0 110.091 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -137.02 -70.41 0.45 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.865 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -82.99 -39.72 20.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.237 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.418 ' OD1' ' HB3' ' A' ' 254' ' ' ASN . 4.3 t0 -146.21 -174.31 4.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.127 -174.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -150.47 124.07 1.67 Allowed Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 20.3 m120 64.88 57.19 1.03 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.067 0.46 . . . . 0.0 110.755 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -72.46 -11.7 60.78 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.099 -175.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 51.3 t -84.34 -14.29 11.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 122.063 0.935 . . . . 0.0 109.796 176.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -92.45 -179.02 5.08 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.236 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 4.7 p -49.4 133.39 7.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-O 120.692 0.282 . . . . 0.0 110.356 175.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -48.46 121.8 4.83 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.569 -173.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.418 ' HB3' ' OD1' ' A' ' 246' ' ' ASP . 18.4 t30 -83.2 -51.16 7.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.312 -176.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.47 ' NE ' ' HA ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -79.15 -21.53 46.35 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.607 -177.429 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.459 ' HA ' ' O ' ' A' ' 308' ' ' ILE . 52.0 m-85 -111.63 140.89 45.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.808 -176.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -106.49 120.72 42.65 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.171 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.8 m -87.35 97.45 10.81 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.128 0.489 . . . . 0.0 110.899 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.5 t -83.91 125.39 40.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.546 -173.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' THR . . . . . 0.571 ' HB ' ' NE2' ' A' ' 234' ' ' GLN . 13.3 m -97.53 106.97 19.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.187 0.518 . . . . 0.0 109.853 175.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.456 ' HB2' HG22 ' A' ' 264' ' ' THR . 17.4 mt -121.2 163.02 19.15 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -177.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.1 t -56.75 -51.88 67.16 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -137.88 136.95 37.59 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.456 HG22 ' HB2' ' A' ' 261' ' ' LEU . 17.5 p -125.25 24.13 7.47 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 122.005 0.907 . . . . 0.0 108.922 175.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 10.4 m -77.71 145.4 36.6 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.301 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 96.83 -15.9 61.88 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -174.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' MET . . . . . 0.466 ' O ' HG22 ' A' ' 300' ' ' VAL . 54.1 mtt -92.28 132.84 36.37 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -129.75 149.73 51.37 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -49.71 114.07 0.98 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.548 0.69 . . . . 0.0 110.851 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 107.64 11.15 25.58 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.56 -0.745 . . . . 0.0 113.024 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -98.25 147.6 24.46 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 117.757 0.778 . . . . 0.0 110.991 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -94.63 117.53 30.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.334 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 22.7 pt -112.41 139.58 36.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.003 0.43 . . . . 0.0 110.238 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.417 ' HB3' HG21 ' A' ' 294' ' ' THR . 77.9 p -112.61 137.95 50.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.306 -177.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -105.89 119.95 40.49 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.368 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -63.3 136.27 57.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.892 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 81.95 -35.36 2.54 Favored Glycine 0 N--CA 1.454 -0.109 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.667 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 52.3 t -82.36 105.15 11.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.486 ' HB3' ' HZ3' ' A' ' 279' ' ' LYS . 0.5 OUTLIER -128.88 165.02 21.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.968 0.413 . . . . 0.0 111.46 -176.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.541 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 70.8 m-85 -79.26 144.75 34.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.3 -176.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 82.5 mt -78.88 172.67 13.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.523 175.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 97.85 -21.29 46.87 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.605 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -115.88 -7.42 12.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.781 0.324 . . . . 0.0 111.055 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 83.4 mtp -87.79 49.8 1.87 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.231 0.539 . . . . 0.0 111.445 -174.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -102.06 -51.6 3.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.721 174.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.32 24.49 0.36 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.485 175.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -106.11 110.1 22.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.517 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.96 -29.73 34.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.237 0.541 . . . . 0.0 110.009 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 87.8 mt -89.06 33.89 0.79 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.671 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.77 120.7 11.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.877 175.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -57.31 130.63 47.07 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.958 -173.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 47.7 m-20 -75.78 161.88 28.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.335 178.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.551 ' HB3' ' CE2' ' A' ' 295' ' ' PHE . . . -67.62 97.7 0.63 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.57 -175.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.417 HG21 ' HB3' ' A' ' 274' ' ' SER . 30.3 p -100.38 105.0 16.46 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.285 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.551 ' CE2' ' HB3' ' A' ' 293' ' ' ALA . 68.2 m-85 -112.62 145.87 39.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.937 0.399 . . . . 0.0 110.95 -178.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 50.1 m -86.08 124.91 33.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.324 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 11.2 p -69.85 132.61 32.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.062 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.74 -33.94 4.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.951 0.405 . . . . 0.0 110.419 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -157.99 133.46 8.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.071 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 267' ' ' MET . 96.7 t -91.48 101.35 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.6 t -73.77 -59.06 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.686 -171.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -109.39 -11.44 14.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.001 0.429 . . . . 0.0 111.691 -174.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.79 12.98 83.49 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -170.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 5.2 p -147.55 18.09 1.17 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 173.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.468 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.7 t-160 -169.64 114.7 0.54 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.207 -167.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.31 167.91 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -174.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -126.18 119.72 28.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.257 0.551 . . . . 0.0 109.958 169.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 256' ' ' PHE . 27.1 pt -113.99 171.21 4.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.705 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 12.6 t -153.52 145.51 16.93 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.84 179.29 30.99 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.498 -1.459 . . . . 0.0 112.933 -2.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -82.64 121.1 77.75 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.913 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.85 113.28 3.24 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.798 2.332 . . . . 0.0 112.912 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' A' ' 328' ' ' ALA . 0.1 OUTLIER -114.38 139.52 39.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.818 173.915 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -87.07 131.31 34.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.673 -177.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . 0.47 ' O ' HD12 ' A' ' 315' ' ' LEU . 2.7 tm? -65.91 -28.06 68.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.881 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.69 24.97 3.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.198 178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -91.91 122.04 34.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 8.4 p -84.05 -0.99 5.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.246 0.546 . . . . 0.0 111.483 -175.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 33.3 t -93.93 -25.52 17.25 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.069 -0.394 . . . . 0.0 111.474 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.44 HD21 ' O ' ' A' ' 314' ' ' ALA . 1.3 pp -83.7 162.85 20.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.238 0.542 . . . . 0.0 111.533 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.426 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 7.1 m -100.57 167.4 10.93 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.504 -176.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 42.2 Cg_exo -41.13 -51.51 3.85 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.8 3.0 . . . . 0.0 114.787 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.71 -39.28 93.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.002 0.429 . . . . 0.0 111.076 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -64.43 -28.95 70.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.906 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 325' ' ' ARG . 43.3 mtp85 -63.99 -28.73 70.01 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.796 0.331 . . . . 0.0 110.844 175.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -74.88 -19.34 60.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.104 0.478 . . . . 0.0 110.658 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -96.17 -2.78 45.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.444 ' HA ' HG21 ' A' ' 313' ' ' VAL . . . -72.74 106.39 4.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.661 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -98.31 -17.83 18.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.314 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.8 m -116.47 156.68 17.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.175 0.512 . . . . 0.0 110.417 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -82.38 -32.47 29.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.418 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 12.0 t -139.98 154.08 47.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.572 -174.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.2 p -86.95 169.66 12.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.318 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 18.1 tp -71.15 115.5 10.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.192 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.433 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -80.58 -178.92 6.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.32 -177.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -78.97 -9.83 59.64 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -138.7 72.56 1.41 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.924 0.392 . . . . 0.0 111.376 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' MET . . . . . 0.504 ' H ' HG12 ' A' ' 230' ' ' VAL . 21.0 mmt -125.11 146.37 49.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -93.81 139.5 30.78 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.735 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 40.9 t -121.81 119.36 58.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.965 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -135.83 143.9 45.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.967 -176.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 52.7 mt -85.73 121.64 37.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.948 173.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 63.9 mt -78.85 127.06 31.54 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.399 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -81.38 87.67 6.16 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 0 C--O 1.248 0.983 0 CA-C-N 115.278 -0.873 . . . . 0.0 112.085 -174.756 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.902 0 CA-C-O 120.094 -0.281 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.0 m 63.8 -80.16 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.965 0.506 . . . . 0.0 111.02 -176.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 20.6 p -122.0 -66.51 1.03 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -128.28 163.58 24.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.806 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.481 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 19.5 p -61.13 -65.09 0.75 Allowed 'General case' 0 C--N 1.322 -0.589 0 O-C-N 122.982 0.176 . . . . 0.0 111.459 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 58.44 39.91 93.59 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.764 -177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.63 HG21 ' O ' ' A' ' 263' ' ' ALA . 62.2 mt -103.23 146.63 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 21.8 p -108.24 156.08 19.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.398 0.618 . . . . 0.0 111.405 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 335' ' ' ALA . 8.5 p -63.0 151.63 8.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.825 176.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.7 t -105.02 83.73 2.03 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 84.12 165.24 38.68 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.177 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.88 129.81 40.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.792 0.33 . . . . 0.0 110.425 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -123.39 127.4 48.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.049 0.452 . . . . 0.0 110.853 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 21.4 p -127.14 131.58 50.73 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.206 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 312' ' ' PRO . 78.4 m-85 -111.91 142.77 43.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.88 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -133.71 132.75 21.82 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.04 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -88.36 151.38 6.61 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.689 2.259 . . . . 0.0 111.388 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.433 ' O ' HG12 ' A' ' 239' ' ' VAL . 6.3 p -85.33 83.57 2.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 122.114 0.959 . . . . 0.0 109.261 175.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -99.64 80.24 2.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.202 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -141.87 156.13 45.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.498 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -85.2 101.98 12.94 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -95.83 76.26 3.18 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.063 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -90.15 -46.04 8.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.654 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -87.87 -37.78 16.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.088 0.47 . . . . 0.0 110.196 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -107.8 -173.65 2.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.636 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -149.57 -176.0 22.36 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -133.16 130.27 38.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 117.115 0.458 . . . . 0.0 110.228 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -125.31 -9.68 6.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 30.5 m -73.02 162.88 4.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.88 0.371 . . . . 0.0 110.81 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -73.64 86.11 1.62 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.093 -177.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.35 65.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 122.341 1.067 . . . . 0.0 109.781 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -79.45 146.56 32.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.951 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -94.55 4.56 53.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.08 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -96.87 -52.86 3.73 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -170.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -110.11 171.89 7.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.993 0.425 . . . . 0.0 111.173 -172.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -146.9 132.67 18.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.897 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -92.03 104.93 17.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.131 0.491 . . . . 0.0 111.131 177.443 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.8 t -85.65 117.45 30.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.495 -174.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 19.4 m -87.22 105.83 17.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.171 0.51 . . . . 0.0 110.195 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.436 ' HB2' ' CG2' ' A' ' 264' ' ' THR . 20.5 mt -122.17 164.92 16.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.652 -177.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.3 t -59.9 -51.8 68.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.171 0.51 . . . . 0.0 109.776 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.63 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.37 131.45 32.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.22 176.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.436 ' CG2' ' HB2' ' A' ' 261' ' ' LEU . 12.8 p -126.0 18.09 7.84 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.774 0.797 . . . . 0.0 109.029 175.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 26.5 m -82.62 148.11 28.17 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.857 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 95.51 -0.18 63.21 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 42.9 mtm -117.07 158.08 24.79 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.43 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 23.4 pttm -139.94 172.45 12.74 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -59.29 121.07 10.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.631 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 103.04 18.85 13.88 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.244 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.43 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 59.8 m-20 -100.62 152.64 20.19 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 117.433 0.616 . . . . 0.0 110.135 178.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -95.07 116.32 28.57 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.97 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 308' ' ' ILE . 15.0 pt -115.84 138.92 44.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.237 176.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 4.5 m -123.92 131.47 53.58 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.832 -178.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -99.26 112.2 24.41 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.964 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.61 115.39 3.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.459 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.27 -34.86 4.95 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.937 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 45.2 t -81.66 142.13 14.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.517 ' NZ ' ' HB3' ' A' ' 279' ' ' LYS . 0.1 OUTLIER -162.13 152.19 16.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.916 0.389 . . . . 0.0 111.276 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -80.85 154.16 27.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.465 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.63 156.12 39.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.154 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.18 -39.14 3.1 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.671 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -80.75 2.98 23.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.986 0.422 . . . . 0.0 110.565 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.461 ' SD ' ' HG3' ' A' ' 279' ' ' LYS . 65.8 mtm -123.19 17.37 9.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.66 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -57.79 -54.65 44.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.011 0.434 . . . . 0.0 110.738 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -141.44 47.37 1.68 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -122.03 107.87 12.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.937 -176.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 45.6 t -80.89 -29.61 11.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 173.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 64.2 mt -100.6 54.96 0.87 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.826 177.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -78.88 145.05 34.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.747 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -76.18 173.65 11.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.271 0.558 . . . . 0.0 110.984 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -93.33 163.26 13.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.625 173.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -68.0 104.0 1.64 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.367 -175.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 30.3 p -90.88 106.69 18.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.511 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.402 ' CZ ' ' HG3' ' A' ' 312' ' ' PRO . 88.4 m-85 -105.31 149.89 25.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.158 0.504 . . . . 0.0 111.105 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 12.8 m -96.7 119.87 35.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.777 176.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.421 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.5 p -78.71 130.45 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.163 0.506 . . . . 0.0 110.231 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 21.1 t -93.49 -28.09 4.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.392 -178.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -172.88 140.62 0.96 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.63 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 95.7 t -90.31 109.54 20.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 170.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 42.8 t -78.03 -59.0 3.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.294 -172.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -110.33 -10.05 14.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.046 0.45 . . . . 0.0 111.737 -174.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.56 11.95 84.05 Favored Glycine 0 C--N 1.32 -0.343 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 27.9 p -146.01 13.91 1.31 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.6 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 3.7 t-160 -165.16 116.51 1.14 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.357 -167.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.9 m -119.26 162.13 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -176.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.31 120.65 42.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.926 0.393 . . . . 0.0 110.0 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 273' ' ' ILE . 39.8 pt -122.36 176.74 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.092 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.5 t -154.45 145.6 16.46 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.13 -179.99 26.64 Favored 'Cis proline' 0 C--N 1.346 0.428 0 C-N-CA 124.23 -1.154 . . . . 0.0 112.84 -0.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -78.88 113.64 37.12 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.96 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.431 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 23.5 Cg_exo -63.68 107.94 0.81 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.351 2.034 . . . . 0.0 112.365 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.5 t -124.39 126.3 71.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 317' ' ' ASP . . . -83.54 137.44 33.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.569 0.699 . . . . 0.0 111.897 -173.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.0 tm? -77.74 -25.2 49.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.54 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.6 5.2 43.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.426 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . 0.409 ' HB2' ' HB2' ' A' ' 314' ' ' ALA . 12.2 t70 -74.51 120.03 19.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.03 0.443 . . . . 0.0 110.186 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.9 p -84.79 -15.43 10.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.323 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 33.7 m -77.13 -23.93 51.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.498 -174.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 2.0 pp -85.75 164.41 17.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.456 0.646 . . . . 0.0 111.915 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 21.4 m -92.33 159.25 37.5 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.693 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 2.6 Cg_endo -41.34 -51.12 4.22 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 124.276 3.317 . . . . 0.0 114.311 -177.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -65.11 -29.03 69.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.853 0.359 . . . . 0.0 111.257 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 23.5 mt-30 -71.76 -38.52 70.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.089 -178.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -73.73 -19.88 60.67 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.489 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.23 -18.68 64.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.155 0.502 . . . . 0.0 110.023 172.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -112.15 12.03 20.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.084 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -60.54 152.62 25.54 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.927 0.394 . . . . 0.0 110.999 176.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -118.27 -29.73 5.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.663 -175.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.7 m -133.19 170.7 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 121.014 -0.275 . . . . 0.0 110.759 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -84.13 -51.44 7.06 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.594 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 11.4 t -107.27 146.3 31.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.03 0.443 . . . . 0.0 110.778 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.1 p -80.46 157.98 26.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.739 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.9 tp -68.56 101.96 1.38 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.717 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -82.53 165.89 19.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.489 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -76.96 25.41 0.15 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -149.1 30.92 0.77 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.962 0.41 . . . . 0.0 110.842 176.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.8 mmt -88.64 137.82 31.97 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.33 141.45 28.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.742 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 12.4 t -110.07 116.89 53.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.079 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . 0.481 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 27.8 t-20 -127.44 139.8 52.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.162 -177.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 16.3 mt -98.58 131.33 45.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 121.045 0.45 . . . . 0.0 111.125 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 33.5 mt -97.11 146.34 25.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.482 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -100.43 106.64 18.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.774 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 43.9 t . . . . . 0 C--O 1.252 1.234 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.635 -177.737 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.859 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 44.2 m -87.22 -46.47 9.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.847 0.324 . . . . 0.0 110.629 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.562 ' HB ' ' O ' ' A' ' 342' ' ' ILE . 32.4 p -80.72 -29.9 36.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.287 0.565 . . . . 0.0 110.345 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -79.99 76.57 6.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.342 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 54.8 p -67.72 -31.72 71.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.055 -174.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 69.97 31.27 69.71 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.056 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 263' ' ' ALA . 89.0 mt -99.88 144.4 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.451 0.167 . . . . 0.0 110.613 -174.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 21.6 p -105.97 167.28 9.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.042 0.449 . . . . 0.0 111.549 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 335' ' ' ALA . 8.0 p -73.17 151.06 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.711 174.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 8.5 t -116.41 68.26 0.73 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.231 0.539 . . . . 0.0 109.909 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 103.94 141.83 11.41 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.856 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.8 127.6 33.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.919 0.39 . . . . 0.0 110.946 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -123.57 126.04 45.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.119 0.485 . . . . 0.0 110.427 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 5.4 p -111.08 103.36 11.8 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.197 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -81.65 151.76 27.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.337 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -145.03 127.7 8.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.257 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -86.6 176.48 4.73 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.763 2.309 . . . . 0.0 110.45 169.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.62 123.22 70.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.198 0.523 . . . . 0.0 111.104 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.0 148.2 46.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.295 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -81.5 92.28 6.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.283 0.563 . . . . 0.0 109.912 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -148.19 114.99 6.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.746 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 77.1 mt 69.34 94.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 O-C-N 124.151 0.907 . . . . 0.0 110.819 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -70.02 -21.55 63.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.817 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -74.93 -29.08 60.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.603 0.239 . . . . 0.0 111.033 -177.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -152.41 95.01 1.98 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.905 0.383 . . . . 0.0 110.193 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -161.51 86.42 0.11 Allowed Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 8.8 t30 58.54 73.59 0.47 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.358 0.599 . . . . 0.0 109.888 -176.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -81.7 -26.1 34.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.733 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 25.6 m -63.82 152.34 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.087 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -81.27 104.81 11.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.308 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 7.4 p -159.69 124.84 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.689 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -68.22 125.28 25.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.562 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -92.84 -15.25 26.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.394 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -82.14 -15.26 53.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.068 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.409 ' CD1' ' HB ' ' A' ' 309' ' ' THR . 83.6 m-85 -114.0 140.44 48.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.669 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -110.19 135.32 51.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.249 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.3 OUTLIER -103.63 100.39 10.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.08 0.467 . . . . 0.0 110.58 -177.513 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.51 ' HB ' HG23 ' A' ' 306' ' ' VAL . 2.8 t -83.97 124.52 39.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.1 -170.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 21.8 m -93.74 106.21 18.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.259 0.552 . . . . 0.0 110.358 175.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.474 ' HB2' HG21 ' A' ' 264' ' ' THR . 21.8 mt -123.09 164.16 19.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.771 -176.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.7 m -57.48 -53.48 57.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.285 0.565 . . . . 0.0 109.987 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.604 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -136.85 133.53 35.94 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.257 177.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.474 HG21 ' HB2' ' A' ' 261' ' ' LEU . 4.3 p -127.96 17.48 6.73 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 11.4 m -80.32 150.49 29.92 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.772 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 91.72 -3.22 77.91 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.823 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 57.8 mtm -108.79 161.25 15.29 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.42 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 23.1 pttm -132.45 175.45 9.28 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -65.95 136.87 56.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.902 0.382 . . . . 0.0 110.338 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.99 7.6 62.4 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.213 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.42 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 44.3 m-20 -85.25 142.23 29.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.621 0.71 . . . . 0.0 109.903 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 1.3 tpmt? -87.71 115.32 25.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.776 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.428 HD11 HG23 ' A' ' 308' ' ' ILE . 6.8 pt -113.41 139.04 40.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.394 176.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 44.2 t -128.45 132.18 48.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.315 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -101.6 112.03 24.46 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.461 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.02 117.46 7.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.602 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.19 -11.19 26.68 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.458 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.2 133.55 58.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.516 ' HB3' ' HZ2' ' A' ' 279' ' ' LYS . 0.2 OUTLIER -159.16 162.89 36.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.963 0.411 . . . . 0.0 111.602 -178.193 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -81.11 156.66 25.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.266 -174.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -81.68 152.14 27.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.437 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.83 -56.46 0.47 Allowed Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.431 176.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -68.62 -19.84 64.45 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -174.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 71.0 mtm -75.45 -11.29 60.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.154 -177.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.24 -36.72 61.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.744 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -122.25 -39.9 2.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.724 0.297 . . . . 0.0 111.584 -177.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -82.59 119.18 23.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.086 0.47 . . . . 0.0 110.721 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.65 -28.03 12.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 73.8 mt -86.34 61.92 7.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.343 175.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -82.16 114.17 20.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.725 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.74 163.98 13.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.186 -177.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -95.6 143.88 26.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.695 177.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -54.56 123.17 12.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.374 -171.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 14.0 p -99.4 127.0 45.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.888 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 312' ' ' PRO . 86.0 m-85 -127.74 150.4 49.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.598 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 24.1 t -97.4 122.65 40.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.102 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.8 134.91 28.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.08 0.467 . . . . 0.0 109.949 177.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 37.3 t -98.59 -35.21 4.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.725 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -164.63 136.72 4.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 0.0 110.761 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 88.9 t -83.84 109.78 17.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 171.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 42.5 t -74.43 -59.33 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.708 -173.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -120.65 -14.5 8.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.413 0.625 . . . . 0.0 111.101 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 84.08 13.91 73.3 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -169.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 31.9 p -140.92 13.57 2.27 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 171.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 3.6 t-160 -168.71 121.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.038 -170.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 258' ' ' THR . 2.0 m -119.71 162.97 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.654 -175.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -116.69 123.0 46.16 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 170.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.428 HG23 HD11 ' A' ' 273' ' ' ILE . 43.7 pt -122.44 170.69 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.38 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' THR . . . . . 0.409 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 5.1 t -153.41 144.85 16.44 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 172.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.18 179.84 25.69 Favored 'Cis proline' 0 C--N 1.345 0.368 0 C-N-CA 124.061 -1.225 . . . . 0.0 112.817 -1.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -88.97 119.7 69.87 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.977 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 295' ' ' PHE . 38.2 Cg_endo -69.68 116.48 4.57 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.673 2.249 . . . . 0.0 112.527 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.518 ' CG2' ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -124.67 131.79 72.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.524 176.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.503 ' HB3' ' HB2' ' A' ' 317' ' ' ASP . . . -78.96 130.92 36.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.259 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.34 -28.28 66.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.935 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -98.9 25.72 6.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.294 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . 0.503 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 10.0 t70 -78.59 123.55 27.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.2 m -83.5 3.29 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 16.8 m -109.77 18.63 20.0 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.672 0.272 . . . . 0.0 111.287 -174.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.8 pp -127.91 168.58 15.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.083 0.468 . . . . 0.0 111.945 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 4.1 m -102.82 169.97 6.86 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.568 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -47.35 -48.95 13.95 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.234 2.623 . . . . 0.0 113.915 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -65.45 -33.95 77.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.284 0.564 . . . . 0.0 110.554 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 13.0 mm100 -67.44 -42.47 83.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.148 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -71.82 -17.01 62.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.913 0.387 . . . . 0.0 111.167 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.2 -29.16 67.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.067 0.46 . . . . 0.0 110.098 173.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -86.4 -13.17 47.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.827 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.518 ' HA ' ' CG2' ' A' ' 313' ' ' VAL . . . -58.41 143.68 44.48 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.29 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -131.13 -8.95 3.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.049 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.5 174.22 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.046 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -84.88 -45.23 12.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.684 0.278 . . . . 0.0 111.115 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 6.2 t -129.57 144.43 51.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.366 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.496 ' N ' ' HB1' ' A' ' 314' ' ' ALA . 22.5 m -68.22 169.48 10.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 21.4 tp -70.16 102.22 2.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.547 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -90.75 -173.69 3.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.312 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -73.3 158.98 34.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.89 0.376 . . . . 0.0 110.826 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 60.6 39.1 18.26 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.207 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' MET . . . . . 0.427 ' H ' HG12 ' A' ' 230' ' ' VAL . 26.1 mmt -104.6 133.08 50.05 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -89.01 137.6 32.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.066 0.46 . . . . 0.0 111.354 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 12.5 t -103.21 124.35 57.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.565 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -138.24 134.34 34.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.557 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.562 ' O ' ' HB ' ' A' ' 224' ' ' THR . 70.7 mt -88.46 119.72 36.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.917 0.389 . . . . 0.0 110.088 176.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 40.8 mt -86.23 138.61 31.74 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.721 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -139.76 150.2 44.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.991 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.25 1.105 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.053 -177.238 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.724 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.0 m -132.13 22.19 4.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.091 0.472 . . . . 0.0 110.671 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.7 p -101.71 -32.15 10.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.936 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -76.31 96.28 3.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.395 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 33.7 p -81.36 80.5 7.75 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.194 -178.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -81.23 67.83 3.55 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 174.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 263' ' ' ALA . 40.0 mm -100.1 145.01 11.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.585 -0.308 . . . . 0.0 110.685 -174.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.2 p -128.16 159.97 33.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.291 0.567 . . . . 0.0 110.681 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.65 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.4 p -84.68 151.88 3.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.537 -175.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 67.8 m -109.14 82.23 1.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.841 0.353 . . . . 0.0 110.408 174.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 93.58 165.22 37.29 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.592 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 334' ' ' LEU . . . -84.22 114.15 21.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.874 0.368 . . . . 0.0 110.15 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -120.61 128.43 53.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.026 -175.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.47 ' HB3' ' HB3' ' A' ' 333' ' ' SER . 26.9 p -145.84 102.08 3.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.4 0.619 . . . . 0.0 110.092 172.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.415 ' C ' ' HD3' ' A' ' 311' ' ' LYS . 79.3 m-85 -95.15 148.15 22.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.927 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 237' ' ' LYS . 12.9 mptt -110.01 146.0 33.25 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.974 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 254' ' ' ASN . 71.6 Cg_endo -82.57 130.36 6.02 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.494 2.129 . . . . 0.0 111.677 174.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 44.3 t -81.75 94.54 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.255 0.55 . . . . 0.0 110.561 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -90.33 161.07 15.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.383 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 93.6 m95 70.95 126.19 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 O-C-N 124.017 0.823 . . . . 0.0 111.332 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -99.28 112.25 24.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.057 178.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -109.33 -78.65 0.59 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -138.61 144.12 39.61 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -67.9 -10.52 53.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.161 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -77.78 -29.56 50.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.266 175.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -95.01 -64.33 0.99 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.713 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -86.66 70.84 10.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.627 0.727 . . . . 0.0 110.237 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -61.74 125.23 23.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.141 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.34 -13.51 11.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.516 0.674 . . . . 0.0 111.245 -174.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -82.62 68.76 9.2 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.318 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 7.8 p -177.29 156.82 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.612 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -76.93 75.28 3.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.131 0.491 . . . . 0.0 109.783 177.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 238' ' ' PRO . 23.1 p30 -91.56 -26.04 18.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.398 -177.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -93.96 -50.86 5.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.0 0.429 . . . . 0.0 110.021 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.429 ' CD2' ' HB ' ' A' ' 309' ' ' THR . 97.2 m-85 -85.72 152.02 23.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.531 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -105.08 118.24 36.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.611 0.244 . . . . 0.0 111.424 -177.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -87.06 103.48 15.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.177 0.513 . . . . 0.0 110.586 175.399 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -82.22 118.23 29.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.021 -173.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 23.5 m -84.93 105.64 15.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.013 176.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 31.3 mt -126.09 166.45 16.98 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.949 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.4 t -64.59 -52.85 55.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.096 0.474 . . . . 0.0 109.798 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.518 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.69 127.31 27.04 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.802 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 10.6 p -125.22 32.37 5.39 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 173.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 1.4 m -81.31 145.99 30.61 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.163 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 90.28 -2.8 81.63 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.758 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 59.7 mtt -97.79 146.3 25.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -133.05 172.73 12.25 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -59.36 138.49 57.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.034 0.445 . . . . 0.0 111.069 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 88.12 11.83 66.65 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.257 176.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.401 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 53.1 m-20 -90.64 153.84 20.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.555 0.678 . . . . 0.0 110.49 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -103.8 117.67 34.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.824 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 40.4 pt -112.72 139.87 35.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.137 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.464 ' HB3' HG23 ' A' ' 294' ' ' THR . 77.3 p -120.27 133.63 55.43 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.766 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -95.04 110.43 22.35 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.83 118.72 13.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.122 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 108.49 -22.7 26.06 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.62 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 41.2 t -101.32 133.76 43.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -144.25 156.82 44.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.706 0.288 . . . . 0.0 111.131 -174.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.529 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 82.4 m-85 -77.55 169.35 18.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.599 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 86.1 mt -77.39 68.68 3.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.686 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -162.16 138.96 5.67 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.478 ' O ' ' HB3' ' A' ' 287' ' ' ASN . 23.8 mt-30 64.02 36.64 9.78 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.76 0.424 . . . . 0.0 110.575 -178.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 89.0 mmm -119.12 37.25 4.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.077 0.465 . . . . 0.0 111.182 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -98.25 -54.81 2.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.975 174.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -138.88 13.01 2.68 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.395 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 283' ' ' GLN . 39.5 t-20 -113.51 136.96 52.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.358 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 30.6 t -102.1 -26.92 3.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.294 0.569 . . . . 0.0 110.087 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 97.2 mt -85.0 48.85 1.63 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.685 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.28 170.67 11.27 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.393 177.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -67.83 118.23 10.79 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.943 0.401 . . . . 0.0 110.516 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -65.57 153.49 41.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.023 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.529 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -71.56 95.48 1.42 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.249 -177.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.464 HG23 ' HB3' ' A' ' 274' ' ' SER . 70.8 p -103.78 126.72 51.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.35 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.414 ' CE2' ' HG3' ' A' ' 312' ' ' PRO . 92.5 m-85 -131.59 155.98 46.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.888 0.375 . . . . 0.0 110.828 -179.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 5.6 m -100.86 129.5 46.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.153 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.401 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 11.9 p -83.17 135.93 23.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.143 0.497 . . . . 0.0 110.462 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 27.9 t -98.48 -28.91 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.704 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 307' ' ' GLU . 27.8 tpt180 -167.17 137.92 3.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.506 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 97.6 t -87.85 111.36 22.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 14.9 t -75.86 -56.43 8.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.869 -170.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -119.3 -6.06 10.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.902 0.382 . . . . 0.0 111.65 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.94 12.16 84.17 Favored Glycine 0 C--N 1.322 -0.202 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -170.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 6.6 p -148.03 19.85 1.11 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.434 ' NE2' ' HB ' ' A' ' 258' ' ' THR . 3.6 t-160 -167.08 116.93 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.052 -1.431 . . . . 0.0 107.965 -170.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -118.64 152.15 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -175.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 299' ' ' ARG . 9.9 pt-20 -110.37 118.07 35.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.079 0.466 . . . . 0.0 110.002 173.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 27.2 pt -120.57 171.06 9.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.531 -177.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' THR . . . . . 0.429 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 7.1 t -148.91 140.32 14.21 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.625 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.4 -179.91 28.49 Favored 'Cis proline' 0 C--N 1.344 0.31 0 C-N-CA 123.906 -1.289 . . . . 0.0 112.375 -2.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.415 ' HD3' ' C ' ' A' ' 236' ' ' PHE . 37.2 ttmt -85.47 125.28 70.0 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.954 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.414 ' HG3' ' CE2' ' A' ' 295' ' ' PHE . 16.1 Cg_exo -67.74 108.97 1.76 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.661 2.241 . . . . 0.0 112.755 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -120.92 131.23 73.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.744 173.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -91.62 141.06 29.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.334 0.588 . . . . 0.0 111.377 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.7 tm? -72.84 -22.89 60.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.567 177.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.4 17.38 14.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.409 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.07 115.26 22.28 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 9.4 p -83.11 -9.68 11.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.005 0.431 . . . . 0.0 111.29 -175.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 15.0 m -82.33 -29.75 30.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.347 -174.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 2.4 pp -84.65 162.62 19.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.4 0.619 . . . . 0.0 112.002 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.458 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 41.9 m -95.93 166.07 15.19 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.076 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 71.3 Cg_exo -43.68 -44.23 11.33 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.554 2.836 . . . . 0.0 114.666 -177.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.27 -33.91 75.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.254 0.55 . . . . 0.0 111.201 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.508 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 46.4 mt-30 -79.86 -36.93 35.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.675 -175.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.44 ' HB3' ' CD1' ' A' ' 320' ' ' LEU . 13.6 ptm180 -73.2 -20.19 60.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.053 0.454 . . . . 0.0 110.161 177.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.01 -29.89 69.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.994 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -101.19 11.37 39.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.378 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.469 ' HA ' ' CG2' ' A' ' 313' ' ' VAL . . . -59.67 149.74 29.65 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.88 0.372 . . . . 0.0 111.212 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -125.95 -36.29 2.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.711 -176.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 30.7 m -110.31 155.19 11.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.229 0.537 . . . . 0.0 111.182 -175.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -85.61 -17.04 37.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.428 -176.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.1 t -144.0 139.74 29.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.225 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.47 ' HB3' ' HB3' ' A' ' 235' ' ' SER . 73.0 m -70.89 163.62 27.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.241 175.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 233' ' ' ALA . 29.0 tp -69.05 104.26 2.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.65 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -78.98 170.23 17.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.699 -175.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -76.44 12.41 1.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -170.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -152.93 65.31 0.78 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.356 0.598 . . . . 0.0 110.347 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' MET . . . . . 0.429 ' H ' HG13 ' A' ' 230' ' ' VAL . 22.2 mmt -114.85 141.95 47.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.255 178.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -90.77 129.62 36.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.528 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 19.2 t -104.19 117.27 49.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -131.57 138.72 48.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.747 0.308 . . . . 0.0 111.185 -174.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 3.3 mt -90.42 133.37 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.137 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 60.4 mt -80.96 147.4 30.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.31 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -95.84 99.87 11.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.277 -175.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.569 175.429 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.658 0 N-CA-C 111.865 -0.494 . . . . 0.0 111.865 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 13.3 m 60.77 37.14 19.02 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.749 0.42 . . . . 0.0 111.427 178.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 7.0 p -104.49 -43.41 5.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.038 0.447 . . . . 0.0 111.106 -179.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -92.02 74.61 5.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.571 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 53.8 p -107.37 89.4 2.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.344 0.592 . . . . 0.0 110.811 179.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -123.39 48.12 0.97 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 175.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 263' ' ' ALA . 17.4 mt -87.26 150.46 3.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -175.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 6.1 p -107.86 166.02 11.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.309 0.576 . . . . 0.0 111.722 -178.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.626 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.7 p -72.82 150.32 8.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.971 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.477 ' HB2' ' N ' ' A' ' 262' ' ' SER . 7.0 t -110.87 74.48 0.87 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.344 0.592 . . . . 0.0 109.72 177.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 92.8 144.3 14.3 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.996 -178.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.51 126.89 29.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.857 0.361 . . . . 0.0 110.808 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -125.33 126.35 44.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.134 -179.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.9 m -105.65 104.42 14.14 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.693 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -80.52 113.64 18.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.977 -176.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -124.64 121.78 25.76 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.92 0.391 . . . . 0.0 111.763 -174.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.446 ' HA ' ' OD1' ' A' ' 254' ' ' ASN . 76.2 Cg_endo -86.01 128.55 3.24 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.782 2.321 . . . . 0.0 110.997 170.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 5.4 p -86.57 108.9 18.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.599 0.714 . . . . 0.0 110.859 -177.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -81.35 81.18 7.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.054 178.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -128.99 75.73 1.67 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.91 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -142.3 101.88 3.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.979 177.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 53.4 mt -105.74 -13.13 15.64 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 176.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -166.48 -171.4 1.89 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.029 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.491 ' O ' ' HE2' ' A' ' 249' ' ' LYS . 4.1 p-10 -65.16 -30.7 71.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 117.639 0.199 . . . . 0.0 111.321 -178.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -89.51 40.99 1.02 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.932 0.396 . . . . 0.0 111.394 -178.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -95.17 -126.84 4.97 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 176.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -88.14 66.06 8.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.289 0.566 . . . . 0.0 109.609 174.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.491 ' HE2' ' O ' ' A' ' 245' ' ' ASN . 21.8 ttmm -85.14 -57.93 2.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.113 -177.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 251' ' ' ASN . 14.4 m -79.96 99.32 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.661 0.743 . . . . 0.0 111.469 -177.203 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 250' ' ' VAL . 26.4 t-20 168.79 119.29 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.841 -178.401 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.4 m -119.4 36.07 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.549 0.69 . . . . 0.0 110.333 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -120.31 -47.9 2.34 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.966 -178.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.446 ' OD1' ' HA ' ' A' ' 238' ' ' PRO . 19.7 t-20 -68.73 -14.35 62.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.349 -174.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -82.7 -6.58 59.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.09 177.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.83 154.86 39.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.807 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -101.99 115.69 31.09 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.727 0.299 . . . . 0.0 110.408 178.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.7 OUTLIER -92.78 103.61 15.95 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.164 0.507 . . . . 0.0 109.995 179.639 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.1 t -82.84 117.0 28.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.466 -171.189 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 16.2 m -87.04 105.3 17.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.101 177.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 29.0 mt -125.59 162.73 24.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.13 -176.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.477 ' N ' ' HB2' ' A' ' 231' ' ' SER . 14.0 m -62.21 -50.2 72.73 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.428 0.632 . . . . 0.0 109.697 179.229 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.567 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -138.13 142.06 40.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.269 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.44 ' HB ' ' SD ' ' A' ' 267' ' ' MET . 19.1 p -129.39 26.86 5.36 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.087 0.946 . . . . 0.0 108.875 174.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 15.5 m -77.71 138.3 38.97 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.343 -1.298 . . . . 0.0 109.513 175.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 104.9 -7.1 44.45 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -172.224 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 267' ' ' MET . . . . . 0.44 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 61.1 mtt -101.5 144.74 29.89 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.389 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -154.89 141.98 19.31 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.464 ' HA ' HG13 ' A' ' 297' ' ' VAL . 24.3 ptt180 -44.46 116.52 1.05 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.96 0.788 . . . . 0.0 112.582 -171.586 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.62 -6.63 20.44 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.426 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.512 ' H ' HG11 ' A' ' 297' ' ' VAL . 1.6 p30 -85.15 -177.9 6.64 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.482 0.641 . . . . 0.0 111.534 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -124.65 117.11 23.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.897 -177.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.417 HD12 HG22 ' A' ' 308' ' ' ILE . 40.8 pt -112.72 139.88 35.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.108 0.48 . . . . 0.0 110.208 177.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.485 ' OG ' HG22 ' A' ' 294' ' ' THR . 4.9 m -127.98 149.28 50.42 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.822 -178.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -113.59 111.85 22.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.424 -178.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.52 115.71 6.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.823 -178.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.32 -25.62 12.2 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.708 -178.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 47.2 t -99.04 115.15 38.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.42 ' HD3' ' HB1' ' A' ' 290' ' ' ALA . 15.9 ptpt -132.7 162.55 31.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.867 0.365 . . . . 0.0 111.896 -173.541 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.436 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 60.1 m-85 -80.46 154.16 27.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.86 -175.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.423 HD12 ' HB2' ' A' ' 315' ' ' LEU . 40.2 mt -81.94 161.34 23.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.796 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 102.11 -3.56 51.68 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.492 175.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.403 ' OE1' ' HG2' ' A' ' 291' ' ' GLN . 89.5 mt-30 -123.74 -16.48 6.67 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 70.1 mtm -79.67 14.3 1.74 Allowed 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.084 -0.385 . . . . 0.0 111.923 -173.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -95.63 -21.5 18.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.926 0.393 . . . . 0.0 110.729 178.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -154.25 -46.6 0.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.564 -178.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -75.84 95.04 3.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.394 -178.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.55 -32.12 55.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.16 -176.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 85.2 mt -84.17 49.51 1.67 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.152 0.501 . . . . 0.0 110.005 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.42 ' HB1' ' HD3' ' A' ' 279' ' ' LYS . . . -57.89 128.79 38.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.112 -178.377 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . 0.403 ' HG2' ' OE1' ' A' ' 283' ' ' GLN . 23.7 pt20 -60.98 132.96 55.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.443 -176.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -72.48 166.13 23.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.942 177.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.485 ' HB3' ' CE2' ' A' ' 295' ' ' PHE . . . -70.69 87.9 0.69 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.464 -176.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.485 HG22 ' OG ' ' A' ' 274' ' ' SER . 70.5 p -90.99 112.53 24.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.288 178.416 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 293' ' ' ALA . 68.0 m-85 -123.07 145.43 48.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.931 0.396 . . . . 0.0 110.857 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 11.9 m -80.3 130.0 34.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.696 175.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.512 HG11 ' H ' ' A' ' 271' ' ' ASP . 5.2 p -67.75 132.72 32.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.255 0.55 . . . . 0.0 109.668 179.293 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 84.6 t -94.07 -45.34 13.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.105 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -167.51 139.08 3.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.126 178.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 93.7 t -88.11 108.79 18.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 171.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.0 t -78.54 -59.66 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.971 -173.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -111.91 -8.16 14.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.948 0.404 . . . . 0.0 111.529 -174.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.16 12.85 83.22 Favored Glycine 0 CA--C 1.517 0.193 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -170.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 20.4 p -146.05 16.25 1.37 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 174.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.419 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.2 t-160 -170.73 115.53 0.46 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.384 -168.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.58 161.92 18.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.537 -175.227 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -116.22 129.29 56.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.003 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.488 HG21 ' HA ' ' A' ' 297' ' ' VAL . 27.1 pt -132.07 169.83 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.031 0.443 . . . . 0.0 111.471 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 7.2 t -150.02 143.58 16.78 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.41 177.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -76.44 -179.95 29.0 Favored 'Cis proline' 0 C--N 1.345 0.378 0 C-N-CA 124.129 -1.196 . . . . 0.0 112.419 -3.113 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -87.41 123.35 69.84 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.207 -178.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.15 109.29 2.9 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.593 2.196 . . . . 0.0 112.658 178.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.467 ' CG2' ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -107.06 133.92 50.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.62 175.745 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.442 ' O ' HD22 ' A' ' 320' ' ' LEU . . . -82.84 126.06 32.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.11 0.481 . . . . 0.0 111.409 -178.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . 0.423 ' HB2' HD12 ' A' ' 281' ' ' LEU . 2.7 tm? -68.64 -29.6 68.13 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.968 177.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -79.52 -0.81 34.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.751 -179.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -79.92 122.5 26.76 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.984 0.421 . . . . 0.0 110.622 -178.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 14.2 p -83.96 -16.64 10.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.237 -178.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 24.5 m -74.42 -35.82 63.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.721 -175.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 320' ' ' LEU . 1.7 pp -75.4 152.64 38.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.276 0.56 . . . . 0.0 110.884 178.423 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.462 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.8 m -91.09 170.84 9.06 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.259 -173.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 91.2 Cg_exo -46.98 -50.45 10.89 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 123.446 2.764 . . . . 0.0 114.517 -175.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.35 -28.85 69.98 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.149 -177.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -76.03 -39.65 55.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.631 0.253 . . . . 0.0 111.026 -178.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.431 ' HB3' ' CD1' ' A' ' 320' ' ' LEU . 13.0 ptp180 -73.37 -22.85 60.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.009 0.433 . . . . 0.0 110.538 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.87 -34.21 77.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.217 174.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -96.6 6.23 49.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.185 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.467 ' HA ' ' CG2' ' A' ' 313' ' ' VAL . . . -61.41 135.61 57.75 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.887 0.375 . . . . 0.0 110.753 178.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -108.89 -29.2 8.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.365 -176.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.8 171.53 9.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.946 0.403 . . . . 0.0 111.132 -175.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -88.55 -38.77 14.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.449 -178.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.1 t -128.3 143.17 50.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.909 0.385 . . . . 0.0 110.763 -176.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.432 ' N ' ' HB3' ' A' ' 314' ' ' ALA . 44.1 m -72.29 162.71 29.09 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 172.389 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 23.0 tp -68.66 102.42 1.5 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -177.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.626 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -95.72 -179.24 4.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.269 -178.337 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -67.57 150.45 48.79 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 65.45 45.62 2.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.819 179.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 26.4 mmt -112.0 131.07 55.63 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -87.07 133.6 33.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.604 -176.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 10.3 t -101.83 114.86 42.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.476 177.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -125.85 134.52 51.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.098 -174.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 19.5 mt -93.01 131.43 40.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 174.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 68.0 mt -74.18 111.34 9.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.022 0.439 . . . . 0.0 110.586 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -94.67 82.74 3.97 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.517 178.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.733 -178.719 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.781 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.8 m -87.87 -42.75 12.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.853 0.359 . . . . 0.0 110.696 -179.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 18.4 m -111.35 70.56 0.72 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.492 0.663 . . . . 0.0 110.257 178.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -130.17 123.54 30.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.26 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 23.1 p -77.84 79.06 4.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.222 0.534 . . . . 0.0 111.501 -177.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.43 68.1 3.39 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 174.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 340' ' ' VAL . 40.6 mm -100.17 143.45 13.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 122.339 0.256 . . . . 0.0 111.101 -173.356 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 74.4 p -121.89 149.41 43.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.195 0.521 . . . . 0.0 110.506 173.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.653 HG12 ' O ' ' A' ' 335' ' ' ALA . 9.5 p -64.48 152.97 8.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.678 175.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 14.2 t -124.58 88.78 2.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.914 0.388 . . . . 0.0 110.017 175.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 103.4 165.34 25.51 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.038 -178.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -86.52 125.13 33.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.718 0.294 . . . . 0.0 110.428 179.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -120.58 129.51 53.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.929 0.395 . . . . 0.0 110.961 -176.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 25.5 t -153.89 103.04 2.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.899 177.404 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -114.26 141.65 47.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.892 -179.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.429 ' HE3' ' HB3' ' A' ' 320' ' ' LEU . 2.9 mptp? -111.9 145.89 33.66 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.822 -175.544 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.25 128.37 12.86 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.261 1.974 . . . . 0.0 110.846 174.115 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 13.5 t -78.05 84.93 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.333 0.587 . . . . 0.0 110.382 -175.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -89.41 86.04 6.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.575 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 11.5 t90 56.08 68.78 0.81 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.604 0.716 . . . . 0.0 110.206 -177.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -138.3 105.91 5.59 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.634 -178.015 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 82.7 mt 70.47 4.61 5.01 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.651 -177.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 60.83 -171.07 0.15 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.966 -177.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -82.58 -15.34 52.6 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.292 0.567 . . . . 0.0 109.689 175.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -80.17 -43.09 22.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.212 -177.376 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.72 -22.95 78.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.785 -176.625 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -83.88 90.31 7.35 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.139 0.495 . . . . 0.0 110.205 178.195 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -77.75 -33.85 52.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.066 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 27.5 m -78.16 152.71 5.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.113 176.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -92.87 85.66 5.24 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.051 0.453 . . . . 0.0 110.949 -176.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 38.8 t -87.79 127.91 40.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.697 176.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.575 ' OD2' ' HA ' ' A' ' 257' ' ' ALA . 0.8 OUTLIER -58.51 116.08 3.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.17 0.51 . . . . 0.0 110.231 176.365 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -90.79 -50.8 5.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.836 -176.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -88.74 -30.22 19.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.112 -176.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.492 ' CE1' HG22 ' A' ' 298' ' ' VAL . 48.1 m-85 -102.64 -175.09 2.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.306 -179.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.575 ' HA ' ' OD2' ' A' ' 253' ' ' ASP . . . -145.36 118.44 8.85 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.861 176.33 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 3.8 m -83.22 113.01 20.37 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.076 0.465 . . . . 0.0 110.484 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.5 t -98.08 120.5 47.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.427 -173.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 79.5 m -89.64 108.2 19.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.04 0.448 . . . . 0.0 109.958 174.167 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.408 ' HB2' ' CG2' ' A' ' 264' ' ' THR . 23.9 mt -125.04 168.32 13.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.732 -177.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.8 t -64.7 -52.84 55.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.526 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.68 127.24 26.94 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.328 179.426 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.408 ' CG2' ' HB2' ' A' ' 261' ' ' LEU . 11.5 p -125.23 25.5 7.15 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.885 174.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 24.1 m -82.01 145.29 30.32 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.156 175.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.93 -18.17 57.2 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -173.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 59.9 mtt -91.46 138.81 31.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.936 -0.632 . . . . 0.0 109.317 176.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -133.35 153.61 51.43 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -58.13 134.63 56.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.971 0.415 . . . . 0.0 111.366 -175.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 99.6 14.45 34.87 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.296 -177.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.401 ' H ' HG13 ' A' ' 297' ' ' VAL . 0.6 OUTLIER -109.45 175.59 5.39 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.8 0.3 . . . . 0.0 110.224 179.487 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.446 ' HD3' ' HB ' ' A' ' 294' ' ' THR . 5.2 tmmm? -127.09 117.49 22.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.564 -174.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 31.0 pt -111.65 142.57 23.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.906 -177.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 14.8 m -124.55 138.55 54.32 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.507 -178.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -100.87 112.0 24.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.485 -178.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.96 116.56 9.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.97 -178.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.19 -34.22 5.3 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 60.2 t -89.06 122.09 39.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 175.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -139.88 158.38 44.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.043 0.449 . . . . 0.0 111.608 -176.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -73.48 145.41 45.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.155 -173.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 77.2 mt -69.77 141.32 53.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.359 176.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.46 -22.59 15.59 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.344 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.608 ' O ' ' HA ' ' A' ' 290' ' ' ALA . 11.8 mm100 -91.2 25.96 2.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.678 0.275 . . . . 0.0 111.109 -176.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 54.9 mtt -108.26 -22.51 12.32 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 172.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -88.53 -55.65 3.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.307 177.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -64.86 -59.87 3.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.567 177.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 283' ' ' GLN . 14.4 m120 -81.01 101.57 9.63 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 171.486 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 64.1 t -61.81 -33.77 59.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.994 -177.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 74.0 mt -92.9 -2.58 55.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.806 177.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 283' ' ' GLN . . . 63.65 168.56 0.15 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.41 -178.381 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -130.69 126.33 36.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.395 176.036 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.2 157.61 37.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.056 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.547 ' HB3' ' CE2' ' A' ' 295' ' ' PHE . . . -60.39 102.56 0.18 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.526 -170.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.446 ' HB ' ' HD3' ' A' ' 272' ' ' LYS . 19.7 p -95.19 111.19 23.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.603 177.045 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.547 ' CE2' ' HB3' ' A' ' 293' ' ' ALA . 65.1 m-85 -123.68 150.53 44.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.859 0.362 . . . . 0.0 110.897 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 16.2 m -96.06 134.03 39.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.255 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.401 HG13 ' H ' ' A' ' 271' ' ' ASP . 9.5 p -86.98 135.53 24.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.964 0.411 . . . . 0.0 110.359 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.492 HG22 ' CE1' ' A' ' 256' ' ' PHE . 46.0 t -105.48 -31.5 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.274 -176.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -162.27 138.4 7.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.826 0.346 . . . . 0.0 110.593 -178.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 89.3 t -92.4 114.23 28.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.83 -59.29 3.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.842 -172.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.77 -2.47 10.91 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.873 0.368 . . . . 0.0 111.794 -174.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.08 11.71 83.84 Favored Glycine 0 N--CA 1.459 0.2 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -174.075 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 5.9 p -150.75 23.03 0.78 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 173.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.441 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.2 t-160 -167.78 112.75 0.68 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 113.594 -1.639 . . . . 0.0 107.896 -165.454 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.27 169.89 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.559 -174.174 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 10.9 pt-20 -128.22 121.74 30.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.215 0.531 . . . . 0.0 109.931 169.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 22.7 pt -120.98 174.65 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.143 -177.136 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.7 t -155.19 147.06 17.18 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.121 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -69.23 179.94 19.86 Favored 'Cis proline' 0 C--N 1.349 0.567 0 C-N-CA 124.163 -1.182 . . . . 0.0 113.162 -2.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 24.1 ttmm -82.26 124.81 78.02 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.212 -177.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 13.3 Cg_exo -69.25 109.89 2.32 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.84 2.36 . . . . 0.0 112.606 177.106 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.488 ' CG2' ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -126.04 130.69 72.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.905 174.161 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -95.32 143.7 26.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.272 0.558 . . . . 0.0 111.506 -175.431 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -76.43 -26.5 55.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.101 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -98.05 26.0 5.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.647 178.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . 0.481 ' HB2' ' HB1' ' A' ' 314' ' ' ALA . 20.3 t70 -86.14 131.3 34.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.528 -179.412 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 11.3 p -84.49 -18.53 9.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.946 -176.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 19.7 m -91.77 5.11 51.09 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -168.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.429 ' HB3' ' HE3' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -115.67 157.53 24.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.365 0.602 . . . . 0.0 112.056 -179.378 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 16.9 m -86.55 158.47 54.28 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.552 177.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.547 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 61.9 Cg_exo -39.66 -49.78 3.27 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.434 3.423 . . . . 0.0 114.882 -176.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.9 -39.39 85.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.849 0.357 . . . . 0.0 111.68 -177.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -72.71 -29.57 63.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -172.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 9.7 ptm180 -76.14 -18.77 58.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.449 0.642 . . . . 0.0 109.862 178.43 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.79 -21.7 61.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.78 172.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -96.74 1.24 50.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.706 175.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.488 ' HA ' ' CG2' ' A' ' 313' ' ' VAL . . . -59.09 144.43 45.56 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.551 179.412 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -118.17 -27.28 6.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.436 -176.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.8 m -119.31 170.89 8.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.685 0.278 . . . . 0.0 111.218 -177.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -82.71 -53.97 5.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.922 -176.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.4 t -114.91 145.28 42.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.066 0.46 . . . . 0.0 110.876 -171.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.0 m -75.23 154.62 37.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.438 178.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.1 103.34 2.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.653 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -95.76 162.33 13.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.958 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . 0.416 ' HA ' HG13 ' A' ' 230' ' ' VAL . 38.4 t70 -75.21 62.72 1.27 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.097 0.475 . . . . 0.0 112.1 -174.143 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -176.6 33.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.696 171.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 338' ' ' MET . . . . . 0.472 ' H ' HG11 ' A' ' 230' ' ' VAL . 23.9 mmt -104.54 130.7 52.48 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -83.63 135.1 34.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.607 178.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.528 ' O ' ' HB ' ' A' ' 228' ' ' ILE . 22.0 t -112.22 115.05 48.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.525 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -132.6 135.2 45.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.875 0.369 . . . . 0.0 111.6 -174.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 45.8 mt -84.29 123.59 39.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.855 174.072 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . 0.423 HD11 ' HE3' ' A' ' 272' ' ' LYS . 51.3 mt -80.04 112.31 17.22 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.846 178.839 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -86.25 146.52 26.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.526 -178.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 51.4 t . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.537 -0.744 . . . . 0.0 110.289 -178.727 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 14.3 p -93.75 38.92 1.06 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.052 0.453 . . . . 0.0 110.963 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.6 m -80.76 60.73 4.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.426 0.631 . . . . 0.0 110.293 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -118.27 129.6 55.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.217 -179.316 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.415 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 16.3 p -121.67 -92.37 0.54 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.383 -178.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 60.45 36.98 92.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.7 -177.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 58.6 mt -91.17 144.04 9.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -176.151 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 13.4 p -96.65 153.26 17.96 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.555 0.693 . . . . 0.0 111.998 -172.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 335' ' ' ALA . 8.6 p -67.06 151.09 10.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.052 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 71.5 m -113.75 82.0 1.62 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.919 0.39 . . . . 0.0 110.463 177.104 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 95.34 147.57 22.85 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.013 -179.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -82.59 139.07 34.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.839 0.352 . . . . 0.0 111.116 -177.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -141.38 135.18 30.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.251 0.548 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.9 p -139.87 103.07 4.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.245 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -115.38 153.95 30.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.352 -177.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -108.63 138.76 20.35 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.077 177.316 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.03 147.23 38.18 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.677 2.251 . . . . 0.0 112.112 -179.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.411 ' O ' HG11 ' A' ' 239' ' ' VAL . 4.3 p -67.82 101.08 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.552 0.691 . . . . 0.0 110.829 179.309 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.34 152.69 45.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.631 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -92.58 96.33 10.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.556 -178.006 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . 0.445 ' HB3' ' H ' ' A' ' 243' ' ' LEU . 2.5 mp0 -81.26 -153.29 0.1 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.504 174.639 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.445 ' H ' ' HB3' ' A' ' 242' ' ' GLN . 87.8 mt -82.0 177.56 8.77 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.418 177.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.39 -61.0 2.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.947 0.403 . . . . 0.0 110.338 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -70.86 -41.49 71.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.21 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -105.44 75.96 1.18 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.291 176.226 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -168.68 -125.22 0.77 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.041 -179.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -147.35 119.71 8.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.401 0.62 . . . . 0.0 111.05 179.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -105.06 69.93 0.88 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.555 176.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.9 m -101.1 150.46 5.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.402 -174.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -105.72 24.12 12.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.424 0.63 . . . . 0.0 110.305 178.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 25.1 m -120.27 144.01 30.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.092 178.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.37 82.7 5.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.351 0.596 . . . . 0.0 111.492 -177.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -77.5 4.95 9.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.71 176.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.469 ' HD2' ' H ' ' A' ' 255' ' ' ARG . 1.8 mpt_? -74.36 -40.08 62.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.353 -178.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -78.83 147.53 33.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.725 -175.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.55 124.87 46.7 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.343 178.269 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.3 m -93.37 101.41 13.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.302 0.572 . . . . 0.0 110.363 -179.374 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -82.97 122.92 38.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.146 -173.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 29.8 m -98.01 106.43 18.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.36 0.6 . . . . 0.0 110.299 179.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 16.5 mt -125.08 164.56 19.94 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.727 -174.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 51.1 m -58.54 -54.75 43.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.198 0.523 . . . . 0.0 109.927 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -136.78 130.66 32.25 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.258 178.304 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 10.5 p -126.37 25.94 6.49 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.7 m -79.68 143.13 34.88 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.69 -1.595 . . . . 0.0 109.819 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 99.29 -19.76 52.64 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -175.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 85.2 mtp -75.72 152.56 37.44 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -154.83 147.26 24.03 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -178.232 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.419 ' HA ' HG11 ' A' ' 297' ' ' VAL . 32.1 ptt180 -51.9 114.43 1.3 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.366 0.603 . . . . 0.0 111.15 -176.066 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 116.33 6.13 15.94 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.557 -174.078 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -88.7 179.84 6.16 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 117.094 0.447 . . . . 0.0 110.928 176.067 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.522 ' HB2' ' HZ1' ' A' ' 272' ' ' LYS . 0.2 OUTLIER -141.45 117.18 10.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.647 -178.115 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 21.9 pt -113.22 139.95 35.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.026 0.441 . . . . 0.0 110.876 -178.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 69.9 p -120.88 133.99 55.3 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.706 176.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.437 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 95.5 m-85 -94.11 111.46 23.18 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.179 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.463 ' HA ' ' OD1' ' A' ' 292' ' ' ASP . . . -66.0 111.53 3.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.02 -177.671 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.22 -35.3 4.73 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.7 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 83.9 t -82.62 129.69 37.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 173.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.413 ' HD2' ' SD ' ' A' ' 284' ' ' MET . 10.0 ptpp? -148.35 160.23 43.21 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.26 -175.542 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -77.08 150.94 35.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.931 -178.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.0 130.58 47.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.765 177.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 124.39 -5.32 8.74 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 -177.464 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.422 ' C ' ' H ' ' A' ' 285' ' ' ALA . 68.7 mt-30 -110.03 164.06 12.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.587 -0.306 . . . . 0.0 110.224 178.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.413 ' SD ' ' HD2' ' A' ' 279' ' ' LYS . 90.7 mtp 71.76 -31.33 0.22 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.574 0.75 . . . . 0.0 112.766 176.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.422 ' H ' ' C ' ' A' ' 283' ' ' GLN . . . -58.51 -40.49 83.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.074 0.464 . . . . 0.0 110.84 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -142.91 -36.29 0.39 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.07 176.596 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -79.89 113.95 18.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.713 179.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 23.1 t -77.69 -32.05 17.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.231 0.539 . . . . 0.0 109.641 177.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 86.1 mt -75.69 92.87 3.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.817 176.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -108.9 123.69 49.48 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.516 -171.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -87.04 127.9 35.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.426 -179.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.463 ' OD1' ' HA ' ' A' ' 276' ' ' ALA . 57.3 m-20 -62.9 146.93 51.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.182 -178.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -58.66 108.97 0.71 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.607 -175.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.3 p -91.49 118.17 30.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.164 -178.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.67 148.25 48.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.225 177.473 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 25.4 m -98.67 136.73 38.32 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.603 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 269' ' ' ARG . 8.7 p -67.56 142.56 16.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.449 178.566 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.2 t -105.74 -45.03 8.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.742 173.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -154.94 139.36 16.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.637 179.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 77.3 t -86.05 109.23 18.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 171.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 31.9 t -76.45 -58.26 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.821 -172.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -122.58 -2.7 8.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.866 0.365 . . . . 0.0 111.318 -176.085 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 72.18 12.88 76.37 Favored Glycine 0 CA--C 1.518 0.268 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -172.056 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 4.4 p -149.11 21.75 0.97 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.176 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.9 t-160 -173.41 115.73 0.25 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 113.833 -1.531 . . . . 0.0 107.667 -167.326 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.64 162.67 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -173.63 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 10.1 pt-20 -123.19 126.11 46.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.113 0.482 . . . . 0.0 110.189 171.744 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 25.5 pt -125.24 168.8 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.38 -176.031 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 6.0 t -140.59 138.47 18.68 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.802 176.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.04 179.45 25.95 Favored 'Cis proline' 0 C--N 1.344 0.318 0 C-N-CA 123.364 -1.515 . . . . 0.0 112.411 -1.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.518 ' HZ3' ' HB2' ' A' ' 311' ' ' LYS . 3.0 ttmp? -80.12 123.57 83.31 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.384 177.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 15.0 Cg_exo -67.85 113.36 2.97 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.821 2.348 . . . . 0.0 112.647 178.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.449 HG21 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -117.32 128.96 74.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.125 174.817 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -81.19 130.62 35.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.261 0.553 . . . . 0.0 111.201 -178.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . 0.408 HD11 ' O ' ' A' ' 315' ' ' LEU . 3.0 tm? -65.18 -27.06 68.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.052 177.325 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.43 10.94 27.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.567 -178.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.68 128.96 36.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.789 0.328 . . . . 0.0 110.133 178.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.1 p -83.92 -17.89 10.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.93 0.395 . . . . 0.0 111.58 -175.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 12.3 m -79.06 -36.33 41.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.489 -173.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.475 ' CD1' ' HB3' ' A' ' 325' ' ' ARG . 1.5 pp -72.25 162.53 29.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.448 0.642 . . . . 0.0 112.141 -178.522 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.462 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 12.5 m -108.26 173.87 2.78 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.697 -179.009 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 72.8 Cg_exo -44.19 -53.17 4.98 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 123.429 2.753 . . . . 0.0 114.987 -173.172 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -62.96 -39.12 93.72 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.071 -176.425 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -65.38 -41.37 93.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.452 -179.006 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.475 ' HB3' ' CD1' ' A' ' 320' ' ' LEU . 5.4 ppt_? -74.68 -19.0 60.44 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.972 179.132 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.78 -18.39 62.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.202 173.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -103.21 -0.61 30.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.485 176.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.449 ' HA ' HG21 ' A' ' 313' ' ' VAL . . . -62.27 127.33 30.84 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.774 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -106.5 -26.61 11.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.493 -176.001 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 27.0 m -116.29 161.45 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.0 110.858 -177.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -89.18 -16.75 30.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.109 -177.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.3 t -143.01 139.46 30.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.967 0.413 . . . . 0.0 111.002 -178.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.411 ' N ' ' HB2' ' A' ' 314' ' ' ALA . 20.2 m -74.56 174.56 8.83 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.431 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 19.1 tp -78.05 102.89 7.66 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.641 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -84.04 169.29 15.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.147 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -81.36 32.26 0.34 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -171.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.94 48.57 0.39 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.059 0.457 . . . . 0.0 110.841 174.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 338' ' ' MET . . . . . 0.409 ' H ' HG11 ' A' ' 230' ' ' VAL . 26.2 mmt -110.68 137.66 48.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.243 179.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.48 132.58 40.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.946 0.403 . . . . 0.0 110.874 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 31.8 t -102.83 114.36 42.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.897 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . 0.415 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 8.4 t30 -126.07 124.46 40.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.398 -176.32 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 32.3 mt -77.65 128.54 38.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.921 172.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 74.9 mt -71.32 111.31 6.55 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -102.03 77.9 1.74 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.909 -177.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 36.6 t . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.725 178.864 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.86 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.544 ' HB2' ' O ' ' A' ' 266' ' ' GLY . 20.6 p -89.61 50.93 1.98 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.189 0.518 . . . . 0.0 111.438 -175.389 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 12.5 t -131.12 17.03 5.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.505 0.669 . . . . 0.0 109.879 176.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -125.92 102.46 7.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.921 179.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 11.7 p -90.01 -77.58 0.39 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.011 -176.378 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 63.07 33.66 87.86 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.769 -176.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 263' ' ' ALA . 51.4 mt -102.99 149.96 6.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -175.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.88 148.07 32.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.812 0.339 . . . . 0.0 110.487 177.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 335' ' ' ALA . 8.9 p -53.97 151.75 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.589 178.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.439 ' HB2' ' N ' ' A' ' 262' ' ' SER . 9.4 t -100.79 69.57 1.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.068 0.461 . . . . 0.0 110.026 178.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 89.52 166.16 41.57 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.013 -178.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.11 117.49 10.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.995 0.426 . . . . 0.0 110.756 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -114.77 126.43 54.83 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.967 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 57.2 p -125.27 149.57 47.9 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.152 -178.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -125.75 154.87 41.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.631 -178.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -143.02 138.42 15.77 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.159 177.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.488 ' HD2' ' OE1' ' A' ' 324' ' ' GLN . 5.5 Cg_endo -84.91 118.02 2.01 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 121.766 1.644 . . . . 0.0 110.602 171.55 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.45 83.27 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.388 0.613 . . . . 0.0 109.8 -178.276 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -114.5 135.66 53.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.134 176.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -88.79 36.69 0.81 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.367 0.603 . . . . 0.0 110.581 -177.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 63.77 -168.55 0.2 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.373 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 94.4 mt 70.49 -73.14 0.1 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.789 0.681 . . . . 0.0 111.577 178.529 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -147.08 168.36 21.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.918 0.39 . . . . 0.0 111.043 -174.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -69.72 -16.26 63.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.104 176.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -93.97 23.99 4.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.248 175.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.85 -34.5 15.24 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.729 177.316 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -97.84 124.13 42.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.226 0.536 . . . . 0.0 110.403 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -80.2 -13.22 59.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.784 -175.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.6 m -67.21 125.74 25.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.136 0.494 . . . . 0.0 110.513 176.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -112.51 139.15 48.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.241 -173.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 20.6 t 59.0 75.38 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.535 176.475 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -169.21 -46.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.036 176.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -76.74 -22.98 53.07 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -174.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -81.53 -2.3 49.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.123 0.487 . . . . 0.0 110.11 175.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.425 ' CD2' ' HB ' ' A' ' 309' ' ' THR . 78.8 m-85 -121.26 160.21 24.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.814 -179.244 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -136.33 132.79 36.11 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.702 0.286 . . . . 0.0 110.771 178.194 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.7 m -98.94 103.05 14.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.109 0.481 . . . . 0.0 110.069 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.51 125.81 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.744 -171.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 23.5 m -93.4 106.15 18.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.193 175.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.417 ' HB2' ' CG2' ' A' ' 264' ' ' THR . 19.6 mt -126.0 160.62 29.56 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -177.388 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.468 ' O ' HG22 ' A' ' 304' ' ' THR . 15.9 p -61.57 -48.09 82.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.147 0.499 . . . . 0.0 110.127 -178.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.44 ' O ' HG23 ' A' ' 228' ' ' ILE . . . -136.72 138.33 40.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.294 175.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.417 ' CG2' ' HB2' ' A' ' 261' ' ' LEU . 9.4 p -134.61 28.45 3.62 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.503 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.6 m -78.07 145.02 36.07 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.486 -178.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 223' ' ' SER . . . 97.08 -4.12 62.55 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.428 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 62.0 mtt -93.58 158.57 15.63 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 178.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.422 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 25.1 pttm -150.08 163.8 37.24 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.594 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -56.07 123.99 16.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.068 0.461 . . . . 0.0 110.791 -178.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 98.72 18.25 25.89 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.418 178.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.422 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 0.3 OUTLIER -99.1 160.22 14.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.634 0.717 . . . . 0.0 110.127 179.056 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -108.96 117.07 33.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.834 -175.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.405 HD11 HG23 ' A' ' 308' ' ' ILE . 36.8 pt -117.91 140.7 40.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.234 0.54 . . . . 0.0 110.407 177.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 39.0 t -126.97 153.81 45.38 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.371 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -117.46 111.69 19.63 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.08 117.73 5.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.234 -177.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.03 -34.7 5.06 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 96.3 t -88.37 114.44 26.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.412 ' HD2' ' SD ' ' A' ' 284' ' ' MET . 9.0 ptpp? -137.12 157.15 47.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.962 0.411 . . . . 0.0 111.035 -175.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.408 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 63.0 m-85 -76.6 135.9 39.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.029 -176.239 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 68.9 mt -65.73 133.48 51.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.974 175.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 121.89 -16.21 8.87 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -171.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.402 ' OE1' ' HB2' ' A' ' 279' ' ' LYS . 98.0 mt-30 -92.23 -169.08 2.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.921 -0.639 . . . . 0.0 109.698 174.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.412 ' SD ' ' HD2' ' A' ' 279' ' ' LYS . 75.9 mtm 63.63 17.58 10.51 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.735 176.671 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -101.99 -51.04 3.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.3 0.572 . . . . 0.0 109.57 174.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -130.33 32.05 4.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.281 176.104 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -114.97 108.75 17.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.604 -175.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 43.4 t -67.78 -62.29 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.162 -176.123 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 82.2 mt -93.64 -32.56 14.03 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 176.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . 61.24 107.19 0.02 OUTLIER 'General case' 0 C--O 1.236 0.37 0 O-C-N 124.169 0.918 . . . . 0.0 112.218 178.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -65.46 122.44 17.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.396 0.617 . . . . 0.0 109.749 176.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -66.71 167.91 10.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.265 -175.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.408 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -49.61 110.07 0.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.621 -175.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 4.9 p -100.49 120.5 40.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.08 -178.249 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -122.44 151.28 41.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.629 -178.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.8 m -98.32 130.59 45.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.211 178.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 14.1 p -80.83 132.08 32.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.322 0.582 . . . . 0.0 110.629 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 37.3 t -91.53 -33.9 5.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.317 -178.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -166.37 139.9 4.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.418 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 57.5 t -88.32 107.36 17.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 169.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 39.9 t -68.59 -54.79 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.874 -172.048 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -128.5 -6.42 5.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.154 0.502 . . . . 0.0 111.514 -174.156 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.04 12.67 80.69 Favored Glycine 0 N--CA 1.457 0.095 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -176.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 304' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 262' ' ' SER . 0.7 OUTLIER -150.65 20.84 0.81 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.229 1.014 . . . . 0.0 108.304 175.03 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -172.02 115.07 0.34 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.35 -171.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.89 162.59 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.514 -172.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -119.79 120.04 35.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.052 0.453 . . . . 0.0 110.014 171.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.405 HG23 HD11 ' A' ' 273' ' ' ILE . 27.6 pt -119.87 171.59 8.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.047 -177.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 309' ' ' THR . . . . . 0.425 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 12.7 t -150.05 142.2 15.51 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.235 175.342 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.18 -179.53 27.42 Favored 'Cis proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.764 -1.348 . . . . 0.0 113.135 -1.563 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -78.85 121.39 83.39 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.161 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.25 109.5 1.78 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.697 2.265 . . . . 0.0 111.902 175.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.3 OUTLIER -130.2 127.3 62.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.58 178.161 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -77.26 129.2 35.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.195 -177.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 44.6 tp -73.86 -26.4 60.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.664 178.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -86.25 3.97 40.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.266 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -65.61 125.09 24.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.119 177.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 31.3 m -84.46 -6.42 10.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 17.3 m -91.49 -29.25 17.11 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.61 0.243 . . . . 0.0 111.248 -173.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 1.7 pp -73.4 167.38 21.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.405 0.622 . . . . 0.0 111.79 -179.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.407 ' H ' ' NE2' ' A' ' 324' ' ' GLN . 5.8 m -99.23 160.96 26.25 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.198 -177.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.435 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 46.5 Cg_exo -39.97 -52.94 2.61 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.578 2.852 . . . . 0.0 114.165 178.438 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -61.37 -34.02 74.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.05 0.453 . . . . 0.0 111.187 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.488 ' OE1' ' HD2' ' A' ' 238' ' ' PRO . 45.7 mt-30 -67.45 -25.07 65.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.025 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 44.8 mtm180 -63.31 -36.05 82.39 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.06 0.457 . . . . 0.0 110.042 175.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -63.54 -31.06 72.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.067 179.25 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -87.51 -10.53 51.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.392 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.465 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -69.79 146.99 51.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.699 0.285 . . . . 0.0 111.267 -177.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . 0.435 ' OD1' HG12 ' A' ' 330' ' ' VAL . 3.3 p30 -134.39 -36.6 0.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -174.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.435 HG12 ' OD1' ' A' ' 329' ' ' ASN . 34.5 m -101.75 170.1 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.935 -178.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -82.89 -47.4 11.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.886 0.374 . . . . 0.0 110.83 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 72.1 p -124.72 141.48 52.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.768 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 34.9 m -70.66 171.81 9.75 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.091 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 20.5 tp -71.72 103.12 2.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.093 0.473 . . . . 0.0 110.065 -175.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.572 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -91.51 -177.89 4.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.331 179.303 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -73.53 151.02 41.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.937 0.399 . . . . 0.0 110.867 -178.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 66.15 29.01 10.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.198 179.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.7 mmt -88.67 127.02 35.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -82.7 130.68 35.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.989 0.423 . . . . 0.0 111.323 -176.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 13.8 t -92.36 120.08 40.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.427 178.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -125.96 128.4 47.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.119 -175.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 9.6 mt -93.6 134.1 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 172.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 69.8 mt -72.49 122.38 21.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.145 179.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -76.65 77.58 3.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 -176.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 C--O 1.25 1.083 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.567 177.16 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.9 p -73.26 -20.02 60.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.029 0.414 . . . . 0.0 111.416 -177.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 22.5 p -87.61 -2.58 58.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.106 0.479 . . . . 0.0 110.594 176.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -99.7 136.65 39.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.433 176.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 20.0 p -91.78 -89.53 0.18 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.717 -177.305 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 60.55 54.98 32.6 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.897 -178.253 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 263' ' ' ALA . 55.9 mt -102.11 146.26 10.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 7.7 p -97.7 147.35 24.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.536 0.684 . . . . 0.0 111.903 -177.424 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.638 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.7 p -59.81 150.94 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.708 -178.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.9 t -97.96 74.63 2.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 79.99 158.69 16.89 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.596 179.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.51 146.58 53.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.709 0.29 . . . . 0.0 110.431 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -155.93 136.3 13.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.155 0.503 . . . . 0.0 110.721 -179.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.1 p -118.97 122.1 41.45 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.805 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.53 ' O ' HG13 ' A' ' 313' ' ' VAL . 54.3 m-85 -88.74 147.59 24.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.394 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.43 ' HD2' ' HB3' ' A' ' 320' ' ' LEU . 34.4 mmtp -127.28 139.85 36.3 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.023 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -91.04 163.64 3.85 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.922 2.415 . . . . 0.0 110.993 173.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.65 121.02 62.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.163 0.506 . . . . 0.0 110.192 177.562 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -125.29 79.73 1.83 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.215 178.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 43.0 t-105 175.59 135.3 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.782 -176.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -72.29 103.98 3.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.15 0.5 . . . . 0.0 110.03 176.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 16.3 tp -140.08 114.61 9.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.909 -175.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -141.87 -36.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.84 0.353 . . . . 0.0 111.59 -176.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -67.81 -55.02 14.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.835 0.35 . . . . 0.0 110.969 -178.136 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -134.64 162.04 33.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.078 -178.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.92 -60.23 4.82 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.4 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -137.2 136.43 38.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -120.04 -49.55 2.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.906 0.384 . . . . 0.0 110.223 178.071 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.8 m -96.87 115.73 37.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.265 0.555 . . . . 0.0 110.946 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -114.65 85.01 2.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.041 177.408 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.401 ' O ' HG21 ' A' ' 252' ' ' VAL . 12.4 p -138.08 28.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 122.906 1.336 . . . . 0.0 109.077 177.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -133.98 13.71 3.95 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.22 -177.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -92.92 -43.2 9.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.232 178.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -81.5 -11.97 59.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.801 177.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -114.76 160.36 19.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.455 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -140.08 131.63 27.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.192 175.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.3 OUTLIER -101.02 102.6 13.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.093 0.473 . . . . 0.0 110.226 179.862 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.443 ' O ' ' HD2' ' A' ' 305' ' ' HIS . 3.3 t -82.48 120.87 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.059 -172.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 9.6 m -91.2 105.51 17.85 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.197 -179.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 19.3 mt -126.61 163.71 22.85 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -175.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 10.4 t -63.18 -49.17 75.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.191 0.52 . . . . 0.0 109.704 -178.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.452 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -137.08 138.22 40.14 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.333 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 15.8 p -130.51 25.22 5.11 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.84 0.828 . . . . 0.0 109.087 175.626 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.2 m -76.64 147.48 37.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.295 175.134 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.0 -18.82 56.57 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -175.021 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 56.8 mtt -87.03 139.58 30.43 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 11.5 ptmm? -143.75 145.46 32.41 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.035 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -46.34 122.6 4.14 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.921 0.763 . . . . 0.0 112.891 -170.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 98.36 18.85 24.99 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.689 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 268' ' ' LYS . 1.1 t70 -100.08 -176.92 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.926 0.393 . . . . 0.0 110.749 -176.513 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.444 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 3.7 tppp? -122.69 116.27 23.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.225 -175.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 308' ' ' ILE . 17.9 pt -120.21 139.9 46.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 120.916 0.389 . . . . 0.0 110.326 175.652 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 54.8 p -124.1 141.06 52.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.008 179.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -107.47 111.06 23.18 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.874 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.47 119.24 10.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.605 -178.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.26 -34.1 5.35 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.137 -0.554 . . . . 0.0 111.794 -178.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 70.6 t -90.93 137.15 22.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 177.044 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 279' ' ' LYS . 8.3 ptpt -159.97 160.79 33.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.076 0.465 . . . . 0.0 111.548 178.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -78.37 154.25 30.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.729 -172.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 65.8 mt -68.27 146.33 53.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.456 179.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.1 -19.89 36.22 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.138 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -78.39 -13.91 59.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.063 0.459 . . . . 0.0 110.455 -178.392 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 36.4 mtm -117.17 42.11 2.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.115 -179.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -69.56 -56.64 6.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.881 -177.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -132.03 -29.64 1.64 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.419 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -83.31 126.08 32.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.4 178.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 24.4 t -83.31 -24.04 8.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.443 178.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 90.2 mt -78.25 70.21 4.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.582 175.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -94.97 127.08 40.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.136 -176.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -60.52 134.34 56.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.695 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -71.14 153.18 42.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.131 -178.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -59.14 111.19 1.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.048 -172.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.444 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 0.8 OUTLIER -94.3 123.39 37.67 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.795 176.32 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -121.39 148.57 44.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.407 178.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.6 m -91.62 122.22 33.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.722 178.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 271' ' ' ASP . 11.3 p -73.21 121.5 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.388 0.613 . . . . 0.0 110.112 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.2 t -84.53 -41.59 16.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.447 -178.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.516 ' HD2' ' OE2' ' A' ' 307' ' ' GLU . 0.9 OUTLIER -165.55 136.22 3.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.825 -175.749 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 84.4 t -90.17 111.77 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.416 175.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 14.9 t -78.09 -58.94 3.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.78 -173.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -116.87 -3.39 11.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.904 0.383 . . . . 0.0 111.8 -172.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 69.3 12.86 66.75 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -170.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.8 p -145.6 16.79 1.47 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 174.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.443 ' HD2' ' O ' ' A' ' 259' ' ' VAL . 5.6 t-160 -170.89 118.32 0.49 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.631 -1.168 . . . . 0.0 107.865 -170.316 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -118.73 156.97 20.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -173.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.516 ' OE2' ' HD2' ' A' ' 299' ' ' ARG . 10.8 pt-20 -114.26 122.14 45.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.126 0.488 . . . . 0.0 109.864 171.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.435 HG21 HD13 ' A' ' 273' ' ' ILE . 33.6 pt -118.88 175.01 4.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.232 -177.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 15.1 t -154.23 138.34 11.06 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.071 174.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.61 -178.94 25.51 Favored 'Cis proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.909 -1.288 . . . . 0.0 112.806 -1.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 22.0 ttmm -80.24 131.28 62.83 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.044 -179.146 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 3.7 Cg_exo -75.73 108.44 2.69 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.249 1.966 . . . . 0.0 111.496 173.614 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 236' ' ' PHE . 1.0 OUTLIER -126.02 136.58 60.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.106 177.557 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -91.95 138.03 31.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.348 0.594 . . . . 0.0 112.292 -170.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 315' ' ' LEU . 3.3 tm? -80.77 -31.73 35.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.185 178.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -85.38 8.18 19.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.265 -177.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . 0.492 ' OD2' ' HG ' ' A' ' 320' ' ' LEU . 23.5 t70 -83.22 129.52 35.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.203 179.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 11.9 p -84.8 -19.62 8.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.804 0.335 . . . . 0.0 111.268 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 36.8 t -69.66 -42.97 73.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.36 -172.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.492 ' HG ' ' OD2' ' A' ' 317' ' ' ASP . 0.4 OUTLIER -76.92 152.08 35.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.485 0.659 . . . . 0.0 111.165 176.426 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 18.1 m -86.1 163.18 44.02 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.151 -173.526 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 41.6 Cg_exo -37.59 -54.37 1.25 Allowed 'Trans proline' 0 C--N 1.356 0.974 0 C-N-CA 124.306 3.337 . . . . 0.0 114.889 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -64.96 -34.04 77.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.945 0.402 . . . . 0.0 111.235 -176.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -69.18 -32.74 72.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.032 0.444 . . . . 0.0 109.906 177.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.485 ' HG2' HD13 ' A' ' 320' ' ' LEU . 98.2 mtt180 -65.7 -26.71 67.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.744 175.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -72.64 -20.19 61.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.143 0.496 . . . . 0.0 110.609 176.399 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -97.56 -0.36 45.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.738 176.086 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.513 ' HA ' HG22 ' A' ' 313' ' ' VAL . . . -65.8 132.7 49.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.005 0.431 . . . . 0.0 111.078 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . 0.424 ' H ' HG22 ' A' ' 313' ' ' VAL . 91.5 m-20 -108.29 -32.17 7.58 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.901 -172.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.59 172.83 6.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.668 -177.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -86.23 -48.68 8.33 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.647 0.26 . . . . 0.0 111.452 -178.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.7 t -118.32 149.72 40.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.038 0.447 . . . . 0.0 110.875 -175.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 28.7 p -79.75 174.21 11.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.815 176.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.9 tp -78.27 103.7 8.37 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -176.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.638 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.52 174.69 11.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.743 -178.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -81.55 10.41 5.96 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.178 0.806 . . . . 0.0 113.178 -168.254 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -141.01 33.58 1.75 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.915 0.388 . . . . 0.0 111.318 177.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 14.3 mmt -86.19 131.75 34.17 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -86.18 130.87 34.38 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.774 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 18.1 t -104.75 111.64 35.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.829 178.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -126.04 136.65 53.2 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.67 -177.226 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 17.7 mt -85.25 121.15 36.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.924 0.393 . . . . 0.0 110.64 175.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 41.1 mt -91.53 120.94 32.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.788 175.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -138.93 127.29 22.88 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.131 -178.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.421 -0.799 . . . . 0.0 109.722 178.932 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.824 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 34.1 p -153.26 -49.78 0.1 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.968 0.413 . . . . 0.0 110.397 -178.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 16.8 p -109.34 126.32 53.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.001 178.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 59.35 57.61 3.31 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.142 178.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 29.8 p -67.35 -35.82 80.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.124 179.375 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 52.76 53.23 34.03 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.644 176.517 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.556 HD11 ' O ' ' A' ' 263' ' ' ALA . 42.6 mm -102.85 140.22 21.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -177.504 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.3 p -121.5 159.34 26.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.957 0.408 . . . . 0.0 110.808 175.18 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.606 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.0 p -80.78 150.4 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.236 177.372 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 75.1 m -116.1 86.26 2.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.219 0.533 . . . . 0.0 110.423 176.004 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 94.51 138.55 9.38 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.398 179.592 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.29 132.09 46.5 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.002 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -141.6 127.36 19.2 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.425 0.631 . . . . 0.0 111.067 -175.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.9 p -117.87 114.61 23.5 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.129 179.095 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -81.1 164.02 22.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.075 -178.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . 44.8 mmtm -135.78 130.76 18.84 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.85 0.357 . . . . 0.0 111.348 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.466 ' HA ' ' OD1' ' A' ' 254' ' ' ASN . 71.7 Cg_endo -90.69 127.88 1.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.885 2.39 . . . . 0.0 111.685 177.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 14.1 p -80.39 140.9 16.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 120.901 0.381 . . . . 0.0 110.45 -179.057 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -96.4 167.27 11.27 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.19 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -77.26 -34.61 55.72 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -67.53 102.53 1.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.182 173.026 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 37.8 tp -176.12 82.98 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.049 -175.059 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -94.13 -12.91 27.43 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.859 -176.658 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -87.84 -17.44 31.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.302 -179.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -144.49 152.17 40.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.879 0.371 . . . . 0.0 110.831 -174.762 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -109.9 49.95 0.81 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.609 -178.028 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -83.93 25.45 0.81 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.615 0.721 . . . . 0.0 110.077 178.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -83.85 -58.2 2.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.223 -178.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.31 -5.3 10.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.897 0.856 . . . . 0.0 109.948 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -109.86 139.22 45.18 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.884 -179.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 89.4 t 65.1 99.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.358 0 O-C-N 123.755 0.659 . . . . 0.0 110.248 -175.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -53.12 129.35 30.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.172 -174.61 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.466 ' OD1' ' HA ' ' A' ' 238' ' ' PRO . 63.4 t30 -93.4 -23.46 18.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.201 -174.689 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -89.85 -42.09 11.45 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.761 -174.39 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.504 ' CE1' HG21 ' A' ' 298' ' ' VAL . 56.7 m-85 -103.34 121.33 42.54 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.716 -176.519 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.17 137.21 38.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.597 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.0 OUTLIER -97.69 107.15 19.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.268 0.556 . . . . 0.0 110.671 -177.889 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.455 ' HB ' HG22 ' A' ' 306' ' ' VAL . 3.1 t -89.41 124.22 42.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.408 -172.765 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 37.5 m -93.63 107.4 19.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.162 177.596 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 27.9 mt -124.64 172.12 9.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.422 -174.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.3 m -64.83 -53.69 42.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.37 0.605 . . . . 0.0 109.871 179.396 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.556 ' O ' HD11 ' A' ' 228' ' ' ILE . . . -135.95 130.56 33.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.391 179.038 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.467 ' HB ' ' CG1' ' A' ' 306' ' ' VAL . 6.9 p -129.59 22.66 5.48 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.867 0.841 . . . . 0.0 108.817 174.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 15.5 m -80.59 145.37 31.77 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.564 176.17 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.99 -9.91 61.81 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -175.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 57.9 mtt -93.88 151.8 19.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.515 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 1.9 ptpp? -147.34 157.15 43.47 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.396 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -52.36 117.23 2.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.152 0.501 . . . . 0.0 110.832 -178.074 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 106.28 18.43 11.17 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.741 -177.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.515 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 7.4 m-20 -99.78 159.16 15.27 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 117.236 0.518 . . . . 0.0 110.167 176.721 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -111.62 116.75 31.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.986 -178.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.421 HD13 HG21 ' A' ' 308' ' ' ILE . 34.6 pt -113.19 140.67 32.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.217 178.609 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 22.0 p -123.14 139.98 53.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.22 178.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.403 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 93.1 m-85 -103.57 111.34 23.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.037 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.2 113.03 4.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.146 -176.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.34 -24.98 12.97 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.641 -178.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 90.6 t -97.5 128.18 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 177.296 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.436 ' HB3' ' HA ' ' A' ' 292' ' ' ASP . 15.0 ptpt -160.46 179.73 8.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.2 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -68.56 174.89 3.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.183 -172.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 75.7 mt -71.96 -85.74 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -171.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -87.9 31.11 4.77 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.247 -0.501 . . . . 0.0 112.747 -172.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.448 ' O ' ' HB3' ' A' ' 287' ' ' ASN . 5.4 tt0 -89.36 -4.51 58.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.099 0.476 . . . . 0.0 110.022 -179.772 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 77.2 mtp -109.82 8.97 24.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.018 -174.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -62.69 -52.08 64.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.096 -177.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -130.75 -20.71 2.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.806 178.207 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 283' ' ' GLN . 49.5 t30 -81.11 96.33 7.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.125 0.488 . . . . 0.0 109.96 178.642 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 26.3 t -69.3 -32.64 54.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.93 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 96.1 mt -86.77 43.94 1.12 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.323 177.44 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.0 113.39 3.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.836 -179.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -57.49 143.26 41.29 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.771 -179.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.436 ' HA ' ' HB3' ' A' ' 279' ' ' LYS . 14.9 m-20 -73.55 161.23 30.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.779 179.284 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -64.54 105.19 0.91 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.294 -175.19 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 15.8 p -90.93 132.66 35.81 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.597 177.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 312' ' ' PRO . 97.7 m-85 -129.79 150.78 50.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.427 179.305 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 20.1 m -96.65 125.06 40.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.122 178.56 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.407 HG11 ' H ' ' A' ' 271' ' ' ASP . 12.4 p -80.82 138.07 20.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.161 0.505 . . . . 0.0 110.61 -179.484 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.504 HG21 ' CE1' ' A' ' 256' ' ' PHE . 45.3 t -104.75 -29.53 2.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.021 -178.822 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -164.1 137.2 5.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.017 0.437 . . . . 0.0 111.171 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 87.5 t -95.75 112.19 27.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 45.1 t -75.8 -58.79 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.909 -172.251 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -123.35 -3.06 8.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.298 0.57 . . . . 0.0 111.215 -175.753 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 78.37 13.87 82.8 Favored Glycine 0 C--N 1.322 -0.24 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -173.225 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 27.1 p -142.18 14.57 2.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.3 t-160 -164.02 117.45 1.44 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.491 -169.769 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.6 m -118.46 164.67 14.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -175.459 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.2 pt-20 -125.46 123.32 38.98 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 169.478 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 256' ' ' PHE . 23.4 pt -124.44 164.3 23.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.045 -173.092 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 309' ' ' THR . . . . . 0.422 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 8.2 t -135.57 140.19 33.28 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.637 174.693 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.8 179.55 30.17 Favored 'Cis proline' 0 CA--C 1.531 0.355 0 C-N-CA 123.187 -1.589 . . . . 0.0 112.655 -1.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -70.81 119.53 73.59 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.742 177.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.444 ' HD2' ' CB ' ' A' ' 257' ' ' ALA . 38.1 Cg_endo -69.5 108.94 2.14 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.436 2.091 . . . . 0.0 111.65 175.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.488 ' CG2' ' HA ' ' A' ' 328' ' ' ALA . 0.2 OUTLIER -135.43 135.31 51.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.825 -178.497 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -83.4 129.76 35.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.251 -176.516 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . 0.411 ' O ' HD11 ' A' ' 315' ' ' LEU . 3.1 tm? -68.86 -26.07 64.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.45 178.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -99.31 18.3 17.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.103 -179.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . 0.432 ' HB3' ' HG ' ' A' ' 320' ' ' LEU . 9.9 t0 -65.47 130.85 44.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.726 178.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 30.4 m -83.16 1.98 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -173.194 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 14.2 t -125.78 28.34 6.2 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.064 -0.654 . . . . 0.0 112.441 -176.086 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.468 HD12 ' HG2' ' A' ' 325' ' ' ARG . 0.7 OUTLIER -123.54 164.76 18.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.131 0.491 . . . . 0.0 111.551 175.43 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.413 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.3 m -101.92 164.92 14.88 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.678 -179.284 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 86.4 Cg_exo -44.19 -50.18 7.96 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.641 2.894 . . . . 0.0 114.537 -176.623 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -66.34 -27.7 68.09 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -177.383 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -71.6 -28.9 64.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.005 0.431 . . . . 0.0 109.976 177.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.468 ' HG2' HD12 ' A' ' 320' ' ' LEU . 55.8 mtp180 -70.82 -18.93 62.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.434 178.019 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -74.52 -32.7 62.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.288 176.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -85.51 -4.25 59.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.742 177.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.488 ' HA ' ' CG2' ' A' ' 313' ' ' VAL . . . -63.3 159.62 17.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.06 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -138.65 -49.15 0.52 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.831 0.348 . . . . 0.0 111.244 -175.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.2 m -105.72 161.67 5.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.647 -175.963 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -91.78 -5.46 53.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.01 -176.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 8.0 t -147.73 136.3 21.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.527 -176.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.1 p -80.11 163.56 24.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.365 178.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 19.2 tp -70.57 106.09 3.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.968 0.413 . . . . 0.0 110.724 -173.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.606 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -79.53 173.53 12.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.81 -178.449 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -81.05 4.04 21.16 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -166.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -143.62 45.7 1.49 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.064 0.459 . . . . 0.0 111.421 176.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 338' ' ' MET . . . . . 0.42 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 22.8 mmt -92.17 143.56 26.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.214 178.018 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.42 138.45 33.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.422 179.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 19.1 t -112.9 116.96 54.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.14 0.495 . . . . 0.0 109.91 -178.603 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -125.41 138.9 54.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.891 -175.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 21.7 mt -96.65 132.68 40.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.68 0.276 . . . . 0.0 110.452 174.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 54.9 mt -84.26 115.62 22.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.193 176.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -92.15 110.32 21.7 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.986 -0.531 . . . . 0.0 110.567 179.697 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.7 p -86.91 49.83 1.89 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.27 0.557 . . . . 0.0 110.422 178.834 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.5 m -77.81 75.99 4.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.457 -177.433 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.52 102.88 1.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.734 179.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 33.9 p -114.66 92.11 3.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.626 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.0 61.24 0.43 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 177.054 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 263' ' ' ALA . 23.7 mt -102.87 154.24 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.583 0.23 . . . . 0.0 110.841 -174.065 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 18.9 p -114.75 171.25 7.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.142 0.496 . . . . 0.0 111.571 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 335' ' ' ALA . 8.1 p -87.35 150.15 3.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.87 -178.227 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 62.2 m -114.98 91.44 3.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.827 0.346 . . . . 0.0 110.393 175.638 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 90.46 161.41 37.41 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.143 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -83.27 117.73 23.17 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.934 0.397 . . . . 0.0 110.15 178.651 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -109.07 126.37 53.09 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.097 0.475 . . . . 0.0 109.958 179.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 10.2 p -121.29 125.63 47.52 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.618 -178.318 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.576 ' HB2' ' O ' ' A' ' 312' ' ' PRO . 86.2 m-85 -109.08 145.43 35.66 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.899 -179.118 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -133.4 144.27 51.61 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.984 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.411 ' HD2' HE21 ' A' ' 324' ' ' GLN . 59.9 Cg_endo -80.4 120.82 4.12 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.169 1.912 . . . . 0.0 110.863 173.18 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.16 130.44 36.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.334 0.587 . . . . 0.0 110.631 -177.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.15 -173.77 2.38 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.169 179.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 26.9 m-90 -94.99 -19.86 19.85 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.913 0.387 . . . . 0.0 110.436 178.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -79.66 102.8 9.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 173.207 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 74.1 mt -109.85 73.13 0.83 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.235 -172.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -111.84 -3.44 14.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.145 177.825 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -73.87 -51.35 16.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.05 -178.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -159.84 -40.91 0.05 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.532 -178.533 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 134.55 165.26 10.83 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.672 175.115 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -157.63 74.99 0.77 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -97.93 6.41 47.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.418 -179.086 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 26.7 m -118.4 173.78 4.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.462 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -84.91 144.44 28.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.094 178.111 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.33 135.36 27.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.94 0.4 . . . . 0.0 110.923 -178.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -74.0 93.22 2.21 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 174.339 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -89.48 -15.74 32.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.093 -172.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -96.63 -4.45 41.02 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.966 179.71 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -126.22 133.18 51.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.532 -179.307 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -107.59 117.29 33.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.57 178.044 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 4.1 m -89.68 109.19 20.18 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.034 0.445 . . . . 0.0 110.314 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.0 t -92.73 122.27 44.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.593 -172.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 25.2 m -91.33 115.05 27.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.948 175.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 26.0 mt -132.78 172.41 12.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.273 -175.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 14.9 m -62.95 -56.48 16.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.476 0.655 . . . . 0.0 109.503 177.547 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.649 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -136.93 140.99 42.66 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.8 177.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 10.9 p -131.39 23.15 4.77 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.283 1.04 . . . . 0.0 108.205 173.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 7.6 m -77.93 142.64 38.26 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.859 -1.519 . . . . 0.0 109.649 176.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 97.96 -15.16 62.01 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -175.692 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 61.7 mtt -89.15 151.07 22.4 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -135.44 164.24 28.22 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -62.62 140.24 58.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.867 179.237 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.93 19.04 62.03 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.829 173.059 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.45 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 1.2 t70 -105.74 -166.73 1.24 Allowed 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 118.038 0.919 . . . . 0.0 110.458 -178.293 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -125.54 116.28 21.52 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.702 -178.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 19.6 pt -113.69 139.69 37.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.49 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.481 ' OG ' HG22 ' A' ' 294' ' ' THR . 2.9 m -122.19 140.39 52.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.486 -175.117 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -105.97 111.41 24.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.334 178.273 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -71.5 117.93 13.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.27 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.79 -17.55 22.76 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.611 -176.254 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.53 124.24 71.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.465 ' HZ2' ' HB3' ' A' ' 279' ' ' LYS . 1.0 OUTLIER -138.86 165.23 27.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.917 0.389 . . . . 0.0 111.757 -176.042 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -82.57 148.39 28.07 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.323 -176.226 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 284' ' ' MET . 97.3 mt -80.84 -19.7 44.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.714 -176.775 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -63.09 -18.9 60.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.95 -178.23 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 287' ' ' ASN . 28.6 tt0 -121.08 13.3 11.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.132 0.491 . . . . 0.0 110.218 179.303 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.426 ' HB2' ' HA ' ' A' ' 281' ' ' LEU . 66.7 mmm -105.45 33.89 3.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.252 -178.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -92.34 -27.54 17.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.8 0.333 . . . . 0.0 110.524 178.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -161.8 -25.03 0.05 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.8 179.808 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 283' ' ' GLN . 16.3 m120 -68.97 123.13 20.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.164 0.506 . . . . 0.0 110.754 178.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.49 -34.39 15.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.728 178.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 70.6 mt -91.42 47.03 1.34 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.674 177.702 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.418 ' HB2' ' HD3' ' A' ' 279' ' ' LYS . . . -65.4 134.68 54.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.215 -177.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -53.05 131.27 36.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.819 -178.458 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -74.01 167.93 20.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.483 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.611 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -66.77 81.84 0.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.316 -177.703 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.481 HG22 ' OG ' ' A' ' 274' ' ' SER . 12.6 p -85.07 89.69 7.68 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.309 177.485 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.611 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 51.1 m-85 -96.03 149.24 21.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.279 0.561 . . . . 0.0 111.364 -176.171 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.9 m -91.51 126.76 36.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.969 -179.458 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.45 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 8.7 p -87.77 141.52 14.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.184 -178.346 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 13.3 p -104.78 -26.01 3.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.714 179.339 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -170.34 146.82 2.94 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.931 0.396 . . . . 0.0 111.086 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.69 121.0 41.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 169.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.22 -58.03 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.932 -172.544 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -129.02 -5.23 5.01 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.285 0.564 . . . . 0.0 111.631 -175.244 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.27 12.01 81.33 Favored Glycine 0 CA--C 1.518 0.247 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -175.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 22.2 p -145.05 16.24 1.55 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 171.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.9 t-160 -169.29 117.92 0.65 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.092 -1.413 . . . . 0.0 107.59 -167.264 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.6 m -119.58 168.57 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 117.706 0.23 . . . . 0.0 110.736 -174.651 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -126.18 118.18 24.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.259 0.552 . . . . 0.0 110.026 171.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 297' ' ' VAL . 35.1 pt -119.84 174.28 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.341 -176.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.2 t -154.65 143.07 14.5 Favored Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.461 176.407 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -76.18 -179.12 25.96 Favored 'Cis proline' 0 C--N 1.345 0.344 0 C-N-CA 124.105 -1.206 . . . . 0.0 112.909 -3.076 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.432 ' HD3' ' HB3' ' A' ' 236' ' ' PHE . 2.5 ttmp? -75.09 132.1 77.46 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.12 -178.093 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.576 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 9.3 Cg_exo -71.82 108.15 2.37 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.326 2.017 . . . . 0.0 111.192 173.381 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 329' ' ' ASN . 4.4 m -130.11 128.01 64.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.788 -177.709 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 317' ' ' ASP . . . -87.66 141.56 28.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.307 0.575 . . . . 0.0 112.238 -172.728 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -81.0 -28.8 35.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.996 -179.305 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -100.31 20.66 14.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.671 -176.336 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 11.6 t70 -83.38 124.08 30.3 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.277 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 9.3 p -82.96 -11.96 12.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.874 0.369 . . . . 0.0 111.608 -175.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 15.7 m -86.66 0.74 53.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.693 -172.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 1.5 pp -106.77 169.83 8.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.829 0.347 . . . . 0.0 111.312 179.508 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 28.2 t -85.88 148.03 47.29 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.539 175.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -42.72 -43.99 8.79 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.112 2.541 . . . . 0.0 113.662 -177.683 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -61.01 -29.99 70.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.958 0.408 . . . . 0.0 111.465 -178.139 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.411 HE21 ' HD2' ' A' ' 238' ' ' PRO . 18.8 mt-30 -71.16 -25.55 62.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.509 -178.582 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -62.67 -34.99 78.24 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.214 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.37 -24.06 65.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.948 178.296 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -103.21 11.82 36.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 177.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -73.89 164.87 26.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.865 178.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . 0.416 ' N ' HG22 ' A' ' 313' ' ' VAL . 50.4 t30 -139.99 -43.53 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.606 -172.655 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.6 m -111.21 175.33 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.698 0.285 . . . . 0.0 111.02 -178.663 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -80.48 -50.22 10.35 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.699 0.285 . . . . 0.0 111.454 -177.112 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.7 t -130.91 151.83 50.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.413 -177.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 49.0 m -71.4 167.47 19.51 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 174.004 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 27.8 tp -70.91 103.71 2.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 110.147 -176.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.517 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -89.76 -170.92 2.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.194 178.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -76.86 162.48 27.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.855 0.36 . . . . 0.0 110.705 -179.336 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 58.31 45.97 16.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.089 178.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 338' ' ' MET . . . . . 0.444 ' H ' HG11 ' A' ' 230' ' ' VAL . 24.8 mmt -114.61 131.04 56.84 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.339 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -85.53 138.98 31.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.008 -179.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 14.2 t -113.12 114.47 47.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.649 178.386 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -132.22 138.49 47.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.808 0.337 . . . . 0.0 111.813 -173.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 21.4 mt -91.6 123.29 43.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.846 174.537 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 59.2 mt -79.16 139.1 38.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.282 178.809 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -71.22 110.59 5.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.849 -179.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 51.4 t . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.544 -0.741 . . . . 0.0 109.527 178.144 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.8 t -73.27 -41.1 64.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.858 0.361 . . . . 0.0 110.301 -179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 16.6 p -89.42 51.37 2.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.403 0.62 . . . . 0.0 110.744 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -86.41 98.72 11.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.778 -178.432 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 38.9 p -74.76 -59.09 2.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.341 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.82 50.92 62.45 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.359 178.3 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.485 HD12 ' O ' ' A' ' 263' ' ' ALA . 48.0 mm -89.29 144.35 9.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -178.695 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 23.2 p -122.39 156.66 33.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.297 0.57 . . . . 0.0 111.262 176.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 335' ' ' ALA . 7.1 p -73.84 151.16 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.043 179.395 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.3 t -115.37 64.62 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.208 0.528 . . . . 0.0 109.983 178.124 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 106.11 149.67 17.59 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.323 -179.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -59.37 125.49 23.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.904 0.383 . . . . 0.0 111.127 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 334' ' ' LEU . 26.3 mm-40 -113.24 126.6 55.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.961 0.41 . . . . 0.0 110.269 179.133 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 p -122.97 105.04 9.63 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.131 177.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -89.55 146.78 24.35 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.168 -173.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -144.08 121.12 6.54 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.776 178.719 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -91.38 143.08 3.02 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.777 2.318 . . . . 0.0 110.694 168.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 239' ' ' VAL . 7.3 p -78.4 84.93 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 122.255 1.026 . . . . 0.0 110.465 -179.41 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -82.26 80.87 8.35 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.571 178.121 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 15.0 t-105 -163.7 -69.96 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.148 -177.264 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 60.24 101.94 0.02 OUTLIER 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.049 179.078 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.81 157.56 32.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.666 179.594 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -56.14 -58.78 6.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.703 0.287 . . . . 0.0 110.855 -177.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -80.33 -55.08 5.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.755 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -89.14 71.93 8.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.206 0.527 . . . . 0.0 111.166 -178.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -98.73 139.83 14.67 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.277 176.153 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -78.51 83.38 4.71 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -96.51 -39.21 9.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.457 -173.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 25.7 m -115.06 152.08 16.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 57.9 t30 54.33 64.87 1.67 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.739 0.78 . . . . 0.0 109.48 -174.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 23.4 m -87.65 50.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.454 -173.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -62.11 -16.85 55.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.151 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -69.21 -18.78 63.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.804 178.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -89.29 -15.24 33.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.095 0.474 . . . . 0.0 109.971 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -99.26 142.91 30.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.639 178.008 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.48 122.57 43.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.556 0.217 . . . . 0.0 111.135 -177.724 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.4 m -96.31 107.38 19.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.044 0.45 . . . . 0.0 110.104 -179.526 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.5 t -92.91 119.32 40.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.767 -171.107 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 18.5 m -89.74 106.19 18.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.18 0.514 . . . . 0.0 109.983 174.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.438 ' HB2' ' CG2' ' A' ' 264' ' ' THR . 30.1 mt -121.29 169.37 10.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.058 -176.142 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 30.2 p -67.53 -48.26 67.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.334 0.588 . . . . 0.0 109.881 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.485 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -135.77 130.3 33.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.472 178.279 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.438 ' CG2' ' HB2' ' A' ' 261' ' ' LEU . 4.8 p -132.47 17.93 4.38 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.314 173.609 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 39.4 m -84.2 147.26 27.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.31 174.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 92.96 -5.48 75.98 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -171.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 70.9 mtp -108.67 138.66 44.63 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -137.7 154.33 49.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.779 0.323 . . . . 0.0 110.547 -178.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -59.61 135.32 57.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.64 -174.503 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 102.86 18.32 15.96 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.728 -0.749 . . . . 0.0 113.027 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.479 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 2.7 t0 -113.82 -169.57 1.54 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 117.369 0.585 . . . . 0.0 109.814 177.314 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.459 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 4.7 tppp? -124.18 116.56 22.91 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.592 -178.125 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.428 HD12 HG21 ' A' ' 308' ' ' ILE . 15.6 pt -117.19 140.48 39.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 120.131 -0.627 . . . . 0.0 109.965 179.106 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 44.2 p -126.21 150.87 48.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.145 -178.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.446 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 89.0 m-85 -111.83 111.32 22.2 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.065 -178.862 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.01 111.98 3.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 -178.032 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 113.67 -35.52 4.48 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -178.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 97.6 t -87.06 110.83 20.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -137.14 179.48 6.36 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.328 -174.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -69.08 172.81 6.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.109 -177.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 73.6 mt -64.91 -62.02 1.81 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -175.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -100.6 51.17 1.01 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.21 -177.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.408 ' HG3' ' HB2' ' A' ' 290' ' ' ALA . 6.1 tp-100 -92.42 -41.5 10.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.843 0.354 . . . . 0.0 110.749 -176.587 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 58.9 mtm -97.37 30.21 2.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.053 0.454 . . . . 0.0 110.253 177.162 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -77.37 -32.42 54.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.165 179.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -153.6 -42.24 0.09 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.653 179.219 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -62.4 127.98 33.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.291 0.567 . . . . 0.0 111.282 -177.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 44.6 t -86.07 -28.88 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.331 177.127 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 88.1 mt -87.82 54.59 3.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.149 174.29 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.408 ' HB2' ' HG3' ' A' ' 283' ' ' GLN . . . -66.61 116.39 7.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.103 -177.059 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -82.11 132.62 35.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.291 177.384 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -76.19 167.94 20.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.374 -178.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.441 ' HB2' ' CE2' ' A' ' 295' ' ' PHE . . . -61.31 107.3 0.74 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.006 -177.392 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 61.2 p -95.01 125.35 39.61 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.572 -179.491 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.473 ' CE2' ' HG3' ' A' ' 312' ' ' PRO . 88.1 m-85 -128.18 152.92 47.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.103 0.478 . . . . 0.0 111.132 -179.316 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 41.9 m -92.1 125.79 36.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.312 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.479 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.0 p -76.98 127.74 37.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.085 0.469 . . . . 0.0 110.415 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 23.4 t -100.59 -35.72 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.202 -175.594 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -164.32 142.57 7.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 111.124 -179.107 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 94.5 t -102.69 117.84 48.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 170.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 46.0 t -77.19 -55.7 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.122 -172.369 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -128.49 -1.27 5.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.057 0.456 . . . . 0.0 111.604 -175.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 83.25 14.31 74.68 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.216 -176.501 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 1.8 p -145.97 19.93 1.44 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 171.449 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -165.71 115.75 1.03 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.476 -171.584 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.2 m -119.05 164.89 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 110.235 -0.284 . . . . 0.0 110.235 -174.585 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 10.9 pt-20 -125.48 132.02 52.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.118 0.485 . . . . 0.0 109.9 169.673 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.428 HG21 HD12 ' A' ' 273' ' ' ILE . 21.5 pt -125.38 164.32 24.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.363 -176.347 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.4 t -141.86 141.16 21.26 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.714 175.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.75 -179.61 27.04 Favored 'Cis proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.964 -1.265 . . . . 0.0 112.532 -3.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 31.4 ttmt -86.31 126.25 65.32 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.473 ' HG3' ' CE2' ' A' ' 295' ' ' PHE . 8.7 Cg_exo -70.07 112.14 3.05 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.875 2.384 . . . . 0.0 112.712 178.609 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.479 HG21 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -119.39 128.94 75.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.789 172.661 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.677 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -88.02 138.72 31.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.906 -176.12 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -68.53 -28.63 67.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.689 178.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -92.44 10.03 31.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.755 -179.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 314' ' ' ALA . 9.9 t70 -72.57 122.22 21.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.996 0.426 . . . . 0.0 109.909 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.2 m -84.49 2.32 4.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.225 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.7 p -119.84 29.17 7.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -174.343 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 2.0 pp -128.74 161.22 30.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.061 0.458 . . . . 0.0 111.633 176.418 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 19.7 m -85.24 162.03 50.16 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.323 -177.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.463 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 96.0 Cg_exo -46.0 -46.3 16.21 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.32 2.68 . . . . 0.0 113.927 -177.649 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.23 -33.07 75.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.679 0.276 . . . . 0.0 111.267 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 50.9 mt-30 -69.32 -35.95 76.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.235 -177.052 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 8.0 ptp180 -74.8 -23.54 58.5 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.089 0.471 . . . . 0.0 110.206 178.91 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -72.03 -18.65 61.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.129 175.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -109.21 11.15 25.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.505 175.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.479 ' HA ' HG21 ' A' ' 313' ' ' VAL . . . -67.36 142.44 56.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.514 177.06 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . 0.405 ' OD1' HG12 ' A' ' 330' ' ' VAL . 5.6 p30 -125.39 -20.55 4.76 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -175.424 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.1 m -115.45 155.09 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.728 179.426 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -91.98 -2.48 56.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.781 -174.18 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 14.7 t -162.4 152.79 16.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.803 0.335 . . . . 0.0 110.254 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.0 p -86.88 165.56 15.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.114 179.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 234' ' ' GLN . 18.0 tp -68.27 108.0 3.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -177.483 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.602 ' O ' HG12 ' A' ' 230' ' ' VAL . . . -80.35 -177.92 6.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.286 -177.122 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.48 1.49 29.13 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -172.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -147.87 54.94 1.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.224 0.535 . . . . 0.0 111.395 177.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 338' ' ' MET . . . . . 0.415 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 22.8 mmt -101.33 142.52 32.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.799 176.102 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.64 140.55 30.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.467 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 22.0 t -114.66 120.11 63.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.312 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -136.78 144.26 43.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.85 0.357 . . . . 0.0 111.147 -175.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 31.3 mt -93.86 128.47 45.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.71 178.093 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 39.4 mt -88.13 111.96 22.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.566 -179.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -90.21 125.93 35.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.334 178.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.593 -0.718 . . . . 0.0 110.222 178.478 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.8 m -92.13 -49.25 6.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.02 0.438 . . . . 0.0 110.551 -179.748 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 23.0 p -126.66 28.93 5.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.309 0.576 . . . . 0.0 109.981 177.745 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.3 91.02 4.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.111 -175.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 29.0 p -79.13 72.97 5.71 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.489 0.661 . . . . 0.0 111.057 177.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -109.8 52.15 0.66 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 173.281 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.546 HG21 ' O ' ' A' ' 263' ' ' ALA . 22.7 mt -93.66 159.07 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.273 -0.463 . . . . 0.0 110.275 -173.0 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 13.3 p -118.23 153.42 33.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.281 0.563 . . . . 0.0 111.332 179.048 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 335' ' ' ALA . 9.3 p -66.74 152.58 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.83 177.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.5 t -114.99 78.92 1.21 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.13 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 101.58 151.07 24.23 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.699 179.574 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -85.63 141.54 29.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.463 0.173 . . . . 0.0 110.609 179.579 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -157.62 150.47 23.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.159 0.504 . . . . 0.0 111.771 -177.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 38.4 p -153.39 102.33 2.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.994 172.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -80.61 143.9 32.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.775 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -107.51 134.46 19.98 Favored Pre-proline 0 C--N 1.323 -0.577 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.264 -177.228 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.511 ' HA ' ' OD1' ' A' ' 254' ' ' ASN . 74.5 Cg_endo -90.01 120.69 0.9 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.747 2.298 . . . . 0.0 110.647 169.065 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.585 ' O ' HD12 ' A' ' 243' ' ' LEU . 49.2 t -82.1 105.57 12.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 120.837 0.351 . . . . 0.0 110.165 -177.313 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -78.96 81.83 5.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.794 -176.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -132.31 -72.86 0.52 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.863 178.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -161.96 108.17 1.31 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.324 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 239' ' ' VAL . 4.7 mp -128.43 71.77 1.41 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.994 -176.436 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -128.31 -77.67 0.56 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.437 176.064 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -74.32 -54.93 6.66 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -118.54 132.35 56.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.119 172.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -121.73 148.79 17.24 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.497 178.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -69.79 132.14 45.6 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.525 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 65.34 66.79 0.53 Allowed 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.744 0.652 . . . . 0.0 110.734 -178.35 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.8 t 72.11 147.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.875 176.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -88.94 131.14 35.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.26 -178.578 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.9 t 54.81 57.45 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.994 0.902 . . . . 0.0 110.109 -178.276 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -151.81 -42.85 0.11 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.032 -179.176 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.511 ' OD1' ' HA ' ' A' ' 238' ' ' PRO . 19.4 t-20 -63.78 -18.32 63.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.619 0.724 . . . . 0.0 109.717 177.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -68.64 -21.84 64.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.756 175.208 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -115.77 160.93 19.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.837 -174.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.27 132.91 53.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 177.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.4 m -94.85 114.27 26.12 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.041 0.448 . . . . 0.0 110.368 178.52 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.9 t -93.76 122.27 45.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.282 -173.882 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 3.0 m -94.0 106.7 18.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.049 179.527 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 23.1 mt -126.35 168.14 14.56 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.412 -174.026 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.6 t -63.25 -54.87 30.5 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.546 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.09 136.84 38.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.266 178.543 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 15.9 p -129.7 25.27 5.36 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.028 0.918 . . . . 0.0 108.558 175.23 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 17.4 m -82.96 153.44 25.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.284 -1.326 . . . . 0.0 109.712 176.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 90.7 -6.44 82.05 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -174.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 47.8 mtt -104.3 147.45 27.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.828 -0.686 . . . . 0.0 109.314 178.524 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 0.0 OUTLIER -139.62 158.05 44.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.307 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -54.47 132.65 45.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.182 0.515 . . . . 0.0 111.437 -176.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 95.11 19.03 31.98 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.099 -177.271 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 268' ' ' LYS . 1.1 t0 -103.46 169.01 8.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.7 0.286 . . . . 0.0 110.289 -178.284 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -118.5 115.46 24.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.996 -178.137 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.429 HD12 HG23 ' A' ' 308' ' ' ILE . 30.0 pt -112.78 139.74 36.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.039 0.447 . . . . 0.0 110.061 179.52 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.4 ' OG ' HG23 ' A' ' 294' ' ' THR . 7.1 m -124.48 133.47 53.34 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.871 -179.188 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -100.0 111.42 23.72 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.206 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.464 ' HA ' ' OD1' ' A' ' 292' ' ' ASP . . . -66.51 120.54 13.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.342 -179.2 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.95 -25.95 12.2 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -176.591 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.546 ' HA ' ' OG1' ' A' ' 332' ' ' THR . 47.0 t -100.28 119.74 48.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.772 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -136.34 157.48 46.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.035 0.445 . . . . 0.0 111.436 -173.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -72.94 118.87 16.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.245 179.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 331' ' ' ASN . 1.5 pt? -76.06 171.42 14.5 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.33 -45.78 3.52 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 -174.312 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -64.2 -28.48 69.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 110.491 177.276 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 82.7 mtp -72.11 -10.51 59.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.357 -175.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.32 -14.16 60.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.924 0.392 . . . . 0.0 111.245 -179.249 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -138.93 -38.83 0.5 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.913 0.387 . . . . 0.0 110.812 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -86.33 124.23 32.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.399 -178.349 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 40.8 t -88.73 -33.44 6.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 176.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 88.7 mt -92.24 54.11 2.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.763 177.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.24 130.24 42.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.368 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -77.62 161.85 27.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.626 -177.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.464 ' OD1' ' HA ' ' A' ' 276' ' ' ALA . 49.4 m-20 -72.99 158.91 34.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.876 177.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -65.81 101.14 0.61 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.037 -178.661 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.4 HG23 ' OG ' ' A' ' 274' ' ' SER . 45.4 p -84.05 117.16 23.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.959 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -120.64 148.31 44.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.921 0.391 . . . . 0.0 110.624 177.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 8.5 m -94.88 127.75 41.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.257 -178.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.464 HG12 ' H ' ' A' ' 271' ' ' ASP . 7.4 p -79.9 134.02 28.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.271 0.558 . . . . 0.0 110.286 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.413 ' HB ' ' HG3' ' A' ' 307' ' ' GLU . 61.0 t -95.13 -38.7 9.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.859 -178.927 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -166.82 139.88 3.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.752 0.311 . . . . 0.0 110.235 -179.199 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 86.8 t -83.88 103.75 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.622 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 18.4 t -72.58 -58.21 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.024 -171.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -116.69 -9.98 11.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.98 0.419 . . . . 0.0 111.817 -174.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 78.03 11.39 85.43 Favored Glycine 0 CA--C 1.516 0.136 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -173.378 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 20.3 p -148.98 18.53 0.98 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 173.43 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.524 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.8 t-160 -169.43 113.59 0.53 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.006 -165.079 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.5 m -119.06 163.17 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 121.206 -0.198 . . . . 0.0 110.57 -173.413 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.413 ' HG3' ' HB ' ' A' ' 298' ' ' VAL . 11.5 pt-20 -116.92 128.5 55.29 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 171.255 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.429 HG23 HD12 ' A' ' 273' ' ' ILE . 29.8 pt -126.61 168.15 20.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.123 0.487 . . . . 0.0 111.938 -176.104 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.3 t -146.92 138.57 13.38 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.049 174.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.36 -179.66 27.75 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.815 -1.327 . . . . 0.0 112.721 -1.599 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 38.6 ttmt -79.51 124.07 84.03 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.258 -178.479 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 13.4 Cg_exo -68.86 113.44 3.22 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.972 2.448 . . . . 0.0 112.384 177.416 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.415 HG21 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -123.96 129.28 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.355 176.229 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -86.53 129.34 34.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.876 -177.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.83 -27.49 68.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.719 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -95.75 15.19 20.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -81.96 127.66 33.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.291 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.2 m -84.17 -3.48 7.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -174.027 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 14.7 m -96.82 1.38 50.62 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -174.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.0 OUTLIER -111.18 156.37 21.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.211 0.529 . . . . 0.0 111.403 178.515 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.448 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 16.0 m -94.07 165.7 17.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.11 -175.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 66.6 Cg_exo -42.96 -49.0 7.23 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 123.697 2.932 . . . . 0.0 114.253 -178.627 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -62.53 -39.51 93.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 0.0 110.949 -179.101 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 47.5 mt-30 -67.56 -33.25 74.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.309 179.592 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 321' ' ' SER . 83.2 mtt180 -60.86 -32.6 72.02 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.859 175.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -69.02 -25.11 64.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.677 179.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -95.52 -0.74 51.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 178.51 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.415 ' HA ' HG21 ' A' ' 313' ' ' VAL . . . -73.76 107.4 5.98 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.237 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . 0.493 ' ND2' HG12 ' A' ' 330' ' ' VAL . 5.6 p-10 -92.3 -5.38 52.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.157 -176.004 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.493 HG12 ' ND2' ' A' ' 329' ' ' ASN . 28.1 m -133.21 155.92 41.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.562 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.412 ' HB3' ' HB3' ' A' ' 281' ' ' LEU . 24.9 p-10 -93.99 -26.53 16.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.764 -178.669 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.546 ' OG1' ' HA ' ' A' ' 278' ' ' VAL . 43.2 p -109.21 139.48 44.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.165 0.507 . . . . 0.0 111.311 -179.033 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 46.9 p -86.57 169.56 12.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.328 176.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.9 tp -74.91 102.22 4.69 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.664 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -82.3 165.86 20.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.961 -179.886 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -78.99 26.27 0.26 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -172.498 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -154.49 41.13 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.01 0.433 . . . . 0.0 110.911 176.111 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 338' ' ' MET . . . . . 0.432 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 23.4 mmt -99.32 149.66 22.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 177.786 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 276' ' ' ALA . . . -99.99 143.88 29.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.949 -179.111 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.5 t -110.91 115.8 50.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.143 -178.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -132.7 137.55 46.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.861 -177.273 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 24.2 mt -97.9 129.5 48.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.718 178.375 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 59.8 mt -84.93 143.58 28.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.321 178.123 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -124.87 99.21 6.04 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.906 0.384 . . . . 0.0 110.197 179.504 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.518 179.939 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.666 0 N-CA-C 112.204 -0.358 . . . . 0.0 112.204 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 13.8 p -79.76 -11.68 59.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.775 0.321 . . . . 0.0 111.112 -177.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 20.8 p -74.65 -8.8 57.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.492 179.253 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -75.97 60.37 1.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.303 0.573 . . . . 0.0 110.651 179.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 46.4 p -83.98 73.86 10.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.912 -178.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -73.67 69.45 1.48 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.758 -177.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.498 HG21 ' O ' ' A' ' 263' ' ' ALA . 38.4 mt -102.33 152.6 5.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.477 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -99.86 169.6 9.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.392 0.615 . . . . 0.0 112.315 -177.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 335' ' ' ALA . 10.4 p -81.61 152.08 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.752 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.3 t -104.55 80.77 1.71 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 91.02 165.38 40.07 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.177 -179.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -96.33 136.88 36.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.603 0.239 . . . . 0.0 110.44 179.206 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -149.27 127.16 11.85 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.36 0.6 . . . . 0.0 111.327 179.602 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.486 ' HA ' ' HB3' ' A' ' 333' ' ' SER . 11.6 p -98.14 120.65 38.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.267 177.347 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.86 157.99 25.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.935 -175.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -141.87 132.15 12.77 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.351 -179.498 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.445 ' HD3' HG11 ' A' ' 313' ' ' VAL . 70.6 Cg_endo -87.61 145.69 6.9 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.528 2.152 . . . . 0.0 112.063 178.438 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.44 126.93 38.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.337 0.589 . . . . 0.0 110.622 177.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -131.37 -160.79 1.07 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.627 179.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -74.76 81.17 2.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.221 0.534 . . . . 0.0 110.374 178.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -172.29 173.81 4.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.549 177.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.431 ' N ' HD23 ' A' ' 243' ' ' LEU . 1.8 pt? -144.46 30.08 1.25 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.701 176.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.444 ' HB3' ' H ' ' A' ' 245' ' ' ASN . 3.7 m-20 60.09 -154.58 0.37 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.055 -178.761 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.444 ' H ' ' HB3' ' A' ' 244' ' ' ASP . 16.5 m120 -71.5 -55.21 8.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.599 0.238 . . . . 0.0 111.545 -175.384 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -100.04 -59.35 1.73 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.915 0.388 . . . . 0.0 110.96 -176.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 173.79 163.67 27.68 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.773 -178.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -125.95 122.08 34.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.99 0.424 . . . . 0.0 110.58 -178.835 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -86.7 -25.03 24.98 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.6 m -60.3 115.54 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.572 -179.577 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -141.7 143.69 33.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.353 178.402 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 17.8 t 56.8 65.73 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.741 0.782 . . . . 0.0 109.936 -176.056 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -165.59 -44.23 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.113 -179.318 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -67.4 -13.81 62.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.784 -177.642 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -60.4 -24.8 65.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.35 0.595 . . . . 0.0 110.114 174.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -116.01 163.52 15.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.599 177.214 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -113.88 114.36 26.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.307 177.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -84.16 103.02 13.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.432 0.634 . . . . 0.0 111.306 179.012 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.8 t -83.24 124.62 39.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.351 -177.273 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 6.1 m -97.82 105.77 17.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.912 178.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.433 ' HB2' HG21 ' A' ' 264' ' ' THR . 17.4 mt -123.04 165.76 16.26 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.998 -174.537 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.7 m -57.06 -56.71 18.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.434 0.635 . . . . 0.0 109.649 179.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.498 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -138.12 134.63 34.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.874 177.154 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 264' ' ' THR . . . . . 0.433 HG21 ' HB2' ' A' ' 261' ' ' LEU . 6.7 p -123.99 24.71 8.17 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.938 0.875 . . . . 0.0 108.723 175.132 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 44.9 m -75.4 131.79 40.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.16 173.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 110.48 -26.5 13.06 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -171.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -76.53 140.75 41.26 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 172.674 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -154.35 146.11 23.37 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.183 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.452 ' HA ' HG12 ' A' ' 297' ' ' VAL . 29.9 ptt180 -41.9 119.66 1.36 Allowed 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.149 0.906 . . . . 0.0 112.609 -173.334 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 110.33 -9.16 30.9 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.44 176.683 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.43 ' H ' HG13 ' A' ' 297' ' ' VAL . 2.4 p30 -77.06 -178.12 4.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.372 0.606 . . . . 0.0 111.943 -177.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.52 117.08 18.28 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.628 -178.598 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 35.5 pt -112.63 140.23 33.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.156 0.503 . . . . 0.0 110.763 179.342 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 22.7 t -121.32 145.29 48.03 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.559 178.49 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -112.33 111.46 22.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.023 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.65 120.24 15.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.591 -178.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.96 -34.24 5.19 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -178.068 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 96.1 t -90.29 115.68 30.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 173.235 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -131.46 151.41 51.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.033 0.444 . . . . 0.0 111.739 -173.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.519 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 77.5 m-85 -70.18 115.45 9.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.462 176.332 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.458 HD23 ' C ' ' A' ' 330' ' ' VAL . 2.3 pt? -74.95 -18.28 60.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.717 0.294 . . . . 0.0 111.114 -175.311 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -70.17 -20.73 76.77 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 175.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -71.54 -17.69 62.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.984 0.421 . . . . 0.0 110.091 177.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 58.1 mtt -78.89 2.52 19.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.053 -178.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -58.1 -38.43 76.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.328 -178.407 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -145.27 -32.17 0.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.052 0.454 . . . . 0.0 110.761 178.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -85.34 118.25 24.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.002 0.429 . . . . 0.0 110.57 178.538 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 45.2 t -76.4 -30.12 19.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.26 -179.342 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 87.4 mt -89.12 61.9 6.0 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -178.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -60.24 123.2 16.49 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.784 -174.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -60.9 145.48 50.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.231 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -71.42 154.04 41.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.382 176.499 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.519 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -60.47 127.28 30.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.606 -174.531 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 29.3 p -120.03 122.95 42.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.591 -179.387 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -133.78 152.28 51.83 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 11.9 t -96.28 134.8 38.94 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.41 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 269' ' ' ARG . 4.7 p -69.79 139.98 19.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.145 178.733 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 50.2 t -104.67 -38.4 4.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.151 175.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -163.06 140.74 7.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.615 179.555 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.4 109.18 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.074 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.15 -59.61 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.017 -174.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -111.03 -13.62 14.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.291 0.567 . . . . 0.0 111.57 -175.026 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.22 13.99 77.74 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.255 -174.033 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 40.0 p -136.67 9.86 3.12 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 169.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.484 ' NE2' ' HB ' ' A' ' 258' ' ' THR . 2.2 t-160 -158.18 114.15 2.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.343 -1.299 . . . . 0.0 108.279 -168.749 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.2 m -118.69 150.98 20.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -177.011 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -111.06 117.05 32.24 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.182 0.515 . . . . 0.0 110.092 173.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.429 HG21 ' HA ' ' A' ' 297' ' ' VAL . 24.6 pt -116.67 172.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.069 -179.229 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.9 t -154.53 141.86 13.68 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.324 176.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.98 179.71 29.68 Favored 'Cis proline' 0 CA--C 1.531 0.337 0 C-N-CA 123.487 -1.464 . . . . 0.0 112.838 -3.06 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.524 ' HB2' ' HZ2' ' A' ' 311' ' ' LYS . 3.7 ttmp? -83.87 128.03 64.83 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.58 -177.774 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.97 108.93 2.56 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.379 2.053 . . . . 0.0 111.727 174.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.49 HG21 ' HA ' ' A' ' 328' ' ' ALA . 0.8 OUTLIER -123.99 136.79 59.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.028 -179.063 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -86.88 138.27 31.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.54 0.686 . . . . 0.0 112.285 -173.041 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . 0.44 HD23 ' HB2' ' A' ' 325' ' ' ARG . 3.0 tm? -76.58 -33.67 58.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.253 178.594 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -89.2 13.99 11.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.256 -177.305 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . 0.444 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 11.3 t70 -73.13 123.27 23.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.034 179.266 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 11.8 p -83.75 -16.55 10.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.768 -175.825 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 14.4 m -80.61 -33.78 35.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.441 -172.086 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.5 pp -82.93 159.27 22.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.445 0.641 . . . . 0.0 112.084 -177.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.41 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 18.8 m -81.07 163.97 52.75 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.428 -178.5 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 67.2 Cg_exo -43.39 -52.86 4.69 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.503 2.802 . . . . 0.0 114.35 179.763 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.93 -28.54 70.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.09 0.471 . . . . 0.0 111.135 -177.15 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 11.7 mm100 -69.22 -45.98 68.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.72 -179.008 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 325' ' ' ARG . . . . . 0.44 ' HB2' HD23 ' A' ' 315' ' ' LEU . 2.7 ptp180 -70.47 -21.15 62.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.857 0.361 . . . . 0.0 110.677 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -65.18 -28.4 69.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.983 0.421 . . . . 0.0 110.265 173.394 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -94.66 -0.2 54.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.002 179.575 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.49 ' HA ' HG21 ' A' ' 313' ' ' VAL . . . -60.85 149.87 34.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.422 178.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -124.75 -19.45 5.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.643 -176.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.0 m -127.99 163.61 31.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -83.77 -34.14 24.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.636 0.255 . . . . 0.0 111.337 -176.258 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 12.1 t -132.83 146.92 52.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.199 -178.589 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 235' ' ' SER . 30.6 m -82.2 -175.86 5.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.749 -179.416 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.1 tp -75.99 103.81 6.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.134 -176.549 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . 0.621 ' O ' HG13 ' A' ' 230' ' ' VAL . . . -82.01 169.45 16.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.479 179.697 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -79.44 23.25 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -171.277 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -155.42 46.46 0.5 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.96 0.41 . . . . 0.0 110.805 177.323 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.0 mmt -100.07 132.23 45.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.18 178.3 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -88.5 129.31 35.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.817 179.133 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 10.3 t -97.45 147.6 6.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -160.52 138.01 9.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.496 0.189 . . . . 0.0 110.798 176.212 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 47.3 mt -88.76 121.66 39.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.052 0.453 . . . . 0.0 110.672 176.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 61.5 mt -81.98 143.6 31.48 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.714 179.195 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -123.55 138.52 54.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.468 -178.039 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 45.8 t . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.35 176.466 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.464 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 23.7 p . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.448 0.166 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 61.3 52.13 53.63 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.302 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.442 HG21 ' O ' ' A' ' 263' ' ' ALA . 58.7 mt -103.37 148.39 8.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 34.5 p -97.2 150.58 20.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.603 0.716 . . . . 0.0 111.992 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.62 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.8 p -63.92 151.45 8.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.025 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.9 t -115.34 81.68 1.62 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.899 0.381 . . . . 0.0 110.006 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 102.48 165.09 26.37 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.838 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -101.88 136.44 41.71 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.473 ' OE1' ' HA ' ' A' ' 259' ' ' VAL . 3.9 pt20 -144.14 139.46 28.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.247 0.546 . . . . 0.0 111.475 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 28.1 t -145.98 103.39 3.74 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.384 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -102.39 150.63 23.15 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 320' ' ' LEU . 45.9 mmtm -119.68 131.91 24.22 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.223 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 N--CA 1.462 -0.376 0 C-N-CA 122.603 2.202 . . . . 0.0 111.863 178.972 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.86 0.362 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -117.27 115.83 26.05 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.082 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.2 m -87.36 100.3 12.62 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.107 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.473 ' HA ' ' OE1' ' A' ' 234' ' ' GLN . 2.5 t -83.1 122.27 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.414 -172.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 25.0 m -96.13 105.81 17.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.834 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.534 HD23 HG23 ' A' ' 230' ' ' VAL . 21.0 mt -123.7 165.95 16.37 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.968 -175.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.9 t -60.11 -54.66 43.27 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.442 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.27 139.44 40.95 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.166 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 11.6 p -132.48 24.55 4.43 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.98 0.895 . . . . 0.0 108.867 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.4 m -78.23 139.26 38.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.865 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.77 -9.02 55.12 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -175.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 61.6 mtt -94.13 148.97 21.66 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 24.8 pttm -139.11 163.56 32.1 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -57.52 135.95 56.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.86 0.362 . . . . 0.0 110.935 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 82.71 19.03 64.46 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.801 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.52 ' HB2' ' O ' ' A' ' 268' ' ' LYS . 0.6 OUTLIER -94.21 174.2 7.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.791 0.329 . . . . 0.0 110.178 -178.563 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 0.1 OUTLIER -114.8 116.72 29.07 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.69 -178.269 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.455 HD11 HG21 ' A' ' 308' ' ' ILE . 17.1 pt -122.31 139.93 47.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.898 0.38 . . . . 0.0 110.238 175.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 72.9 p -119.75 145.05 46.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.011 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.4 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 94.0 m-85 -107.0 111.4 23.87 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.19 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.415 ' HA ' ' OD1' ' A' ' 292' ' ' ASP . . . -66.18 113.3 4.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.071 -176.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.26 -34.25 5.4 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 96.6 t -87.9 118.81 34.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -149.44 172.07 15.55 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.214 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -83.47 150.29 26.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.611 0.719 . . . . 0.0 112.364 -169.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' A' ' 315' ' ' LEU . 40.3 mt . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.965 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.415 ' OD1' ' HA ' ' A' ' 276' ' ' ALA . 31.8 m-20 . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 120.651 0.262 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.433 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -57.97 113.32 1.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.291 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 9.5 p -96.77 105.39 17.5 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.052 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.433 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 68.6 m-85 -116.93 147.83 41.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.741 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.8 t -94.94 124.48 39.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.747 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.499 HG12 ' H ' ' A' ' 271' ' ' ASP . 12.9 p -75.15 140.98 16.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.323 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 37.9 t -103.33 -38.04 5.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.861 0.363 . . . . 0.0 110.83 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -158.82 136.75 10.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 0.0 111.026 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.25 106.58 17.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.53 -59.3 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.912 -171.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -112.9 -3.7 14.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.852 0.358 . . . . 0.0 111.445 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 71.24 12.46 72.38 Favored Glycine 0 CA--C 1.517 0.216 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -172.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 16.7 p -147.92 19.49 1.13 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.444 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.4 t-160 -169.98 113.15 0.48 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.056 -167.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.0 166.11 13.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -175.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.95 119.05 28.44 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.232 0.539 . . . . 0.0 109.996 171.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.455 HG21 HD11 ' A' ' 273' ' ' ILE . 36.6 pt -113.61 171.1 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.572 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 10.3 t -155.08 144.94 15.57 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -71.75 -179.91 24.16 Favored 'Cis proline' 0 CA--C 1.532 0.382 0 C-N-CA 124.215 -1.16 . . . . 0.0 113.048 -1.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -87.1 126.9 61.29 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.675 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.93 121.8 8.45 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.586 2.191 . . . . 0.0 112.328 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.696 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.9 OUTLIER -130.78 128.55 63.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.741 178.086 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -85.95 139.1 31.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.158 -174.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.565 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.0 tm? -80.73 -27.05 36.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.986 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -77.7 -10.48 59.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.443 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -83.02 116.02 22.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.037 0.446 . . . . 0.0 110.335 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.3 m -82.68 0.22 4.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.643 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 13.8 m -71.1 -19.18 62.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.609 0.242 . . . . 0.0 111.437 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 0.8 OUTLIER -94.94 168.77 10.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.147 0.498 . . . . 0.0 111.858 -177.631 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.405 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 15.2 t -87.45 152.28 52.01 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.906 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.405 ' HD2' ' OG ' ' A' ' 321' ' ' SER . 60.7 Cg_exo -40.73 -45.3 4.76 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.381 2.721 . . . . 0.0 113.781 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 323' ' ' GLU . 3.0 mp0 -51.33 -45.68 62.36 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.225 0.536 . . . . 0.0 110.855 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 80.7 mm-40 -64.76 -25.23 67.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.28 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -65.33 -31.09 72.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.93 0.395 . . . . 0.0 110.53 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.45 74.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.373 175.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -85.53 -10.28 56.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.15 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.696 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -63.08 135.08 57.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.638 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -119.51 -30.24 4.9 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 34.3 m -112.91 165.69 7.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.044 0.45 . . . . 0.0 111.399 -177.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -78.71 -44.89 22.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.528 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.3 t -130.9 145.91 52.16 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.126 0.489 . . . . 0.0 110.97 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 38.4 m -74.18 169.02 18.42 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.727 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.8 tp -75.86 102.98 5.73 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.62 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -91.66 166.19 12.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.994 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.42 62.19 4.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.09 0.472 . . . . 0.0 111.778 -173.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -176.94 30.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.491 171.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.2 mmt -101.47 134.38 44.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.342 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -90.15 132.85 35.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.009 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 22.8 t -108.3 108.56 25.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.717 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' ASN . . . . . 0.464 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 64.1 t30 -123.6 132.5 53.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.074 -175.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 47.6 mt -76.59 129.94 36.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.125 0.488 . . . . 0.0 110.295 173.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 45.4 mt . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.803 178.837 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.613 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 19.4 p . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.26 0.076 . . . . 0.0 111.061 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.64 49.66 76.16 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.754 177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.493 HG21 ' O ' ' A' ' 263' ' ' ALA . 57.7 mt -102.75 141.76 18.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 29.7 p -97.44 153.13 18.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.532 0.682 . . . . 0.0 111.839 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.611 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.7 p -58.92 151.5 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.289 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 10.2 t -105.33 73.51 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.992 0.425 . . . . 0.0 110.095 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 97.19 158.58 31.06 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.093 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -72.61 116.96 13.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.731 0.3 . . . . 0.0 110.401 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 334' ' ' LEU . 6.2 tp-100 -129.37 127.09 40.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.148 0.499 . . . . 0.0 110.589 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.2 p -118.5 125.38 49.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.105 0.478 . . . . 0.0 109.819 177.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.477 ' CD2' ' HG2' ' A' ' 312' ' ' PRO . 70.1 m-85 -81.23 131.86 35.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.602 -174.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -129.52 111.11 17.71 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -175.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.448 -1.15 0 C-N-CA 122.67 2.247 . . . . 0.0 111.024 169.987 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.956 0.408 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -106.5 117.19 33.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.071 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -92.1 101.82 14.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.107 0.48 . . . . 0.0 110.542 -178.663 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.471 ' HB ' HG22 ' A' ' 306' ' ' VAL . 3.3 t -83.2 118.99 31.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.517 -172.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 20.5 m -90.78 108.54 19.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.186 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.424 ' HB2' HG22 ' A' ' 264' ' ' THR . 20.7 mt -127.11 165.06 20.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.065 -175.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 20.8 m -58.59 -55.68 31.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.398 0.618 . . . . 0.0 109.543 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.493 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -138.2 141.16 40.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.527 ' HB ' ' SD ' ' A' ' 267' ' ' MET . 9.3 p -126.42 24.69 6.69 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.057 0.932 . . . . 0.0 108.766 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 17.0 m -71.59 138.8 49.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.372 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 105.76 -11.26 45.76 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' MET . . . . . 0.53 ' SD ' HG11 ' A' ' 306' ' ' VAL . 63.3 mtt -95.18 142.83 27.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -154.17 140.36 18.5 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.523 ' HA ' HG13 ' A' ' 297' ' ' VAL . 30.0 ptt180 -44.17 118.01 1.38 Allowed 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.977 0.798 . . . . 0.0 112.607 -171.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.47 -10.63 19.4 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.467 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.497 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.5 p30 -82.84 -177.2 6.66 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.552 0.692 . . . . 0.0 112.175 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -124.97 117.73 24.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.973 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.534 HD11 HG21 ' A' ' 308' ' ' ILE . 37.5 pt -111.12 139.3 35.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.038 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.504 ' OG ' HG22 ' A' ' 294' ' ' THR . 3.0 m -125.34 129.51 50.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.508 -174.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -97.27 110.92 23.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.303 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.12 121.42 20.19 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.011 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.36 -27.93 9.58 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.77 131.28 50.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -141.84 157.73 44.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.786 0.327 . . . . 0.0 110.902 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.401 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 43.3 m-85 -83.97 149.33 26.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.082 -174.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 315' ' ' LEU . 96.4 mt . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.391 176.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 C--O 1.235 0.33 0 CA-C-O 120.695 0.283 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.401 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -71.29 85.87 0.79 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.9 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.504 HG22 ' OG ' ' A' ' 274' ' ' SER . 22.2 p -96.79 122.18 39.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.233 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.4 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 90.7 m-85 -124.11 153.65 41.15 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.97 0.414 . . . . 0.0 110.796 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.5 m -90.61 125.83 35.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.579 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 269' ' ' ARG . 4.8 p -67.03 134.45 30.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.034 0.445 . . . . 0.0 109.86 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 99.7 t -101.39 -53.05 7.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.744 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 301' ' ' VAL . 2.7 tmt_? -157.1 131.11 8.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.032 0.444 . . . . 0.0 110.843 -177.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 99.2 t -84.63 114.44 24.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.478 174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 299' ' ' ARG . 46.1 t -76.54 -59.15 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.644 -174.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -128.26 -7.72 5.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.445 0.64 . . . . 0.0 110.989 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.4 14.15 76.98 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 23.7 p -137.3 6.91 2.83 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 172.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.428 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 1.9 t60 -164.14 119.64 1.55 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.456 -169.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.83 161.83 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -176.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -119.8 128.85 54.09 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 172.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.534 HG21 HD11 ' A' ' 273' ' ' ILE . 26.8 pt -133.94 171.64 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.102 0.477 . . . . 0.0 111.848 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 8.5 t -152.35 143.35 15.71 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.191 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.38 -179.96 27.88 Favored 'Cis proline' 0 CA--C 1.53 0.302 0 C-N-CA 123.752 -1.353 . . . . 0.0 112.939 -0.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -92.26 123.67 61.8 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.167 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.477 ' HG2' ' CD2' ' A' ' 236' ' ' PHE . 38.2 Cg_endo -70.48 109.46 2.45 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.49 2.127 . . . . 0.0 112.404 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 46.7 t -117.42 129.65 73.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.893 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -87.12 132.73 33.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.27 0.557 . . . . 0.0 111.473 -175.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.428 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.0 tm? -68.96 -26.99 65.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.205 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -98.27 19.48 14.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.719 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ASP . . . . . 0.489 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 11.2 t70 -72.96 130.22 39.87 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.17 -16.61 10.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -174.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 18.9 t -90.76 -36.07 14.5 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -169.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.489 ' HG ' ' OD1' ' A' ' 317' ' ' ASP . 0.5 OUTLIER -71.15 175.92 4.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.526 0.679 . . . . 0.0 112.783 -175.3 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 13.5 m -103.13 158.53 31.58 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.21 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -39.7 -52.39 2.63 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.087 3.192 . . . . 0.0 114.756 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -58.54 -34.28 70.83 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -71.63 -26.46 62.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.788 0.328 . . . . 0.0 110.658 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -69.23 -22.97 63.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.975 0.416 . . . . 0.0 110.611 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -70.9 -34.3 71.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.29 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -86.24 -0.25 55.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.171 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -64.7 144.02 57.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.072 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -137.03 -9.26 1.78 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 32.5 m -123.4 155.25 29.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -84.88 -25.57 27.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 6.8 t -134.11 140.76 46.82 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.078 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 14.6 p -79.36 173.49 12.52 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 234' ' ' GLN . 19.1 tp -73.95 102.22 4.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.611 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -90.82 164.15 14.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.254 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' ASP . . . . . 0.427 ' HA ' ' CG1' ' A' ' 230' ' ' VAL . 23.8 t0 -77.89 60.57 2.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.181 0.515 . . . . 0.0 111.693 -173.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -178.23 29.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.473 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.5 mmt -98.17 134.37 41.32 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.228 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -94.48 131.14 40.5 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.79 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.404 HG21 HD22 ' A' ' 261' ' ' LEU . 9.0 t -104.75 114.05 43.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.048 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' ASN . . . . . 0.613 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 63.2 t30 -130.83 150.86 51.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.4 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 27.6 mt -102.84 130.73 52.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.115 0.483 . . . . 0.0 111.419 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 46.3 mt . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.192 173.804 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 33.8 p . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 111.231 0.086 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.13 48.39 86.16 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.644 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 263' ' ' ALA . 27.3 mm -100.87 143.75 13.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.836 -0.182 . . . . 0.0 110.733 -174.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 18.9 p -119.79 167.76 11.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.181 0.515 . . . . 0.0 111.417 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.57 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.9 p -85.38 150.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.835 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.3 t -107.11 60.04 0.62 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.155 0.503 . . . . 0.0 110.37 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 102.67 159.71 25.78 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.591 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 334' ' ' LEU . . . -70.81 131.12 43.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.929 0.395 . . . . 0.0 110.649 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -133.96 126.35 30.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.106 -175.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 27.1 p -110.07 142.64 41.25 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.786 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.586 ' O ' HG12 ' A' ' 313' ' ' VAL . 98.7 m-85 -124.97 130.6 52.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.241 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -129.61 139.27 35.17 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.05 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.506 ' HD3' HG11 ' A' ' 313' ' ' VAL . 94.8 Cg_endo . . . . . 0 N--CA 1.453 -0.908 0 C-N-CA 122.763 2.309 . . . . 0.0 112.151 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.441 ' HB2' ' HD2' ' A' ' 312' ' ' PRO . . . -121.24 114.97 22.14 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.664 0.269 . . . . 0.0 110.773 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.653 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -87.09 97.59 10.82 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.236 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -85.17 126.81 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.333 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 40.4 m -96.53 109.15 21.79 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 173.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.4 HD22 HG21 ' A' ' 340' ' ' VAL . 22.2 mt -122.43 172.52 8.28 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.7 m -58.87 -57.4 13.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.241 0.543 . . . . 0.0 109.754 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.479 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -137.2 135.98 37.76 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.956 178.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 8.2 p -130.79 23.88 5.01 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.544 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 89.7 m -82.89 137.05 34.39 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.87 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 112.54 -29.5 8.2 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -171.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -69.66 155.42 40.53 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 170.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -154.43 143.43 21.06 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.48 ' HA ' HG13 ' A' ' 297' ' ' VAL . 37.4 ptt180 -52.32 114.21 1.28 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.23 0.538 . . . . 0.0 111.06 -174.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 113.78 -2.7 24.51 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.903 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.426 ' H ' HG12 ' A' ' 297' ' ' VAL . 0.6 OUTLIER -83.6 175.1 9.99 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 117.1 0.45 . . . . 0.0 111.052 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -126.47 117.39 22.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.245 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.413 HG23 ' OD1' ' A' ' 271' ' ' ASP . 40.8 pt -112.13 140.28 32.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.188 0.518 . . . . 0.0 110.356 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.486 ' OG ' HG22 ' A' ' 294' ' ' THR . 2.7 m -120.5 137.48 54.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.987 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -101.24 111.35 23.54 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.68 116.34 9.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.023 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.27 -36.19 4.27 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 85.2 t -86.47 114.54 26.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 172.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -136.25 158.17 45.05 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.633 -172.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.481 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 66.7 m-85 -76.18 133.93 40.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.344 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.401 ' CD1' ' HB3' ' A' ' 315' ' ' LEU . 96.3 mt . . . . . 0 C--N 1.322 -0.611 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.663 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.481 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -73.6 106.96 5.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.982 -176.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.498 HG21 HD11 ' A' ' 343' ' ' LEU . 67.0 p -97.34 133.62 41.71 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.97 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -131.33 148.89 52.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.941 0.401 . . . . 0.0 110.579 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.1 m -92.29 129.95 38.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.087 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.55 ' HA ' HG22 ' A' ' 308' ' ' ILE . 4.0 p -72.4 143.72 13.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.795 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 62.0 t -105.41 -38.95 4.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.682 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -162.66 136.35 6.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.654 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 58.7 t -86.53 110.45 20.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 169.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 24.3 t -77.32 -56.83 6.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.732 -171.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -127.49 13.92 7.06 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.618 -173.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 59.55 13.84 25.39 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-O 121.438 0.466 . . . . 0.0 112.055 -174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.3 p -150.27 19.49 0.85 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.476 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.3 t-160 -169.03 115.84 0.62 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.817 -1.538 . . . . 0.0 108.074 -166.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.5 m -119.43 163.42 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.313 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.1 pt-20 -124.44 116.38 22.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.143 0.496 . . . . 0.0 109.674 169.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.55 HG22 ' HA ' ' A' ' 297' ' ' VAL . 24.2 pt -115.87 169.83 6.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.104 -177.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' THR . . . . . 0.409 ' OG1' ' HA ' ' A' ' 310' ' ' PRO . 6.3 t -154.32 145.21 16.22 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.409 ' HA ' ' OG1' ' A' ' 309' ' ' THR . 59.4 Cg_endo -70.24 179.7 22.57 Favored 'Cis proline' 0 C--N 1.346 0.403 0 C-N-CA 124.038 -1.234 . . . . 0.0 113.238 1.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.46 ' HE3' ' HB3' ' A' ' 236' ' ' PHE . 31.7 tttp -83.53 119.11 73.28 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.255 -177.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 19.9 Cg_endo -62.29 109.11 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.51 2.14 . . . . 0.0 112.091 178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.791 HG23 ' HA ' ' A' ' 328' ' ' ALA . 8.9 m -127.81 128.33 69.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.324 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -87.34 136.16 33.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.953 -173.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.401 ' HB3' ' CD1' ' A' ' 281' ' ' LEU . 43.9 tp -80.62 -28.81 36.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.512 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -85.91 13.53 7.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.334 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -76.02 117.78 18.1 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 29.5 m -82.87 1.17 3.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.743 -175.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 16.1 m -94.51 -27.95 15.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.69 0.281 . . . . 0.0 111.107 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.6 pp -79.38 174.27 11.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.061 0.457 . . . . 0.0 111.291 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.533 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.6 m -116.36 168.37 8.79 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.16 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 29.3 Cg_exo -39.62 -49.1 3.38 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.793 2.995 . . . . 0.0 114.925 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -61.53 -36.94 82.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.039 0.447 . . . . 0.0 111.297 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 15.5 mm-40 -68.84 -30.4 68.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.603 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -62.86 -25.58 68.35 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.216 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.78 -34.05 69.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.128 0.489 . . . . 0.0 110.298 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -76.05 -30.67 58.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.297 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.791 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -59.26 139.69 56.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.08 -175.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -135.13 -33.36 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.822 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 27.6 m -101.35 171.24 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.969 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -75.33 -57.18 4.05 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.739 -176.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.8 t -139.41 164.1 30.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.666 0.269 . . . . 0.0 110.358 -175.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.6 p -73.91 164.48 26.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.743 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.504 ' HG ' HG21 ' A' ' 230' ' ' VAL . 25.6 tp -67.43 104.27 1.5 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.254 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.57 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -87.07 -174.35 4.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.598 -178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -80.99 157.31 25.55 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.579 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 59.33 39.08 22.75 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.864 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.9 mmt -103.78 130.17 51.27 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -81.69 137.81 35.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.214 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.431 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 22.0 t -111.18 110.06 30.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -123.29 144.21 49.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.638 -173.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 55.6 mt -96.84 127.56 48.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.31 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' LEU . . . . . 0.498 HD11 HG21 ' A' ' 294' ' ' THR . 84.0 mt . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.415 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 32.2 p . . . . . 0 CA--C 1.533 0.294 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -82.14 76.06 2.26 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.083 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 40.1 mt -95.82 153.51 3.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 3.2 p -96.6 151.69 19.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.485 0.659 . . . . 0.0 112.211 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.548 HG11 ' O ' ' A' ' 335' ' ' ALA . 4.2 p -64.5 151.01 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.638 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.1 t -105.52 76.77 1.23 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.61 165.16 40.73 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.059 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.44 122.8 18.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.953 0.406 . . . . 0.0 110.596 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 236' ' ' PHE . 15.9 mm100 -110.0 126.91 54.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.235 0.54 . . . . 0.0 110.496 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.4 p -137.21 112.17 8.97 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.76 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 234' ' ' GLN . 40.9 m-85 -116.95 132.41 56.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.86 0.362 . . . . 0.0 110.926 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -115.94 131.55 23.67 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.367 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 N--CA 1.458 -0.565 0 C-N-CA 122.381 2.054 . . . . 0.0 111.512 177.209 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 121.0 0.428 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.454 ' HB2' ' HG3' ' A' ' 311' ' ' LYS . . . -100.41 115.97 31.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.616 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -85.83 97.78 10.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.978 179.459 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.0 t -81.98 114.18 22.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.977 -173.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 17.5 m -86.42 107.19 17.93 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.985 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.453 HD12 HG22 ' A' ' 264' ' ' THR . 21.0 mt -122.12 167.12 13.53 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -177.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.8 m -55.86 -54.6 42.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.372 0.606 . . . . 0.0 109.65 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -138.4 146.83 42.68 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.453 HG22 HD12 ' A' ' 261' ' ' LEU . 24.3 p -133.6 31.38 3.7 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.889 0.852 . . . . 0.0 108.904 174.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.9 m -80.24 152.7 28.95 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.65 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 90.36 -28.73 7.19 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 52.7 mtt -78.2 135.62 37.65 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.512 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 3.2 ptpp? -134.36 163.53 29.46 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -52.85 126.58 20.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.941 0.4 . . . . 0.0 111.147 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 95.21 18.82 32.43 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.098 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.512 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 66.5 m-20 -100.77 161.39 13.63 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 117.349 0.574 . . . . 0.0 110.892 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.489 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 12.0 tppt? -106.53 117.53 34.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.782 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.475 HD11 HG21 ' A' ' 308' ' ' ILE . 36.5 pt -112.25 139.74 35.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.128 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.416 ' HB3' HG22 ' A' ' 294' ' ' THR . 32.6 p -113.06 134.35 54.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.317 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -100.06 111.55 23.84 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.932 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.96 130.73 46.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.837 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 89.43 -35.51 3.7 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.082 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.6 124.23 35.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -143.01 159.91 41.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.879 0.371 . . . . 0.0 111.183 -175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.435 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 80.7 m-85 -78.66 156.3 29.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.478 -173.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 91.5 mt . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.291 177.104 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 . . . . . 0 C--O 1.233 0.189 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.435 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -65.17 108.93 2.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.123 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.489 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 4.4 p -103.54 110.99 23.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.142 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -115.79 157.68 24.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.158 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 27.8 t -96.89 127.24 42.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.471 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.468 HG12 ' H ' ' A' ' 271' ' ' ASP . 12.1 p -82.85 131.23 34.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.169 0.509 . . . . 0.0 110.228 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 39.2 t -92.21 -36.08 7.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.193 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.408 ' O ' ' HG2' ' A' ' 307' ' ' GLU . 11.1 tpt180 -162.67 144.1 10.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.228 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.464 HG12 ' H ' ' A' ' 303' ' ' GLY . 93.1 t -91.24 114.71 28.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 16.8 t -77.83 -52.29 16.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.976 -172.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -125.11 3.16 7.93 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -172.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' GLY . . . . . 0.464 ' H ' HG12 ' A' ' 300' ' ' VAL . . . 65.22 13.98 58.73 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.295 -171.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -151.9 20.57 0.69 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.561 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.0 t-160 -171.43 114.94 0.39 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 113.821 -1.536 . . . . 0.0 108.296 -164.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.6 m -118.84 160.66 18.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -176.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 299' ' ' ARG . 12.2 pt-20 -118.03 120.5 37.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.081 0.467 . . . . 0.0 109.984 173.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 273' ' ' ILE . 31.0 pt -118.56 164.47 14.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.273 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' THR . . . . . 0.405 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 8.8 t -154.11 140.91 13.15 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.141 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.405 ' C ' ' HA ' ' A' ' 309' ' ' THR . 15.5 Cg_exo -69.02 177.2 27.69 Favored 'Cis proline' 0 C--N 1.347 0.492 0 C-N-CA 123.932 -1.278 . . . . 0.0 112.567 -0.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.454 ' HG3' ' HB2' ' A' ' 257' ' ' ALA . 39.3 ttmt -90.42 124.88 61.62 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.731 -178.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.06 109.38 2.16 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.789 2.326 . . . . 0.0 112.467 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.49 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -112.69 130.83 65.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.897 176.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -81.93 126.97 32.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.173 0.511 . . . . 0.0 111.133 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.2 -31.58 70.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.61 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -82.55 3.61 27.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.588 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ASP . . . . . 0.461 ' OD2' ' HG ' ' A' ' 320' ' ' LEU . 20.2 t70 -72.96 123.11 22.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.888 0.375 . . . . 0.0 110.119 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.51 2.11 4.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 29.1 t -93.93 -31.27 14.36 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -173.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.604 HD13 ' HG2' ' A' ' 325' ' ' ARG . 0.4 OUTLIER -84.09 155.17 22.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.595 0.712 . . . . 0.0 112.492 -177.163 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.485 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 47.1 t -80.12 154.92 75.02 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.919 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.485 ' HD2' ' OG ' ' A' ' 321' ' ' SER . 41.3 Cg_exo -36.13 -52.65 1.05 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 124.087 3.191 . . . . 0.0 114.291 177.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.28 -38.84 84.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.815 0.34 . . . . 0.0 111.122 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 15.3 mm100 -64.65 -26.72 68.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.637 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.604 ' HG2' HD13 ' A' ' 320' ' ' LEU . 88.2 mtt180 -73.33 -19.23 61.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.912 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -78.83 -25.42 44.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.987 175.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -88.69 -11.63 44.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.536 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.49 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -66.76 121.65 15.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.782 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' ASN . . . . . 0.483 ' OD1' HG13 ' A' ' 330' ' ' VAL . 3.2 p30 -102.35 -27.45 12.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.823 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.483 HG13 ' OD1' ' A' ' 329' ' ' ASN . 36.0 m -113.85 168.08 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.998 0.427 . . . . 0.0 110.995 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -88.48 -41.43 12.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.328 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.5 t -123.64 145.36 49.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.252 0.548 . . . . 0.0 110.853 -174.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 7.5 p -73.0 162.57 29.33 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.339 172.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.451 ' HG ' HG21 ' A' ' 230' ' ' VAL . 40.6 tp -71.57 104.16 3.22 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.548 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.01 178.0 8.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.639 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -81.01 153.45 27.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.551 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 66.41 34.51 6.21 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 124.083 0.864 . . . . 0.0 111.897 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.515 ' H ' HG12 ' A' ' 230' ' ' VAL . 78.5 mmm -106.55 149.8 26.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -94.32 140.25 30.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.031 0.443 . . . . 0.0 111.588 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 41.7 t -125.28 120.35 57.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -138.51 148.21 44.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.711 0.291 . . . . 0.0 111.218 -174.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 60.5 mt -87.92 122.57 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.005 0.431 . . . . 0.0 110.585 174.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 47.8 mt . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.281 178.754 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.554 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 22.2 p . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 120.386 0.136 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.99 48.01 88.18 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.569 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.408 HG21 ' O ' ' A' ' 263' ' ' ALA . 71.3 mt -102.25 143.7 14.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 17.5 p -96.84 150.21 20.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.703 0.763 . . . . 0.0 112.243 -173.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.709 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.9 p -62.77 151.26 8.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.469 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 70.9 m -102.2 72.52 1.3 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.95 0.405 . . . . 0.0 110.724 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 99.09 164.86 29.95 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.377 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -88.93 138.53 31.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.618 0.246 . . . . 0.0 110.436 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' A' ' 234' ' ' GLN . 3.1 pt20 -153.58 147.32 25.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.143 0.497 . . . . 0.0 110.849 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 50.7 p -119.06 124.23 46.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.224 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -81.36 146.91 30.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.129 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.408 ' HB3' HE22 ' A' ' 324' ' ' GLN . 48.0 mmtm -141.76 116.57 6.9 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.112 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 N--CA 1.45 -1.058 0 C-N-CA 122.476 2.117 . . . . 0.0 110.436 166.791 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.555 ' O ' ' HE3' ' A' ' 311' ' ' LYS . 40.9 m-85 . . . . . 0 C--O 1.23 0.045 0 CA-C-O 120.823 0.344 . . . . 0.0 111.455 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -130.98 138.52 49.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.662 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 4.0 m -101.54 114.41 28.42 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.434 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.7 t -95.42 125.02 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.234 -174.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 28.3 m -98.74 111.55 23.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.022 177.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 340' ' ' VAL . 14.7 mt -130.59 169.34 15.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.455 -174.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.5 m -62.5 -55.38 28.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.492 0.663 . . . . 0.0 109.829 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.408 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.6 135.04 36.24 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.194 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.4 p -127.45 26.64 5.95 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 172.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 37.8 m -74.5 140.67 44.69 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.129 -1.851 . . . . 0.0 110.548 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 94.32 -11.93 69.68 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 66.0 mtt -86.09 145.2 27.15 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 25.2 pttm -136.22 155.23 50.42 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -57.34 128.48 37.22 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.92 18.47 34.38 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.447 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.548 ' H ' HG12 ' A' ' 297' ' ' VAL . 0.6 OUTLIER -101.28 178.02 4.77 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.5 ' HD3' ' HB ' ' A' ' 294' ' ' THR . 2.3 tmmm? -130.75 116.21 17.69 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.172 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 308' ' ' ILE . 37.7 pt -112.48 151.42 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.936 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.411 ' OG ' HG22 ' A' ' 294' ' ' THR . 18.5 m -140.41 144.07 35.97 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.395 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.486 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 88.7 m-85 -102.77 111.97 24.54 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.593 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.86 113.02 5.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.431 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.44 -18.19 23.11 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.712 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 59.4 t -110.32 114.08 46.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.05 159.4 37.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.814 0.34 . . . . 0.0 111.472 -176.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -69.86 161.46 29.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.045 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 315' ' ' LEU . 87.2 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.916 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.846 0.355 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.659 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -64.21 86.09 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.734 -176.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.5 ' HB ' ' HD3' ' A' ' 272' ' ' LYS . 43.7 p -87.93 110.37 20.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.526 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.659 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 64.7 m-85 -119.45 147.49 44.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.037 0.446 . . . . 0.0 111.381 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.7 m -91.89 127.82 37.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.689 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 271' ' ' ASP . 7.5 p -83.29 130.82 35.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.16 0.505 . . . . 0.0 110.289 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 307' ' ' GLU . 12.8 p -95.06 -30.05 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.498 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -163.38 139.84 7.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.11 0.481 . . . . 0.0 111.253 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 72.7 t -97.36 119.51 45.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.88 -59.88 2.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.838 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -129.23 -3.69 4.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.375 0.607 . . . . 0.0 111.091 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.6 14.44 75.91 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.413 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 14.4 p -143.0 16.09 1.92 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 174.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.414 ' CE1' HG22 ' A' ' 258' ' ' THR . 1.8 t60 -171.54 116.28 0.4 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.807 -168.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.54 163.55 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.632 -174.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.439 ' O ' HG12 ' A' ' 298' ' ' VAL . 6.7 pt-20 -124.85 123.36 39.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.105 0.478 . . . . 0.0 109.943 172.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 297' ' ' VAL . 28.4 pt -129.17 175.05 11.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.284 -174.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' THR . . . . . 0.413 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 11.6 t -154.17 145.39 16.46 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 176.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.79 179.36 29.52 Favored 'Cis proline' 0 C--N 1.345 0.393 0 C-N-CA 124.002 -1.249 . . . . 0.0 112.65 -2.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.555 ' HE3' ' O ' ' A' ' 256' ' ' PHE . 30.1 ttmt -84.42 128.84 60.1 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.854 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.497 ' HG3' ' CE2' ' A' ' 295' ' ' PHE . 7.6 Cg_exo -71.28 108.87 2.45 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.448 2.099 . . . . 0.0 112.283 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.613 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -123.33 129.99 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.546 175.048 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -85.59 131.03 34.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.796 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.405 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.2 tm? -62.29 -32.69 73.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.716 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -92.83 24.83 3.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.351 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.27 128.55 34.31 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 29.3 m -84.48 -1.89 6.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -173.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 33.7 t -110.13 -14.34 14.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -173.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.95 167.9 21.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.6 0.714 . . . . 0.0 112.312 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.4 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 7.9 t -99.98 154.03 37.45 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.15 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.49 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 67.0 Cg_exo -41.86 -47.81 6.27 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.158 2.572 . . . . 0.0 113.549 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 323' ' ' GLU . 1.6 mp0 -53.76 -39.94 65.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.186 0.517 . . . . 0.0 110.933 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.408 HE22 ' HB3' ' A' ' 237' ' ' LYS . 40.5 mt-30 -72.76 -23.88 60.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.823 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.49 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 29.6 mtm180 -66.36 -27.46 67.89 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.942 0.401 . . . . 0.0 110.297 176.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.82 63.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.222 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -96.06 7.57 46.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.939 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.613 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -58.9 140.09 55.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.898 0.38 . . . . 0.0 110.527 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -123.17 -33.43 3.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.412 -170.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 27.5 m -125.47 169.01 17.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.862 0.363 . . . . 0.0 110.16 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -94.07 -16.87 23.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.809 0.338 . . . . 0.0 110.916 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.0 t -144.62 141.33 29.31 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.894 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 50.1 m -80.18 171.99 14.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.2 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 17.7 tp -68.25 103.89 1.7 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.187 0.518 . . . . 0.0 110.364 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.709 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -81.02 170.82 15.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.917 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -79.31 11.56 2.85 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.373 -171.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -142.85 40.99 1.54 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.025 0.44 . . . . 0.0 110.979 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 21.6 mmt -98.99 133.07 43.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.355 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -94.33 130.6 40.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.822 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.469 HG21 HD13 ' A' ' 261' ' ' LEU . 12.2 t -99.78 113.17 34.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.613 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' ASN . . . . . 0.554 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 57.9 t30 -130.65 139.61 50.36 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.032 -177.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.6 mt -86.93 122.82 39.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.939 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 38.0 mt . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.747 -177.943 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 341' ' ' ASN . 31.0 p . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 121.329 0.585 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -113.94 56.43 0.49 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.573 HG21 ' O ' ' A' ' 263' ' ' ALA . 10.9 mt -92.51 161.2 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.22 -0.49 . . . . 0.0 110.342 -172.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 37.0 p -113.22 157.99 21.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.305 0.574 . . . . 0.0 111.369 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.697 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.2 p -72.07 151.63 8.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.454 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 39.8 t -106.24 95.43 5.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.921 174.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 83.42 165.04 37.42 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.92 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -92.99 126.08 37.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -142.0 129.53 21.39 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.249 0.547 . . . . 0.0 111.357 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 15.5 t -106.42 121.9 45.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.551 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.46 ' O ' HG13 ' A' ' 313' ' ' VAL . 91.2 m-85 -83.89 113.53 21.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.862 0.363 . . . . 0.0 110.596 -176.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.419 ' HE2' HD23 ' A' ' 320' ' ' LEU . 33.3 mmtp -124.04 118.48 26.8 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.528 -176.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo . . . . . 0 C--O 1.233 0.254 0 C-N-CA 122.516 2.144 . . . . 0.0 111.774 177.285 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.876 0.37 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.417 ' HB2' ' HA ' ' A' ' 311' ' ' LYS . . . -140.04 120.48 14.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.47 177.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.0 OUTLIER -90.27 104.24 16.84 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.991 0.424 . . . . 0.0 110.338 -179.466 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.456 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.6 t -88.94 117.9 33.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 -173.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 60.6 m -89.59 107.69 19.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.018 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.423 HD12 HG22 ' A' ' 264' ' ' THR . 18.6 mt -123.6 164.11 19.68 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.68 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 17.2 m -57.52 -52.93 63.38 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.432 0.634 . . . . 0.0 109.681 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.573 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.47 146.13 43.9 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 175.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.423 HG22 HD12 ' A' ' 261' ' ' LEU . 16.0 p -132.0 29.93 4.34 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.102 0.953 . . . . 0.0 108.569 174.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 18.3 m -73.74 138.97 44.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.291 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 100.15 -1.06 56.15 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.312 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' MET . . . . . 0.402 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 54.9 mtt -102.04 142.86 32.65 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 62.0 pttt -143.33 148.18 35.87 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -50.18 122.32 6.68 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.601 0.563 . . . . 0.0 111.876 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 97.45 18.35 28.59 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.678 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.523 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.4 t70 -98.06 -171.02 2.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.98 0.39 . . . . 0.0 110.168 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -135.12 117.06 15.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.872 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.498 HD11 HG21 ' A' ' 308' ' ' ILE . 29.6 pt -112.64 140.37 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.421 -0.512 . . . . 0.0 109.974 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 6.8 m -120.86 137.03 54.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.233 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -103.18 111.55 23.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.3 119.03 12.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.365 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.03 -32.14 6.53 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -176.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.49 ' HA ' ' CG2' ' A' ' 332' ' ' THR . 43.7 t -96.73 122.37 48.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 279' ' ' LYS . 11.2 ptpt -140.12 170.1 16.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.878 0.37 . . . . 0.0 111.379 -176.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -81.18 173.41 12.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.753 -174.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 71.9 mt . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.257 -176.724 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 . . . . . 0 C--O 1.235 0.316 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.578 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -52.91 104.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.513 0.508 . . . . 0.0 111.199 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.05 106.48 16.73 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.037 -176.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.519 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 50.2 m-85 -122.96 154.82 37.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.949 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 31.6 t -91.69 134.84 34.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.303 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 271' ' ' ASP . 11.9 p -87.15 126.74 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.218 0.533 . . . . 0.0 110.171 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.6 t -92.59 -38.77 10.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.581 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -159.13 133.89 8.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 50.3 t -93.8 110.28 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 39.5 t -70.16 -58.28 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.887 -171.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -124.34 -8.92 7.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.257 0.551 . . . . 0.0 111.151 -176.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.9 13.86 76.67 Favored Glycine 0 C--N 1.32 -0.309 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -172.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 29.6 p -138.71 13.2 2.72 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 172.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -166.35 120.65 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.519 -170.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.6 159.81 20.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 -176.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -122.77 115.48 22.11 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.284 0.564 . . . . 0.0 109.724 168.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.498 HG21 HD11 ' A' ' 273' ' ' ILE . 30.1 pt -111.83 178.35 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.102 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 15.0 t -153.73 142.73 14.67 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.428 ' HD2' ' CD1' ' A' ' 295' ' ' PHE . 4.8 Cg_exo -82.13 -179.87 25.15 Favored 'Cis proline' 0 C--N 1.344 0.317 0 C-N-CA 124.282 -1.133 . . . . 0.0 112.522 -2.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 257' ' ' ALA . 24.4 ttmm -77.27 124.42 87.04 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.491 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.507 ' HA ' ' OD1' ' A' ' 329' ' ' ASN . 64.3 Cg_endo -77.94 108.6 2.56 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.374 2.05 . . . . 0.0 112.365 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 236' ' ' PHE . 0.2 OUTLIER -109.49 136.17 46.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.028 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' A' ' 317' ' ' ASP . . . -81.47 115.8 20.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.057 0.456 . . . . 0.0 111.106 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.96 -26.54 66.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.528 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.09 12.54 21.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.864 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ASP . . . . . 0.43 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 21.4 t70 -85.66 118.63 25.29 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.88 -14.34 11.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.004 0.43 . . . . 0.0 111.221 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.5 t -77.7 -28.28 50.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.47 -174.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.419 HD23 ' HE2' ' A' ' 237' ' ' LYS . 1.8 pp -71.07 172.92 8.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.31 0.576 . . . . 0.0 112.009 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.436 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 23.5 m -102.65 162.98 18.53 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.483 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.438 ' O ' ' HG3' ' A' ' 325' ' ' ARG . 85.3 Cg_exo -44.62 -52.21 6.31 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.004 3.136 . . . . 0.0 115.39 -172.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -73.42 -18.13 61.18 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.771 -0.581 . . . . 0.0 111.743 -172.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -73.92 -39.7 63.65 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.224 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 322' ' ' PRO . 0.0 OUTLIER -75.07 -16.29 60.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.121 0.486 . . . . 0.0 110.785 178.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -66.71 -35.48 80.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.551 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -95.43 -0.62 52.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.138 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.447 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -66.19 128.45 36.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.15 0.5 . . . . 0.0 111.266 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' ASN . . . . . 0.507 ' OD1' ' HA ' ' A' ' 312' ' ' PRO . 10.2 p30 -110.85 -26.85 9.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.699 -176.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 29.2 m -108.54 164.07 5.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.017 0.437 . . . . 0.0 110.834 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -98.86 -5.66 30.54 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.49 ' CG2' ' HA ' ' A' ' 278' ' ' VAL . 8.9 t -146.05 148.11 32.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.059 0.457 . . . . 0.0 110.882 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 59.5 m -81.26 167.33 19.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.492 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.43 ' HG ' HG21 ' A' ' 230' ' ' VAL . 18.7 tp -76.02 102.92 5.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.697 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.58 167.63 19.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.297 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -80.68 28.7 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -171.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -153.09 32.23 0.48 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.874 0.368 . . . . 0.0 110.838 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.6 mmt -94.22 129.99 40.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.871 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -85.15 140.69 30.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.618 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.4 HG21 HD13 ' A' ' 261' ' ' LEU . 11.2 t -109.46 108.11 24.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.919 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' ASN . . . . . 0.515 ' HA ' ' O ' ' A' ' 226' ' ' THR . 6.8 t30 -119.6 132.11 55.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.15 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 4.0 mt -92.72 129.57 43.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.02 0.438 . . . . 0.0 110.591 175.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 50.8 mt . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.807 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 50.96 37.73 36.76 Favored Glycine 0 C--N 1.332 0.361 0 O-C-N 123.331 0.394 . . . . 0.0 113.056 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.406 HG21 ' O ' ' A' ' 263' ' ' ALA . 44.2 mt -82.5 141.7 14.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -176.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 5.4 p -95.29 147.14 23.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.724 0.773 . . . . 0.0 112.131 -171.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.67 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.6 p -57.54 151.37 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.089 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 33.1 t -101.93 47.7 0.89 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.084 0.469 . . . . 0.0 110.427 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 122.57 163.94 12.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.407 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -79.34 123.26 27.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.797 0.332 . . . . 0.0 110.417 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.437 HE22 ' CB ' ' A' ' 260' ' ' THR . 95.1 mt-30 -132.88 131.55 41.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.228 0.537 . . . . 0.0 111.217 -177.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.1 t -131.34 101.93 5.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.571 ' O ' HG13 ' A' ' 313' ' ' VAL . 64.8 m-85 -94.68 137.45 33.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.219 -176.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.69 ' HB3' ' NE2' ' A' ' 324' ' ' GLN . 3.3 mptp? -109.85 146.56 34.36 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.681 -177.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.456 -0.726 0 C-N-CA 122.571 2.181 . . . . 0.0 111.029 170.776 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 120.928 0.394 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -100.55 122.9 44.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.475 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -90.68 101.26 14.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.016 0.436 . . . . 0.0 111.089 179.002 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.6 t -83.15 121.48 36.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.977 -175.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' THR . . . . . 0.437 ' CB ' HE22 ' A' ' 234' ' ' GLN . 29.0 m -94.28 107.02 18.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.312 0.577 . . . . 0.0 109.985 176.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.481 ' HB2' HG22 ' A' ' 264' ' ' THR . 17.8 mt -121.04 163.19 18.71 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.634 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 26.2 m -55.03 -54.0 48.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.172 0.51 . . . . 0.0 109.958 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.406 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.47 135.45 36.84 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.481 HG22 ' HB2' ' A' ' 261' ' ' LEU . 7.9 p -126.37 29.25 5.82 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.5 m -82.21 139.51 34.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.023 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 96.05 18.48 31.53 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 65.4 mtt -121.45 147.26 45.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.022 -0.589 . . . . 0.0 109.722 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -139.14 169.5 17.66 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.527 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 298' ' ' VAL . 47.6 mtt180 -56.48 128.56 36.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.777 0.323 . . . . 0.0 111.371 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.02 18.57 42.89 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.354 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.488 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 92.0 m-20 -93.78 156.12 16.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.169 0.484 . . . . 0.0 110.302 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -102.9 116.6 32.87 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.423 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.478 HD11 HG21 ' A' ' 308' ' ' ILE . 28.5 pt -113.51 138.69 42.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.095 176.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 10.5 t -120.19 132.25 55.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.461 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.453 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 92.5 m-85 -94.43 110.33 22.12 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.97 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.44 111.37 8.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.374 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.63 -19.95 20.98 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.577 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 74.7 t -104.44 128.7 57.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 174.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -147.11 159.7 43.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.956 0.407 . . . . 0.0 111.106 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 76.9 m-85 -73.66 166.08 23.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.277 -175.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 89.6 mt . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.489 178.267 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 C--O 1.235 0.327 0 CA-C-O 121.037 0.446 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -68.99 129.99 41.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.762 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 9.3 p -119.74 110.6 16.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.847 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -116.95 151.75 36.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.057 0.455 . . . . 0.0 110.95 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.3 m -98.56 131.08 45.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.713 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.488 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.3 p -79.09 131.33 34.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.263 0.554 . . . . 0.0 110.8 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.554 ' O ' ' HG2' ' A' ' 269' ' ' ARG . 25.6 t -94.61 -24.55 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.532 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.445 ' HB3' ' CD ' ' A' ' 307' ' ' GLU . 12.4 tpt180 -176.85 139.33 0.29 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.369 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 75.6 t -90.59 111.02 22.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 36.9 t -73.27 -55.59 12.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.047 -171.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -128.96 -4.26 5.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.191 0.519 . . . . 0.0 111.463 -176.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 80.55 13.32 81.79 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.46 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.3 p -143.51 16.42 1.83 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.1 t-160 -165.47 118.25 1.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.269 -170.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.5 m -118.95 157.54 20.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -176.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.445 ' CD ' ' HB3' ' A' ' 299' ' ' ARG . 8.8 pt-20 -115.39 121.72 43.66 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 173.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.478 HG21 HD11 ' A' ' 273' ' ' ILE . 30.0 pt -122.45 163.75 20.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.184 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.9 t -149.21 142.28 15.85 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.447 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.05 179.63 28.93 Favored 'Cis proline' 0 C--N 1.345 0.35 0 C-N-CA 123.463 -1.474 . . . . 0.0 112.696 -0.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -83.14 124.45 76.33 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.053 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -72.78 109.2 2.74 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.835 2.357 . . . . 0.0 112.225 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 236' ' ' PHE . 0.0 OUTLIER -118.82 137.3 53.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.642 176.16 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -81.46 131.15 35.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.285 0.564 . . . . 0.0 110.459 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -73.79 -29.35 62.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.111 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -93.9 24.79 3.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.346 0.593 . . . . 0.0 110.498 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ASP . . . . . 0.646 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 14.8 t70 -82.05 121.4 26.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.198 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 13.1 p -84.32 -19.09 9.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.986 0.422 . . . . 0.0 110.996 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 34.2 t -71.72 -46.61 58.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.51 -174.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.646 ' HG ' ' OD1' ' A' ' 317' ' ' ASP . 0.3 OUTLIER -74.82 170.15 16.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.739 0.781 . . . . 0.0 113.066 -175.167 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 41.2 t -83.77 151.59 61.49 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.624 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.45 ' HA ' ' HD2' ' A' ' 325' ' ' ARG . 99.9 Cg_exo -45.84 -40.3 19.6 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.183 2.588 . . . . 0.0 113.414 176.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -60.44 -41.53 94.24 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.444 0.64 . . . . 0.0 110.914 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.69 ' NE2' ' HB3' ' A' ' 237' ' ' LYS . 39.2 mt-30 -70.21 -24.44 63.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.037 -177.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.45 ' HD2' ' HA ' ' A' ' 322' ' ' PRO . 90.6 mtt180 -70.34 -26.51 63.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.585 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.5 -29.07 68.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.236 0.541 . . . . 0.0 110.17 176.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -97.38 6.36 48.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.342 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.423 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -71.79 150.13 44.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 0.0 110.884 177.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -126.97 -32.25 2.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.915 0.388 . . . . 0.0 111.387 -174.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.9 m -112.46 155.14 13.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.24 -176.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -83.76 -22.1 32.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.252 0.548 . . . . 0.0 109.99 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 278' ' ' VAL . 1.4 t -129.46 131.44 46.71 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.606 -176.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 8.7 p -75.39 168.13 20.58 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.682 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 20.5 tp -70.22 103.73 2.44 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.67 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.49 173.14 12.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.294 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.31 10.37 3.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.858 -173.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -143.0 57.85 1.41 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.234 0.54 . . . . 0.0 110.786 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.8 mmt -117.11 136.14 53.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.282 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -96.38 131.93 42.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.903 0.382 . . . . 0.0 110.823 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.408 HG22 ' CD1' ' A' ' 275' ' ' PHE . 38.5 t -103.51 108.2 23.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.669 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -123.11 129.55 51.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.337 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 42.9 mt -80.17 125.14 38.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.525 175.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 78.5 mt . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.853 177.194 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 28.6 p . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 120.866 0.365 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.79 63.96 3.06 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.742 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 263' ' ' ALA . 45.5 mm -98.66 139.58 20.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.583 0.23 . . . . 0.0 111.112 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.3 p -121.72 160.24 24.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.949 0.404 . . . . 0.0 110.581 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.629 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.8 p -78.5 151.04 5.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.345 177.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.8 t -116.73 78.81 1.24 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.234 0.54 . . . . 0.0 109.755 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 110.68 166.33 19.1 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.46 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -97.35 110.12 22.74 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -97.51 127.36 43.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.36 0.6 . . . . 0.0 111.604 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.6 m -127.33 101.2 6.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.101 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.419 ' HB3' ' HE2' ' A' ' 311' ' ' LYS . 94.1 m-85 -85.49 167.92 15.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.497 -174.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . 42.7 mmtm -137.65 136.63 20.4 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.496 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.542 ' HD3' HG11 ' A' ' 313' ' ' VAL . 71.6 Cg_endo . . . . . 0 N--CA 1.45 -1.076 0 C-N-CA 122.638 2.226 . . . . 0.0 111.686 177.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 . . . . . 0 C--O 1.233 0.205 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.75 122.67 43.76 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.825 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -90.96 104.3 16.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.501 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.6 t -86.33 121.96 38.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.441 -173.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 63.3 m -91.12 105.35 17.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.218 0.533 . . . . 0.0 110.202 175.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.496 HD23 HG23 ' A' ' 230' ' ' VAL . 21.7 mt -122.02 162.85 20.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.623 -177.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 8.0 m -59.79 -52.05 67.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.169 0.509 . . . . 0.0 109.875 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.533 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.08 125.09 24.29 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.667 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.54 ' HB ' ' SD ' ' A' ' 267' ' ' MET . 6.7 p -124.92 27.07 6.86 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.138 0.971 . . . . 0.0 108.589 174.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 8.3 m -82.89 138.05 34.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.585 177.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 101.7 -14.31 57.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -175.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' MET . . . . . 0.54 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 64.5 mtt -82.82 153.73 25.04 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -153.67 142.61 21.17 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.549 ' HA ' HG13 ' A' ' 297' ' ' VAL . 34.6 ptt180 -50.87 114.03 1.06 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.624 0.578 . . . . 0.0 111.401 -173.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.16 -2.43 22.49 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.74 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.489 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.4 p30 -81.67 -179.25 7.3 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 117.258 0.529 . . . . 0.0 111.243 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -131.93 116.51 17.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.845 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.402 HD11 HG21 ' A' ' 308' ' ' ILE . 22.3 pt -114.14 138.9 42.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.148 0.499 . . . . 0.0 110.769 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 13.3 t -118.51 137.07 53.45 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.615 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -103.69 111.36 23.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.037 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.54 118.82 13.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.688 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.99 -13.74 26.56 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.682 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.02 147.94 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -161.24 156.55 24.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.912 0.387 . . . . 0.0 111.48 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -81.15 153.46 27.24 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.465 -171.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.46 HD11 ' HB2' ' A' ' 315' ' ' LEU . 83.7 mt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.213 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 . . . . . 0 C--O 1.233 0.235 0 CA-C-O 121.017 0.437 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -57.71 117.76 4.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.085 -172.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 37.9 p -105.01 113.75 27.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.565 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -110.94 148.44 32.5 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.992 0.425 . . . . 0.0 110.735 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 16.0 m -96.23 127.92 42.67 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.001 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.58 ' HA ' HG22 ' A' ' 308' ' ' ILE . 2.5 p -73.95 140.62 17.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.7 t -104.09 -31.85 2.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.055 0.455 . . . . 0.0 109.88 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.552 ' HD2' ' OE2' ' A' ' 307' ' ' GLU . 1.2 tmt_? -173.47 138.41 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.0 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 79.4 t -90.64 116.8 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 22.2 t -78.01 -58.8 3.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.042 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -116.71 -10.62 11.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.918 0.389 . . . . 0.0 111.864 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 78.53 12.22 84.48 Favored Glycine 0 CA--C 1.517 0.204 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -171.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.8 p -149.92 22.3 0.88 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.473 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 8.5 t-160 -174.08 115.59 0.21 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 113.561 -1.654 . . . . 0.0 107.999 -166.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.23 166.51 13.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.552 ' OE2' ' HD2' ' A' ' 299' ' ' ARG . 10.5 pt-20 -123.79 122.34 37.8 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 169.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.58 HG22 ' HA ' ' A' ' 297' ' ' VAL . 30.0 pt -121.2 170.74 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.51 -174.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' THR . . . . . 0.408 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 11.8 t -152.01 139.93 13.07 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.969 172.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.408 ' C ' ' HA ' ' A' ' 309' ' ' THR . 61.6 Cg_endo -71.14 179.4 25.39 Favored 'Cis proline' 0 C--N 1.345 0.368 0 C-N-CA 123.846 -1.314 . . . . 0.0 113.209 2.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.509 ' HG2' HG13 ' A' ' 313' ' ' VAL . 19.6 ttmt -84.95 126.37 68.17 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.669 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 19.9 Cg_exo -65.9 108.11 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.316 2.011 . . . . 0.0 111.84 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.542 HG11 ' HD3' ' A' ' 238' ' ' PRO . 1.3 m -130.87 129.54 63.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.151 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -93.06 141.5 28.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.433 -173.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.46 ' HB2' HD11 ' A' ' 281' ' ' LEU . 2.8 tm? -75.07 -26.16 59.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.483 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -94.83 26.0 3.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.644 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -83.49 136.56 34.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 27.8 m -83.81 -9.77 11.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 9.6 t -120.22 23.33 11.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.938 0.399 . . . . 0.0 111.626 -171.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.23 168.67 10.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.077 0.465 . . . . 0.0 111.026 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 51.9 m -112.49 165.25 13.43 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.358 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.462 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 85.5 Cg_exo -45.25 -49.45 10.16 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.517 2.812 . . . . 0.0 114.737 -175.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.2 -28.94 61.51 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.807 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -67.99 -41.13 82.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.663 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.462 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 28.8 ptt180 -69.12 -23.43 63.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.145 0.498 . . . . 0.0 110.17 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -80.68 -10.25 59.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.628 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -118.41 16.52 13.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.783 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.413 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -65.1 151.27 46.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.223 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' ASN . . . . . 0.413 ' H ' HG23 ' A' ' 313' ' ' VAL . 83.3 m-20 -115.21 -39.64 3.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.796 -175.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 30.7 m -118.26 168.28 10.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.22 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -82.31 -49.63 9.83 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.874 0.368 . . . . 0.0 110.798 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 13.5 t -117.79 149.82 40.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.202 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 22.6 p -80.8 171.23 15.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.009 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 20.1 tp -73.75 111.27 8.74 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.629 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -82.0 170.68 15.29 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.137 0.494 . . . . 0.0 111.435 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.07 -8.92 57.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.506 -169.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -138.33 55.36 1.75 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.04 0.448 . . . . 0.0 111.578 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.52 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 14.5 mmt -102.33 147.57 26.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.162 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -96.14 143.56 27.16 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.68 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.463 ' O ' ' HB ' ' A' ' 228' ' ' ILE . 17.7 t -115.52 126.89 73.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -133.35 136.35 45.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.177 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 25.2 mt -90.1 124.38 42.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.919 0.39 . . . . 0.0 110.324 174.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 45.2 mt . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.212 178.385 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.531 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 23.2 p . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 60.67 39.3 96.41 Favored Glycine 0 CA--C 1.516 0.144 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.313 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.553 HG21 ' O ' ' A' ' 263' ' ' ALA . 71.9 mt -102.95 143.86 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 7.0 p -111.3 151.43 28.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.079 0.466 . . . . 0.0 111.246 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.644 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.5 p -60.75 150.48 6.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.807 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 8.8 t -112.3 82.21 1.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.115 0.484 . . . . 0.0 109.747 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 92.66 149.61 24.99 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.858 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.56 121.75 17.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.837 0.351 . . . . 0.0 110.552 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -113.25 126.96 55.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.203 0.525 . . . . 0.0 110.238 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 20.3 p -127.9 104.0 7.57 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.171 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -81.51 161.51 23.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.789 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -142.02 133.74 13.38 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.601 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.57 ' HD3' HG11 ' A' ' 313' ' ' VAL . 84.7 Cg_endo . . . . . 0 N--CA 1.454 -0.819 0 C-N-CA 122.853 2.368 . . . . 0.0 111.435 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.991 0.424 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -119.86 126.98 52.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.524 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.5 m -93.96 99.19 11.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.01 0.433 . . . . 0.0 110.62 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.456 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.7 t -83.66 120.16 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.168 -174.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 19.3 m -91.55 105.75 17.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.835 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.428 ' HB2' HG22 ' A' ' 264' ' ' THR . 19.9 mt -121.63 169.41 10.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.257 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 6.6 m -63.05 -55.19 27.68 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.553 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -136.62 131.15 33.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.696 178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.438 ' HB ' ' SD ' ' A' ' 267' ' ' MET . 3.2 p -129.51 27.49 5.27 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 18.4 m -82.69 141.88 32.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.096 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.03 -3.95 60.62 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -174.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' MET . . . . . 0.438 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 89.5 mtp -86.9 152.85 22.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -154.84 140.85 18.34 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.22 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.655 ' HA ' HG13 ' A' ' 297' ' ' VAL . 35.9 ptt180 -52.45 117.82 3.14 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.374 0.606 . . . . 0.0 111.089 -175.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.47 1.12 21.8 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.378 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -84.06 179.68 7.45 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.132 0.466 . . . . 0.0 110.507 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.485 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 5.1 tppp? -137.67 115.94 11.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.827 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 308' ' ' ILE . 35.7 pt -112.99 140.0 35.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.206 0.527 . . . . 0.0 110.389 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 17.9 m -131.39 138.73 49.24 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.663 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -100.29 113.5 26.25 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.096 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.94 113.56 2.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.499 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.77 -34.34 5.16 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.932 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.7 t -81.14 127.85 39.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -149.12 161.75 41.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.708 0.289 . . . . 0.0 110.896 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 91.8 m-85 -83.67 158.42 21.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.053 -175.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 315' ' ' LEU . 95.5 mt . . . . . 0 C--O 1.235 0.328 0 CA-C-O 121.305 0.574 . . . . 0.0 111.26 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -59.78 106.76 0.52 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.957 0.408 . . . . 0.0 111.334 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.485 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 21.3 p -88.59 115.6 26.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.501 -177.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -121.31 144.31 48.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.367 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 68.4 m -101.32 132.39 46.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.749 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.655 HG13 ' HA ' ' A' ' 269' ' ' ARG . 9.3 p -67.49 140.35 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.126 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.63 -42.65 7.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.111 175.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.417 ' HB3' ' CD ' ' A' ' 307' ' ' GLU . 23.5 tpt180 -157.33 128.06 6.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.85 -178.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 97.8 t -86.3 97.8 6.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 172.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 25.4 t -65.9 -58.74 5.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.691 -173.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -126.66 -8.31 6.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.141 0.496 . . . . 0.0 111.472 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.15 13.81 78.27 Favored Glycine 0 C--N 1.321 -0.252 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.677 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 21.6 p -138.95 10.31 2.6 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 170.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.478 ' CE1' HG22 ' A' ' 258' ' ' THR . 1.5 t60 -162.74 116.6 1.71 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.453 -1.249 . . . . 0.0 107.894 -169.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.99 160.29 18.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.674 -172.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.0 pt-20 -121.28 122.58 40.22 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 168.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.52 HG21 HD11 ' A' ' 273' ' ' ILE . 23.4 pt -123.49 169.39 14.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.228 0.537 . . . . 0.0 112.309 -174.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.0 t -145.38 138.83 14.38 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.788 172.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.33 -179.75 24.62 Favored 'Cis proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.759 -1.35 . . . . 0.0 113.313 -1.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.449 ' HG3' ' HB2' ' A' ' 257' ' ' ALA . 3.3 ttmp? -87.42 125.53 65.29 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.558 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 14.4 Cg_exo -68.61 108.85 1.94 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.369 2.046 . . . . 0.0 111.861 175.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 328' ' ' ALA . 1.5 m -136.3 120.86 25.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -82.49 134.43 35.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.838 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.9 tm? -75.69 -25.05 56.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.618 176.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -85.9 6.02 30.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.14 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -77.2 126.8 31.53 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.2 m -83.94 2.35 3.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 7.7 m -103.5 23.22 12.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.703 0.287 . . . . 0.0 111.77 -172.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.472 HD13 ' HG2' ' A' ' 325' ' ' ARG . 1.0 OUTLIER -126.18 157.2 38.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.44 0.638 . . . . 0.0 112.25 -179.29 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.497 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 2.8 m -92.25 166.81 16.35 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.554 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 2.3 Cg_endo -42.18 -58.08 1.34 Allowed 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.759 2.973 . . . . 0.0 113.864 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -60.4 -36.88 79.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.137 0.494 . . . . 0.0 111.084 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 64.2 mm-40 -63.4 -30.5 71.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.664 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.472 ' HG2' HD13 ' A' ' 320' ' ' LEU . 34.2 mtp85 -61.28 -39.31 89.93 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.226 176.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.04 -26.15 68.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.066 0.46 . . . . 0.0 110.922 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -87.11 -12.88 45.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.232 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.605 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -72.3 151.63 42.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.515 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -137.18 -35.72 0.68 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -173.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.3 m -101.93 167.62 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.852 0.358 . . . . 0.0 111.092 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -83.63 -39.3 20.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.919 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.1 t -126.69 139.54 53.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.673 -177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.461 ' N ' ' HB2' ' A' ' 314' ' ' ALA . 46.3 m -70.42 171.92 9.24 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.411 ' HG ' HG21 ' A' ' 230' ' ' VAL . 20.3 tp -71.24 103.91 2.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.644 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -79.62 172.12 14.22 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.878 -175.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.51 -11.61 60.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.129 -171.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -132.49 71.27 1.47 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.016 0.436 . . . . 0.0 111.223 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.477 ' H ' HG12 ' A' ' 230' ' ' VAL . 23.5 mmt -121.84 133.84 54.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.666 175.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -85.38 136.54 33.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.906 0.384 . . . . 0.0 111.301 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 17.4 t -101.4 112.82 35.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.703 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' ASN . . . . . 0.531 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 5.7 t-20 -129.91 138.8 51.1 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.815 0.34 . . . . 0.0 111.382 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 62.3 mt -92.1 125.92 44.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 172.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 40.4 mt . . . . . 0 C--N 1.323 -0.577 0 CA-C-O 120.97 0.414 . . . . 0.0 111.012 -178.38 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 3.8 p . . . . . 0 N--CA 1.448 -0.55 0 CA-C-O 121.146 0.498 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -116.52 37.53 3.35 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.505 HG21 ' O ' ' A' ' 263' ' ' ALA . 37.9 mt -82.28 152.44 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.277 -0.461 . . . . 0.0 109.883 -173.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 22.0 p -114.64 162.59 16.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.454 0.645 . . . . 0.0 111.808 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.641 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.8 p -62.7 151.75 7.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.897 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 16.5 t -116.82 78.9 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.195 0.521 . . . . 0.0 109.615 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 100.82 145.79 17.89 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.904 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.83 111.74 5.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.844 0.354 . . . . 0.0 110.304 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -109.15 127.8 54.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.264 0.554 . . . . 0.0 110.834 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 16.7 p -115.95 143.12 45.88 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.639 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -115.99 154.45 29.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.791 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -143.45 135.56 13.2 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.501 ' HD3' HG11 ' A' ' 313' ' ' VAL . 10.9 Cg_endo . . . . . 0 N--CA 1.454 -0.836 0 C-N-CA 122.892 2.395 . . . . 0.0 110.66 169.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 308' ' ' ILE . 51.7 m-85 . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 120.908 0.385 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -153.57 125.23 7.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.677 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -90.18 104.13 16.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.246 0.546 . . . . 0.0 111.147 178.004 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.8 t -86.61 121.09 37.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.998 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 30.5 m -92.84 109.54 20.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.992 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.413 HD22 HG21 ' A' ' 340' ' ' VAL . 17.4 mt -124.54 176.03 6.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.918 -176.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 35.0 t -64.56 -59.66 4.03 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.505 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.58 138.7 39.83 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 7.6 p -126.97 28.09 5.86 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.004 0.906 . . . . 0.0 108.914 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 1.3 m -78.81 151.28 32.02 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.981 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 93.11 -22.44 34.57 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' MET . . . . . 0.462 ' HG2' HD11 ' A' ' 342' ' ' ILE . 53.8 mtt -79.6 144.67 33.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.574 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 0.3 OUTLIER -137.31 152.48 49.8 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -50.82 126.03 14.87 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.568 0.542 . . . . 0.0 111.474 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.95 19.23 37.35 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.567 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.574 ' HB2' ' O ' ' A' ' 268' ' ' LYS . 0.8 OUTLIER -98.81 177.39 5.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.973 0.416 . . . . 0.0 110.673 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -122.02 116.34 24.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.908 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.504 HD11 HG21 ' A' ' 308' ' ' ILE . 40.3 pt -113.19 140.28 34.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.215 177.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -118.24 133.47 55.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.215 -176.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -99.63 110.99 23.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.894 0.378 . . . . 0.0 110.028 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.09 117.81 15.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.531 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.79 -24.41 15.09 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 42.4 t -99.99 133.85 41.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -151.1 160.63 43.77 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 120.993 0.425 . . . . 0.0 111.066 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -78.19 154.33 31.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.369 -169.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.463 HD11 ' HB2' ' A' ' 315' ' ' LEU . 84.4 mt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.388 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 . . . . . 0 C--O 1.235 0.296 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.484 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -60.33 102.05 0.16 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.26 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 1.2 p -103.44 117.84 35.38 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.245 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.484 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 85.1 m-85 -124.36 152.59 42.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.13 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.7 m -92.2 125.5 36.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.198 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 271' ' ' ASP . 10.9 p -81.48 130.17 36.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.301 0.572 . . . . 0.0 110.521 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 58.6 t -90.53 -38.7 11.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.548 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -160.41 141.47 12.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.202 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 90.4 t -94.38 107.56 19.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 27.3 t -77.41 -59.17 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.873 -172.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -120.21 -7.58 9.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.384 0.611 . . . . 0.0 111.116 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 79.27 14.18 81.93 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.316 -174.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 25.6 p -137.18 7.55 2.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.155 0.979 . . . . 0.0 108.525 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.568 ' NE2' ' HB ' ' A' ' 258' ' ' THR . 3.5 t-160 -160.88 118.96 2.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.392 -170.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -118.73 155.49 20.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -115.04 115.01 26.14 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.504 HG21 HD11 ' A' ' 273' ' ' ILE . 25.4 pt -114.2 176.72 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.711 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 5.2 t -154.17 141.53 13.59 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.674 174.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.09 -179.9 28.35 Favored 'Cis proline' 0 C--N 1.346 0.4 0 C-N-CA 123.818 -1.326 . . . . 0.0 112.568 -4.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -81.18 126.11 77.75 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.857 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.49 109.13 2.78 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.43 2.087 . . . . 0.0 111.887 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.755 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.4 OUTLIER -126.56 134.16 66.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.694 178.425 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -91.85 135.29 34.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.72 -173.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.463 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.3 tm? -70.55 -30.24 66.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.834 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -86.2 11.13 12.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.186 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.52 121.91 25.19 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 31.1 m -83.54 1.81 3.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -174.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.2 t -102.56 -6.5 22.76 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.424 -174.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.4 pp -102.82 153.77 19.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.49 0.662 . . . . 0.0 111.684 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 14.8 m -87.51 160.95 46.78 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.004 -177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -39.14 -50.49 2.72 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.923 3.082 . . . . 0.0 114.612 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -58.09 -41.17 82.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.255 0.55 . . . . 0.0 111.333 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 47.9 mt-30 -70.48 -26.31 63.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.711 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.421 ' HG2' ' CD1' ' A' ' 320' ' ' LEU . 76.6 mtt180 -61.04 -35.43 76.89 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 121.018 0.437 . . . . 0.0 110.445 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.89 -28.88 67.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.431 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' TYR . . . . . 0.455 ' CD2' ' HA ' ' A' ' 324' ' ' GLN . 12.0 m-85 -81.71 -11.05 59.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.824 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.755 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -65.59 139.01 58.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.991 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -127.62 -17.07 4.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.882 -175.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 31.5 m -122.11 158.23 25.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.929 0.395 . . . . 0.0 110.113 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -91.16 -7.01 52.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.307 -174.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.7 t -147.72 140.98 25.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.096 0.474 . . . . 0.0 110.824 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 26.9 p -78.28 168.05 20.42 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.316 175.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 19.3 tp -74.11 105.42 5.32 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.641 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -79.82 -178.8 6.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.055 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.06 -7.1 57.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.973 -172.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -133.74 57.83 1.79 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.849 0.357 . . . . 0.0 111.736 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.407 ' H ' HG12 ' A' ' 230' ' ' VAL . 25.2 mmt -111.78 137.46 49.67 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -92.25 145.46 24.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.778 0.323 . . . . 0.0 111.047 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.413 HG21 HD22 ' A' ' 261' ' ' LEU . 19.3 t -118.69 118.2 57.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.866 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -134.73 135.75 42.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.99 0.424 . . . . 0.0 111.557 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.462 HD11 ' HG2' ' A' ' 267' ' ' MET . 21.1 mt -87.62 127.46 40.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.813 176.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.05 176.303 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.561 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 34.2 p . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 55.65 48.94 68.05 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.834 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.508 HG21 ' O ' ' A' ' 263' ' ' ALA . 57.2 mt -103.07 142.54 16.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 37.1 p -97.82 150.12 21.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.408 0.623 . . . . 0.0 112.261 -173.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.564 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.2 p -61.53 150.93 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.599 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 37.0 m -126.05 84.94 2.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.152 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 113.0 130.56 5.32 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.477 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -79.37 123.43 27.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -142.22 130.33 22.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.223 0.535 . . . . 0.0 111.474 -172.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.9 t -107.98 110.46 22.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.281 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.532 ' O ' HG13 ' A' ' 313' ' ' VAL . 62.4 m-85 -81.05 120.13 24.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.507 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -115.27 127.42 26.83 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.696 -175.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo . . . . . 0 N--CA 1.46 -0.464 0 C-N-CA 122.895 2.396 . . . . 0.0 111.265 173.563 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.442 ' CD2' ' HB ' ' A' ' 309' ' ' THR . 96.7 m-85 . . . . . 0 N--CA 1.456 -0.136 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -136.01 129.31 31.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.479 0.18 . . . . 0.0 110.785 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.5 m -97.88 107.64 20.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.05 0.452 . . . . 0.0 109.984 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.41 120.27 36.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.205 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 60.4 m -91.01 115.33 27.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.823 173.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 17.2 mt -132.24 168.86 17.31 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 5.3 p -60.52 -55.96 27.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.196 0.522 . . . . 0.0 110.136 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.508 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -136.75 136.81 39.26 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.146 177.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 15.8 p -132.11 32.75 3.97 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 6.9 m -82.47 149.25 27.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.308 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 93.51 13.37 55.64 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 62.7 mtt -114.02 148.0 37.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.367 -0.417 . . . . 0.0 110.141 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -134.41 156.33 48.73 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -54.15 121.96 9.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.074 0.464 . . . . 0.0 110.762 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 106.75 7.97 33.01 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.862 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.503 ' H ' HG12 ' A' ' 297' ' ' VAL . 80.1 m-20 -90.79 148.54 22.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.419 0.609 . . . . 0.0 110.16 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 4.6 tppp? -96.03 117.67 31.13 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.725 -177.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.435 HD11 HG21 ' A' ' 308' ' ' ILE . 38.5 pt -112.58 139.96 34.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 176.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 45.5 m -120.5 136.48 54.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.516 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -100.7 111.46 23.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.871 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -74.15 114.21 12.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.709 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.55 -34.39 5.17 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 86.0 t -90.95 111.71 24.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.85 170.07 13.82 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.406 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -75.95 171.73 13.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.644 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.105 177.881 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -59.18 100.33 0.07 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.882 -174.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.0 p -98.99 99.63 10.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.673 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.474 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 61.3 m-85 -118.23 142.8 47.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.09 0.472 . . . . 0.0 111.139 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.2 t -89.97 126.27 35.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.494 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 271' ' ' ASP . 11.5 p -69.12 135.13 28.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.122 0.487 . . . . 0.0 110.136 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.24 -32.93 4.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.684 -176.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.592 ' HD2' ' OE2' ' A' ' 307' ' ' GLU . 0.4 OUTLIER -167.85 137.07 2.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.255 -176.129 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 75.3 t -85.02 111.38 20.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 19.2 t -77.76 -53.9 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.646 -173.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -125.89 -11.63 6.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.81 0.338 . . . . 0.0 111.812 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 77.6 12.49 84.45 Favored Glycine 0 CA--C 1.516 0.145 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -170.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.0 p -149.9 22.17 0.88 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 174.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -174.04 112.63 0.18 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 113.378 -1.737 . . . . 0.0 107.991 -163.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.0 OUTLIER -119.43 164.05 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -174.685 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.592 ' OE2' ' HD2' ' A' ' 299' ' ' ARG . 11.4 pt-20 -125.01 127.01 46.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.218 0.532 . . . . 0.0 110.127 170.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.435 HG21 HD11 ' A' ' 273' ' ' ILE . 24.0 pt -120.42 175.79 4.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.884 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' THR . . . . . 0.442 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 14.2 t -154.61 143.53 14.84 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.853 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.98 179.4 31.15 Favored 'Cis proline' 0 C--N 1.346 0.406 0 C-N-CA 123.709 -1.371 . . . . 0.0 112.512 -4.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' A' ' 257' ' ' ALA . 22.4 ttmm -76.94 121.68 85.16 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.504 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.09 108.54 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.217 1.944 . . . . 0.0 112.327 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 236' ' ' PHE . 0.1 OUTLIER -109.35 137.67 40.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.121 175.674 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -81.98 123.25 28.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.095 0.474 . . . . 0.0 110.513 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.5 -29.5 70.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.894 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.45 19.65 4.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.495 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -83.47 119.91 25.26 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.9 m -84.43 0.4 5.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -174.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 37.2 t -95.47 -28.16 15.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.566 0.222 . . . . 0.0 111.404 -174.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.425 ' CD1' ' HG2' ' A' ' 325' ' ' ARG . 0.9 OUTLIER -80.64 160.61 25.0 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.413 0.625 . . . . 0.0 112.41 -175.8 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.533 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 34.4 t -87.04 157.42 54.15 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.146 -178.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.533 ' HD2' ' OG ' ' A' ' 321' ' ' SER . 2.8 Cg_exo -35.61 -58.01 0.47 Allowed 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 124.764 3.643 . . . . 0.0 115.513 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.64 -25.08 64.65 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.376 -174.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 321' ' ' SER . 61.6 mm-40 -61.15 -34.48 75.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.038 0.447 . . . . 0.0 110.116 174.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.425 ' HG2' ' CD1' ' A' ' 320' ' ' LEU . 31.1 mtm180 -64.77 -32.67 74.46 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.724 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -70.62 -24.94 62.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.087 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.77 -2.3 57.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.685 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.455 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -67.81 156.27 37.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.066 0.46 . . . . 0.0 111.022 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -138.42 -20.84 1.05 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.292 -173.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 23.4 m -125.28 160.17 31.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.946 0.403 . . . . 0.0 110.399 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -89.16 -17.14 29.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.527 -175.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 8.8 t -143.42 142.89 31.39 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 22.6 p -75.72 170.33 16.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.736 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.463 ' HG ' HG21 ' A' ' 230' ' ' VAL . 17.0 tp -72.34 103.3 3.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.564 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -81.99 -170.88 3.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.19 -176.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -80.32 -8.5 59.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.013 -175.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -137.42 66.97 1.44 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.0 0.429 . . . . 0.0 111.567 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.559 ' H ' HG12 ' A' ' 230' ' ' VAL . 23.1 mmt -119.86 132.48 55.58 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -91.25 137.16 32.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.839 0.352 . . . . 0.0 111.007 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 32.7 t -114.25 107.2 22.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.239 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 341' ' ' ASN . . . . . 0.561 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 64.5 t30 -126.35 145.62 50.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.922 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 22.8 mt -89.56 132.37 34.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 177.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 80.8 mt . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.542 176.566 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 120.343 0.116 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.56 39.77 95.46 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.006 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.6 HG21 ' O ' ' A' ' 263' ' ' ALA . 55.7 mt -103.05 145.28 12.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 36.0 p -99.22 160.79 14.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.417 0.627 . . . . 0.0 112.248 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.678 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.7 p -68.88 152.04 9.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.495 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.1 m -122.08 86.77 2.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.949 0.404 . . . . 0.0 110.7 173.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 102.56 137.2 9.47 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.337 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.54 130.27 42.69 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -132.9 127.14 33.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.165 0.507 . . . . 0.0 111.31 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.8 t -117.26 103.12 9.85 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -80.8 129.1 34.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.319 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -117.19 125.75 27.96 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.052 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 N--CA 1.461 -0.438 0 C-N-CA 123.111 2.541 . . . . 0.0 111.639 176.472 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 . . . . . 0 N--CA 1.45 -0.467 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -109.26 124.03 50.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.951 176.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.7 m -97.47 107.14 19.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.225 0.536 . . . . 0.0 110.275 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -89.0 124.86 42.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.603 -170.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 55.6 m -95.18 114.59 26.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.799 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.556 HD13 HG21 ' A' ' 340' ' ' VAL . 17.4 mt -129.87 170.52 13.8 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -176.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 16.8 m -57.31 -56.93 15.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.389 0.614 . . . . 0.0 109.599 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.6 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -138.52 141.02 39.34 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.776 175.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 11.2 p -130.8 26.49 4.98 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.7 m -80.49 147.5 30.86 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.526 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 95.24 -28.11 12.98 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -177.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 62.1 mtt -71.42 153.47 42.25 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -135.53 151.02 49.92 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.807 0.337 . . . . 0.0 110.58 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -56.39 131.8 49.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.204 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.77 19.14 32.53 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.352 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.488 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.8 t70 -103.28 -167.51 1.39 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 117.555 0.677 . . . . 0.0 110.159 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.441 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 3.9 tppp? -129.76 115.7 17.67 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.593 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.442 HD11 HG21 ' A' ' 308' ' ' ILE . 20.0 pt -115.06 142.76 26.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.134 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.516 ' HB3' HG22 ' A' ' 294' ' ' THR . 73.5 p -128.85 143.69 50.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.149 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -105.2 114.02 27.95 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.044 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.82 115.98 3.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.828 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.94 -31.15 6.95 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.105 -177.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 292' ' ' ASP . 48.5 t -84.54 136.08 23.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.525 ' NZ ' ' HB3' ' A' ' 279' ' ' LYS . 0.1 OUTLIER -160.76 156.33 25.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.112 0.482 . . . . 0.0 111.413 -177.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 329' ' ' ASN . 63.0 m-85 -76.58 148.63 36.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.372 -170.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.495 HD11 ' HB2' ' A' ' 315' ' ' LEU . 59.5 mt . . . . . 0 CA--C 1.519 -0.214 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.461 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 60.3 m-20 . . . . . 0 CA--C 1.518 -0.26 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -57.07 116.07 3.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.636 -174.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 274' ' ' SER . 28.1 p -97.81 129.17 44.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.866 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -130.63 143.14 50.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.783 0.325 . . . . 0.0 110.699 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 62.5 m -78.72 126.96 31.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.101 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.515 ' HA ' HG22 ' A' ' 308' ' ' ILE . 13.5 p -84.06 126.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.262 0.553 . . . . 0.0 110.018 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 44.7 t -84.01 -40.85 16.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.379 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -163.29 142.26 8.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.405 ' CG1' ' HA2' ' A' ' 303' ' ' GLY . 89.6 t -82.59 106.95 13.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 26.7 t -72.82 -58.7 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.945 -170.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -119.59 0.48 11.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.94 0.4 . . . . 0.0 111.331 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' GLY . . . . . 0.405 ' HA2' ' CG1' ' A' ' 300' ' ' VAL . . . 70.81 12.73 71.25 Favored Glycine 0 C--O 1.23 -0.143 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -173.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 19.4 p -149.31 19.72 0.95 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 174.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.551 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.9 t-160 -170.89 115.46 0.44 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 113.737 -1.574 . . . . 0.0 107.976 -164.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.73 165.04 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.494 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -123.86 122.1 37.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.051 0.453 . . . . 0.0 110.264 172.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.515 HG22 ' HA ' ' A' ' 297' ' ' VAL . 28.2 pt -124.03 168.55 16.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.102 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 310' ' ' PRO . 15.1 t -154.57 145.18 16.05 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.4 ' HA ' ' OG1' ' A' ' 309' ' ' THR . 10.2 Cg_exo -72.29 178.13 32.23 Favored 'Cis proline' 0 C--N 1.344 0.337 0 C-N-CA 124.013 -1.245 . . . . 0.0 112.556 0.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -87.39 123.37 69.83 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.743 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.448 ' HA ' ' OD1' ' A' ' 329' ' ' ASN . 48.7 Cg_endo -71.41 108.94 2.49 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.37 2.046 . . . . 0.0 112.091 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.56 132.0 57.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.713 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 317' ' ' ASP . . . -83.09 121.92 27.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.081 0.467 . . . . 0.0 110.448 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.495 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.0 tm? -62.99 -30.2 71.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.725 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -86.39 5.12 36.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.393 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 317' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 10.6 t70 -89.91 111.68 22.8 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 17.9 m -83.61 2.4 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 9.4 t -92.95 29.09 1.91 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.027 0.441 . . . . 0.0 110.832 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 2.5 pp -129.06 171.32 12.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.879 0.371 . . . . 0.0 111.467 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 41.7 t -85.96 149.14 49.85 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.105 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.655 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 1.4 Cg_endo -42.27 -47.29 7.19 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.84 3.027 . . . . 0.0 113.885 -177.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.443 ' O ' ' HD1' ' A' ' 327' ' ' TYR . 58.6 mm-40 -63.16 -23.38 67.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.98 0.419 . . . . 0.0 111.456 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -81.27 -24.34 37.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.784 -174.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 5.3 ptp180 -78.28 -22.31 48.43 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.096 0.474 . . . . 0.0 110.04 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -69.15 -36.03 76.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.183 174.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' TYR . . . . . 0.443 ' HD1' ' O ' ' A' ' 323' ' ' GLU . 77.8 m-85 -90.05 3.05 54.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.839 178.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -70.26 123.94 22.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.03 0.443 . . . . 0.0 110.022 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 329' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 312' ' ' PRO . 26.7 p-10 -109.28 -17.92 13.71 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.506 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.3 m -118.85 159.4 19.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.188 0.518 . . . . 0.0 110.798 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -96.84 -12.04 24.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.164 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.4 t -141.02 148.63 40.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.435 -176.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 7.6 p -85.04 166.27 16.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.694 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.611 HD12 ' SD ' ' A' ' 338' ' ' MET . 21.2 tp -67.74 104.4 1.64 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.678 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -84.04 156.82 22.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.772 -175.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.59 58.08 2.15 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.252 0.549 . . . . 0.0 111.942 -173.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -176.04 27.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.494 172.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.611 ' SD ' HD12 ' A' ' 334' ' ' LEU . 54.4 mtt -100.06 131.83 45.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -176.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -87.64 140.22 29.74 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.924 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.556 HG21 HD13 ' A' ' 261' ' ' LEU . 9.0 t -99.83 113.5 35.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.537 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -122.56 133.4 54.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.404 -175.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.438 ' CG1' HG22 ' A' ' 273' ' ' ILE . 14.6 mt -99.23 130.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.066 0.46 . . . . 0.0 110.798 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 46.3 mt . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.763 -178.82 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.674 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 41.6 p . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 120.394 0.14 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 58.05 43.11 95.26 Favored Glycine 0 C--N 1.329 0.165 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.24 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.479 HG21 ' O ' ' A' ' 263' ' ' ALA . 68.6 mt -90.66 149.46 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 2.3 p -96.8 157.58 15.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.572 0.701 . . . . 0.0 112.428 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.552 HG11 ' O ' ' A' ' 335' ' ' ALA . 6.8 p -76.16 151.35 6.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.499 -176.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 65.0 m -109.63 83.22 1.72 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.025 0.441 . . . . 0.0 110.385 174.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.7 154.75 28.94 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.341 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -73.05 124.91 26.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.966 0.412 . . . . 0.0 111.008 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -113.25 128.56 56.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.059 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 12.8 t -131.16 119.83 22.45 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.414 ' O ' ' HD3' ' A' ' 237' ' ' LYS . 88.2 m-85 -104.08 143.06 33.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.743 -175.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 236' ' ' PHE . 44.7 mmtm -129.41 138.66 33.65 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.631 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.443 ' HD3' HG21 ' A' ' 313' ' ' VAL . 82.9 Cg_endo . . . . . 0 N--CA 1.455 -0.764 0 C-N-CA 123.035 2.49 . . . . 0.0 112.166 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.457 ' CD1' ' HB ' ' A' ' 309' ' ' THR . 75.1 m-85 . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 120.935 0.398 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.448 ' HB2' ' HG3' ' A' ' 311' ' ' LYS . . . -114.59 121.89 44.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.618 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -89.43 106.38 18.41 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.748 177.564 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -86.04 118.13 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.402 -172.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 23.2 m -89.32 105.92 18.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.895 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 20.4 mt -122.07 172.08 8.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.735 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 42.2 m -64.57 -53.42 48.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.108 0.48 . . . . 0.0 109.783 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.57 142.93 41.32 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 18.2 p -134.07 30.0 3.68 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.3 m -81.26 134.63 35.63 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.956 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.7 -26.25 14.87 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -176.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' MET . . . . . 0.468 ' HG3' HD11 ' A' ' 342' ' ' ILE . 1.9 mpt? -70.67 151.3 45.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -136.38 164.33 28.38 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -64.44 144.66 57.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.694 0.283 . . . . 0.0 110.676 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 77.8 19.02 76.29 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.742 173.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.519 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 1.7 t70 -100.68 -167.1 1.39 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 117.779 0.79 . . . . 0.0 109.907 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.462 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 13.1 tppt? -125.04 115.16 20.09 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.502 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.526 HD11 HG21 ' A' ' 308' ' ' ILE . 32.0 pt -116.93 139.31 44.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.677 177.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 50.1 p -118.9 138.4 52.78 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.559 -178.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -103.23 111.56 24.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.519 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.63 132.37 53.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.688 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 93.45 -34.71 4.46 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 56.4 t -86.0 146.04 6.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.502 ' NZ ' ' HB3' ' A' ' 279' ' ' LYS . 0.0 OUTLIER -162.22 162.21 28.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.75 0.31 . . . . 0.0 111.059 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 96.2 m-85 -73.59 170.3 15.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.63 -174.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.483 178.725 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.451 ' HA ' ' NZ ' ' A' ' 279' ' ' LYS . 64.7 m-20 . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.788 0.328 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -70.46 104.27 2.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.649 -174.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 14.0 p -92.14 103.29 15.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.033 177.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.404 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 61.6 m-85 -102.72 154.83 18.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.149 0.5 . . . . 0.0 111.277 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.4 m -89.99 120.89 31.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.088 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.519 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 14.2 p -84.19 139.45 17.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.466 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.2 t -105.76 -42.18 6.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.241 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -156.51 133.74 10.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.027 0.442 . . . . 0.0 111.659 -175.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 87.2 t -81.85 99.47 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 169.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.7 t -70.65 -58.47 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.917 -171.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -120.26 -0.66 10.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.719 0.295 . . . . 0.0 111.576 -174.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 69.31 12.58 66.32 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -172.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 26.6 p -147.4 19.99 1.2 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 7.1 t-160 -172.74 115.82 0.3 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.194 -164.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.52 166.75 13.62 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -176.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -123.86 126.56 46.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.084 0.469 . . . . 0.0 109.994 169.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.526 HG21 HD11 ' A' ' 273' ' ' ILE . 30.3 pt -123.12 170.04 13.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.997 -177.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' THR . . . . . 0.457 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 13.5 t -154.52 145.12 16.03 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.433 ' HA ' ' OG1' ' A' ' 309' ' ' THR . 58.4 Cg_endo -70.2 176.08 35.36 Favored 'Cis proline' 0 C--N 1.347 0.48 0 C-N-CA 123.835 -1.319 . . . . 0.0 112.879 1.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.448 ' HG3' ' HB2' ' A' ' 257' ' ' ALA . 40.5 tttt -77.14 119.88 79.33 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.807 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 257' ' ' ALA . 27.1 Cg_exo -62.14 107.13 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.157 1.905 . . . . 0.0 111.676 177.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 328' ' ' ALA . 55.5 t -121.29 119.81 60.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.037 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.644 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -85.86 128.53 34.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.073 0.463 . . . . 0.0 111.101 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.3 tm? -70.16 -30.39 67.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.246 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -89.0 23.19 2.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.0 0.429 . . . . 0.0 111.25 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 317' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 14.6 t70 -100.52 137.49 38.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 30.1 m -84.29 -15.56 11.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 13.1 m -91.03 34.89 0.91 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.016 0.436 . . . . 0.0 111.485 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.471 HD13 ' HB3' ' A' ' 325' ' ' ARG . 1.9 pp -126.95 164.18 22.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.092 0.472 . . . . 0.0 111.449 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 65.4 p -99.89 168.59 9.25 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.768 176.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.502 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 86.8 Cg_exo -49.35 -36.07 37.14 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.306 2.004 . . . . 0.0 111.818 172.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.82 -46.3 65.96 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.818 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 89.8 mt-30 -69.65 -28.51 65.94 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -175.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.502 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 30.2 ptt180 -72.05 -21.69 61.49 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.324 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -73.4 -27.84 61.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.202 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -94.24 7.97 43.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.82 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.548 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -57.92 142.11 47.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.825 176.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -124.22 -30.02 3.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.2 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 27.7 m -122.4 160.11 24.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.871 0.367 . . . . 0.0 110.293 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -89.04 -20.89 23.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.071 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.1 t -141.6 141.88 33.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.994 0.426 . . . . 0.0 110.481 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 34.8 p -70.27 161.65 29.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.87 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.447 ' HG ' HG21 ' A' ' 230' ' ' VAL . 48.0 tp -69.47 103.41 2.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.552 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -82.93 170.42 14.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.841 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 336' ' ' ASP . . . . . 0.413 ' HA ' ' CG1' ' A' ' 230' ' ' VAL . 29.1 t70 -72.26 151.86 42.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.496 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 68.18 39.75 2.3 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.998 0.811 . . . . 0.0 111.608 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.411 ' H ' HG12 ' A' ' 230' ' ' VAL . 19.9 mmt -110.19 144.42 38.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 176.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.19 138.3 33.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.031 0.443 . . . . 0.0 111.316 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 23.9 t -113.73 110.73 33.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.444 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' ASN . . . . . 0.674 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 60.5 t30 -130.49 145.16 51.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.936 0.398 . . . . 0.0 111.484 -175.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.468 HD11 ' HG3' ' A' ' 267' ' ' MET . 61.0 mt -88.06 116.41 29.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.057 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 63.9 mt . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.182 -176.75 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 C--O 1.234 0.27 0 CA-C-O 120.362 0.125 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 63.25 53.1 42.1 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.283 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.511 HD12 ' O ' ' A' ' 263' ' ' ALA . 29.1 mm -102.21 143.02 15.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 20.7 p -131.49 170.21 15.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.087 0.47 . . . . 0.0 110.305 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.61 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.2 p -78.98 150.39 5.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.56 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.7 t -107.03 75.15 1.02 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.193 0.52 . . . . 0.0 109.654 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.83 155.06 29.57 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.042 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -78.01 141.6 38.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.925 0.393 . . . . 0.0 111.208 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -149.54 137.14 20.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.41 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.5 t -110.08 142.04 42.1 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 312' ' ' PRO . 92.5 m-85 -102.64 156.79 17.39 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . 46.9 mmtm -138.34 130.36 15.92 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.657 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.49 ' HD3' HG11 ' A' ' 313' ' ' VAL . 22.2 Cg_exo . . . . . 0 C--N 1.344 0.325 0 C-N-CA 122.677 2.252 . . . . 0.0 111.335 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 308' ' ' ILE . 60.5 m-85 . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.746 0.308 . . . . 0.0 110.653 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -120.34 134.37 55.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.735 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.642 ' HB ' ' CE1' ' A' ' 305' ' ' HIS . 0.0 OUTLIER -93.91 105.21 17.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.283 0.564 . . . . 0.0 111.231 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.6 t -88.39 122.04 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.056 -175.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 11.9 m -96.51 106.04 18.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.254 0.55 . . . . 0.0 110.053 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.518 HD22 HG21 ' A' ' 340' ' ' VAL . 22.5 mt -122.18 167.26 13.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.574 -173.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 26.3 p -60.14 -52.42 65.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.529 0.68 . . . . 0.0 109.71 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.511 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.28 132.59 35.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.316 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 261' ' ' LEU . 7.7 p -128.9 15.29 6.36 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.214 174.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 25.2 m -83.4 144.78 29.39 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.742 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.74 0.73 57.62 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 71.9 mtm -123.22 153.3 40.31 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -142.07 178.99 7.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -63.43 142.22 58.47 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 123.201 0.313 . . . . 0.0 110.545 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 93.52 19.8 34.0 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.688 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.504 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 7.4 m-20 -116.85 164.78 14.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.546 0.673 . . . . 0.0 111.288 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -106.24 115.94 31.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.336 -177.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.484 HD11 HG21 ' A' ' 308' ' ' ILE . 15.6 pt -115.31 140.28 37.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.476 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 54.1 p -128.15 141.06 51.59 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.373 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -100.21 112.64 24.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.051 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.415 ' HA ' ' OD1' ' A' ' 292' ' ' ASP . . . -61.32 120.05 9.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.472 -175.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.49 -35.84 4.75 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.597 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 49.7 t -77.84 124.68 36.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -142.97 161.5 37.94 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.791 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -84.93 142.02 29.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.378 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 79.7 mt . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.112 176.505 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.415 ' OD1' ' HA ' ' A' ' 276' ' ' ALA . 56.6 m-20 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -60.01 98.86 0.06 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.527 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 38.6 p -79.98 124.03 28.34 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.626 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -124.54 146.78 48.81 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.234 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.8 m -86.19 118.29 25.55 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.151 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.504 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 11.7 p -73.8 123.44 28.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.414 0.626 . . . . 0.0 110.095 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.4 t -94.29 -38.22 9.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.599 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -164.81 133.6 3.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.499 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 79.9 t -90.14 100.89 11.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 167.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.63 -59.4 3.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.737 -172.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -98.67 -12.72 20.76 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.633 -170.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 74.13 13.1 81.4 Favored Glycine 0 CA--C 1.517 0.196 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.08 23.35 0.5 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 171.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.642 ' CE1' ' HB ' ' A' ' 258' ' ' THR . 2.1 t60 -170.67 115.33 0.46 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 113.813 -1.539 . . . . 0.0 107.533 -171.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.7 155.68 20.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -173.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.1 pt-20 -112.02 121.72 45.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.321 0.581 . . . . 0.0 110.128 172.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 256' ' ' PHE . 29.8 pt -118.19 169.37 8.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.968 -177.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.1 t -145.48 140.47 15.92 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.63 -179.24 26.53 Favored 'Cis proline' 0 C--N 1.345 0.374 0 C-N-CA 123.684 -1.382 . . . . 0.0 112.753 -2.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 23.8 ttmm -75.29 124.12 89.03 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.786 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 14.1 Cg_exo -68.52 108.24 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.408 2.072 . . . . 0.0 111.99 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.809 HG23 ' HA ' ' A' ' 328' ' ' ALA . 1.2 m -128.21 132.95 67.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.355 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.517 ' O ' HD21 ' A' ' 320' ' ' LEU . . . -95.22 135.71 36.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.906 -172.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.9 tm? -74.19 -24.1 59.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.547 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -82.25 -2.04 51.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.151 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -77.84 113.31 15.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.6 m -82.98 2.59 3.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.972 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 40.1 m -95.2 -27.61 15.44 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -175.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.517 HD21 ' O ' ' A' ' 314' ' ' ALA . 1.3 pp -79.1 152.74 30.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.56 0.695 . . . . 0.0 111.764 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.494 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.3 m -81.33 167.42 31.9 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.74 -173.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.541 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 78.2 Cg_exo -44.81 -52.26 6.4 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.528 2.819 . . . . 0.0 114.183 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -67.22 -30.98 71.05 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.897 -0.502 . . . . 0.0 111.003 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -71.36 -33.78 69.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.433 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.541 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 18.0 ptp180 -77.37 -14.98 59.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.214 0.53 . . . . 0.0 110.6 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -72.41 -30.8 64.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.122 171.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -85.93 -7.97 58.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.553 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.809 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -65.09 115.37 5.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.047 0.451 . . . . 0.0 110.908 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -104.13 -28.17 11.63 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.49 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 30.2 m -108.32 165.33 4.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.027 0.441 . . . . 0.0 111.355 -175.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -83.54 -40.08 19.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.438 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.8 t -128.79 144.98 51.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.169 0.509 . . . . 0.0 111.007 -176.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 13.5 p -77.76 173.96 11.52 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.428 174.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 14.5 tp -76.71 105.06 7.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.103 0.478 . . . . 0.0 110.179 -175.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.61 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.35 -178.6 6.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.413 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -82.54 -1.13 49.67 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -171.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -139.78 64.95 1.44 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.141 0.496 . . . . 0.0 111.281 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.45 ' H ' HG12 ' A' ' 230' ' ' VAL . 23.9 mmt -116.12 130.74 56.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.538 175.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -84.02 144.16 29.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.997 0.427 . . . . 0.0 111.016 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.518 HG21 HD22 ' A' ' 261' ' ' LEU . 21.5 t -113.86 115.4 49.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.481 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -131.58 138.99 49.09 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.799 -176.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 26.7 mt -87.62 125.22 41.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.653 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 49.1 mt . . . . . 0 C--N 1.322 -0.599 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.335 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 25.6 p . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 111.397 0.147 . . . . 0.0 111.397 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 61.96 35.27 91.15 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.506 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.521 HG21 ' O ' ' A' ' 263' ' ' ALA . 53.7 mt -79.88 153.05 4.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 19.6 p -97.2 143.97 27.48 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.612 0.72 . . . . 0.0 112.495 -173.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.623 HG11 ' O ' ' A' ' 335' ' ' ALA . 4.4 p -61.02 151.9 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.024 177.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 7.6 t -110.52 74.56 0.88 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 0.0 110.001 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 98.39 165.22 30.88 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.052 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -87.98 125.79 34.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.802 0.334 . . . . 0.0 110.442 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -120.39 127.04 51.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.04 0.448 . . . . 0.0 111.01 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 38.4 m -104.86 120.78 42.25 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.635 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.454 ' O ' HG13 ' A' ' 313' ' ' VAL . 93.3 m-85 -100.21 122.38 42.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.657 -176.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.439 ' HE2' HD23 ' A' ' 320' ' ' LEU . 32.4 mmtp -124.85 128.28 24.92 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.208 -178.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo . . . . . 0 N--CA 1.463 -0.296 0 C-N-CA 123.091 2.527 . . . . 0.0 111.855 177.503 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.408 ' CD1' ' HB ' ' A' ' 309' ' ' THR . 97.8 m-85 . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 121.073 0.463 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.438 ' HB2' ' HA ' ' A' ' 311' ' ' LYS . . . -146.19 113.79 6.38 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.065 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.3 m -86.4 104.07 15.55 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.338 0.59 . . . . 0.0 110.208 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.1 t -82.83 118.17 30.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.358 -172.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 21.8 m -86.97 105.24 16.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.212 0.529 . . . . 0.0 110.239 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.583 HD23 HG23 ' A' ' 230' ' ' VAL . 19.5 mt -122.76 161.36 24.1 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.2 m -58.86 -50.5 73.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.255 0.55 . . . . 0.0 109.587 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.521 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.89 144.23 41.24 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.46 HG22 HD12 ' A' ' 261' ' ' LEU . 16.0 p -131.31 26.59 4.82 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.135 0.969 . . . . 0.0 108.514 174.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 24.9 m -74.57 135.88 42.09 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.972 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 103.34 -12.91 54.96 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -176.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 55.7 mtt -96.41 138.79 33.49 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.591 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 6.6 ptpp? -130.88 156.93 44.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -55.93 114.39 1.9 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.945 0.402 . . . . 0.0 110.623 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 110.83 18.57 8.29 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.487 -176.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.591 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 9.6 m-20 -105.14 158.36 16.63 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 117.039 0.419 . . . . 0.0 110.766 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 15.0 tppt? -103.7 116.32 32.11 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.647 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 30.3 pt -112.74 139.56 37.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.189 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 4.1 m -124.45 130.57 52.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.445 -176.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -94.53 111.88 23.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.447 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.84 116.71 9.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.838 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 107.76 -11.78 38.45 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 39.2 t -111.81 128.9 68.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -135.99 157.97 45.55 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.43 ' HE1' ' CZ ' ' A' ' 295' ' ' PHE . 50.0 m-85 -73.45 165.02 25.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.775 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 C--N 1.327 -0.399 0 CA-C-O 121.221 0.534 . . . . 0.0 110.127 178.286 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 . . . . . 0 C--O 1.233 0.185 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -69.29 76.23 0.37 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.158 0.504 . . . . 0.0 111.117 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.421 HG22 ' OG ' ' A' ' 274' ' ' SER . 65.6 p -86.78 105.18 16.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.411 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 312' ' ' PRO . 61.8 m-85 -115.46 143.72 44.89 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.023 0.439 . . . . 0.0 111.035 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.7 m -86.8 124.58 33.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.957 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 271' ' ' ASP . 8.3 p -83.1 136.06 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.038 0.447 . . . . 0.0 110.239 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 37.8 t -101.61 -29.5 3.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.948 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -163.81 142.04 7.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.582 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 78.8 t -98.14 117.62 43.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 38.9 t -77.89 -58.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.92 -172.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -121.21 2.29 10.33 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -173.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 70.45 13.34 70.88 Favored Glycine 0 CA--C 1.518 0.25 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.9 p -146.41 18.04 1.34 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.439 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 1.6 t60 -171.07 113.99 0.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.778 -169.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.35 161.97 16.83 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -173.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -120.78 121.24 37.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.36 0.6 . . . . 0.0 110.739 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.444 HG22 ' HA ' ' A' ' 297' ' ' VAL . 23.3 pt -112.76 174.57 2.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.415 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' THR . . . . . 0.408 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 13.2 t -152.13 141.27 14.13 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.99 -179.79 26.24 Favored 'Cis proline' 0 C--N 1.345 0.349 0 C-N-CA 123.681 -1.383 . . . . 0.0 112.411 0.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.443 ' CG ' ' HB3' ' A' ' 236' ' ' PHE . 23.3 ttmm -74.56 123.12 88.87 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.286 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 295' ' ' PHE . 56.9 Cg_endo -74.46 108.42 2.68 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.115 1.876 . . . . 0.0 112.045 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.556 ' HB ' ' HA ' ' A' ' 328' ' ' ALA . 0.2 OUTLIER -106.54 132.71 53.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.216 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -78.95 116.84 19.52 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 123.53 0.519 . . . . 0.0 110.827 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.0 tm? -64.71 -29.67 70.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.31 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -91.77 15.53 12.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.854 -177.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -90.57 127.26 36.2 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 9.6 p -82.98 -12.53 12.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.989 0.423 . . . . 0.0 111.376 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 5.3 m -93.13 33.71 1.17 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.118 0.485 . . . . 0.0 111.32 -173.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.439 HD23 ' HE2' ' A' ' 237' ' ' LYS . 2.0 pp -132.78 170.91 14.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.745 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 23.3 m -106.23 159.61 29.11 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.341 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -39.97 -48.24 3.79 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.581 2.854 . . . . 0.0 113.913 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -56.28 -41.05 75.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.094 0.473 . . . . 0.0 111.343 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -72.1 -37.67 69.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.777 -175.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -77.05 -16.09 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.936 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -69.22 -30.75 68.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.478 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -96.16 -0.88 49.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.153 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.556 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -61.75 151.24 34.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.19 0.519 . . . . 0.0 111.546 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -138.43 -28.01 0.85 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.141 -171.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 23.4 m -113.89 162.16 12.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -92.51 -14.21 28.72 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.279 -176.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 11.9 t -147.62 148.5 31.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.768 0.318 . . . . 0.0 110.324 -177.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 46.0 m -77.78 158.63 29.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.575 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.429 ' HG ' HG21 ' A' ' 230' ' ' VAL . 41.1 tp -71.31 103.21 2.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.623 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -85.55 -179.24 6.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.407 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 336' ' ' ASP . . . . . 0.462 ' HA ' ' CG1' ' A' ' 230' ' ' VAL . 33.2 t70 -77.83 159.79 28.74 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.14 -0.224 . . . . 0.0 110.409 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 65.1 40.9 4.82 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.91 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.558 ' H ' HG12 ' A' ' 230' ' ' VAL . 25.2 mmt -110.28 140.32 44.56 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 176.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -92.21 135.25 34.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.989 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.435 HG21 HD22 ' A' ' 261' ' ' LEU . 14.0 t -114.26 105.01 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.902 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 341' ' ' ASN . . . . . 0.452 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 64.1 t30 -118.77 150.31 40.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.705 0.288 . . . . 0.0 111.003 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 69.3 mt -95.91 123.67 48.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.643 177.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 60.2 mt . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.394 176.314 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -85.09 57.47 4.99 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 339' ' ' ALA . 31.9 mm -85.78 142.93 12.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 122.282 0.233 . . . . 0.0 110.808 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 12.3 p -118.84 143.22 47.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.089 0.471 . . . . 0.0 110.467 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.632 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.9 p -59.5 149.39 6.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.75 -178.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 25.9 t -113.07 77.91 1.09 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 177.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 90.37 141.71 9.25 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.993 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.68 140.9 55.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.764 0.316 . . . . 0.0 110.927 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -144.76 132.87 21.54 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.544 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.1 t -116.92 114.12 23.4 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 175.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.479 ' O ' HG22 ' A' ' 313' ' ' VAL . 71.5 m-85 -81.15 133.0 35.39 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.343 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -124.09 134.99 25.84 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.436 ' HD3' HG21 ' A' ' 313' ' ' VAL . 84.9 Cg_endo . . . . . 0 N--CA 1.459 -0.519 0 C-N-CA 122.757 2.305 . . . . 0.0 111.831 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 C--O 1.225 -0.236 0 CA-C-O 120.827 0.346 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -146.18 123.37 11.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.677 0.275 . . . . 0.0 110.74 177.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.1 m -94.55 101.45 13.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.892 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.416 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.7 t -86.18 120.46 36.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.234 -173.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 30.3 m -92.9 109.73 21.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.917 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 19.2 mt -126.49 171.0 11.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.023 -175.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 16.6 p -62.07 -55.59 27.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.412 0.625 . . . . 0.0 109.77 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -136.85 139.05 41.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.785 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.4 p -131.38 27.55 4.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.793 0.806 . . . . 0.0 109.138 175.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 48.8 m -76.88 140.46 40.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.639 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 101.77 -2.25 52.49 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -173.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 63.3 mtt -108.03 137.27 46.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.813 -0.694 . . . . 0.0 109.299 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -155.0 141.69 18.95 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.581 ' HA ' HG13 ' A' ' 297' ' ' VAL . 29.1 ptt180 -39.34 119.24 0.9 Allowed 'General case' 0 N--CA 1.469 0.51 0 O-C-N 124.01 0.819 . . . . 0.0 112.694 -173.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 116.0 -9.26 18.47 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.564 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.47 ' H ' HG12 ' A' ' 297' ' ' VAL . 2.1 p30 -87.17 -174.82 5.06 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 117.523 0.662 . . . . 0.0 111.307 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 296' ' ' SER . 4.2 tmmm? -140.99 118.45 11.49 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.11 -177.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.42 HG22 HG13 ' A' ' 342' ' ' ILE . 34.3 pt -110.55 140.77 28.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.149 0.5 . . . . 0.0 110.095 -177.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 15.0 m -126.35 132.38 51.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.365 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -94.5 111.19 22.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.431 -176.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.7 116.75 7.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.722 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.38 -34.15 5.31 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 98.1 t -94.24 118.82 41.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.75 171.91 13.78 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.389 -178.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 95.5 m-85 -74.66 172.92 11.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.189 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.191 179.939 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.638 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -54.41 98.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.918 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.4 p -91.48 99.1 12.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.052 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.638 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 43.1 m-85 -118.61 138.63 52.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.919 0.39 . . . . 0.0 110.925 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 296' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 272' ' ' LYS . 28.1 t -85.4 138.43 32.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.898 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.581 HG13 ' HA ' ' A' ' 269' ' ' ARG . 4.3 p -71.67 137.27 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.966 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.25 -42.18 9.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.939 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 307' ' ' GLU . 28.2 tpt180 -165.1 142.14 5.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.773 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 99.0 t -103.13 119.16 51.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 171.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.07 -58.71 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.01 -174.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -121.6 -9.41 8.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.337 0.589 . . . . 0.0 111.651 -173.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.62 13.98 76.94 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.309 -172.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 55.2 p -140.06 12.14 2.42 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 171.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -163.03 116.05 1.59 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.457 -167.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.41 165.01 15.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 121.194 -0.202 . . . . 0.0 110.577 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 8.0 pt-20 -128.09 123.09 33.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.076 0.465 . . . . 0.0 109.77 170.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.429 HG22 ' HA ' ' A' ' 297' ' ' VAL . 26.6 pt -121.67 176.86 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.314 -175.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.5 t -154.11 144.22 15.59 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.018 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.73 179.37 31.15 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 123.414 -1.494 . . . . 0.0 112.606 -4.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -77.39 121.1 83.94 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.873 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.443 ' HG2' ' CD2' ' A' ' 236' ' ' PHE . 30.5 Cg_endo -68.83 108.38 1.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.067 1.845 . . . . 0.0 111.934 174.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.565 ' HB ' ' HA ' ' A' ' 328' ' ' ALA . 85.8 t -118.02 130.65 72.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.317 178.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.673 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -90.42 131.9 35.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.194 0.521 . . . . 0.0 111.459 -176.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.3 tm? -69.46 -29.08 66.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.719 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -97.63 15.17 24.23 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -83.8 128.3 34.43 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.82 0.21 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 18.0 m -105.49 30.84 5.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.224 -0.298 . . . . 0.0 111.757 -174.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 320' ' ' LEU . 1.7 pp -128.34 159.57 34.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.271 0.557 . . . . 0.0 111.879 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.412 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 2.7 t -91.53 152.75 43.82 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.854 175.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.554 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 50.1 Cg_exo -38.44 -47.99 2.48 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.978 3.118 . . . . 0.0 114.943 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -64.38 -33.58 76.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.828 0.347 . . . . 0.0 111.922 -176.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -68.06 -36.5 79.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.875 0.369 . . . . 0.0 111.243 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 7.4 ptm180 -78.76 -11.16 59.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.315 0.579 . . . . 0.0 110.366 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -74.73 -22.77 58.63 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.617 171.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -99.89 6.19 45.3 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.525 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.565 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -53.61 144.52 17.35 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.648 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -128.63 -34.69 1.98 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.032 -177.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.9 m -113.82 155.27 15.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.364 -178.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -90.97 -8.34 49.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.24 0.543 . . . . 0.0 110.809 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.4 t -148.3 141.28 24.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.881 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 24.1 m -75.38 166.18 24.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.898 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.437 ' HG ' HG21 ' A' ' 230' ' ' VAL . 26.2 tp -71.16 102.97 2.63 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.632 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -93.19 -172.9 3.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -74.35 160.83 30.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.776 0.322 . . . . 0.0 110.427 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 61.18 32.84 19.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.44 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.406 ' H ' HG12 ' A' ' 230' ' ' VAL . 25.5 mmt -102.48 126.89 49.67 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 339' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 228' ' ' ILE . . . -84.47 129.91 34.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.096 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 16.1 t -104.18 108.42 24.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -134.11 142.19 47.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.818 0.342 . . . . 0.0 111.908 -171.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.42 HG13 HG22 ' A' ' 273' ' ' ILE . 58.5 mt -87.96 127.0 41.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.76 175.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 57.8 mt . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.902 177.489 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 38.9 p . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 110.652 -0.129 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 54.4 56.75 20.28 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.247 -0.502 . . . . 0.0 112.832 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.483 HG21 ' O ' ' A' ' 263' ' ' ALA . 51.1 mt -103.24 150.05 6.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 14.6 p -97.58 153.7 18.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.535 0.683 . . . . 0.0 112.082 -177.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.613 HG12 ' H ' ' A' ' 338' ' ' MET . 7.8 p -65.93 150.4 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.025 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' SER . . . . . 0.401 ' HB2' ' C ' ' A' ' 261' ' ' LEU . 10.2 t -102.32 66.89 1.01 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.76 158.37 31.87 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.211 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.22 132.54 53.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.017 0.437 . . . . 0.0 111.681 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.58 ' NE2' ' HB ' ' A' ' 260' ' ' THR . 83.6 mm-40 -120.66 127.37 52.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.293 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 11.2 p -129.86 144.77 51.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.14 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -133.81 158.98 41.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.47 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . 46.1 mmtm -139.81 126.91 12.61 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.886 178.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.466 ' HD3' HG11 ' A' ' 313' ' ' VAL . 2.8 Cg_endo . . . . . 0 N--CA 1.461 -0.419 0 C-N-CA 122.877 2.385 . . . . 0.0 111.641 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 308' ' ' ILE . 52.0 m-85 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.998 0.428 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -106.49 120.72 42.65 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.171 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.8 m -87.35 97.45 10.81 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.128 0.489 . . . . 0.0 110.899 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.5 t -83.91 125.39 40.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.546 -173.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' THR . . . . . 0.58 ' HB ' ' NE2' ' A' ' 234' ' ' GLN . 13.3 m -97.53 106.97 19.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.187 0.518 . . . . 0.0 109.853 175.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.521 ' HB2' HG22 ' A' ' 264' ' ' THR . 17.4 mt -121.2 163.02 19.15 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -177.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.1 t -56.75 -51.88 67.16 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.483 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.88 136.95 37.59 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.521 HG22 ' HB2' ' A' ' 261' ' ' LEU . 17.5 p -125.25 24.13 7.47 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 122.005 0.907 . . . . 0.0 108.922 175.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 10.4 m -77.71 145.4 36.6 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.301 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 96.83 -15.9 61.88 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -174.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' MET . . . . . 0.534 ' O ' HG21 ' A' ' 300' ' ' VAL . 54.1 mtt -92.28 132.84 36.37 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -129.75 149.73 51.37 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -49.71 114.07 0.98 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.548 0.69 . . . . 0.0 110.851 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 107.64 11.15 25.58 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.56 -0.745 . . . . 0.0 113.024 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.449 ' H ' HG12 ' A' ' 297' ' ' VAL . 6.4 m-20 -98.25 147.6 24.46 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 117.757 0.778 . . . . 0.0 110.991 176.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -94.63 117.53 30.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.334 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 22.7 pt -112.41 139.58 36.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.003 0.43 . . . . 0.0 110.238 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.464 ' HB3' HG22 ' A' ' 294' ' ' THR . 77.9 p -112.61 137.95 50.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.306 -177.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -105.89 119.95 40.49 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.368 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -63.3 136.27 57.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.892 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 81.95 -35.36 2.54 Favored Glycine 0 N--CA 1.454 -0.109 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.667 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 52.3 t -82.36 105.15 11.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -128.88 165.02 21.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.968 0.413 . . . . 0.0 111.46 -176.735 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.558 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 70.8 m-85 -79.26 144.75 34.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.3 -176.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.523 175.846 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 47.7 m-20 . . . . . 0 CA--C 1.518 -0.275 0 CA-C-O 120.735 0.303 . . . . 0.0 110.335 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.572 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -67.62 97.7 0.63 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.57 -175.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.464 HG22 ' HB3' ' A' ' 274' ' ' SER . 30.3 p -100.38 105.0 16.46 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.285 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.572 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 68.2 m-85 -112.62 145.87 39.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.937 0.399 . . . . 0.0 110.95 -178.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 50.1 m -86.08 124.91 33.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.324 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.449 HG12 ' H ' ' A' ' 271' ' ' ASP . 11.2 p -69.85 132.61 32.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.062 178.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.74 -33.94 4.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.951 0.405 . . . . 0.0 110.419 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -157.99 133.46 8.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.071 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.534 HG21 ' O ' ' A' ' 267' ' ' MET . 96.7 t -91.48 101.35 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.6 t -73.77 -59.06 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.686 -171.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -109.39 -11.44 14.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.001 0.429 . . . . 0.0 111.691 -174.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.79 12.98 83.49 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -170.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 5.2 p -147.55 18.09 1.17 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 173.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.485 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.7 t-160 -169.64 114.7 0.54 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.207 -167.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.31 167.91 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -174.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -126.18 119.72 28.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.257 0.551 . . . . 0.0 109.958 169.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 256' ' ' PHE . 27.1 pt -113.99 171.21 4.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.705 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 12.6 t -153.52 145.51 16.93 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.84 179.29 30.99 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.498 -1.459 . . . . 0.0 112.933 -2.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -82.64 121.1 77.75 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.913 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.85 113.28 3.24 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.798 2.332 . . . . 0.0 112.912 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.473 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.1 OUTLIER -114.38 139.52 39.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.818 173.915 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -87.07 131.31 34.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.673 -177.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.7 tm? -65.91 -28.06 68.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.881 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.69 24.97 3.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.198 178.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -91.91 122.04 34.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 8.4 p -84.05 -0.99 5.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.246 0.546 . . . . 0.0 111.483 -175.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 33.3 t -93.93 -25.52 17.25 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.069 -0.394 . . . . 0.0 111.474 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.438 HD21 ' O ' ' A' ' 314' ' ' ALA . 1.3 pp -83.7 162.85 20.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.238 0.542 . . . . 0.0 111.533 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.472 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 7.1 m -100.57 167.4 10.93 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.504 -176.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 42.2 Cg_exo -41.13 -51.51 3.85 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.8 3.0 . . . . 0.0 114.787 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.71 -39.28 93.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.002 0.429 . . . . 0.0 111.076 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -64.43 -28.95 70.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.906 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 325' ' ' ARG . 43.3 mtp85 -63.99 -28.73 70.01 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.796 0.331 . . . . 0.0 110.844 175.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -74.88 -19.34 60.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.104 0.478 . . . . 0.0 110.658 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -96.17 -2.78 45.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.473 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -72.74 106.39 4.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.661 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -98.31 -17.83 18.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.314 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.8 m -116.47 156.68 17.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.175 0.512 . . . . 0.0 110.417 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -82.38 -32.47 29.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.418 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 12.0 t -139.98 154.08 47.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.572 -174.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.2 p -86.95 169.66 12.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.318 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.431 ' HG ' HG21 ' A' ' 230' ' ' VAL . 18.1 tp -71.15 115.5 10.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.192 -175.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.481 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.58 -178.92 6.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.32 -177.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -78.97 -9.83 59.64 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -138.7 72.56 1.41 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.924 0.392 . . . . 0.0 111.376 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.613 ' H ' HG12 ' A' ' 230' ' ' VAL . 21.0 mmt -125.11 146.37 49.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -93.81 139.5 30.78 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.735 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.462 HG21 HD22 ' A' ' 261' ' ' LEU . 40.9 t -121.81 119.36 58.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.965 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -135.83 143.9 45.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.967 -176.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 52.7 mt -85.73 121.64 37.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.948 173.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 63.9 mt . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.399 -179.638 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.493 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 19.5 p . . . . . 0 C--O 1.236 0.377 0 N-CA-C 111.459 0.17 . . . . 0.0 111.459 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 58.44 39.91 93.59 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.764 -177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.642 HG21 ' O ' ' A' ' 263' ' ' ALA . 62.2 mt -103.23 146.63 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 21.8 p -108.24 156.08 19.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.398 0.618 . . . . 0.0 111.405 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.73 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.5 p -63.0 151.63 8.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.825 176.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' SER . . . . . 0.403 ' H ' ' HA ' ' A' ' 261' ' ' LEU . 18.7 t -105.02 83.73 2.03 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 84.12 165.24 38.68 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.177 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.88 129.81 40.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.792 0.33 . . . . 0.0 110.425 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -123.39 127.4 48.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.049 0.452 . . . . 0.0 110.853 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 21.4 p -127.14 131.58 50.73 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.206 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 312' ' ' PRO . 78.4 m-85 -111.91 142.77 43.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.88 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -133.71 132.75 21.82 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.04 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.537 ' HD3' HG21 ' A' ' 313' ' ' VAL . 90.3 Cg_endo . . . . . 0 N--CA 1.452 -0.96 0 C-N-CA 122.689 2.259 . . . . 0.0 111.388 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.993 0.425 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -146.9 132.67 18.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.897 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.651 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -92.03 104.93 17.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.131 0.491 . . . . 0.0 111.131 177.443 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.8 t -85.65 117.45 30.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.495 -174.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 19.4 m -87.22 105.83 17.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.171 0.51 . . . . 0.0 110.195 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.505 HD23 HG23 ' A' ' 230' ' ' VAL . 20.5 mt -122.17 164.92 16.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.652 -177.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.3 t -59.9 -51.8 68.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.171 0.51 . . . . 0.0 109.776 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.642 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.37 131.45 32.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.22 176.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.463 HG22 ' HB2' ' A' ' 261' ' ' LEU . 12.8 p -126.0 18.09 7.84 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.774 0.797 . . . . 0.0 109.029 175.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 26.5 m -82.62 148.11 28.17 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.857 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 95.51 -0.18 63.21 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 42.9 mtm -117.07 158.08 24.79 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.449 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 23.4 pttm -139.94 172.45 12.74 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -59.29 121.07 10.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.631 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 103.04 18.85 13.88 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.244 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.47 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 59.8 m-20 -100.62 152.64 20.19 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 117.433 0.616 . . . . 0.0 110.135 178.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.404 ' HA ' ' HE3' ' A' ' 272' ' ' LYS . 1.5 tpmt? -95.07 116.32 28.57 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.97 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.494 HD11 HG21 ' A' ' 308' ' ' ILE . 15.0 pt -115.84 138.92 44.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.237 176.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 4.5 m -123.92 131.47 53.58 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.832 -178.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -99.26 112.2 24.41 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.964 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.61 115.39 3.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.459 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.27 -34.86 4.95 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.937 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 45.2 t -81.66 142.13 14.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.513 ' NZ ' ' HB3' ' A' ' 279' ' ' LYS . 0.1 OUTLIER -162.13 152.19 16.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.916 0.389 . . . . 0.0 111.276 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -80.85 154.16 27.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.465 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.154 177.008 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.419 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -68.0 104.0 1.64 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.367 -175.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 30.3 p -90.88 106.69 18.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.511 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.419 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 88.4 m-85 -105.31 149.89 25.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.158 0.504 . . . . 0.0 111.105 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 12.8 m -96.7 119.87 35.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.777 176.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.47 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.5 p -78.71 130.45 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.163 0.506 . . . . 0.0 110.231 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 21.1 t -93.49 -28.09 4.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.392 -178.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -172.88 140.62 0.96 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.63 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 95.7 t -90.31 109.54 20.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 170.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 42.8 t -78.03 -59.0 3.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.294 -172.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -110.33 -10.05 14.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.046 0.45 . . . . 0.0 111.737 -174.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.56 11.95 84.05 Favored Glycine 0 C--N 1.32 -0.343 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 27.9 p -146.01 13.91 1.31 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.61 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 3.7 t-160 -165.16 116.51 1.14 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.357 -167.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.9 m -119.26 162.13 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -176.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.31 120.65 42.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.926 0.393 . . . . 0.0 110.0 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.494 HG21 HD11 ' A' ' 273' ' ' ILE . 39.8 pt -122.36 176.74 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.092 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.5 t -154.45 145.6 16.46 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.13 -179.99 26.64 Favored 'Cis proline' 0 C--N 1.346 0.428 0 C-N-CA 124.23 -1.154 . . . . 0.0 112.84 -0.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -78.88 113.64 37.12 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.96 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 23.5 Cg_exo -63.68 107.94 0.81 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.351 2.034 . . . . 0.0 112.365 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.537 HG21 ' HD3' ' A' ' 238' ' ' PRO . 97.5 t -124.39 126.3 71.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -83.54 137.44 33.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.569 0.699 . . . . 0.0 111.897 -173.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.0 tm? -77.74 -25.2 49.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.54 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.6 5.2 43.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.426 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 317' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 12.2 t70 -74.51 120.03 19.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.03 0.443 . . . . 0.0 110.186 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.9 p -84.79 -15.43 10.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.323 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 33.7 m -77.13 -23.93 51.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.498 -174.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 2.0 pp -85.75 164.41 17.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.456 0.646 . . . . 0.0 111.915 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 21.4 m -92.33 159.25 37.5 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.693 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 2.6 Cg_endo -41.34 -51.12 4.22 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 124.276 3.317 . . . . 0.0 114.311 -177.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -65.11 -29.03 69.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.853 0.359 . . . . 0.0 111.257 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 75.6 mt-30 -71.76 -38.52 70.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.089 -178.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.421 ' HE ' HD11 ' A' ' 320' ' ' LEU . 10.1 ptp180 -73.73 -19.88 60.67 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.489 176.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.23 -18.68 64.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.155 0.502 . . . . 0.0 110.023 172.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -112.15 12.03 20.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.084 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -60.54 152.62 25.54 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.927 0.394 . . . . 0.0 110.999 176.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -118.27 -29.73 5.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.663 -175.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.7 m -133.19 170.7 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 121.014 -0.275 . . . . 0.0 110.759 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -84.13 -51.44 7.06 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.594 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 11.4 t -107.27 146.3 31.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.03 0.443 . . . . 0.0 110.778 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.1 p -80.46 157.98 26.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.739 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.457 HD12 ' HG3' ' A' ' 338' ' ' MET . 15.9 tp -68.56 101.96 1.38 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.73 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -82.53 165.89 19.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.489 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -76.96 25.41 0.15 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -149.1 30.92 0.77 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.962 0.41 . . . . 0.0 110.842 176.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.457 ' HG3' HD12 ' A' ' 334' ' ' LEU . 23.8 mmt -88.64 137.82 31.97 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.33 141.45 28.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.742 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 12.4 t -110.07 116.89 53.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.079 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 341' ' ' ASN . . . . . 0.493 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 27.8 t-20 -127.44 139.8 52.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.162 -177.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 16.3 mt -98.58 131.33 45.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 121.045 0.45 . . . . 0.0 111.125 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 33.5 mt . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.482 176.491 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 54.8 p . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 69.97 31.27 69.71 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.056 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.615 HG21 ' O ' ' A' ' 263' ' ' ALA . 89.0 mt -99.88 144.4 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.451 0.167 . . . . 0.0 110.613 -174.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 21.6 p -105.97 167.28 9.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.042 0.449 . . . . 0.0 111.549 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.555 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.0 p -73.17 151.06 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.711 174.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 8.5 t -116.41 68.26 0.73 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.231 0.539 . . . . 0.0 109.909 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 103.94 141.83 11.41 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.856 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.8 127.6 33.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.919 0.39 . . . . 0.0 110.946 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -123.57 126.04 45.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.119 0.485 . . . . 0.0 110.427 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 5.4 p -111.08 103.36 11.8 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.197 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -81.65 151.76 27.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.337 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -145.03 127.7 8.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.257 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.4 ' HD3' HG11 ' A' ' 313' ' ' VAL . 94.6 Cg_endo . . . . . 0 N--CA 1.456 -0.677 0 C-N-CA 122.763 2.309 . . . . 0.0 110.45 169.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.414 ' CD1' ' HB ' ' A' ' 309' ' ' THR . 83.6 m-85 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.728 0.299 . . . . 0.0 110.669 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -110.19 135.32 51.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.249 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.3 OUTLIER -103.63 100.39 10.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.08 0.467 . . . . 0.0 110.58 -177.513 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.524 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.8 t -83.97 124.52 39.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.1 -170.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 21.8 m -93.74 106.21 18.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.259 0.552 . . . . 0.0 110.358 175.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.511 ' HB2' HG22 ' A' ' 264' ' ' THR . 21.8 mt -123.09 164.16 19.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.771 -176.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.7 m -57.48 -53.48 57.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.285 0.565 . . . . 0.0 109.987 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.615 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -136.85 133.53 35.94 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.257 177.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.511 HG22 ' HB2' ' A' ' 261' ' ' LEU . 4.3 p -127.96 17.48 6.73 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 11.4 m -80.32 150.49 29.92 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.772 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 91.72 -3.22 77.91 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.823 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 57.8 mtm -108.79 161.25 15.29 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.439 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 23.1 pttm -132.45 175.45 9.28 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -65.95 136.87 56.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.902 0.382 . . . . 0.0 110.338 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.99 7.6 62.4 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.213 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.439 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 44.3 m-20 -85.25 142.23 29.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.621 0.71 . . . . 0.0 109.903 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 1.3 tpmt? -87.71 115.32 25.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.776 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.541 HD11 HG21 ' A' ' 308' ' ' ILE . 6.8 pt -113.41 139.04 40.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.394 176.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 44.2 t -128.45 132.18 48.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.315 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -101.6 112.03 24.46 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.461 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.02 117.46 7.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.602 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.19 -11.19 26.68 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.458 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.2 133.55 58.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.444 ' NZ ' ' HB3' ' A' ' 279' ' ' LYS . 0.2 OUTLIER -159.16 162.89 36.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.963 0.411 . . . . 0.0 111.602 -178.193 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -81.11 156.66 25.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.266 -174.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.414 HD22 ' H ' ' A' ' 281' ' ' LEU . 1.4 mm? . . . . . 0 CA--C 1.518 -0.252 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.437 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -54.56 123.17 12.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.374 -171.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.419 ' CG2' HD12 ' A' ' 343' ' ' LEU . 14.0 p -99.4 127.0 45.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.888 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 312' ' ' PRO . 86.0 m-85 -127.74 150.4 49.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.598 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 24.1 t -97.4 122.65 40.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.102 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.443 ' HA ' HG22 ' A' ' 308' ' ' ILE . 11.1 p -74.8 134.91 28.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.08 0.467 . . . . 0.0 109.949 177.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.404 HG21 ' CE1' ' A' ' 256' ' ' PHE . 37.3 t -98.59 -35.21 4.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.725 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -164.63 136.72 4.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 0.0 110.761 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 88.9 t -83.84 109.78 17.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 171.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 42.5 t -74.43 -59.33 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.708 -173.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -120.65 -14.5 8.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.413 0.625 . . . . 0.0 111.101 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 84.08 13.91 73.3 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -169.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 31.9 p -140.92 13.57 2.27 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 171.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.423 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 2.7 t60 -168.71 121.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.038 -170.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 258' ' ' THR . 2.0 m -119.71 162.97 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.654 -175.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -116.69 123.0 46.16 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 170.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.541 HG21 HD11 ' A' ' 273' ' ' ILE . 43.7 pt -122.44 170.69 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.38 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' THR . . . . . 0.414 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 5.1 t -153.41 144.85 16.44 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 172.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.18 179.84 25.69 Favored 'Cis proline' 0 C--N 1.345 0.368 0 C-N-CA 124.061 -1.225 . . . . 0.0 112.817 -1.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -88.97 119.7 69.87 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.977 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 295' ' ' PHE . 38.2 Cg_endo -69.68 116.48 4.57 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.673 2.249 . . . . 0.0 112.527 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.56 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -124.67 131.79 72.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.524 176.909 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 317' ' ' ASP . . . -78.96 130.92 36.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.259 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.34 -28.28 66.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.935 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -98.9 25.72 6.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.294 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 317' ' ' ASP . . . . . 0.546 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 10.0 t70 -78.59 123.55 27.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.2 m -83.5 3.29 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 16.8 m -109.77 18.63 20.0 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.672 0.272 . . . . 0.0 111.287 -174.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.8 pp -127.91 168.58 15.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.083 0.468 . . . . 0.0 111.945 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.424 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 4.1 m -102.82 169.97 6.86 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.568 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 99.2 Cg_exo -47.35 -48.95 13.95 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.234 2.623 . . . . 0.0 113.915 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -65.45 -33.95 77.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.284 0.564 . . . . 0.0 110.554 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.51 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 13.0 mm100 -67.44 -42.47 83.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.148 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -71.82 -17.01 62.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.913 0.387 . . . . 0.0 111.167 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.2 -29.16 67.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.067 0.46 . . . . 0.0 110.098 173.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -86.4 -13.17 47.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.827 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.56 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -58.41 143.68 44.48 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.29 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -131.13 -8.95 3.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.049 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.5 174.22 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.046 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -84.88 -45.23 12.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.684 0.278 . . . . 0.0 111.115 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 6.2 t -129.57 144.43 51.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.366 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.502 ' N ' ' HB2' ' A' ' 314' ' ' ALA . 22.5 m -68.22 169.48 10.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.414 ' HG ' HG21 ' A' ' 230' ' ' VAL . 21.4 tp -70.16 102.22 2.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -176.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.555 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -90.75 -173.69 3.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.312 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -73.3 158.98 34.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.89 0.376 . . . . 0.0 110.826 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 60.6 39.1 18.26 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.207 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.457 ' H ' HG12 ' A' ' 230' ' ' VAL . 26.1 mmt -104.6 133.08 50.05 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -89.01 137.6 32.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.066 0.46 . . . . 0.0 111.354 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 12.5 t -103.21 124.35 57.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.565 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -138.24 134.34 34.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.557 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 70.7 mt -88.46 119.72 36.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.917 0.389 . . . . 0.0 110.088 176.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 343' ' ' LEU . . . . . 0.419 HD12 ' CG2' ' A' ' 294' ' ' THR . 40.8 mt . . . . . 0 C--N 1.32 -0.697 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.721 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 33.7 p . . . . . 0 N--CA 1.446 -0.637 0 CA-C-O 121.191 0.519 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -81.23 67.83 3.55 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 174.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 263' ' ' ALA . 40.0 mm -100.1 145.01 11.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.585 -0.308 . . . . 0.0 110.685 -174.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.2 p -128.16 159.97 33.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.291 0.567 . . . . 0.0 110.681 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.678 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.4 p -84.68 151.88 3.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.537 -175.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 67.8 m -109.14 82.23 1.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.841 0.353 . . . . 0.0 110.408 174.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 93.58 165.22 37.29 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.592 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 334' ' ' LEU . . . -84.22 114.15 21.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.874 0.368 . . . . 0.0 110.15 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -120.61 128.43 53.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.026 -175.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 333' ' ' SER . 26.9 p -145.84 102.08 3.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.4 0.619 . . . . 0.0 110.092 172.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.421 ' C ' ' HD3' ' A' ' 311' ' ' LYS . 79.3 m-85 -95.15 148.15 22.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.927 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 237' ' ' LYS . 12.9 mptt -110.01 146.0 33.25 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.974 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.456 -0.682 0 C-N-CA 122.494 2.129 . . . . 0.0 111.677 174.729 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.436 ' CD2' ' HB ' ' A' ' 309' ' ' THR . 97.2 m-85 . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.41 ' HB2' ' HG3' ' A' ' 311' ' ' LYS . . . -105.08 118.24 36.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.611 0.244 . . . . 0.0 111.424 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -87.06 103.48 15.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.177 0.513 . . . . 0.0 110.586 175.399 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -82.22 118.23 29.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.021 -173.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 23.5 m -84.93 105.64 15.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.013 176.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.429 HD22 HG21 ' A' ' 340' ' ' VAL . 31.3 mt -126.09 166.45 16.98 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.949 -177.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.4 t -64.59 -52.85 55.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.096 0.474 . . . . 0.0 109.798 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.527 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.69 127.31 27.04 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.802 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 10.6 p -125.22 32.37 5.39 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 173.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 1.4 m -81.31 145.99 30.61 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.163 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 90.28 -2.8 81.63 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.758 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 59.7 mtt -97.79 146.3 25.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -133.05 172.73 12.25 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -59.36 138.49 57.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.034 0.445 . . . . 0.0 111.069 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 88.12 11.83 66.65 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.257 176.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.445 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 53.1 m-20 -90.64 153.84 20.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.555 0.678 . . . . 0.0 110.49 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -103.8 117.67 34.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.824 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.471 HD11 HG21 ' A' ' 308' ' ' ILE . 40.4 pt -112.72 139.87 35.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.137 178.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.506 ' HB3' HG22 ' A' ' 294' ' ' THR . 77.3 p -120.27 133.63 55.43 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.766 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -95.04 110.43 22.35 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 339' ' ' ALA . . . -70.83 118.72 13.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.122 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 108.49 -22.7 26.06 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.62 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 41.2 t -101.32 133.76 43.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -144.25 156.82 44.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.706 0.288 . . . . 0.0 111.131 -174.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.547 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 82.4 m-85 -77.55 169.35 18.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.599 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.686 179.04 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.547 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -71.56 95.48 1.42 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.249 -177.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.506 HG22 ' HB3' ' A' ' 274' ' ' SER . 70.8 p -103.78 126.72 51.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.35 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.424 ' CE2' ' HG3' ' A' ' 312' ' ' PRO . 92.5 m-85 -131.59 155.98 46.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.888 0.375 . . . . 0.0 110.828 -179.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 5.6 m -100.86 129.5 46.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.153 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.445 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 11.9 p -83.17 135.93 23.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.143 0.497 . . . . 0.0 110.462 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 27.9 t -98.48 -28.91 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.704 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 307' ' ' GLU . 27.8 tpt180 -167.17 137.92 3.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.506 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 97.6 t -87.85 111.36 22.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 14.9 t -75.86 -56.43 8.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.869 -170.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -119.3 -6.06 10.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.902 0.382 . . . . 0.0 111.65 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.94 12.16 84.17 Favored Glycine 0 C--N 1.322 -0.202 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -170.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 6.6 p -148.03 19.85 1.11 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.444 ' NE2' ' HB ' ' A' ' 258' ' ' THR . 3.6 t-160 -167.08 116.93 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.052 -1.431 . . . . 0.0 107.965 -170.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -118.64 152.15 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -175.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 299' ' ' ARG . 9.9 pt-20 -110.37 118.07 35.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.079 0.466 . . . . 0.0 110.002 173.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.471 HG21 HD11 ' A' ' 273' ' ' ILE . 27.2 pt -120.57 171.06 9.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.531 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' THR . . . . . 0.436 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 7.1 t -148.91 140.32 14.21 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.625 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.4 -179.91 28.49 Favored 'Cis proline' 0 C--N 1.344 0.31 0 C-N-CA 123.906 -1.289 . . . . 0.0 112.375 -2.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 236' ' ' PHE . 37.2 ttmt -85.47 125.28 70.0 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.954 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.424 ' HG3' ' CE2' ' A' ' 295' ' ' PHE . 16.1 Cg_exo -67.74 108.97 1.76 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.661 2.241 . . . . 0.0 112.755 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.59 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -120.92 131.23 73.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.744 173.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -91.62 141.06 29.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.334 0.588 . . . . 0.0 111.377 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.7 tm? -72.84 -22.89 60.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.567 177.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.4 17.38 14.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.409 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.07 115.26 22.28 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 9.4 p -83.11 -9.68 11.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.005 0.431 . . . . 0.0 111.29 -175.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 15.0 m -82.33 -29.75 30.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.347 -174.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 2.4 pp -84.65 162.62 19.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.4 0.619 . . . . 0.0 112.002 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.491 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 41.9 m -95.93 166.07 15.19 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.076 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 71.3 Cg_exo -43.68 -44.23 11.33 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.554 2.836 . . . . 0.0 114.666 -177.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.27 -33.91 75.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.254 0.55 . . . . 0.0 111.201 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 46.4 mt-30 -79.86 -36.93 35.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.675 -175.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.446 ' HB3' ' CD1' ' A' ' 320' ' ' LEU . 13.6 ptm180 -73.2 -20.19 60.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.053 0.454 . . . . 0.0 110.161 177.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.01 -29.89 69.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.994 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -101.19 11.37 39.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.378 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.59 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -59.67 149.74 29.65 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.88 0.372 . . . . 0.0 111.212 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -125.95 -36.29 2.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.711 -176.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 30.7 m -110.31 155.19 11.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.229 0.537 . . . . 0.0 111.182 -175.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -85.61 -17.04 37.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.428 -176.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.1 t -144.0 139.74 29.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.225 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 235' ' ' SER . 73.0 m -70.89 163.62 27.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.241 175.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.418 ' HG ' HG21 ' A' ' 230' ' ' VAL . 29.0 tp -69.05 104.26 2.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.678 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -78.98 170.23 17.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.699 -175.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -76.44 12.41 1.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -170.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -152.93 65.31 0.78 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.356 0.598 . . . . 0.0 110.347 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.513 ' H ' HG12 ' A' ' 230' ' ' VAL . 22.2 mmt -114.85 141.95 47.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.255 178.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 339' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 276' ' ' ALA . . . -90.77 129.62 36.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.528 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 19.2 t -104.19 117.27 49.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -131.57 138.72 48.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.747 0.308 . . . . 0.0 111.185 -174.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 3.3 mt -90.42 133.37 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.137 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 60.4 mt . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.31 178.427 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 53.8 p . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.344 0.592 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -123.39 48.12 0.97 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 175.433 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.573 HG21 ' O ' ' A' ' 263' ' ' ALA . 17.4 mt -87.26 150.46 3.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -175.495 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 6.1 p -107.86 166.02 11.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.309 0.576 . . . . 0.0 111.722 -178.439 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.636 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.7 p -72.82 150.32 8.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.971 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 231' ' ' SER . . . . . 0.492 ' HB2' ' N ' ' A' ' 262' ' ' SER . 7.0 t -110.87 74.48 0.87 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.344 0.592 . . . . 0.0 109.72 177.852 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 92.8 144.3 14.3 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.996 -178.312 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.51 126.89 29.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.857 0.361 . . . . 0.0 110.808 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -125.33 126.35 44.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.134 -179.098 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.9 m -105.65 104.42 14.14 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.693 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.406 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 55.8 m-85 -80.52 113.64 18.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.977 -176.989 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -124.64 121.78 25.76 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.92 0.391 . . . . 0.0 111.763 -174.619 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo . . . . . 0 N--CA 1.453 -0.893 0 C-N-CA 122.782 2.321 . . . . 0.0 110.997 170.765 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 N--CA 1.454 -0.253 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -101.99 115.69 31.09 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.727 0.299 . . . . 0.0 110.408 178.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.7 OUTLIER -92.78 103.61 15.95 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.164 0.507 . . . . 0.0 109.995 179.639 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.1 t -82.84 117.0 28.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.466 -171.189 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 16.2 m -87.04 105.3 17.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.101 177.271 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.48 HD12 HG22 ' A' ' 264' ' ' THR . 29.0 mt -125.59 162.73 24.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.13 -176.163 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.492 ' N ' ' HB2' ' A' ' 231' ' ' SER . 14.0 m -62.21 -50.2 72.73 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.428 0.632 . . . . 0.0 109.697 179.229 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.573 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -138.13 142.06 40.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.269 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.48 HG22 HD12 ' A' ' 261' ' ' LEU . 19.1 p -129.39 26.86 5.36 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.087 0.946 . . . . 0.0 108.875 174.296 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 15.5 m -77.71 138.3 38.97 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.343 -1.298 . . . . 0.0 109.513 175.55 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 104.9 -7.1 44.45 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -172.224 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 267' ' ' MET . . . . . 0.451 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 61.1 mtt -101.5 144.74 29.89 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.389 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -154.89 141.98 19.31 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.518 ' HA ' HG13 ' A' ' 297' ' ' VAL . 24.3 ptt180 -44.46 116.52 1.05 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.96 0.788 . . . . 0.0 112.582 -171.586 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.62 -6.63 20.44 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.426 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.549 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.6 p30 -85.15 -177.9 6.64 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.482 0.641 . . . . 0.0 111.534 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -124.65 117.11 23.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.897 -177.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.503 HD11 HG21 ' A' ' 308' ' ' ILE . 40.8 pt -112.72 139.88 35.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.108 0.48 . . . . 0.0 110.208 177.363 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.501 ' OG ' HG22 ' A' ' 294' ' ' THR . 4.9 m -127.98 149.28 50.42 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.822 -178.504 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -113.59 111.85 22.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.424 -178.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.52 115.71 6.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.823 -178.42 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.32 -25.62 12.2 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.708 -178.258 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 47.2 t -99.04 115.15 38.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.714 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -132.7 162.55 31.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.867 0.365 . . . . 0.0 111.896 -173.541 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.457 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 60.1 m-85 -80.46 154.16 27.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.86 -175.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 315' ' ' LEU . 40.2 mt . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.796 179.741 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 C--O 1.234 0.261 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.516 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -70.69 87.9 0.69 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.464 -176.542 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.501 HG22 ' OG ' ' A' ' 274' ' ' SER . 70.5 p -90.99 112.53 24.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.288 178.416 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.516 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 68.0 m-85 -123.07 145.43 48.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.931 0.396 . . . . 0.0 110.857 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 11.9 m -80.3 130.0 34.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.696 175.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.549 HG12 ' H ' ' A' ' 271' ' ' ASP . 5.2 p -67.75 132.72 32.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.255 0.55 . . . . 0.0 109.668 179.293 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.425 HG23 ' HA ' ' A' ' 308' ' ' ILE . 84.6 t -94.07 -45.34 13.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.105 178.751 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -167.51 139.08 3.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.126 178.675 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 93.7 t -88.11 108.79 18.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 171.363 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.0 t -78.54 -59.66 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.971 -173.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -111.91 -8.16 14.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.948 0.404 . . . . 0.0 111.529 -174.081 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.16 12.85 83.22 Favored Glycine 0 CA--C 1.517 0.193 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -170.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 20.4 p -146.05 16.25 1.37 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 174.417 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.44 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 1.6 t60 -170.73 115.53 0.46 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.384 -168.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.58 161.92 18.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.537 -175.227 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -116.22 129.29 56.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.003 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.511 HG22 ' HA ' ' A' ' 297' ' ' VAL . 27.1 pt -132.07 169.83 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.031 0.443 . . . . 0.0 111.471 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 7.2 t -150.02 143.58 16.78 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.41 177.575 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -76.44 -179.95 29.0 Favored 'Cis proline' 0 C--N 1.345 0.378 0 C-N-CA 124.129 -1.196 . . . . 0.0 112.419 -3.113 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.406 ' HG3' ' HB3' ' A' ' 236' ' ' PHE . 35.9 ttmt -87.41 123.35 69.84 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.207 -178.016 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.15 109.29 2.9 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.593 2.196 . . . . 0.0 112.658 178.497 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.477 ' CG2' ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -107.06 133.92 50.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.62 175.745 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.447 ' HB2' ' N ' ' A' ' 333' ' ' SER . . . -82.84 126.06 32.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.11 0.481 . . . . 0.0 111.409 -178.458 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.546 ' HB2' HD11 ' A' ' 281' ' ' LEU . 2.7 tm? -68.64 -29.6 68.13 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.968 177.496 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -79.52 -0.81 34.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.751 -179.073 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -79.92 122.5 26.76 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.984 0.421 . . . . 0.0 110.622 -178.675 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 14.2 p -83.96 -16.64 10.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.237 -178.559 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 24.5 m -74.42 -35.82 63.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.721 -175.189 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.474 ' O ' HD12 ' A' ' 320' ' ' LEU . 1.7 pp -75.4 152.64 38.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.276 0.56 . . . . 0.0 110.884 178.423 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.508 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.8 m -91.09 170.84 9.06 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.259 -173.931 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 91.2 Cg_exo -46.98 -50.45 10.89 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 123.446 2.764 . . . . 0.0 114.517 -175.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.35 -28.85 69.98 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.149 -177.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 50.9 mt-30 -76.03 -39.65 55.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.631 0.253 . . . . 0.0 111.026 -178.663 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.445 ' HB3' ' CD1' ' A' ' 320' ' ' LEU . 13.0 ptp180 -73.37 -22.85 60.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.009 0.433 . . . . 0.0 110.538 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.87 -34.21 77.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.217 174.02 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -96.6 6.23 49.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.185 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.477 ' HA ' ' CG2' ' A' ' 313' ' ' VAL . . . -61.41 135.61 57.75 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.887 0.375 . . . . 0.0 110.753 178.664 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -108.89 -29.2 8.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.365 -176.121 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.8 171.53 9.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.946 0.403 . . . . 0.0 111.132 -175.345 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -88.55 -38.77 14.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.449 -178.055 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.1 t -128.3 143.17 50.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.909 0.385 . . . . 0.0 110.763 -176.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.447 ' N ' ' HB2' ' A' ' 314' ' ' ALA . 44.1 m -72.29 162.71 29.09 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 172.389 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.419 ' HG ' HG21 ' A' ' 230' ' ' VAL . 23.0 tp -68.66 102.42 1.5 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -177.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.636 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -95.72 -179.24 4.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.269 -178.337 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -67.57 150.45 48.79 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.094 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 65.45 45.62 2.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.819 179.195 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 26.4 mmt -112.0 131.07 55.63 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.207 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -87.07 133.6 33.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.604 -176.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.424 HG21 HD22 ' A' ' 261' ' ' LEU . 10.3 t -101.83 114.86 42.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.476 177.569 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -125.85 134.52 51.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.098 -174.035 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 19.5 mt -93.01 131.43 40.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 174.207 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 121.022 0.439 . . . . 0.0 110.586 179.758 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 121.222 0.534 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.43 68.1 3.39 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 174.433 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.541 ' HB ' ' O ' ' A' ' 340' ' ' VAL . 40.6 mm -100.17 143.45 13.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 122.339 0.256 . . . . 0.0 111.101 -173.356 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 74.4 p -121.89 149.41 43.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.195 0.521 . . . . 0.0 110.506 173.166 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.668 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.5 p -64.48 152.97 8.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.678 175.65 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 14.2 t -124.58 88.78 2.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.914 0.388 . . . . 0.0 110.017 175.539 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 103.4 165.34 25.51 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.038 -178.834 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -86.52 125.13 33.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.718 0.294 . . . . 0.0 110.428 179.145 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -120.58 129.51 53.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.929 0.395 . . . . 0.0 110.961 -176.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 25.5 t -153.89 103.04 2.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.899 177.404 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -114.26 141.65 47.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.892 -179.244 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 237' ' ' LYS . 2.9 mptp? -111.9 145.89 33.66 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.822 -175.544 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.459 -0.539 0 C-N-CA 122.261 1.974 . . . . 0.0 110.846 174.115 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.504 ' CE1' HG21 ' A' ' 298' ' ' VAL . 48.1 m-85 . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 120.744 0.307 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -145.36 118.44 8.85 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.861 176.33 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 3.8 m -83.22 113.01 20.37 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.076 0.465 . . . . 0.0 110.484 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.5 t -98.08 120.5 47.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.427 -173.542 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 79.5 m -89.64 108.2 19.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.04 0.448 . . . . 0.0 109.958 174.167 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.51 HD23 HG23 ' A' ' 230' ' ' VAL . 23.9 mt -125.04 168.32 13.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.732 -177.684 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.8 t -64.7 -52.84 55.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.532 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.68 127.24 26.94 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.328 179.426 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.419 ' CG2' ' HB2' ' A' ' 261' ' ' LEU . 11.5 p -125.23 25.5 7.15 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.885 174.76 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 24.1 m -82.01 145.29 30.32 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.156 175.626 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.93 -18.17 57.2 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -173.333 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 59.9 mtt -91.46 138.81 31.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.936 -0.632 . . . . 0.0 109.317 176.245 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -133.35 153.61 51.43 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.339 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.423 ' HA ' HG13 ' A' ' 297' ' ' VAL . 30.9 ptt180 -58.13 134.63 56.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.971 0.415 . . . . 0.0 111.366 -175.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 99.6 14.45 34.87 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.296 -177.399 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.528 ' H ' HG12 ' A' ' 297' ' ' VAL . 0.6 OUTLIER -109.45 175.59 5.39 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.8 0.3 . . . . 0.0 110.224 179.487 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.468 ' HE3' HD12 ' A' ' 343' ' ' LEU . 5.2 tmmm? -127.09 117.49 22.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.564 -174.371 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.439 HD11 HG21 ' A' ' 308' ' ' ILE . 31.0 pt -111.65 142.57 23.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.906 -177.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 14.8 m -124.55 138.55 54.32 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.507 -178.785 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -100.87 112.0 24.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.485 -178.51 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.96 116.56 9.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.97 -178.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.19 -34.22 5.3 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 60.2 t -89.06 122.09 39.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 175.145 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -139.88 158.38 44.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.043 0.449 . . . . 0.0 111.608 -176.137 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -73.48 145.41 45.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.155 -173.209 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 315' ' ' LEU . 77.2 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.359 176.612 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.584 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -60.39 102.56 0.18 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.526 -170.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.466 ' HB ' ' HD3' ' A' ' 272' ' ' LYS . 19.7 p -95.19 111.19 23.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.603 177.045 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.584 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 65.1 m-85 -123.68 150.53 44.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.859 0.362 . . . . 0.0 110.897 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 16.2 m -96.06 134.03 39.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.255 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 271' ' ' ASP . 9.5 p -86.98 135.53 24.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.964 0.411 . . . . 0.0 110.359 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.504 HG21 ' CE1' ' A' ' 256' ' ' PHE . 46.0 t -105.48 -31.5 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.274 -176.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -162.27 138.4 7.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.826 0.346 . . . . 0.0 110.593 -178.345 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 89.3 t -92.4 114.23 28.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.587 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.83 -59.29 3.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.842 -172.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.77 -2.47 10.91 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.873 0.368 . . . . 0.0 111.794 -174.129 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.08 11.71 83.84 Favored Glycine 0 N--CA 1.459 0.2 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -174.075 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 5.9 p -150.75 23.03 0.78 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 173.179 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.465 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.2 t-160 -167.78 112.75 0.68 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 113.594 -1.639 . . . . 0.0 107.896 -165.454 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.27 169.89 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.559 -174.174 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 10.9 pt-20 -128.22 121.74 30.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.215 0.531 . . . . 0.0 109.931 169.589 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 273' ' ' ILE . 22.7 pt -120.98 174.65 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.143 -177.136 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.7 t -155.19 147.06 17.18 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.121 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -69.23 179.94 19.86 Favored 'Cis proline' 0 C--N 1.349 0.567 0 C-N-CA 124.163 -1.182 . . . . 0.0 113.162 -2.403 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 24.1 ttmm -82.26 124.81 78.02 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.212 -177.402 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 13.3 Cg_exo -69.25 109.89 2.32 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.84 2.36 . . . . 0.0 112.606 177.106 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -126.04 130.69 72.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.905 174.161 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -95.32 143.7 26.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.272 0.558 . . . . 0.0 111.506 -175.431 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.527 ' HB2' HD11 ' A' ' 281' ' ' LEU . 2.6 tm? -76.43 -26.5 55.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.101 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -98.05 26.0 5.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.647 178.381 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 317' ' ' ASP . . . . . 0.51 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 20.3 t70 -86.14 131.3 34.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.528 -179.412 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 11.3 p -84.49 -18.53 9.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.946 -176.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 19.7 m -91.77 5.11 51.09 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -168.731 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' A' ' 325' ' ' ARG . 0.8 OUTLIER -115.67 157.53 24.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.365 0.602 . . . . 0.0 112.056 -179.378 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 16.9 m -86.55 158.47 54.28 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.552 177.774 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.574 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 61.9 Cg_exo -39.66 -49.78 3.27 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.434 3.423 . . . . 0.0 114.882 -176.862 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.9 -39.39 85.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.849 0.357 . . . . 0.0 111.68 -177.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -72.71 -29.57 63.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -172.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 9.7 ptm180 -76.14 -18.77 58.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.449 0.642 . . . . 0.0 109.862 178.43 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.79 -21.7 61.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.78 172.241 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -96.74 1.24 50.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.706 175.501 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.527 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -59.09 144.43 45.56 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.551 179.412 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -118.17 -27.28 6.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.436 -176.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.8 m -119.31 170.89 8.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.685 0.278 . . . . 0.0 111.218 -177.606 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -82.71 -53.97 5.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.922 -176.715 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.4 t -114.91 145.28 42.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.066 0.46 . . . . 0.0 110.876 -171.682 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.0 m -75.23 154.62 37.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.438 178.563 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.451 ' HG ' HG21 ' A' ' 230' ' ' VAL . 16.7 tp -70.1 103.34 2.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.092 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.668 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -95.76 162.33 13.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.958 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 336' ' ' ASP . . . . . 0.458 ' HA ' HG13 ' A' ' 230' ' ' VAL . 38.4 t70 -75.21 62.72 1.27 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.097 0.475 . . . . 0.0 112.1 -174.143 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -176.6 33.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.696 171.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.451 ' H ' HG12 ' A' ' 230' ' ' VAL . 23.9 mmt -104.54 130.7 52.48 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -83.63 135.1 34.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.607 178.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.541 ' O ' ' HB ' ' A' ' 228' ' ' ILE . 22.0 t -112.22 115.05 48.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.525 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -132.6 135.2 45.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.875 0.369 . . . . 0.0 111.6 -174.118 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.407 ' CG1' HG22 ' A' ' 273' ' ' ILE . 45.8 mt -84.29 123.59 39.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.855 174.072 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 343' ' ' LEU . . . . . 0.468 HD12 ' HE3' ' A' ' 272' ' ' LYS . 51.3 mt . . . . . 0 C--N 1.32 -0.705 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.846 178.839 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.433 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 16.3 p . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 111.383 0.142 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 60.45 36.98 92.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.7 -177.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 58.6 mt -91.17 144.04 9.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -176.151 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 13.4 p -96.65 153.26 17.96 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.555 0.693 . . . . 0.0 111.998 -172.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.654 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.6 p -67.06 151.09 10.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.052 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 71.5 m -113.75 82.0 1.62 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.919 0.39 . . . . 0.0 110.463 177.104 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 95.34 147.57 22.85 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.013 -179.375 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -82.59 139.07 34.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.839 0.352 . . . . 0.0 111.116 -177.64 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -141.38 135.18 30.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.251 0.548 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.9 p -139.87 103.07 4.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.245 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -115.38 153.95 30.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.352 -177.919 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 320' ' ' LEU . 13.4 mptt -108.63 138.76 20.35 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.077 177.316 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 N--CA 1.462 -0.348 0 C-N-CA 122.677 2.251 . . . . 0.0 112.112 -179.762 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 . . . . . 0 CA--C 1.52 -0.188 0 CA-C-O 120.833 0.349 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.55 124.87 46.7 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.343 178.269 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.3 m -93.37 101.41 13.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.302 0.572 . . . . 0.0 110.363 -179.374 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -82.97 122.92 38.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.146 -173.557 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 29.8 m -98.01 106.43 18.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.36 0.6 . . . . 0.0 110.299 179.179 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.443 HD23 HG23 ' A' ' 230' ' ' VAL . 16.5 mt -125.08 164.56 19.94 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.727 -174.94 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 51.1 m -58.54 -54.75 43.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.198 0.523 . . . . 0.0 109.927 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -136.78 130.66 32.25 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.258 178.304 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.402 ' CG2' ' HB2' ' A' ' 261' ' ' LEU . 10.5 p -126.37 25.94 6.49 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.183 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.7 m -79.68 143.13 34.88 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.69 -1.595 . . . . 0.0 109.819 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 99.29 -19.76 52.64 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -175.204 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 85.2 mtp -75.72 152.56 37.44 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.131 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -154.83 147.26 24.03 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -178.232 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.478 ' HA ' HG13 ' A' ' 297' ' ' VAL . 32.1 ptt180 -51.9 114.43 1.3 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.366 0.603 . . . . 0.0 111.15 -176.066 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 116.33 6.13 15.94 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.557 -174.078 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -88.7 179.84 6.16 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 117.094 0.447 . . . . 0.0 110.928 176.067 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 0.2 OUTLIER -141.45 117.18 10.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.647 -178.115 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 308' ' ' ILE . 21.9 pt -113.22 139.95 35.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.026 0.441 . . . . 0.0 110.876 -178.584 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 69.9 p -120.88 133.99 55.3 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.706 176.929 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.471 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 95.5 m-85 -94.11 111.46 23.18 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.179 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.481 ' HA ' ' OD1' ' A' ' 292' ' ' ASP . . . -66.0 111.53 3.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.02 -177.671 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.22 -35.3 4.73 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.7 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 83.9 t -82.62 129.69 37.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 173.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -148.35 160.23 43.21 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.26 -175.542 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -77.08 150.94 35.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.931 -178.661 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.765 177.93 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.481 ' OD1' ' HA ' ' A' ' 276' ' ' ALA . 57.3 m-20 . . . . . 0 C--O 1.232 0.166 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -58.66 108.97 0.71 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.607 -175.432 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.3 p -91.49 118.17 30.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.164 -178.367 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.67 148.25 48.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.225 177.473 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 25.4 m -98.67 136.73 38.32 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.603 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' A' ' 269' ' ' ARG . 8.7 p -67.56 142.56 16.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.449 178.566 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.2 t -105.74 -45.03 8.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.742 173.274 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -154.94 139.36 16.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.637 179.589 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 77.3 t -86.05 109.23 18.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 171.388 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 31.9 t -76.45 -58.26 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.821 -172.366 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -122.58 -2.7 8.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.866 0.365 . . . . 0.0 111.318 -176.085 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 72.18 12.88 76.37 Favored Glycine 0 CA--C 1.518 0.268 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -172.056 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 4.4 p -149.11 21.75 0.97 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.176 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.468 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.9 t-160 -173.41 115.73 0.25 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 113.833 -1.531 . . . . 0.0 107.667 -167.326 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.64 162.67 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -173.63 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 10.1 pt-20 -123.19 126.11 46.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.113 0.482 . . . . 0.0 110.189 171.744 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.42 HG21 HD11 ' A' ' 273' ' ' ILE . 25.5 pt -125.24 168.8 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.38 -176.031 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 6.0 t -140.59 138.47 18.68 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.802 176.381 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.04 179.45 25.95 Favored 'Cis proline' 0 C--N 1.344 0.318 0 C-N-CA 123.364 -1.515 . . . . 0.0 112.411 -1.403 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 3.0 ttmp? -80.12 123.57 83.31 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.384 177.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 15.0 Cg_exo -67.85 113.36 2.97 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.821 2.348 . . . . 0.0 112.647 178.782 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.602 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -117.32 128.96 74.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.125 174.817 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -81.19 130.62 35.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.261 0.553 . . . . 0.0 111.201 -178.484 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.0 tm? -65.18 -27.06 68.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.052 177.325 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.43 10.94 27.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.567 -178.732 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 317' ' ' ASP . . . . . 0.404 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 12.9 t70 -74.68 128.96 36.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.789 0.328 . . . . 0.0 110.133 178.652 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.1 p -83.92 -17.89 10.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.93 0.395 . . . . 0.0 111.58 -175.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 12.3 m -79.06 -36.33 41.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.489 -173.542 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.557 HD13 ' HB3' ' A' ' 325' ' ' ARG . 1.5 pp -72.25 162.53 29.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.448 0.642 . . . . 0.0 112.141 -178.522 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.518 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 12.5 m -108.26 173.87 2.78 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.697 -179.009 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 72.8 Cg_exo -44.19 -53.17 4.98 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 123.429 2.753 . . . . 0.0 114.987 -173.172 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -62.96 -39.12 93.72 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.071 -176.425 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -65.38 -41.37 93.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.452 -179.006 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.557 ' HB3' HD13 ' A' ' 320' ' ' LEU . 5.4 ppt_? -74.68 -19.0 60.44 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.972 179.132 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.78 -18.39 62.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.202 173.119 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -103.21 -0.61 30.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.485 176.539 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.602 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -62.27 127.33 30.84 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.774 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -106.5 -26.61 11.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.493 -176.001 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 27.0 m -116.29 161.45 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.0 110.858 -177.739 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -89.18 -16.75 30.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.109 -177.493 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.3 t -143.01 139.46 30.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.967 0.413 . . . . 0.0 111.002 -178.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.425 ' N ' ' HB2' ' A' ' 314' ' ' ALA . 20.2 m -74.56 174.56 8.83 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.431 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 19.1 tp -78.05 102.89 7.66 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.507 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.654 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -84.04 169.29 15.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.147 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -81.36 32.26 0.34 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -171.424 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.94 48.57 0.39 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.059 0.457 . . . . 0.0 110.841 174.784 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.455 ' H ' HG12 ' A' ' 230' ' ' VAL . 26.2 mmt -110.68 137.66 48.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.243 179.541 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.48 132.58 40.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.946 0.403 . . . . 0.0 110.874 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 31.8 t -102.83 114.36 42.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.897 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 341' ' ' ASN . . . . . 0.433 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 8.4 t30 -126.07 124.46 40.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.398 -176.32 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 32.3 mt -77.65 128.54 38.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.921 172.004 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 74.9 mt . . . . . 0 C--N 1.322 -0.62 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.743 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 63.07 33.66 87.86 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.769 -176.324 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.45 HG21 ' O ' ' A' ' 263' ' ' ALA . 51.4 mt -102.99 149.96 6.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -175.761 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.88 148.07 32.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.812 0.339 . . . . 0.0 110.487 177.617 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.58 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.9 p -53.97 151.75 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.589 178.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 231' ' ' SER . . . . . 0.45 ' HB2' ' N ' ' A' ' 262' ' ' SER . 9.4 t -100.79 69.57 1.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.068 0.461 . . . . 0.0 110.026 178.585 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 89.52 166.16 41.57 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.013 -178.761 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.11 117.49 10.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.995 0.426 . . . . 0.0 110.756 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -114.77 126.43 54.83 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.967 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 57.2 p -125.27 149.57 47.9 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.152 -178.058 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -125.75 154.87 41.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.631 -178.484 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -143.02 138.42 15.77 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.159 177.367 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.5 ' HD2' ' OE1' ' A' ' 324' ' ' GLN . 5.5 Cg_endo . . . . . 0 N--CA 1.448 -1.166 0 C-N-CA 121.766 1.644 . . . . 0.0 110.602 171.55 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.429 ' CD2' ' HB ' ' A' ' 309' ' ' THR . 78.8 m-85 . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -136.33 132.79 36.11 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.702 0.286 . . . . 0.0 110.771 178.194 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.7 m -98.94 103.05 14.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.109 0.481 . . . . 0.0 110.069 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.51 125.81 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.744 -171.212 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 23.5 m -93.4 106.15 18.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.193 175.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.451 ' HB2' HG22 ' A' ' 264' ' ' THR . 19.6 mt -126.0 160.62 29.56 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -177.388 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.459 ' O ' HG22 ' A' ' 304' ' ' THR . 15.9 p -61.57 -48.09 82.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.147 0.499 . . . . 0.0 110.127 -178.672 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.45 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -136.72 138.33 40.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.294 175.862 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.451 HG22 ' HB2' ' A' ' 261' ' ' LEU . 9.4 p -134.61 28.45 3.62 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.503 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.6 m -78.07 145.02 36.07 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.486 -178.843 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 97.08 -4.12 62.55 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.428 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 62.0 mtt -93.58 158.57 15.63 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 178.392 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.444 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 25.1 pttm -150.08 163.8 37.24 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.594 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -56.07 123.99 16.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.068 0.461 . . . . 0.0 110.791 -178.244 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 98.72 18.25 25.89 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.418 178.132 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.451 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 0.3 OUTLIER -99.1 160.22 14.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.634 0.717 . . . . 0.0 110.127 179.056 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -108.96 117.07 33.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.834 -175.5 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 308' ' ' ILE . 36.8 pt -117.91 140.7 40.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.234 0.54 . . . . 0.0 110.407 177.415 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.436 ' HB2' HG22 ' A' ' 294' ' ' THR . 39.0 t -126.97 153.81 45.38 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.371 179.29 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -117.46 111.69 19.63 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.08 117.73 5.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.234 -177.538 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.03 -34.7 5.06 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 96.3 t -88.37 114.44 26.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.304 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -137.12 157.15 47.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.962 0.411 . . . . 0.0 111.035 -175.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.421 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 63.0 m-85 -76.6 135.9 39.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.029 -176.239 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 68.9 mt . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.974 175.026 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.646 0.26 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.421 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -49.61 110.07 0.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.621 -175.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.515 HG21 HD11 ' A' ' 343' ' ' LEU . 4.9 p -100.49 120.5 40.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.08 -178.249 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -122.44 151.28 41.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.629 -178.636 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.8 m -98.32 130.59 45.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.211 178.389 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.451 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 14.1 p -80.83 132.08 32.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.322 0.582 . . . . 0.0 110.629 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 37.3 t -91.53 -33.9 5.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.317 -178.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -166.37 139.9 4.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.418 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 57.5 t -88.32 107.36 17.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 169.9 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 39.9 t -68.59 -54.79 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.874 -172.048 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -128.5 -6.42 5.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.154 0.502 . . . . 0.0 111.514 -174.156 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.04 12.67 80.69 Favored Glycine 0 N--CA 1.457 0.095 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -176.245 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 304' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 262' ' ' SER . 0.7 OUTLIER -150.65 20.84 0.81 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.229 1.014 . . . . 0.0 108.304 175.03 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -172.02 115.07 0.34 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.35 -171.325 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.89 162.59 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.514 -172.92 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -119.79 120.04 35.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.052 0.453 . . . . 0.0 110.014 171.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.459 HG21 HD11 ' A' ' 273' ' ' ILE . 27.6 pt -119.87 171.59 8.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.047 -177.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 309' ' ' THR . . . . . 0.429 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 12.7 t -150.05 142.2 15.51 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.235 175.342 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.18 -179.53 27.42 Favored 'Cis proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.764 -1.348 . . . . 0.0 113.135 -1.563 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 31.0 ttmt -78.85 121.39 83.39 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.161 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 16.2 Cg_exo -67.25 109.5 1.78 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.697 2.265 . . . . 0.0 111.902 175.373 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.7 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.3 OUTLIER -130.2 127.3 62.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.58 178.161 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -77.26 129.2 35.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.195 -177.708 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 44.6 tp -73.86 -26.4 60.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.664 178.696 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -86.25 3.97 40.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.266 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -65.61 125.09 24.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.119 177.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 31.3 m -84.46 -6.42 10.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.397 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 17.3 m -91.49 -29.25 17.11 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.61 0.243 . . . . 0.0 111.248 -173.386 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 1.7 pp -73.4 167.38 21.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.405 0.622 . . . . 0.0 111.79 -179.403 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.43 ' H ' ' NE2' ' A' ' 324' ' ' GLN . 5.8 m -99.23 160.96 26.25 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.198 -177.83 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.459 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 46.5 Cg_exo -39.97 -52.94 2.61 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.578 2.852 . . . . 0.0 114.165 178.438 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -61.37 -34.02 74.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.05 0.453 . . . . 0.0 111.187 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.5 ' OE1' ' HD2' ' A' ' 238' ' ' PRO . 45.7 mt-30 -67.45 -25.07 65.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.025 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.459 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 44.8 mtm180 -63.31 -36.05 82.39 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.06 0.457 . . . . 0.0 110.042 175.429 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -63.54 -31.06 72.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.067 179.25 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -87.51 -10.53 51.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.392 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.7 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -69.79 146.99 51.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.699 0.285 . . . . 0.0 111.267 -177.6 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 329' ' ' ASN . . . . . 0.447 ' OD1' HG13 ' A' ' 330' ' ' VAL . 3.3 p30 -134.39 -36.6 0.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -174.752 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.447 HG13 ' OD1' ' A' ' 329' ' ' ASN . 34.5 m -101.75 170.1 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.935 -178.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -82.89 -47.4 11.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.886 0.374 . . . . 0.0 110.83 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 72.1 p -124.72 141.48 52.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.768 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 34.9 m -70.66 171.81 9.75 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.091 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 20.5 tp -71.72 103.12 2.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.093 0.473 . . . . 0.0 110.065 -175.789 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.58 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -91.51 -177.89 4.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.331 179.303 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -73.53 151.02 41.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.937 0.399 . . . . 0.0 110.867 -178.75 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 66.15 29.01 10.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.198 179.077 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.7 mmt -88.67 127.02 35.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -82.7 130.68 35.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.989 0.423 . . . . 0.0 111.323 -176.708 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 13.8 t -92.36 120.08 40.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.427 178.211 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -125.96 128.4 47.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.119 -175.934 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 9.6 mt -93.6 134.1 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 172.032 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 343' ' ' LEU . . . . . 0.515 HD11 HG21 ' A' ' 294' ' ' THR . 69.8 mt . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.145 179.032 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 60.55 54.98 32.6 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.897 -178.253 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.455 HG21 ' O ' ' A' ' 263' ' ' ALA . 55.9 mt -102.11 146.26 10.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 7.7 p -97.7 147.35 24.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.536 0.684 . . . . 0.0 111.903 -177.424 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.642 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.7 p -59.81 150.94 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.708 -178.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.9 t -97.96 74.63 2.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.625 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 79.99 158.69 16.89 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.596 179.617 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.51 146.58 53.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.709 0.29 . . . . 0.0 110.431 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -155.93 136.3 13.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.155 0.503 . . . . 0.0 110.721 -179.152 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.1 p -118.97 122.1 41.45 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.805 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.58 ' O ' HG12 ' A' ' 313' ' ' VAL . 54.3 m-85 -88.74 147.59 24.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.394 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 320' ' ' LEU . 34.4 mmtp -127.28 139.85 36.3 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.023 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.514 ' HD3' HG11 ' A' ' 313' ' ' VAL . 74.3 Cg_endo . . . . . 0 N--CA 1.453 -0.902 0 C-N-CA 122.922 2.415 . . . . 0.0 110.993 173.27 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.812 0.339 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -140.08 131.63 27.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.192 175.906 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.3 OUTLIER -101.02 102.6 13.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.093 0.473 . . . . 0.0 110.226 179.862 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.3 t -82.48 120.87 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.059 -172.249 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 9.6 m -91.2 105.51 17.85 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.197 -179.621 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.439 HD22 HG21 ' A' ' 340' ' ' VAL . 19.3 mt -126.61 163.71 22.85 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -175.571 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 10.4 t -63.18 -49.17 75.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.191 0.52 . . . . 0.0 109.704 -178.29 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.455 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.08 138.22 40.14 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.333 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.41 HG22 ' HB2' ' A' ' 261' ' ' LEU . 15.8 p -130.51 25.22 5.11 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.84 0.828 . . . . 0.0 109.087 175.626 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.2 m -76.64 147.48 37.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.295 175.134 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.0 -18.82 56.57 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -175.021 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 56.8 mtt -87.03 139.58 30.43 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.763 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 11.5 ptmm? -143.75 145.46 32.41 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.035 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -46.34 122.6 4.14 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.921 0.763 . . . . 0.0 112.891 -170.826 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 98.36 18.85 24.99 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.689 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.575 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.1 t70 -100.08 -176.92 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.926 0.393 . . . . 0.0 110.749 -176.513 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.486 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 3.7 tppp? -122.69 116.27 23.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.225 -175.747 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.483 HD11 HG21 ' A' ' 308' ' ' ILE . 17.9 pt -120.21 139.9 46.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 120.916 0.389 . . . . 0.0 110.326 175.652 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 54.8 p -124.1 141.06 52.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.008 179.188 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -107.47 111.06 23.18 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.874 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.47 119.24 10.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.605 -178.618 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.26 -34.1 5.35 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.137 -0.554 . . . . 0.0 111.794 -178.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 70.6 t -90.93 137.15 22.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 177.044 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 279' ' ' LYS . 8.3 ptpt -159.97 160.79 33.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.076 0.465 . . . . 0.0 111.548 178.741 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -78.37 154.25 30.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.729 -172.785 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 315' ' ' LEU . 65.8 mt . . . . . 0 C--N 1.325 -0.496 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.456 179.064 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 . . . . . 0 C--O 1.233 0.218 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -59.14 111.19 1.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.048 -172.908 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.486 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 0.8 OUTLIER -94.3 123.39 37.67 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.795 176.32 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -121.39 148.57 44.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.407 178.153 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.6 m -91.62 122.22 33.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.722 178.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 271' ' ' ASP . 11.3 p -73.21 121.5 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.388 0.613 . . . . 0.0 110.112 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.2 t -84.53 -41.59 16.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.447 -178.219 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.532 ' HD2' ' OE2' ' A' ' 307' ' ' GLU . 0.9 OUTLIER -165.55 136.22 3.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.825 -175.749 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 84.4 t -90.17 111.77 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.416 175.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 14.9 t -78.09 -58.94 3.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.78 -173.714 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -116.87 -3.39 11.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.904 0.383 . . . . 0.0 111.8 -172.699 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 69.3 12.86 66.75 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -170.848 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.8 p -145.6 16.79 1.47 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 174.488 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -170.89 118.32 0.49 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.631 -1.168 . . . . 0.0 107.865 -170.316 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -118.73 156.97 20.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -173.888 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.532 ' OE2' ' HD2' ' A' ' 299' ' ' ARG . 10.8 pt-20 -114.26 122.14 45.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.126 0.488 . . . . 0.0 109.864 171.703 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.483 HG21 HD11 ' A' ' 273' ' ' ILE . 33.6 pt -118.88 175.01 4.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.232 -177.631 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 15.1 t -154.23 138.34 11.06 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.071 174.315 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.61 -178.94 25.51 Favored 'Cis proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.909 -1.288 . . . . 0.0 112.806 -1.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 22.0 ttmm -80.24 131.28 62.83 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.044 -179.146 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 3.7 Cg_exo -75.73 108.44 2.69 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.249 1.966 . . . . 0.0 111.496 173.614 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.684 HG23 ' HA ' ' A' ' 328' ' ' ALA . 1.0 OUTLIER -126.02 136.58 60.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.106 177.557 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -91.95 138.03 31.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.348 0.594 . . . . 0.0 112.292 -170.188 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.422 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.3 tm? -80.77 -31.73 35.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.185 178.647 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -85.38 8.18 19.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.265 -177.74 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 317' ' ' ASP . . . . . 0.507 ' OD2' ' HG ' ' A' ' 320' ' ' LEU . 23.5 t70 -83.22 129.52 35.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.203 179.488 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 11.9 p -84.8 -19.62 8.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.804 0.335 . . . . 0.0 111.268 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 36.8 t -69.66 -42.97 73.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.36 -172.892 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.557 HD13 ' HG2' ' A' ' 325' ' ' ARG . 0.4 OUTLIER -76.92 152.08 35.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.485 0.659 . . . . 0.0 111.165 176.426 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.479 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 18.1 m -86.1 163.18 44.02 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.151 -173.526 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 41.6 Cg_exo -37.59 -54.37 1.25 Allowed 'Trans proline' 0 C--N 1.356 0.974 0 C-N-CA 124.306 3.337 . . . . 0.0 114.889 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -64.96 -34.04 77.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.945 0.402 . . . . 0.0 111.235 -176.806 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 53.8 mt-30 -69.18 -32.74 72.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.032 0.444 . . . . 0.0 109.906 177.961 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.557 ' HG2' HD13 ' A' ' 320' ' ' LEU . 98.2 mtt180 -65.7 -26.71 67.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.744 175.954 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -72.64 -20.19 61.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.143 0.496 . . . . 0.0 110.609 176.399 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -97.56 -0.36 45.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.738 176.086 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.684 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -65.8 132.7 49.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.005 0.431 . . . . 0.0 111.078 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -108.29 -32.17 7.58 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.901 -172.565 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.59 172.83 6.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.668 -177.772 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -86.23 -48.68 8.33 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.647 0.26 . . . . 0.0 111.452 -178.592 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.7 t -118.32 149.72 40.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.038 0.447 . . . . 0.0 110.875 -175.784 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 28.7 p -79.75 174.21 11.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.815 176.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.44 HD12 ' HG3' ' A' ' 338' ' ' MET . 15.9 tp -78.27 103.7 8.37 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -176.216 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.642 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.52 174.69 11.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.743 -178.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -81.55 10.41 5.96 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.178 0.806 . . . . 0.0 113.178 -168.254 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -141.01 33.58 1.75 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.915 0.388 . . . . 0.0 111.318 177.558 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.44 ' HG3' HD12 ' A' ' 334' ' ' LEU . 14.3 mmt -86.19 131.75 34.17 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -86.18 130.87 34.38 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.774 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.439 HG21 HD22 ' A' ' 261' ' ' LEU . 18.1 t -104.75 111.64 35.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.829 178.773 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -126.04 136.65 53.2 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.67 -177.226 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 17.7 mt -85.25 121.15 36.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.924 0.393 . . . . 0.0 110.64 175.366 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 41.1 mt . . . . . 0 C--N 1.323 -0.575 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.788 175.772 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 29.8 p . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 119.918 -0.087 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 52.76 53.23 34.03 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.644 176.517 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 263' ' ' ALA . 42.6 mm -102.85 140.22 21.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -177.504 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.3 p -121.5 159.34 26.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.957 0.408 . . . . 0.0 110.808 175.18 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.614 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.0 p -80.78 150.4 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.236 177.372 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 75.1 m -116.1 86.26 2.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.219 0.533 . . . . 0.0 110.423 176.004 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 94.51 138.55 9.38 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.398 179.592 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.29 132.09 46.5 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.002 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -141.6 127.36 19.2 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.425 0.631 . . . . 0.0 111.067 -175.74 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.9 p -117.87 114.61 23.5 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.129 179.095 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -81.1 164.02 22.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.075 -178.717 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . 44.8 mmtm -135.78 130.76 18.84 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.85 0.357 . . . . 0.0 111.348 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.551 ' HD3' HG11 ' A' ' 313' ' ' VAL . 71.7 Cg_endo . . . . . 0 N--CA 1.449 -1.126 0 C-N-CA 122.885 2.39 . . . . 0.0 111.685 177.631 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.514 ' CE1' HG21 ' A' ' 298' ' ' VAL . 56.7 m-85 . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.004 0.431 . . . . 0.0 110.716 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.17 137.21 38.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.597 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.0 OUTLIER -97.69 107.15 19.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.268 0.556 . . . . 0.0 110.671 -177.889 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.47 ' HB ' HG22 ' A' ' 306' ' ' VAL . 3.1 t -89.41 124.22 42.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.408 -172.765 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 37.5 m -93.63 107.4 19.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.162 177.596 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.427 HD23 HG23 ' A' ' 230' ' ' VAL . 27.9 mt -124.64 172.12 9.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.422 -174.889 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.3 m -64.83 -53.69 42.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.37 0.605 . . . . 0.0 109.871 179.396 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.562 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -135.95 130.56 33.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.391 179.038 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.449 ' HB ' ' CG1' ' A' ' 306' ' ' VAL . 6.9 p -129.59 22.66 5.48 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.867 0.841 . . . . 0.0 108.817 174.92 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 15.5 m -80.59 145.37 31.77 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.564 176.17 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.99 -9.91 61.81 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -175.672 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 267' ' ' MET . . . . . 0.461 ' HG2' HD11 ' A' ' 342' ' ' ILE . 57.9 mtt -93.88 151.8 19.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.007 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.52 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 1.9 ptpp? -147.34 157.15 43.47 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.396 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -52.36 117.23 2.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.152 0.501 . . . . 0.0 110.832 -178.074 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 106.28 18.43 11.17 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.741 -177.631 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.52 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 7.4 m-20 -99.78 159.16 15.27 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 117.236 0.518 . . . . 0.0 110.167 176.721 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -111.62 116.75 31.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.986 -178.346 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.535 HD11 HG21 ' A' ' 308' ' ' ILE . 34.6 pt -113.19 140.67 32.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.217 178.609 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.448 ' HB3' HG22 ' A' ' 294' ' ' THR . 22.0 p -123.14 139.98 53.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.22 178.822 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.437 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 93.1 m-85 -103.57 111.34 23.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.037 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.2 113.03 4.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.146 -176.764 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.34 -24.98 12.97 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.641 -178.398 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 90.6 t -97.5 128.18 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 177.296 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 292' ' ' ASP . 15.0 ptpt -160.46 179.73 8.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.2 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -68.56 174.89 3.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.183 -172.911 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 75.7 mt . . . . . 0 C--N 1.326 -0.429 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -171.438 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 279' ' ' LYS . 14.9 m-20 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -64.54 105.19 0.91 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.294 -175.19 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 274' ' ' SER . 15.8 p -90.93 132.66 35.81 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.597 177.007 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.408 ' CG ' HD12 ' A' ' 308' ' ' ILE . 97.7 m-85 -129.79 150.78 50.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.427 179.305 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 20.1 m -96.65 125.06 40.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.122 178.56 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 271' ' ' ASP . 12.4 p -80.82 138.07 20.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.161 0.505 . . . . 0.0 110.61 -179.484 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.514 HG21 ' CE1' ' A' ' 256' ' ' PHE . 45.3 t -104.75 -29.53 2.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.021 -178.822 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -164.1 137.2 5.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.017 0.437 . . . . 0.0 111.171 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 87.5 t -95.75 112.19 27.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.246 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 45.1 t -75.8 -58.79 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.909 -172.251 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -123.35 -3.06 8.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.298 0.57 . . . . 0.0 111.215 -175.753 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 78.37 13.87 82.8 Favored Glycine 0 C--N 1.322 -0.24 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -173.225 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 27.1 p -142.18 14.57 2.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.273 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.452 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 1.7 t60 -164.02 117.45 1.44 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.491 -169.769 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.6 m -118.46 164.67 14.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -175.459 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.2 pt-20 -125.46 123.32 38.98 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 169.478 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.535 HG21 HD11 ' A' ' 273' ' ' ILE . 23.4 pt -124.44 164.3 23.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.045 -173.092 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 309' ' ' THR . . . . . 0.432 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 8.2 t -135.57 140.19 33.28 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.637 174.693 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.8 179.55 30.17 Favored 'Cis proline' 0 CA--C 1.531 0.355 0 C-N-CA 123.187 -1.589 . . . . 0.0 112.655 -1.863 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.462 ' HG2' HG13 ' A' ' 313' ' ' VAL . 31.1 ttmt -70.81 119.53 73.59 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.742 177.575 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.466 ' HD2' ' CB ' ' A' ' 257' ' ' ALA . 38.1 Cg_endo -69.5 108.94 2.14 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.436 2.091 . . . . 0.0 111.65 175.891 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.714 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.2 OUTLIER -135.43 135.31 51.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.825 -178.497 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -83.4 129.76 35.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.251 -176.516 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.1 tm? -68.86 -26.07 64.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.45 178.978 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -99.31 18.3 17.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.103 -179.211 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 317' ' ' ASP . . . . . 0.441 ' HB3' ' CD2' ' A' ' 320' ' ' LEU . 9.9 t0 -65.47 130.85 44.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.726 178.791 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 30.4 m -83.16 1.98 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -173.194 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 14.2 t -125.78 28.34 6.2 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.064 -0.654 . . . . 0.0 112.441 -176.086 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.638 HD13 ' HG2' ' A' ' 325' ' ' ARG . 0.7 OUTLIER -123.54 164.76 18.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.131 0.491 . . . . 0.0 111.551 175.43 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.44 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.3 m -101.92 164.92 14.88 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.678 -179.284 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 86.4 Cg_exo -44.19 -50.18 7.96 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.641 2.894 . . . . 0.0 114.537 -176.623 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -66.34 -27.7 68.09 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -177.383 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 49.8 mt-30 -71.6 -28.9 64.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.005 0.431 . . . . 0.0 109.976 177.785 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.638 ' HG2' HD13 ' A' ' 320' ' ' LEU . 55.8 mtp180 -70.82 -18.93 62.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.434 178.019 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -74.52 -32.7 62.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.288 176.343 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -85.51 -4.25 59.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.742 177.707 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.714 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -63.3 159.62 17.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.06 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -138.65 -49.15 0.52 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.831 0.348 . . . . 0.0 111.244 -175.657 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.2 m -105.72 161.67 5.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.647 -175.963 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -91.78 -5.46 53.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.01 -176.617 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 8.0 t -147.73 136.3 21.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.527 -176.757 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.1 p -80.11 163.56 24.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.365 178.872 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 19.2 tp -70.57 106.09 3.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.968 0.413 . . . . 0.0 110.724 -173.906 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.614 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -79.53 173.53 12.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.81 -178.449 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -81.05 4.04 21.16 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -166.035 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -143.62 45.7 1.49 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.064 0.459 . . . . 0.0 111.421 176.713 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.444 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 22.8 mmt -92.17 143.56 26.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.214 178.018 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.42 138.45 33.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.422 179.444 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.544 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 19.1 t -112.9 116.96 54.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.14 0.495 . . . . 0.0 109.91 -178.603 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -125.41 138.9 54.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.891 -175.726 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.461 HD11 ' HG2' ' A' ' 267' ' ' MET . 21.7 mt -96.65 132.68 40.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.68 0.276 . . . . 0.0 110.452 174.637 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 54.9 mt . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.193 176.563 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 33.9 p . . . . . 0 N--CA 1.447 -0.58 0 CA-C-O 121.084 0.468 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.0 61.24 0.43 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 177.054 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.658 HG21 ' O ' ' A' ' 263' ' ' ALA . 23.7 mt -102.87 154.24 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.583 0.23 . . . . 0.0 110.841 -174.065 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 18.9 p -114.75 171.25 7.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.142 0.496 . . . . 0.0 111.571 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.533 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.1 p -87.35 150.15 3.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.87 -178.227 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 62.2 m -114.98 91.44 3.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.827 0.346 . . . . 0.0 110.393 175.638 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 90.46 161.41 37.41 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.143 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -83.27 117.73 23.17 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.934 0.397 . . . . 0.0 110.15 178.651 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -109.07 126.37 53.09 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.097 0.475 . . . . 0.0 109.958 179.672 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 10.2 p -121.29 125.63 47.52 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.618 -178.318 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.584 ' HB2' ' O ' ' A' ' 312' ' ' PRO . 86.2 m-85 -109.08 145.43 35.66 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.899 -179.118 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -133.4 144.27 51.61 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.984 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 N--CA 1.456 -0.713 0 C-N-CA 122.169 1.912 . . . . 0.0 110.863 173.18 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 . . . . . 0 CA--C 1.521 -0.147 0 CA-C-O 120.726 0.298 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -107.59 117.29 33.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.57 178.044 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 4.1 m -89.68 109.19 20.18 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.034 0.445 . . . . 0.0 110.314 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.0 t -92.73 122.27 44.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.593 -172.782 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 25.2 m -91.33 115.05 27.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.948 175.822 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 26.0 mt -132.78 172.41 12.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.273 -175.353 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 14.9 m -62.95 -56.48 16.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.476 0.655 . . . . 0.0 109.503 177.547 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.658 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -136.93 140.99 42.66 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.8 177.782 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 10.9 p -131.39 23.15 4.77 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.283 1.04 . . . . 0.0 108.205 173.384 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 7.6 m -77.93 142.64 38.26 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.859 -1.519 . . . . 0.0 109.649 176.771 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 97.96 -15.16 62.01 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -175.692 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 61.7 mtt -89.15 151.07 22.4 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.715 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -135.44 164.24 28.22 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.726 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -62.62 140.24 58.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.867 179.237 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.93 19.04 62.03 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.829 173.059 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.498 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 1.2 t70 -105.74 -166.73 1.24 Allowed 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 118.038 0.919 . . . . 0.0 110.458 -178.293 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -125.54 116.28 21.52 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.702 -178.901 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.466 HD11 HG21 ' A' ' 308' ' ' ILE . 19.6 pt -113.69 139.69 37.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.49 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.491 ' OG ' HG22 ' A' ' 294' ' ' THR . 2.9 m -122.19 140.39 52.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.486 -175.117 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -105.97 111.41 24.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.334 178.273 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -71.5 117.93 13.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.27 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.79 -17.55 22.76 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.611 -176.254 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.53 124.24 71.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.998 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -138.86 165.23 27.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.917 0.389 . . . . 0.0 111.757 -176.042 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -82.57 148.39 28.07 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.323 -176.226 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.714 -176.775 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.771 0.319 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.623 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -66.77 81.84 0.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.316 -177.703 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.491 HG22 ' OG ' ' A' ' 274' ' ' SER . 12.6 p -85.07 89.69 7.68 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.309 177.485 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.623 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 51.1 m-85 -96.03 149.24 21.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.279 0.561 . . . . 0.0 111.364 -176.171 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.9 m -91.51 126.76 36.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.969 -179.458 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.498 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 8.7 p -87.77 141.52 14.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.184 -178.346 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 13.3 p -104.78 -26.01 3.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.714 179.339 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -170.34 146.82 2.94 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.931 0.396 . . . . 0.0 111.086 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.69 121.0 41.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 169.182 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.22 -58.03 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.932 -172.544 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -129.02 -5.23 5.01 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.285 0.564 . . . . 0.0 111.631 -175.244 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.27 12.01 81.33 Favored Glycine 0 CA--C 1.518 0.247 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -175.617 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 22.2 p -145.05 16.24 1.55 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 171.611 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.521 ' CE1' HG22 ' A' ' 258' ' ' THR . 1.6 t60 -169.29 117.92 0.65 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.092 -1.413 . . . . 0.0 107.59 -167.264 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.6 m -119.58 168.57 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 117.706 0.23 . . . . 0.0 110.736 -174.651 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -126.18 118.18 24.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.259 0.552 . . . . 0.0 110.026 171.471 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.466 HG21 HD11 ' A' ' 273' ' ' ILE . 35.1 pt -119.84 174.28 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.341 -176.928 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.2 t -154.65 143.07 14.5 Favored Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.461 176.407 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -76.18 -179.12 25.96 Favored 'Cis proline' 0 C--N 1.345 0.344 0 C-N-CA 124.105 -1.206 . . . . 0.0 112.909 -3.076 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.454 ' HD3' ' HB3' ' A' ' 236' ' ' PHE . 2.5 ttmp? -75.09 132.1 77.46 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.12 -178.093 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.584 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 9.3 Cg_exo -71.82 108.15 2.37 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.326 2.017 . . . . 0.0 111.192 173.381 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 329' ' ' ASN . 4.4 m -130.11 128.01 64.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.788 -177.709 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -87.66 141.56 28.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.307 0.575 . . . . 0.0 112.238 -172.728 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -81.0 -28.8 35.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.996 -179.305 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -100.31 20.66 14.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.671 -176.336 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 317' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 11.6 t70 -83.38 124.08 30.3 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.277 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 9.3 p -82.96 -11.96 12.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.874 0.369 . . . . 0.0 111.608 -175.795 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 15.7 m -86.66 0.74 53.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.693 -172.708 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 1.5 pp -106.77 169.83 8.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.829 0.347 . . . . 0.0 111.312 179.508 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 28.2 t -85.88 148.03 47.29 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.539 175.383 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -42.72 -43.99 8.79 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.112 2.541 . . . . 0.0 113.662 -177.683 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -61.01 -29.99 70.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.958 0.408 . . . . 0.0 111.465 -178.139 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -71.16 -25.55 62.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.509 -178.582 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -62.67 -34.99 78.24 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.214 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.37 -24.06 65.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.948 178.296 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -103.21 11.82 36.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 177.823 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -73.89 164.87 26.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.865 178.343 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 329' ' ' ASN . . . . . 0.424 ' N ' HG23 ' A' ' 313' ' ' VAL . 50.4 t30 -139.99 -43.53 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.606 -172.655 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.6 m -111.21 175.33 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.698 0.285 . . . . 0.0 111.02 -178.663 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -80.48 -50.22 10.35 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.699 0.285 . . . . 0.0 111.454 -177.112 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.7 t -130.91 151.83 50.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.413 -177.983 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 49.0 m -71.4 167.47 19.51 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 174.004 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 27.8 tp -70.91 103.71 2.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 110.147 -176.95 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.533 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -89.76 -170.92 2.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.194 178.782 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -76.86 162.48 27.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.855 0.36 . . . . 0.0 110.705 -179.336 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 58.31 45.97 16.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.089 178.409 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.511 ' H ' HG12 ' A' ' 230' ' ' VAL . 24.8 mmt -114.61 131.04 56.84 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.339 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -85.53 138.98 31.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.008 -179.259 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 14.2 t -113.12 114.47 47.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.649 178.386 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -132.22 138.49 47.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.808 0.337 . . . . 0.0 111.813 -173.989 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.432 ' CG1' HG22 ' A' ' 273' ' ' ILE . 21.4 mt -91.6 123.29 43.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.846 174.537 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 59.2 mt . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.282 178.809 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 38.9 p . . . . . 0 N--CA 1.45 -0.435 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.82 50.92 62.45 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.359 178.3 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.496 ' HB ' ' HB ' ' A' ' 340' ' ' VAL . 48.0 mm -89.29 144.35 9.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -178.695 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 23.2 p -122.39 156.66 33.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.297 0.57 . . . . 0.0 111.262 176.861 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.61 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.1 p -73.84 151.16 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.043 179.395 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.3 t -115.37 64.62 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.208 0.528 . . . . 0.0 109.983 178.124 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 106.11 149.67 17.59 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.323 -179.419 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -59.37 125.49 23.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.904 0.383 . . . . 0.0 111.127 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 334' ' ' LEU . 26.3 mm-40 -113.24 126.6 55.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.961 0.41 . . . . 0.0 110.269 179.133 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 p -122.97 105.04 9.63 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.131 177.777 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -89.55 146.78 24.35 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.168 -173.816 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -144.08 121.12 6.54 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.776 178.719 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo . . . . . 0 N--CA 1.453 -0.893 0 C-N-CA 122.777 2.318 . . . . 0.0 110.694 168.144 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.48 122.57 43.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.556 0.217 . . . . 0.0 111.135 -177.724 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.4 m -96.31 107.38 19.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.044 0.45 . . . . 0.0 110.104 -179.526 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.5 t -92.91 119.32 40.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.767 -171.107 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 18.5 m -89.74 106.19 18.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.18 0.514 . . . . 0.0 109.983 174.769 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.45 ' HB2' ' CG2' ' A' ' 264' ' ' THR . 30.1 mt -121.29 169.37 10.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.058 -176.142 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 30.2 p -67.53 -48.26 67.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.334 0.588 . . . . 0.0 109.881 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.492 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -135.77 130.3 33.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.472 178.279 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.45 ' CG2' ' HB2' ' A' ' 261' ' ' LEU . 4.8 p -132.47 17.93 4.38 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.314 173.609 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 39.4 m -84.2 147.26 27.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.31 174.927 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 92.96 -5.48 75.98 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -171.652 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 70.9 mtp -108.67 138.66 44.63 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.467 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -137.7 154.33 49.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.779 0.323 . . . . 0.0 110.547 -178.931 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.455 ' HA ' HG13 ' A' ' 297' ' ' VAL . 26.2 ptt180 -59.61 135.32 57.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.64 -174.503 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 102.86 18.32 15.96 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.728 -0.749 . . . . 0.0 113.027 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.539 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 2.7 t0 -113.82 -169.57 1.54 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 117.369 0.585 . . . . 0.0 109.814 177.314 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.484 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 4.7 tppp? -124.18 116.56 22.91 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.592 -178.125 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.542 HD11 HG21 ' A' ' 308' ' ' ILE . 15.6 pt -117.19 140.48 39.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 120.131 -0.627 . . . . 0.0 109.965 179.106 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 44.2 p -126.21 150.87 48.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.145 -178.915 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.481 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 89.0 m-85 -111.83 111.32 22.2 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.065 -178.862 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.01 111.98 3.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 -178.032 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 113.67 -35.52 4.48 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -178.147 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 97.6 t -87.06 110.83 20.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.973 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -137.14 179.48 6.36 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.328 -174.877 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -69.08 172.81 6.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.109 -177.389 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 73.6 mt . . . . . 0 C--N 1.326 -0.446 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -175.001 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 120.747 0.308 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.458 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -61.31 107.3 0.74 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.006 -177.392 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.484 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 61.2 p -95.01 125.35 39.61 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.572 -179.491 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.48 ' CE2' ' HG3' ' A' ' 312' ' ' PRO . 88.1 m-85 -128.18 152.92 47.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.103 0.478 . . . . 0.0 111.132 -179.316 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 41.9 m -92.1 125.79 36.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.312 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.539 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.0 p -76.98 127.74 37.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.085 0.469 . . . . 0.0 110.415 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 23.4 t -100.59 -35.72 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.202 -175.594 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 299' ' ' ARG . 6.8 tpt180 -164.32 142.57 7.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 111.124 -179.107 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 94.5 t -102.69 117.84 48.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 170.713 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 46.0 t -77.19 -55.7 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.122 -172.369 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -128.49 -1.27 5.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.057 0.456 . . . . 0.0 111.604 -175.734 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 83.25 14.31 74.68 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.216 -176.501 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 1.8 p -145.97 19.93 1.44 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 171.449 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.413 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 1.8 t60 -165.71 115.75 1.03 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.476 -171.584 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.2 m -119.05 164.89 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 110.235 -0.284 . . . . 0.0 110.235 -174.585 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 10.9 pt-20 -125.48 132.02 52.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.118 0.485 . . . . 0.0 109.9 169.673 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.542 HG21 HD11 ' A' ' 273' ' ' ILE . 21.5 pt -125.38 164.32 24.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.363 -176.347 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.4 t -141.86 141.16 21.26 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.714 175.781 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.75 -179.61 27.04 Favored 'Cis proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.964 -1.265 . . . . 0.0 112.532 -3.256 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 31.4 ttmt -86.31 126.25 65.32 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.48 ' HG3' ' CE2' ' A' ' 295' ' ' PHE . 8.7 Cg_exo -70.07 112.14 3.05 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.875 2.384 . . . . 0.0 112.712 178.609 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.622 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -119.39 128.94 75.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.789 172.661 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.692 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -88.02 138.72 31.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.906 -176.12 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 325' ' ' ARG . 3.0 tm? -68.53 -28.63 67.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.689 178.679 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -92.44 10.03 31.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.755 -179.571 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 317' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 9.9 t70 -72.57 122.22 21.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.996 0.426 . . . . 0.0 109.909 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.2 m -84.49 2.32 4.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.225 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.7 p -119.84 29.17 7.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -174.343 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 2.0 pp -128.74 161.22 30.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.061 0.458 . . . . 0.0 111.633 176.418 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 19.7 m -85.24 162.03 50.16 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.323 -177.953 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.49 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 96.0 Cg_exo -46.0 -46.3 16.21 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.32 2.68 . . . . 0.0 113.927 -177.649 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.23 -33.07 75.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.679 0.276 . . . . 0.0 111.267 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.497 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 50.9 mt-30 -69.32 -35.95 76.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.235 -177.052 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 8.0 ptp180 -74.8 -23.54 58.5 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.089 0.471 . . . . 0.0 110.206 178.91 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -72.03 -18.65 61.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.129 175.067 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -109.21 11.15 25.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.505 175.256 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.622 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -67.36 142.44 56.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.514 177.06 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 329' ' ' ASN . . . . . 0.413 ' OD1' HG13 ' A' ' 330' ' ' VAL . 5.6 p30 -125.39 -20.55 4.76 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -175.424 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.1 m -115.45 155.09 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.728 179.426 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -91.98 -2.48 56.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.781 -174.18 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 14.7 t -162.4 152.79 16.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.803 0.335 . . . . 0.0 110.254 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.0 p -86.88 165.56 15.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.114 179.57 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 234' ' ' GLN . 18.0 tp -68.27 108.0 3.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -177.483 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.61 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.35 -177.92 6.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.286 -177.122 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.48 1.49 29.13 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -172.919 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -147.87 54.94 1.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.224 0.535 . . . . 0.0 111.395 177.877 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.441 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 22.8 mmt -101.33 142.52 32.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.799 176.102 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.64 140.55 30.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.467 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 22.0 t -114.66 120.11 63.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.312 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -136.78 144.26 43.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.85 0.357 . . . . 0.0 111.147 -175.436 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 31.3 mt -93.86 128.47 45.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.71 178.093 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.566 -179.809 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 29.0 p . . . . . 0 N--CA 1.446 -0.652 0 CA-C-O 121.489 0.661 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -109.8 52.15 0.66 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 173.281 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.555 HG21 ' O ' ' A' ' 263' ' ' ALA . 22.7 mt -93.66 159.07 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.273 -0.463 . . . . 0.0 110.275 -173.0 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 13.3 p -118.23 153.42 33.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.281 0.563 . . . . 0.0 111.332 179.048 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.673 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.3 p -66.74 152.58 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.83 177.819 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.5 t -114.99 78.92 1.21 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.13 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 101.58 151.07 24.23 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.699 179.574 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -85.63 141.54 29.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.463 0.173 . . . . 0.0 110.609 179.579 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -157.62 150.47 23.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.159 0.504 . . . . 0.0 111.771 -177.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 38.4 p -153.39 102.33 2.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.994 172.57 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -80.61 143.9 32.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.775 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -107.51 134.46 19.98 Favored Pre-proline 0 C--N 1.323 -0.577 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.264 -177.228 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 N--CA 1.449 -1.113 0 C-N-CA 122.747 2.298 . . . . 0.0 110.647 169.065 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.824 0.345 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.27 132.91 53.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 177.895 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.4 m -94.85 114.27 26.12 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.041 0.448 . . . . 0.0 110.368 178.52 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.9 t -93.76 122.27 45.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.282 -173.882 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 3.0 m -94.0 106.7 18.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.049 179.527 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.551 HD23 HG23 ' A' ' 230' ' ' VAL . 23.1 mt -126.35 168.14 14.56 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.412 -174.026 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.6 t -63.25 -54.87 30.5 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.965 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.555 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.09 136.84 38.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.266 178.543 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.437 HG22 HD12 ' A' ' 261' ' ' LEU . 15.9 p -129.7 25.27 5.36 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.028 0.918 . . . . 0.0 108.558 175.23 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 17.4 m -82.96 153.44 25.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.284 -1.326 . . . . 0.0 109.712 176.885 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 90.7 -6.44 82.05 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -174.901 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 267' ' ' MET . . . . . 0.415 ' HG2' HD11 ' A' ' 342' ' ' ILE . 47.8 mtt -104.3 147.45 27.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.828 -0.686 . . . . 0.0 109.314 178.524 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 0.0 OUTLIER -139.62 158.05 44.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.307 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -54.47 132.65 45.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.182 0.515 . . . . 0.0 111.437 -176.816 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 95.11 19.03 31.98 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.099 -177.271 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.574 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.1 t0 -103.46 169.01 8.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.7 0.286 . . . . 0.0 110.289 -178.284 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -118.5 115.46 24.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.996 -178.137 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.488 HD11 HG21 ' A' ' 308' ' ' ILE . 30.0 pt -112.78 139.74 36.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.039 0.447 . . . . 0.0 110.061 179.52 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.41 ' OG ' HG22 ' A' ' 294' ' ' THR . 7.1 m -124.48 133.47 53.34 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.871 -179.188 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -100.0 111.42 23.72 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.206 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 339' ' ' ALA . . . -66.51 120.54 13.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.342 -179.2 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.95 -25.95 12.2 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -176.591 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.559 ' HA ' ' OG1' ' A' ' 332' ' ' THR . 47.0 t -100.28 119.74 48.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.772 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -136.34 157.48 46.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.035 0.445 . . . . 0.0 111.436 -173.585 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -72.94 118.87 16.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.245 179.714 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 331' ' ' ASN . 1.5 pt? . . . . . 0 C--N 1.323 -0.544 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.964 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 276' ' ' ALA . 49.4 m-20 . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -65.81 101.14 0.61 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.037 -178.661 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.41 HG22 ' OG ' ' A' ' 274' ' ' SER . 45.4 p -84.05 117.16 23.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.959 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -120.64 148.31 44.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.921 0.391 . . . . 0.0 110.624 177.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 8.5 m -94.88 127.75 41.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.257 -178.651 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 271' ' ' ASP . 7.4 p -79.9 134.02 28.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.271 0.558 . . . . 0.0 110.286 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.428 ' HB ' ' HG3' ' A' ' 307' ' ' GLU . 61.0 t -95.13 -38.7 9.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.859 -178.927 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -166.82 139.88 3.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.752 0.311 . . . . 0.0 110.235 -179.199 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 86.8 t -83.88 103.75 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.622 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 18.4 t -72.58 -58.21 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.024 -171.952 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -116.69 -9.98 11.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.98 0.419 . . . . 0.0 111.817 -174.828 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 78.03 11.39 85.43 Favored Glycine 0 CA--C 1.516 0.136 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -173.378 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 20.3 p -148.98 18.53 0.98 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 173.43 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.8 t-160 -169.43 113.59 0.53 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.006 -165.079 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.5 m -119.06 163.17 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 121.206 -0.198 . . . . 0.0 110.57 -173.413 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.428 ' HG3' ' HB ' ' A' ' 298' ' ' VAL . 11.5 pt-20 -116.92 128.5 55.29 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 171.255 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.488 HG21 HD11 ' A' ' 273' ' ' ILE . 29.8 pt -126.61 168.15 20.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.123 0.487 . . . . 0.0 111.938 -176.104 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.3 t -146.92 138.57 13.38 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.049 174.758 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.36 -179.66 27.75 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.815 -1.327 . . . . 0.0 112.721 -1.599 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 38.6 ttmt -79.51 124.07 84.03 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.258 -178.479 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 312' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 13.4 Cg_exo -68.86 113.44 3.22 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.972 2.448 . . . . 0.0 112.384 177.416 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.513 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -123.96 129.28 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.355 176.229 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 317' ' ' ASP . . . -86.53 129.34 34.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.876 -177.893 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.83 -27.49 68.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.719 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -95.75 15.19 20.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.639 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 317' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 10.2 t70 -81.96 127.66 33.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.291 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.2 m -84.17 -3.48 7.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -174.027 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 14.7 m -96.82 1.38 50.62 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -174.676 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.0 OUTLIER -111.18 156.37 21.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.211 0.529 . . . . 0.0 111.403 178.515 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 16.0 m -94.07 165.7 17.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.11 -175.84 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 66.6 Cg_exo -42.96 -49.0 7.23 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 123.697 2.932 . . . . 0.0 114.253 -178.627 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -62.53 -39.51 93.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 0.0 110.949 -179.101 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 47.5 mt-30 -67.56 -33.25 74.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.309 179.592 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.458 ' HG2' HD13 ' A' ' 320' ' ' LEU . 83.2 mtt180 -60.86 -32.6 72.02 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.859 175.85 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -69.02 -25.11 64.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.677 179.502 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -95.52 -0.74 51.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 178.51 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.513 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -73.76 107.4 5.98 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.237 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 329' ' ' ASN . . . . . 0.504 ' ND2' HG13 ' A' ' 330' ' ' VAL . 5.6 p-10 -92.3 -5.38 52.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.157 -176.004 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.504 HG13 ' ND2' ' A' ' 329' ' ' ASN . 28.1 m -133.21 155.92 41.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.562 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.43 ' HB3' ' HB3' ' A' ' 281' ' ' LEU . 24.9 p-10 -93.99 -26.53 16.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.764 -178.669 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 332' ' ' THR . . . . . 0.559 ' OG1' ' HA ' ' A' ' 278' ' ' VAL . 43.2 p -109.21 139.48 44.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.165 0.507 . . . . 0.0 111.311 -179.033 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 46.9 p -86.57 169.56 12.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.328 176.787 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.9 tp -74.91 102.22 4.69 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.673 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -82.3 165.86 20.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.961 -179.886 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -78.99 26.27 0.26 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -172.498 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -154.49 41.13 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.01 0.433 . . . . 0.0 110.911 176.111 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.463 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 23.4 mmt -99.32 149.66 22.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 177.786 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 339' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 276' ' ' ALA . . . -99.99 143.88 29.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.949 -179.111 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.5 t -110.91 115.8 50.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.143 -178.793 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -132.7 137.55 46.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.861 -177.273 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.415 HD11 ' HG2' ' A' ' 267' ' ' MET . 24.2 mt -97.9 129.5 48.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.718 178.375 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 59.8 mt . . . . . 0 C--N 1.325 -0.484 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.321 178.123 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 46.4 p . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 120.471 0.177 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -73.67 69.45 1.48 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.758 -177.932 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.502 HG21 ' O ' ' A' ' 263' ' ' ALA . 38.4 mt -102.33 152.6 5.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.477 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -99.86 169.6 9.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.392 0.615 . . . . 0.0 112.315 -177.528 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.632 HG11 ' O ' ' A' ' 335' ' ' ALA . 10.4 p -81.61 152.08 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.752 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.3 t -104.55 80.77 1.71 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.933 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 91.02 165.38 40.07 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.177 -179.632 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -96.33 136.88 36.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.603 0.239 . . . . 0.0 110.44 179.206 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -149.27 127.16 11.85 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.36 0.6 . . . . 0.0 111.327 179.602 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.513 ' HA ' ' HB3' ' A' ' 333' ' ' SER . 11.6 p -98.14 120.65 38.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.267 177.347 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.86 157.99 25.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.935 -175.435 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.408 ' HD2' ' HB3' ' A' ' 320' ' ' LEU . 46.6 mmtm -141.87 132.15 12.77 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.351 -179.498 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.612 ' HD3' HG11 ' A' ' 313' ' ' VAL . 70.6 Cg_endo . . . . . 0 N--CA 1.455 -0.762 0 C-N-CA 122.528 2.152 . . . . 0.0 112.063 178.438 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -113.88 114.36 26.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.307 177.301 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -84.16 103.02 13.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.432 0.634 . . . . 0.0 111.306 179.012 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.8 t -83.24 124.62 39.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.351 -177.273 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 6.1 m -97.82 105.77 17.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.912 178.613 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.473 ' HB2' HG22 ' A' ' 264' ' ' THR . 17.4 mt -123.04 165.76 16.26 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.998 -174.537 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.7 m -57.06 -56.71 18.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.434 0.635 . . . . 0.0 109.649 179.436 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.502 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -138.12 134.63 34.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.874 177.154 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 264' ' ' THR . . . . . 0.473 HG22 ' HB2' ' A' ' 261' ' ' LEU . 6.7 p -123.99 24.71 8.17 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.938 0.875 . . . . 0.0 108.723 175.132 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 44.9 m -75.4 131.79 40.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.16 173.655 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 110.48 -26.5 13.06 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -171.828 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -76.53 140.75 41.26 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 172.674 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -154.35 146.11 23.37 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.183 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.505 ' HA ' HG13 ' A' ' 297' ' ' VAL . 29.9 ptt180 -41.9 119.66 1.36 Allowed 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.149 0.906 . . . . 0.0 112.609 -173.334 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 110.33 -9.16 30.9 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.44 176.683 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.459 ' H ' HG12 ' A' ' 297' ' ' VAL . 2.4 p30 -77.06 -178.12 4.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.372 0.606 . . . . 0.0 111.943 -177.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.52 117.08 18.28 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.628 -178.598 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.435 HD11 HG21 ' A' ' 308' ' ' ILE . 35.5 pt -112.63 140.23 33.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.156 0.503 . . . . 0.0 110.763 179.342 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 22.7 t -121.32 145.29 48.03 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.559 178.49 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -112.33 111.46 22.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.023 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.65 120.24 15.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.591 -178.901 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.96 -34.24 5.19 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -178.068 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 96.1 t -90.29 115.68 30.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 173.235 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -131.46 151.41 51.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.033 0.444 . . . . 0.0 111.739 -173.734 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.533 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 77.5 m-85 -70.18 115.45 9.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.462 176.332 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 281' ' ' LEU . 2.3 pt? . . . . . 0 C--N 1.322 -0.611 0 CA-C-O 120.717 0.294 . . . . 0.0 111.114 -175.311 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 . . . . . 0 C--O 1.235 0.311 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.533 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -60.47 127.28 30.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.606 -174.531 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 29.3 p -120.03 122.95 42.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.591 -179.387 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.453 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 75.2 m-85 -133.78 152.28 51.83 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 11.9 t -96.28 134.8 38.94 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.41 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.505 HG13 ' HA ' ' A' ' 269' ' ' ARG . 4.7 p -69.79 139.98 19.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.145 178.733 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 50.2 t -104.67 -38.4 4.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.151 175.95 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -163.06 140.74 7.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.615 179.555 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.4 109.18 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.074 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.15 -59.61 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.017 -174.2 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -111.03 -13.62 14.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.291 0.567 . . . . 0.0 111.57 -175.026 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.22 13.99 77.74 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.255 -174.033 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 40.0 p -136.67 9.86 3.12 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 169.962 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.496 ' NE2' ' HB ' ' A' ' 258' ' ' THR . 2.2 t-160 -158.18 114.15 2.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.343 -1.299 . . . . 0.0 108.279 -168.749 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.2 m -118.69 150.98 20.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -177.011 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -111.06 117.05 32.24 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.182 0.515 . . . . 0.0 110.092 173.895 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.483 HG22 ' HA ' ' A' ' 297' ' ' VAL . 24.6 pt -116.67 172.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.069 -179.229 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.9 t -154.53 141.86 13.68 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.324 176.745 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.98 179.71 29.68 Favored 'Cis proline' 0 CA--C 1.531 0.337 0 C-N-CA 123.487 -1.464 . . . . 0.0 112.838 -3.06 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -83.87 128.03 64.83 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.58 -177.774 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.97 108.93 2.56 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.379 2.053 . . . . 0.0 111.727 174.459 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.697 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.8 OUTLIER -123.99 136.79 59.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.028 -179.063 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 314' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -86.88 138.27 31.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.54 0.686 . . . . 0.0 112.285 -173.041 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 315' ' ' LEU . . . . . 0.48 HD22 ' HB2' ' A' ' 325' ' ' ARG . 3.0 tm? -76.58 -33.67 58.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.253 178.594 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -89.2 13.99 11.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.256 -177.305 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 317' ' ' ASP . . . . . 0.454 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 11.3 t70 -73.13 123.27 23.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.034 179.266 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 11.8 p -83.75 -16.55 10.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.768 -175.825 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 14.4 m -80.61 -33.78 35.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.441 -172.086 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.5 pp -82.93 159.27 22.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.445 0.641 . . . . 0.0 112.084 -177.879 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.442 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 18.8 m -81.07 163.97 52.75 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.428 -178.5 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 67.2 Cg_exo -43.39 -52.86 4.69 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.503 2.802 . . . . 0.0 114.35 179.763 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.93 -28.54 70.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.09 0.471 . . . . 0.0 111.135 -177.15 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 324' ' ' GLN . . . . . 0.494 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 72.9 mm-40 -69.22 -45.98 68.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.72 -179.008 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 325' ' ' ARG . . . . . 0.48 ' HB2' HD22 ' A' ' 315' ' ' LEU . 2.7 ptp180 -70.47 -21.15 62.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.857 0.361 . . . . 0.0 110.677 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -65.18 -28.4 69.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.983 0.421 . . . . 0.0 110.265 173.394 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -94.66 -0.2 54.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.002 179.575 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.697 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -60.85 149.87 34.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.422 178.715 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -124.75 -19.45 5.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.643 -176.806 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.0 m -127.99 163.61 31.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 331' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 281' ' ' LEU . 20.6 p-10 -83.77 -34.14 24.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.636 0.255 . . . . 0.0 111.337 -176.258 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 12.1 t -132.83 146.92 52.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.199 -178.589 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.513 ' HB3' ' HA ' ' A' ' 235' ' ' SER . 30.6 m -82.2 -175.86 5.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.749 -179.416 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.1 tp -75.99 103.81 6.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.134 -176.549 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 335' ' ' ALA . . . . . 0.632 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -82.01 169.45 16.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.479 179.697 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -79.44 23.25 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -171.277 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -155.42 46.46 0.5 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.96 0.41 . . . . 0.0 110.805 177.323 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.0 mmt -100.07 132.23 45.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.18 178.3 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -88.5 129.31 35.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.817 179.133 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 10.3 t -97.45 147.6 6.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -160.52 138.01 9.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.496 0.189 . . . . 0.0 110.798 176.212 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 47.3 mt -88.76 121.66 39.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.052 0.453 . . . . 0.0 110.672 176.365 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 61.5 mt . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.714 179.195 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 11.7 t 61.99 31.67 17.95 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.321 0.581 . . . . 0.0 110.41 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 13.9 m -113.67 -32.76 6.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.153 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -77.35 138.11 39.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.396 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.464 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 23.7 p -108.39 -62.61 1.43 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.075 -178.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 61.3 52.13 53.63 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.302 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.442 HG21 ' O ' ' A' ' 263' ' ' ALA . 58.7 mt -103.37 148.39 8.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 34.5 p -97.2 150.58 20.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.603 0.716 . . . . 0.0 111.992 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.62 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.8 p -63.92 151.45 8.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.025 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.9 t -115.34 81.68 1.62 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.899 0.381 . . . . 0.0 110.006 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 102.48 165.09 26.37 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.838 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -101.88 136.44 41.71 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.473 ' OE1' ' HA ' ' A' ' 259' ' ' VAL . 3.9 pt20 -144.14 139.46 28.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.247 0.546 . . . . 0.0 111.475 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 28.1 t -145.98 103.39 3.74 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.384 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -102.39 150.63 23.15 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 320' ' ' LEU . 45.9 mmtm -119.68 131.91 24.22 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.223 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.92 148.77 25.36 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.603 2.202 . . . . 0.0 111.863 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.17 124.64 29.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.228 0.537 . . . . 0.0 109.704 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -87.83 -177.7 5.86 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.397 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -67.4 -40.83 85.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.235 0.541 . . . . 0.0 109.788 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -97.42 103.01 14.91 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.047 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 7.5 mp -83.44 59.07 4.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.283 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -85.83 -55.02 4.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.148 -177.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -73.48 -55.29 6.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.927 0.394 . . . . 0.0 110.339 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -112.74 112.3 23.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.586 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -100.0 44.52 1.62 Allowed Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.028 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -58.45 121.1 10.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.94 0.4 . . . . 0.0 110.426 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -80.94 -37.05 30.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.548 -174.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 34.2 m -79.4 145.76 8.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.933 0.397 . . . . 0.0 110.654 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -105.91 95.67 5.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.025 0.441 . . . . 0.0 109.961 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.76 139.39 16.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.382 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 10.3 t70 57.76 40.97 25.79 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.605 0.717 . . . . 0.0 109.98 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -93.78 -53.65 3.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.332 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -100.15 -23.3 14.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.975 0.416 . . . . 0.0 110.542 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -95.7 144.77 25.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.216 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -117.27 115.83 26.05 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.082 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.2 m -87.36 100.3 12.62 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.107 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.473 ' HA ' ' OE1' ' A' ' 234' ' ' GLN . 2.5 t -83.1 122.27 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.414 -172.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 25.0 m -96.13 105.81 17.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.834 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.534 HD23 HG23 ' A' ' 230' ' ' VAL . 21.0 mt -123.7 165.95 16.37 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.968 -175.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.9 t -60.11 -54.66 43.27 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.442 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.27 139.44 40.95 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.166 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 11.6 p -132.48 24.55 4.43 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.98 0.895 . . . . 0.0 108.867 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.4 m -78.23 139.26 38.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.865 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.77 -9.02 55.12 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -175.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 61.6 mtt -94.13 148.97 21.66 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 24.8 pttm -139.11 163.56 32.1 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -57.52 135.95 56.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.86 0.362 . . . . 0.0 110.935 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 82.71 19.03 64.46 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.801 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.52 ' HB2' ' O ' ' A' ' 268' ' ' LYS . 0.6 OUTLIER -94.21 174.2 7.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.791 0.329 . . . . 0.0 110.178 -178.563 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 0.1 OUTLIER -114.8 116.72 29.07 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.69 -178.269 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.455 HD11 HG21 ' A' ' 308' ' ' ILE . 17.1 pt -122.31 139.93 47.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.898 0.38 . . . . 0.0 110.238 175.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 72.9 p -119.75 145.05 46.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.011 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.4 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 94.0 m-85 -107.0 111.4 23.87 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.19 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.415 ' HA ' ' OD1' ' A' ' 292' ' ' ASP . . . -66.18 113.3 4.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.071 -176.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.26 -34.25 5.4 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 96.6 t -87.9 118.81 34.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.416 ' HB2' ' OE1' ' A' ' 283' ' ' GLN . 14.6 ptpt -149.44 172.07 15.55 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.214 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -83.47 150.29 26.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.611 0.719 . . . . 0.0 112.364 -169.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' A' ' 315' ' ' LEU . 40.3 mt -67.29 124.76 24.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.965 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 112.91 -27.79 9.38 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.176 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.416 ' OE1' ' HB2' ' A' ' 279' ' ' LYS . 97.3 mt-30 -63.85 -48.87 75.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.701 0.286 . . . . 0.0 110.975 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 55.6 mtm -68.96 -20.12 64.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.675 -173.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -71.8 -15.28 62.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.485 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -131.05 -52.06 1.04 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.995 0.426 . . . . 0.0 110.598 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -83.72 107.03 15.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.095 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.14 -41.21 91.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.351 0.596 . . . . 0.0 109.888 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 87.0 mt -97.25 55.51 1.29 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.208 174.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.43 131.9 49.69 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.254 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.27 155.58 34.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.252 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.415 ' OD1' ' HA ' ' A' ' 276' ' ' ALA . 31.8 m-20 -81.41 166.52 20.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.491 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.433 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -57.97 113.32 1.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.291 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 9.5 p -96.77 105.39 17.5 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.052 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.433 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 68.6 m-85 -116.93 147.83 41.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.741 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.8 t -94.94 124.48 39.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.747 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.499 HG12 ' H ' ' A' ' 271' ' ' ASP . 12.9 p -75.15 140.98 16.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.323 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 37.9 t -103.33 -38.04 5.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.861 0.363 . . . . 0.0 110.83 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -158.82 136.75 10.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 0.0 111.026 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.25 106.58 17.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.53 -59.3 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.912 -171.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -112.9 -3.7 14.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.852 0.358 . . . . 0.0 111.445 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 71.24 12.46 72.38 Favored Glycine 0 CA--C 1.517 0.216 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -172.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 16.7 p -147.92 19.49 1.13 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.444 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.4 t-160 -169.98 113.15 0.48 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.056 -167.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.0 166.11 13.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -175.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.95 119.05 28.44 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.232 0.539 . . . . 0.0 109.996 171.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.455 HG21 HD11 ' A' ' 273' ' ' ILE . 36.6 pt -113.61 171.1 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.572 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 10.3 t -155.08 144.94 15.57 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -71.75 -179.91 24.16 Favored 'Cis proline' 0 CA--C 1.532 0.382 0 C-N-CA 124.215 -1.16 . . . . 0.0 113.048 -1.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -87.1 126.9 61.29 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.675 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.93 121.8 8.45 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.586 2.191 . . . . 0.0 112.328 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.696 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.9 OUTLIER -130.78 128.55 63.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.741 178.086 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -85.95 139.1 31.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.158 -174.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.565 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.0 tm? -80.73 -27.05 36.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.986 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -77.7 -10.48 59.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.443 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -83.02 116.02 22.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.037 0.446 . . . . 0.0 110.335 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.3 m -82.68 0.22 4.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.643 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 13.8 m -71.1 -19.18 62.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.609 0.242 . . . . 0.0 111.437 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 0.8 OUTLIER -94.94 168.77 10.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.147 0.498 . . . . 0.0 111.858 -177.631 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.405 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 15.2 t -87.45 152.28 52.01 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.906 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.405 ' HD2' ' OG ' ' A' ' 321' ' ' SER . 60.7 Cg_exo -40.73 -45.3 4.76 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.381 2.721 . . . . 0.0 113.781 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 323' ' ' GLU . 3.0 mp0 -51.33 -45.68 62.36 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.225 0.536 . . . . 0.0 110.855 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 13.7 mm100 -64.76 -25.23 67.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.28 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -65.33 -31.09 72.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.93 0.395 . . . . 0.0 110.53 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.45 74.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.373 175.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -85.53 -10.28 56.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.15 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.696 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -63.08 135.08 57.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.638 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -119.51 -30.24 4.9 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 34.3 m -112.91 165.69 7.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.044 0.45 . . . . 0.0 111.399 -177.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -78.71 -44.89 22.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.528 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.3 t -130.9 145.91 52.16 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.126 0.489 . . . . 0.0 110.97 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 38.4 m -74.18 169.02 18.42 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.727 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.8 tp -75.86 102.98 5.73 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.62 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -91.66 166.19 12.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.994 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.42 62.19 4.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.09 0.472 . . . . 0.0 111.778 -173.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -176.94 30.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.491 171.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.2 mmt -101.47 134.38 44.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.342 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -90.15 132.85 35.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.009 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 22.8 t -108.3 108.56 25.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.717 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' ASN . . . . . 0.464 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 64.1 t30 -123.6 132.5 53.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.074 -175.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 47.6 mt -76.59 129.94 36.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.125 0.488 . . . . 0.0 110.295 173.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 45.4 mt -82.8 135.57 34.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.803 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -90.91 113.13 25.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.495 0.664 . . . . 0.0 110.607 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.252 1.193 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.827 179.936 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 112.349 -0.3 . . . . 0.0 112.349 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.3 t -152.8 129.83 11.08 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.516 ' HA ' ' OD1' ' A' ' 344' ' ' ASN . 3.2 p -95.5 -8.45 35.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.091 0.472 . . . . 0.0 110.843 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -155.66 98.91 1.97 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.093 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.613 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 19.4 p -80.92 -56.06 4.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.061 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.64 49.66 76.16 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.754 177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.493 HG21 ' O ' ' A' ' 263' ' ' ALA . 57.7 mt -102.75 141.76 18.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 29.7 p -97.44 153.13 18.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.532 0.682 . . . . 0.0 111.839 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.611 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.7 p -58.92 151.5 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.289 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 10.2 t -105.33 73.51 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.992 0.425 . . . . 0.0 110.095 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 97.19 158.58 31.06 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.093 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -72.61 116.96 13.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.731 0.3 . . . . 0.0 110.401 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 334' ' ' LEU . 6.2 tp-100 -129.37 127.09 40.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.148 0.499 . . . . 0.0 110.589 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.2 p -118.5 125.38 49.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.105 0.478 . . . . 0.0 109.819 177.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.477 ' CD2' ' HG2' ' A' ' 312' ' ' PRO . 70.1 m-85 -81.23 131.86 35.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.602 -174.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -129.52 111.11 17.71 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -175.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -91.28 119.47 0.59 Allowed 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.67 2.247 . . . . 0.0 111.024 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.5 p -70.6 111.84 4.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.304 0.574 . . . . 0.0 109.966 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -132.88 133.91 43.9 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.787 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 81.2 m95 56.11 41.3 29.7 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.919 0.762 . . . . 0.0 111.354 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -142.94 145.13 32.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.915 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 91.5 mt 68.14 -174.72 0.19 Allowed 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.795 0.684 . . . . 0.0 111.107 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -96.47 -157.93 0.62 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.449 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -60.53 -32.19 71.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.135 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -91.12 111.49 22.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.115 0.483 . . . . 0.0 110.868 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -136.32 -154.05 6.72 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.567 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -71.18 106.86 3.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.791 0.329 . . . . 0.0 110.425 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -118.02 -7.67 10.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.199 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 55.5 t -81.61 -39.45 17.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.71 0.766 . . . . 0.0 110.585 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ASN . . . . . 0.445 ' ND2' ' HB2' ' A' ' 253' ' ' ASP . 31.4 p-10 -95.7 161.56 13.98 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.209 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 3.5 t -115.62 45.28 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 122.025 0.916 . . . . 0.0 109.433 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.445 ' HB2' ' ND2' ' A' ' 251' ' ' ASN . 3.0 m-20 -103.18 10.36 37.83 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.15 -178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -79.88 -52.33 8.02 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -90.71 -64.29 1.15 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.609 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -78.7 153.14 31.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.733 -176.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -106.5 117.19 33.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.071 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -92.1 101.82 14.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.107 0.48 . . . . 0.0 110.542 -178.663 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.471 ' HB ' HG22 ' A' ' 306' ' ' VAL . 3.3 t -83.2 118.99 31.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.517 -172.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 20.5 m -90.78 108.54 19.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.186 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.424 ' HB2' HG22 ' A' ' 264' ' ' THR . 20.7 mt -127.11 165.06 20.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.065 -175.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 20.8 m -58.59 -55.68 31.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.398 0.618 . . . . 0.0 109.543 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.493 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -138.2 141.16 40.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.527 ' HB ' ' SD ' ' A' ' 267' ' ' MET . 9.3 p -126.42 24.69 6.69 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.057 0.932 . . . . 0.0 108.766 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 17.0 m -71.59 138.8 49.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.372 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 105.76 -11.26 45.76 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' MET . . . . . 0.53 ' SD ' HG11 ' A' ' 306' ' ' VAL . 63.3 mtt -95.18 142.83 27.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -154.17 140.36 18.5 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.523 ' HA ' HG13 ' A' ' 297' ' ' VAL . 30.0 ptt180 -44.17 118.01 1.38 Allowed 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.977 0.798 . . . . 0.0 112.607 -171.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.47 -10.63 19.4 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.467 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.497 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.5 p30 -82.84 -177.2 6.66 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.552 0.692 . . . . 0.0 112.175 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -124.97 117.73 24.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.973 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.534 HD11 HG21 ' A' ' 308' ' ' ILE . 37.5 pt -111.12 139.3 35.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.038 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.504 ' OG ' HG22 ' A' ' 294' ' ' THR . 3.0 m -125.34 129.51 50.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.508 -174.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -97.27 110.92 23.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.303 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.12 121.42 20.19 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.011 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.36 -27.93 9.58 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.77 131.28 50.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.438 ' HG3' ' SD ' ' A' ' 284' ' ' MET . 16.2 ptpt -141.84 157.73 44.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.786 0.327 . . . . 0.0 110.902 -175.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.401 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 43.3 m-85 -83.97 149.33 26.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.082 -174.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 315' ' ' LEU . 96.4 mt -79.06 179.01 7.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.391 176.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 82.67 -40.35 2.76 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.426 ' HB2' ' HB1' ' A' ' 290' ' ' ALA . 13.4 mm100 -90.67 -9.07 48.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.097 0.475 . . . . 0.0 109.937 176.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.438 ' SD ' ' HG3' ' A' ' 279' ' ' LYS . 86.0 mtp -98.42 31.62 2.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.185 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -66.28 -46.96 75.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.203 0.525 . . . . 0.0 109.894 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -138.16 -19.48 1.12 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.167 174.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -86.95 123.58 32.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.501 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.06 -30.51 7.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.798 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.443 ' H ' ' HG ' ' A' ' 289' ' ' LEU . 1.0 OUTLIER -84.39 46.1 1.19 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.056 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 283' ' ' GLN . . . -68.6 167.63 14.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.128 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -60.36 125.44 23.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.149 0.5 . . . . 0.0 111.021 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -62.17 158.73 16.22 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.295 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.401 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -71.29 85.87 0.79 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.9 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.504 HG22 ' OG ' ' A' ' 274' ' ' SER . 22.2 p -96.79 122.18 39.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.233 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.4 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 90.7 m-85 -124.11 153.65 41.15 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.97 0.414 . . . . 0.0 110.796 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.5 m -90.61 125.83 35.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.579 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 269' ' ' ARG . 4.8 p -67.03 134.45 30.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.034 0.445 . . . . 0.0 109.86 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 99.7 t -101.39 -53.05 7.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.744 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 301' ' ' VAL . 2.7 tmt_? -157.1 131.11 8.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.032 0.444 . . . . 0.0 110.843 -177.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 99.2 t -84.63 114.44 24.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.478 174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 299' ' ' ARG . 46.1 t -76.54 -59.15 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.644 -174.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -128.26 -7.72 5.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.445 0.64 . . . . 0.0 110.989 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.4 14.15 76.98 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 23.7 p -137.3 6.91 2.83 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 172.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.428 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 1.9 t60 -164.14 119.64 1.55 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.456 -169.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.83 161.83 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -176.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -119.8 128.85 54.09 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 172.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.534 HG21 HD11 ' A' ' 273' ' ' ILE . 26.8 pt -133.94 171.64 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.102 0.477 . . . . 0.0 111.848 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 8.5 t -152.35 143.35 15.71 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.191 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.38 -179.96 27.88 Favored 'Cis proline' 0 CA--C 1.53 0.302 0 C-N-CA 123.752 -1.353 . . . . 0.0 112.939 -0.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -92.26 123.67 61.8 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.167 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.477 ' HG2' ' CD2' ' A' ' 236' ' ' PHE . 38.2 Cg_endo -70.48 109.46 2.45 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.49 2.127 . . . . 0.0 112.404 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 46.7 t -117.42 129.65 73.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.893 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -87.12 132.73 33.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.27 0.557 . . . . 0.0 111.473 -175.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.428 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.0 tm? -68.96 -26.99 65.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.205 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -98.27 19.48 14.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.719 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ASP . . . . . 0.489 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 11.2 t70 -72.96 130.22 39.87 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.17 -16.61 10.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -174.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 18.9 t -90.76 -36.07 14.5 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -169.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.489 ' HG ' ' OD1' ' A' ' 317' ' ' ASP . 0.5 OUTLIER -71.15 175.92 4.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.526 0.679 . . . . 0.0 112.783 -175.3 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 13.5 m -103.13 158.53 31.58 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.21 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -39.7 -52.39 2.63 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.087 3.192 . . . . 0.0 114.756 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -58.54 -34.28 70.83 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -71.63 -26.46 62.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.788 0.328 . . . . 0.0 110.658 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -69.23 -22.97 63.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.975 0.416 . . . . 0.0 110.611 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -70.9 -34.3 71.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.29 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -86.24 -0.25 55.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.171 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -64.7 144.02 57.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.072 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -137.03 -9.26 1.78 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 32.5 m -123.4 155.25 29.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -84.88 -25.57 27.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 6.8 t -134.11 140.76 46.82 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.078 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 14.6 p -79.36 173.49 12.52 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 234' ' ' GLN . 19.1 tp -73.95 102.22 4.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.611 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -90.82 164.15 14.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.254 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' ASP . . . . . 0.427 ' HA ' ' CG1' ' A' ' 230' ' ' VAL . 23.8 t0 -77.89 60.57 2.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.181 0.515 . . . . 0.0 111.693 -173.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -178.23 29.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.473 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.5 mmt -98.17 134.37 41.32 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.228 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -94.48 131.14 40.5 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.79 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.404 HG21 HD22 ' A' ' 261' ' ' LEU . 9.0 t -104.75 114.05 43.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.048 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' ASN . . . . . 0.613 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 63.2 t30 -130.83 150.86 51.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.4 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 27.6 mt -102.84 130.73 52.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.115 0.483 . . . . 0.0 111.419 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 46.3 mt -86.41 116.18 24.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.192 173.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ASN . . . . . 0.516 ' OD1' ' HA ' ' A' ' 224' ' ' THR . 15.6 m120 -101.08 146.88 26.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.932 0.396 . . . . 0.0 111.412 -176.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 89.1 t . . . . . 0 C--O 1.246 0.907 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.048 177.747 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.576 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 43.3 t -91.79 133.17 35.87 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.4 p -82.86 -21.36 34.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.911 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 47.23 70.61 0.39 Allowed 'General case' 0 C--O 1.235 0.317 0 O-C-N 123.76 0.662 . . . . 0.0 112.452 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 33.8 p -106.36 -79.0 0.57 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.231 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.13 48.39 86.16 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.644 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 263' ' ' ALA . 27.3 mm -100.87 143.75 13.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.836 -0.182 . . . . 0.0 110.733 -174.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 18.9 p -119.79 167.76 11.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.181 0.515 . . . . 0.0 111.417 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.57 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.9 p -85.38 150.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.835 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.3 t -107.11 60.04 0.62 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.155 0.503 . . . . 0.0 110.37 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 102.67 159.71 25.78 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.591 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 334' ' ' LEU . . . -70.81 131.12 43.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.929 0.395 . . . . 0.0 110.649 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -133.96 126.35 30.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.106 -175.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 27.1 p -110.07 142.64 41.25 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.786 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.586 ' O ' HG12 ' A' ' 313' ' ' VAL . 98.7 m-85 -124.97 130.6 52.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.241 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -129.61 139.27 35.17 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.05 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.517 ' HA ' ' OD1' ' A' ' 254' ' ' ASN . 94.8 Cg_endo -88.84 160.52 6.14 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.763 2.309 . . . . 0.0 112.151 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 47.8 t -79.91 84.94 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.225 0.536 . . . . 0.0 110.212 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -103.61 104.75 14.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.054 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -133.83 134.0 42.29 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.768 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -62.01 124.19 20.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.528 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.09 58.23 1.96 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.528 0.68 . . . . 0.0 111.772 -177.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -72.67 -50.5 24.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.098 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -70.39 -48.62 55.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.329 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -175.34 -44.13 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.229 0.538 . . . . 0.0 110.418 175.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 149.62 144.54 3.96 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.214 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -95.6 75.24 3.25 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.27 0.557 . . . . 0.0 110.533 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -83.14 72.03 10.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.815 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.0 m -80.7 124.08 38.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.116 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -76.56 86.16 3.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.374 0.607 . . . . 0.0 110.633 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 14.6 p -147.25 150.71 14.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.293 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -76.64 60.03 1.61 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.38 0.61 . . . . 0.0 111.092 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.517 ' OD1' ' HA ' ' A' ' 238' ' ' PRO . 28.6 t-20 -87.77 -22.0 24.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.056 -177.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -76.95 -8.78 58.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.634 0.73 . . . . 0.0 109.692 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -110.6 159.33 17.66 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.127 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.441 ' HB2' ' HD2' ' A' ' 312' ' ' PRO . . . -121.24 114.97 22.14 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.664 0.269 . . . . 0.0 110.773 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.653 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -87.09 97.59 10.82 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.236 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -85.17 126.81 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.333 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 40.4 m -96.53 109.15 21.79 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 173.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.4 HD22 HG21 ' A' ' 340' ' ' VAL . 22.2 mt -122.43 172.52 8.28 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.7 m -58.87 -57.4 13.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.241 0.543 . . . . 0.0 109.754 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.479 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -137.2 135.98 37.76 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.956 178.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 8.2 p -130.79 23.88 5.01 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.544 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 89.7 m -82.89 137.05 34.39 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.87 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 112.54 -29.5 8.2 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -171.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -69.66 155.42 40.53 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 170.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -154.43 143.43 21.06 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.48 ' HA ' HG13 ' A' ' 297' ' ' VAL . 37.4 ptt180 -52.32 114.21 1.28 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.23 0.538 . . . . 0.0 111.06 -174.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 113.78 -2.7 24.51 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.903 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.426 ' H ' HG12 ' A' ' 297' ' ' VAL . 0.6 OUTLIER -83.6 175.1 9.99 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 117.1 0.45 . . . . 0.0 111.052 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -126.47 117.39 22.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.245 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.413 HG23 ' OD1' ' A' ' 271' ' ' ASP . 40.8 pt -112.13 140.28 32.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.188 0.518 . . . . 0.0 110.356 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.486 ' OG ' HG22 ' A' ' 294' ' ' THR . 2.7 m -120.5 137.48 54.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.987 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -101.24 111.35 23.54 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.68 116.34 9.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.023 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.27 -36.19 4.27 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 85.2 t -86.47 114.54 26.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 172.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -136.25 158.17 45.05 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.633 -172.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.481 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 66.7 m-85 -76.18 133.93 40.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.344 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.401 ' CD1' ' HB3' ' A' ' 315' ' ' LEU . 96.3 mt -76.17 154.74 35.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.663 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 102.17 -31.38 8.77 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 287' ' ' ASN . 84.6 mm-40 -74.81 -18.49 60.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.472 0.177 . . . . 0.0 111.067 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 74.0 mtm -91.6 10.24 28.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.656 0.265 . . . . 0.0 110.947 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -69.06 -27.75 65.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.058 0.456 . . . . 0.0 110.297 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -148.94 -41.6 0.15 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.739 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 283' ' ' GLN . 91.6 m-20 -70.95 108.25 4.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.973 0.416 . . . . 0.0 110.888 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 39.6 t -70.68 -32.09 48.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.596 0.713 . . . . 0.0 109.323 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.09 51.08 2.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.882 175.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -57.78 127.0 29.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.401 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -61.12 138.09 58.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.081 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -77.42 167.06 22.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.958 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.481 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -73.6 106.96 5.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.982 -176.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.498 HG21 HD11 ' A' ' 343' ' ' LEU . 67.0 p -97.34 133.62 41.71 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.97 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -131.33 148.89 52.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.941 0.401 . . . . 0.0 110.579 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.1 m -92.29 129.95 38.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.087 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.55 ' HA ' HG22 ' A' ' 308' ' ' ILE . 4.0 p -72.4 143.72 13.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.795 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 62.0 t -105.41 -38.95 4.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.682 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -162.66 136.35 6.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.654 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 58.7 t -86.53 110.45 20.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 169.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 24.3 t -77.32 -56.83 6.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.732 -171.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -127.49 13.92 7.06 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.618 -173.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 59.55 13.84 25.39 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-O 121.438 0.466 . . . . 0.0 112.055 -174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.3 p -150.27 19.49 0.85 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.476 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.3 t-160 -169.03 115.84 0.62 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.817 -1.538 . . . . 0.0 108.074 -166.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.5 m -119.43 163.42 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.313 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.1 pt-20 -124.44 116.38 22.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.143 0.496 . . . . 0.0 109.674 169.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.55 HG22 ' HA ' ' A' ' 297' ' ' VAL . 24.2 pt -115.87 169.83 6.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.104 -177.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' THR . . . . . 0.409 ' OG1' ' HA ' ' A' ' 310' ' ' PRO . 6.3 t -154.32 145.21 16.22 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.409 ' HA ' ' OG1' ' A' ' 309' ' ' THR . 59.4 Cg_endo -70.24 179.7 22.57 Favored 'Cis proline' 0 C--N 1.346 0.403 0 C-N-CA 124.038 -1.234 . . . . 0.0 113.238 1.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.46 ' HE3' ' HB3' ' A' ' 236' ' ' PHE . 31.7 tttp -83.53 119.11 73.28 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.255 -177.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 19.9 Cg_endo -62.29 109.11 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.51 2.14 . . . . 0.0 112.091 178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.791 HG23 ' HA ' ' A' ' 328' ' ' ALA . 8.9 m -127.81 128.33 69.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.324 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -87.34 136.16 33.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.953 -173.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.401 ' HB3' ' CD1' ' A' ' 281' ' ' LEU . 43.9 tp -80.62 -28.81 36.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.512 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -85.91 13.53 7.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.334 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -76.02 117.78 18.1 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 29.5 m -82.87 1.17 3.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.743 -175.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 16.1 m -94.51 -27.95 15.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.69 0.281 . . . . 0.0 111.107 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.6 pp -79.38 174.27 11.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.061 0.457 . . . . 0.0 111.291 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.533 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.6 m -116.36 168.37 8.79 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.16 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 29.3 Cg_exo -39.62 -49.1 3.38 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.793 2.995 . . . . 0.0 114.925 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -61.53 -36.94 82.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.039 0.447 . . . . 0.0 111.297 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 15.5 mm-40 -68.84 -30.4 68.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.603 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -62.86 -25.58 68.35 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.216 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.78 -34.05 69.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.128 0.489 . . . . 0.0 110.298 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -76.05 -30.67 58.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.297 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.791 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -59.26 139.69 56.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.08 -175.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -135.13 -33.36 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.822 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 27.6 m -101.35 171.24 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.969 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -75.33 -57.18 4.05 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.739 -176.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.8 t -139.41 164.1 30.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.666 0.269 . . . . 0.0 110.358 -175.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.6 p -73.91 164.48 26.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.743 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.504 ' HG ' HG21 ' A' ' 230' ' ' VAL . 25.6 tp -67.43 104.27 1.5 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.254 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.57 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -87.07 -174.35 4.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.598 -178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -80.99 157.31 25.55 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.579 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 59.33 39.08 22.75 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.864 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.9 mmt -103.78 130.17 51.27 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -81.69 137.81 35.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.214 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.431 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 22.0 t -111.18 110.06 30.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -123.29 144.21 49.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.638 -173.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 55.6 mt -96.84 127.56 48.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.31 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.498 HD11 HG21 ' A' ' 294' ' ' THR . 84.0 mt -69.6 140.67 53.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.415 -178.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -82.7 77.48 9.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.458 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.36 178.498 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.3 m 60.53 41.75 15.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.161 0.505 . . . . 0.0 111.053 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 86.1 m -68.3 -49.73 58.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.965 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 57.36 75.46 0.37 Allowed 'General case' 0 C--O 1.234 0.256 0 O-C-N 123.489 0.493 . . . . 0.0 110.875 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 32.2 p -73.16 40.32 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.306 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -82.14 76.06 2.26 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.083 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 40.1 mt -95.82 153.51 3.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 3.2 p -96.6 151.69 19.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.485 0.659 . . . . 0.0 112.211 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.548 HG11 ' O ' ' A' ' 335' ' ' ALA . 4.2 p -64.5 151.01 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.638 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.1 t -105.52 76.77 1.23 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.61 165.16 40.73 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.059 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.44 122.8 18.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.953 0.406 . . . . 0.0 110.596 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 236' ' ' PHE . 15.9 mm100 -110.0 126.91 54.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.235 0.54 . . . . 0.0 110.496 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.4 p -137.21 112.17 8.97 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.76 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 234' ' ' GLN . 40.9 m-85 -116.95 132.41 56.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.86 0.362 . . . . 0.0 110.926 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -115.94 131.55 23.67 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.367 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 254' ' ' ASN . 72.9 Cg_endo -79.65 132.07 9.65 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.381 2.054 . . . . 0.0 111.512 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 24.1 t -82.71 83.73 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.242 0.544 . . . . 0.0 109.773 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -100.82 93.51 5.58 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.802 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.418 ' HA ' ' OD1' ' A' ' 244' ' ' ASP . 91.4 m95 67.09 -174.03 0.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.535 -177.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 68.47 122.85 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.121 0.568 . . . . 0.0 110.729 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 6.4 mp 58.37 42.68 21.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.388 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' A' ' 241' ' ' TRP . 30.3 m-20 -74.18 -19.27 60.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.782 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -88.05 -53.15 4.87 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.39 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -103.76 -20.45 13.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -173.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -81.73 163.42 44.06 Favored Glycine 0 C--N 1.321 -0.266 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.23 -174.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 65.6 t30 55.53 58.05 4.86 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.511 0.724 . . . . 0.0 110.967 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -77.84 -42.73 32.63 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.78 177.38 4.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.166 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 63.49 81.33 0.21 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.474 0.654 . . . . 0.0 110.109 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 12.3 t -81.86 62.91 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.8 0.809 . . . . 0.0 110.083 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.53 42.26 3.0 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.537 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 238' ' ' PRO . 6.0 p30 -72.63 -51.54 19.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.706 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -86.78 -47.27 9.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.817 0.341 . . . . 0.0 110.929 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -78.93 139.08 38.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.505 -176.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.454 ' HB2' ' HG3' ' A' ' 311' ' ' LYS . . . -100.41 115.97 31.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.616 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -85.83 97.78 10.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.978 179.459 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.0 t -81.98 114.18 22.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.977 -173.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 17.5 m -86.42 107.19 17.93 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.985 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.453 HD12 HG22 ' A' ' 264' ' ' THR . 21.0 mt -122.12 167.12 13.53 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -177.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.8 m -55.86 -54.6 42.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.372 0.606 . . . . 0.0 109.65 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -138.4 146.83 42.68 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.453 HG22 HD12 ' A' ' 261' ' ' LEU . 24.3 p -133.6 31.38 3.7 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.889 0.852 . . . . 0.0 108.904 174.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.9 m -80.24 152.7 28.95 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.65 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 90.36 -28.73 7.19 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 52.7 mtt -78.2 135.62 37.65 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.512 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 3.2 ptpp? -134.36 163.53 29.46 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -52.85 126.58 20.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.941 0.4 . . . . 0.0 111.147 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 95.21 18.82 32.43 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.098 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.512 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 66.5 m-20 -100.77 161.39 13.63 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 117.349 0.574 . . . . 0.0 110.892 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.489 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 12.0 tppt? -106.53 117.53 34.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.782 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.475 HD11 HG21 ' A' ' 308' ' ' ILE . 36.5 pt -112.25 139.74 35.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.128 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.416 ' HB3' HG22 ' A' ' 294' ' ' THR . 32.6 p -113.06 134.35 54.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.317 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -100.06 111.55 23.84 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.932 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.96 130.73 46.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.837 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 89.43 -35.51 3.7 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.082 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.6 124.23 35.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.504 ' HD2' ' SD ' ' A' ' 284' ' ' MET . 8.6 ptpp? -143.01 159.91 41.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.879 0.371 . . . . 0.0 111.183 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.435 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 80.7 m-85 -78.66 156.3 29.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.478 -173.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.11 143.3 57.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.291 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 107.03 -15.94 39.57 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.417 HE21 ' HB1' ' A' ' 290' ' ' ALA . 20.9 mt-30 -91.26 175.16 7.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.504 ' SD ' ' HD2' ' A' ' 279' ' ' LYS . 48.9 mtm 70.76 12.76 7.22 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.425 0.453 . . . . 0.0 111.422 176.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -83.7 -43.16 15.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.313 0.578 . . . . 0.0 109.501 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -166.21 54.19 0.09 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.555 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -153.69 119.47 5.3 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.702 0.763 . . . . 0.0 110.992 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 23.0 t -87.13 -20.92 7.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.181 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 83.9 mt -87.43 42.72 1.06 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.031 175.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.417 ' HB1' HE21 ' A' ' 283' ' ' GLN . . . -63.88 132.14 49.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.823 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -79.09 150.76 31.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.346 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -87.3 158.19 19.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.913 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.435 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -65.17 108.93 2.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.123 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.489 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 4.4 p -103.54 110.99 23.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.142 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -115.79 157.68 24.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.158 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 27.8 t -96.89 127.24 42.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.471 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.468 HG12 ' H ' ' A' ' 271' ' ' ASP . 12.1 p -82.85 131.23 34.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.169 0.509 . . . . 0.0 110.228 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 39.2 t -92.21 -36.08 7.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.193 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.408 ' O ' ' HG2' ' A' ' 307' ' ' GLU . 11.1 tpt180 -162.67 144.1 10.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.228 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.464 HG12 ' H ' ' A' ' 303' ' ' GLY . 93.1 t -91.24 114.71 28.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 16.8 t -77.83 -52.29 16.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.976 -172.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -125.11 3.16 7.93 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -172.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' GLY . . . . . 0.464 ' H ' HG12 ' A' ' 300' ' ' VAL . . . 65.22 13.98 58.73 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.295 -171.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -151.9 20.57 0.69 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.561 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.0 t-160 -171.43 114.94 0.39 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 113.821 -1.536 . . . . 0.0 108.296 -164.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.6 m -118.84 160.66 18.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -176.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 299' ' ' ARG . 12.2 pt-20 -118.03 120.5 37.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.081 0.467 . . . . 0.0 109.984 173.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 273' ' ' ILE . 31.0 pt -118.56 164.47 14.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.273 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' THR . . . . . 0.405 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 8.8 t -154.11 140.91 13.15 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.141 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.405 ' C ' ' HA ' ' A' ' 309' ' ' THR . 15.5 Cg_exo -69.02 177.2 27.69 Favored 'Cis proline' 0 C--N 1.347 0.492 0 C-N-CA 123.932 -1.278 . . . . 0.0 112.567 -0.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.454 ' HG3' ' HB2' ' A' ' 257' ' ' ALA . 39.3 ttmt -90.42 124.88 61.62 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.731 -178.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.06 109.38 2.16 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.789 2.326 . . . . 0.0 112.467 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.49 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -112.69 130.83 65.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.897 176.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -81.93 126.97 32.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.173 0.511 . . . . 0.0 111.133 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.2 -31.58 70.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.61 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -82.55 3.61 27.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.588 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ASP . . . . . 0.461 ' OD2' ' HG ' ' A' ' 320' ' ' LEU . 20.2 t70 -72.96 123.11 22.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.888 0.375 . . . . 0.0 110.119 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.51 2.11 4.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 29.1 t -93.93 -31.27 14.36 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -173.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.604 HD13 ' HG2' ' A' ' 325' ' ' ARG . 0.4 OUTLIER -84.09 155.17 22.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.595 0.712 . . . . 0.0 112.492 -177.163 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.485 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 47.1 t -80.12 154.92 75.02 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.919 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.485 ' HD2' ' OG ' ' A' ' 321' ' ' SER . 41.3 Cg_exo -36.13 -52.65 1.05 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 124.087 3.191 . . . . 0.0 114.291 177.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.28 -38.84 84.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.815 0.34 . . . . 0.0 111.122 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 15.3 mm100 -64.65 -26.72 68.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.637 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.604 ' HG2' HD13 ' A' ' 320' ' ' LEU . 88.2 mtt180 -73.33 -19.23 61.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.912 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -78.83 -25.42 44.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.987 175.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -88.69 -11.63 44.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.536 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.49 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -66.76 121.65 15.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.782 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ASN . . . . . 0.483 ' OD1' HG13 ' A' ' 330' ' ' VAL . 3.2 p30 -102.35 -27.45 12.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.823 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.483 HG13 ' OD1' ' A' ' 329' ' ' ASN . 36.0 m -113.85 168.08 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.998 0.427 . . . . 0.0 110.995 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -88.48 -41.43 12.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.328 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.5 t -123.64 145.36 49.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.252 0.548 . . . . 0.0 110.853 -174.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 7.5 p -73.0 162.57 29.33 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.339 172.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.451 ' HG ' HG21 ' A' ' 230' ' ' VAL . 40.6 tp -71.57 104.16 3.22 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.548 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.01 178.0 8.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.639 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -81.01 153.45 27.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.551 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 66.41 34.51 6.21 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 124.083 0.864 . . . . 0.0 111.897 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.515 ' H ' HG12 ' A' ' 230' ' ' VAL . 78.5 mmm -106.55 149.8 26.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -94.32 140.25 30.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.031 0.443 . . . . 0.0 111.588 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 41.7 t -125.28 120.35 57.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -138.51 148.21 44.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.711 0.291 . . . . 0.0 111.218 -174.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 60.5 mt -87.92 122.57 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.005 0.431 . . . . 0.0 110.585 174.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 47.8 mt -86.35 112.19 21.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.281 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -99.53 89.15 4.06 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.528 -0.749 . . . . 0.0 110.678 -178.538 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.912 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.7 p -86.33 71.57 10.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.191 0.52 . . . . 0.0 111.177 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 16.5 p -100.11 27.04 5.87 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.125 0.488 . . . . 0.0 111.158 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.08 96.43 5.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.785 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.554 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 22.2 p -72.68 -60.57 2.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.033 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.99 48.01 88.18 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.569 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.408 HG21 ' O ' ' A' ' 263' ' ' ALA . 71.3 mt -102.25 143.7 14.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 17.5 p -96.84 150.21 20.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.703 0.763 . . . . 0.0 112.243 -173.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.709 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.9 p -62.77 151.26 8.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.469 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 70.9 m -102.2 72.52 1.3 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.95 0.405 . . . . 0.0 110.724 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 99.09 164.86 29.95 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.377 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -88.93 138.53 31.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.618 0.246 . . . . 0.0 110.436 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' A' ' 234' ' ' GLN . 3.1 pt20 -153.58 147.32 25.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.143 0.497 . . . . 0.0 110.849 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 50.7 p -119.06 124.23 46.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.224 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -81.36 146.91 30.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.129 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.408 ' HB3' HE22 ' A' ' 324' ' ' GLN . 48.0 mmtm -141.76 116.57 6.9 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.112 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -92.08 119.33 0.49 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.476 2.117 . . . . 0.0 110.436 166.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.458 ' CG2' ' HB2' ' A' ' 242' ' ' GLN . 7.7 p -88.61 133.99 29.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.101 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -116.35 104.17 11.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.431 -175.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 85.8 m95 69.36 30.63 4.12 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.292 0.637 . . . . 0.0 111.598 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLN . . . . . 0.458 ' HB2' ' CG2' ' A' ' 239' ' ' VAL . 93.9 mt-30 -138.89 124.26 19.3 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 91.9 mt 61.53 21.48 12.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.107 0.48 . . . . 0.0 110.696 -175.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.406 ' HA ' ' HB2' ' A' ' 248' ' ' ASN . 2.6 m-20 -82.52 -36.96 25.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.364 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -65.06 -46.15 82.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.478 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -137.11 105.76 5.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.063 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 144.09 -58.6 0.53 Allowed Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.549 -0.621 . . . . 0.0 111.549 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ASN . . . . . 0.406 ' HB2' ' HA ' ' A' ' 244' ' ' ASP . 35.7 m-80 -100.61 73.18 1.6 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.188 0.518 . . . . 0.0 109.711 175.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -90.17 -50.29 6.07 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.681 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.1 m -112.66 161.23 11.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.766 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 69.96 126.56 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.993 0.808 . . . . 0.0 111.202 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 3.8 m -84.98 62.27 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.773 0.797 . . . . 0.0 110.797 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -66.36 -17.31 64.69 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.995 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -75.94 -17.13 59.86 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.728 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -111.73 -32.87 6.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.154 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.555 ' O ' ' HE3' ' A' ' 311' ' ' LYS . 40.9 m-85 -115.01 164.96 13.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.455 -176.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -130.98 138.52 49.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.662 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 4.0 m -101.54 114.41 28.42 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.434 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.7 t -95.42 125.02 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.234 -174.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 28.3 m -98.74 111.55 23.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.022 177.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 340' ' ' VAL . 14.7 mt -130.59 169.34 15.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.455 -174.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.5 m -62.5 -55.38 28.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.492 0.663 . . . . 0.0 109.829 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.408 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.6 135.04 36.24 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.194 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.4 p -127.45 26.64 5.95 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 172.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 37.8 m -74.5 140.67 44.69 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.129 -1.851 . . . . 0.0 110.548 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 94.32 -11.93 69.68 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 66.0 mtt -86.09 145.2 27.15 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 25.2 pttm -136.22 155.23 50.42 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -57.34 128.48 37.22 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.92 18.47 34.38 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.447 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.548 ' H ' HG12 ' A' ' 297' ' ' VAL . 0.6 OUTLIER -101.28 178.02 4.77 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.5 ' HD3' ' HB ' ' A' ' 294' ' ' THR . 2.3 tmmm? -130.75 116.21 17.69 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.172 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 308' ' ' ILE . 37.7 pt -112.48 151.42 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.936 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.411 ' OG ' HG22 ' A' ' 294' ' ' THR . 18.5 m -140.41 144.07 35.97 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.395 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.486 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 88.7 m-85 -102.77 111.97 24.54 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.593 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.86 113.02 5.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.431 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.44 -18.19 23.11 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.712 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 59.4 t -110.32 114.08 46.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.591 ' HD3' ' HB3' ' A' ' 290' ' ' ALA . 0.6 OUTLIER -131.05 159.4 37.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.814 0.34 . . . . 0.0 111.472 -176.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -69.86 161.46 29.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.045 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 315' ' ' LEU . 87.2 mt -77.21 -177.94 4.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.916 177.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 72.05 16.71 76.78 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.726 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.441 ' OE1' ' HG2' ' A' ' 291' ' ' GLN . 37.2 mt-30 -135.14 -161.78 1.19 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 69.5 mtp 75.93 -45.84 0.54 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.83 0.706 . . . . 0.0 111.723 173.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.23 -36.46 84.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.463 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -128.34 -43.71 1.44 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.998 0.428 . . . . 0.0 110.337 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -75.45 104.0 5.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.193 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 48.6 t -74.4 -48.55 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.265 0.555 . . . . 0.0 109.645 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 93.0 mt -83.97 55.0 3.11 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.591 ' HB3' ' HD3' ' A' ' 279' ' ' LYS . . . -66.11 125.61 26.04 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.135 -176.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLN . . . . . 0.441 ' HG2' ' OE1' ' A' ' 283' ' ' GLN . 10.7 pt20 -55.58 129.8 40.45 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 123.939 0.774 . . . . 0.0 111.255 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -74.78 168.26 20.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.393 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.659 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -64.21 86.09 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.734 -176.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.5 ' HB ' ' HD3' ' A' ' 272' ' ' LYS . 43.7 p -87.93 110.37 20.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.526 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.659 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 64.7 m-85 -119.45 147.49 44.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.037 0.446 . . . . 0.0 111.381 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.7 m -91.89 127.82 37.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.689 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 271' ' ' ASP . 7.5 p -83.29 130.82 35.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.16 0.505 . . . . 0.0 110.289 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 307' ' ' GLU . 12.8 p -95.06 -30.05 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.498 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -163.38 139.84 7.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.11 0.481 . . . . 0.0 111.253 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 72.7 t -97.36 119.51 45.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.88 -59.88 2.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.838 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -129.23 -3.69 4.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.375 0.607 . . . . 0.0 111.091 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.6 14.44 75.91 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.413 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 14.4 p -143.0 16.09 1.92 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 174.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.414 ' CE1' HG22 ' A' ' 258' ' ' THR . 1.8 t60 -171.54 116.28 0.4 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.807 -168.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.54 163.55 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.632 -174.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.439 ' O ' HG12 ' A' ' 298' ' ' VAL . 6.7 pt-20 -124.85 123.36 39.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.105 0.478 . . . . 0.0 109.943 172.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 297' ' ' VAL . 28.4 pt -129.17 175.05 11.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.284 -174.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' THR . . . . . 0.413 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 11.6 t -154.17 145.39 16.46 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 176.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.79 179.36 29.52 Favored 'Cis proline' 0 C--N 1.345 0.393 0 C-N-CA 124.002 -1.249 . . . . 0.0 112.65 -2.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.555 ' HE3' ' O ' ' A' ' 256' ' ' PHE . 30.1 ttmt -84.42 128.84 60.1 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.854 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.497 ' HG3' ' CE2' ' A' ' 295' ' ' PHE . 7.6 Cg_exo -71.28 108.87 2.45 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.448 2.099 . . . . 0.0 112.283 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.613 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -123.33 129.99 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.546 175.048 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -85.59 131.03 34.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.796 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.405 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.2 tm? -62.29 -32.69 73.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.716 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -92.83 24.83 3.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.351 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.27 128.55 34.31 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 29.3 m -84.48 -1.89 6.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -173.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 33.7 t -110.13 -14.34 14.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -173.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.95 167.9 21.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.6 0.714 . . . . 0.0 112.312 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.4 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 7.9 t -99.98 154.03 37.45 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.15 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.49 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 67.0 Cg_exo -41.86 -47.81 6.27 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.158 2.572 . . . . 0.0 113.549 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 323' ' ' GLU . 1.6 mp0 -53.76 -39.94 65.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.186 0.517 . . . . 0.0 110.933 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.408 HE22 ' HB3' ' A' ' 237' ' ' LYS . 40.5 mt-30 -72.76 -23.88 60.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.823 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.49 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 29.6 mtm180 -66.36 -27.46 67.89 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.942 0.401 . . . . 0.0 110.297 176.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.82 63.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.222 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -96.06 7.57 46.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.939 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.613 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -58.9 140.09 55.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.898 0.38 . . . . 0.0 110.527 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -123.17 -33.43 3.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.412 -170.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 27.5 m -125.47 169.01 17.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.862 0.363 . . . . 0.0 110.16 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -94.07 -16.87 23.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.809 0.338 . . . . 0.0 110.916 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.0 t -144.62 141.33 29.31 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.894 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 50.1 m -80.18 171.99 14.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.2 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 17.7 tp -68.25 103.89 1.7 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.187 0.518 . . . . 0.0 110.364 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.709 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -81.02 170.82 15.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.917 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -79.31 11.56 2.85 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.373 -171.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -142.85 40.99 1.54 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.025 0.44 . . . . 0.0 110.979 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 21.6 mmt -98.99 133.07 43.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.355 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -94.33 130.6 40.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.822 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.469 HG21 HD13 ' A' ' 261' ' ' LEU . 12.2 t -99.78 113.17 34.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.613 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' ASN . . . . . 0.554 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 57.9 t30 -130.65 139.61 50.36 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.032 -177.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.6 mt -86.93 122.82 39.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.939 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 38.0 mt -86.03 118.28 25.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.747 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -95.87 102.48 14.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.715 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.068 -0.967 . . . . 0.0 110.657 -178.947 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.674 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.6 p -76.04 -19.51 58.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.711 0.291 . . . . 0.0 111.464 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 28.4 m -71.27 -30.3 66.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.263 0.554 . . . . 0.0 110.323 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.31 63.03 6.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.499 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 341' ' ' ASN . 31.0 p -130.72 66.02 1.53 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.329 0.585 . . . . 0.0 111.189 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -113.94 56.43 0.49 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.573 HG21 ' O ' ' A' ' 263' ' ' ALA . 10.9 mt -92.51 161.2 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.22 -0.49 . . . . 0.0 110.342 -172.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 37.0 p -113.22 157.99 21.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.305 0.574 . . . . 0.0 111.369 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.697 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.2 p -72.07 151.63 8.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.454 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 39.8 t -106.24 95.43 5.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.921 174.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 83.42 165.04 37.42 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.92 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -92.99 126.08 37.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -142.0 129.53 21.39 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.249 0.547 . . . . 0.0 111.357 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 15.5 t -106.42 121.9 45.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.551 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.46 ' O ' HG13 ' A' ' 313' ' ' VAL . 91.2 m-85 -83.89 113.53 21.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.862 0.363 . . . . 0.0 110.596 -176.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.419 ' HE2' HD23 ' A' ' 320' ' ' LEU . 33.3 mmtp -124.04 118.48 26.8 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.528 -176.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.39 134.97 16.11 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.516 2.144 . . . . 0.0 111.774 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 5.9 p -71.76 95.33 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.804 0.811 . . . . 0.0 110.965 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -125.31 80.8 1.91 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.376 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -141.39 97.46 3.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.148 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 28.4 mp0 -70.07 103.99 2.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.831 0.348 . . . . 0.0 110.209 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 79.7 mt -74.04 -58.11 3.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.91 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -107.93 -92.52 0.41 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.132 174.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -88.6 -40.87 13.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.528 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.528 ' CG ' ' HD2' ' A' ' 249' ' ' LYS . 3.7 p30 -132.93 179.23 6.3 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.093 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -138.09 76.53 0.35 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.442 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 19.2 m120 59.43 52.76 5.6 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 122.746 0.418 . . . . 0.0 110.827 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.528 ' HD2' ' CG ' ' A' ' 246' ' ' ASP . 0.1 OUTLIER -77.56 -18.91 56.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.811 -175.262 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 40.4 t -80.7 -19.93 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.714 0.768 . . . . 0.0 109.571 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -86.28 84.52 7.45 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.265 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 28.1 m -90.37 25.22 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 122.018 0.913 . . . . 0.0 110.392 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -77.62 -15.45 59.2 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.538 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.413 ' O ' ' HE2' ' A' ' 311' ' ' LYS . 53.5 m-80 -71.96 -7.69 50.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.292 -178.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.504 ' NE ' ' HA ' ' A' ' 255' ' ' ARG . 3.3 mmp_? -75.8 -15.48 60.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.152 0.501 . . . . 0.0 109.744 174.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -108.68 165.62 11.41 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.353 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.417 ' HB2' ' HA ' ' A' ' 311' ' ' LYS . . . -140.04 120.48 14.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.47 177.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.0 OUTLIER -90.27 104.24 16.84 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.991 0.424 . . . . 0.0 110.338 -179.466 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.456 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.6 t -88.94 117.9 33.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 -173.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 60.6 m -89.59 107.69 19.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.018 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.423 HD12 HG22 ' A' ' 264' ' ' THR . 18.6 mt -123.6 164.11 19.68 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.68 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 17.2 m -57.52 -52.93 63.38 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.432 0.634 . . . . 0.0 109.681 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.573 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.47 146.13 43.9 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 175.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.423 HG22 HD12 ' A' ' 261' ' ' LEU . 16.0 p -132.0 29.93 4.34 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.102 0.953 . . . . 0.0 108.569 174.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 18.3 m -73.74 138.97 44.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.291 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 100.15 -1.06 56.15 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.312 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' MET . . . . . 0.402 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 54.9 mtt -102.04 142.86 32.65 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 62.0 pttt -143.33 148.18 35.87 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -50.18 122.32 6.68 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.601 0.563 . . . . 0.0 111.876 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 97.45 18.35 28.59 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.678 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.523 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.4 t70 -98.06 -171.02 2.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.98 0.39 . . . . 0.0 110.168 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -135.12 117.06 15.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.872 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.498 HD11 HG21 ' A' ' 308' ' ' ILE . 29.6 pt -112.64 140.37 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.421 -0.512 . . . . 0.0 109.974 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 6.8 m -120.86 137.03 54.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.233 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -103.18 111.55 23.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.3 119.03 12.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.365 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.03 -32.14 6.53 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -176.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.49 ' HA ' ' CG2' ' A' ' 332' ' ' THR . 43.7 t -96.73 122.37 48.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 279' ' ' LYS . 11.2 ptpt -140.12 170.1 16.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.878 0.37 . . . . 0.0 111.379 -176.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -81.18 173.41 12.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.753 -174.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 71.9 mt -80.1 71.28 6.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.257 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 143.84 -163.67 27.61 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.97 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 60.86 30.88 19.93 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.053 0.454 . . . . 0.0 110.85 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 65.4 mtm -123.1 -15.87 7.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.916 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.79 -55.9 14.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.239 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -113.95 -24.51 9.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.138 0.494 . . . . 0.0 110.299 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -82.48 105.04 13.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.301 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 19.7 t -74.52 -34.3 35.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.354 0.597 . . . . 0.0 109.454 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 94.9 mt -89.66 61.27 5.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.311 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -61.89 124.51 20.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.407 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -63.5 127.3 30.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.179 0.514 . . . . 0.0 110.264 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -76.0 166.91 22.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.463 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.578 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -52.91 104.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.513 0.508 . . . . 0.0 111.199 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.05 106.48 16.73 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.037 -176.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.519 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 50.2 m-85 -122.96 154.82 37.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.949 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 31.6 t -91.69 134.84 34.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.303 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 271' ' ' ASP . 11.9 p -87.15 126.74 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.218 0.533 . . . . 0.0 110.171 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.6 t -92.59 -38.77 10.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.581 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -159.13 133.89 8.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 50.3 t -93.8 110.28 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 39.5 t -70.16 -58.28 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.887 -171.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -124.34 -8.92 7.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.257 0.551 . . . . 0.0 111.151 -176.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.9 13.86 76.67 Favored Glycine 0 C--N 1.32 -0.309 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -172.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 29.6 p -138.71 13.2 2.72 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 172.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -166.35 120.65 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.519 -170.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.6 159.81 20.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 -176.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -122.77 115.48 22.11 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.284 0.564 . . . . 0.0 109.724 168.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.498 HG21 HD11 ' A' ' 273' ' ' ILE . 30.1 pt -111.83 178.35 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.102 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 15.0 t -153.73 142.73 14.67 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.428 ' HD2' ' CD1' ' A' ' 295' ' ' PHE . 4.8 Cg_exo -82.13 -179.87 25.15 Favored 'Cis proline' 0 C--N 1.344 0.317 0 C-N-CA 124.282 -1.133 . . . . 0.0 112.522 -2.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 257' ' ' ALA . 24.4 ttmm -77.27 124.42 87.04 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.491 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.507 ' HA ' ' OD1' ' A' ' 329' ' ' ASN . 64.3 Cg_endo -77.94 108.6 2.56 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.374 2.05 . . . . 0.0 112.365 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 236' ' ' PHE . 0.2 OUTLIER -109.49 136.17 46.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.028 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' A' ' 317' ' ' ASP . . . -81.47 115.8 20.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.057 0.456 . . . . 0.0 111.106 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.96 -26.54 66.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.528 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.09 12.54 21.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.864 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ASP . . . . . 0.43 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 21.4 t70 -85.66 118.63 25.29 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.88 -14.34 11.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.004 0.43 . . . . 0.0 111.221 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.5 t -77.7 -28.28 50.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.47 -174.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.419 HD23 ' HE2' ' A' ' 237' ' ' LYS . 1.8 pp -71.07 172.92 8.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.31 0.576 . . . . 0.0 112.009 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.436 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 23.5 m -102.65 162.98 18.53 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.483 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.438 ' O ' ' HG3' ' A' ' 325' ' ' ARG . 85.3 Cg_exo -44.62 -52.21 6.31 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.004 3.136 . . . . 0.0 115.39 -172.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -73.42 -18.13 61.18 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.771 -0.581 . . . . 0.0 111.743 -172.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -73.92 -39.7 63.65 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.224 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 322' ' ' PRO . 0.0 OUTLIER -75.07 -16.29 60.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.121 0.486 . . . . 0.0 110.785 178.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -66.71 -35.48 80.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.551 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -95.43 -0.62 52.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.138 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.447 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -66.19 128.45 36.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.15 0.5 . . . . 0.0 111.266 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ASN . . . . . 0.507 ' OD1' ' HA ' ' A' ' 312' ' ' PRO . 10.2 p30 -110.85 -26.85 9.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.699 -176.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 29.2 m -108.54 164.07 5.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.017 0.437 . . . . 0.0 110.834 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -98.86 -5.66 30.54 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.49 ' CG2' ' HA ' ' A' ' 278' ' ' VAL . 8.9 t -146.05 148.11 32.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.059 0.457 . . . . 0.0 110.882 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 59.5 m -81.26 167.33 19.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.492 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.43 ' HG ' HG21 ' A' ' 230' ' ' VAL . 18.7 tp -76.02 102.92 5.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.697 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.58 167.63 19.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.297 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -80.68 28.7 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -171.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -153.09 32.23 0.48 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.874 0.368 . . . . 0.0 110.838 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.6 mmt -94.22 129.99 40.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.871 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -85.15 140.69 30.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.618 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.4 HG21 HD13 ' A' ' 261' ' ' LEU . 11.2 t -109.46 108.11 24.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.919 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' ASN . . . . . 0.515 ' HA ' ' O ' ' A' ' 226' ' ' THR . 6.8 t30 -119.6 132.11 55.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.15 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 4.0 mt -92.72 129.57 43.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.02 0.438 . . . . 0.0 110.591 175.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 50.8 mt -76.17 111.1 11.23 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -123.77 144.91 49.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.97 0.414 . . . . 0.0 110.75 -174.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.248 1.015 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.986 -177.317 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.708 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 48.8 m -124.66 165.93 17.03 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 14.9 t -160.06 160.21 32.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.946 0.403 . . . . 0.0 110.366 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -132.05 -172.56 2.91 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 20.1 p -66.81 -77.24 0.07 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.275 176.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 50.96 37.73 36.76 Favored Glycine 0 C--N 1.332 0.361 0 O-C-N 123.331 0.394 . . . . 0.0 113.056 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.406 HG21 ' O ' ' A' ' 263' ' ' ALA . 44.2 mt -82.5 141.7 14.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -176.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 5.4 p -95.29 147.14 23.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.724 0.773 . . . . 0.0 112.131 -171.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.67 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.6 p -57.54 151.37 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.089 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 33.1 t -101.93 47.7 0.89 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.084 0.469 . . . . 0.0 110.427 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 122.57 163.94 12.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.407 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -79.34 123.26 27.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.797 0.332 . . . . 0.0 110.417 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.437 HE22 ' CB ' ' A' ' 260' ' ' THR . 95.1 mt-30 -132.88 131.55 41.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.228 0.537 . . . . 0.0 111.217 -177.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.1 t -131.34 101.93 5.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.571 ' O ' HG13 ' A' ' 313' ' ' VAL . 64.8 m-85 -94.68 137.45 33.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.219 -176.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.69 ' HB3' ' NE2' ' A' ' 324' ' ' GLN . 3.3 mptp? -109.85 146.56 34.36 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.681 -177.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.553 ' HA ' ' OD1' ' A' ' 254' ' ' ASN . 73.5 Cg_endo -80.25 137.24 11.87 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.571 2.181 . . . . 0.0 111.029 170.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.67 109.22 7.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.431 0.634 . . . . 0.0 110.539 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -136.41 129.77 31.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.538 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 28.2 t90 71.74 -53.21 0.69 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.022 0.826 . . . . 0.0 111.492 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -74.8 153.38 38.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.449 ' HG ' ' H ' ' A' ' 247' ' ' GLY . 39.3 tp 58.53 51.37 8.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.403 0.62 . . . . 0.0 110.012 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -75.67 -9.08 58.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.458 -175.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -80.4 -25.91 38.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.881 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -124.47 -59.87 1.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.434 -173.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.449 ' H ' ' HG ' ' A' ' 243' ' ' LEU . . . 60.67 -142.58 48.18 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.961 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -105.12 12.88 31.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.351 0.596 . . . . 0.0 109.772 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -79.08 -33.48 44.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.809 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.09 179.9 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.692 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 62.54 -154.7 0.34 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.45 138.44 22.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 171.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -77.13 110.41 11.78 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.553 ' OD1' ' HA ' ' A' ' 238' ' ' PRO . 20.1 t-20 -71.79 -7.63 49.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.108 -174.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -67.42 -17.19 64.62 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.705 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -107.4 135.58 48.65 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.652 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -100.55 122.9 44.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.475 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -90.68 101.26 14.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.016 0.436 . . . . 0.0 111.089 179.002 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.6 t -83.15 121.48 36.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.977 -175.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.437 ' CB ' HE22 ' A' ' 234' ' ' GLN . 29.0 m -94.28 107.02 18.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.312 0.577 . . . . 0.0 109.985 176.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.481 ' HB2' HG22 ' A' ' 264' ' ' THR . 17.8 mt -121.04 163.19 18.71 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.634 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 26.2 m -55.03 -54.0 48.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.172 0.51 . . . . 0.0 109.958 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.406 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.47 135.45 36.84 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.481 HG22 ' HB2' ' A' ' 261' ' ' LEU . 7.9 p -126.37 29.25 5.82 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.5 m -82.21 139.51 34.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.023 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 96.05 18.48 31.53 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 65.4 mtt -121.45 147.26 45.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.022 -0.589 . . . . 0.0 109.722 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -139.14 169.5 17.66 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.527 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 298' ' ' VAL . 47.6 mtt180 -56.48 128.56 36.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.777 0.323 . . . . 0.0 111.371 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.02 18.57 42.89 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.354 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.488 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 92.0 m-20 -93.78 156.12 16.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.169 0.484 . . . . 0.0 110.302 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -102.9 116.6 32.87 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.423 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.478 HD11 HG21 ' A' ' 308' ' ' ILE . 28.5 pt -113.51 138.69 42.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.095 176.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 10.5 t -120.19 132.25 55.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.461 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.453 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 92.5 m-85 -94.43 110.33 22.12 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.97 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.44 111.37 8.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.374 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.63 -19.95 20.98 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.577 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 74.7 t -104.44 128.7 57.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 174.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -147.11 159.7 43.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.956 0.407 . . . . 0.0 111.106 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 76.9 m-85 -73.66 166.08 23.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.277 -175.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 89.6 mt -61.32 136.86 58.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.489 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 99.23 -22.35 41.23 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.028 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -75.78 128.74 35.8 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 287' ' ' ASN . 86.1 mtp 69.48 17.54 8.0 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.599 -176.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.38 -36.99 60.83 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -151.85 24.02 0.67 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.923 171.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 284' ' ' MET . 9.6 m120 -130.85 96.16 4.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.026 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 83.7 t -62.99 -49.41 83.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.175 0.512 . . . . 0.0 110.219 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 80.5 mt -87.59 61.11 6.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.864 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -82.78 173.44 11.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.973 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -102.27 137.73 40.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.438 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -76.41 166.74 23.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.465 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -68.99 129.99 41.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.762 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 9.3 p -119.74 110.6 16.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.847 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -116.95 151.75 36.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.057 0.455 . . . . 0.0 110.95 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.3 m -98.56 131.08 45.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.713 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.488 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.3 p -79.09 131.33 34.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.263 0.554 . . . . 0.0 110.8 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.554 ' O ' ' HG2' ' A' ' 269' ' ' ARG . 25.6 t -94.61 -24.55 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.532 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.445 ' HB3' ' CD ' ' A' ' 307' ' ' GLU . 12.4 tpt180 -176.85 139.33 0.29 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.369 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 75.6 t -90.59 111.02 22.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 36.9 t -73.27 -55.59 12.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.047 -171.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -128.96 -4.26 5.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.191 0.519 . . . . 0.0 111.463 -176.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 80.55 13.32 81.79 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.46 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.3 p -143.51 16.42 1.83 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.1 t-160 -165.47 118.25 1.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.269 -170.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.5 m -118.95 157.54 20.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -176.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.445 ' CD ' ' HB3' ' A' ' 299' ' ' ARG . 8.8 pt-20 -115.39 121.72 43.66 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 173.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.478 HG21 HD11 ' A' ' 273' ' ' ILE . 30.0 pt -122.45 163.75 20.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.184 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.9 t -149.21 142.28 15.85 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.447 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.05 179.63 28.93 Favored 'Cis proline' 0 C--N 1.345 0.35 0 C-N-CA 123.463 -1.474 . . . . 0.0 112.696 -0.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -83.14 124.45 76.33 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.053 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -72.78 109.2 2.74 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.835 2.357 . . . . 0.0 112.225 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 236' ' ' PHE . 0.0 OUTLIER -118.82 137.3 53.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.642 176.16 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -81.46 131.15 35.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.285 0.564 . . . . 0.0 110.459 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -73.79 -29.35 62.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.111 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -93.9 24.79 3.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.346 0.593 . . . . 0.0 110.498 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ASP . . . . . 0.646 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 14.8 t70 -82.05 121.4 26.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.198 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 13.1 p -84.32 -19.09 9.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.986 0.422 . . . . 0.0 110.996 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 34.2 t -71.72 -46.61 58.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.51 -174.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.646 ' HG ' ' OD1' ' A' ' 317' ' ' ASP . 0.3 OUTLIER -74.82 170.15 16.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.739 0.781 . . . . 0.0 113.066 -175.167 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 41.2 t -83.77 151.59 61.49 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.624 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.45 ' HA ' ' HD2' ' A' ' 325' ' ' ARG . 99.9 Cg_exo -45.84 -40.3 19.6 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.183 2.588 . . . . 0.0 113.414 176.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -60.44 -41.53 94.24 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.444 0.64 . . . . 0.0 110.914 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.69 ' NE2' ' HB3' ' A' ' 237' ' ' LYS . 39.2 mt-30 -70.21 -24.44 63.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.037 -177.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.45 ' HD2' ' HA ' ' A' ' 322' ' ' PRO . 90.6 mtt180 -70.34 -26.51 63.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.585 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.5 -29.07 68.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.236 0.541 . . . . 0.0 110.17 176.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -97.38 6.36 48.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.342 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.423 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -71.79 150.13 44.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 0.0 110.884 177.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -126.97 -32.25 2.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.915 0.388 . . . . 0.0 111.387 -174.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.9 m -112.46 155.14 13.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.24 -176.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -83.76 -22.1 32.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.252 0.548 . . . . 0.0 109.99 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 278' ' ' VAL . 1.4 t -129.46 131.44 46.71 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.606 -176.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 8.7 p -75.39 168.13 20.58 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.682 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 20.5 tp -70.22 103.73 2.44 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.67 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.49 173.14 12.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.294 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.31 10.37 3.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.858 -173.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -143.0 57.85 1.41 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.234 0.54 . . . . 0.0 110.786 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.8 mmt -117.11 136.14 53.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.282 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -96.38 131.93 42.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.903 0.382 . . . . 0.0 110.823 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.408 HG22 ' CD1' ' A' ' 275' ' ' PHE . 38.5 t -103.51 108.2 23.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.669 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -123.11 129.55 51.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.337 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 42.9 mt -80.17 125.14 38.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.525 175.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 78.5 mt -72.75 112.29 8.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.853 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -88.71 77.94 7.79 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.873 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.34 177.784 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.858 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.1 m -75.46 -42.19 53.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.702 0.287 . . . . 0.0 110.675 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 13.4 t -70.75 149.62 46.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -130.37 112.71 13.54 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.223 0.535 . . . . 0.0 111.066 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 28.6 p -96.18 82.65 3.49 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.972 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.79 63.96 3.06 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.742 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 263' ' ' ALA . 45.5 mm -98.66 139.58 20.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.583 0.23 . . . . 0.0 111.112 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.3 p -121.72 160.24 24.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.949 0.404 . . . . 0.0 110.581 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.629 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.8 p -78.5 151.04 5.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.345 177.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.8 t -116.73 78.81 1.24 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.234 0.54 . . . . 0.0 109.755 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 110.68 166.33 19.1 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.46 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -97.35 110.12 22.74 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -97.51 127.36 43.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.36 0.6 . . . . 0.0 111.604 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.6 m -127.33 101.2 6.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.101 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.419 ' HB3' ' HE2' ' A' ' 311' ' ' LYS . 94.1 m-85 -85.49 167.92 15.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.497 -174.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . 42.7 mmtm -137.65 136.63 20.4 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.496 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.542 ' HD3' HG11 ' A' ' 313' ' ' VAL . 71.6 Cg_endo -89.86 127.97 1.59 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.638 2.226 . . . . 0.0 111.686 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 8.0 p -61.77 125.37 17.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.058 0.456 . . . . 0.0 110.359 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -73.58 114.36 11.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.304 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 74.7 m95 72.51 155.62 0.16 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.05 0.844 . . . . 0.0 111.444 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -79.17 133.72 36.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.171 -175.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 87.3 mt -97.03 167.93 10.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.963 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -119.16 -151.29 0.48 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -60.86 -39.74 90.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.253 0.549 . . . . 0.0 110.079 174.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -102.59 179.17 4.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.548 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 116.4 -90.76 0.53 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.772 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -100.85 171.95 7.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.546 0.212 . . . . 0.0 110.61 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -80.19 -39.25 29.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.051 0.453 . . . . 0.0 110.169 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.6 m -73.51 113.89 12.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.431 0.634 . . . . 0.0 110.706 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -103.75 22.26 14.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.575 0.703 . . . . 0.0 110.489 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.0 p -99.18 148.63 6.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.328 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -59.94 118.64 6.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.842 0.353 . . . . 0.0 110.25 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -93.52 2.14 56.53 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.843 -175.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -85.93 -32.71 21.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.134 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -79.45 127.91 32.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.963 173.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.75 122.67 43.76 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.825 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -90.96 104.3 16.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.501 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.6 t -86.33 121.96 38.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.441 -173.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 63.3 m -91.12 105.35 17.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.218 0.533 . . . . 0.0 110.202 175.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.496 HD23 HG23 ' A' ' 230' ' ' VAL . 21.7 mt -122.02 162.85 20.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.623 -177.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 8.0 m -59.79 -52.05 67.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.169 0.509 . . . . 0.0 109.875 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.533 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.08 125.09 24.29 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.667 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.54 ' HB ' ' SD ' ' A' ' 267' ' ' MET . 6.7 p -124.92 27.07 6.86 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.138 0.971 . . . . 0.0 108.589 174.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 8.3 m -82.89 138.05 34.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.585 177.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 101.7 -14.31 57.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -175.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' MET . . . . . 0.54 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 64.5 mtt -82.82 153.73 25.04 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -153.67 142.61 21.17 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.549 ' HA ' HG13 ' A' ' 297' ' ' VAL . 34.6 ptt180 -50.87 114.03 1.06 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.624 0.578 . . . . 0.0 111.401 -173.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.16 -2.43 22.49 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.74 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.489 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.4 p30 -81.67 -179.25 7.3 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 117.258 0.529 . . . . 0.0 111.243 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -131.93 116.51 17.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.845 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.402 HD11 HG21 ' A' ' 308' ' ' ILE . 22.3 pt -114.14 138.9 42.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.148 0.499 . . . . 0.0 110.769 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 13.3 t -118.51 137.07 53.45 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.615 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -103.69 111.36 23.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.037 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.54 118.82 13.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.688 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.99 -13.74 26.56 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.682 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.02 147.94 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.605 ' HG3' ' SD ' ' A' ' 284' ' ' MET . 11.6 ptpt -161.24 156.55 24.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.912 0.387 . . . . 0.0 111.48 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -81.15 153.46 27.24 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.465 -171.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.46 HD11 ' HB2' ' A' ' 315' ' ' LEU . 83.7 mt -72.07 143.02 49.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.213 175.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 100.22 -39.8 2.63 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.45 ' O ' ' HB3' ' A' ' 287' ' ' ASN . 6.3 tp-100 -76.69 -20.11 56.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.238 0.542 . . . . 0.0 109.649 178.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.605 ' SD ' ' HG3' ' A' ' 279' ' ' LYS . 88.2 mtp -98.03 17.19 18.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.703 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.57 -56.06 4.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.805 0.336 . . . . 0.0 110.94 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -121.59 -29.95 4.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.589 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 283' ' ' GLN . 3.0 t-20 -75.42 108.95 8.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.036 0.446 . . . . 0.0 109.954 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.04 -31.26 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.241 0.543 . . . . 0.0 109.872 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 73.5 mt -91.56 53.93 2.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.509 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.408 ' HB3' ' HD3' ' A' ' 279' ' ' LYS . . . -65.52 124.87 23.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.05 -177.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -59.74 141.86 54.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.096 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -66.02 148.23 52.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.357 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -57.71 117.76 4.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.085 -172.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 37.9 p -105.01 113.75 27.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.565 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -110.94 148.44 32.5 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.992 0.425 . . . . 0.0 110.735 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 16.0 m -96.23 127.92 42.67 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.001 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.58 ' HA ' HG22 ' A' ' 308' ' ' ILE . 2.5 p -73.95 140.62 17.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.7 t -104.09 -31.85 2.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.055 0.455 . . . . 0.0 109.88 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.552 ' HD2' ' OE2' ' A' ' 307' ' ' GLU . 1.2 tmt_? -173.47 138.41 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.0 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 79.4 t -90.64 116.8 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 22.2 t -78.01 -58.8 3.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.042 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -116.71 -10.62 11.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.918 0.389 . . . . 0.0 111.864 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 78.53 12.22 84.48 Favored Glycine 0 CA--C 1.517 0.204 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -171.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.8 p -149.92 22.3 0.88 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.473 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 8.5 t-160 -174.08 115.59 0.21 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 113.561 -1.654 . . . . 0.0 107.999 -166.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.23 166.51 13.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.552 ' OE2' ' HD2' ' A' ' 299' ' ' ARG . 10.5 pt-20 -123.79 122.34 37.8 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 169.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.58 HG22 ' HA ' ' A' ' 297' ' ' VAL . 30.0 pt -121.2 170.74 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.51 -174.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' THR . . . . . 0.408 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 11.8 t -152.01 139.93 13.07 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.969 172.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.408 ' C ' ' HA ' ' A' ' 309' ' ' THR . 61.6 Cg_endo -71.14 179.4 25.39 Favored 'Cis proline' 0 C--N 1.345 0.368 0 C-N-CA 123.846 -1.314 . . . . 0.0 113.209 2.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.509 ' HG2' HG13 ' A' ' 313' ' ' VAL . 19.6 ttmt -84.95 126.37 68.17 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.669 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 19.9 Cg_exo -65.9 108.11 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.316 2.011 . . . . 0.0 111.84 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.542 HG11 ' HD3' ' A' ' 238' ' ' PRO . 1.3 m -130.87 129.54 63.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.151 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -93.06 141.5 28.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.433 -173.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.46 ' HB2' HD11 ' A' ' 281' ' ' LEU . 2.8 tm? -75.07 -26.16 59.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.483 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -94.83 26.0 3.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.644 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -83.49 136.56 34.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 27.8 m -83.81 -9.77 11.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 9.6 t -120.22 23.33 11.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.938 0.399 . . . . 0.0 111.626 -171.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.23 168.67 10.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.077 0.465 . . . . 0.0 111.026 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 51.9 m -112.49 165.25 13.43 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.358 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.462 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 85.5 Cg_exo -45.25 -49.45 10.16 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.517 2.812 . . . . 0.0 114.737 -175.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.2 -28.94 61.51 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.807 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -67.99 -41.13 82.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.663 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.462 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 28.8 ptt180 -69.12 -23.43 63.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.145 0.498 . . . . 0.0 110.17 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -80.68 -10.25 59.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.628 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -118.41 16.52 13.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.783 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.413 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -65.1 151.27 46.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.223 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ASN . . . . . 0.413 ' H ' HG23 ' A' ' 313' ' ' VAL . 83.3 m-20 -115.21 -39.64 3.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.796 -175.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 30.7 m -118.26 168.28 10.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.22 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -82.31 -49.63 9.83 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.874 0.368 . . . . 0.0 110.798 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 13.5 t -117.79 149.82 40.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.202 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 22.6 p -80.8 171.23 15.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.009 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 20.1 tp -73.75 111.27 8.74 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.629 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -82.0 170.68 15.29 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.137 0.494 . . . . 0.0 111.435 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.07 -8.92 57.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.506 -169.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -138.33 55.36 1.75 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.04 0.448 . . . . 0.0 111.578 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.52 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 14.5 mmt -102.33 147.57 26.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.162 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -96.14 143.56 27.16 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.68 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.463 ' O ' ' HB ' ' A' ' 228' ' ' ILE . 17.7 t -115.52 126.89 73.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -133.35 136.35 45.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.177 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 25.2 mt -90.1 124.38 42.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.919 0.39 . . . . 0.0 110.324 174.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 45.2 mt -75.16 113.16 12.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.212 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -75.96 88.59 2.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 175.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.247 0.94 0 CA-C-O 117.642 -1.17 . . . . 0.0 110.409 -178.102 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.63 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 35.4 m -108.09 104.46 13.9 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.769 0.319 . . . . 0.0 110.357 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.44 ' OG1' ' HB2' ' A' ' 344' ' ' ASN . 13.5 p -91.56 1.76 56.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.84 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -76.64 69.9 3.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.203 0.525 . . . . 0.0 110.716 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.531 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 23.2 p -66.95 -59.6 3.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.693 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 60.67 39.3 96.41 Favored Glycine 0 CA--C 1.516 0.144 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.313 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.553 HG21 ' O ' ' A' ' 263' ' ' ALA . 71.9 mt -102.95 143.86 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 7.0 p -111.3 151.43 28.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.079 0.466 . . . . 0.0 111.246 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.644 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.5 p -60.75 150.48 6.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.807 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 8.8 t -112.3 82.21 1.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.115 0.484 . . . . 0.0 109.747 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 92.66 149.61 24.99 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.858 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.56 121.75 17.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.837 0.351 . . . . 0.0 110.552 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -113.25 126.96 55.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.203 0.525 . . . . 0.0 110.238 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 20.3 p -127.9 104.0 7.57 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.171 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -81.51 161.51 23.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.789 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -142.02 133.74 13.38 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.601 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.57 ' HD3' HG11 ' A' ' 313' ' ' VAL . 84.7 Cg_endo -87.76 174.51 4.77 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.853 2.368 . . . . 0.0 111.435 176.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 46.3 t -108.7 96.79 4.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.913 0.387 . . . . 0.0 110.012 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.415 ' HB1' ' HB3' ' A' ' 323' ' ' GLU . . . -95.43 -164.39 1.16 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.64 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -79.21 -52.39 8.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.707 0.289 . . . . 0.0 110.753 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLN . . . . . 0.573 ' HB2' ' OE1' ' A' ' 323' ' ' GLU . 26.8 mt-30 -105.89 139.01 41.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.821 0.343 . . . . 0.0 110.62 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.8 35.51 1.6 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.809 -175.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 59.9 -108.67 0.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.465 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -88.63 -47.31 8.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.921 0.391 . . . . 0.0 110.983 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -161.67 155.7 22.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.601 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -146.33 -69.47 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.111 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -83.52 65.5 8.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.469 0.652 . . . . 0.0 111.403 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -74.25 -57.19 4.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.991 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.468 HG23 HG13 ' A' ' 252' ' ' VAL . 17.4 m -86.11 162.79 2.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.083 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -80.15 96.3 6.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.129 0.49 . . . . 0.0 110.966 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.468 HG13 HG23 ' A' ' 250' ' ' VAL . 18.1 m -116.4 154.42 17.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.5 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -86.66 129.09 35.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.71 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -67.73 -33.42 74.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.657 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 44.0 mtm-85 -95.2 -49.22 5.59 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -174.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -79.19 147.66 32.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.991 0.424 . . . . 0.0 111.019 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -119.86 126.98 52.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.524 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.5 m -93.96 99.19 11.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.01 0.433 . . . . 0.0 110.62 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.456 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.7 t -83.66 120.16 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.168 -174.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 19.3 m -91.55 105.75 17.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.835 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.428 ' HB2' HG22 ' A' ' 264' ' ' THR . 19.9 mt -121.63 169.41 10.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.257 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 6.6 m -63.05 -55.19 27.68 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.553 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -136.62 131.15 33.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.696 178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.438 ' HB ' ' SD ' ' A' ' 267' ' ' MET . 3.2 p -129.51 27.49 5.27 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 18.4 m -82.69 141.88 32.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.096 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.03 -3.95 60.62 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -174.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' MET . . . . . 0.438 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 89.5 mtp -86.9 152.85 22.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -154.84 140.85 18.34 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.22 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.655 ' HA ' HG13 ' A' ' 297' ' ' VAL . 35.9 ptt180 -52.45 117.82 3.14 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.374 0.606 . . . . 0.0 111.089 -175.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.47 1.12 21.8 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.378 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -84.06 179.68 7.45 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.132 0.466 . . . . 0.0 110.507 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.485 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 5.1 tppp? -137.67 115.94 11.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.827 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 308' ' ' ILE . 35.7 pt -112.99 140.0 35.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.206 0.527 . . . . 0.0 110.389 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 17.9 m -131.39 138.73 49.24 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.663 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -100.29 113.5 26.25 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.096 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.94 113.56 2.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.499 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.77 -34.34 5.16 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.932 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.7 t -81.14 127.85 39.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -149.12 161.75 41.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.708 0.289 . . . . 0.0 110.896 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 91.8 m-85 -83.67 158.42 21.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.053 -175.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 315' ' ' LEU . 95.5 mt -81.65 44.35 0.81 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.305 0.574 . . . . 0.0 111.26 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -144.08 25.8 2.05 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.471 HE21 ' HB1' ' A' ' 290' ' ' ALA . 12.3 mt-30 -130.42 170.86 13.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.272 -0.464 . . . . 0.0 109.815 -175.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 19.1 mmt 62.54 26.54 15.77 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.499 0.499 . . . . 0.0 111.11 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -78.41 -32.62 48.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.205 0.526 . . . . 0.0 109.955 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -155.23 -41.39 0.08 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.441 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -72.6 125.49 27.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.475 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 22.4 t -85.94 -22.09 7.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.186 0.517 . . . . 0.0 109.924 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 86.0 mt -81.42 59.62 4.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.718 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.471 ' HB1' HE21 ' A' ' 283' ' ' GLN . . . -80.14 133.64 36.08 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.136 -176.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -69.56 167.51 16.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.397 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -95.3 166.85 11.69 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 172.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -59.78 106.76 0.52 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.957 0.408 . . . . 0.0 111.334 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.485 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 21.3 p -88.59 115.6 26.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.501 -177.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -121.31 144.31 48.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.367 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 68.4 m -101.32 132.39 46.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.749 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.655 HG13 ' HA ' ' A' ' 269' ' ' ARG . 9.3 p -67.49 140.35 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.126 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.63 -42.65 7.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.111 175.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.417 ' HB3' ' CD ' ' A' ' 307' ' ' GLU . 23.5 tpt180 -157.33 128.06 6.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.85 -178.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 97.8 t -86.3 97.8 6.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 172.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 25.4 t -65.9 -58.74 5.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.691 -173.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -126.66 -8.31 6.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.141 0.496 . . . . 0.0 111.472 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.15 13.81 78.27 Favored Glycine 0 C--N 1.321 -0.252 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.677 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 21.6 p -138.95 10.31 2.6 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 170.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.478 ' CE1' HG22 ' A' ' 258' ' ' THR . 1.5 t60 -162.74 116.6 1.71 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.453 -1.249 . . . . 0.0 107.894 -169.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.99 160.29 18.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.674 -172.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.0 pt-20 -121.28 122.58 40.22 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 168.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.52 HG21 HD11 ' A' ' 273' ' ' ILE . 23.4 pt -123.49 169.39 14.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.228 0.537 . . . . 0.0 112.309 -174.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.0 t -145.38 138.83 14.38 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.788 172.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.33 -179.75 24.62 Favored 'Cis proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.759 -1.35 . . . . 0.0 113.313 -1.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.449 ' HG3' ' HB2' ' A' ' 257' ' ' ALA . 3.3 ttmp? -87.42 125.53 65.29 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.558 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 14.4 Cg_exo -68.61 108.85 1.94 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.369 2.046 . . . . 0.0 111.861 175.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 328' ' ' ALA . 1.5 m -136.3 120.86 25.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -82.49 134.43 35.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.838 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.9 tm? -75.69 -25.05 56.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.618 176.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -85.9 6.02 30.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.14 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -77.2 126.8 31.53 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.2 m -83.94 2.35 3.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 7.7 m -103.5 23.22 12.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.703 0.287 . . . . 0.0 111.77 -172.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.472 HD13 ' HG2' ' A' ' 325' ' ' ARG . 1.0 OUTLIER -126.18 157.2 38.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.44 0.638 . . . . 0.0 112.25 -179.29 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.497 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 2.8 m -92.25 166.81 16.35 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.554 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 2.3 Cg_endo -42.18 -58.08 1.34 Allowed 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.759 2.973 . . . . 0.0 113.864 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.573 ' OE1' ' HB2' ' A' ' 242' ' ' GLN . 15.8 mp0 -60.4 -36.88 79.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.137 0.494 . . . . 0.0 111.084 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 9.2 mm100 -63.4 -30.5 71.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.664 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.472 ' HG2' HD13 ' A' ' 320' ' ' LEU . 34.2 mtp85 -61.28 -39.31 89.93 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.226 176.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.04 -26.15 68.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.066 0.46 . . . . 0.0 110.922 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -87.11 -12.88 45.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.232 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.605 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -72.3 151.63 42.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.515 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -137.18 -35.72 0.68 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -173.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.3 m -101.93 167.62 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.852 0.358 . . . . 0.0 111.092 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -83.63 -39.3 20.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.919 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.1 t -126.69 139.54 53.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.673 -177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.461 ' N ' ' HB2' ' A' ' 314' ' ' ALA . 46.3 m -70.42 171.92 9.24 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.411 ' HG ' HG21 ' A' ' 230' ' ' VAL . 20.3 tp -71.24 103.91 2.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.644 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -79.62 172.12 14.22 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.878 -175.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.51 -11.61 60.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.129 -171.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -132.49 71.27 1.47 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.016 0.436 . . . . 0.0 111.223 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.477 ' H ' HG12 ' A' ' 230' ' ' VAL . 23.5 mmt -121.84 133.84 54.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.666 175.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -85.38 136.54 33.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.906 0.384 . . . . 0.0 111.301 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 17.4 t -101.4 112.82 35.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.703 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' ASN . . . . . 0.531 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 5.7 t-20 -129.91 138.8 51.1 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.815 0.34 . . . . 0.0 111.382 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 62.3 mt -92.1 125.92 44.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 172.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 40.4 mt -75.75 124.7 27.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.97 0.414 . . . . 0.0 111.012 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ASN . . . . . 0.44 ' HB2' ' OG1' ' A' ' 224' ' ' THR . 46.2 t-20 -86.86 81.56 8.11 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.505 -0.759 . . . . 0.0 110.3 -177.7 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.815 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.6 m -75.12 144.77 42.68 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 12.2 m 59.16 69.13 0.74 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.307 0.575 . . . . 0.0 110.213 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.21 106.41 2.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.57 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 3.8 p -129.84 97.92 4.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.27 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -116.52 37.53 3.35 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.505 HG21 ' O ' ' A' ' 263' ' ' ALA . 37.9 mt -82.28 152.44 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.277 -0.461 . . . . 0.0 109.883 -173.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 22.0 p -114.64 162.59 16.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.454 0.645 . . . . 0.0 111.808 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.641 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.8 p -62.7 151.75 7.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.897 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 16.5 t -116.82 78.9 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.195 0.521 . . . . 0.0 109.615 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 100.82 145.79 17.89 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.904 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.83 111.74 5.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.844 0.354 . . . . 0.0 110.304 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -109.15 127.8 54.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.264 0.554 . . . . 0.0 110.834 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 16.7 p -115.95 143.12 45.88 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.639 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -115.99 154.45 29.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.791 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -143.45 135.56 13.2 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.501 ' HD3' HG11 ' A' ' 313' ' ' VAL . 10.9 Cg_endo -91.24 121.0 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.892 2.395 . . . . 0.0 110.66 169.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.468 HG12 ' OD1' ' A' ' 254' ' ' ASN . 8.9 p -62.43 132.21 28.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 121.359 0.6 . . . . 0.0 111.171 -176.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -100.32 -169.34 1.71 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.992 -177.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 98.9 m95 72.87 127.09 0.04 OUTLIER 'General case' 0 C--O 1.234 0.274 0 O-C-N 124.013 0.82 . . . . 0.0 111.358 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -68.76 154.89 41.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.491 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 246' ' ' ASP . 1.4 pp -113.14 34.39 4.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.077 0.465 . . . . 0.0 111.488 -173.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -73.66 -54.06 9.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.474 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -87.78 -52.01 5.54 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 243' ' ' LEU . 3.6 p-10 -147.8 159.28 43.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.15 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 179.14 -166.17 35.52 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.998 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -92.35 78.83 5.04 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.042 0.448 . . . . 0.0 110.669 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -81.21 59.41 3.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.455 0.645 . . . . 0.0 110.108 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.4 m -136.65 -169.21 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.959 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -73.84 72.47 1.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.133 0.492 . . . . 0.0 110.156 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.418 ' HB ' ' OD1' ' A' ' 254' ' ' ASN . 15.8 m -77.92 129.46 37.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.698 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -93.76 53.02 1.76 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.343 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.468 ' OD1' HG12 ' A' ' 239' ' ' VAL . 4.0 m-20 -68.28 -49.62 59.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.165 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.443 ' NE ' ' HA ' ' A' ' 255' ' ' ARG . 5.7 tpm_? -79.44 -33.34 42.56 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.48 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 308' ' ' ILE . 51.7 m-85 -99.91 176.95 5.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.171 -172.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -153.57 125.23 7.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.677 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -90.18 104.13 16.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.246 0.546 . . . . 0.0 111.147 178.004 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.8 t -86.61 121.09 37.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.998 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 30.5 m -92.84 109.54 20.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.992 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.413 HD22 HG21 ' A' ' 340' ' ' VAL . 17.4 mt -124.54 176.03 6.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.918 -176.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 35.0 t -64.56 -59.66 4.03 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.505 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.58 138.7 39.83 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 7.6 p -126.97 28.09 5.86 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.004 0.906 . . . . 0.0 108.914 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 1.3 m -78.81 151.28 32.02 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.981 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 93.11 -22.44 34.57 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' MET . . . . . 0.462 ' HG2' HD11 ' A' ' 342' ' ' ILE . 53.8 mtt -79.6 144.67 33.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.574 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 0.3 OUTLIER -137.31 152.48 49.8 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -50.82 126.03 14.87 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.568 0.542 . . . . 0.0 111.474 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.95 19.23 37.35 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.567 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.574 ' HB2' ' O ' ' A' ' 268' ' ' LYS . 0.8 OUTLIER -98.81 177.39 5.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.973 0.416 . . . . 0.0 110.673 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -122.02 116.34 24.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.908 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.504 HD11 HG21 ' A' ' 308' ' ' ILE . 40.3 pt -113.19 140.28 34.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.215 177.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -118.24 133.47 55.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.215 -176.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -99.63 110.99 23.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.894 0.378 . . . . 0.0 110.028 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.09 117.81 15.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.531 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.79 -24.41 15.09 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 42.4 t -99.99 133.85 41.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -151.1 160.63 43.77 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 120.993 0.425 . . . . 0.0 111.066 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -78.19 154.33 31.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.369 -169.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.463 HD11 ' HB2' ' A' ' 315' ' ' LEU . 84.4 mt -71.32 141.01 50.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.388 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 94.69 -29.34 9.26 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.54 ' O ' ' HB2' ' A' ' 287' ' ' ASN . 28.6 mm-40 -84.4 8.13 17.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.995 0.426 . . . . 0.0 110.746 -177.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 90.5 mtp -122.77 8.92 9.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.955 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -83.82 -32.77 25.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.144 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -160.26 31.62 0.17 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.419 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ASN . . . . . 0.54 ' HB2' ' O ' ' A' ' 283' ' ' GLN . 17.0 m120 -128.35 103.16 7.0 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.455 -175.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 50.6 t -70.73 -31.36 45.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.341 0.591 . . . . 0.0 109.658 176.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 93.8 mt -89.49 55.58 3.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.032 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.97 112.74 7.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.677 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLN . . . . . 0.423 ' CD ' ' H ' ' A' ' 291' ' ' GLN . 1.0 OUTLIER -68.57 144.82 54.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.617 -178.086 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -69.63 154.32 42.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.52 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.484 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -60.33 102.05 0.16 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.26 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 1.2 p -103.44 117.84 35.38 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.245 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.484 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 85.1 m-85 -124.36 152.59 42.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.13 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.7 m -92.2 125.5 36.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.198 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 271' ' ' ASP . 10.9 p -81.48 130.17 36.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.301 0.572 . . . . 0.0 110.521 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 58.6 t -90.53 -38.7 11.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.548 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -160.41 141.47 12.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.202 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 90.4 t -94.38 107.56 19.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 27.3 t -77.41 -59.17 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.873 -172.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -120.21 -7.58 9.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.384 0.611 . . . . 0.0 111.116 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 79.27 14.18 81.93 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.316 -174.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 25.6 p -137.18 7.55 2.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.155 0.979 . . . . 0.0 108.525 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.568 ' NE2' ' HB ' ' A' ' 258' ' ' THR . 3.5 t-160 -160.88 118.96 2.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.392 -170.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -118.73 155.49 20.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -115.04 115.01 26.14 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.504 HG21 HD11 ' A' ' 273' ' ' ILE . 25.4 pt -114.2 176.72 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.711 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 5.2 t -154.17 141.53 13.59 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.674 174.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.09 -179.9 28.35 Favored 'Cis proline' 0 C--N 1.346 0.4 0 C-N-CA 123.818 -1.326 . . . . 0.0 112.568 -4.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -81.18 126.11 77.75 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.857 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.49 109.13 2.78 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.43 2.087 . . . . 0.0 111.887 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.755 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.4 OUTLIER -126.56 134.16 66.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.694 178.425 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -91.85 135.29 34.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.72 -173.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.463 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.3 tm? -70.55 -30.24 66.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.834 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -86.2 11.13 12.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.186 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.52 121.91 25.19 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 31.1 m -83.54 1.81 3.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -174.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.2 t -102.56 -6.5 22.76 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.424 -174.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.4 pp -102.82 153.77 19.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.49 0.662 . . . . 0.0 111.684 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 14.8 m -87.51 160.95 46.78 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.004 -177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -39.14 -50.49 2.72 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.923 3.082 . . . . 0.0 114.612 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -58.09 -41.17 82.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.255 0.55 . . . . 0.0 111.333 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 47.9 mt-30 -70.48 -26.31 63.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.711 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.421 ' HG2' ' CD1' ' A' ' 320' ' ' LEU . 76.6 mtt180 -61.04 -35.43 76.89 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 121.018 0.437 . . . . 0.0 110.445 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.89 -28.88 67.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.431 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' TYR . . . . . 0.455 ' CD2' ' HA ' ' A' ' 324' ' ' GLN . 12.0 m-85 -81.71 -11.05 59.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.824 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.755 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -65.59 139.01 58.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.991 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -127.62 -17.07 4.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.882 -175.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 31.5 m -122.11 158.23 25.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.929 0.395 . . . . 0.0 110.113 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -91.16 -7.01 52.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.307 -174.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.7 t -147.72 140.98 25.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.096 0.474 . . . . 0.0 110.824 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 26.9 p -78.28 168.05 20.42 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.316 175.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 19.3 tp -74.11 105.42 5.32 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.641 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -79.82 -178.8 6.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.055 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.06 -7.1 57.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.973 -172.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -133.74 57.83 1.79 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.849 0.357 . . . . 0.0 111.736 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.407 ' H ' HG12 ' A' ' 230' ' ' VAL . 25.2 mmt -111.78 137.46 49.67 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -92.25 145.46 24.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.778 0.323 . . . . 0.0 111.047 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.413 HG21 HD22 ' A' ' 261' ' ' LEU . 19.3 t -118.69 118.2 57.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.866 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -134.73 135.75 42.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.99 0.424 . . . . 0.0 111.557 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.462 HD11 ' HG2' ' A' ' 267' ' ' MET . 21.1 mt -87.62 127.46 40.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.813 176.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 65.3 mt -75.13 111.19 10.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.05 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -81.52 146.1 30.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.981 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 34.0 t . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.348 -0.834 . . . . 0.0 110.789 -177.376 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.617 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 34.8 t -79.64 -37.33 36.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.922 0.391 . . . . 0.0 110.144 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 20.8 p -82.31 -83.45 0.13 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.865 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 47.73 69.08 0.56 Allowed 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.711 0.632 . . . . 0.0 110.953 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.561 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 34.2 p -75.55 -64.95 0.96 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.441 -174.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 55.65 48.94 68.05 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.834 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.508 HG21 ' O ' ' A' ' 263' ' ' ALA . 57.2 mt -103.07 142.54 16.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 37.1 p -97.82 150.12 21.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.408 0.623 . . . . 0.0 112.261 -173.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.564 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.2 p -61.53 150.93 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.599 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 37.0 m -126.05 84.94 2.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.152 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 113.0 130.56 5.32 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.477 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -79.37 123.43 27.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -142.22 130.33 22.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.223 0.535 . . . . 0.0 111.474 -172.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.9 t -107.98 110.46 22.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.281 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.532 ' O ' HG13 ' A' ' 313' ' ' VAL . 62.4 m-85 -81.05 120.13 24.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.507 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -115.27 127.42 26.83 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.696 -175.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -83.69 -178.02 3.42 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.895 2.396 . . . . 0.0 111.265 173.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.427 HG12 ' HB3' ' A' ' 254' ' ' ASN . 7.7 p -112.94 110.56 32.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.263 0.554 . . . . 0.0 110.574 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.18 133.06 49.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.539 174.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -73.78 102.59 4.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.191 0.519 . . . . 0.0 110.281 -175.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -119.5 103.09 9.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.826 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 29.7 tp -84.51 68.95 10.49 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.392 0.615 . . . . 0.0 110.118 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -134.73 -63.36 0.71 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.544 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -87.57 -55.85 3.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.145 0.497 . . . . 0.0 110.404 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -123.95 150.26 44.98 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.94 -6.12 87.13 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.569 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ASN . . . . . 0.528 ' HA ' ' OD1' ' A' ' 251' ' ' ASN . 13.1 m120 59.18 39.29 23.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.279 0.562 . . . . 0.0 111.203 176.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -68.52 -63.1 1.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.558 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 5.0 m -132.23 106.23 10.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.309 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ASN . . . . . 0.528 ' OD1' ' HA ' ' A' ' 248' ' ' ASN . 11.9 m120 -137.56 52.81 1.88 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.283 -175.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 251' ' ' ASN . 96.1 t 74.13 143.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.351 0 O-C-N 123.683 0.614 . . . . 0.0 110.535 -178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -59.05 104.26 0.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.363 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.427 ' HB3' HG12 ' A' ' 239' ' ' VAL . 9.2 p30 -93.85 -16.06 24.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.291 -174.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 310' ' ' PRO . 23.9 mmt180 -91.69 -6.66 51.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.156 0.503 . . . . 0.0 110.402 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.442 ' CD2' ' HB ' ' A' ' 309' ' ' THR . 96.7 m-85 -120.14 160.98 21.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.017 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -136.01 129.31 31.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.479 0.18 . . . . 0.0 110.785 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.5 m -97.88 107.64 20.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.05 0.452 . . . . 0.0 109.984 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.41 120.27 36.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.205 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 60.4 m -91.01 115.33 27.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.823 173.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 17.2 mt -132.24 168.86 17.31 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 5.3 p -60.52 -55.96 27.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.196 0.522 . . . . 0.0 110.136 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.508 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -136.75 136.81 39.26 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.146 177.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 15.8 p -132.11 32.75 3.97 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 6.9 m -82.47 149.25 27.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.308 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 93.51 13.37 55.64 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 62.7 mtt -114.02 148.0 37.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.367 -0.417 . . . . 0.0 110.141 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -134.41 156.33 48.73 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -54.15 121.96 9.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.074 0.464 . . . . 0.0 110.762 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 106.75 7.97 33.01 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.862 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.503 ' H ' HG12 ' A' ' 297' ' ' VAL . 80.1 m-20 -90.79 148.54 22.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.419 0.609 . . . . 0.0 110.16 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 4.6 tppp? -96.03 117.67 31.13 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.725 -177.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.435 HD11 HG21 ' A' ' 308' ' ' ILE . 38.5 pt -112.58 139.96 34.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 176.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 45.5 m -120.5 136.48 54.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.516 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -100.7 111.46 23.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.871 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -74.15 114.21 12.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.709 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.55 -34.39 5.17 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 86.0 t -90.95 111.71 24.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.418 ' HD2' ' SD ' ' A' ' 284' ' ' MET . 0.5 OUTLIER -128.85 170.07 13.82 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.406 -177.109 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -75.95 171.73 13.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.644 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 89.0 mt -83.33 81.51 8.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.105 177.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 179.89 165.54 33.97 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.405 ' OE1' ' HG2' ' A' ' 291' ' ' GLN . 51.1 mt-30 61.97 -153.95 0.35 Allowed 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.792 0.348 . . . . 0.0 110.354 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.418 ' SD ' ' HD2' ' A' ' 279' ' ' LYS . 89.8 mtp 73.67 6.99 5.03 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.203 0.601 . . . . 0.0 111.545 175.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -82.64 -54.19 5.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.11 0.481 . . . . 0.0 110.143 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -133.73 -35.2 0.99 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.851 176.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -70.05 133.33 47.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.788 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.62 -21.64 6.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.491 0.662 . . . . 0.0 110.195 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 94.9 mt -83.85 56.84 3.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.686 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -77.86 111.28 13.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.073 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' GLN . . . . . 0.405 ' HG2' ' OE1' ' A' ' 283' ' ' GLN . 10.2 pt20 -50.58 124.61 11.14 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.777 0.673 . . . . 0.0 112.268 -173.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -76.21 166.39 23.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.844 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -59.18 100.33 0.07 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.882 -174.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.0 p -98.99 99.63 10.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.673 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.474 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 61.3 m-85 -118.23 142.8 47.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.09 0.472 . . . . 0.0 111.139 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.2 t -89.97 126.27 35.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.494 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 271' ' ' ASP . 11.5 p -69.12 135.13 28.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.122 0.487 . . . . 0.0 110.136 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.24 -32.93 4.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.684 -176.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.592 ' HD2' ' OE2' ' A' ' 307' ' ' GLU . 0.4 OUTLIER -167.85 137.07 2.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.255 -176.129 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 75.3 t -85.02 111.38 20.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 19.2 t -77.76 -53.9 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.646 -173.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -125.89 -11.63 6.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.81 0.338 . . . . 0.0 111.812 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 77.6 12.49 84.45 Favored Glycine 0 CA--C 1.516 0.145 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -170.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.0 p -149.9 22.17 0.88 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 174.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -174.04 112.63 0.18 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 113.378 -1.737 . . . . 0.0 107.991 -163.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.0 OUTLIER -119.43 164.05 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -174.685 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.592 ' OE2' ' HD2' ' A' ' 299' ' ' ARG . 11.4 pt-20 -125.01 127.01 46.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.218 0.532 . . . . 0.0 110.127 170.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.435 HG21 HD11 ' A' ' 273' ' ' ILE . 24.0 pt -120.42 175.79 4.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.884 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' THR . . . . . 0.442 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 14.2 t -154.61 143.53 14.84 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.853 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 255' ' ' ARG . 74.1 Cg_endo -75.98 179.4 31.15 Favored 'Cis proline' 0 C--N 1.346 0.406 0 C-N-CA 123.709 -1.371 . . . . 0.0 112.512 -4.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' A' ' 257' ' ' ALA . 22.4 ttmm -76.94 121.68 85.16 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.504 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.09 108.54 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.217 1.944 . . . . 0.0 112.327 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 236' ' ' PHE . 0.1 OUTLIER -109.35 137.67 40.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.121 175.674 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -81.98 123.25 28.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.095 0.474 . . . . 0.0 110.513 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.5 -29.5 70.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.894 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.45 19.65 4.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.495 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -83.47 119.91 25.26 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.9 m -84.43 0.4 5.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -174.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 37.2 t -95.47 -28.16 15.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.566 0.222 . . . . 0.0 111.404 -174.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.425 ' CD1' ' HG2' ' A' ' 325' ' ' ARG . 0.9 OUTLIER -80.64 160.61 25.0 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.413 0.625 . . . . 0.0 112.41 -175.8 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.533 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 34.4 t -87.04 157.42 54.15 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.146 -178.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.533 ' HD2' ' OG ' ' A' ' 321' ' ' SER . 2.8 Cg_exo -35.61 -58.01 0.47 Allowed 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 124.764 3.643 . . . . 0.0 115.513 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.64 -25.08 64.65 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.376 -174.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 321' ' ' SER . 8.5 mm100 -61.15 -34.48 75.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.038 0.447 . . . . 0.0 110.116 174.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.425 ' HG2' ' CD1' ' A' ' 320' ' ' LEU . 31.1 mtm180 -64.77 -32.67 74.46 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.724 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -70.62 -24.94 62.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.087 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.77 -2.3 57.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.685 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.455 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -67.81 156.27 37.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.066 0.46 . . . . 0.0 111.022 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -138.42 -20.84 1.05 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.292 -173.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 23.4 m -125.28 160.17 31.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.946 0.403 . . . . 0.0 110.399 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -89.16 -17.14 29.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.527 -175.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 8.8 t -143.42 142.89 31.39 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 22.6 p -75.72 170.33 16.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.736 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.463 ' HG ' HG21 ' A' ' 230' ' ' VAL . 17.0 tp -72.34 103.3 3.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.564 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -81.99 -170.88 3.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.19 -176.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -80.32 -8.5 59.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.013 -175.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -137.42 66.97 1.44 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.0 0.429 . . . . 0.0 111.567 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.559 ' H ' HG12 ' A' ' 230' ' ' VAL . 23.1 mmt -119.86 132.48 55.58 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -91.25 137.16 32.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.839 0.352 . . . . 0.0 111.007 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 32.7 t -114.25 107.2 22.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.239 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' ASN . . . . . 0.561 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 64.5 t30 -126.35 145.62 50.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.922 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 22.8 mt -89.56 132.37 34.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 177.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 80.8 mt -76.14 118.97 19.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.542 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -125.87 149.41 48.7 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 28.9 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.824 -179.671 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.53 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 42.2 p 49.55 44.77 24.35 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.178 0.591 . . . . 0.0 111.571 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.9 t -159.82 157.72 29.75 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.444 -178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 52.4 64.79 1.72 Allowed 'General case' 0 C--O 1.234 0.287 0 O-C-N 123.575 0.547 . . . . 0.0 111.482 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 24.2 p -72.37 -72.05 0.26 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.172 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.56 39.77 95.46 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.006 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.6 HG21 ' O ' ' A' ' 263' ' ' ALA . 55.7 mt -103.05 145.28 12.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 36.0 p -99.22 160.79 14.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.417 0.627 . . . . 0.0 112.248 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.678 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.7 p -68.88 152.04 9.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.495 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.1 m -122.08 86.77 2.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.949 0.404 . . . . 0.0 110.7 173.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 102.56 137.2 9.47 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.337 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.54 130.27 42.69 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -132.9 127.14 33.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.165 0.507 . . . . 0.0 111.31 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.8 t -117.26 103.12 9.85 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -80.8 129.1 34.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.319 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -117.19 125.75 27.96 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.052 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.545 ' HA ' ' OD1' ' A' ' 254' ' ' ASN . 95.2 Cg_endo -80.32 172.91 13.09 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.111 2.541 . . . . 0.0 111.639 176.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.11 127.14 40.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.092 0.472 . . . . 0.0 110.477 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -73.97 107.21 6.05 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 30.0 m-90 -63.32 -18.85 64.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.067 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -99.97 103.57 15.13 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.0 mp -107.11 -159.4 0.69 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.623 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -78.21 -155.66 0.08 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -63.67 -32.1 73.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.775 0.322 . . . . 0.0 111.041 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -106.28 107.06 17.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.421 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.67 -173.82 45.59 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.56 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -88.45 129.4 35.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.106 0.479 . . . . 0.0 110.179 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -103.11 -20.83 14.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.25 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 36.0 m -78.62 155.84 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.726 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -89.06 85.26 6.65 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 254' ' ' ASN . 8.1 p -83.67 131.81 32.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.216 -174.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -80.83 40.56 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.551 0.691 . . . . 0.0 110.501 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.545 ' OD1' ' HA ' ' A' ' 238' ' ' PRO . 11.9 t-20 -77.55 -12.35 59.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.208 -175.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -70.67 -12.15 61.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.766 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -114.47 148.54 37.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.919 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -109.26 124.03 50.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.951 176.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.7 m -97.47 107.14 19.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.225 0.536 . . . . 0.0 110.275 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -89.0 124.86 42.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.603 -170.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 55.6 m -95.18 114.59 26.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.799 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.556 HD13 HG21 ' A' ' 340' ' ' VAL . 17.4 mt -129.87 170.52 13.8 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -176.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 16.8 m -57.31 -56.93 15.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.389 0.614 . . . . 0.0 109.599 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.6 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -138.52 141.02 39.34 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.776 175.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 11.2 p -130.8 26.49 4.98 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.7 m -80.49 147.5 30.86 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.526 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 95.24 -28.11 12.98 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -177.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 62.1 mtt -71.42 153.47 42.25 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -135.53 151.02 49.92 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.807 0.337 . . . . 0.0 110.58 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -56.39 131.8 49.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.204 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.77 19.14 32.53 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.352 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.488 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.8 t70 -103.28 -167.51 1.39 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 117.555 0.677 . . . . 0.0 110.159 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.441 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 3.9 tppp? -129.76 115.7 17.67 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.593 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.442 HD11 HG21 ' A' ' 308' ' ' ILE . 20.0 pt -115.06 142.76 26.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.134 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.516 ' HB3' HG22 ' A' ' 294' ' ' THR . 73.5 p -128.85 143.69 50.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.149 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -105.2 114.02 27.95 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.044 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.82 115.98 3.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.828 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.94 -31.15 6.95 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.105 -177.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 292' ' ' ASP . 48.5 t -84.54 136.08 23.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.525 ' NZ ' ' HB3' ' A' ' 279' ' ' LYS . 0.1 OUTLIER -160.76 156.33 25.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.112 0.482 . . . . 0.0 111.413 -177.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 329' ' ' ASN . 63.0 m-85 -76.58 148.63 36.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.372 -170.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.495 HD11 ' HB2' ' A' ' 315' ' ' LEU . 59.5 mt -63.34 -34.7 78.28 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.461 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -64.65 -19.1 64.62 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.788 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -112.22 4.48 17.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.661 0.267 . . . . 0.0 110.861 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 90.5 mmm -121.47 22.88 10.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.96 0.41 . . . . 0.0 110.724 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -81.35 -52.05 7.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.176 0.512 . . . . 0.0 110.211 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -130.67 -7.34 4.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.946 175.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -102.7 149.15 24.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.042 178.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.41 -15.56 10.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.726 0.774 . . . . 0.0 109.505 178.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 92.5 mt -88.47 50.71 2.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.973 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.446 ' HB3' ' HD3' ' A' ' 279' ' ' LYS . . . -84.58 124.14 31.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.364 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -60.41 146.14 45.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.083 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 60.3 m-20 -60.05 139.8 57.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.212 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -57.07 116.07 3.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.636 -174.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 274' ' ' SER . 28.1 p -97.81 129.17 44.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.866 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -130.63 143.14 50.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.783 0.325 . . . . 0.0 110.699 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 62.5 m -78.72 126.96 31.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.101 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.515 ' HA ' HG22 ' A' ' 308' ' ' ILE . 13.5 p -84.06 126.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.262 0.553 . . . . 0.0 110.018 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 44.7 t -84.01 -40.85 16.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.379 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -163.29 142.26 8.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.405 ' CG1' ' HA2' ' A' ' 303' ' ' GLY . 89.6 t -82.59 106.95 13.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 26.7 t -72.82 -58.7 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.945 -170.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -119.59 0.48 11.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.94 0.4 . . . . 0.0 111.331 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' GLY . . . . . 0.405 ' HA2' ' CG1' ' A' ' 300' ' ' VAL . . . 70.81 12.73 71.25 Favored Glycine 0 C--O 1.23 -0.143 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -173.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 19.4 p -149.31 19.72 0.95 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 174.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.551 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.9 t-160 -170.89 115.46 0.44 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 113.737 -1.574 . . . . 0.0 107.976 -164.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.73 165.04 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.494 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -123.86 122.1 37.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.051 0.453 . . . . 0.0 110.264 172.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.515 HG22 ' HA ' ' A' ' 297' ' ' VAL . 28.2 pt -124.03 168.55 16.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.102 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 310' ' ' PRO . 15.1 t -154.57 145.18 16.05 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.4 ' HA ' ' OG1' ' A' ' 309' ' ' THR . 10.2 Cg_exo -72.29 178.13 32.23 Favored 'Cis proline' 0 C--N 1.344 0.337 0 C-N-CA 124.013 -1.245 . . . . 0.0 112.556 0.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -87.39 123.37 69.83 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.743 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.448 ' HA ' ' OD1' ' A' ' 329' ' ' ASN . 48.7 Cg_endo -71.41 108.94 2.49 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.37 2.046 . . . . 0.0 112.091 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.56 132.0 57.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.713 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 317' ' ' ASP . . . -83.09 121.92 27.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.081 0.467 . . . . 0.0 110.448 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.495 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.0 tm? -62.99 -30.2 71.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.725 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -86.39 5.12 36.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.393 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 10.6 t70 -89.91 111.68 22.8 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 17.9 m -83.61 2.4 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 9.4 t -92.95 29.09 1.91 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.027 0.441 . . . . 0.0 110.832 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 2.5 pp -129.06 171.32 12.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.879 0.371 . . . . 0.0 111.467 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 41.7 t -85.96 149.14 49.85 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.105 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.655 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 1.4 Cg_endo -42.27 -47.29 7.19 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.84 3.027 . . . . 0.0 113.885 -177.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.443 ' O ' ' HD1' ' A' ' 327' ' ' TYR . 58.6 mm-40 -63.16 -23.38 67.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.98 0.419 . . . . 0.0 111.456 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -81.27 -24.34 37.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.784 -174.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 5.3 ptp180 -78.28 -22.31 48.43 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.096 0.474 . . . . 0.0 110.04 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -69.15 -36.03 76.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.183 174.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' TYR . . . . . 0.443 ' HD1' ' O ' ' A' ' 323' ' ' GLU . 77.8 m-85 -90.05 3.05 54.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.839 178.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -70.26 123.94 22.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.03 0.443 . . . . 0.0 110.022 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 312' ' ' PRO . 26.7 p-10 -109.28 -17.92 13.71 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.506 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.3 m -118.85 159.4 19.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.188 0.518 . . . . 0.0 110.798 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -96.84 -12.04 24.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.164 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.4 t -141.02 148.63 40.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.435 -176.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 7.6 p -85.04 166.27 16.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.694 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.611 HD12 ' SD ' ' A' ' 338' ' ' MET . 21.2 tp -67.74 104.4 1.64 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.678 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -84.04 156.82 22.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.772 -175.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.59 58.08 2.15 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.252 0.549 . . . . 0.0 111.942 -173.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -176.04 27.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.494 172.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.611 ' SD ' HD12 ' A' ' 334' ' ' LEU . 54.4 mtt -100.06 131.83 45.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -176.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -87.64 140.22 29.74 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.924 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.556 HG21 HD13 ' A' ' 261' ' ' LEU . 9.0 t -99.83 113.5 35.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.537 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -122.56 133.4 54.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.404 -175.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.438 ' CG1' HG22 ' A' ' 273' ' ' ILE . 14.6 mt -99.23 130.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.066 0.46 . . . . 0.0 110.798 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 46.3 mt -82.7 115.95 21.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.763 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -80.43 100.69 8.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.408 177.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 C--O 1.246 0.878 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.31 -177.518 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 112.174 -0.371 . . . . 0.0 112.174 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.458 ' N ' ' HB2' ' A' ' 344' ' ' ASN . 15.7 m -73.68 -61.58 1.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.875 0.369 . . . . 0.0 111.185 -176.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.417 ' HB ' HG23 ' A' ' 226' ' ' THR . 7.7 m -85.46 -18.6 33.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.856 -177.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 58.32 60.11 2.76 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.532 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.674 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 41.6 p -82.38 -69.9 0.59 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.967 -176.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 58.05 43.11 95.26 Favored Glycine 0 C--N 1.329 0.165 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.24 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.479 HG21 ' O ' ' A' ' 263' ' ' ALA . 68.6 mt -90.66 149.46 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 2.3 p -96.8 157.58 15.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.572 0.701 . . . . 0.0 112.428 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.552 HG11 ' O ' ' A' ' 335' ' ' ALA . 6.8 p -76.16 151.35 6.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.499 -176.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 65.0 m -109.63 83.22 1.72 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.025 0.441 . . . . 0.0 110.385 174.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.7 154.75 28.94 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.341 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -73.05 124.91 26.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.966 0.412 . . . . 0.0 111.008 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -113.25 128.56 56.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.059 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 12.8 t -131.16 119.83 22.45 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.414 ' O ' ' HD3' ' A' ' 237' ' ' LYS . 88.2 m-85 -104.08 143.06 33.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.743 -175.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 236' ' ' PHE . 44.7 mmtm -129.41 138.66 33.65 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.631 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.443 ' HD3' HG21 ' A' ' 313' ' ' VAL . 82.9 Cg_endo -89.69 135.75 2.52 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.035 2.49 . . . . 0.0 112.166 177.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 84.3 t -73.01 98.21 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.136 0.493 . . . . 0.0 110.788 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -92.97 89.91 6.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.295 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -147.4 -76.72 0.18 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.468 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLN . . . . . 0.4 ' OE1' ' HD2' ' A' ' 249' ' ' LYS . 51.7 tp60 58.94 102.69 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.781 0.675 . . . . 0.0 111.177 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 62.2 tp -109.55 -51.55 2.86 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.3 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -143.21 -178.06 5.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.657 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -52.79 -42.61 65.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.239 0.543 . . . . 0.0 110.164 175.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -106.75 146.08 31.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.949 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 158.85 -138.51 5.73 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.069 -1.062 . . . . 0.0 112.975 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -78.8 45.17 0.58 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.4 ' HD2' ' OE1' ' A' ' 242' ' ' GLN . 27.7 mtpp -119.79 4.08 11.05 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.126 0.489 . . . . 0.0 110.394 174.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 30.0 m -103.87 155.28 5.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.637 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 65.38 107.57 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.777 0.673 . . . . 0.0 110.66 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 96.1 t 70.8 112.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.779 -175.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.439 ' CB ' ' HB2' ' A' ' 256' ' ' PHE . 60.7 m-20 -60.54 139.97 57.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.152 -173.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.541 ' O ' ' HD2' ' A' ' 311' ' ' LYS . 9.9 m120 -82.61 -46.39 13.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.375 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -91.9 -12.73 32.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.872 -174.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.457 ' CD1' ' HB ' ' A' ' 309' ' ' THR . 75.1 m-85 -115.56 144.68 43.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.393 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.448 ' HB2' ' HG3' ' A' ' 311' ' ' LYS . . . -114.59 121.89 44.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.618 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -89.43 106.38 18.41 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.748 177.564 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -86.04 118.13 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.402 -172.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 23.2 m -89.32 105.92 18.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.895 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 20.4 mt -122.07 172.08 8.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.735 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 42.2 m -64.57 -53.42 48.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.108 0.48 . . . . 0.0 109.783 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.57 142.93 41.32 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 18.2 p -134.07 30.0 3.68 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.3 m -81.26 134.63 35.63 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.956 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.7 -26.25 14.87 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -176.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' MET . . . . . 0.468 ' HG3' HD11 ' A' ' 342' ' ' ILE . 1.9 mpt? -70.67 151.3 45.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -136.38 164.33 28.38 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -64.44 144.66 57.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.694 0.283 . . . . 0.0 110.676 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 77.8 19.02 76.29 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.742 173.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.519 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 1.7 t70 -100.68 -167.1 1.39 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 117.779 0.79 . . . . 0.0 109.907 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.462 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 13.1 tppt? -125.04 115.16 20.09 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.502 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.526 HD11 HG21 ' A' ' 308' ' ' ILE . 32.0 pt -116.93 139.31 44.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.677 177.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 50.1 p -118.9 138.4 52.78 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.559 -178.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -103.23 111.56 24.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.519 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.63 132.37 53.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.688 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 93.45 -34.71 4.46 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 56.4 t -86.0 146.04 6.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.578 ' HD2' ' SD ' ' A' ' 284' ' ' MET . 0.0 OUTLIER -162.22 162.21 28.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.75 0.31 . . . . 0.0 111.059 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 96.2 m-85 -73.59 170.3 15.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.63 -174.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.99 141.38 56.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.483 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 102.8 -26.36 24.31 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -173.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -78.14 146.97 34.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.578 ' SD ' ' HD2' ' A' ' 279' ' ' LYS . 94.0 mtp 66.76 20.44 10.65 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.797 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -96.11 -31.73 12.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.543 0.687 . . . . 0.0 109.649 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -161.87 39.94 0.13 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -124.02 100.17 6.61 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.726 -171.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 42.6 t -68.75 -41.54 82.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.02 -0.734 . . . . 0.0 109.02 173.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 74.0 mt -105.68 79.62 1.46 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.655 175.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -90.9 123.49 34.46 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.998 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -68.34 165.8 17.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.695 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.451 ' HA ' ' NZ ' ' A' ' 279' ' ' LYS . 64.7 m-20 -94.72 164.01 13.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.683 -178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -70.46 104.27 2.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.649 -174.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 14.0 p -92.14 103.29 15.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.033 177.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.404 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 61.6 m-85 -102.72 154.83 18.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.149 0.5 . . . . 0.0 111.277 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.4 m -89.99 120.89 31.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.088 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.519 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 14.2 p -84.19 139.45 17.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.466 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.2 t -105.76 -42.18 6.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.241 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -156.51 133.74 10.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.027 0.442 . . . . 0.0 111.659 -175.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 87.2 t -81.85 99.47 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 169.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.7 t -70.65 -58.47 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.917 -171.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -120.26 -0.66 10.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.719 0.295 . . . . 0.0 111.576 -174.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 69.31 12.58 66.32 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -172.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 26.6 p -147.4 19.99 1.2 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 7.1 t-160 -172.74 115.82 0.3 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.194 -164.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.52 166.75 13.62 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -176.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -123.86 126.56 46.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.084 0.469 . . . . 0.0 109.994 169.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.526 HG21 HD11 ' A' ' 273' ' ' ILE . 30.3 pt -123.12 170.04 13.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.997 -177.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' THR . . . . . 0.457 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 13.5 t -154.52 145.12 16.03 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.433 ' HA ' ' OG1' ' A' ' 309' ' ' THR . 58.4 Cg_endo -70.2 176.08 35.36 Favored 'Cis proline' 0 C--N 1.347 0.48 0 C-N-CA 123.835 -1.319 . . . . 0.0 112.879 1.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.541 ' HD2' ' O ' ' A' ' 254' ' ' ASN . 40.5 tttt -77.14 119.88 79.33 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.807 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 257' ' ' ALA . 27.1 Cg_exo -62.14 107.13 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.157 1.905 . . . . 0.0 111.676 177.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 328' ' ' ALA . 55.5 t -121.29 119.81 60.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.037 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.644 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -85.86 128.53 34.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.073 0.463 . . . . 0.0 111.101 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.3 tm? -70.16 -30.39 67.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.246 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -89.0 23.19 2.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.0 0.429 . . . . 0.0 111.25 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 14.6 t70 -100.52 137.49 38.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 30.1 m -84.29 -15.56 11.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 13.1 m -91.03 34.89 0.91 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.016 0.436 . . . . 0.0 111.485 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.471 HD13 ' HB3' ' A' ' 325' ' ' ARG . 1.9 pp -126.95 164.18 22.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.092 0.472 . . . . 0.0 111.449 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 65.4 p -99.89 168.59 9.25 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.768 176.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.502 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 86.8 Cg_exo -49.35 -36.07 37.14 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.306 2.004 . . . . 0.0 111.818 172.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.82 -46.3 65.96 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.818 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 89.8 mt-30 -69.65 -28.51 65.94 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -175.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.502 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 30.2 ptt180 -72.05 -21.69 61.49 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.324 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -73.4 -27.84 61.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.202 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -94.24 7.97 43.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.82 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.548 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -57.92 142.11 47.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.825 176.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -124.22 -30.02 3.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.2 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 27.7 m -122.4 160.11 24.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.871 0.367 . . . . 0.0 110.293 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -89.04 -20.89 23.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.071 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.1 t -141.6 141.88 33.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.994 0.426 . . . . 0.0 110.481 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 34.8 p -70.27 161.65 29.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.87 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.447 ' HG ' HG21 ' A' ' 230' ' ' VAL . 48.0 tp -69.47 103.41 2.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.552 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -82.93 170.42 14.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.841 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 336' ' ' ASP . . . . . 0.413 ' HA ' ' CG1' ' A' ' 230' ' ' VAL . 29.1 t70 -72.26 151.86 42.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.496 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 68.18 39.75 2.3 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.998 0.811 . . . . 0.0 111.608 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.411 ' H ' HG12 ' A' ' 230' ' ' VAL . 19.9 mmt -110.19 144.42 38.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 176.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.19 138.3 33.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.031 0.443 . . . . 0.0 111.316 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 23.9 t -113.73 110.73 33.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.444 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' ASN . . . . . 0.674 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 60.5 t30 -130.49 145.16 51.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.936 0.398 . . . . 0.0 111.484 -175.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.468 HD11 ' HG3' ' A' ' 267' ' ' MET . 61.0 mt -88.06 116.41 29.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.057 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 63.9 mt -78.13 154.17 31.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.182 -176.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' ASN . . . . . 0.458 ' HB2' ' N ' ' A' ' 223' ' ' SER . 7.5 t30 -123.35 128.95 50.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.755 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.55 -0.738 . . . . 0.0 109.939 179.259 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.773 0 N-CA-C 111.956 -0.458 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.4 m 61.51 60.03 1.75 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.41 0.624 . . . . 0.0 111.195 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 11.8 t -156.58 141.82 17.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.384 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 56.3 48.26 17.52 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.233 0.539 . . . . 0.0 110.285 -174.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 20.0 p -69.38 -56.79 6.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.186 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 63.25 53.1 42.1 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.283 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.511 HD12 ' O ' ' A' ' 263' ' ' ALA . 29.1 mm -102.21 143.02 15.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 20.7 p -131.49 170.21 15.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.087 0.47 . . . . 0.0 110.305 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.61 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.2 p -78.98 150.39 5.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.56 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.7 t -107.03 75.15 1.02 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.193 0.52 . . . . 0.0 109.654 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.83 155.06 29.57 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.042 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -78.01 141.6 38.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.925 0.393 . . . . 0.0 111.208 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -149.54 137.14 20.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.41 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.5 t -110.08 142.04 42.1 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 312' ' ' PRO . 92.5 m-85 -102.64 156.79 17.39 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . 46.9 mmtm -138.34 130.36 15.92 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.657 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.49 ' HD3' HG11 ' A' ' 313' ' ' VAL . 22.2 Cg_exo -65.16 121.04 8.38 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.677 2.252 . . . . 0.0 111.335 177.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 254' ' ' ASN . 23.3 t -78.17 84.88 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.418 -176.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -82.44 82.17 7.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.602 176.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 70.03 -60.64 0.48 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 124.046 0.841 . . . . 0.0 110.748 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLN . . . . . 0.614 ' O ' ' HA2' ' A' ' 247' ' ' GLY . 7.5 tp60 61.5 101.62 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.506 0.722 . . . . 0.0 110.9 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.41 77.34 2.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.774 -176.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -79.67 -86.85 0.07 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.618 177.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -89.56 -55.84 3.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.229 0.537 . . . . 0.0 110.047 172.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -127.62 -31.32 2.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.563 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 242' ' ' GLN . . . 137.04 150.5 5.79 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.411 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -108.54 47.49 0.9 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.134 0.493 . . . . 0.0 109.906 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -80.53 -35.8 33.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.534 -174.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.0 t -87.89 -6.9 10.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 122.059 0.933 . . . . 0.0 109.818 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -74.55 113.01 11.3 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.27 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.463 ' O ' ' HD2' ' A' ' 256' ' ' PHE . 28.7 m -88.16 36.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.519 0.676 . . . . 0.0 111.716 -176.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -99.01 15.22 26.49 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.331 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.571 ' O ' ' HE2' ' A' ' 311' ' ' LYS . 58.6 t30 -94.03 -50.43 5.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.943 176.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -68.96 -25.63 64.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.887 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 308' ' ' ILE . 60.5 m-85 -114.66 143.9 44.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.653 -177.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -120.34 134.37 55.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.735 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.642 ' HB ' ' CE1' ' A' ' 305' ' ' HIS . 0.0 OUTLIER -93.91 105.21 17.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.283 0.564 . . . . 0.0 111.231 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.6 t -88.39 122.04 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.056 -175.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 11.9 m -96.51 106.04 18.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.254 0.55 . . . . 0.0 110.053 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.518 HD22 HG21 ' A' ' 340' ' ' VAL . 22.5 mt -122.18 167.26 13.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.574 -173.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 26.3 p -60.14 -52.42 65.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.529 0.68 . . . . 0.0 109.71 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.511 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.28 132.59 35.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.316 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 261' ' ' LEU . 7.7 p -128.9 15.29 6.36 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.214 174.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 25.2 m -83.4 144.78 29.39 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.742 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.74 0.73 57.62 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 71.9 mtm -123.22 153.3 40.31 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -142.07 178.99 7.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -63.43 142.22 58.47 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 123.201 0.313 . . . . 0.0 110.545 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 93.52 19.8 34.0 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.688 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.504 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 7.4 m-20 -116.85 164.78 14.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.546 0.673 . . . . 0.0 111.288 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -106.24 115.94 31.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.336 -177.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.484 HD11 HG21 ' A' ' 308' ' ' ILE . 15.6 pt -115.31 140.28 37.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.476 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 54.1 p -128.15 141.06 51.59 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.373 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -100.21 112.64 24.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.051 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.415 ' HA ' ' OD1' ' A' ' 292' ' ' ASP . . . -61.32 120.05 9.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.472 -175.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.49 -35.84 4.75 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.597 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 49.7 t -77.84 124.68 36.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -142.97 161.5 37.94 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.791 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -84.93 142.02 29.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.378 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.475 HD23 ' SD ' ' A' ' 284' ' ' MET . 79.7 mt -75.56 164.17 26.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.112 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 100.42 -40.85 2.3 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.965 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -99.43 -7.96 25.39 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.766 -0.255 . . . . 0.0 111.205 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.475 ' SD ' HD23 ' A' ' 281' ' ' LEU . 81.6 mtp -72.14 -26.5 62.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -63.6 -45.19 91.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.846 0.355 . . . . 0.0 111.322 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -95.63 -42.24 8.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.964 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -92.38 91.07 7.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.93 0.395 . . . . 0.0 110.66 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.76 -31.83 55.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.411 ' HG ' ' H ' ' A' ' 289' ' ' LEU . 0.9 OUTLIER -86.56 38.23 0.78 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.423 174.379 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -56.55 139.35 49.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.381 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -61.23 148.42 41.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.556 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.415 ' OD1' ' HA ' ' A' ' 276' ' ' ALA . 56.6 m-20 -69.55 149.58 48.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -60.01 98.86 0.06 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.527 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 38.6 p -79.98 124.03 28.34 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.626 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -124.54 146.78 48.81 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.234 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.8 m -86.19 118.29 25.55 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.151 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.504 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 11.7 p -73.8 123.44 28.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.414 0.626 . . . . 0.0 110.095 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.4 t -94.29 -38.22 9.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.599 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -164.81 133.6 3.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.499 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 79.9 t -90.14 100.89 11.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 167.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.63 -59.4 3.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.737 -172.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -98.67 -12.72 20.76 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.633 -170.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 74.13 13.1 81.4 Favored Glycine 0 CA--C 1.517 0.196 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.08 23.35 0.5 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 171.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.642 ' CE1' ' HB ' ' A' ' 258' ' ' THR . 2.1 t60 -170.67 115.33 0.46 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 113.813 -1.539 . . . . 0.0 107.533 -171.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.7 155.68 20.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -173.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.1 pt-20 -112.02 121.72 45.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.321 0.581 . . . . 0.0 110.128 172.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 256' ' ' PHE . 29.8 pt -118.19 169.37 8.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.968 -177.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.1 t -145.48 140.47 15.92 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.63 -179.24 26.53 Favored 'Cis proline' 0 C--N 1.345 0.374 0 C-N-CA 123.684 -1.382 . . . . 0.0 112.753 -2.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.571 ' HE2' ' O ' ' A' ' 254' ' ' ASN . 23.8 ttmm -75.29 124.12 89.03 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.786 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 14.1 Cg_exo -68.52 108.24 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.408 2.072 . . . . 0.0 111.99 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.809 HG23 ' HA ' ' A' ' 328' ' ' ALA . 1.2 m -128.21 132.95 67.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.355 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.517 ' O ' HD21 ' A' ' 320' ' ' LEU . . . -95.22 135.71 36.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.906 -172.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.9 tm? -74.19 -24.1 59.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.547 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -82.25 -2.04 51.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.151 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -77.84 113.31 15.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.6 m -82.98 2.59 3.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.972 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 40.1 m -95.2 -27.61 15.44 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -175.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.517 HD21 ' O ' ' A' ' 314' ' ' ALA . 1.3 pp -79.1 152.74 30.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.56 0.695 . . . . 0.0 111.764 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.494 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.3 m -81.33 167.42 31.9 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.74 -173.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.541 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 78.2 Cg_exo -44.81 -52.26 6.4 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.528 2.819 . . . . 0.0 114.183 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -67.22 -30.98 71.05 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.897 -0.502 . . . . 0.0 111.003 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -71.36 -33.78 69.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.433 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.541 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 18.0 ptp180 -77.37 -14.98 59.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.214 0.53 . . . . 0.0 110.6 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -72.41 -30.8 64.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.122 171.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -85.93 -7.97 58.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.553 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.809 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -65.09 115.37 5.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.047 0.451 . . . . 0.0 110.908 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -104.13 -28.17 11.63 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.49 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 30.2 m -108.32 165.33 4.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.027 0.441 . . . . 0.0 111.355 -175.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -83.54 -40.08 19.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.438 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.8 t -128.79 144.98 51.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.169 0.509 . . . . 0.0 111.007 -176.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 13.5 p -77.76 173.96 11.52 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.428 174.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 14.5 tp -76.71 105.06 7.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.103 0.478 . . . . 0.0 110.179 -175.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.61 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.35 -178.6 6.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.413 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -82.54 -1.13 49.67 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -171.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -139.78 64.95 1.44 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.141 0.496 . . . . 0.0 111.281 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.45 ' H ' HG12 ' A' ' 230' ' ' VAL . 23.9 mmt -116.12 130.74 56.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.538 175.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -84.02 144.16 29.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.997 0.427 . . . . 0.0 111.016 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.518 HG21 HD22 ' A' ' 261' ' ' LEU . 21.5 t -113.86 115.4 49.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.481 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -131.58 138.99 49.09 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.799 -176.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 26.7 mt -87.62 125.22 41.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.653 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 49.1 mt -85.02 123.06 30.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -74.9 92.1 2.53 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.95 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 6.8 m . . . . . 0 C--O 1.249 1.049 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.924 -179.764 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 25.6 m -106.0 -179.05 3.83 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 15.7 m 65.85 66.98 0.49 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.474 0.654 . . . . 0.0 111.341 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.46 113.09 24.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.577 174.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 25.6 p -71.8 -71.88 0.25 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.397 -176.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 61.96 35.27 91.15 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.506 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.521 HG21 ' O ' ' A' ' 263' ' ' ALA . 53.7 mt -79.88 153.05 4.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 19.6 p -97.2 143.97 27.48 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.612 0.72 . . . . 0.0 112.495 -173.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.623 HG11 ' O ' ' A' ' 335' ' ' ALA . 4.4 p -61.02 151.9 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.024 177.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 7.6 t -110.52 74.56 0.88 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 0.0 110.001 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 98.39 165.22 30.88 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.052 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -87.98 125.79 34.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.802 0.334 . . . . 0.0 110.442 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -120.39 127.04 51.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.04 0.448 . . . . 0.0 111.01 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 38.4 m -104.86 120.78 42.25 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.635 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.454 ' O ' HG13 ' A' ' 313' ' ' VAL . 93.3 m-85 -100.21 122.38 42.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.657 -176.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.439 ' HE2' HD23 ' A' ' 320' ' ' LEU . 32.4 mmtp -124.85 128.28 24.92 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.208 -178.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.77 177.12 8.76 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 123.091 2.527 . . . . 0.0 111.855 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 12.6 p -81.67 129.38 37.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.153 0.501 . . . . 0.0 110.693 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -89.97 125.8 35.51 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.895 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -74.28 91.7 2.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.864 0.364 . . . . 0.0 110.128 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLN . . . . . 0.503 ' O ' ' HA2' ' A' ' 247' ' ' GLY . 1.6 pp0? -152.0 146.0 25.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.005 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.7 pp -133.25 13.33 4.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.817 173.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -84.31 -41.0 17.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.672 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -87.81 -50.07 6.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.089 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -155.51 -68.72 0.12 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.114 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 242' ' ' GLN . . . 154.65 -153.48 24.83 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.929 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -103.88 130.36 51.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.117 0.484 . . . . 0.0 110.563 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -114.16 -46.04 3.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.745 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 24.9 m -69.58 110.96 3.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.678 0.751 . . . . 0.0 111.098 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -129.41 148.67 51.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.192 -176.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.6 t 54.09 53.64 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.991 0.901 . . . . 0.0 109.713 -175.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -165.32 -35.89 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.606 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -77.64 -1.02 28.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -168.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -99.27 -8.38 25.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.978 0.418 . . . . 0.0 110.368 173.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.408 ' CD1' ' HB ' ' A' ' 309' ' ' THR . 97.8 m-85 -134.85 -176.11 4.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.073 0.463 . . . . 0.0 110.448 -177.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.438 ' HB2' ' HA ' ' A' ' 311' ' ' LYS . . . -146.19 113.79 6.38 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.065 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.3 m -86.4 104.07 15.55 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.338 0.59 . . . . 0.0 110.208 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.1 t -82.83 118.17 30.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.358 -172.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 21.8 m -86.97 105.24 16.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.212 0.529 . . . . 0.0 110.239 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.583 HD23 HG23 ' A' ' 230' ' ' VAL . 19.5 mt -122.76 161.36 24.1 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.2 m -58.86 -50.5 73.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.255 0.55 . . . . 0.0 109.587 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.521 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.89 144.23 41.24 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.46 HG22 HD12 ' A' ' 261' ' ' LEU . 16.0 p -131.31 26.59 4.82 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.135 0.969 . . . . 0.0 108.514 174.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 24.9 m -74.57 135.88 42.09 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.972 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 103.34 -12.91 54.96 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -176.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 55.7 mtt -96.41 138.79 33.49 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.591 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 6.6 ptpp? -130.88 156.93 44.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -55.93 114.39 1.9 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.945 0.402 . . . . 0.0 110.623 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 110.83 18.57 8.29 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.487 -176.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.591 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 9.6 m-20 -105.14 158.36 16.63 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 117.039 0.419 . . . . 0.0 110.766 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 15.0 tppt? -103.7 116.32 32.11 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.647 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 30.3 pt -112.74 139.56 37.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.189 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 4.1 m -124.45 130.57 52.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.445 -176.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -94.53 111.88 23.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.447 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.84 116.71 9.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.838 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 107.76 -11.78 38.45 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 39.2 t -111.81 128.9 68.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -135.99 157.97 45.55 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.43 ' HE1' ' CZ ' ' A' ' 295' ' ' PHE . 50.0 m-85 -73.45 165.02 25.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.775 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 82.8 mt -67.21 -39.17 86.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.221 0.534 . . . . 0.0 110.127 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -70.11 148.48 46.08 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.718 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.543 ' O ' ' HB2' ' A' ' 287' ' ' ASN . 83.4 mm-40 72.86 23.0 2.94 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.048 0.539 . . . . 0.0 110.703 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 73.2 mtp -113.33 25.45 11.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.018 0.437 . . . . 0.0 110.528 175.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -94.98 -56.29 2.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.929 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -143.93 37.0 1.28 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.182 0.515 . . . . 0.0 109.918 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' ASN . . . . . 0.543 ' HB2' ' O ' ' A' ' 283' ' ' GLN . 15.5 m120 -125.12 109.21 12.62 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.517 -175.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 43.1 t -76.27 -35.05 26.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.332 0.587 . . . . 0.0 109.71 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 89.7 mt -91.35 51.85 1.98 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.401 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -61.67 150.33 36.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.361 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -63.63 118.62 8.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.08 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -65.66 166.43 10.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.633 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -69.29 76.23 0.37 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.158 0.504 . . . . 0.0 111.117 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.421 HG22 ' OG ' ' A' ' 274' ' ' SER . 65.6 p -86.78 105.18 16.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.411 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 312' ' ' PRO . 61.8 m-85 -115.46 143.72 44.89 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.023 0.439 . . . . 0.0 111.035 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.7 m -86.8 124.58 33.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.957 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 271' ' ' ASP . 8.3 p -83.1 136.06 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.038 0.447 . . . . 0.0 110.239 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 37.8 t -101.61 -29.5 3.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.948 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -163.81 142.04 7.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.582 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 78.8 t -98.14 117.62 43.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 38.9 t -77.89 -58.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.92 -172.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -121.21 2.29 10.33 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -173.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 70.45 13.34 70.88 Favored Glycine 0 CA--C 1.518 0.25 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.9 p -146.41 18.04 1.34 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.439 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 1.6 t60 -171.07 113.99 0.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.778 -169.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.35 161.97 16.83 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -173.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -120.78 121.24 37.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.36 0.6 . . . . 0.0 110.739 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.444 HG22 ' HA ' ' A' ' 297' ' ' VAL . 23.3 pt -112.76 174.57 2.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.415 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' THR . . . . . 0.408 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 13.2 t -152.13 141.27 14.13 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.99 -179.79 26.24 Favored 'Cis proline' 0 C--N 1.345 0.349 0 C-N-CA 123.681 -1.383 . . . . 0.0 112.411 0.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.443 ' CG ' ' HB3' ' A' ' 236' ' ' PHE . 23.3 ttmm -74.56 123.12 88.87 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.286 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 295' ' ' PHE . 56.9 Cg_endo -74.46 108.42 2.68 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.115 1.876 . . . . 0.0 112.045 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.556 ' HB ' ' HA ' ' A' ' 328' ' ' ALA . 0.2 OUTLIER -106.54 132.71 53.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.216 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -78.95 116.84 19.52 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 123.53 0.519 . . . . 0.0 110.827 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.0 tm? -64.71 -29.67 70.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.31 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -91.77 15.53 12.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.854 -177.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -90.57 127.26 36.2 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 9.6 p -82.98 -12.53 12.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.989 0.423 . . . . 0.0 111.376 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 5.3 m -93.13 33.71 1.17 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.118 0.485 . . . . 0.0 111.32 -173.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.439 HD23 ' HE2' ' A' ' 237' ' ' LYS . 2.0 pp -132.78 170.91 14.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.745 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 23.3 m -106.23 159.61 29.11 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.341 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -39.97 -48.24 3.79 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.581 2.854 . . . . 0.0 113.913 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -56.28 -41.05 75.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.094 0.473 . . . . 0.0 111.343 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -72.1 -37.67 69.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.777 -175.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -77.05 -16.09 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.936 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -69.22 -30.75 68.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.478 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -96.16 -0.88 49.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.153 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.556 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -61.75 151.24 34.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.19 0.519 . . . . 0.0 111.546 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -138.43 -28.01 0.85 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.141 -171.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 23.4 m -113.89 162.16 12.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -92.51 -14.21 28.72 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.279 -176.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 11.9 t -147.62 148.5 31.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.768 0.318 . . . . 0.0 110.324 -177.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 46.0 m -77.78 158.63 29.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.575 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.429 ' HG ' HG21 ' A' ' 230' ' ' VAL . 41.1 tp -71.31 103.21 2.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.623 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -85.55 -179.24 6.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.407 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' ASP . . . . . 0.462 ' HA ' ' CG1' ' A' ' 230' ' ' VAL . 33.2 t70 -77.83 159.79 28.74 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.14 -0.224 . . . . 0.0 110.409 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 65.1 40.9 4.82 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.91 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.558 ' H ' HG12 ' A' ' 230' ' ' VAL . 25.2 mmt -110.28 140.32 44.56 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 176.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -92.21 135.25 34.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.989 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.435 HG21 HD22 ' A' ' 261' ' ' LEU . 14.0 t -114.26 105.01 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.902 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' ASN . . . . . 0.452 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 64.1 t30 -118.77 150.31 40.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.705 0.288 . . . . 0.0 111.003 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 69.3 mt -95.91 123.67 48.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.643 177.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 60.2 mt -84.26 147.78 27.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.394 176.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -82.86 95.82 8.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.008 0.433 . . . . 0.0 110.181 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.55 -0.738 . . . . 0.0 109.763 179.179 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.536 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 23.3 t -87.42 102.57 14.67 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.161 0.505 . . . . 0.0 110.566 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.8 t -116.04 43.66 2.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.092 0.949 . . . . 0.0 109.247 175.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -65.88 104.0 1.02 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.551 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 17.4 p -74.72 73.2 2.03 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.536 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -85.09 57.47 4.99 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 339' ' ' ALA . 31.9 mm -85.78 142.93 12.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 122.282 0.233 . . . . 0.0 110.808 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 12.3 p -118.84 143.22 47.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.089 0.471 . . . . 0.0 110.467 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.632 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.9 p -59.5 149.39 6.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.75 -178.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 25.9 t -113.07 77.91 1.09 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 177.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 90.37 141.71 9.25 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.993 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.68 140.9 55.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.764 0.316 . . . . 0.0 110.927 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -144.76 132.87 21.54 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.544 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.1 t -116.92 114.12 23.4 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 175.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.479 ' O ' HG22 ' A' ' 313' ' ' VAL . 71.5 m-85 -81.15 133.0 35.39 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.343 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -124.09 134.99 25.84 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.436 ' HD3' HG21 ' A' ' 313' ' ' VAL . 84.9 Cg_endo -86.19 152.88 9.49 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.757 2.305 . . . . 0.0 111.831 178.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.08 83.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.151 0.5 . . . . 0.0 110.407 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -131.28 81.87 2.01 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.789 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -129.86 -51.94 1.14 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.696 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -151.47 159.77 44.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.07 177.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 79.0 mt -112.76 117.43 32.19 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.94 0.4 . . . . 0.0 110.714 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -77.59 163.23 26.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.017 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -55.85 -40.0 72.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.73 0.3 . . . . 0.0 111.166 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -97.96 17.55 18.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.14 0.495 . . . . 0.0 110.146 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 82.04 -62.12 4.59 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.676 -0.57 . . . . 0.0 111.676 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -164.92 174.15 10.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 249' ' ' LYS . 52.8 tttp -135.44 32.33 3.09 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.682 0.753 . . . . 0.0 109.564 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 28.5 m -134.58 176.6 8.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.624 -176.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -80.41 74.3 7.28 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 254' ' ' ASN . 7.4 p -64.14 114.22 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.669 0.747 . . . . 0.0 111.406 -174.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -101.69 31.64 3.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.616 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.4 ' H ' HG22 ' A' ' 252' ' ' VAL . 28.2 p-10 -62.35 -21.89 65.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.925 -175.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.507 ' NE ' ' HA ' ' A' ' 255' ' ' ARG . 4.9 mmp_? -104.79 -3.45 23.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.516 0.198 . . . . 0.0 111.366 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -122.21 169.94 10.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.827 0.346 . . . . 0.0 110.883 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -146.18 123.37 11.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.677 0.275 . . . . 0.0 110.74 177.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.1 m -94.55 101.45 13.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.892 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.416 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.7 t -86.18 120.46 36.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.234 -173.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 30.3 m -92.9 109.73 21.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.917 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 19.2 mt -126.49 171.0 11.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.023 -175.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 16.6 p -62.07 -55.59 27.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.412 0.625 . . . . 0.0 109.77 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -136.85 139.05 41.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.785 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.4 p -131.38 27.55 4.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.793 0.806 . . . . 0.0 109.138 175.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 48.8 m -76.88 140.46 40.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.639 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 101.77 -2.25 52.49 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -173.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 63.3 mtt -108.03 137.27 46.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.813 -0.694 . . . . 0.0 109.299 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -155.0 141.69 18.95 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.581 ' HA ' HG13 ' A' ' 297' ' ' VAL . 29.1 ptt180 -39.34 119.24 0.9 Allowed 'General case' 0 N--CA 1.469 0.51 0 O-C-N 124.01 0.819 . . . . 0.0 112.694 -173.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 116.0 -9.26 18.47 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.564 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.47 ' H ' HG12 ' A' ' 297' ' ' VAL . 2.1 p30 -87.17 -174.82 5.06 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 117.523 0.662 . . . . 0.0 111.307 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 296' ' ' SER . 4.2 tmmm? -140.99 118.45 11.49 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.11 -177.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.42 HG22 HG13 ' A' ' 342' ' ' ILE . 34.3 pt -110.55 140.77 28.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.149 0.5 . . . . 0.0 110.095 -177.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 15.0 m -126.35 132.38 51.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.365 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -94.5 111.19 22.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.431 -176.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.7 116.75 7.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.722 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.38 -34.15 5.31 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 98.1 t -94.24 118.82 41.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.75 171.91 13.78 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.389 -178.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 95.5 m-85 -74.66 172.92 11.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.189 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 94.0 mt -75.92 92.74 3.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.191 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 135.95 171.53 12.36 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.724 173.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 59.4 45.54 13.65 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 122.816 0.446 . . . . 0.0 111.298 177.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 58.4 mtm -128.78 -6.36 5.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.301 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -70.75 -55.41 8.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.024 0.44 . . . . 0.0 110.607 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -114.84 -28.42 7.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.772 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -74.68 109.81 8.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.103 -176.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 31.4 t -82.43 -33.35 11.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.579 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 94.0 mt -82.87 48.53 1.36 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.375 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -77.91 111.26 13.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.397 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' GLN . . . . . 0.431 ' CD ' ' H ' ' A' ' 291' ' ' GLN . 4.5 pm0 -51.34 129.71 25.46 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 123.71 0.631 . . . . 0.0 111.37 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -74.88 168.49 19.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.381 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.638 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -54.41 98.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.918 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.4 p -91.48 99.1 12.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.052 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.638 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 43.1 m-85 -118.61 138.63 52.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.919 0.39 . . . . 0.0 110.925 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 272' ' ' LYS . 28.1 t -85.4 138.43 32.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.898 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.581 HG13 ' HA ' ' A' ' 269' ' ' ARG . 4.3 p -71.67 137.27 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.966 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.25 -42.18 9.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.939 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 307' ' ' GLU . 28.2 tpt180 -165.1 142.14 5.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.773 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 99.0 t -103.13 119.16 51.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 171.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.07 -58.71 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.01 -174.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -121.6 -9.41 8.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.337 0.589 . . . . 0.0 111.651 -173.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.62 13.98 76.94 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.309 -172.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 55.2 p -140.06 12.14 2.42 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 171.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -163.03 116.05 1.59 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.457 -167.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.41 165.01 15.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 121.194 -0.202 . . . . 0.0 110.577 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 8.0 pt-20 -128.09 123.09 33.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.076 0.465 . . . . 0.0 109.77 170.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.429 HG22 ' HA ' ' A' ' 297' ' ' VAL . 26.6 pt -121.67 176.86 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.314 -175.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.5 t -154.11 144.22 15.59 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.018 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.73 179.37 31.15 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 123.414 -1.494 . . . . 0.0 112.606 -4.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -77.39 121.1 83.94 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.873 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.443 ' HG2' ' CD2' ' A' ' 236' ' ' PHE . 30.5 Cg_endo -68.83 108.38 1.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.067 1.845 . . . . 0.0 111.934 174.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.565 ' HB ' ' HA ' ' A' ' 328' ' ' ALA . 85.8 t -118.02 130.65 72.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.317 178.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.673 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -90.42 131.9 35.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.194 0.521 . . . . 0.0 111.459 -176.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.3 tm? -69.46 -29.08 66.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.719 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -97.63 15.17 24.23 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -83.8 128.3 34.43 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.82 0.21 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 18.0 m -105.49 30.84 5.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.224 -0.298 . . . . 0.0 111.757 -174.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 320' ' ' LEU . 1.7 pp -128.34 159.57 34.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.271 0.557 . . . . 0.0 111.879 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.412 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 2.7 t -91.53 152.75 43.82 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.854 175.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.554 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 50.1 Cg_exo -38.44 -47.99 2.48 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.978 3.118 . . . . 0.0 114.943 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -64.38 -33.58 76.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.828 0.347 . . . . 0.0 111.922 -176.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -68.06 -36.5 79.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.875 0.369 . . . . 0.0 111.243 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 7.4 ptm180 -78.76 -11.16 59.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.315 0.579 . . . . 0.0 110.366 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -74.73 -22.77 58.63 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.617 171.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -99.89 6.19 45.3 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.525 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.565 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -53.61 144.52 17.35 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.648 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -128.63 -34.69 1.98 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.032 -177.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.9 m -113.82 155.27 15.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.364 -178.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -90.97 -8.34 49.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.24 0.543 . . . . 0.0 110.809 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.4 t -148.3 141.28 24.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.881 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 24.1 m -75.38 166.18 24.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.898 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.437 ' HG ' HG21 ' A' ' 230' ' ' VAL . 26.2 tp -71.16 102.97 2.63 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.632 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -93.19 -172.9 3.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -74.35 160.83 30.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.776 0.322 . . . . 0.0 110.427 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 61.18 32.84 19.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.44 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.406 ' H ' HG12 ' A' ' 230' ' ' VAL . 25.5 mmt -102.48 126.89 49.67 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 339' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 228' ' ' ILE . . . -84.47 129.91 34.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.096 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 16.1 t -104.18 108.42 24.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -134.11 142.19 47.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.818 0.342 . . . . 0.0 111.908 -171.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.42 HG13 HG22 ' A' ' 273' ' ' ILE . 58.5 mt -87.96 127.0 41.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.76 175.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 57.8 mt -80.48 111.69 17.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.902 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -102.85 83.64 2.27 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.167 0.508 . . . . 0.0 110.629 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.248 0.977 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.133 176.074 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.851 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 17.9 m -119.57 31.94 6.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.007 0.432 . . . . 0.0 111.059 -176.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 20.4 m -131.92 116.96 17.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.204 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 56.09 70.63 0.62 Allowed 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.568 0.543 . . . . 0.0 110.989 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 38.9 p -81.51 -49.8 10.16 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.652 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 54.4 56.75 20.28 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.247 -0.502 . . . . 0.0 112.832 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.483 HG21 ' O ' ' A' ' 263' ' ' ALA . 51.1 mt -103.24 150.05 6.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 14.6 p -97.58 153.7 18.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.535 0.683 . . . . 0.0 112.082 -177.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.613 HG12 ' H ' ' A' ' 338' ' ' MET . 7.8 p -65.93 150.4 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.025 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.401 ' HB2' ' C ' ' A' ' 261' ' ' LEU . 10.2 t -102.32 66.89 1.01 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.76 158.37 31.87 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.211 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.22 132.54 53.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.017 0.437 . . . . 0.0 111.681 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.58 ' NE2' ' HB ' ' A' ' 260' ' ' THR . 83.6 mm-40 -120.66 127.37 52.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.293 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 11.2 p -129.86 144.77 51.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.14 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -133.81 158.98 41.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.47 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . 46.1 mmtm -139.81 126.91 12.61 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.886 178.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.466 ' HD3' HG11 ' A' ' 313' ' ' VAL . 2.8 Cg_endo -79.73 143.08 16.44 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.877 2.385 . . . . 0.0 111.641 175.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 59.6 t -81.38 123.61 38.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.77 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -81.92 152.13 26.92 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 18.8 t90 67.43 91.51 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.743 0.652 . . . . 0.0 109.508 -174.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -113.03 167.64 10.36 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.501 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -82.97 -75.94 0.29 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.967 0.413 . . . . 0.0 110.091 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -137.02 -70.41 0.45 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.865 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -82.99 -39.72 20.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.237 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 254' ' ' ASN . 4.3 t0 -146.21 -174.31 4.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.127 -174.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -150.47 124.07 1.67 Allowed Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 20.3 m120 64.88 57.19 1.03 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.067 0.46 . . . . 0.0 110.755 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -72.46 -11.7 60.78 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.099 -175.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 51.3 t -84.34 -14.29 11.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 122.063 0.935 . . . . 0.0 109.796 176.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -92.45 -179.02 5.08 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.236 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 4.7 p -49.4 133.39 7.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-O 120.692 0.282 . . . . 0.0 110.356 175.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -48.46 121.8 4.83 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.569 -173.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.422 ' HB3' ' OD1' ' A' ' 246' ' ' ASP . 18.4 t30 -83.2 -51.16 7.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.312 -176.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.476 ' NE ' ' HA ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -79.15 -21.53 46.35 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.607 -177.429 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 308' ' ' ILE . 52.0 m-85 -111.63 140.89 45.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.808 -176.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -106.49 120.72 42.65 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.171 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.8 m -87.35 97.45 10.81 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.128 0.489 . . . . 0.0 110.899 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.5 t -83.91 125.39 40.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.546 -173.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.58 ' HB ' ' NE2' ' A' ' 234' ' ' GLN . 13.3 m -97.53 106.97 19.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.187 0.518 . . . . 0.0 109.853 175.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.521 ' HB2' HG22 ' A' ' 264' ' ' THR . 17.4 mt -121.2 163.02 19.15 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -177.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.1 t -56.75 -51.88 67.16 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.483 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.88 136.95 37.59 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.521 HG22 ' HB2' ' A' ' 261' ' ' LEU . 17.5 p -125.25 24.13 7.47 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 122.005 0.907 . . . . 0.0 108.922 175.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 10.4 m -77.71 145.4 36.6 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.301 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 96.83 -15.9 61.88 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -174.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' MET . . . . . 0.534 ' O ' HG21 ' A' ' 300' ' ' VAL . 54.1 mtt -92.28 132.84 36.37 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -129.75 149.73 51.37 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -49.71 114.07 0.98 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.548 0.69 . . . . 0.0 110.851 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 107.64 11.15 25.58 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.56 -0.745 . . . . 0.0 113.024 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.449 ' H ' HG12 ' A' ' 297' ' ' VAL . 6.4 m-20 -98.25 147.6 24.46 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 117.757 0.778 . . . . 0.0 110.991 176.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -94.63 117.53 30.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.334 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 22.7 pt -112.41 139.58 36.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.003 0.43 . . . . 0.0 110.238 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.464 ' HB3' HG22 ' A' ' 294' ' ' THR . 77.9 p -112.61 137.95 50.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.306 -177.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -105.89 119.95 40.49 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.368 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -63.3 136.27 57.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.892 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 81.95 -35.36 2.54 Favored Glycine 0 N--CA 1.454 -0.109 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.667 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 52.3 t -82.36 105.15 11.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -128.88 165.02 21.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.968 0.413 . . . . 0.0 111.46 -176.735 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.558 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 70.8 m-85 -79.26 144.75 34.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.3 -176.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 82.5 mt -78.88 172.67 13.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.523 175.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 97.85 -21.29 46.87 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.605 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -115.88 -7.42 12.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.781 0.324 . . . . 0.0 111.055 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 83.4 mtp -87.79 49.8 1.87 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.231 0.539 . . . . 0.0 111.445 -174.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -102.06 -51.6 3.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.721 174.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.32 24.49 0.36 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.485 175.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -106.11 110.1 22.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.517 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.96 -29.73 34.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.237 0.541 . . . . 0.0 110.009 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 87.8 mt -89.06 33.89 0.79 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.671 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.401 ' HB3' ' HD3' ' A' ' 279' ' ' LYS . . . -62.77 120.7 11.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.877 175.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -57.31 130.63 47.07 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.958 -173.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 47.7 m-20 -75.78 161.88 28.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.335 178.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.572 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -67.62 97.7 0.63 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.57 -175.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.464 HG22 ' HB3' ' A' ' 274' ' ' SER . 30.3 p -100.38 105.0 16.46 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.285 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.572 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 68.2 m-85 -112.62 145.87 39.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.937 0.399 . . . . 0.0 110.95 -178.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 50.1 m -86.08 124.91 33.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.324 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.449 HG12 ' H ' ' A' ' 271' ' ' ASP . 11.2 p -69.85 132.61 32.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.062 178.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.74 -33.94 4.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.951 0.405 . . . . 0.0 110.419 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -157.99 133.46 8.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.071 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.534 HG21 ' O ' ' A' ' 267' ' ' MET . 96.7 t -91.48 101.35 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.6 t -73.77 -59.06 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.686 -171.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -109.39 -11.44 14.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.001 0.429 . . . . 0.0 111.691 -174.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.79 12.98 83.49 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -170.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 5.2 p -147.55 18.09 1.17 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 173.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.485 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.7 t-160 -169.64 114.7 0.54 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.207 -167.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.31 167.91 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -174.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -126.18 119.72 28.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.257 0.551 . . . . 0.0 109.958 169.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 256' ' ' PHE . 27.1 pt -113.99 171.21 4.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.705 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 12.6 t -153.52 145.51 16.93 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.84 179.29 30.99 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.498 -1.459 . . . . 0.0 112.933 -2.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -82.64 121.1 77.75 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.913 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.85 113.28 3.24 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.798 2.332 . . . . 0.0 112.912 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.473 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.1 OUTLIER -114.38 139.52 39.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.818 173.915 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -87.07 131.31 34.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.673 -177.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.7 tm? -65.91 -28.06 68.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.881 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.69 24.97 3.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.198 178.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -91.91 122.04 34.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 8.4 p -84.05 -0.99 5.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.246 0.546 . . . . 0.0 111.483 -175.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 33.3 t -93.93 -25.52 17.25 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.069 -0.394 . . . . 0.0 111.474 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.438 HD21 ' O ' ' A' ' 314' ' ' ALA . 1.3 pp -83.7 162.85 20.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.238 0.542 . . . . 0.0 111.533 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.472 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 7.1 m -100.57 167.4 10.93 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.504 -176.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 42.2 Cg_exo -41.13 -51.51 3.85 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.8 3.0 . . . . 0.0 114.787 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.71 -39.28 93.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.002 0.429 . . . . 0.0 111.076 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -64.43 -28.95 70.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.906 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 325' ' ' ARG . 43.3 mtp85 -63.99 -28.73 70.01 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.796 0.331 . . . . 0.0 110.844 175.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -74.88 -19.34 60.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.104 0.478 . . . . 0.0 110.658 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -96.17 -2.78 45.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.473 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -72.74 106.39 4.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.661 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -98.31 -17.83 18.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.314 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.8 m -116.47 156.68 17.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.175 0.512 . . . . 0.0 110.417 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -82.38 -32.47 29.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.418 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 12.0 t -139.98 154.08 47.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.572 -174.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.2 p -86.95 169.66 12.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.318 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.431 ' HG ' HG21 ' A' ' 230' ' ' VAL . 18.1 tp -71.15 115.5 10.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.192 -175.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.481 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.58 -178.92 6.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.32 -177.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -78.97 -9.83 59.64 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -138.7 72.56 1.41 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.924 0.392 . . . . 0.0 111.376 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.613 ' H ' HG12 ' A' ' 230' ' ' VAL . 21.0 mmt -125.11 146.37 49.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -93.81 139.5 30.78 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.735 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.462 HG21 HD22 ' A' ' 261' ' ' LEU . 40.9 t -121.81 119.36 58.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.965 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -135.83 143.9 45.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.967 -176.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 52.7 mt -85.73 121.64 37.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.948 173.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 63.9 mt -78.85 127.06 31.54 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.399 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -81.38 87.67 6.16 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 0 C--O 1.248 0.983 0 CA-C-N 115.278 -0.873 . . . . 0.0 112.085 -174.756 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.902 0 CA-C-O 120.094 -0.281 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.0 m 63.8 -80.16 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.965 0.506 . . . . 0.0 111.02 -176.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 20.6 p -122.0 -66.51 1.03 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -128.28 163.58 24.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.806 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.493 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 19.5 p -61.13 -65.09 0.75 Allowed 'General case' 0 C--N 1.322 -0.589 0 O-C-N 122.982 0.176 . . . . 0.0 111.459 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 58.44 39.91 93.59 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.764 -177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.642 HG21 ' O ' ' A' ' 263' ' ' ALA . 62.2 mt -103.23 146.63 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 21.8 p -108.24 156.08 19.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.398 0.618 . . . . 0.0 111.405 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.73 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.5 p -63.0 151.63 8.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.825 176.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.403 ' H ' ' HA ' ' A' ' 261' ' ' LEU . 18.7 t -105.02 83.73 2.03 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 84.12 165.24 38.68 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.177 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.88 129.81 40.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.792 0.33 . . . . 0.0 110.425 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -123.39 127.4 48.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.049 0.452 . . . . 0.0 110.853 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 21.4 p -127.14 131.58 50.73 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.206 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 312' ' ' PRO . 78.4 m-85 -111.91 142.77 43.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.88 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -133.71 132.75 21.82 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.04 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.537 ' HD3' HG21 ' A' ' 313' ' ' VAL . 90.3 Cg_endo -88.36 151.38 6.61 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.689 2.259 . . . . 0.0 111.388 174.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 239' ' ' VAL . 6.3 p -85.33 83.57 2.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 122.114 0.959 . . . . 0.0 109.261 175.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -99.64 80.24 2.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.202 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -141.87 156.13 45.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.498 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -85.2 101.98 12.94 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -95.83 76.26 3.18 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.063 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -90.15 -46.04 8.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.654 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -87.87 -37.78 16.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.088 0.47 . . . . 0.0 110.196 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -107.8 -173.65 2.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.636 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -149.57 -176.0 22.36 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -133.16 130.27 38.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 117.115 0.458 . . . . 0.0 110.228 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -125.31 -9.68 6.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 30.5 m -73.02 162.88 4.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.88 0.371 . . . . 0.0 110.81 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -73.64 86.11 1.62 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.093 -177.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 252' ' ' VAL . 7.6 p -147.35 65.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 122.341 1.067 . . . . 0.0 109.781 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -79.45 146.56 32.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.951 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -94.55 4.56 53.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.08 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -96.87 -52.86 3.73 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -170.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -110.11 171.89 7.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.993 0.425 . . . . 0.0 111.173 -172.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -146.9 132.67 18.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.897 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.651 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -92.03 104.93 17.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.131 0.491 . . . . 0.0 111.131 177.443 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.8 t -85.65 117.45 30.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.495 -174.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 19.4 m -87.22 105.83 17.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.171 0.51 . . . . 0.0 110.195 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.505 HD23 HG23 ' A' ' 230' ' ' VAL . 20.5 mt -122.17 164.92 16.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.652 -177.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.3 t -59.9 -51.8 68.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.171 0.51 . . . . 0.0 109.776 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.642 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.37 131.45 32.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.22 176.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.463 HG22 ' HB2' ' A' ' 261' ' ' LEU . 12.8 p -126.0 18.09 7.84 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.774 0.797 . . . . 0.0 109.029 175.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 26.5 m -82.62 148.11 28.17 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.857 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 95.51 -0.18 63.21 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 42.9 mtm -117.07 158.08 24.79 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.449 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 23.4 pttm -139.94 172.45 12.74 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -59.29 121.07 10.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.631 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 103.04 18.85 13.88 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.244 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.47 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 59.8 m-20 -100.62 152.64 20.19 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 117.433 0.616 . . . . 0.0 110.135 178.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.404 ' HA ' ' HE3' ' A' ' 272' ' ' LYS . 1.5 tpmt? -95.07 116.32 28.57 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.97 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.494 HD11 HG21 ' A' ' 308' ' ' ILE . 15.0 pt -115.84 138.92 44.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.237 176.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 4.5 m -123.92 131.47 53.58 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.832 -178.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -99.26 112.2 24.41 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.964 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.61 115.39 3.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.459 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.27 -34.86 4.95 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.937 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 45.2 t -81.66 142.13 14.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.513 ' NZ ' ' HB3' ' A' ' 279' ' ' LYS . 0.1 OUTLIER -162.13 152.19 16.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.916 0.389 . . . . 0.0 111.276 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -80.85 154.16 27.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.465 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.63 156.12 39.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.154 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.18 -39.14 3.1 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.671 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -80.75 2.98 23.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.986 0.422 . . . . 0.0 110.565 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.459 ' SD ' ' HG3' ' A' ' 279' ' ' LYS . 65.8 mtm -123.19 17.37 9.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.66 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -57.79 -54.65 44.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.011 0.434 . . . . 0.0 110.738 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -141.44 47.37 1.68 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -122.03 107.87 12.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.937 -176.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 45.6 t -80.89 -29.61 11.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 173.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 64.2 mt -100.6 54.96 0.87 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.826 177.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -78.88 145.05 34.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.747 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -76.18 173.65 11.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.271 0.558 . . . . 0.0 110.984 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -93.33 163.26 13.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.625 173.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.419 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -68.0 104.0 1.64 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.367 -175.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 30.3 p -90.88 106.69 18.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.511 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.419 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 88.4 m-85 -105.31 149.89 25.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.158 0.504 . . . . 0.0 111.105 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 12.8 m -96.7 119.87 35.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.777 176.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.47 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.5 p -78.71 130.45 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.163 0.506 . . . . 0.0 110.231 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 21.1 t -93.49 -28.09 4.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.392 -178.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -172.88 140.62 0.96 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.63 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 95.7 t -90.31 109.54 20.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 170.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 42.8 t -78.03 -59.0 3.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.294 -172.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -110.33 -10.05 14.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.046 0.45 . . . . 0.0 111.737 -174.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.56 11.95 84.05 Favored Glycine 0 C--N 1.32 -0.343 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 27.9 p -146.01 13.91 1.31 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.61 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 3.7 t-160 -165.16 116.51 1.14 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.357 -167.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.9 m -119.26 162.13 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -176.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.31 120.65 42.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.926 0.393 . . . . 0.0 110.0 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.494 HG21 HD11 ' A' ' 273' ' ' ILE . 39.8 pt -122.36 176.74 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.092 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.5 t -154.45 145.6 16.46 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.13 -179.99 26.64 Favored 'Cis proline' 0 C--N 1.346 0.428 0 C-N-CA 124.23 -1.154 . . . . 0.0 112.84 -0.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -78.88 113.64 37.12 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.96 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 23.5 Cg_exo -63.68 107.94 0.81 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.351 2.034 . . . . 0.0 112.365 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.537 HG21 ' HD3' ' A' ' 238' ' ' PRO . 97.5 t -124.39 126.3 71.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -83.54 137.44 33.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.569 0.699 . . . . 0.0 111.897 -173.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.0 tm? -77.74 -25.2 49.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.54 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.6 5.2 43.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.426 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 12.2 t70 -74.51 120.03 19.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.03 0.443 . . . . 0.0 110.186 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.9 p -84.79 -15.43 10.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.323 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 33.7 m -77.13 -23.93 51.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.498 -174.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 2.0 pp -85.75 164.41 17.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.456 0.646 . . . . 0.0 111.915 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 21.4 m -92.33 159.25 37.5 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.693 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 2.6 Cg_endo -41.34 -51.12 4.22 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 124.276 3.317 . . . . 0.0 114.311 -177.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -65.11 -29.03 69.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.853 0.359 . . . . 0.0 111.257 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 75.6 mt-30 -71.76 -38.52 70.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.089 -178.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.421 ' HE ' HD11 ' A' ' 320' ' ' LEU . 10.1 ptp180 -73.73 -19.88 60.67 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.489 176.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.23 -18.68 64.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.155 0.502 . . . . 0.0 110.023 172.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -112.15 12.03 20.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.084 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -60.54 152.62 25.54 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.927 0.394 . . . . 0.0 110.999 176.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -118.27 -29.73 5.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.663 -175.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.7 m -133.19 170.7 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 121.014 -0.275 . . . . 0.0 110.759 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -84.13 -51.44 7.06 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.594 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 11.4 t -107.27 146.3 31.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.03 0.443 . . . . 0.0 110.778 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.1 p -80.46 157.98 26.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.739 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.457 HD12 ' HG3' ' A' ' 338' ' ' MET . 15.9 tp -68.56 101.96 1.38 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.73 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -82.53 165.89 19.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.489 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -76.96 25.41 0.15 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -149.1 30.92 0.77 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.962 0.41 . . . . 0.0 110.842 176.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.457 ' HG3' HD12 ' A' ' 334' ' ' LEU . 23.8 mmt -88.64 137.82 31.97 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.33 141.45 28.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.742 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 12.4 t -110.07 116.89 53.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.079 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' ASN . . . . . 0.493 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 27.8 t-20 -127.44 139.8 52.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.162 -177.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 16.3 mt -98.58 131.33 45.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 121.045 0.45 . . . . 0.0 111.125 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 33.5 mt -97.11 146.34 25.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.482 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -100.43 106.64 18.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.774 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 43.9 t . . . . . 0 C--O 1.252 1.234 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.635 -177.737 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.859 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 44.2 m -87.22 -46.47 9.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.847 0.324 . . . . 0.0 110.629 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 342' ' ' ILE . 32.4 p -80.72 -29.9 36.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.287 0.565 . . . . 0.0 110.345 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -79.99 76.57 6.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.342 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 54.8 p -67.72 -31.72 71.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.055 -174.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 69.97 31.27 69.71 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.056 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.615 HG21 ' O ' ' A' ' 263' ' ' ALA . 89.0 mt -99.88 144.4 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.451 0.167 . . . . 0.0 110.613 -174.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 21.6 p -105.97 167.28 9.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.042 0.449 . . . . 0.0 111.549 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.555 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.0 p -73.17 151.06 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.711 174.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 8.5 t -116.41 68.26 0.73 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.231 0.539 . . . . 0.0 109.909 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 103.94 141.83 11.41 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.856 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.8 127.6 33.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.919 0.39 . . . . 0.0 110.946 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -123.57 126.04 45.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.119 0.485 . . . . 0.0 110.427 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 5.4 p -111.08 103.36 11.8 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.197 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -81.65 151.76 27.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.337 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -145.03 127.7 8.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.257 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.4 ' HD3' HG11 ' A' ' 313' ' ' VAL . 94.6 Cg_endo -86.6 176.48 4.73 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.763 2.309 . . . . 0.0 110.45 169.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.62 123.22 70.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.198 0.523 . . . . 0.0 111.104 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.0 148.2 46.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.295 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -81.5 92.28 6.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.283 0.563 . . . . 0.0 109.912 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -148.19 114.99 6.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.746 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 77.1 mt 69.34 94.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 O-C-N 124.151 0.907 . . . . 0.0 110.819 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -70.02 -21.55 63.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.817 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -74.93 -29.08 60.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.603 0.239 . . . . 0.0 111.033 -177.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -152.41 95.01 1.98 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.905 0.383 . . . . 0.0 110.193 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -161.51 86.42 0.11 Allowed Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 8.8 t30 58.54 73.59 0.47 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.358 0.599 . . . . 0.0 109.888 -176.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -81.7 -26.1 34.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.733 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 25.6 m -63.82 152.34 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.087 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -81.27 104.81 11.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.308 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 7.4 p -159.69 124.84 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.689 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -68.22 125.28 25.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.562 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -92.84 -15.25 26.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.394 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -82.14 -15.26 53.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.068 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.414 ' CD1' ' HB ' ' A' ' 309' ' ' THR . 83.6 m-85 -114.0 140.44 48.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.669 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -110.19 135.32 51.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.249 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.3 OUTLIER -103.63 100.39 10.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.08 0.467 . . . . 0.0 110.58 -177.513 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.524 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.8 t -83.97 124.52 39.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.1 -170.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 21.8 m -93.74 106.21 18.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.259 0.552 . . . . 0.0 110.358 175.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.511 ' HB2' HG22 ' A' ' 264' ' ' THR . 21.8 mt -123.09 164.16 19.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.771 -176.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.7 m -57.48 -53.48 57.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.285 0.565 . . . . 0.0 109.987 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.615 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -136.85 133.53 35.94 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.257 177.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.511 HG22 ' HB2' ' A' ' 261' ' ' LEU . 4.3 p -127.96 17.48 6.73 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 11.4 m -80.32 150.49 29.92 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.772 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 91.72 -3.22 77.91 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.823 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 57.8 mtm -108.79 161.25 15.29 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.439 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 23.1 pttm -132.45 175.45 9.28 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -65.95 136.87 56.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.902 0.382 . . . . 0.0 110.338 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.99 7.6 62.4 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.213 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.439 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 44.3 m-20 -85.25 142.23 29.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.621 0.71 . . . . 0.0 109.903 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 1.3 tpmt? -87.71 115.32 25.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.776 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.541 HD11 HG21 ' A' ' 308' ' ' ILE . 6.8 pt -113.41 139.04 40.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.394 176.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 44.2 t -128.45 132.18 48.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.315 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -101.6 112.03 24.46 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.461 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.02 117.46 7.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.602 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.19 -11.19 26.68 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.458 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.2 133.55 58.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.444 ' NZ ' ' HB3' ' A' ' 279' ' ' LYS . 0.2 OUTLIER -159.16 162.89 36.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.963 0.411 . . . . 0.0 111.602 -178.193 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -81.11 156.66 25.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.266 -174.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.414 HD22 ' H ' ' A' ' 281' ' ' LEU . 1.4 mm? -81.68 152.14 27.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.437 -177.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.83 -56.46 0.47 Allowed Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.431 176.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -68.62 -19.84 64.45 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -174.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 71.0 mtm -75.45 -11.29 60.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.154 -177.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.24 -36.72 61.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.744 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -122.25 -39.9 2.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.724 0.297 . . . . 0.0 111.584 -177.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -82.59 119.18 23.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.086 0.47 . . . . 0.0 110.721 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.65 -28.03 12.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 73.8 mt -86.34 61.92 7.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.343 175.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -82.16 114.17 20.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.725 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.74 163.98 13.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.186 -177.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -95.6 143.88 26.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.695 177.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -54.56 123.17 12.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.374 -171.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.419 ' CG2' HD12 ' A' ' 343' ' ' LEU . 14.0 p -99.4 127.0 45.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.888 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 312' ' ' PRO . 86.0 m-85 -127.74 150.4 49.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.598 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 24.1 t -97.4 122.65 40.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.102 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.443 ' HA ' HG22 ' A' ' 308' ' ' ILE . 11.1 p -74.8 134.91 28.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.08 0.467 . . . . 0.0 109.949 177.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.404 HG21 ' CE1' ' A' ' 256' ' ' PHE . 37.3 t -98.59 -35.21 4.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.725 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -164.63 136.72 4.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 0.0 110.761 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 88.9 t -83.84 109.78 17.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 171.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 42.5 t -74.43 -59.33 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.708 -173.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -120.65 -14.5 8.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.413 0.625 . . . . 0.0 111.101 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 84.08 13.91 73.3 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -169.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 31.9 p -140.92 13.57 2.27 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 171.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.423 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 2.7 t60 -168.71 121.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.038 -170.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 258' ' ' THR . 2.0 m -119.71 162.97 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.654 -175.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -116.69 123.0 46.16 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 170.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.541 HG21 HD11 ' A' ' 273' ' ' ILE . 43.7 pt -122.44 170.69 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.38 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' THR . . . . . 0.414 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 5.1 t -153.41 144.85 16.44 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 172.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.18 179.84 25.69 Favored 'Cis proline' 0 C--N 1.345 0.368 0 C-N-CA 124.061 -1.225 . . . . 0.0 112.817 -1.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -88.97 119.7 69.87 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.977 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 295' ' ' PHE . 38.2 Cg_endo -69.68 116.48 4.57 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.673 2.249 . . . . 0.0 112.527 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.56 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -124.67 131.79 72.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.524 176.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 317' ' ' ASP . . . -78.96 130.92 36.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.259 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.34 -28.28 66.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.935 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -98.9 25.72 6.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.294 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' ASP . . . . . 0.546 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 10.0 t70 -78.59 123.55 27.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.2 m -83.5 3.29 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 16.8 m -109.77 18.63 20.0 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.672 0.272 . . . . 0.0 111.287 -174.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.8 pp -127.91 168.58 15.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.083 0.468 . . . . 0.0 111.945 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.424 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 4.1 m -102.82 169.97 6.86 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.568 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 99.2 Cg_exo -47.35 -48.95 13.95 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.234 2.623 . . . . 0.0 113.915 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -65.45 -33.95 77.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.284 0.564 . . . . 0.0 110.554 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.51 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 13.0 mm100 -67.44 -42.47 83.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.148 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -71.82 -17.01 62.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.913 0.387 . . . . 0.0 111.167 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.2 -29.16 67.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.067 0.46 . . . . 0.0 110.098 173.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -86.4 -13.17 47.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.827 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.56 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -58.41 143.68 44.48 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.29 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -131.13 -8.95 3.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.049 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.5 174.22 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.046 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -84.88 -45.23 12.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.684 0.278 . . . . 0.0 111.115 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 6.2 t -129.57 144.43 51.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.366 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.502 ' N ' ' HB2' ' A' ' 314' ' ' ALA . 22.5 m -68.22 169.48 10.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.414 ' HG ' HG21 ' A' ' 230' ' ' VAL . 21.4 tp -70.16 102.22 2.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -176.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.555 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -90.75 -173.69 3.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.312 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -73.3 158.98 34.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.89 0.376 . . . . 0.0 110.826 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 60.6 39.1 18.26 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.207 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.457 ' H ' HG12 ' A' ' 230' ' ' VAL . 26.1 mmt -104.6 133.08 50.05 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -89.01 137.6 32.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.066 0.46 . . . . 0.0 111.354 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 12.5 t -103.21 124.35 57.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.565 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -138.24 134.34 34.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.557 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.571 ' O ' ' HB ' ' A' ' 224' ' ' THR . 70.7 mt -88.46 119.72 36.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.917 0.389 . . . . 0.0 110.088 176.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.419 HD12 ' CG2' ' A' ' 294' ' ' THR . 40.8 mt -86.23 138.61 31.74 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.721 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -139.76 150.2 44.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.991 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.25 1.105 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.053 -177.238 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.724 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.0 m -132.13 22.19 4.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.091 0.472 . . . . 0.0 110.671 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.7 p -101.71 -32.15 10.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.936 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -76.31 96.28 3.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.395 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 33.7 p -81.36 80.5 7.75 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.194 -178.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -81.23 67.83 3.55 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 174.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 263' ' ' ALA . 40.0 mm -100.1 145.01 11.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.585 -0.308 . . . . 0.0 110.685 -174.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.2 p -128.16 159.97 33.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.291 0.567 . . . . 0.0 110.681 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.678 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.4 p -84.68 151.88 3.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.537 -175.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 67.8 m -109.14 82.23 1.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.841 0.353 . . . . 0.0 110.408 174.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 93.58 165.22 37.29 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.592 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 334' ' ' LEU . . . -84.22 114.15 21.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.874 0.368 . . . . 0.0 110.15 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -120.61 128.43 53.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.026 -175.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 333' ' ' SER . 26.9 p -145.84 102.08 3.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.4 0.619 . . . . 0.0 110.092 172.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.421 ' C ' ' HD3' ' A' ' 311' ' ' LYS . 79.3 m-85 -95.15 148.15 22.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.927 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 237' ' ' LYS . 12.9 mptt -110.01 146.0 33.25 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.974 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 254' ' ' ASN . 71.6 Cg_endo -82.57 130.36 6.02 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.494 2.129 . . . . 0.0 111.677 174.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 44.3 t -81.75 94.54 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.255 0.55 . . . . 0.0 110.561 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -90.33 161.07 15.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.383 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 93.6 m95 70.95 126.19 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 O-C-N 124.017 0.823 . . . . 0.0 111.332 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -99.28 112.25 24.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.057 178.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -109.33 -78.65 0.59 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -138.61 144.12 39.61 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -67.9 -10.52 53.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.161 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -77.78 -29.56 50.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.266 175.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -95.01 -64.33 0.99 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.713 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -86.66 70.84 10.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.627 0.727 . . . . 0.0 110.237 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -61.74 125.23 23.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.141 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.34 -13.51 11.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.516 0.674 . . . . 0.0 111.245 -174.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -82.62 68.76 9.2 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.318 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 7.8 p -177.29 156.82 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.612 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -76.93 75.28 3.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.131 0.491 . . . . 0.0 109.783 177.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 238' ' ' PRO . 23.1 p30 -91.56 -26.04 18.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.398 -177.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -93.96 -50.86 5.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.0 0.429 . . . . 0.0 110.021 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.436 ' CD2' ' HB ' ' A' ' 309' ' ' THR . 97.2 m-85 -85.72 152.02 23.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.531 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.41 ' HB2' ' HG3' ' A' ' 311' ' ' LYS . . . -105.08 118.24 36.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.611 0.244 . . . . 0.0 111.424 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -87.06 103.48 15.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.177 0.513 . . . . 0.0 110.586 175.399 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -82.22 118.23 29.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.021 -173.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 23.5 m -84.93 105.64 15.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.013 176.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.429 HD22 HG21 ' A' ' 340' ' ' VAL . 31.3 mt -126.09 166.45 16.98 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.949 -177.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.4 t -64.59 -52.85 55.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.096 0.474 . . . . 0.0 109.798 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.527 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.69 127.31 27.04 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.802 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 10.6 p -125.22 32.37 5.39 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 173.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 1.4 m -81.31 145.99 30.61 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.163 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 90.28 -2.8 81.63 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.758 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 59.7 mtt -97.79 146.3 25.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -133.05 172.73 12.25 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -59.36 138.49 57.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.034 0.445 . . . . 0.0 111.069 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 88.12 11.83 66.65 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.257 176.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.445 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 53.1 m-20 -90.64 153.84 20.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.555 0.678 . . . . 0.0 110.49 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -103.8 117.67 34.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.824 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.471 HD11 HG21 ' A' ' 308' ' ' ILE . 40.4 pt -112.72 139.87 35.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.137 178.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.506 ' HB3' HG22 ' A' ' 294' ' ' THR . 77.3 p -120.27 133.63 55.43 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.766 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -95.04 110.43 22.35 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 339' ' ' ALA . . . -70.83 118.72 13.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.122 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 108.49 -22.7 26.06 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.62 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 41.2 t -101.32 133.76 43.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -144.25 156.82 44.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.706 0.288 . . . . 0.0 111.131 -174.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.547 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 82.4 m-85 -77.55 169.35 18.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.599 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 86.1 mt -77.39 68.68 3.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.686 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -162.16 138.96 5.67 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.486 ' O ' ' HB3' ' A' ' 287' ' ' ASN . 73.6 mt-30 64.02 36.64 9.78 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.76 0.424 . . . . 0.0 110.575 -178.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 89.0 mmm -119.12 37.25 4.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.077 0.465 . . . . 0.0 111.182 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -98.25 -54.81 2.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.975 174.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -138.88 13.01 2.68 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.395 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 283' ' ' GLN . 39.5 t-20 -113.51 136.96 52.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.358 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 30.6 t -102.1 -26.92 3.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.294 0.569 . . . . 0.0 110.087 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 97.2 mt -85.0 48.85 1.63 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.685 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.28 170.67 11.27 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.393 177.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -67.83 118.23 10.79 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.943 0.401 . . . . 0.0 110.516 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -65.57 153.49 41.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.023 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.547 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -71.56 95.48 1.42 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.249 -177.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.506 HG22 ' HB3' ' A' ' 274' ' ' SER . 70.8 p -103.78 126.72 51.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.35 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.424 ' CE2' ' HG3' ' A' ' 312' ' ' PRO . 92.5 m-85 -131.59 155.98 46.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.888 0.375 . . . . 0.0 110.828 -179.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 5.6 m -100.86 129.5 46.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.153 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.445 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 11.9 p -83.17 135.93 23.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.143 0.497 . . . . 0.0 110.462 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 27.9 t -98.48 -28.91 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.704 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 307' ' ' GLU . 27.8 tpt180 -167.17 137.92 3.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.506 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 97.6 t -87.85 111.36 22.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 14.9 t -75.86 -56.43 8.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.869 -170.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -119.3 -6.06 10.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.902 0.382 . . . . 0.0 111.65 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.94 12.16 84.17 Favored Glycine 0 C--N 1.322 -0.202 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -170.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 6.6 p -148.03 19.85 1.11 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.444 ' NE2' ' HB ' ' A' ' 258' ' ' THR . 3.6 t-160 -167.08 116.93 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.052 -1.431 . . . . 0.0 107.965 -170.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -118.64 152.15 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -175.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 299' ' ' ARG . 9.9 pt-20 -110.37 118.07 35.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.079 0.466 . . . . 0.0 110.002 173.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.471 HG21 HD11 ' A' ' 273' ' ' ILE . 27.2 pt -120.57 171.06 9.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.531 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' THR . . . . . 0.436 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 7.1 t -148.91 140.32 14.21 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.625 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.4 -179.91 28.49 Favored 'Cis proline' 0 C--N 1.344 0.31 0 C-N-CA 123.906 -1.289 . . . . 0.0 112.375 -2.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 236' ' ' PHE . 37.2 ttmt -85.47 125.28 70.0 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.954 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.424 ' HG3' ' CE2' ' A' ' 295' ' ' PHE . 16.1 Cg_exo -67.74 108.97 1.76 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.661 2.241 . . . . 0.0 112.755 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.59 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -120.92 131.23 73.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.744 173.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -91.62 141.06 29.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.334 0.588 . . . . 0.0 111.377 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.7 tm? -72.84 -22.89 60.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.567 177.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.4 17.38 14.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.409 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.07 115.26 22.28 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 9.4 p -83.11 -9.68 11.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.005 0.431 . . . . 0.0 111.29 -175.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 15.0 m -82.33 -29.75 30.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.347 -174.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 2.4 pp -84.65 162.62 19.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.4 0.619 . . . . 0.0 112.002 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.491 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 41.9 m -95.93 166.07 15.19 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.076 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 71.3 Cg_exo -43.68 -44.23 11.33 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.554 2.836 . . . . 0.0 114.666 -177.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.27 -33.91 75.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.254 0.55 . . . . 0.0 111.201 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 46.4 mt-30 -79.86 -36.93 35.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.675 -175.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.446 ' HB3' ' CD1' ' A' ' 320' ' ' LEU . 13.6 ptm180 -73.2 -20.19 60.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.053 0.454 . . . . 0.0 110.161 177.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.01 -29.89 69.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.994 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -101.19 11.37 39.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.378 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.59 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -59.67 149.74 29.65 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.88 0.372 . . . . 0.0 111.212 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -125.95 -36.29 2.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.711 -176.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 30.7 m -110.31 155.19 11.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.229 0.537 . . . . 0.0 111.182 -175.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -85.61 -17.04 37.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.428 -176.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.1 t -144.0 139.74 29.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.225 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 235' ' ' SER . 73.0 m -70.89 163.62 27.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.241 175.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.418 ' HG ' HG21 ' A' ' 230' ' ' VAL . 29.0 tp -69.05 104.26 2.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.678 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -78.98 170.23 17.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.699 -175.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -76.44 12.41 1.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -170.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -152.93 65.31 0.78 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.356 0.598 . . . . 0.0 110.347 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.513 ' H ' HG12 ' A' ' 230' ' ' VAL . 22.2 mmt -114.85 141.95 47.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.255 178.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 339' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 276' ' ' ALA . . . -90.77 129.62 36.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.528 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 19.2 t -104.19 117.27 49.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -131.57 138.72 48.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.747 0.308 . . . . 0.0 111.185 -174.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 3.3 mt -90.42 133.37 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.137 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 60.4 mt -80.96 147.4 30.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.31 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -95.84 99.87 11.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.277 -175.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.569 175.429 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.658 0 N-CA-C 111.865 -0.494 . . . . 0.0 111.865 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 13.3 m 60.77 37.14 19.02 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.749 0.42 . . . . 0.0 111.427 178.068 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 7.0 p -104.49 -43.41 5.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.038 0.447 . . . . 0.0 111.106 -179.051 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -92.02 74.61 5.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.571 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 53.8 p -107.37 89.4 2.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.344 0.592 . . . . 0.0 110.811 179.138 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -123.39 48.12 0.97 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 175.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.573 HG21 ' O ' ' A' ' 263' ' ' ALA . 17.4 mt -87.26 150.46 3.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -175.495 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 6.1 p -107.86 166.02 11.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.309 0.576 . . . . 0.0 111.722 -178.439 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.636 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.7 p -72.82 150.32 8.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.971 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.492 ' HB2' ' N ' ' A' ' 262' ' ' SER . 7.0 t -110.87 74.48 0.87 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.344 0.592 . . . . 0.0 109.72 177.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 92.8 144.3 14.3 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.996 -178.312 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.51 126.89 29.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.857 0.361 . . . . 0.0 110.808 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -125.33 126.35 44.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.134 -179.098 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.9 m -105.65 104.42 14.14 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.693 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.406 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 55.8 m-85 -80.52 113.64 18.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.977 -176.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -124.64 121.78 25.76 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.92 0.391 . . . . 0.0 111.763 -174.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.481 ' HA ' ' OD1' ' A' ' 254' ' ' ASN . 76.2 Cg_endo -86.01 128.55 3.24 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.782 2.321 . . . . 0.0 110.997 170.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 5.4 p -86.57 108.9 18.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.599 0.714 . . . . 0.0 110.859 -177.412 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -81.35 81.18 7.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.054 178.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -128.99 75.73 1.67 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.91 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -142.3 101.88 3.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.979 177.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 53.4 mt -105.74 -13.13 15.64 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 176.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -166.48 -171.4 1.89 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.029 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.508 ' O ' ' HE2' ' A' ' 249' ' ' LYS . 4.1 p-10 -65.16 -30.7 71.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 117.639 0.199 . . . . 0.0 111.321 -178.379 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -89.51 40.99 1.02 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.932 0.396 . . . . 0.0 111.394 -178.533 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -95.17 -126.84 4.97 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 176.042 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -88.14 66.06 8.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.289 0.566 . . . . 0.0 109.609 174.552 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.508 ' HE2' ' O ' ' A' ' 245' ' ' ASN . 21.8 ttmm -85.14 -57.93 2.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.113 -177.302 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 251' ' ' ASN . 14.4 m -79.96 99.32 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.661 0.743 . . . . 0.0 111.469 -177.203 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 251' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 250' ' ' VAL . 26.4 t-20 168.79 119.29 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.841 -178.401 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.4 m -119.4 36.07 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.549 0.69 . . . . 0.0 110.333 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -120.31 -47.9 2.34 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.966 -178.007 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' A' ' 238' ' ' PRO . 19.7 t-20 -68.73 -14.35 62.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.349 -174.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -82.7 -6.58 59.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.09 177.342 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.83 154.86 39.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.807 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -101.99 115.69 31.09 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.727 0.299 . . . . 0.0 110.408 178.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.7 OUTLIER -92.78 103.61 15.95 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.164 0.507 . . . . 0.0 109.995 179.639 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.1 t -82.84 117.0 28.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.466 -171.189 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 16.2 m -87.04 105.3 17.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.101 177.271 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.48 HD12 HG22 ' A' ' 264' ' ' THR . 29.0 mt -125.59 162.73 24.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.13 -176.163 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.492 ' N ' ' HB2' ' A' ' 231' ' ' SER . 14.0 m -62.21 -50.2 72.73 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.428 0.632 . . . . 0.0 109.697 179.229 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.573 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -138.13 142.06 40.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.269 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.48 HG22 HD12 ' A' ' 261' ' ' LEU . 19.1 p -129.39 26.86 5.36 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.087 0.946 . . . . 0.0 108.875 174.296 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 15.5 m -77.71 138.3 38.97 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.343 -1.298 . . . . 0.0 109.513 175.55 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 104.9 -7.1 44.45 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -172.224 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 267' ' ' MET . . . . . 0.451 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 61.1 mtt -101.5 144.74 29.89 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.389 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -154.89 141.98 19.31 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.518 ' HA ' HG13 ' A' ' 297' ' ' VAL . 24.3 ptt180 -44.46 116.52 1.05 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.96 0.788 . . . . 0.0 112.582 -171.586 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.62 -6.63 20.44 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.426 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.549 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.6 p30 -85.15 -177.9 6.64 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.482 0.641 . . . . 0.0 111.534 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -124.65 117.11 23.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.897 -177.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.503 HD11 HG21 ' A' ' 308' ' ' ILE . 40.8 pt -112.72 139.88 35.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.108 0.48 . . . . 0.0 110.208 177.363 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.501 ' OG ' HG22 ' A' ' 294' ' ' THR . 4.9 m -127.98 149.28 50.42 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.822 -178.504 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -113.59 111.85 22.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.424 -178.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.52 115.71 6.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.823 -178.42 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.32 -25.62 12.2 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.708 -178.258 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 47.2 t -99.04 115.15 38.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.437 ' HD3' ' HB3' ' A' ' 290' ' ' ALA . 15.9 ptpt -132.7 162.55 31.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.867 0.365 . . . . 0.0 111.896 -173.541 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.457 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 60.1 m-85 -80.46 154.16 27.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.86 -175.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 315' ' ' LEU . 40.2 mt -81.94 161.34 23.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.796 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 102.11 -3.56 51.68 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.492 175.027 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.414 ' OE1' ' HG2' ' A' ' 291' ' ' GLN . 89.5 mt-30 -123.74 -16.48 6.67 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.835 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 70.1 mtm -79.67 14.3 1.74 Allowed 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.084 -0.385 . . . . 0.0 111.923 -173.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -95.63 -21.5 18.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.926 0.393 . . . . 0.0 110.729 178.678 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -154.25 -46.6 0.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.564 -178.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -75.84 95.04 3.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.394 -178.638 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.55 -32.12 55.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.16 -176.169 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 85.2 mt -84.17 49.51 1.67 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.152 0.501 . . . . 0.0 110.005 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.437 ' HB3' ' HD3' ' A' ' 279' ' ' LYS . . . -57.89 128.79 38.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.112 -178.377 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 291' ' ' GLN . . . . . 0.414 ' HG2' ' OE1' ' A' ' 283' ' ' GLN . 23.7 pt20 -60.98 132.96 55.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.443 -176.564 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -72.48 166.13 23.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.942 177.501 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.516 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -70.69 87.9 0.69 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.464 -176.542 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.501 HG22 ' OG ' ' A' ' 274' ' ' SER . 70.5 p -90.99 112.53 24.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.288 178.416 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.516 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 68.0 m-85 -123.07 145.43 48.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.931 0.396 . . . . 0.0 110.857 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 11.9 m -80.3 130.0 34.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.696 175.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.549 HG12 ' H ' ' A' ' 271' ' ' ASP . 5.2 p -67.75 132.72 32.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.255 0.55 . . . . 0.0 109.668 179.293 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.425 HG23 ' HA ' ' A' ' 308' ' ' ILE . 84.6 t -94.07 -45.34 13.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.105 178.751 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -167.51 139.08 3.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.126 178.675 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 93.7 t -88.11 108.79 18.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 171.363 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.0 t -78.54 -59.66 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.971 -173.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -111.91 -8.16 14.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.948 0.404 . . . . 0.0 111.529 -174.081 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.16 12.85 83.22 Favored Glycine 0 CA--C 1.517 0.193 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -170.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 20.4 p -146.05 16.25 1.37 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 174.417 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.44 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 1.6 t60 -170.73 115.53 0.46 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.384 -168.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.58 161.92 18.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.537 -175.227 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -116.22 129.29 56.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.003 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.511 HG22 ' HA ' ' A' ' 297' ' ' VAL . 27.1 pt -132.07 169.83 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.031 0.443 . . . . 0.0 111.471 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 7.2 t -150.02 143.58 16.78 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.41 177.575 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -76.44 -179.95 29.0 Favored 'Cis proline' 0 C--N 1.345 0.378 0 C-N-CA 124.129 -1.196 . . . . 0.0 112.419 -3.113 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.406 ' HG3' ' HB3' ' A' ' 236' ' ' PHE . 35.9 ttmt -87.41 123.35 69.84 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.207 -178.016 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.15 109.29 2.9 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.593 2.196 . . . . 0.0 112.658 178.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.477 ' CG2' ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -107.06 133.92 50.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.62 175.745 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.447 ' HB2' ' N ' ' A' ' 333' ' ' SER . . . -82.84 126.06 32.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.11 0.481 . . . . 0.0 111.409 -178.458 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.546 ' HB2' HD11 ' A' ' 281' ' ' LEU . 2.7 tm? -68.64 -29.6 68.13 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.968 177.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -79.52 -0.81 34.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.751 -179.073 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -79.92 122.5 26.76 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.984 0.421 . . . . 0.0 110.622 -178.675 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 14.2 p -83.96 -16.64 10.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.237 -178.559 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 24.5 m -74.42 -35.82 63.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.721 -175.189 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.474 ' O ' HD12 ' A' ' 320' ' ' LEU . 1.7 pp -75.4 152.64 38.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.276 0.56 . . . . 0.0 110.884 178.423 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.508 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.8 m -91.09 170.84 9.06 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.259 -173.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 91.2 Cg_exo -46.98 -50.45 10.89 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 123.446 2.764 . . . . 0.0 114.517 -175.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.35 -28.85 69.98 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.149 -177.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 50.9 mt-30 -76.03 -39.65 55.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.631 0.253 . . . . 0.0 111.026 -178.663 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.445 ' HB3' ' CD1' ' A' ' 320' ' ' LEU . 13.0 ptp180 -73.37 -22.85 60.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.009 0.433 . . . . 0.0 110.538 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.87 -34.21 77.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.217 174.02 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -96.6 6.23 49.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.185 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.477 ' HA ' ' CG2' ' A' ' 313' ' ' VAL . . . -61.41 135.61 57.75 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.887 0.375 . . . . 0.0 110.753 178.664 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -108.89 -29.2 8.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.365 -176.121 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.8 171.53 9.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.946 0.403 . . . . 0.0 111.132 -175.345 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -88.55 -38.77 14.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.449 -178.055 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.1 t -128.3 143.17 50.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.909 0.385 . . . . 0.0 110.763 -176.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.447 ' N ' ' HB2' ' A' ' 314' ' ' ALA . 44.1 m -72.29 162.71 29.09 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 172.389 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.419 ' HG ' HG21 ' A' ' 230' ' ' VAL . 23.0 tp -68.66 102.42 1.5 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -177.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.636 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -95.72 -179.24 4.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.269 -178.337 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -67.57 150.45 48.79 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.094 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 65.45 45.62 2.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.819 179.195 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 26.4 mmt -112.0 131.07 55.63 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.207 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -87.07 133.6 33.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.604 -176.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.424 HG21 HD22 ' A' ' 261' ' ' LEU . 10.3 t -101.83 114.86 42.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.476 177.569 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -125.85 134.52 51.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.098 -174.035 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 19.5 mt -93.01 131.43 40.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 174.207 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 68.0 mt -74.18 111.34 9.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.022 0.439 . . . . 0.0 110.586 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -94.67 82.74 3.97 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.517 178.358 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.733 -178.719 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.781 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.8 m -87.87 -42.75 12.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.853 0.359 . . . . 0.0 110.696 -179.568 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 18.4 m -111.35 70.56 0.72 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.492 0.663 . . . . 0.0 110.257 178.678 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -130.17 123.54 30.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.26 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 23.1 p -77.84 79.06 4.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.222 0.534 . . . . 0.0 111.501 -177.704 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.43 68.1 3.39 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 174.433 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.541 ' HB ' ' O ' ' A' ' 340' ' ' VAL . 40.6 mm -100.17 143.45 13.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 122.339 0.256 . . . . 0.0 111.101 -173.356 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 74.4 p -121.89 149.41 43.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.195 0.521 . . . . 0.0 110.506 173.166 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.668 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.5 p -64.48 152.97 8.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.678 175.65 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 14.2 t -124.58 88.78 2.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.914 0.388 . . . . 0.0 110.017 175.539 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 103.4 165.34 25.51 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.038 -178.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -86.52 125.13 33.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.718 0.294 . . . . 0.0 110.428 179.145 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -120.58 129.51 53.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.929 0.395 . . . . 0.0 110.961 -176.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 25.5 t -153.89 103.04 2.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.899 177.404 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -114.26 141.65 47.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.892 -179.244 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 237' ' ' LYS . 2.9 mptp? -111.9 145.89 33.66 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.822 -175.544 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.25 128.37 12.86 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.261 1.974 . . . . 0.0 110.846 174.115 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.467 HG13 ' HB3' ' A' ' 242' ' ' GLN . 13.5 t -78.05 84.93 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.333 0.587 . . . . 0.0 110.382 -175.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -89.41 86.04 6.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.575 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 11.5 t90 56.08 68.78 0.81 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.604 0.716 . . . . 0.0 110.206 -177.487 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 242' ' ' GLN . . . . . 0.467 ' HB3' HG13 ' A' ' 239' ' ' VAL . 50.3 tt0 -138.3 105.91 5.59 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.634 -178.015 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 82.7 mt 70.47 4.61 5.01 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.651 -177.344 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 60.83 -171.07 0.15 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.966 -177.44 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -82.58 -15.34 52.6 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.292 0.567 . . . . 0.0 109.689 175.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -80.17 -43.09 22.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.212 -177.376 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.72 -22.95 78.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.785 -176.625 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -83.88 90.31 7.35 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.139 0.495 . . . . 0.0 110.205 178.195 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -77.75 -33.85 52.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.066 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 252' ' ' VAL . 27.5 m -78.16 152.71 5.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.113 176.18 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -92.87 85.66 5.24 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.051 0.453 . . . . 0.0 110.949 -176.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 250' ' ' VAL . 38.8 t -87.79 127.91 40.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.697 176.735 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.583 ' OD2' ' HA ' ' A' ' 257' ' ' ALA . 0.8 OUTLIER -58.51 116.08 3.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.17 0.51 . . . . 0.0 110.231 176.365 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -90.79 -50.8 5.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.836 -176.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -88.74 -30.22 19.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.112 -176.697 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.504 ' CE1' HG21 ' A' ' 298' ' ' VAL . 48.1 m-85 -102.64 -175.09 2.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.306 -179.085 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.583 ' HA ' ' OD2' ' A' ' 253' ' ' ASP . . . -145.36 118.44 8.85 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.861 176.33 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 3.8 m -83.22 113.01 20.37 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.076 0.465 . . . . 0.0 110.484 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.5 t -98.08 120.5 47.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.427 -173.542 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 79.5 m -89.64 108.2 19.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.04 0.448 . . . . 0.0 109.958 174.167 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.51 HD23 HG23 ' A' ' 230' ' ' VAL . 23.9 mt -125.04 168.32 13.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.732 -177.684 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.8 t -64.7 -52.84 55.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.532 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.68 127.24 26.94 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.328 179.426 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.419 ' CG2' ' HB2' ' A' ' 261' ' ' LEU . 11.5 p -125.23 25.5 7.15 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.885 174.76 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 24.1 m -82.01 145.29 30.32 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.156 175.626 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.93 -18.17 57.2 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -173.333 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 59.9 mtt -91.46 138.81 31.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.936 -0.632 . . . . 0.0 109.317 176.245 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -133.35 153.61 51.43 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.339 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.423 ' HA ' HG13 ' A' ' 297' ' ' VAL . 30.9 ptt180 -58.13 134.63 56.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.971 0.415 . . . . 0.0 111.366 -175.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 99.6 14.45 34.87 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.296 -177.399 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.528 ' H ' HG12 ' A' ' 297' ' ' VAL . 0.6 OUTLIER -109.45 175.59 5.39 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.8 0.3 . . . . 0.0 110.224 179.487 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.468 ' HE3' HD12 ' A' ' 343' ' ' LEU . 5.2 tmmm? -127.09 117.49 22.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.564 -174.371 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.439 HD11 HG21 ' A' ' 308' ' ' ILE . 31.0 pt -111.65 142.57 23.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.906 -177.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 14.8 m -124.55 138.55 54.32 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.507 -178.785 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -100.87 112.0 24.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.485 -178.51 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.96 116.56 9.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.97 -178.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.19 -34.22 5.3 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 60.2 t -89.06 122.09 39.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 175.145 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -139.88 158.38 44.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.043 0.449 . . . . 0.0 111.608 -176.137 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -73.48 145.41 45.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.155 -173.209 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 315' ' ' LEU . 77.2 mt -69.77 141.32 53.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.359 176.612 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.46 -22.59 15.59 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.344 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.604 ' O ' ' HA ' ' A' ' 290' ' ' ALA . 11.8 mm100 -91.2 25.96 2.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.678 0.275 . . . . 0.0 111.109 -176.496 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 54.9 mtt -108.26 -22.51 12.32 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 172.502 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -88.53 -55.65 3.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.307 177.359 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -64.86 -59.87 3.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.567 177.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 287' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 283' ' ' GLN . 14.4 m120 -81.01 101.57 9.63 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 171.486 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 64.1 t -61.81 -33.77 59.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.994 -177.071 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 74.0 mt -92.9 -2.58 55.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.806 177.354 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 283' ' ' GLN . . . 63.65 168.56 0.15 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.41 -178.381 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -130.69 126.33 36.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.395 176.036 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.2 157.61 37.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.056 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.584 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -60.39 102.56 0.18 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.526 -170.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.466 ' HB ' ' HD3' ' A' ' 272' ' ' LYS . 19.7 p -95.19 111.19 23.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.603 177.045 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.584 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 65.1 m-85 -123.68 150.53 44.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.859 0.362 . . . . 0.0 110.897 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 16.2 m -96.06 134.03 39.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.255 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 271' ' ' ASP . 9.5 p -86.98 135.53 24.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.964 0.411 . . . . 0.0 110.359 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.504 HG21 ' CE1' ' A' ' 256' ' ' PHE . 46.0 t -105.48 -31.5 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.274 -176.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -162.27 138.4 7.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.826 0.346 . . . . 0.0 110.593 -178.345 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 89.3 t -92.4 114.23 28.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.83 -59.29 3.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.842 -172.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.77 -2.47 10.91 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.873 0.368 . . . . 0.0 111.794 -174.129 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.08 11.71 83.84 Favored Glycine 0 N--CA 1.459 0.2 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -174.075 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 5.9 p -150.75 23.03 0.78 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 173.179 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.465 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.2 t-160 -167.78 112.75 0.68 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 113.594 -1.639 . . . . 0.0 107.896 -165.454 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.27 169.89 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.559 -174.174 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 10.9 pt-20 -128.22 121.74 30.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.215 0.531 . . . . 0.0 109.931 169.589 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 273' ' ' ILE . 22.7 pt -120.98 174.65 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.143 -177.136 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.7 t -155.19 147.06 17.18 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.121 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -69.23 179.94 19.86 Favored 'Cis proline' 0 C--N 1.349 0.567 0 C-N-CA 124.163 -1.182 . . . . 0.0 113.162 -2.403 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 24.1 ttmm -82.26 124.81 78.02 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.212 -177.402 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 13.3 Cg_exo -69.25 109.89 2.32 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.84 2.36 . . . . 0.0 112.606 177.106 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -126.04 130.69 72.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.905 174.161 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -95.32 143.7 26.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.272 0.558 . . . . 0.0 111.506 -175.431 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.527 ' HB2' HD11 ' A' ' 281' ' ' LEU . 2.6 tm? -76.43 -26.5 55.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.101 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -98.05 26.0 5.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.647 178.381 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 317' ' ' ASP . . . . . 0.51 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 20.3 t70 -86.14 131.3 34.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.528 -179.412 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 11.3 p -84.49 -18.53 9.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.946 -176.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 19.7 m -91.77 5.11 51.09 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -168.731 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' A' ' 325' ' ' ARG . 0.8 OUTLIER -115.67 157.53 24.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.365 0.602 . . . . 0.0 112.056 -179.378 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 16.9 m -86.55 158.47 54.28 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.552 177.774 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.574 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 61.9 Cg_exo -39.66 -49.78 3.27 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.434 3.423 . . . . 0.0 114.882 -176.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.9 -39.39 85.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.849 0.357 . . . . 0.0 111.68 -177.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -72.71 -29.57 63.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -172.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 9.7 ptm180 -76.14 -18.77 58.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.449 0.642 . . . . 0.0 109.862 178.43 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.79 -21.7 61.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.78 172.241 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -96.74 1.24 50.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.706 175.501 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.527 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -59.09 144.43 45.56 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.551 179.412 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -118.17 -27.28 6.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.436 -176.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.8 m -119.31 170.89 8.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.685 0.278 . . . . 0.0 111.218 -177.606 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -82.71 -53.97 5.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.922 -176.715 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.4 t -114.91 145.28 42.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.066 0.46 . . . . 0.0 110.876 -171.682 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.0 m -75.23 154.62 37.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.438 178.563 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.451 ' HG ' HG21 ' A' ' 230' ' ' VAL . 16.7 tp -70.1 103.34 2.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.092 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.668 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -95.76 162.33 13.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.958 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 336' ' ' ASP . . . . . 0.458 ' HA ' HG13 ' A' ' 230' ' ' VAL . 38.4 t70 -75.21 62.72 1.27 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.097 0.475 . . . . 0.0 112.1 -174.143 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -176.6 33.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.696 171.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.451 ' H ' HG12 ' A' ' 230' ' ' VAL . 23.9 mmt -104.54 130.7 52.48 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -83.63 135.1 34.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.607 178.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.541 ' O ' ' HB ' ' A' ' 228' ' ' ILE . 22.0 t -112.22 115.05 48.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.525 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -132.6 135.2 45.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.875 0.369 . . . . 0.0 111.6 -174.118 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.407 ' CG1' HG22 ' A' ' 273' ' ' ILE . 45.8 mt -84.29 123.59 39.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.855 174.072 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.468 HD12 ' HE3' ' A' ' 272' ' ' LYS . 51.3 mt -80.04 112.31 17.22 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.846 178.839 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -86.25 146.52 26.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.526 -178.772 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 51.4 t . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.537 -0.744 . . . . 0.0 110.289 -178.727 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 14.3 p -93.75 38.92 1.06 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.052 0.453 . . . . 0.0 110.963 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.6 m -80.76 60.73 4.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.426 0.631 . . . . 0.0 110.293 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -118.27 129.6 55.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.217 -179.316 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.433 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 16.3 p -121.67 -92.37 0.54 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.383 -178.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 60.45 36.98 92.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.7 -177.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 58.6 mt -91.17 144.04 9.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -176.151 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 13.4 p -96.65 153.26 17.96 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.555 0.693 . . . . 0.0 111.998 -172.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.654 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.6 p -67.06 151.09 10.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.052 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 71.5 m -113.75 82.0 1.62 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.919 0.39 . . . . 0.0 110.463 177.104 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 95.34 147.57 22.85 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.013 -179.375 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -82.59 139.07 34.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.839 0.352 . . . . 0.0 111.116 -177.64 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -141.38 135.18 30.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.251 0.548 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.9 p -139.87 103.07 4.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.245 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -115.38 153.95 30.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.352 -177.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 320' ' ' LEU . 13.4 mptt -108.63 138.76 20.35 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.077 177.316 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.03 147.23 38.18 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.677 2.251 . . . . 0.0 112.112 -179.762 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.411 ' CG1' ' HB2' ' A' ' 254' ' ' ASN . 4.3 p -67.82 101.08 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.552 0.691 . . . . 0.0 110.829 179.309 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.34 152.69 45.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.631 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -92.58 96.33 10.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.556 -178.006 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -81.26 -153.29 0.1 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.504 174.639 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.0 177.56 8.77 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.418 177.587 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.39 -61.0 2.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.947 0.403 . . . . 0.0 110.338 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -70.86 -41.49 71.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.21 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -105.44 75.96 1.18 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.291 176.226 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -168.68 -125.22 0.77 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.041 -179.139 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -147.35 119.71 8.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.401 0.62 . . . . 0.0 111.05 179.725 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -105.06 69.93 0.88 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.555 176.413 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.9 m -101.1 150.46 5.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.402 -174.857 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -105.72 24.12 12.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.424 0.63 . . . . 0.0 110.305 178.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 25.1 m -120.27 144.01 30.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.092 178.438 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.37 82.7 5.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.351 0.596 . . . . 0.0 111.492 -177.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.411 ' HB2' ' CG1' ' A' ' 239' ' ' VAL . 90.5 m-20 -77.5 4.95 9.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.71 176.608 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.546 ' HD2' ' H ' ' A' ' 255' ' ' ARG . 1.8 mpt_? -74.36 -40.08 62.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.353 -178.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -78.83 147.53 33.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.725 -175.851 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.55 124.87 46.7 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.343 178.269 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.3 m -93.37 101.41 13.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.302 0.572 . . . . 0.0 110.363 -179.374 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -82.97 122.92 38.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.146 -173.557 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 29.8 m -98.01 106.43 18.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.36 0.6 . . . . 0.0 110.299 179.179 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.443 HD23 HG23 ' A' ' 230' ' ' VAL . 16.5 mt -125.08 164.56 19.94 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.727 -174.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 51.1 m -58.54 -54.75 43.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.198 0.523 . . . . 0.0 109.927 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -136.78 130.66 32.25 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.258 178.304 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.402 ' CG2' ' HB2' ' A' ' 261' ' ' LEU . 10.5 p -126.37 25.94 6.49 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.183 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.7 m -79.68 143.13 34.88 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.69 -1.595 . . . . 0.0 109.819 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 99.29 -19.76 52.64 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -175.204 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 85.2 mtp -75.72 152.56 37.44 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.131 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -154.83 147.26 24.03 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -178.232 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.478 ' HA ' HG13 ' A' ' 297' ' ' VAL . 32.1 ptt180 -51.9 114.43 1.3 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.366 0.603 . . . . 0.0 111.15 -176.066 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 116.33 6.13 15.94 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.557 -174.078 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -88.7 179.84 6.16 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 117.094 0.447 . . . . 0.0 110.928 176.067 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 0.2 OUTLIER -141.45 117.18 10.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.647 -178.115 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 308' ' ' ILE . 21.9 pt -113.22 139.95 35.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.026 0.441 . . . . 0.0 110.876 -178.584 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 69.9 p -120.88 133.99 55.3 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.706 176.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.471 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 95.5 m-85 -94.11 111.46 23.18 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.179 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.481 ' HA ' ' OD1' ' A' ' 292' ' ' ASP . . . -66.0 111.53 3.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.02 -177.671 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.22 -35.3 4.73 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.7 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 83.9 t -82.62 129.69 37.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 173.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.412 ' HD2' ' SD ' ' A' ' 284' ' ' MET . 10.0 ptpp? -148.35 160.23 43.21 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.26 -175.542 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -77.08 150.94 35.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.931 -178.661 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.0 130.58 47.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.765 177.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 124.39 -5.32 8.74 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 -177.464 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -110.03 164.06 12.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.587 -0.306 . . . . 0.0 110.224 178.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.412 ' SD ' ' HD2' ' A' ' 279' ' ' LYS . 90.7 mtp 71.76 -31.33 0.22 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.574 0.75 . . . . 0.0 112.766 176.772 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -58.51 -40.49 83.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.074 0.464 . . . . 0.0 110.84 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -142.91 -36.29 0.39 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.07 176.596 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -79.89 113.95 18.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.713 179.58 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 23.1 t -77.69 -32.05 17.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.231 0.539 . . . . 0.0 109.641 177.636 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 86.1 mt -75.69 92.87 3.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.817 176.661 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -108.9 123.69 49.48 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.516 -171.634 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -87.04 127.9 35.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.426 -179.451 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.481 ' OD1' ' HA ' ' A' ' 276' ' ' ALA . 57.3 m-20 -62.9 146.93 51.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.182 -178.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -58.66 108.97 0.71 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.607 -175.432 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.3 p -91.49 118.17 30.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.164 -178.367 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.67 148.25 48.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.225 177.473 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 25.4 m -98.67 136.73 38.32 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.603 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' A' ' 269' ' ' ARG . 8.7 p -67.56 142.56 16.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.449 178.566 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.2 t -105.74 -45.03 8.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.742 173.274 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -154.94 139.36 16.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.637 179.589 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 77.3 t -86.05 109.23 18.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 171.388 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 31.9 t -76.45 -58.26 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.821 -172.366 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -122.58 -2.7 8.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.866 0.365 . . . . 0.0 111.318 -176.085 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 72.18 12.88 76.37 Favored Glycine 0 CA--C 1.518 0.268 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -172.056 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 4.4 p -149.11 21.75 0.97 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.176 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.468 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.9 t-160 -173.41 115.73 0.25 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 113.833 -1.531 . . . . 0.0 107.667 -167.326 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.64 162.67 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -173.63 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 10.1 pt-20 -123.19 126.11 46.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.113 0.482 . . . . 0.0 110.189 171.744 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.42 HG21 HD11 ' A' ' 273' ' ' ILE . 25.5 pt -125.24 168.8 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.38 -176.031 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 6.0 t -140.59 138.47 18.68 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.802 176.381 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.04 179.45 25.95 Favored 'Cis proline' 0 C--N 1.344 0.318 0 C-N-CA 123.364 -1.515 . . . . 0.0 112.411 -1.403 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 3.0 ttmp? -80.12 123.57 83.31 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.384 177.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 15.0 Cg_exo -67.85 113.36 2.97 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.821 2.348 . . . . 0.0 112.647 178.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.602 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -117.32 128.96 74.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.125 174.817 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -81.19 130.62 35.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.261 0.553 . . . . 0.0 111.201 -178.484 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.0 tm? -65.18 -27.06 68.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.052 177.325 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.43 10.94 27.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.567 -178.732 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 317' ' ' ASP . . . . . 0.404 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 12.9 t70 -74.68 128.96 36.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.789 0.328 . . . . 0.0 110.133 178.652 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.1 p -83.92 -17.89 10.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.93 0.395 . . . . 0.0 111.58 -175.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 12.3 m -79.06 -36.33 41.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.489 -173.542 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.557 HD13 ' HB3' ' A' ' 325' ' ' ARG . 1.5 pp -72.25 162.53 29.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.448 0.642 . . . . 0.0 112.141 -178.522 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.518 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 12.5 m -108.26 173.87 2.78 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.697 -179.009 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 72.8 Cg_exo -44.19 -53.17 4.98 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 123.429 2.753 . . . . 0.0 114.987 -173.172 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -62.96 -39.12 93.72 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.071 -176.425 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -65.38 -41.37 93.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.452 -179.006 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.557 ' HB3' HD13 ' A' ' 320' ' ' LEU . 5.4 ppt_? -74.68 -19.0 60.44 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.972 179.132 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.78 -18.39 62.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.202 173.119 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -103.21 -0.61 30.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.485 176.539 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.602 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -62.27 127.33 30.84 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.774 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -106.5 -26.61 11.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.493 -176.001 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 27.0 m -116.29 161.45 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.0 110.858 -177.739 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -89.18 -16.75 30.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.109 -177.493 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.3 t -143.01 139.46 30.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.967 0.413 . . . . 0.0 111.002 -178.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.425 ' N ' ' HB2' ' A' ' 314' ' ' ALA . 20.2 m -74.56 174.56 8.83 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.431 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 19.1 tp -78.05 102.89 7.66 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.507 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.654 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -84.04 169.29 15.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.147 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -81.36 32.26 0.34 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -171.424 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.94 48.57 0.39 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.059 0.457 . . . . 0.0 110.841 174.784 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.455 ' H ' HG12 ' A' ' 230' ' ' VAL . 26.2 mmt -110.68 137.66 48.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.243 179.541 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.48 132.58 40.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.946 0.403 . . . . 0.0 110.874 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 31.8 t -102.83 114.36 42.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.897 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 341' ' ' ASN . . . . . 0.433 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 8.4 t30 -126.07 124.46 40.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.398 -176.32 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 32.3 mt -77.65 128.54 38.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.921 172.004 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 74.9 mt -71.32 111.31 6.55 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.743 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -102.03 77.9 1.74 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.909 -177.381 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 36.6 t . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.725 178.864 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.86 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.555 ' HB2' ' O ' ' A' ' 266' ' ' GLY . 20.6 p -89.61 50.93 1.98 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.189 0.518 . . . . 0.0 111.438 -175.389 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 12.5 t -131.12 17.03 5.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.505 0.669 . . . . 0.0 109.879 176.582 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -125.92 102.46 7.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.921 179.013 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 11.7 p -90.01 -77.58 0.39 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.011 -176.378 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 63.07 33.66 87.86 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.769 -176.324 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.45 HG21 ' O ' ' A' ' 263' ' ' ALA . 51.4 mt -102.99 149.96 6.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -175.761 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.88 148.07 32.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.812 0.339 . . . . 0.0 110.487 177.617 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.58 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.9 p -53.97 151.75 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.589 178.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.45 ' HB2' ' N ' ' A' ' 262' ' ' SER . 9.4 t -100.79 69.57 1.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.068 0.461 . . . . 0.0 110.026 178.585 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 89.52 166.16 41.57 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.013 -178.761 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.11 117.49 10.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.995 0.426 . . . . 0.0 110.756 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -114.77 126.43 54.83 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.967 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 57.2 p -125.27 149.57 47.9 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.152 -178.058 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -125.75 154.87 41.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.631 -178.484 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -143.02 138.42 15.77 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.159 177.367 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.5 ' HD2' ' OE1' ' A' ' 324' ' ' GLN . 5.5 Cg_endo -84.91 118.02 2.01 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 121.766 1.644 . . . . 0.0 110.602 171.55 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.45 83.27 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.388 0.613 . . . . 0.0 109.8 -178.276 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -114.5 135.66 53.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.134 176.409 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -88.79 36.69 0.81 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.367 0.603 . . . . 0.0 110.581 -177.237 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 63.77 -168.55 0.2 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.373 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 94.4 mt 70.49 -73.14 0.1 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.789 0.681 . . . . 0.0 111.577 178.529 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -147.08 168.36 21.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.918 0.39 . . . . 0.0 111.043 -174.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -69.72 -16.26 63.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.104 176.28 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -93.97 23.99 4.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.248 175.599 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.85 -34.5 15.24 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.729 177.316 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -97.84 124.13 42.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.226 0.536 . . . . 0.0 110.403 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -80.2 -13.22 59.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.784 -175.264 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.6 m -67.21 125.74 25.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.136 0.494 . . . . 0.0 110.513 176.51 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -112.51 139.15 48.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.241 -173.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 20.6 t 59.0 75.38 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.535 176.475 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -169.21 -46.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.036 176.285 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -76.74 -22.98 53.07 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -174.216 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -81.53 -2.3 49.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.123 0.487 . . . . 0.0 110.11 175.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.429 ' CD2' ' HB ' ' A' ' 309' ' ' THR . 78.8 m-85 -121.26 160.21 24.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.814 -179.244 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -136.33 132.79 36.11 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.702 0.286 . . . . 0.0 110.771 178.194 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.7 m -98.94 103.05 14.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.109 0.481 . . . . 0.0 110.069 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.51 125.81 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.744 -171.212 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 23.5 m -93.4 106.15 18.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.193 175.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.451 ' HB2' HG22 ' A' ' 264' ' ' THR . 19.6 mt -126.0 160.62 29.56 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -177.388 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.459 ' O ' HG22 ' A' ' 304' ' ' THR . 15.9 p -61.57 -48.09 82.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.147 0.499 . . . . 0.0 110.127 -178.672 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.45 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -136.72 138.33 40.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.294 175.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.451 HG22 ' HB2' ' A' ' 261' ' ' LEU . 9.4 p -134.61 28.45 3.62 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.503 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.6 m -78.07 145.02 36.07 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.486 -178.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 266' ' ' GLY . . . . . 0.555 ' O ' ' HB2' ' A' ' 223' ' ' SER . . . 97.08 -4.12 62.55 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.428 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 62.0 mtt -93.58 158.57 15.63 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 178.392 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.444 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 25.1 pttm -150.08 163.8 37.24 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.594 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -56.07 123.99 16.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.068 0.461 . . . . 0.0 110.791 -178.244 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 98.72 18.25 25.89 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.418 178.132 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.451 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 0.3 OUTLIER -99.1 160.22 14.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.634 0.717 . . . . 0.0 110.127 179.056 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -108.96 117.07 33.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.834 -175.5 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 308' ' ' ILE . 36.8 pt -117.91 140.7 40.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.234 0.54 . . . . 0.0 110.407 177.415 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.436 ' HB2' HG22 ' A' ' 294' ' ' THR . 39.0 t -126.97 153.81 45.38 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.371 179.29 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -117.46 111.69 19.63 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.08 117.73 5.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.234 -177.538 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.03 -34.7 5.06 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 96.3 t -88.37 114.44 26.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.304 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.431 ' HD2' ' SD ' ' A' ' 284' ' ' MET . 9.0 ptpp? -137.12 157.15 47.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.962 0.411 . . . . 0.0 111.035 -175.914 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.421 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 63.0 m-85 -76.6 135.9 39.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.029 -176.239 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 68.9 mt -65.73 133.48 51.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.974 175.026 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 121.89 -16.21 8.87 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -171.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.415 ' OE1' ' HB2' ' A' ' 279' ' ' LYS . 98.0 mt-30 -92.23 -169.08 2.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.921 -0.639 . . . . 0.0 109.698 174.489 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.431 ' SD ' ' HD2' ' A' ' 279' ' ' LYS . 75.9 mtm 63.63 17.58 10.51 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.735 176.671 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -101.99 -51.04 3.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.3 0.572 . . . . 0.0 109.57 174.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -130.33 32.05 4.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.281 176.104 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -114.97 108.75 17.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.604 -175.232 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 43.4 t -67.78 -62.29 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.162 -176.123 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 82.2 mt -93.64 -32.56 14.03 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 176.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . 61.24 107.19 0.02 OUTLIER 'General case' 0 C--O 1.236 0.37 0 O-C-N 124.169 0.918 . . . . 0.0 112.218 178.722 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -65.46 122.44 17.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.396 0.617 . . . . 0.0 109.749 176.398 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -66.71 167.91 10.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.265 -175.753 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.421 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -49.61 110.07 0.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.621 -175.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.515 HG21 HD11 ' A' ' 343' ' ' LEU . 4.9 p -100.49 120.5 40.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.08 -178.249 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -122.44 151.28 41.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.629 -178.636 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.8 m -98.32 130.59 45.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.211 178.389 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.451 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 14.1 p -80.83 132.08 32.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.322 0.582 . . . . 0.0 110.629 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 37.3 t -91.53 -33.9 5.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.317 -178.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -166.37 139.9 4.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.418 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 57.5 t -88.32 107.36 17.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 169.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 39.9 t -68.59 -54.79 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.874 -172.048 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -128.5 -6.42 5.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.154 0.502 . . . . 0.0 111.514 -174.156 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.04 12.67 80.69 Favored Glycine 0 N--CA 1.457 0.095 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -176.245 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 304' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 262' ' ' SER . 0.7 OUTLIER -150.65 20.84 0.81 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.229 1.014 . . . . 0.0 108.304 175.03 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -172.02 115.07 0.34 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.35 -171.325 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.89 162.59 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.514 -172.92 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -119.79 120.04 35.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.052 0.453 . . . . 0.0 110.014 171.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.459 HG21 HD11 ' A' ' 273' ' ' ILE . 27.6 pt -119.87 171.59 8.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.047 -177.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 309' ' ' THR . . . . . 0.429 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 12.7 t -150.05 142.2 15.51 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.235 175.342 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.18 -179.53 27.42 Favored 'Cis proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.764 -1.348 . . . . 0.0 113.135 -1.563 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 31.0 ttmt -78.85 121.39 83.39 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.161 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 16.2 Cg_exo -67.25 109.5 1.78 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.697 2.265 . . . . 0.0 111.902 175.373 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.7 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.3 OUTLIER -130.2 127.3 62.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.58 178.161 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -77.26 129.2 35.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.195 -177.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 44.6 tp -73.86 -26.4 60.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.664 178.696 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -86.25 3.97 40.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.266 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -65.61 125.09 24.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.119 177.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 31.3 m -84.46 -6.42 10.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.397 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 17.3 m -91.49 -29.25 17.11 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.61 0.243 . . . . 0.0 111.248 -173.386 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 1.7 pp -73.4 167.38 21.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.405 0.622 . . . . 0.0 111.79 -179.403 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.43 ' H ' ' NE2' ' A' ' 324' ' ' GLN . 5.8 m -99.23 160.96 26.25 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.198 -177.83 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.459 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 46.5 Cg_exo -39.97 -52.94 2.61 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.578 2.852 . . . . 0.0 114.165 178.438 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -61.37 -34.02 74.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.05 0.453 . . . . 0.0 111.187 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.5 ' OE1' ' HD2' ' A' ' 238' ' ' PRO . 45.7 mt-30 -67.45 -25.07 65.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.025 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.459 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 44.8 mtm180 -63.31 -36.05 82.39 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.06 0.457 . . . . 0.0 110.042 175.429 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -63.54 -31.06 72.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.067 179.25 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -87.51 -10.53 51.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.392 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.7 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -69.79 146.99 51.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.699 0.285 . . . . 0.0 111.267 -177.6 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 329' ' ' ASN . . . . . 0.447 ' OD1' HG13 ' A' ' 330' ' ' VAL . 3.3 p30 -134.39 -36.6 0.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -174.752 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.447 HG13 ' OD1' ' A' ' 329' ' ' ASN . 34.5 m -101.75 170.1 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.935 -178.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -82.89 -47.4 11.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.886 0.374 . . . . 0.0 110.83 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 72.1 p -124.72 141.48 52.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.768 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 34.9 m -70.66 171.81 9.75 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.091 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 20.5 tp -71.72 103.12 2.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.093 0.473 . . . . 0.0 110.065 -175.789 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.58 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -91.51 -177.89 4.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.331 179.303 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -73.53 151.02 41.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.937 0.399 . . . . 0.0 110.867 -178.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 66.15 29.01 10.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.198 179.077 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.7 mmt -88.67 127.02 35.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -82.7 130.68 35.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.989 0.423 . . . . 0.0 111.323 -176.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 13.8 t -92.36 120.08 40.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.427 178.211 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -125.96 128.4 47.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.119 -175.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 9.6 mt -93.6 134.1 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 172.032 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 343' ' ' LEU . . . . . 0.515 HD11 HG21 ' A' ' 294' ' ' THR . 69.8 mt -72.49 122.38 21.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.145 179.032 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -76.65 77.58 3.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 -176.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 C--O 1.25 1.083 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.567 177.16 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.9 p -73.26 -20.02 60.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.029 0.414 . . . . 0.0 111.416 -177.643 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 22.5 p -87.61 -2.58 58.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.106 0.479 . . . . 0.0 110.594 176.33 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -99.7 136.65 39.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.433 176.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 20.0 p -91.78 -89.53 0.18 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.717 -177.305 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 60.55 54.98 32.6 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.897 -178.253 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.455 HG21 ' O ' ' A' ' 263' ' ' ALA . 55.9 mt -102.11 146.26 10.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 7.7 p -97.7 147.35 24.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.536 0.684 . . . . 0.0 111.903 -177.424 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.642 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.7 p -59.81 150.94 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.708 -178.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.9 t -97.96 74.63 2.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.625 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 79.99 158.69 16.89 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.596 179.617 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.51 146.58 53.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.709 0.29 . . . . 0.0 110.431 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -155.93 136.3 13.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.155 0.503 . . . . 0.0 110.721 -179.152 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.1 p -118.97 122.1 41.45 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.805 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.58 ' O ' HG12 ' A' ' 313' ' ' VAL . 54.3 m-85 -88.74 147.59 24.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.394 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 320' ' ' LEU . 34.4 mmtp -127.28 139.85 36.3 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.023 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.514 ' HD3' HG11 ' A' ' 313' ' ' VAL . 74.3 Cg_endo -91.04 163.64 3.85 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.922 2.415 . . . . 0.0 110.993 173.27 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.65 121.02 62.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.163 0.506 . . . . 0.0 110.192 177.562 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -125.29 79.73 1.83 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.215 178.381 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 43.0 t-105 175.59 135.3 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.782 -176.548 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -72.29 103.98 3.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.15 0.5 . . . . 0.0 110.03 176.165 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 16.3 tp -140.08 114.61 9.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.909 -175.417 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -141.87 -36.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.84 0.353 . . . . 0.0 111.59 -176.575 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -67.81 -55.02 14.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.835 0.35 . . . . 0.0 110.969 -178.136 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -134.64 162.04 33.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.078 -178.255 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.92 -60.23 4.82 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.4 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -137.2 136.43 38.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -120.04 -49.55 2.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.906 0.384 . . . . 0.0 110.223 178.071 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.8 m -96.87 115.73 37.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.265 0.555 . . . . 0.0 110.946 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -114.65 85.01 2.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.041 177.408 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 252' ' ' VAL . 12.4 p -138.08 28.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 122.906 1.336 . . . . 0.0 109.077 177.762 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -133.98 13.71 3.95 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.22 -177.313 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -92.92 -43.2 9.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.232 178.577 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -81.5 -11.97 59.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.801 177.803 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -114.76 160.36 19.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.455 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -140.08 131.63 27.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.192 175.906 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.3 OUTLIER -101.02 102.6 13.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.093 0.473 . . . . 0.0 110.226 179.862 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.3 t -82.48 120.87 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.059 -172.249 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 9.6 m -91.2 105.51 17.85 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.197 -179.621 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.439 HD22 HG21 ' A' ' 340' ' ' VAL . 19.3 mt -126.61 163.71 22.85 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -175.571 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 10.4 t -63.18 -49.17 75.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.191 0.52 . . . . 0.0 109.704 -178.29 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.455 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.08 138.22 40.14 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.333 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.41 HG22 ' HB2' ' A' ' 261' ' ' LEU . 15.8 p -130.51 25.22 5.11 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.84 0.828 . . . . 0.0 109.087 175.626 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.2 m -76.64 147.48 37.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.295 175.134 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.0 -18.82 56.57 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -175.021 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 56.8 mtt -87.03 139.58 30.43 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.763 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 11.5 ptmm? -143.75 145.46 32.41 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.035 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -46.34 122.6 4.14 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.921 0.763 . . . . 0.0 112.891 -170.826 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 98.36 18.85 24.99 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.689 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.575 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.1 t70 -100.08 -176.92 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.926 0.393 . . . . 0.0 110.749 -176.513 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.486 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 3.7 tppp? -122.69 116.27 23.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.225 -175.747 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.483 HD11 HG21 ' A' ' 308' ' ' ILE . 17.9 pt -120.21 139.9 46.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 120.916 0.389 . . . . 0.0 110.326 175.652 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 54.8 p -124.1 141.06 52.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.008 179.188 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -107.47 111.06 23.18 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.874 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.47 119.24 10.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.605 -178.618 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.26 -34.1 5.35 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.137 -0.554 . . . . 0.0 111.794 -178.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 70.6 t -90.93 137.15 22.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 177.044 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 279' ' ' LYS . 8.3 ptpt -159.97 160.79 33.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.076 0.465 . . . . 0.0 111.548 178.741 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -78.37 154.25 30.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.729 -172.785 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 315' ' ' LEU . 65.8 mt -68.27 146.33 53.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.456 179.064 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.1 -19.89 36.22 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.138 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -78.39 -13.91 59.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.063 0.459 . . . . 0.0 110.455 -178.392 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 36.4 mtm -117.17 42.11 2.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.115 -179.353 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -69.56 -56.64 6.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.881 -177.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -132.03 -29.64 1.64 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.419 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -83.31 126.08 32.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.4 178.497 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 24.4 t -83.31 -24.04 8.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.443 178.725 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 90.2 mt -78.25 70.21 4.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.582 175.161 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -94.97 127.08 40.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.136 -176.177 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -60.52 134.34 56.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.695 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -71.14 153.18 42.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.131 -178.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -59.14 111.19 1.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.048 -172.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.486 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 0.8 OUTLIER -94.3 123.39 37.67 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.795 176.32 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -121.39 148.57 44.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.407 178.153 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.6 m -91.62 122.22 33.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.722 178.804 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 271' ' ' ASP . 11.3 p -73.21 121.5 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.388 0.613 . . . . 0.0 110.112 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.2 t -84.53 -41.59 16.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.447 -178.219 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.532 ' HD2' ' OE2' ' A' ' 307' ' ' GLU . 0.9 OUTLIER -165.55 136.22 3.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.825 -175.749 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 84.4 t -90.17 111.77 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.416 175.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 14.9 t -78.09 -58.94 3.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.78 -173.714 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -116.87 -3.39 11.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.904 0.383 . . . . 0.0 111.8 -172.699 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 69.3 12.86 66.75 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -170.848 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.8 p -145.6 16.79 1.47 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 174.488 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -170.89 118.32 0.49 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.631 -1.168 . . . . 0.0 107.865 -170.316 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -118.73 156.97 20.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -173.888 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.532 ' OE2' ' HD2' ' A' ' 299' ' ' ARG . 10.8 pt-20 -114.26 122.14 45.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.126 0.488 . . . . 0.0 109.864 171.703 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.483 HG21 HD11 ' A' ' 273' ' ' ILE . 33.6 pt -118.88 175.01 4.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.232 -177.631 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 15.1 t -154.23 138.34 11.06 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.071 174.315 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.61 -178.94 25.51 Favored 'Cis proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.909 -1.288 . . . . 0.0 112.806 -1.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 22.0 ttmm -80.24 131.28 62.83 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.044 -179.146 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 3.7 Cg_exo -75.73 108.44 2.69 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.249 1.966 . . . . 0.0 111.496 173.614 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.684 HG23 ' HA ' ' A' ' 328' ' ' ALA . 1.0 OUTLIER -126.02 136.58 60.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.106 177.557 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -91.95 138.03 31.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.348 0.594 . . . . 0.0 112.292 -170.188 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.422 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.3 tm? -80.77 -31.73 35.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.185 178.647 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -85.38 8.18 19.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.265 -177.74 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 317' ' ' ASP . . . . . 0.507 ' OD2' ' HG ' ' A' ' 320' ' ' LEU . 23.5 t70 -83.22 129.52 35.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.203 179.488 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 11.9 p -84.8 -19.62 8.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.804 0.335 . . . . 0.0 111.268 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 36.8 t -69.66 -42.97 73.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.36 -172.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.557 HD13 ' HG2' ' A' ' 325' ' ' ARG . 0.4 OUTLIER -76.92 152.08 35.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.485 0.659 . . . . 0.0 111.165 176.426 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.479 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 18.1 m -86.1 163.18 44.02 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.151 -173.526 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 41.6 Cg_exo -37.59 -54.37 1.25 Allowed 'Trans proline' 0 C--N 1.356 0.974 0 C-N-CA 124.306 3.337 . . . . 0.0 114.889 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -64.96 -34.04 77.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.945 0.402 . . . . 0.0 111.235 -176.806 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 53.8 mt-30 -69.18 -32.74 72.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.032 0.444 . . . . 0.0 109.906 177.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.557 ' HG2' HD13 ' A' ' 320' ' ' LEU . 98.2 mtt180 -65.7 -26.71 67.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.744 175.954 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -72.64 -20.19 61.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.143 0.496 . . . . 0.0 110.609 176.399 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -97.56 -0.36 45.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.738 176.086 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.684 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -65.8 132.7 49.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.005 0.431 . . . . 0.0 111.078 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -108.29 -32.17 7.58 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.901 -172.565 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.59 172.83 6.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.668 -177.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -86.23 -48.68 8.33 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.647 0.26 . . . . 0.0 111.452 -178.592 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.7 t -118.32 149.72 40.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.038 0.447 . . . . 0.0 110.875 -175.784 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 28.7 p -79.75 174.21 11.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.815 176.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.44 HD12 ' HG3' ' A' ' 338' ' ' MET . 15.9 tp -78.27 103.7 8.37 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -176.216 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.642 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.52 174.69 11.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.743 -178.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -81.55 10.41 5.96 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.178 0.806 . . . . 0.0 113.178 -168.254 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -141.01 33.58 1.75 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.915 0.388 . . . . 0.0 111.318 177.558 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.44 ' HG3' HD12 ' A' ' 334' ' ' LEU . 14.3 mmt -86.19 131.75 34.17 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -86.18 130.87 34.38 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.774 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.439 HG21 HD22 ' A' ' 261' ' ' LEU . 18.1 t -104.75 111.64 35.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.829 178.773 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -126.04 136.65 53.2 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.67 -177.226 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 17.7 mt -85.25 121.15 36.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.924 0.393 . . . . 0.0 110.64 175.366 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 41.1 mt -91.53 120.94 32.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.788 175.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -138.93 127.29 22.88 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.131 -178.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.421 -0.799 . . . . 0.0 109.722 178.932 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.824 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 34.1 p -153.26 -49.78 0.1 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.968 0.413 . . . . 0.0 110.397 -178.4 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 16.8 p -109.34 126.32 53.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.001 178.914 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 59.35 57.61 3.31 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.142 178.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 29.8 p -67.35 -35.82 80.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.124 179.375 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 52.76 53.23 34.03 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.644 176.517 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 263' ' ' ALA . 42.6 mm -102.85 140.22 21.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -177.504 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.3 p -121.5 159.34 26.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.957 0.408 . . . . 0.0 110.808 175.18 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.614 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.0 p -80.78 150.4 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.236 177.372 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 75.1 m -116.1 86.26 2.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.219 0.533 . . . . 0.0 110.423 176.004 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 94.51 138.55 9.38 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.398 179.592 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.29 132.09 46.5 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.002 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -141.6 127.36 19.2 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.425 0.631 . . . . 0.0 111.067 -175.74 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.9 p -117.87 114.61 23.5 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.129 179.095 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -81.1 164.02 22.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.075 -178.717 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . 44.8 mmtm -135.78 130.76 18.84 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.85 0.357 . . . . 0.0 111.348 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.551 ' HD3' HG11 ' A' ' 313' ' ' VAL . 71.7 Cg_endo -90.69 127.88 1.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.885 2.39 . . . . 0.0 111.685 177.631 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 14.1 p -80.39 140.9 16.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 120.901 0.381 . . . . 0.0 110.45 -179.057 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -96.4 167.27 11.27 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.19 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -77.26 -34.61 55.72 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.601 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -67.53 102.53 1.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.182 173.026 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 37.8 tp -176.12 82.98 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.049 -175.059 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -94.13 -12.91 27.43 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.859 -176.658 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -87.84 -17.44 31.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.302 -179.785 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -144.49 152.17 40.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.879 0.371 . . . . 0.0 110.831 -174.762 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -109.9 49.95 0.81 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.609 -178.028 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -83.93 25.45 0.81 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.615 0.721 . . . . 0.0 110.077 178.773 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -83.85 -58.2 2.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.223 -178.487 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.31 -5.3 10.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.897 0.856 . . . . 0.0 109.948 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -109.86 139.22 45.18 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.884 -179.707 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 89.4 t 65.1 99.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.358 0 O-C-N 123.755 0.659 . . . . 0.0 110.248 -175.007 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -53.12 129.35 30.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.172 -174.61 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.482 ' OD1' ' HA ' ' A' ' 238' ' ' PRO . 63.4 t30 -93.4 -23.46 18.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.201 -174.689 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -89.85 -42.09 11.45 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.761 -174.39 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.514 ' CE1' HG21 ' A' ' 298' ' ' VAL . 56.7 m-85 -103.34 121.33 42.54 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.716 -176.519 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.17 137.21 38.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.597 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.0 OUTLIER -97.69 107.15 19.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.268 0.556 . . . . 0.0 110.671 -177.889 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.47 ' HB ' HG22 ' A' ' 306' ' ' VAL . 3.1 t -89.41 124.22 42.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.408 -172.765 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 37.5 m -93.63 107.4 19.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.162 177.596 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.427 HD23 HG23 ' A' ' 230' ' ' VAL . 27.9 mt -124.64 172.12 9.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.422 -174.889 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.3 m -64.83 -53.69 42.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.37 0.605 . . . . 0.0 109.871 179.396 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.562 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -135.95 130.56 33.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.391 179.038 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.449 ' HB ' ' CG1' ' A' ' 306' ' ' VAL . 6.9 p -129.59 22.66 5.48 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.867 0.841 . . . . 0.0 108.817 174.92 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 15.5 m -80.59 145.37 31.77 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.564 176.17 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.99 -9.91 61.81 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -175.672 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 267' ' ' MET . . . . . 0.461 ' HG2' HD11 ' A' ' 342' ' ' ILE . 57.9 mtt -93.88 151.8 19.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.007 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.52 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 1.9 ptpp? -147.34 157.15 43.47 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.396 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -52.36 117.23 2.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.152 0.501 . . . . 0.0 110.832 -178.074 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 106.28 18.43 11.17 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.741 -177.631 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.52 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 7.4 m-20 -99.78 159.16 15.27 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 117.236 0.518 . . . . 0.0 110.167 176.721 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -111.62 116.75 31.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.986 -178.346 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.535 HD11 HG21 ' A' ' 308' ' ' ILE . 34.6 pt -113.19 140.67 32.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.217 178.609 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.448 ' HB3' HG22 ' A' ' 294' ' ' THR . 22.0 p -123.14 139.98 53.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.22 178.822 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.437 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 93.1 m-85 -103.57 111.34 23.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.037 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.2 113.03 4.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.146 -176.764 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.34 -24.98 12.97 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.641 -178.398 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 90.6 t -97.5 128.18 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 177.296 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 292' ' ' ASP . 15.0 ptpt -160.46 179.73 8.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.2 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -68.56 174.89 3.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.183 -172.911 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 75.7 mt -71.96 -85.74 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -171.438 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -87.9 31.11 4.77 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.247 -0.501 . . . . 0.0 112.747 -172.742 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.458 ' O ' ' HB3' ' A' ' 287' ' ' ASN . 5.4 tt0 -89.36 -4.51 58.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.099 0.476 . . . . 0.0 110.022 -179.772 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 77.2 mtp -109.82 8.97 24.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.018 -174.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -62.69 -52.08 64.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.096 -177.862 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -130.75 -20.71 2.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.806 178.207 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 287' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 283' ' ' GLN . 49.5 t30 -81.11 96.33 7.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.125 0.488 . . . . 0.0 109.96 178.642 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 26.3 t -69.3 -32.64 54.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.93 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 96.1 mt -86.77 43.94 1.12 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.323 177.44 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.0 113.39 3.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.836 -179.812 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -57.49 143.26 41.29 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.771 -179.698 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 279' ' ' LYS . 14.9 m-20 -73.55 161.23 30.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.779 179.284 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -64.54 105.19 0.91 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.294 -175.19 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 274' ' ' SER . 15.8 p -90.93 132.66 35.81 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.597 177.007 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.408 ' CG ' HD12 ' A' ' 308' ' ' ILE . 97.7 m-85 -129.79 150.78 50.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.427 179.305 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 20.1 m -96.65 125.06 40.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.122 178.56 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 271' ' ' ASP . 12.4 p -80.82 138.07 20.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.161 0.505 . . . . 0.0 110.61 -179.484 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.514 HG21 ' CE1' ' A' ' 256' ' ' PHE . 45.3 t -104.75 -29.53 2.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.021 -178.822 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -164.1 137.2 5.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.017 0.437 . . . . 0.0 111.171 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 87.5 t -95.75 112.19 27.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.246 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 45.1 t -75.8 -58.79 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.909 -172.251 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -123.35 -3.06 8.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.298 0.57 . . . . 0.0 111.215 -175.753 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 78.37 13.87 82.8 Favored Glycine 0 C--N 1.322 -0.24 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -173.225 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 27.1 p -142.18 14.57 2.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.273 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.452 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 1.7 t60 -164.02 117.45 1.44 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.491 -169.769 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.6 m -118.46 164.67 14.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -175.459 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.2 pt-20 -125.46 123.32 38.98 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 169.478 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.535 HG21 HD11 ' A' ' 273' ' ' ILE . 23.4 pt -124.44 164.3 23.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.045 -173.092 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 309' ' ' THR . . . . . 0.432 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 8.2 t -135.57 140.19 33.28 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.637 174.693 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.8 179.55 30.17 Favored 'Cis proline' 0 CA--C 1.531 0.355 0 C-N-CA 123.187 -1.589 . . . . 0.0 112.655 -1.863 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.462 ' HG2' HG13 ' A' ' 313' ' ' VAL . 31.1 ttmt -70.81 119.53 73.59 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.742 177.575 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.466 ' HD2' ' CB ' ' A' ' 257' ' ' ALA . 38.1 Cg_endo -69.5 108.94 2.14 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.436 2.091 . . . . 0.0 111.65 175.891 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.714 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.2 OUTLIER -135.43 135.31 51.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.825 -178.497 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -83.4 129.76 35.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.251 -176.516 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.1 tm? -68.86 -26.07 64.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.45 178.978 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -99.31 18.3 17.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.103 -179.211 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 317' ' ' ASP . . . . . 0.441 ' HB3' ' CD2' ' A' ' 320' ' ' LEU . 9.9 t0 -65.47 130.85 44.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.726 178.791 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 30.4 m -83.16 1.98 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -173.194 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 14.2 t -125.78 28.34 6.2 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.064 -0.654 . . . . 0.0 112.441 -176.086 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.638 HD13 ' HG2' ' A' ' 325' ' ' ARG . 0.7 OUTLIER -123.54 164.76 18.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.131 0.491 . . . . 0.0 111.551 175.43 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.44 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.3 m -101.92 164.92 14.88 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.678 -179.284 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 86.4 Cg_exo -44.19 -50.18 7.96 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.641 2.894 . . . . 0.0 114.537 -176.623 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -66.34 -27.7 68.09 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -177.383 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 49.8 mt-30 -71.6 -28.9 64.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.005 0.431 . . . . 0.0 109.976 177.785 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.638 ' HG2' HD13 ' A' ' 320' ' ' LEU . 55.8 mtp180 -70.82 -18.93 62.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.434 178.019 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -74.52 -32.7 62.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.288 176.343 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -85.51 -4.25 59.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.742 177.707 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.714 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -63.3 159.62 17.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.06 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -138.65 -49.15 0.52 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.831 0.348 . . . . 0.0 111.244 -175.657 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.2 m -105.72 161.67 5.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.647 -175.963 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -91.78 -5.46 53.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.01 -176.617 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 8.0 t -147.73 136.3 21.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.527 -176.757 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.1 p -80.11 163.56 24.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.365 178.872 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 19.2 tp -70.57 106.09 3.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.968 0.413 . . . . 0.0 110.724 -173.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.614 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -79.53 173.53 12.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.81 -178.449 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -81.05 4.04 21.16 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -166.035 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -143.62 45.7 1.49 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.064 0.459 . . . . 0.0 111.421 176.713 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.444 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 22.8 mmt -92.17 143.56 26.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.214 178.018 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.42 138.45 33.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.422 179.444 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.544 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 19.1 t -112.9 116.96 54.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.14 0.495 . . . . 0.0 109.91 -178.603 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -125.41 138.9 54.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.891 -175.726 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.461 HD11 ' HG2' ' A' ' 267' ' ' MET . 21.7 mt -96.65 132.68 40.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.68 0.276 . . . . 0.0 110.452 174.637 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 54.9 mt -84.26 115.62 22.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.193 176.563 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -92.15 110.32 21.7 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.833 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.986 -0.531 . . . . 0.0 110.567 179.697 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.7 p -86.91 49.83 1.89 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.27 0.557 . . . . 0.0 110.422 178.834 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.5 m -77.81 75.99 4.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.457 -177.433 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.52 102.88 1.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.734 179.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 33.9 p -114.66 92.11 3.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.626 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.0 61.24 0.43 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 177.054 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.658 HG21 ' O ' ' A' ' 263' ' ' ALA . 23.7 mt -102.87 154.24 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.583 0.23 . . . . 0.0 110.841 -174.065 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 18.9 p -114.75 171.25 7.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.142 0.496 . . . . 0.0 111.571 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.533 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.1 p -87.35 150.15 3.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.87 -178.227 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 62.2 m -114.98 91.44 3.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.827 0.346 . . . . 0.0 110.393 175.638 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 90.46 161.41 37.41 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.143 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -83.27 117.73 23.17 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.934 0.397 . . . . 0.0 110.15 178.651 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -109.07 126.37 53.09 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.097 0.475 . . . . 0.0 109.958 179.672 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 10.2 p -121.29 125.63 47.52 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.618 -178.318 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.584 ' HB2' ' O ' ' A' ' 312' ' ' PRO . 86.2 m-85 -109.08 145.43 35.66 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.899 -179.118 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -133.4 144.27 51.61 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.984 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -80.4 120.82 4.12 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.169 1.912 . . . . 0.0 110.863 173.18 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.16 130.44 36.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.334 0.587 . . . . 0.0 110.631 -177.11 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.15 -173.77 2.38 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.169 179.471 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 26.9 m-90 -94.99 -19.86 19.85 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.913 0.387 . . . . 0.0 110.436 178.677 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -79.66 102.8 9.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 173.207 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 74.1 mt -109.85 73.13 0.83 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.235 -172.455 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -111.84 -3.44 14.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.145 177.825 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -73.87 -51.35 16.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.05 -178.841 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -159.84 -40.91 0.05 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.532 -178.533 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 134.55 165.26 10.83 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.672 175.115 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -157.63 74.99 0.77 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.409 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -97.93 6.41 47.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.418 -179.086 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 26.7 m -118.4 173.78 4.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.462 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -84.91 144.44 28.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.094 178.111 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.33 135.36 27.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.94 0.4 . . . . 0.0 110.923 -178.821 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -74.0 93.22 2.21 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 174.339 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -89.48 -15.74 32.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.093 -172.247 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -96.63 -4.45 41.02 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.966 179.71 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -126.22 133.18 51.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.532 -179.307 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -107.59 117.29 33.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.57 178.044 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 4.1 m -89.68 109.19 20.18 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.034 0.445 . . . . 0.0 110.314 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.0 t -92.73 122.27 44.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.593 -172.782 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 25.2 m -91.33 115.05 27.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.948 175.822 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 26.0 mt -132.78 172.41 12.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.273 -175.353 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 14.9 m -62.95 -56.48 16.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.476 0.655 . . . . 0.0 109.503 177.547 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.658 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -136.93 140.99 42.66 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.8 177.782 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 10.9 p -131.39 23.15 4.77 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.283 1.04 . . . . 0.0 108.205 173.384 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 7.6 m -77.93 142.64 38.26 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.859 -1.519 . . . . 0.0 109.649 176.771 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 97.96 -15.16 62.01 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -175.692 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 61.7 mtt -89.15 151.07 22.4 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.715 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -135.44 164.24 28.22 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.726 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -62.62 140.24 58.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.867 179.237 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.93 19.04 62.03 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.829 173.059 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.498 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 1.2 t70 -105.74 -166.73 1.24 Allowed 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 118.038 0.919 . . . . 0.0 110.458 -178.293 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -125.54 116.28 21.52 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.702 -178.901 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.466 HD11 HG21 ' A' ' 308' ' ' ILE . 19.6 pt -113.69 139.69 37.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.49 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.491 ' OG ' HG22 ' A' ' 294' ' ' THR . 2.9 m -122.19 140.39 52.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.486 -175.117 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -105.97 111.41 24.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.334 178.273 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -71.5 117.93 13.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.27 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.79 -17.55 22.76 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.611 -176.254 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.53 124.24 71.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.486 ' HD3' ' HB3' ' A' ' 290' ' ' ALA . 1.0 OUTLIER -138.86 165.23 27.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.917 0.389 . . . . 0.0 111.757 -176.042 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -82.57 148.39 28.07 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.323 -176.226 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 284' ' ' MET . 97.3 mt -80.84 -19.7 44.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.714 -176.775 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -63.09 -18.9 60.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.95 -178.23 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 287' ' ' ASN . 28.6 tt0 -121.08 13.3 11.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.132 0.491 . . . . 0.0 110.218 179.303 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.448 ' HB2' ' HA ' ' A' ' 281' ' ' LEU . 66.7 mmm -105.45 33.89 3.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.252 -178.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -92.34 -27.54 17.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.8 0.333 . . . . 0.0 110.524 178.427 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -161.8 -25.03 0.05 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.8 179.808 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 287' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 283' ' ' GLN . 16.3 m120 -68.97 123.13 20.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.164 0.506 . . . . 0.0 110.754 178.812 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.49 -34.39 15.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.728 178.706 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 70.6 mt -91.42 47.03 1.34 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.674 177.702 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 279' ' ' LYS . . . -65.4 134.68 54.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.215 -177.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -53.05 131.27 36.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.819 -178.458 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -74.01 167.93 20.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.483 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.623 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -66.77 81.84 0.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.316 -177.703 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.491 HG22 ' OG ' ' A' ' 274' ' ' SER . 12.6 p -85.07 89.69 7.68 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.309 177.485 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.623 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 51.1 m-85 -96.03 149.24 21.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.279 0.561 . . . . 0.0 111.364 -176.171 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.9 m -91.51 126.76 36.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.969 -179.458 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.498 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 8.7 p -87.77 141.52 14.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.184 -178.346 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 13.3 p -104.78 -26.01 3.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.714 179.339 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -170.34 146.82 2.94 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.931 0.396 . . . . 0.0 111.086 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.69 121.0 41.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 169.182 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.22 -58.03 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.932 -172.544 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -129.02 -5.23 5.01 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.285 0.564 . . . . 0.0 111.631 -175.244 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.27 12.01 81.33 Favored Glycine 0 CA--C 1.518 0.247 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -175.617 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 22.2 p -145.05 16.24 1.55 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 171.611 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.521 ' CE1' HG22 ' A' ' 258' ' ' THR . 1.6 t60 -169.29 117.92 0.65 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.092 -1.413 . . . . 0.0 107.59 -167.264 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.6 m -119.58 168.57 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 117.706 0.23 . . . . 0.0 110.736 -174.651 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -126.18 118.18 24.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.259 0.552 . . . . 0.0 110.026 171.471 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.466 HG21 HD11 ' A' ' 273' ' ' ILE . 35.1 pt -119.84 174.28 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.341 -176.928 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.2 t -154.65 143.07 14.5 Favored Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.461 176.407 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -76.18 -179.12 25.96 Favored 'Cis proline' 0 C--N 1.345 0.344 0 C-N-CA 124.105 -1.206 . . . . 0.0 112.909 -3.076 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.454 ' HD3' ' HB3' ' A' ' 236' ' ' PHE . 2.5 ttmp? -75.09 132.1 77.46 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.12 -178.093 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.584 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 9.3 Cg_exo -71.82 108.15 2.37 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.326 2.017 . . . . 0.0 111.192 173.381 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 329' ' ' ASN . 4.4 m -130.11 128.01 64.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.788 -177.709 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -87.66 141.56 28.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.307 0.575 . . . . 0.0 112.238 -172.728 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -81.0 -28.8 35.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.996 -179.305 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -100.31 20.66 14.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.671 -176.336 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 317' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 11.6 t70 -83.38 124.08 30.3 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.277 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 9.3 p -82.96 -11.96 12.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.874 0.369 . . . . 0.0 111.608 -175.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 15.7 m -86.66 0.74 53.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.693 -172.708 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 1.5 pp -106.77 169.83 8.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.829 0.347 . . . . 0.0 111.312 179.508 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 28.2 t -85.88 148.03 47.29 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.539 175.383 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -42.72 -43.99 8.79 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.112 2.541 . . . . 0.0 113.662 -177.683 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -61.01 -29.99 70.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.958 0.408 . . . . 0.0 111.465 -178.139 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -71.16 -25.55 62.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.509 -178.582 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -62.67 -34.99 78.24 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.214 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.37 -24.06 65.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.948 178.296 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -103.21 11.82 36.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 177.823 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -73.89 164.87 26.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.865 178.343 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 329' ' ' ASN . . . . . 0.424 ' N ' HG23 ' A' ' 313' ' ' VAL . 50.4 t30 -139.99 -43.53 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.606 -172.655 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.6 m -111.21 175.33 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.698 0.285 . . . . 0.0 111.02 -178.663 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -80.48 -50.22 10.35 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.699 0.285 . . . . 0.0 111.454 -177.112 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.7 t -130.91 151.83 50.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.413 -177.983 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 49.0 m -71.4 167.47 19.51 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 174.004 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 27.8 tp -70.91 103.71 2.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 110.147 -176.95 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.533 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -89.76 -170.92 2.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.194 178.782 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -76.86 162.48 27.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.855 0.36 . . . . 0.0 110.705 -179.336 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 58.31 45.97 16.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.089 178.409 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.511 ' H ' HG12 ' A' ' 230' ' ' VAL . 24.8 mmt -114.61 131.04 56.84 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.339 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -85.53 138.98 31.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.008 -179.259 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 14.2 t -113.12 114.47 47.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.649 178.386 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -132.22 138.49 47.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.808 0.337 . . . . 0.0 111.813 -173.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.432 ' CG1' HG22 ' A' ' 273' ' ' ILE . 21.4 mt -91.6 123.29 43.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.846 174.537 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 59.2 mt -79.16 139.1 38.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.282 178.809 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -71.22 110.59 5.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.849 -179.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 51.4 t . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.544 -0.741 . . . . 0.0 109.527 178.144 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.8 t -73.27 -41.1 64.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.858 0.361 . . . . 0.0 110.301 -179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 16.6 p -89.42 51.37 2.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.403 0.62 . . . . 0.0 110.744 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -86.41 98.72 11.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.778 -178.432 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 38.9 p -74.76 -59.09 2.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.341 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.82 50.92 62.45 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.359 178.3 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.496 ' HB ' ' HB ' ' A' ' 340' ' ' VAL . 48.0 mm -89.29 144.35 9.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -178.695 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 23.2 p -122.39 156.66 33.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.297 0.57 . . . . 0.0 111.262 176.861 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.61 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.1 p -73.84 151.16 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.043 179.395 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.3 t -115.37 64.62 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.208 0.528 . . . . 0.0 109.983 178.124 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 106.11 149.67 17.59 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.323 -179.419 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -59.37 125.49 23.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.904 0.383 . . . . 0.0 111.127 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 334' ' ' LEU . 26.3 mm-40 -113.24 126.6 55.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.961 0.41 . . . . 0.0 110.269 179.133 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 p -122.97 105.04 9.63 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.131 177.777 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -89.55 146.78 24.35 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.168 -173.816 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -144.08 121.12 6.54 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.776 178.719 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -91.38 143.08 3.02 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.777 2.318 . . . . 0.0 110.694 168.144 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 239' ' ' VAL . 7.3 p -78.4 84.93 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 122.255 1.026 . . . . 0.0 110.465 -179.41 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -82.26 80.87 8.35 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.571 178.121 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 15.0 t-105 -163.7 -69.96 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.148 -177.264 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 60.24 101.94 0.02 OUTLIER 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.049 179.078 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.81 157.56 32.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.666 179.594 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -56.14 -58.78 6.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.703 0.287 . . . . 0.0 110.855 -177.321 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -80.33 -55.08 5.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.755 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -89.14 71.93 8.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.206 0.527 . . . . 0.0 111.166 -178.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -98.73 139.83 14.67 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.277 176.153 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -78.51 83.38 4.71 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.67 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -96.51 -39.21 9.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.457 -173.922 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 25.7 m -115.06 152.08 16.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 57.9 t30 54.33 64.87 1.67 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.739 0.78 . . . . 0.0 109.48 -174.851 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 23.4 m -87.65 50.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.454 -173.727 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -62.11 -16.85 55.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.151 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -69.21 -18.78 63.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.804 178.229 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -89.29 -15.24 33.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.095 0.474 . . . . 0.0 109.971 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -99.26 142.91 30.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.639 178.008 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.48 122.57 43.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.556 0.217 . . . . 0.0 111.135 -177.724 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.4 m -96.31 107.38 19.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.044 0.45 . . . . 0.0 110.104 -179.526 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.5 t -92.91 119.32 40.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.767 -171.107 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 18.5 m -89.74 106.19 18.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.18 0.514 . . . . 0.0 109.983 174.769 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.45 ' HB2' ' CG2' ' A' ' 264' ' ' THR . 30.1 mt -121.29 169.37 10.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.058 -176.142 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 30.2 p -67.53 -48.26 67.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.334 0.588 . . . . 0.0 109.881 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.492 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -135.77 130.3 33.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.472 178.279 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.45 ' CG2' ' HB2' ' A' ' 261' ' ' LEU . 4.8 p -132.47 17.93 4.38 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.314 173.609 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 39.4 m -84.2 147.26 27.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.31 174.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 92.96 -5.48 75.98 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -171.652 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 70.9 mtp -108.67 138.66 44.63 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.467 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -137.7 154.33 49.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.779 0.323 . . . . 0.0 110.547 -178.931 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.455 ' HA ' HG13 ' A' ' 297' ' ' VAL . 26.2 ptt180 -59.61 135.32 57.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.64 -174.503 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 102.86 18.32 15.96 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.728 -0.749 . . . . 0.0 113.027 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.539 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 2.7 t0 -113.82 -169.57 1.54 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 117.369 0.585 . . . . 0.0 109.814 177.314 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.484 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 4.7 tppp? -124.18 116.56 22.91 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.592 -178.125 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.542 HD11 HG21 ' A' ' 308' ' ' ILE . 15.6 pt -117.19 140.48 39.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 120.131 -0.627 . . . . 0.0 109.965 179.106 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 44.2 p -126.21 150.87 48.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.145 -178.915 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.481 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 89.0 m-85 -111.83 111.32 22.2 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.065 -178.862 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.01 111.98 3.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 -178.032 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 113.67 -35.52 4.48 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -178.147 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 97.6 t -87.06 110.83 20.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.973 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -137.14 179.48 6.36 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.328 -174.877 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -69.08 172.81 6.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.109 -177.389 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 73.6 mt -64.91 -62.02 1.81 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -175.001 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -100.6 51.17 1.01 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.21 -177.864 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.473 ' HG3' ' HB1' ' A' ' 290' ' ' ALA . 6.1 tp-100 -92.42 -41.5 10.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.843 0.354 . . . . 0.0 110.749 -176.587 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 58.9 mtm -97.37 30.21 2.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.053 0.454 . . . . 0.0 110.253 177.162 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -77.37 -32.42 54.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.165 179.119 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -153.6 -42.24 0.09 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.653 179.219 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -62.4 127.98 33.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.291 0.567 . . . . 0.0 111.282 -177.764 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 44.6 t -86.07 -28.88 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.331 177.127 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 88.1 mt -87.82 54.59 3.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.149 174.29 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.473 ' HB1' ' HG3' ' A' ' 283' ' ' GLN . . . -66.61 116.39 7.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.103 -177.059 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -82.11 132.62 35.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.291 177.384 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -76.19 167.94 20.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.374 -178.913 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.458 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -61.31 107.3 0.74 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.006 -177.392 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.484 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 61.2 p -95.01 125.35 39.61 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.572 -179.491 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.48 ' CE2' ' HG3' ' A' ' 312' ' ' PRO . 88.1 m-85 -128.18 152.92 47.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.103 0.478 . . . . 0.0 111.132 -179.316 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 41.9 m -92.1 125.79 36.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.312 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.539 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.0 p -76.98 127.74 37.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.085 0.469 . . . . 0.0 110.415 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 23.4 t -100.59 -35.72 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.202 -175.594 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 299' ' ' ARG . 6.8 tpt180 -164.32 142.57 7.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 111.124 -179.107 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 94.5 t -102.69 117.84 48.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 170.713 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 46.0 t -77.19 -55.7 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.122 -172.369 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -128.49 -1.27 5.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.057 0.456 . . . . 0.0 111.604 -175.734 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 83.25 14.31 74.68 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.216 -176.501 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 1.8 p -145.97 19.93 1.44 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 171.449 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.413 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 1.8 t60 -165.71 115.75 1.03 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.476 -171.584 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.2 m -119.05 164.89 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 110.235 -0.284 . . . . 0.0 110.235 -174.585 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 10.9 pt-20 -125.48 132.02 52.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.118 0.485 . . . . 0.0 109.9 169.673 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.542 HG21 HD11 ' A' ' 273' ' ' ILE . 21.5 pt -125.38 164.32 24.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.363 -176.347 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.4 t -141.86 141.16 21.26 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.714 175.781 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.75 -179.61 27.04 Favored 'Cis proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.964 -1.265 . . . . 0.0 112.532 -3.256 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 31.4 ttmt -86.31 126.25 65.32 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.48 ' HG3' ' CE2' ' A' ' 295' ' ' PHE . 8.7 Cg_exo -70.07 112.14 3.05 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.875 2.384 . . . . 0.0 112.712 178.609 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.622 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -119.39 128.94 75.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.789 172.661 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.692 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -88.02 138.72 31.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.906 -176.12 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 325' ' ' ARG . 3.0 tm? -68.53 -28.63 67.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.689 178.679 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -92.44 10.03 31.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.755 -179.571 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 317' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 9.9 t70 -72.57 122.22 21.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.996 0.426 . . . . 0.0 109.909 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.2 m -84.49 2.32 4.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.225 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.7 p -119.84 29.17 7.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -174.343 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 2.0 pp -128.74 161.22 30.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.061 0.458 . . . . 0.0 111.633 176.418 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 19.7 m -85.24 162.03 50.16 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.323 -177.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.49 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 96.0 Cg_exo -46.0 -46.3 16.21 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.32 2.68 . . . . 0.0 113.927 -177.649 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.23 -33.07 75.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.679 0.276 . . . . 0.0 111.267 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.497 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 50.9 mt-30 -69.32 -35.95 76.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.235 -177.052 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 8.0 ptp180 -74.8 -23.54 58.5 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.089 0.471 . . . . 0.0 110.206 178.91 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -72.03 -18.65 61.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.129 175.067 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -109.21 11.15 25.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.505 175.256 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.622 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -67.36 142.44 56.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.514 177.06 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 329' ' ' ASN . . . . . 0.413 ' OD1' HG13 ' A' ' 330' ' ' VAL . 5.6 p30 -125.39 -20.55 4.76 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -175.424 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.1 m -115.45 155.09 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.728 179.426 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -91.98 -2.48 56.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.781 -174.18 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 14.7 t -162.4 152.79 16.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.803 0.335 . . . . 0.0 110.254 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.0 p -86.88 165.56 15.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.114 179.57 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 234' ' ' GLN . 18.0 tp -68.27 108.0 3.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -177.483 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.61 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.35 -177.92 6.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.286 -177.122 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.48 1.49 29.13 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -172.919 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -147.87 54.94 1.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.224 0.535 . . . . 0.0 111.395 177.877 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.441 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 22.8 mmt -101.33 142.52 32.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.799 176.102 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.64 140.55 30.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.467 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 22.0 t -114.66 120.11 63.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.312 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -136.78 144.26 43.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.85 0.357 . . . . 0.0 111.147 -175.436 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 31.3 mt -93.86 128.47 45.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.71 178.093 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 39.4 mt -88.13 111.96 22.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.566 -179.809 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -90.21 125.93 35.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.334 178.0 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.593 -0.718 . . . . 0.0 110.222 178.478 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.8 m -92.13 -49.25 6.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.02 0.438 . . . . 0.0 110.551 -179.748 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 23.0 p -126.66 28.93 5.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.309 0.576 . . . . 0.0 109.981 177.745 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.3 91.02 4.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.111 -175.217 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 29.0 p -79.13 72.97 5.71 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.489 0.661 . . . . 0.0 111.057 177.596 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -109.8 52.15 0.66 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 173.281 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.555 HG21 ' O ' ' A' ' 263' ' ' ALA . 22.7 mt -93.66 159.07 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.273 -0.463 . . . . 0.0 110.275 -173.0 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 13.3 p -118.23 153.42 33.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.281 0.563 . . . . 0.0 111.332 179.048 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.673 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.3 p -66.74 152.58 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.83 177.819 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.5 t -114.99 78.92 1.21 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.13 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 101.58 151.07 24.23 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.699 179.574 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -85.63 141.54 29.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.463 0.173 . . . . 0.0 110.609 179.579 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -157.62 150.47 23.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.159 0.504 . . . . 0.0 111.771 -177.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 38.4 p -153.39 102.33 2.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.994 172.57 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -80.61 143.9 32.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.775 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -107.51 134.46 19.98 Favored Pre-proline 0 C--N 1.323 -0.577 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.264 -177.228 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.502 ' HA ' ' OD1' ' A' ' 254' ' ' ASN . 74.5 Cg_endo -90.01 120.69 0.9 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.747 2.298 . . . . 0.0 110.647 169.065 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.598 ' O ' HD11 ' A' ' 243' ' ' LEU . 49.2 t -82.1 105.57 12.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 120.837 0.351 . . . . 0.0 110.165 -177.313 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -78.96 81.83 5.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.794 -176.825 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -132.31 -72.86 0.52 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.863 178.914 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -161.96 108.17 1.31 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.324 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.598 HD11 ' O ' ' A' ' 239' ' ' VAL . 4.7 mp -128.43 71.77 1.41 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.994 -176.436 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -128.31 -77.67 0.56 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.437 176.064 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -74.32 -54.93 6.66 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.707 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -118.54 132.35 56.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.119 172.812 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -121.73 148.79 17.24 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.497 178.602 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 248' ' ' ASN . . . . . 0.401 ' OD1' HG21 ' A' ' 239' ' ' VAL . 3.5 t-20 -69.79 132.14 45.6 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.525 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 65.34 66.79 0.53 Allowed 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.744 0.652 . . . . 0.0 110.734 -178.35 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.8 t 72.11 147.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.875 176.506 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -88.94 131.14 35.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.26 -178.578 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.9 t 54.81 57.45 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.994 0.902 . . . . 0.0 110.109 -178.276 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -151.81 -42.85 0.11 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.032 -179.176 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 238' ' ' PRO . 19.4 t-20 -63.78 -18.32 63.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.619 0.724 . . . . 0.0 109.717 177.941 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -68.64 -21.84 64.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.756 175.208 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -115.77 160.93 19.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.837 -174.59 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.27 132.91 53.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 177.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.4 m -94.85 114.27 26.12 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.041 0.448 . . . . 0.0 110.368 178.52 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.9 t -93.76 122.27 45.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.282 -173.882 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 3.0 m -94.0 106.7 18.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.049 179.527 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.551 HD23 HG23 ' A' ' 230' ' ' VAL . 23.1 mt -126.35 168.14 14.56 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.412 -174.026 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.6 t -63.25 -54.87 30.5 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.555 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.09 136.84 38.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.266 178.543 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.437 HG22 HD12 ' A' ' 261' ' ' LEU . 15.9 p -129.7 25.27 5.36 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.028 0.918 . . . . 0.0 108.558 175.23 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 17.4 m -82.96 153.44 25.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.284 -1.326 . . . . 0.0 109.712 176.885 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 90.7 -6.44 82.05 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -174.901 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 267' ' ' MET . . . . . 0.415 ' HG2' HD11 ' A' ' 342' ' ' ILE . 47.8 mtt -104.3 147.45 27.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.828 -0.686 . . . . 0.0 109.314 178.524 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 0.0 OUTLIER -139.62 158.05 44.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.307 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -54.47 132.65 45.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.182 0.515 . . . . 0.0 111.437 -176.816 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 95.11 19.03 31.98 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.099 -177.271 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.574 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.1 t0 -103.46 169.01 8.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.7 0.286 . . . . 0.0 110.289 -178.284 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -118.5 115.46 24.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.996 -178.137 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.488 HD11 HG21 ' A' ' 308' ' ' ILE . 30.0 pt -112.78 139.74 36.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.039 0.447 . . . . 0.0 110.061 179.52 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.41 ' OG ' HG22 ' A' ' 294' ' ' THR . 7.1 m -124.48 133.47 53.34 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.871 -179.188 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -100.0 111.42 23.72 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.206 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 339' ' ' ALA . . . -66.51 120.54 13.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.342 -179.2 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.95 -25.95 12.2 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -176.591 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.559 ' HA ' ' OG1' ' A' ' 332' ' ' THR . 47.0 t -100.28 119.74 48.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.772 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -136.34 157.48 46.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.035 0.445 . . . . 0.0 111.436 -173.585 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -72.94 118.87 16.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.245 179.714 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 331' ' ' ASN . 1.5 pt? -76.06 171.42 14.5 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.964 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.33 -45.78 3.52 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 -174.312 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -64.2 -28.48 69.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 110.491 177.276 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 82.7 mtp -72.11 -10.51 59.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.357 -175.716 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.32 -14.16 60.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.924 0.392 . . . . 0.0 111.245 -179.249 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -138.93 -38.83 0.5 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.913 0.387 . . . . 0.0 110.812 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -86.33 124.23 32.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.399 -178.349 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 40.8 t -88.73 -33.44 6.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 176.376 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 88.7 mt -92.24 54.11 2.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.763 177.267 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.24 130.24 42.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.368 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -77.62 161.85 27.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.626 -177.394 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 276' ' ' ALA . 49.4 m-20 -72.99 158.91 34.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.876 177.875 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -65.81 101.14 0.61 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.037 -178.661 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.41 HG22 ' OG ' ' A' ' 274' ' ' SER . 45.4 p -84.05 117.16 23.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.959 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -120.64 148.31 44.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.921 0.391 . . . . 0.0 110.624 177.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 8.5 m -94.88 127.75 41.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.257 -178.651 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 271' ' ' ASP . 7.4 p -79.9 134.02 28.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.271 0.558 . . . . 0.0 110.286 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.428 ' HB ' ' HG3' ' A' ' 307' ' ' GLU . 61.0 t -95.13 -38.7 9.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.859 -178.927 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -166.82 139.88 3.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.752 0.311 . . . . 0.0 110.235 -179.199 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 86.8 t -83.88 103.75 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.622 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 18.4 t -72.58 -58.21 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.024 -171.952 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -116.69 -9.98 11.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.98 0.419 . . . . 0.0 111.817 -174.828 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 78.03 11.39 85.43 Favored Glycine 0 CA--C 1.516 0.136 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -173.378 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 20.3 p -148.98 18.53 0.98 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 173.43 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.8 t-160 -169.43 113.59 0.53 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.006 -165.079 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.5 m -119.06 163.17 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 121.206 -0.198 . . . . 0.0 110.57 -173.413 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.428 ' HG3' ' HB ' ' A' ' 298' ' ' VAL . 11.5 pt-20 -116.92 128.5 55.29 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 171.255 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.488 HG21 HD11 ' A' ' 273' ' ' ILE . 29.8 pt -126.61 168.15 20.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.123 0.487 . . . . 0.0 111.938 -176.104 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.3 t -146.92 138.57 13.38 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.049 174.758 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.36 -179.66 27.75 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.815 -1.327 . . . . 0.0 112.721 -1.599 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 38.6 ttmt -79.51 124.07 84.03 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.258 -178.479 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 312' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 13.4 Cg_exo -68.86 113.44 3.22 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.972 2.448 . . . . 0.0 112.384 177.416 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.513 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -123.96 129.28 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.355 176.229 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 317' ' ' ASP . . . -86.53 129.34 34.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.876 -177.893 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.83 -27.49 68.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.719 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -95.75 15.19 20.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.639 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 317' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 10.2 t70 -81.96 127.66 33.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.291 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.2 m -84.17 -3.48 7.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -174.027 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 14.7 m -96.82 1.38 50.62 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -174.676 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.0 OUTLIER -111.18 156.37 21.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.211 0.529 . . . . 0.0 111.403 178.515 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 16.0 m -94.07 165.7 17.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.11 -175.84 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 66.6 Cg_exo -42.96 -49.0 7.23 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 123.697 2.932 . . . . 0.0 114.253 -178.627 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -62.53 -39.51 93.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 0.0 110.949 -179.101 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 47.5 mt-30 -67.56 -33.25 74.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.309 179.592 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.458 ' HG2' HD13 ' A' ' 320' ' ' LEU . 83.2 mtt180 -60.86 -32.6 72.02 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.859 175.85 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -69.02 -25.11 64.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.677 179.502 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -95.52 -0.74 51.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 178.51 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.513 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -73.76 107.4 5.98 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.237 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 329' ' ' ASN . . . . . 0.504 ' ND2' HG13 ' A' ' 330' ' ' VAL . 5.6 p-10 -92.3 -5.38 52.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.157 -176.004 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.504 HG13 ' ND2' ' A' ' 329' ' ' ASN . 28.1 m -133.21 155.92 41.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.562 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.43 ' HB3' ' HB3' ' A' ' 281' ' ' LEU . 24.9 p-10 -93.99 -26.53 16.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.764 -178.669 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.559 ' OG1' ' HA ' ' A' ' 278' ' ' VAL . 43.2 p -109.21 139.48 44.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.165 0.507 . . . . 0.0 111.311 -179.033 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 46.9 p -86.57 169.56 12.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.328 176.787 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.9 tp -74.91 102.22 4.69 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.673 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -82.3 165.86 20.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.961 -179.886 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -78.99 26.27 0.26 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -172.498 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -154.49 41.13 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.01 0.433 . . . . 0.0 110.911 176.111 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.463 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 23.4 mmt -99.32 149.66 22.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 177.786 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 339' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 276' ' ' ALA . . . -99.99 143.88 29.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.949 -179.111 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.5 t -110.91 115.8 50.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.143 -178.793 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -132.7 137.55 46.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.861 -177.273 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.415 HD11 ' HG2' ' A' ' 267' ' ' MET . 24.2 mt -97.9 129.5 48.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.718 178.375 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 59.8 mt -84.93 143.58 28.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.321 178.123 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -124.87 99.21 6.04 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.906 0.384 . . . . 0.0 110.197 179.504 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.518 179.939 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.666 0 N-CA-C 112.204 -0.358 . . . . 0.0 112.204 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 13.8 p -79.76 -11.68 59.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.775 0.321 . . . . 0.0 111.112 -177.661 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 342' ' ' ILE . 20.8 p -74.65 -8.8 57.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.492 179.253 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -75.97 60.37 1.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.303 0.573 . . . . 0.0 110.651 179.141 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 46.4 p -83.98 73.86 10.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.912 -178.724 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -73.67 69.45 1.48 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.758 -177.932 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.502 HG21 ' O ' ' A' ' 263' ' ' ALA . 38.4 mt -102.33 152.6 5.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.477 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -99.86 169.6 9.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.392 0.615 . . . . 0.0 112.315 -177.528 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.632 HG11 ' O ' ' A' ' 335' ' ' ALA . 10.4 p -81.61 152.08 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.752 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.3 t -104.55 80.77 1.71 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 91.02 165.38 40.07 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.177 -179.632 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -96.33 136.88 36.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.603 0.239 . . . . 0.0 110.44 179.206 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -149.27 127.16 11.85 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.36 0.6 . . . . 0.0 111.327 179.602 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.513 ' HA ' ' HB3' ' A' ' 333' ' ' SER . 11.6 p -98.14 120.65 38.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.267 177.347 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.86 157.99 25.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.935 -175.435 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.408 ' HD2' ' HB3' ' A' ' 320' ' ' LEU . 46.6 mmtm -141.87 132.15 12.77 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.351 -179.498 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.612 ' HD3' HG11 ' A' ' 313' ' ' VAL . 70.6 Cg_endo -87.61 145.69 6.9 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.528 2.152 . . . . 0.0 112.063 178.438 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.44 126.93 38.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.337 0.589 . . . . 0.0 110.622 177.453 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -131.37 -160.79 1.07 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.627 179.031 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -74.76 81.17 2.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.221 0.534 . . . . 0.0 110.374 178.889 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -172.29 173.81 4.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.549 177.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.428 ' N ' HD23 ' A' ' 243' ' ' LEU . 1.8 pt? -144.46 30.08 1.25 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.701 176.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.45 ' HB3' ' H ' ' A' ' 245' ' ' ASN . 3.7 m-20 60.09 -154.58 0.37 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.055 -178.761 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.45 ' H ' ' HB3' ' A' ' 244' ' ' ASP . 16.5 m120 -71.5 -55.21 8.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.599 0.238 . . . . 0.0 111.545 -175.384 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -100.04 -59.35 1.73 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.915 0.388 . . . . 0.0 110.96 -176.921 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 173.79 163.67 27.68 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.773 -178.84 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -125.95 122.08 34.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.99 0.424 . . . . 0.0 110.58 -178.835 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -86.7 -25.03 24.98 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.753 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.6 m -60.3 115.54 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.572 -179.577 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -141.7 143.69 33.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.353 178.402 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 17.8 t 56.8 65.73 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.741 0.782 . . . . 0.0 109.936 -176.056 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -165.59 -44.23 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.113 -179.318 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -67.4 -13.81 62.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.784 -177.642 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -60.4 -24.8 65.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.35 0.595 . . . . 0.0 110.114 174.586 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -116.01 163.52 15.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.599 177.214 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -113.88 114.36 26.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.307 177.301 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -84.16 103.02 13.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.432 0.634 . . . . 0.0 111.306 179.012 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.8 t -83.24 124.62 39.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.351 -177.273 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 6.1 m -97.82 105.77 17.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.912 178.613 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.473 ' HB2' HG22 ' A' ' 264' ' ' THR . 17.4 mt -123.04 165.76 16.26 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.998 -174.537 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.7 m -57.06 -56.71 18.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.434 0.635 . . . . 0.0 109.649 179.436 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.502 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -138.12 134.63 34.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.874 177.154 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 264' ' ' THR . . . . . 0.473 HG22 ' HB2' ' A' ' 261' ' ' LEU . 6.7 p -123.99 24.71 8.17 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.938 0.875 . . . . 0.0 108.723 175.132 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 44.9 m -75.4 131.79 40.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.16 173.655 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 110.48 -26.5 13.06 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -171.828 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -76.53 140.75 41.26 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 172.674 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -154.35 146.11 23.37 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.183 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.505 ' HA ' HG13 ' A' ' 297' ' ' VAL . 29.9 ptt180 -41.9 119.66 1.36 Allowed 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.149 0.906 . . . . 0.0 112.609 -173.334 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 110.33 -9.16 30.9 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.44 176.683 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.459 ' H ' HG12 ' A' ' 297' ' ' VAL . 2.4 p30 -77.06 -178.12 4.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.372 0.606 . . . . 0.0 111.943 -177.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.52 117.08 18.28 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.628 -178.598 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.435 HD11 HG21 ' A' ' 308' ' ' ILE . 35.5 pt -112.63 140.23 33.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.156 0.503 . . . . 0.0 110.763 179.342 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 22.7 t -121.32 145.29 48.03 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.559 178.49 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -112.33 111.46 22.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.023 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.65 120.24 15.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.591 -178.901 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.96 -34.24 5.19 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -178.068 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 96.1 t -90.29 115.68 30.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 173.235 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -131.46 151.41 51.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.033 0.444 . . . . 0.0 111.739 -173.734 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.533 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 77.5 m-85 -70.18 115.45 9.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.462 176.332 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 281' ' ' LEU . 2.3 pt? -74.95 -18.28 60.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.717 0.294 . . . . 0.0 111.114 -175.311 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -70.17 -20.73 76.77 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 175.303 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -71.54 -17.69 62.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.984 0.421 . . . . 0.0 110.091 177.719 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 58.1 mtt -78.89 2.52 19.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.053 -178.31 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -58.1 -38.43 76.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.328 -178.407 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -145.27 -32.17 0.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.052 0.454 . . . . 0.0 110.761 178.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -85.34 118.25 24.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.002 0.429 . . . . 0.0 110.57 178.538 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 45.2 t -76.4 -30.12 19.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.26 -179.342 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 87.4 mt -89.12 61.9 6.0 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -178.611 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -60.24 123.2 16.49 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.784 -174.974 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -60.9 145.48 50.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.231 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -71.42 154.04 41.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.382 176.499 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.533 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -60.47 127.28 30.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.606 -174.531 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 29.3 p -120.03 122.95 42.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.591 -179.387 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.453 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 75.2 m-85 -133.78 152.28 51.83 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 11.9 t -96.28 134.8 38.94 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.41 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.505 HG13 ' HA ' ' A' ' 269' ' ' ARG . 4.7 p -69.79 139.98 19.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.145 178.733 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 50.2 t -104.67 -38.4 4.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.151 175.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -163.06 140.74 7.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.615 179.555 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.4 109.18 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.074 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.15 -59.61 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.017 -174.2 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -111.03 -13.62 14.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.291 0.567 . . . . 0.0 111.57 -175.026 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.22 13.99 77.74 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.255 -174.033 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 40.0 p -136.67 9.86 3.12 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 169.962 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.496 ' NE2' ' HB ' ' A' ' 258' ' ' THR . 2.2 t-160 -158.18 114.15 2.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.343 -1.299 . . . . 0.0 108.279 -168.749 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.2 m -118.69 150.98 20.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -177.011 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -111.06 117.05 32.24 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.182 0.515 . . . . 0.0 110.092 173.895 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.483 HG22 ' HA ' ' A' ' 297' ' ' VAL . 24.6 pt -116.67 172.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.069 -179.229 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.9 t -154.53 141.86 13.68 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.324 176.745 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.98 179.71 29.68 Favored 'Cis proline' 0 CA--C 1.531 0.337 0 C-N-CA 123.487 -1.464 . . . . 0.0 112.838 -3.06 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.419 ' HZ3' ' HB2' ' A' ' 311' ' ' LYS . 3.7 ttmp? -83.87 128.03 64.83 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.58 -177.774 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.97 108.93 2.56 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.379 2.053 . . . . 0.0 111.727 174.459 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.697 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.8 OUTLIER -123.99 136.79 59.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.028 -179.063 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 314' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -86.88 138.27 31.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.54 0.686 . . . . 0.0 112.285 -173.041 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 315' ' ' LEU . . . . . 0.48 HD22 ' HB2' ' A' ' 325' ' ' ARG . 3.0 tm? -76.58 -33.67 58.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.253 178.594 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -89.2 13.99 11.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.256 -177.305 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 317' ' ' ASP . . . . . 0.454 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 11.3 t70 -73.13 123.27 23.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.034 179.266 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 11.8 p -83.75 -16.55 10.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.768 -175.825 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 14.4 m -80.61 -33.78 35.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.441 -172.086 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.5 pp -82.93 159.27 22.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.445 0.641 . . . . 0.0 112.084 -177.879 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.442 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 18.8 m -81.07 163.97 52.75 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.428 -178.5 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 67.2 Cg_exo -43.39 -52.86 4.69 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.503 2.802 . . . . 0.0 114.35 179.763 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.93 -28.54 70.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.09 0.471 . . . . 0.0 111.135 -177.15 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.494 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 11.7 mm100 -69.22 -45.98 68.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.72 -179.008 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 325' ' ' ARG . . . . . 0.48 ' HB2' HD22 ' A' ' 315' ' ' LEU . 2.7 ptp180 -70.47 -21.15 62.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.857 0.361 . . . . 0.0 110.677 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -65.18 -28.4 69.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.983 0.421 . . . . 0.0 110.265 173.394 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -94.66 -0.2 54.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.002 179.575 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.697 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -60.85 149.87 34.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.422 178.715 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -124.75 -19.45 5.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.643 -176.806 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.0 m -127.99 163.61 31.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 281' ' ' LEU . 20.6 p-10 -83.77 -34.14 24.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.636 0.255 . . . . 0.0 111.337 -176.258 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 12.1 t -132.83 146.92 52.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.199 -178.589 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.513 ' HB3' ' HA ' ' A' ' 235' ' ' SER . 30.6 m -82.2 -175.86 5.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.749 -179.416 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.1 tp -75.99 103.81 6.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.134 -176.549 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.632 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -82.01 169.45 16.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.479 179.697 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -79.44 23.25 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -171.277 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -155.42 46.46 0.5 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.96 0.41 . . . . 0.0 110.805 177.323 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.0 mmt -100.07 132.23 45.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.18 178.3 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -88.5 129.31 35.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.817 179.133 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 10.3 t -97.45 147.6 6.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -160.52 138.01 9.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.496 0.189 . . . . 0.0 110.798 176.212 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.404 ' O ' ' HB ' ' A' ' 224' ' ' THR . 47.3 mt -88.76 121.66 39.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.052 0.453 . . . . 0.0 110.672 176.365 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 61.5 mt -81.98 143.6 31.48 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.714 179.195 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -123.55 138.52 54.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.468 -178.039 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 45.8 t . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.35 176.466 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.464 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 23.7 p . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.448 0.166 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 61.3 52.13 53.63 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.302 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.442 HG21 ' O ' ' A' ' 263' ' ' ALA . 58.7 mt -103.37 148.39 8.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 34.5 p -97.2 150.58 20.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.603 0.716 . . . . 0.0 111.992 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.62 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.8 p -63.92 151.45 8.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.025 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.9 t -115.34 81.68 1.62 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.899 0.381 . . . . 0.0 110.006 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 102.48 165.09 26.37 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.838 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -101.88 136.44 41.71 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.473 ' OE1' ' HA ' ' A' ' 259' ' ' VAL . 3.9 pt20 -144.14 139.46 28.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.247 0.546 . . . . 0.0 111.475 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 28.1 t -145.98 103.39 3.74 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.384 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -102.39 150.63 23.15 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 320' ' ' LEU . 45.9 mmtm -119.68 131.91 24.22 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.223 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 N--CA 1.462 -0.376 0 C-N-CA 122.603 2.202 . . . . 0.0 111.863 178.972 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.86 0.362 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -117.27 115.83 26.05 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.082 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.2 m -87.36 100.3 12.62 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.107 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.473 ' HA ' ' OE1' ' A' ' 234' ' ' GLN . 2.5 t -83.1 122.27 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.414 -172.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 25.0 m -96.13 105.81 17.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.834 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.534 HD23 HG23 ' A' ' 230' ' ' VAL . 21.0 mt -123.7 165.95 16.37 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.968 -175.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.9 t -60.11 -54.66 43.27 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.442 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.27 139.44 40.95 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.166 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 11.6 p -132.48 24.55 4.43 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.98 0.895 . . . . 0.0 108.867 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.4 m -78.23 139.26 38.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.865 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.77 -9.02 55.12 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -175.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 61.6 mtt -94.13 148.97 21.66 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 24.8 pttm -139.11 163.56 32.1 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -57.52 135.95 56.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.86 0.362 . . . . 0.0 110.935 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 82.71 19.03 64.46 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.801 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.52 ' HB2' ' O ' ' A' ' 268' ' ' LYS . 0.6 OUTLIER -94.21 174.2 7.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.791 0.329 . . . . 0.0 110.178 -178.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 0.1 OUTLIER -114.8 116.72 29.07 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.69 -178.269 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.455 HD11 HG21 ' A' ' 308' ' ' ILE . 17.1 pt -122.31 139.93 47.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.898 0.38 . . . . 0.0 110.238 175.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 72.9 p -119.75 145.05 46.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.011 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.4 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 94.0 m-85 -107.0 111.4 23.87 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.19 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.415 ' HA ' ' OD1' ' A' ' 292' ' ' ASP . . . -66.18 113.3 4.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.071 -176.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.26 -34.25 5.4 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 96.6 t -87.9 118.81 34.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -149.44 172.07 15.55 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.214 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -83.47 150.29 26.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.611 0.719 . . . . 0.0 112.364 -169.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' A' ' 315' ' ' LEU . 40.3 mt . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.965 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.415 ' OD1' ' HA ' ' A' ' 276' ' ' ALA . 31.8 m-20 . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 120.651 0.262 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.433 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -57.97 113.32 1.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.291 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 9.5 p -96.77 105.39 17.5 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.052 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.433 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 68.6 m-85 -116.93 147.83 41.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.741 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.8 t -94.94 124.48 39.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.747 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.499 HG12 ' H ' ' A' ' 271' ' ' ASP . 12.9 p -75.15 140.98 16.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.323 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 37.9 t -103.33 -38.04 5.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.861 0.363 . . . . 0.0 110.83 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -158.82 136.75 10.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 0.0 111.026 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.25 106.58 17.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.53 -59.3 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.912 -171.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -112.9 -3.7 14.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.852 0.358 . . . . 0.0 111.445 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 71.24 12.46 72.38 Favored Glycine 0 CA--C 1.517 0.216 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -172.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 16.7 p -147.92 19.49 1.13 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.444 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.4 t-160 -169.98 113.15 0.48 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.056 -167.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.0 166.11 13.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -175.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.95 119.05 28.44 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.232 0.539 . . . . 0.0 109.996 171.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.455 HG21 HD11 ' A' ' 273' ' ' ILE . 36.6 pt -113.61 171.1 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.572 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 10.3 t -155.08 144.94 15.57 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -71.75 -179.91 24.16 Favored 'Cis proline' 0 CA--C 1.532 0.382 0 C-N-CA 124.215 -1.16 . . . . 0.0 113.048 -1.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -87.1 126.9 61.29 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.675 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.93 121.8 8.45 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.586 2.191 . . . . 0.0 112.328 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.696 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.9 OUTLIER -130.78 128.55 63.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.741 178.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -85.95 139.1 31.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.158 -174.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.565 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.0 tm? -80.73 -27.05 36.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.986 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -77.7 -10.48 59.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.443 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -83.02 116.02 22.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.037 0.446 . . . . 0.0 110.335 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.3 m -82.68 0.22 4.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.643 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 13.8 m -71.1 -19.18 62.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.609 0.242 . . . . 0.0 111.437 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 0.8 OUTLIER -94.94 168.77 10.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.147 0.498 . . . . 0.0 111.858 -177.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.405 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 15.2 t -87.45 152.28 52.01 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.906 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.405 ' HD2' ' OG ' ' A' ' 321' ' ' SER . 60.7 Cg_exo -40.73 -45.3 4.76 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.381 2.721 . . . . 0.0 113.781 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 323' ' ' GLU . 3.0 mp0 -51.33 -45.68 62.36 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.225 0.536 . . . . 0.0 110.855 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 13.7 mm100 -64.76 -25.23 67.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.28 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -65.33 -31.09 72.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.93 0.395 . . . . 0.0 110.53 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.45 74.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.373 175.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -85.53 -10.28 56.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.15 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.696 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -63.08 135.08 57.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.638 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -119.51 -30.24 4.9 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 34.3 m -112.91 165.69 7.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.044 0.45 . . . . 0.0 111.399 -177.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -78.71 -44.89 22.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.528 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.3 t -130.9 145.91 52.16 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.126 0.489 . . . . 0.0 110.97 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 38.4 m -74.18 169.02 18.42 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.727 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.8 tp -75.86 102.98 5.73 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.62 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -91.66 166.19 12.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.994 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.42 62.19 4.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.09 0.472 . . . . 0.0 111.778 -173.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -176.94 30.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.491 171.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.2 mmt -101.47 134.38 44.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.342 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -90.15 132.85 35.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.009 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 22.8 t -108.3 108.56 25.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.717 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . 0.464 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 64.1 t30 -123.6 132.5 53.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.074 -175.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 47.6 mt -76.59 129.94 36.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.125 0.488 . . . . 0.0 110.295 173.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 45.4 mt . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.803 178.837 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.613 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 19.4 p . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.26 0.076 . . . . 0.0 111.061 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.64 49.66 76.16 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.754 177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.493 HG21 ' O ' ' A' ' 263' ' ' ALA . 57.7 mt -102.75 141.76 18.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 29.7 p -97.44 153.13 18.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.532 0.682 . . . . 0.0 111.839 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.611 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.7 p -58.92 151.5 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.289 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 10.2 t -105.33 73.51 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.992 0.425 . . . . 0.0 110.095 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 97.19 158.58 31.06 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.093 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -72.61 116.96 13.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.731 0.3 . . . . 0.0 110.401 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 334' ' ' LEU . 6.2 tp-100 -129.37 127.09 40.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.148 0.499 . . . . 0.0 110.589 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.2 p -118.5 125.38 49.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.105 0.478 . . . . 0.0 109.819 177.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.477 ' CD2' ' HG2' ' A' ' 312' ' ' PRO . 70.1 m-85 -81.23 131.86 35.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.602 -174.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -129.52 111.11 17.71 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -175.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.448 -1.15 0 C-N-CA 122.67 2.247 . . . . 0.0 111.024 169.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.956 0.408 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -106.5 117.19 33.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.071 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -92.1 101.82 14.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.107 0.48 . . . . 0.0 110.542 -178.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.471 ' HB ' HG22 ' A' ' 306' ' ' VAL . 3.3 t -83.2 118.99 31.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.517 -172.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 20.5 m -90.78 108.54 19.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.186 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.424 ' HB2' HG22 ' A' ' 264' ' ' THR . 20.7 mt -127.11 165.06 20.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.065 -175.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 20.8 m -58.59 -55.68 31.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.398 0.618 . . . . 0.0 109.543 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.493 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -138.2 141.16 40.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.527 ' HB ' ' SD ' ' A' ' 267' ' ' MET . 9.3 p -126.42 24.69 6.69 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.057 0.932 . . . . 0.0 108.766 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 17.0 m -71.59 138.8 49.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.372 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 105.76 -11.26 45.76 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . 0.53 ' SD ' HG11 ' A' ' 306' ' ' VAL . 63.3 mtt -95.18 142.83 27.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -154.17 140.36 18.5 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.523 ' HA ' HG13 ' A' ' 297' ' ' VAL . 30.0 ptt180 -44.17 118.01 1.38 Allowed 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.977 0.798 . . . . 0.0 112.607 -171.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.47 -10.63 19.4 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.467 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.497 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.5 p30 -82.84 -177.2 6.66 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.552 0.692 . . . . 0.0 112.175 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -124.97 117.73 24.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.973 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.534 HD11 HG21 ' A' ' 308' ' ' ILE . 37.5 pt -111.12 139.3 35.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.038 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.504 ' OG ' HG22 ' A' ' 294' ' ' THR . 3.0 m -125.34 129.51 50.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.508 -174.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -97.27 110.92 23.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.303 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.12 121.42 20.19 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.011 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.36 -27.93 9.58 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.77 131.28 50.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -141.84 157.73 44.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.786 0.327 . . . . 0.0 110.902 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.401 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 43.3 m-85 -83.97 149.33 26.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.082 -174.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 315' ' ' LEU . 96.4 mt . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.391 176.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 C--O 1.235 0.33 0 CA-C-O 120.695 0.283 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.401 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -71.29 85.87 0.79 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.9 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.504 HG22 ' OG ' ' A' ' 274' ' ' SER . 22.2 p -96.79 122.18 39.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.233 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.4 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 90.7 m-85 -124.11 153.65 41.15 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.97 0.414 . . . . 0.0 110.796 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.5 m -90.61 125.83 35.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.579 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 269' ' ' ARG . 4.8 p -67.03 134.45 30.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.034 0.445 . . . . 0.0 109.86 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 99.7 t -101.39 -53.05 7.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.744 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 301' ' ' VAL . 2.7 tmt_? -157.1 131.11 8.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.032 0.444 . . . . 0.0 110.843 -177.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 99.2 t -84.63 114.44 24.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.478 174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 299' ' ' ARG . 46.1 t -76.54 -59.15 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.644 -174.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -128.26 -7.72 5.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.445 0.64 . . . . 0.0 110.989 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.4 14.15 76.98 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 23.7 p -137.3 6.91 2.83 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 172.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.428 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.7 t-160 -164.14 119.64 1.55 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.456 -169.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.83 161.83 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -176.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -119.8 128.85 54.09 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 172.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.534 HG21 HD11 ' A' ' 273' ' ' ILE . 26.8 pt -133.94 171.64 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.102 0.477 . . . . 0.0 111.848 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 8.5 t -152.35 143.35 15.71 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.191 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.38 -179.96 27.88 Favored 'Cis proline' 0 CA--C 1.53 0.302 0 C-N-CA 123.752 -1.353 . . . . 0.0 112.939 -0.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -92.26 123.67 61.8 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.167 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.477 ' HG2' ' CD2' ' A' ' 236' ' ' PHE . 38.2 Cg_endo -70.48 109.46 2.45 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.49 2.127 . . . . 0.0 112.404 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 46.7 t -117.42 129.65 73.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.893 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -87.12 132.73 33.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.27 0.557 . . . . 0.0 111.473 -175.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.428 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.0 tm? -68.96 -26.99 65.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.205 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -98.27 19.48 14.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.719 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . 0.489 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 11.2 t70 -72.96 130.22 39.87 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.17 -16.61 10.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -174.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 18.9 t -90.76 -36.07 14.5 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -169.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.489 ' HG ' ' OD1' ' A' ' 317' ' ' ASP . 0.5 OUTLIER -71.15 175.92 4.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.526 0.679 . . . . 0.0 112.783 -175.3 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 13.5 m -103.13 158.53 31.58 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.21 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -39.7 -52.39 2.63 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.087 3.192 . . . . 0.0 114.756 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -58.54 -34.28 70.83 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -71.63 -26.46 62.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.788 0.328 . . . . 0.0 110.658 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -69.23 -22.97 63.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.975 0.416 . . . . 0.0 110.611 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -70.9 -34.3 71.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.29 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -86.24 -0.25 55.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.171 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -64.7 144.02 57.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.072 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -137.03 -9.26 1.78 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 32.5 m -123.4 155.25 29.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -84.88 -25.57 27.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 6.8 t -134.11 140.76 46.82 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.078 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 14.6 p -79.36 173.49 12.52 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 234' ' ' GLN . 19.1 tp -73.95 102.22 4.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.611 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -90.82 164.15 14.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.254 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . 0.427 ' HA ' ' CG1' ' A' ' 230' ' ' VAL . 23.8 t0 -77.89 60.57 2.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.181 0.515 . . . . 0.0 111.693 -173.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -178.23 29.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.473 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.5 mmt -98.17 134.37 41.32 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.228 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -94.48 131.14 40.5 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.79 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.404 HG21 HD22 ' A' ' 261' ' ' LEU . 9.0 t -104.75 114.05 43.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.048 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . 0.613 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 63.2 t30 -130.83 150.86 51.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.4 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 27.6 mt -102.84 130.73 52.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.115 0.483 . . . . 0.0 111.419 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 46.3 mt . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.192 173.804 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 33.8 p . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 111.231 0.086 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.13 48.39 86.16 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.644 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 263' ' ' ALA . 27.3 mm -100.87 143.75 13.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.836 -0.182 . . . . 0.0 110.733 -174.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 18.9 p -119.79 167.76 11.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.181 0.515 . . . . 0.0 111.417 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.57 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.9 p -85.38 150.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.835 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.3 t -107.11 60.04 0.62 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.155 0.503 . . . . 0.0 110.37 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 102.67 159.71 25.78 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.591 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 334' ' ' LEU . . . -70.81 131.12 43.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.929 0.395 . . . . 0.0 110.649 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -133.96 126.35 30.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.106 -175.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 27.1 p -110.07 142.64 41.25 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.786 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.586 ' O ' HG12 ' A' ' 313' ' ' VAL . 98.7 m-85 -124.97 130.6 52.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.241 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -129.61 139.27 35.17 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.05 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.506 ' HD3' HG11 ' A' ' 313' ' ' VAL . 94.8 Cg_endo . . . . . 0 N--CA 1.453 -0.908 0 C-N-CA 122.763 2.309 . . . . 0.0 112.151 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.441 ' HB2' ' HD2' ' A' ' 312' ' ' PRO . . . -121.24 114.97 22.14 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.664 0.269 . . . . 0.0 110.773 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.653 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -87.09 97.59 10.82 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.236 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -85.17 126.81 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.333 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 40.4 m -96.53 109.15 21.79 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 173.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.4 HD22 HG21 ' A' ' 340' ' ' VAL . 22.2 mt -122.43 172.52 8.28 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.7 m -58.87 -57.4 13.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.241 0.543 . . . . 0.0 109.754 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.479 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -137.2 135.98 37.76 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.956 178.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 8.2 p -130.79 23.88 5.01 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.544 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 89.7 m -82.89 137.05 34.39 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.87 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 112.54 -29.5 8.2 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -171.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -69.66 155.42 40.53 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 170.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -154.43 143.43 21.06 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.48 ' HA ' HG13 ' A' ' 297' ' ' VAL . 37.4 ptt180 -52.32 114.21 1.28 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.23 0.538 . . . . 0.0 111.06 -174.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 113.78 -2.7 24.51 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.903 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.426 ' H ' HG12 ' A' ' 297' ' ' VAL . 0.6 OUTLIER -83.6 175.1 9.99 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 117.1 0.45 . . . . 0.0 111.052 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -126.47 117.39 22.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.245 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.413 HG23 ' OD1' ' A' ' 271' ' ' ASP . 40.8 pt -112.13 140.28 32.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.188 0.518 . . . . 0.0 110.356 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.486 ' OG ' HG22 ' A' ' 294' ' ' THR . 2.7 m -120.5 137.48 54.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.987 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -101.24 111.35 23.54 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.68 116.34 9.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.023 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.27 -36.19 4.27 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 85.2 t -86.47 114.54 26.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 172.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -136.25 158.17 45.05 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.633 -172.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.481 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 66.7 m-85 -76.18 133.93 40.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.344 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.401 ' CD1' ' HB3' ' A' ' 315' ' ' LEU . 96.3 mt . . . . . 0 C--N 1.322 -0.611 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.663 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.481 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -73.6 106.96 5.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.982 -176.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.498 HG21 HD11 ' A' ' 343' ' ' LEU . 67.0 p -97.34 133.62 41.71 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.97 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -131.33 148.89 52.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.941 0.401 . . . . 0.0 110.579 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.1 m -92.29 129.95 38.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.087 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.55 ' HA ' HG22 ' A' ' 308' ' ' ILE . 4.0 p -72.4 143.72 13.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.795 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 62.0 t -105.41 -38.95 4.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.682 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -162.66 136.35 6.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.654 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 58.7 t -86.53 110.45 20.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 169.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 24.3 t -77.32 -56.83 6.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.732 -171.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -127.49 13.92 7.06 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.618 -173.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 59.55 13.84 25.39 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-O 121.438 0.466 . . . . 0.0 112.055 -174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.3 p -150.27 19.49 0.85 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.476 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.3 t-160 -169.03 115.84 0.62 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.817 -1.538 . . . . 0.0 108.074 -166.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.5 m -119.43 163.42 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.313 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.1 pt-20 -124.44 116.38 22.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.143 0.496 . . . . 0.0 109.674 169.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.55 HG22 ' HA ' ' A' ' 297' ' ' VAL . 24.2 pt -115.87 169.83 6.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.104 -177.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . 0.409 ' OG1' ' HA ' ' A' ' 310' ' ' PRO . 6.3 t -154.32 145.21 16.22 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.409 ' HA ' ' OG1' ' A' ' 309' ' ' THR . 59.4 Cg_endo -70.24 179.7 22.57 Favored 'Cis proline' 0 C--N 1.346 0.403 0 C-N-CA 124.038 -1.234 . . . . 0.0 113.238 1.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.46 ' HE3' ' HB3' ' A' ' 236' ' ' PHE . 31.7 tttp -83.53 119.11 73.28 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.255 -177.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 19.9 Cg_endo -62.29 109.11 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.51 2.14 . . . . 0.0 112.091 178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.791 HG23 ' HA ' ' A' ' 328' ' ' ALA . 8.9 m -127.81 128.33 69.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.324 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -87.34 136.16 33.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.953 -173.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.401 ' HB3' ' CD1' ' A' ' 281' ' ' LEU . 43.9 tp -80.62 -28.81 36.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.512 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -85.91 13.53 7.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.334 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -76.02 117.78 18.1 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 29.5 m -82.87 1.17 3.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.743 -175.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 16.1 m -94.51 -27.95 15.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.69 0.281 . . . . 0.0 111.107 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.6 pp -79.38 174.27 11.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.061 0.457 . . . . 0.0 111.291 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.533 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.6 m -116.36 168.37 8.79 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.16 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 29.3 Cg_exo -39.62 -49.1 3.38 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.793 2.995 . . . . 0.0 114.925 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -61.53 -36.94 82.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.039 0.447 . . . . 0.0 111.297 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 15.5 mm-40 -68.84 -30.4 68.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.603 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -62.86 -25.58 68.35 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.216 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.78 -34.05 69.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.128 0.489 . . . . 0.0 110.298 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -76.05 -30.67 58.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.297 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.791 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -59.26 139.69 56.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.08 -175.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -135.13 -33.36 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.822 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 27.6 m -101.35 171.24 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.969 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -75.33 -57.18 4.05 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.739 -176.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.8 t -139.41 164.1 30.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.666 0.269 . . . . 0.0 110.358 -175.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.6 p -73.91 164.48 26.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.743 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.504 ' HG ' HG21 ' A' ' 230' ' ' VAL . 25.6 tp -67.43 104.27 1.5 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.254 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.57 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -87.07 -174.35 4.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.598 -178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -80.99 157.31 25.55 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.579 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 59.33 39.08 22.75 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.864 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.9 mmt -103.78 130.17 51.27 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -81.69 137.81 35.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.214 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.431 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 22.0 t -111.18 110.06 30.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -123.29 144.21 49.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.638 -173.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 55.6 mt -96.84 127.56 48.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.31 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . 0.498 HD11 HG21 ' A' ' 294' ' ' THR . 84.0 mt . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.415 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 32.2 p . . . . . 0 CA--C 1.533 0.294 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -82.14 76.06 2.26 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.083 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 40.1 mt -95.82 153.51 3.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 3.2 p -96.6 151.69 19.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.485 0.659 . . . . 0.0 112.211 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.548 HG11 ' O ' ' A' ' 335' ' ' ALA . 4.2 p -64.5 151.01 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.638 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.1 t -105.52 76.77 1.23 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.61 165.16 40.73 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.059 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.44 122.8 18.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.953 0.406 . . . . 0.0 110.596 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.448 ' NE2' ' HB ' ' A' ' 260' ' ' THR . 86.1 mm-40 -110.0 126.91 54.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.235 0.54 . . . . 0.0 110.496 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.4 p -137.21 112.17 8.97 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.76 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 234' ' ' GLN . 40.9 m-85 -116.95 132.41 56.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.86 0.362 . . . . 0.0 110.926 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -115.94 131.55 23.67 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.367 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 N--CA 1.458 -0.565 0 C-N-CA 122.381 2.054 . . . . 0.0 111.512 177.209 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 121.0 0.428 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.454 ' HB2' ' HG3' ' A' ' 311' ' ' LYS . . . -100.41 115.97 31.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.616 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -85.83 97.78 10.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.978 179.459 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.0 t -81.98 114.18 22.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.977 -173.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . 0.448 ' HB ' ' NE2' ' A' ' 234' ' ' GLN . 17.5 m -86.42 107.19 17.93 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.985 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.453 HD12 HG22 ' A' ' 264' ' ' THR . 21.0 mt -122.12 167.12 13.53 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -177.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.8 m -55.86 -54.6 42.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.372 0.606 . . . . 0.0 109.65 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -138.4 146.83 42.68 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.453 HG22 HD12 ' A' ' 261' ' ' LEU . 24.3 p -133.6 31.38 3.7 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.889 0.852 . . . . 0.0 108.904 174.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.9 m -80.24 152.7 28.95 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.65 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 90.36 -28.73 7.19 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 52.7 mtt -78.2 135.62 37.65 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.512 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 3.2 ptpp? -134.36 163.53 29.46 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -52.85 126.58 20.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.941 0.4 . . . . 0.0 111.147 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 95.21 18.82 32.43 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.098 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.512 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 66.5 m-20 -100.77 161.39 13.63 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 117.349 0.574 . . . . 0.0 110.892 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.489 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 12.0 tppt? -106.53 117.53 34.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.782 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.475 HD11 HG21 ' A' ' 308' ' ' ILE . 36.5 pt -112.25 139.74 35.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.128 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.416 ' HB3' HG22 ' A' ' 294' ' ' THR . 32.6 p -113.06 134.35 54.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.317 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -100.06 111.55 23.84 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.932 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.96 130.73 46.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.837 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 89.43 -35.51 3.7 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.082 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.6 124.23 35.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -143.01 159.91 41.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.879 0.371 . . . . 0.0 111.183 -175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.435 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 80.7 m-85 -78.66 156.3 29.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.478 -173.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 91.5 mt . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.291 177.104 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 . . . . . 0 C--O 1.233 0.189 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.435 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -65.17 108.93 2.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.123 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.489 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 4.4 p -103.54 110.99 23.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.142 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -115.79 157.68 24.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.158 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 27.8 t -96.89 127.24 42.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.471 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.468 HG12 ' H ' ' A' ' 271' ' ' ASP . 12.1 p -82.85 131.23 34.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.169 0.509 . . . . 0.0 110.228 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 39.2 t -92.21 -36.08 7.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.193 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.408 ' O ' ' HG2' ' A' ' 307' ' ' GLU . 11.1 tpt180 -162.67 144.1 10.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.228 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.464 HG12 ' H ' ' A' ' 303' ' ' GLY . 93.1 t -91.24 114.71 28.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 16.8 t -77.83 -52.29 16.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.976 -172.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -125.11 3.16 7.93 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -172.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . 0.464 ' H ' HG12 ' A' ' 300' ' ' VAL . . . 65.22 13.98 58.73 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.295 -171.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -151.9 20.57 0.69 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.561 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.0 t-160 -171.43 114.94 0.39 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 113.821 -1.536 . . . . 0.0 108.296 -164.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.6 m -118.84 160.66 18.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -176.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 299' ' ' ARG . 12.2 pt-20 -118.03 120.5 37.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.081 0.467 . . . . 0.0 109.984 173.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 273' ' ' ILE . 31.0 pt -118.56 164.47 14.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.273 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . 0.405 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 8.8 t -154.11 140.91 13.15 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.141 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.405 ' C ' ' HA ' ' A' ' 309' ' ' THR . 15.5 Cg_exo -69.02 177.2 27.69 Favored 'Cis proline' 0 C--N 1.347 0.492 0 C-N-CA 123.932 -1.278 . . . . 0.0 112.567 -0.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.454 ' HG3' ' HB2' ' A' ' 257' ' ' ALA . 39.3 ttmt -90.42 124.88 61.62 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.731 -178.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.06 109.38 2.16 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.789 2.326 . . . . 0.0 112.467 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.49 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -112.69 130.83 65.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.897 176.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -81.93 126.97 32.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.173 0.511 . . . . 0.0 111.133 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.2 -31.58 70.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.61 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -82.55 3.61 27.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.588 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . 0.461 ' OD2' ' HG ' ' A' ' 320' ' ' LEU . 20.2 t70 -72.96 123.11 22.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.888 0.375 . . . . 0.0 110.119 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.51 2.11 4.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 29.1 t -93.93 -31.27 14.36 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -173.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.604 HD13 ' HG2' ' A' ' 325' ' ' ARG . 0.4 OUTLIER -84.09 155.17 22.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.595 0.712 . . . . 0.0 112.492 -177.163 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.485 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 47.1 t -80.12 154.92 75.02 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.919 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.485 ' HD2' ' OG ' ' A' ' 321' ' ' SER . 41.3 Cg_exo -36.13 -52.65 1.05 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 124.087 3.191 . . . . 0.0 114.291 177.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.28 -38.84 84.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.815 0.34 . . . . 0.0 111.122 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 15.3 mm100 -64.65 -26.72 68.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.637 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.604 ' HG2' HD13 ' A' ' 320' ' ' LEU . 88.2 mtt180 -73.33 -19.23 61.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.912 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -78.83 -25.42 44.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.987 175.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -88.69 -11.63 44.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.536 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.49 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -66.76 121.65 15.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.782 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . 0.483 ' OD1' HG13 ' A' ' 330' ' ' VAL . 3.2 p30 -102.35 -27.45 12.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.823 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.483 HG13 ' OD1' ' A' ' 329' ' ' ASN . 36.0 m -113.85 168.08 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.998 0.427 . . . . 0.0 110.995 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -88.48 -41.43 12.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.328 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.5 t -123.64 145.36 49.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.252 0.548 . . . . 0.0 110.853 -174.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 7.5 p -73.0 162.57 29.33 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.339 172.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.451 ' HG ' HG21 ' A' ' 230' ' ' VAL . 40.6 tp -71.57 104.16 3.22 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.548 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.01 178.0 8.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.639 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -81.01 153.45 27.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.551 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 66.41 34.51 6.21 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 124.083 0.864 . . . . 0.0 111.897 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.515 ' H ' HG12 ' A' ' 230' ' ' VAL . 78.5 mmm -106.55 149.8 26.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -94.32 140.25 30.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.031 0.443 . . . . 0.0 111.588 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 41.7 t -125.28 120.35 57.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -138.51 148.21 44.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.711 0.291 . . . . 0.0 111.218 -174.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 60.5 mt -87.92 122.57 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.005 0.431 . . . . 0.0 110.585 174.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 47.8 mt . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.281 178.754 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.554 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 22.2 p . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 120.386 0.136 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.99 48.01 88.18 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.569 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.408 HG21 ' O ' ' A' ' 263' ' ' ALA . 71.3 mt -102.25 143.7 14.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 17.5 p -96.84 150.21 20.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.703 0.763 . . . . 0.0 112.243 -173.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.709 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.9 p -62.77 151.26 8.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.469 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 70.9 m -102.2 72.52 1.3 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.95 0.405 . . . . 0.0 110.724 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 99.09 164.86 29.95 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.377 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -88.93 138.53 31.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.618 0.246 . . . . 0.0 110.436 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' A' ' 234' ' ' GLN . 3.1 pt20 -153.58 147.32 25.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.143 0.497 . . . . 0.0 110.849 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 50.7 p -119.06 124.23 46.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.224 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -81.36 146.91 30.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.129 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.408 ' HB3' HE22 ' A' ' 324' ' ' GLN . 48.0 mmtm -141.76 116.57 6.9 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.112 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 N--CA 1.45 -1.058 0 C-N-CA 122.476 2.117 . . . . 0.0 110.436 166.791 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.555 ' O ' ' HE3' ' A' ' 311' ' ' LYS . 40.9 m-85 . . . . . 0 C--O 1.23 0.045 0 CA-C-O 120.823 0.344 . . . . 0.0 111.455 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -130.98 138.52 49.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.662 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 4.0 m -101.54 114.41 28.42 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.434 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.7 t -95.42 125.02 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.234 -174.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 28.3 m -98.74 111.55 23.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.022 177.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 340' ' ' VAL . 14.7 mt -130.59 169.34 15.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.455 -174.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.5 m -62.5 -55.38 28.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.492 0.663 . . . . 0.0 109.829 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.408 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.6 135.04 36.24 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.194 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.4 p -127.45 26.64 5.95 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 172.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 37.8 m -74.5 140.67 44.69 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.129 -1.851 . . . . 0.0 110.548 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 94.32 -11.93 69.68 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 66.0 mtt -86.09 145.2 27.15 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 25.2 pttm -136.22 155.23 50.42 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -57.34 128.48 37.22 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.92 18.47 34.38 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.447 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.548 ' H ' HG12 ' A' ' 297' ' ' VAL . 0.6 OUTLIER -101.28 178.02 4.77 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.5 ' HD3' ' HB ' ' A' ' 294' ' ' THR . 2.3 tmmm? -130.75 116.21 17.69 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.172 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 308' ' ' ILE . 37.7 pt -112.48 151.42 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.936 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.411 ' OG ' HG22 ' A' ' 294' ' ' THR . 18.5 m -140.41 144.07 35.97 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.395 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.486 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 88.7 m-85 -102.77 111.97 24.54 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.593 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.86 113.02 5.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.431 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.44 -18.19 23.11 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.712 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 59.4 t -110.32 114.08 46.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.05 159.4 37.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.814 0.34 . . . . 0.0 111.472 -176.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -69.86 161.46 29.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.045 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 315' ' ' LEU . 87.2 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.916 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.846 0.355 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.659 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -64.21 86.09 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.734 -176.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.5 ' HB ' ' HD3' ' A' ' 272' ' ' LYS . 43.7 p -87.93 110.37 20.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.526 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.659 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 64.7 m-85 -119.45 147.49 44.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.037 0.446 . . . . 0.0 111.381 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.7 m -91.89 127.82 37.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.689 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 271' ' ' ASP . 7.5 p -83.29 130.82 35.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.16 0.505 . . . . 0.0 110.289 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 307' ' ' GLU . 12.8 p -95.06 -30.05 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.498 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -163.38 139.84 7.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.11 0.481 . . . . 0.0 111.253 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 72.7 t -97.36 119.51 45.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.88 -59.88 2.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.838 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -129.23 -3.69 4.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.375 0.607 . . . . 0.0 111.091 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.6 14.44 75.91 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.413 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 14.4 p -143.0 16.09 1.92 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 174.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -171.54 116.28 0.4 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.807 -168.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.54 163.55 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.632 -174.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.439 ' O ' HG12 ' A' ' 298' ' ' VAL . 6.7 pt-20 -124.85 123.36 39.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.105 0.478 . . . . 0.0 109.943 172.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 297' ' ' VAL . 28.4 pt -129.17 175.05 11.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.284 -174.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . 0.413 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 11.6 t -154.17 145.39 16.46 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 176.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.79 179.36 29.52 Favored 'Cis proline' 0 C--N 1.345 0.393 0 C-N-CA 124.002 -1.249 . . . . 0.0 112.65 -2.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.555 ' HE3' ' O ' ' A' ' 256' ' ' PHE . 30.1 ttmt -84.42 128.84 60.1 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.854 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.497 ' HG3' ' CE2' ' A' ' 295' ' ' PHE . 7.6 Cg_exo -71.28 108.87 2.45 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.448 2.099 . . . . 0.0 112.283 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.613 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -123.33 129.99 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.546 175.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -85.59 131.03 34.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.796 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.405 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.2 tm? -62.29 -32.69 73.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.716 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -92.83 24.83 3.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.351 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.27 128.55 34.31 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 29.3 m -84.48 -1.89 6.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -173.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 33.7 t -110.13 -14.34 14.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -173.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.95 167.9 21.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.6 0.714 . . . . 0.0 112.312 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.4 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 7.9 t -99.98 154.03 37.45 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.15 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.49 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 67.0 Cg_exo -41.86 -47.81 6.27 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.158 2.572 . . . . 0.0 113.549 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 323' ' ' GLU . 1.6 mp0 -53.76 -39.94 65.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.186 0.517 . . . . 0.0 110.933 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.408 HE22 ' HB3' ' A' ' 237' ' ' LYS . 40.5 mt-30 -72.76 -23.88 60.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.823 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.49 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 29.6 mtm180 -66.36 -27.46 67.89 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.942 0.401 . . . . 0.0 110.297 176.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.82 63.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.222 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -96.06 7.57 46.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.939 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.613 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -58.9 140.09 55.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.898 0.38 . . . . 0.0 110.527 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -123.17 -33.43 3.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.412 -170.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 27.5 m -125.47 169.01 17.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.862 0.363 . . . . 0.0 110.16 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -94.07 -16.87 23.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.809 0.338 . . . . 0.0 110.916 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.0 t -144.62 141.33 29.31 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.894 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 50.1 m -80.18 171.99 14.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.2 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 17.7 tp -68.25 103.89 1.7 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.187 0.518 . . . . 0.0 110.364 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.709 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -81.02 170.82 15.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.917 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -79.31 11.56 2.85 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.373 -171.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -142.85 40.99 1.54 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.025 0.44 . . . . 0.0 110.979 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 21.6 mmt -98.99 133.07 43.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.355 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -94.33 130.6 40.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.822 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.469 HG21 HD13 ' A' ' 261' ' ' LEU . 12.2 t -99.78 113.17 34.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.613 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . 0.554 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 57.9 t30 -130.65 139.61 50.36 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.032 -177.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.6 mt -86.93 122.82 39.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.939 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 38.0 mt . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.747 -177.943 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 341' ' ' ASN . 31.0 p . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 121.329 0.585 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -113.94 56.43 0.49 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.573 HG21 ' O ' ' A' ' 263' ' ' ALA . 10.9 mt -92.51 161.2 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.22 -0.49 . . . . 0.0 110.342 -172.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 37.0 p -113.22 157.99 21.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.305 0.574 . . . . 0.0 111.369 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.697 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.2 p -72.07 151.63 8.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.454 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 39.8 t -106.24 95.43 5.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.921 174.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 83.42 165.04 37.42 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.92 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -92.99 126.08 37.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -142.0 129.53 21.39 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.249 0.547 . . . . 0.0 111.357 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 15.5 t -106.42 121.9 45.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.551 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.46 ' O ' HG13 ' A' ' 313' ' ' VAL . 91.2 m-85 -83.89 113.53 21.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.862 0.363 . . . . 0.0 110.596 -176.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.419 ' HE2' HD23 ' A' ' 320' ' ' LEU . 33.3 mmtp -124.04 118.48 26.8 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.528 -176.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo . . . . . 0 C--O 1.233 0.254 0 C-N-CA 122.516 2.144 . . . . 0.0 111.774 177.285 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.876 0.37 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.417 ' HB2' ' HA ' ' A' ' 311' ' ' LYS . . . -140.04 120.48 14.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.47 177.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.0 OUTLIER -90.27 104.24 16.84 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.991 0.424 . . . . 0.0 110.338 -179.466 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.456 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.6 t -88.94 117.9 33.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 -173.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 60.6 m -89.59 107.69 19.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.018 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.423 HD12 HG22 ' A' ' 264' ' ' THR . 18.6 mt -123.6 164.11 19.68 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.68 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 17.2 m -57.52 -52.93 63.38 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.432 0.634 . . . . 0.0 109.681 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.573 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.47 146.13 43.9 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 175.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.423 HG22 HD12 ' A' ' 261' ' ' LEU . 16.0 p -132.0 29.93 4.34 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.102 0.953 . . . . 0.0 108.569 174.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 18.3 m -73.74 138.97 44.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.291 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 100.15 -1.06 56.15 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.312 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . 0.402 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 54.9 mtt -102.04 142.86 32.65 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 62.0 pttt -143.33 148.18 35.87 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -50.18 122.32 6.68 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.601 0.563 . . . . 0.0 111.876 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 97.45 18.35 28.59 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.678 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.523 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.4 t70 -98.06 -171.02 2.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.98 0.39 . . . . 0.0 110.168 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -135.12 117.06 15.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.872 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.498 HD11 HG21 ' A' ' 308' ' ' ILE . 29.6 pt -112.64 140.37 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.421 -0.512 . . . . 0.0 109.974 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 6.8 m -120.86 137.03 54.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.233 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -103.18 111.55 23.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.3 119.03 12.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.365 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.03 -32.14 6.53 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -176.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.49 ' HA ' ' CG2' ' A' ' 332' ' ' THR . 43.7 t -96.73 122.37 48.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 279' ' ' LYS . 11.2 ptpt -140.12 170.1 16.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.878 0.37 . . . . 0.0 111.379 -176.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -81.18 173.41 12.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.753 -174.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 71.9 mt . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.257 -176.724 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 . . . . . 0 C--O 1.235 0.316 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.578 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -52.91 104.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.513 0.508 . . . . 0.0 111.199 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.05 106.48 16.73 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.037 -176.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.519 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 50.2 m-85 -122.96 154.82 37.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.949 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 31.6 t -91.69 134.84 34.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.303 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 271' ' ' ASP . 11.9 p -87.15 126.74 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.218 0.533 . . . . 0.0 110.171 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.6 t -92.59 -38.77 10.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.581 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -159.13 133.89 8.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 50.3 t -93.8 110.28 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 39.5 t -70.16 -58.28 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.887 -171.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -124.34 -8.92 7.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.257 0.551 . . . . 0.0 111.151 -176.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.9 13.86 76.67 Favored Glycine 0 C--N 1.32 -0.309 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -172.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 29.6 p -138.71 13.2 2.72 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 172.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -166.35 120.65 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.519 -170.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.6 159.81 20.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 -176.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -122.77 115.48 22.11 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.284 0.564 . . . . 0.0 109.724 168.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.498 HG21 HD11 ' A' ' 273' ' ' ILE . 30.1 pt -111.83 178.35 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.102 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 15.0 t -153.73 142.73 14.67 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.428 ' HD2' ' CD1' ' A' ' 295' ' ' PHE . 4.8 Cg_exo -82.13 -179.87 25.15 Favored 'Cis proline' 0 C--N 1.344 0.317 0 C-N-CA 124.282 -1.133 . . . . 0.0 112.522 -2.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 257' ' ' ALA . 24.4 ttmm -77.27 124.42 87.04 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.491 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.507 ' HA ' ' OD1' ' A' ' 329' ' ' ASN . 64.3 Cg_endo -77.94 108.6 2.56 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.374 2.05 . . . . 0.0 112.365 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 236' ' ' PHE . 0.2 OUTLIER -109.49 136.17 46.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' A' ' 317' ' ' ASP . . . -81.47 115.8 20.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.057 0.456 . . . . 0.0 111.106 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.96 -26.54 66.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.528 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.09 12.54 21.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.864 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . 0.43 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 21.4 t70 -85.66 118.63 25.29 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.88 -14.34 11.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.004 0.43 . . . . 0.0 111.221 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.5 t -77.7 -28.28 50.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.47 -174.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.419 HD23 ' HE2' ' A' ' 237' ' ' LYS . 1.8 pp -71.07 172.92 8.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.31 0.576 . . . . 0.0 112.009 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.436 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 23.5 m -102.65 162.98 18.53 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.483 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.438 ' O ' ' HG3' ' A' ' 325' ' ' ARG . 85.3 Cg_exo -44.62 -52.21 6.31 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.004 3.136 . . . . 0.0 115.39 -172.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -73.42 -18.13 61.18 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.771 -0.581 . . . . 0.0 111.743 -172.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -73.92 -39.7 63.65 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.224 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 322' ' ' PRO . 0.0 OUTLIER -75.07 -16.29 60.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.121 0.486 . . . . 0.0 110.785 178.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -66.71 -35.48 80.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.551 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -95.43 -0.62 52.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.138 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.447 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -66.19 128.45 36.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.15 0.5 . . . . 0.0 111.266 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . 0.507 ' OD1' ' HA ' ' A' ' 312' ' ' PRO . 10.2 p30 -110.85 -26.85 9.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.699 -176.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 29.2 m -108.54 164.07 5.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.017 0.437 . . . . 0.0 110.834 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -98.86 -5.66 30.54 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.49 ' CG2' ' HA ' ' A' ' 278' ' ' VAL . 8.9 t -146.05 148.11 32.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.059 0.457 . . . . 0.0 110.882 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 59.5 m -81.26 167.33 19.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.492 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.43 ' HG ' HG21 ' A' ' 230' ' ' VAL . 18.7 tp -76.02 102.92 5.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.697 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.58 167.63 19.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.297 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -80.68 28.7 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -171.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -153.09 32.23 0.48 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.874 0.368 . . . . 0.0 110.838 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.6 mmt -94.22 129.99 40.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.871 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -85.15 140.69 30.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.618 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.4 HG21 HD13 ' A' ' 261' ' ' LEU . 11.2 t -109.46 108.11 24.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.919 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . 0.515 ' HA ' ' O ' ' A' ' 226' ' ' THR . 6.8 t30 -119.6 132.11 55.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.15 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 4.0 mt -92.72 129.57 43.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.02 0.438 . . . . 0.0 110.591 175.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 50.8 mt . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.807 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 50.96 37.73 36.76 Favored Glycine 0 C--N 1.332 0.361 0 O-C-N 123.331 0.394 . . . . 0.0 113.056 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.406 HG21 ' O ' ' A' ' 263' ' ' ALA . 44.2 mt -82.5 141.7 14.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -176.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 5.4 p -95.29 147.14 23.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.724 0.773 . . . . 0.0 112.131 -171.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.67 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.6 p -57.54 151.37 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.089 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 33.1 t -101.93 47.7 0.89 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.084 0.469 . . . . 0.0 110.427 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 122.57 163.94 12.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.407 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -79.34 123.26 27.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.797 0.332 . . . . 0.0 110.417 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.437 HE22 ' CB ' ' A' ' 260' ' ' THR . 95.1 mt-30 -132.88 131.55 41.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.228 0.537 . . . . 0.0 111.217 -177.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.1 t -131.34 101.93 5.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.571 ' O ' HG13 ' A' ' 313' ' ' VAL . 64.8 m-85 -94.68 137.45 33.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.219 -176.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.69 ' HB3' ' NE2' ' A' ' 324' ' ' GLN . 3.3 mptp? -109.85 146.56 34.36 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.681 -177.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.456 -0.726 0 C-N-CA 122.571 2.181 . . . . 0.0 111.029 170.776 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 120.928 0.394 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -100.55 122.9 44.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.475 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -90.68 101.26 14.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.016 0.436 . . . . 0.0 111.089 179.002 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.6 t -83.15 121.48 36.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.977 -175.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . 0.437 ' CB ' HE22 ' A' ' 234' ' ' GLN . 29.0 m -94.28 107.02 18.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.312 0.577 . . . . 0.0 109.985 176.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.481 ' HB2' HG22 ' A' ' 264' ' ' THR . 17.8 mt -121.04 163.19 18.71 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.634 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 26.2 m -55.03 -54.0 48.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.172 0.51 . . . . 0.0 109.958 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.406 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.47 135.45 36.84 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.481 HG22 ' HB2' ' A' ' 261' ' ' LEU . 7.9 p -126.37 29.25 5.82 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.5 m -82.21 139.51 34.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.023 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 96.05 18.48 31.53 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 65.4 mtt -121.45 147.26 45.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.022 -0.589 . . . . 0.0 109.722 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -139.14 169.5 17.66 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.527 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 298' ' ' VAL . 47.6 mtt180 -56.48 128.56 36.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.777 0.323 . . . . 0.0 111.371 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.02 18.57 42.89 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.354 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.488 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 92.0 m-20 -93.78 156.12 16.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.169 0.484 . . . . 0.0 110.302 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -102.9 116.6 32.87 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.423 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.478 HD11 HG21 ' A' ' 308' ' ' ILE . 28.5 pt -113.51 138.69 42.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.095 176.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 10.5 t -120.19 132.25 55.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.461 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.453 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 92.5 m-85 -94.43 110.33 22.12 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.97 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.44 111.37 8.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.374 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.63 -19.95 20.98 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.577 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 74.7 t -104.44 128.7 57.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 174.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -147.11 159.7 43.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.956 0.407 . . . . 0.0 111.106 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 76.9 m-85 -73.66 166.08 23.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.277 -175.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 89.6 mt . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.489 178.267 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 C--O 1.235 0.327 0 CA-C-O 121.037 0.446 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -68.99 129.99 41.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.762 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 9.3 p -119.74 110.6 16.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.847 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -116.95 151.75 36.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.057 0.455 . . . . 0.0 110.95 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.3 m -98.56 131.08 45.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.713 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.488 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.3 p -79.09 131.33 34.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.263 0.554 . . . . 0.0 110.8 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.554 ' O ' ' HG2' ' A' ' 269' ' ' ARG . 25.6 t -94.61 -24.55 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.532 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.445 ' HB3' ' CD ' ' A' ' 307' ' ' GLU . 12.4 tpt180 -176.85 139.33 0.29 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.369 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 75.6 t -90.59 111.02 22.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 36.9 t -73.27 -55.59 12.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.047 -171.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -128.96 -4.26 5.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.191 0.519 . . . . 0.0 111.463 -176.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 80.55 13.32 81.79 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.46 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.3 p -143.51 16.42 1.83 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.1 t-160 -165.47 118.25 1.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.269 -170.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.5 m -118.95 157.54 20.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -176.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.445 ' CD ' ' HB3' ' A' ' 299' ' ' ARG . 8.8 pt-20 -115.39 121.72 43.66 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 173.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.478 HG21 HD11 ' A' ' 273' ' ' ILE . 30.0 pt -122.45 163.75 20.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.184 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.9 t -149.21 142.28 15.85 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.447 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.05 179.63 28.93 Favored 'Cis proline' 0 C--N 1.345 0.35 0 C-N-CA 123.463 -1.474 . . . . 0.0 112.696 -0.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -83.14 124.45 76.33 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.053 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -72.78 109.2 2.74 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.835 2.357 . . . . 0.0 112.225 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 236' ' ' PHE . 0.0 OUTLIER -118.82 137.3 53.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.642 176.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -81.46 131.15 35.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.285 0.564 . . . . 0.0 110.459 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -73.79 -29.35 62.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.111 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -93.9 24.79 3.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.346 0.593 . . . . 0.0 110.498 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . 0.646 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 14.8 t70 -82.05 121.4 26.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.198 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 13.1 p -84.32 -19.09 9.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.986 0.422 . . . . 0.0 110.996 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 34.2 t -71.72 -46.61 58.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.51 -174.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.646 ' HG ' ' OD1' ' A' ' 317' ' ' ASP . 0.3 OUTLIER -74.82 170.15 16.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.739 0.781 . . . . 0.0 113.066 -175.167 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 41.2 t -83.77 151.59 61.49 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.624 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.45 ' HA ' ' HD2' ' A' ' 325' ' ' ARG . 99.9 Cg_exo -45.84 -40.3 19.6 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.183 2.588 . . . . 0.0 113.414 176.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -60.44 -41.53 94.24 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.444 0.64 . . . . 0.0 110.914 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.69 ' NE2' ' HB3' ' A' ' 237' ' ' LYS . 39.2 mt-30 -70.21 -24.44 63.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.037 -177.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.45 ' HD2' ' HA ' ' A' ' 322' ' ' PRO . 90.6 mtt180 -70.34 -26.51 63.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.585 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.5 -29.07 68.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.236 0.541 . . . . 0.0 110.17 176.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -97.38 6.36 48.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.342 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.423 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -71.79 150.13 44.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 0.0 110.884 177.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -126.97 -32.25 2.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.915 0.388 . . . . 0.0 111.387 -174.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.9 m -112.46 155.14 13.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.24 -176.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -83.76 -22.1 32.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.252 0.548 . . . . 0.0 109.99 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 278' ' ' VAL . 1.4 t -129.46 131.44 46.71 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.606 -176.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 8.7 p -75.39 168.13 20.58 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.682 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 20.5 tp -70.22 103.73 2.44 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.67 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.49 173.14 12.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.294 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.31 10.37 3.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.858 -173.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -143.0 57.85 1.41 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.234 0.54 . . . . 0.0 110.786 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.8 mmt -117.11 136.14 53.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.282 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -96.38 131.93 42.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.903 0.382 . . . . 0.0 110.823 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.408 HG22 ' CD1' ' A' ' 275' ' ' PHE . 38.5 t -103.51 108.2 23.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.669 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -123.11 129.55 51.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.337 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 42.9 mt -80.17 125.14 38.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.525 175.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 78.5 mt . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.853 177.194 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 28.6 p . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 120.866 0.365 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.79 63.96 3.06 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.742 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 263' ' ' ALA . 45.5 mm -98.66 139.58 20.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.583 0.23 . . . . 0.0 111.112 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.3 p -121.72 160.24 24.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.949 0.404 . . . . 0.0 110.581 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.629 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.8 p -78.5 151.04 5.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.345 177.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.8 t -116.73 78.81 1.24 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.234 0.54 . . . . 0.0 109.755 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 110.68 166.33 19.1 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.46 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -97.35 110.12 22.74 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -97.51 127.36 43.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.36 0.6 . . . . 0.0 111.604 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.6 m -127.33 101.2 6.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.101 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.419 ' HB3' ' HE2' ' A' ' 311' ' ' LYS . 94.1 m-85 -85.49 167.92 15.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.497 -174.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . 42.7 mmtm -137.65 136.63 20.4 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.496 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.542 ' HD3' HG11 ' A' ' 313' ' ' VAL . 71.6 Cg_endo . . . . . 0 N--CA 1.45 -1.076 0 C-N-CA 122.638 2.226 . . . . 0.0 111.686 177.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 . . . . . 0 C--O 1.233 0.205 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.75 122.67 43.76 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.825 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -90.96 104.3 16.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.501 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.6 t -86.33 121.96 38.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.441 -173.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 63.3 m -91.12 105.35 17.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.218 0.533 . . . . 0.0 110.202 175.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.496 HD23 HG23 ' A' ' 230' ' ' VAL . 21.7 mt -122.02 162.85 20.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.623 -177.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 8.0 m -59.79 -52.05 67.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.169 0.509 . . . . 0.0 109.875 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.533 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.08 125.09 24.29 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.667 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.54 ' HB ' ' SD ' ' A' ' 267' ' ' MET . 6.7 p -124.92 27.07 6.86 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.138 0.971 . . . . 0.0 108.589 174.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 8.3 m -82.89 138.05 34.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.585 177.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 101.7 -14.31 57.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -175.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . 0.54 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 64.5 mtt -82.82 153.73 25.04 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -153.67 142.61 21.17 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.549 ' HA ' HG13 ' A' ' 297' ' ' VAL . 34.6 ptt180 -50.87 114.03 1.06 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.624 0.578 . . . . 0.0 111.401 -173.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.16 -2.43 22.49 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.74 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.489 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.4 p30 -81.67 -179.25 7.3 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 117.258 0.529 . . . . 0.0 111.243 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -131.93 116.51 17.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.845 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.402 HD11 HG21 ' A' ' 308' ' ' ILE . 22.3 pt -114.14 138.9 42.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.148 0.499 . . . . 0.0 110.769 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 13.3 t -118.51 137.07 53.45 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.615 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -103.69 111.36 23.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.037 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.54 118.82 13.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.688 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.99 -13.74 26.56 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.682 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.02 147.94 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -161.24 156.55 24.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.912 0.387 . . . . 0.0 111.48 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -81.15 153.46 27.24 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.465 -171.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.46 HD11 ' HB2' ' A' ' 315' ' ' LEU . 83.7 mt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.213 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 . . . . . 0 C--O 1.233 0.235 0 CA-C-O 121.017 0.437 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -57.71 117.76 4.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.085 -172.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 37.9 p -105.01 113.75 27.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.565 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -110.94 148.44 32.5 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.992 0.425 . . . . 0.0 110.735 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 16.0 m -96.23 127.92 42.67 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.001 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.58 ' HA ' HG22 ' A' ' 308' ' ' ILE . 2.5 p -73.95 140.62 17.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.7 t -104.09 -31.85 2.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.055 0.455 . . . . 0.0 109.88 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.552 ' HD2' ' OE2' ' A' ' 307' ' ' GLU . 1.2 tmt_? -173.47 138.41 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.0 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 79.4 t -90.64 116.8 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 22.2 t -78.01 -58.8 3.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.042 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -116.71 -10.62 11.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.918 0.389 . . . . 0.0 111.864 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 78.53 12.22 84.48 Favored Glycine 0 CA--C 1.517 0.204 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -171.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.8 p -149.92 22.3 0.88 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.473 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 8.5 t-160 -174.08 115.59 0.21 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 113.561 -1.654 . . . . 0.0 107.999 -166.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.23 166.51 13.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.552 ' OE2' ' HD2' ' A' ' 299' ' ' ARG . 10.5 pt-20 -123.79 122.34 37.8 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 169.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.58 HG22 ' HA ' ' A' ' 297' ' ' VAL . 30.0 pt -121.2 170.74 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.51 -174.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . 0.408 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 11.8 t -152.01 139.93 13.07 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.969 172.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.408 ' C ' ' HA ' ' A' ' 309' ' ' THR . 61.6 Cg_endo -71.14 179.4 25.39 Favored 'Cis proline' 0 C--N 1.345 0.368 0 C-N-CA 123.846 -1.314 . . . . 0.0 113.209 2.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.509 ' HG2' HG13 ' A' ' 313' ' ' VAL . 19.6 ttmt -84.95 126.37 68.17 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.669 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 19.9 Cg_exo -65.9 108.11 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.316 2.011 . . . . 0.0 111.84 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.542 HG11 ' HD3' ' A' ' 238' ' ' PRO . 1.3 m -130.87 129.54 63.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.151 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -93.06 141.5 28.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.433 -173.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.46 ' HB2' HD11 ' A' ' 281' ' ' LEU . 2.8 tm? -75.07 -26.16 59.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.483 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -94.83 26.0 3.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.644 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -83.49 136.56 34.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 27.8 m -83.81 -9.77 11.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 9.6 t -120.22 23.33 11.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.938 0.399 . . . . 0.0 111.626 -171.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.23 168.67 10.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.077 0.465 . . . . 0.0 111.026 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 51.9 m -112.49 165.25 13.43 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.358 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.462 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 85.5 Cg_exo -45.25 -49.45 10.16 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.517 2.812 . . . . 0.0 114.737 -175.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.2 -28.94 61.51 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.807 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -67.99 -41.13 82.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.663 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.462 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 28.8 ptt180 -69.12 -23.43 63.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.145 0.498 . . . . 0.0 110.17 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -80.68 -10.25 59.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.628 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -118.41 16.52 13.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.783 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.413 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -65.1 151.27 46.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.223 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . 0.413 ' H ' HG23 ' A' ' 313' ' ' VAL . 83.3 m-20 -115.21 -39.64 3.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.796 -175.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 30.7 m -118.26 168.28 10.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.22 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -82.31 -49.63 9.83 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.874 0.368 . . . . 0.0 110.798 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 13.5 t -117.79 149.82 40.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.202 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 22.6 p -80.8 171.23 15.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.009 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 20.1 tp -73.75 111.27 8.74 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.629 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -82.0 170.68 15.29 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.137 0.494 . . . . 0.0 111.435 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.07 -8.92 57.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.506 -169.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -138.33 55.36 1.75 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.04 0.448 . . . . 0.0 111.578 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.52 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 14.5 mmt -102.33 147.57 26.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.162 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -96.14 143.56 27.16 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.68 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.463 ' O ' ' HB ' ' A' ' 228' ' ' ILE . 17.7 t -115.52 126.89 73.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -133.35 136.35 45.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.177 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 25.2 mt -90.1 124.38 42.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.919 0.39 . . . . 0.0 110.324 174.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 45.2 mt . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.212 178.385 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.531 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 23.2 p . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 60.67 39.3 96.41 Favored Glycine 0 CA--C 1.516 0.144 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.313 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.553 HG21 ' O ' ' A' ' 263' ' ' ALA . 71.9 mt -102.95 143.86 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 7.0 p -111.3 151.43 28.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.079 0.466 . . . . 0.0 111.246 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.644 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.5 p -60.75 150.48 6.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.807 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 8.8 t -112.3 82.21 1.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.115 0.484 . . . . 0.0 109.747 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 92.66 149.61 24.99 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.858 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.56 121.75 17.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.837 0.351 . . . . 0.0 110.552 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -113.25 126.96 55.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.203 0.525 . . . . 0.0 110.238 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 20.3 p -127.9 104.0 7.57 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.171 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -81.51 161.51 23.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.789 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -142.02 133.74 13.38 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.601 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.57 ' HD3' HG11 ' A' ' 313' ' ' VAL . 84.7 Cg_endo . . . . . 0 N--CA 1.454 -0.819 0 C-N-CA 122.853 2.368 . . . . 0.0 111.435 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.991 0.424 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -119.86 126.98 52.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.524 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.5 m -93.96 99.19 11.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.01 0.433 . . . . 0.0 110.62 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.456 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.7 t -83.66 120.16 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.168 -174.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 19.3 m -91.55 105.75 17.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.835 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.428 ' HB2' HG22 ' A' ' 264' ' ' THR . 19.9 mt -121.63 169.41 10.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.257 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 6.6 m -63.05 -55.19 27.68 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.553 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -136.62 131.15 33.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.696 178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.438 ' HB ' ' SD ' ' A' ' 267' ' ' MET . 3.2 p -129.51 27.49 5.27 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 18.4 m -82.69 141.88 32.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.096 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.03 -3.95 60.62 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -174.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . 0.438 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 89.5 mtp -86.9 152.85 22.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -154.84 140.85 18.34 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.22 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.655 ' HA ' HG13 ' A' ' 297' ' ' VAL . 35.9 ptt180 -52.45 117.82 3.14 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.374 0.606 . . . . 0.0 111.089 -175.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.47 1.12 21.8 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.378 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -84.06 179.68 7.45 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.132 0.466 . . . . 0.0 110.507 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.485 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 5.1 tppp? -137.67 115.94 11.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.827 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 308' ' ' ILE . 35.7 pt -112.99 140.0 35.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.206 0.527 . . . . 0.0 110.389 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 17.9 m -131.39 138.73 49.24 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.663 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -100.29 113.5 26.25 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.096 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.94 113.56 2.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.499 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.77 -34.34 5.16 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.932 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.7 t -81.14 127.85 39.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -149.12 161.75 41.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.708 0.289 . . . . 0.0 110.896 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 91.8 m-85 -83.67 158.42 21.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.053 -175.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 315' ' ' LEU . 95.5 mt . . . . . 0 C--O 1.235 0.328 0 CA-C-O 121.305 0.574 . . . . 0.0 111.26 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -59.78 106.76 0.52 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.957 0.408 . . . . 0.0 111.334 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.485 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 21.3 p -88.59 115.6 26.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.501 -177.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -121.31 144.31 48.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.367 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 68.4 m -101.32 132.39 46.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.749 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.655 HG13 ' HA ' ' A' ' 269' ' ' ARG . 9.3 p -67.49 140.35 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.126 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.63 -42.65 7.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.111 175.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.417 ' HB3' ' CD ' ' A' ' 307' ' ' GLU . 23.5 tpt180 -157.33 128.06 6.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.85 -178.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 97.8 t -86.3 97.8 6.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 172.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 25.4 t -65.9 -58.74 5.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.691 -173.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -126.66 -8.31 6.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.141 0.496 . . . . 0.0 111.472 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.15 13.81 78.27 Favored Glycine 0 C--N 1.321 -0.252 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.677 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 21.6 p -138.95 10.31 2.6 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 170.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -162.74 116.6 1.71 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.453 -1.249 . . . . 0.0 107.894 -169.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.99 160.29 18.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.674 -172.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.0 pt-20 -121.28 122.58 40.22 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 168.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.52 HG21 HD11 ' A' ' 273' ' ' ILE . 23.4 pt -123.49 169.39 14.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.228 0.537 . . . . 0.0 112.309 -174.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.0 t -145.38 138.83 14.38 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.788 172.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.33 -179.75 24.62 Favored 'Cis proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.759 -1.35 . . . . 0.0 113.313 -1.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.449 ' HG3' ' HB2' ' A' ' 257' ' ' ALA . 3.3 ttmp? -87.42 125.53 65.29 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.558 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 14.4 Cg_exo -68.61 108.85 1.94 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.369 2.046 . . . . 0.0 111.861 175.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 328' ' ' ALA . 1.5 m -136.3 120.86 25.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -82.49 134.43 35.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.838 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.9 tm? -75.69 -25.05 56.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.618 176.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -85.9 6.02 30.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.14 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -77.2 126.8 31.53 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.2 m -83.94 2.35 3.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 7.7 m -103.5 23.22 12.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.703 0.287 . . . . 0.0 111.77 -172.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.472 HD13 ' HG2' ' A' ' 325' ' ' ARG . 1.0 OUTLIER -126.18 157.2 38.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.44 0.638 . . . . 0.0 112.25 -179.29 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.497 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 2.8 m -92.25 166.81 16.35 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.554 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 2.3 Cg_endo -42.18 -58.08 1.34 Allowed 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.759 2.973 . . . . 0.0 113.864 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -60.4 -36.88 79.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.137 0.494 . . . . 0.0 111.084 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 9.2 mm100 -63.4 -30.5 71.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.664 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.472 ' HG2' HD13 ' A' ' 320' ' ' LEU . 34.2 mtp85 -61.28 -39.31 89.93 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.226 176.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.04 -26.15 68.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.066 0.46 . . . . 0.0 110.922 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -87.11 -12.88 45.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.232 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.605 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -72.3 151.63 42.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.515 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -137.18 -35.72 0.68 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -173.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.3 m -101.93 167.62 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.852 0.358 . . . . 0.0 111.092 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -83.63 -39.3 20.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.919 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.1 t -126.69 139.54 53.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.673 -177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.461 ' N ' ' HB2' ' A' ' 314' ' ' ALA . 46.3 m -70.42 171.92 9.24 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.411 ' HG ' HG21 ' A' ' 230' ' ' VAL . 20.3 tp -71.24 103.91 2.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.644 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -79.62 172.12 14.22 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.878 -175.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.51 -11.61 60.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.129 -171.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -132.49 71.27 1.47 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.016 0.436 . . . . 0.0 111.223 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.477 ' H ' HG12 ' A' ' 230' ' ' VAL . 23.5 mmt -121.84 133.84 54.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.666 175.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -85.38 136.54 33.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.906 0.384 . . . . 0.0 111.301 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 17.4 t -101.4 112.82 35.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.703 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . 0.531 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 5.7 t-20 -129.91 138.8 51.1 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.815 0.34 . . . . 0.0 111.382 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 62.3 mt -92.1 125.92 44.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 172.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 40.4 mt . . . . . 0 C--N 1.323 -0.577 0 CA-C-O 120.97 0.414 . . . . 0.0 111.012 -178.38 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 3.8 p . . . . . 0 N--CA 1.448 -0.55 0 CA-C-O 121.146 0.498 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -116.52 37.53 3.35 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.505 HG21 ' O ' ' A' ' 263' ' ' ALA . 37.9 mt -82.28 152.44 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.277 -0.461 . . . . 0.0 109.883 -173.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 22.0 p -114.64 162.59 16.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.454 0.645 . . . . 0.0 111.808 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.641 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.8 p -62.7 151.75 7.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.897 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 16.5 t -116.82 78.9 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.195 0.521 . . . . 0.0 109.615 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 100.82 145.79 17.89 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.904 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.83 111.74 5.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.844 0.354 . . . . 0.0 110.304 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -109.15 127.8 54.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.264 0.554 . . . . 0.0 110.834 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 16.7 p -115.95 143.12 45.88 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.639 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -115.99 154.45 29.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.791 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -143.45 135.56 13.2 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.501 ' HD3' HG11 ' A' ' 313' ' ' VAL . 10.9 Cg_endo . . . . . 0 N--CA 1.454 -0.836 0 C-N-CA 122.892 2.395 . . . . 0.0 110.66 169.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 308' ' ' ILE . 51.7 m-85 . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 120.908 0.385 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -153.57 125.23 7.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.677 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -90.18 104.13 16.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.246 0.546 . . . . 0.0 111.147 178.004 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.8 t -86.61 121.09 37.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.998 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 30.5 m -92.84 109.54 20.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.992 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.413 HD22 HG21 ' A' ' 340' ' ' VAL . 17.4 mt -124.54 176.03 6.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.918 -176.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 35.0 t -64.56 -59.66 4.03 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.505 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.58 138.7 39.83 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 7.6 p -126.97 28.09 5.86 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.004 0.906 . . . . 0.0 108.914 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 1.3 m -78.81 151.28 32.02 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.981 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 93.11 -22.44 34.57 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . 0.462 ' HG2' HD11 ' A' ' 342' ' ' ILE . 53.8 mtt -79.6 144.67 33.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.574 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 0.3 OUTLIER -137.31 152.48 49.8 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -50.82 126.03 14.87 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.568 0.542 . . . . 0.0 111.474 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.95 19.23 37.35 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.567 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.574 ' HB2' ' O ' ' A' ' 268' ' ' LYS . 0.8 OUTLIER -98.81 177.39 5.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.973 0.416 . . . . 0.0 110.673 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -122.02 116.34 24.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.908 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.504 HD11 HG21 ' A' ' 308' ' ' ILE . 40.3 pt -113.19 140.28 34.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.215 177.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -118.24 133.47 55.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.215 -176.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -99.63 110.99 23.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.894 0.378 . . . . 0.0 110.028 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.09 117.81 15.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.531 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.79 -24.41 15.09 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 42.4 t -99.99 133.85 41.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -151.1 160.63 43.77 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 120.993 0.425 . . . . 0.0 111.066 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -78.19 154.33 31.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.369 -169.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.463 HD11 ' HB2' ' A' ' 315' ' ' LEU . 84.4 mt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.388 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 . . . . . 0 C--O 1.235 0.296 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.484 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -60.33 102.05 0.16 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.26 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 1.2 p -103.44 117.84 35.38 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.245 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.484 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 85.1 m-85 -124.36 152.59 42.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.13 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.7 m -92.2 125.5 36.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.198 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 271' ' ' ASP . 10.9 p -81.48 130.17 36.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.301 0.572 . . . . 0.0 110.521 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 58.6 t -90.53 -38.7 11.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.548 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -160.41 141.47 12.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.202 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 90.4 t -94.38 107.56 19.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 27.3 t -77.41 -59.17 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.873 -172.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -120.21 -7.58 9.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.384 0.611 . . . . 0.0 111.116 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 79.27 14.18 81.93 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.316 -174.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 25.6 p -137.18 7.55 2.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.155 0.979 . . . . 0.0 108.525 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.568 ' NE2' ' HB ' ' A' ' 258' ' ' THR . 3.5 t-160 -160.88 118.96 2.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.392 -170.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -118.73 155.49 20.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -115.04 115.01 26.14 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.504 HG21 HD11 ' A' ' 273' ' ' ILE . 25.4 pt -114.2 176.72 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.711 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 5.2 t -154.17 141.53 13.59 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.674 174.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.09 -179.9 28.35 Favored 'Cis proline' 0 C--N 1.346 0.4 0 C-N-CA 123.818 -1.326 . . . . 0.0 112.568 -4.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -81.18 126.11 77.75 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.857 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.49 109.13 2.78 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.43 2.087 . . . . 0.0 111.887 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.755 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.4 OUTLIER -126.56 134.16 66.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.694 178.425 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -91.85 135.29 34.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.72 -173.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.463 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.3 tm? -70.55 -30.24 66.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.834 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -86.2 11.13 12.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.186 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.52 121.91 25.19 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 31.1 m -83.54 1.81 3.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -174.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.2 t -102.56 -6.5 22.76 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.424 -174.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.4 pp -102.82 153.77 19.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.49 0.662 . . . . 0.0 111.684 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 14.8 m -87.51 160.95 46.78 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.004 -177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -39.14 -50.49 2.72 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.923 3.082 . . . . 0.0 114.612 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -58.09 -41.17 82.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.255 0.55 . . . . 0.0 111.333 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 47.9 mt-30 -70.48 -26.31 63.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.711 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.421 ' HG2' ' CD1' ' A' ' 320' ' ' LEU . 76.6 mtt180 -61.04 -35.43 76.89 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 121.018 0.437 . . . . 0.0 110.445 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.89 -28.88 67.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.431 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . 0.455 ' CD2' ' HA ' ' A' ' 324' ' ' GLN . 12.0 m-85 -81.71 -11.05 59.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.824 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.755 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -65.59 139.01 58.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.991 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -127.62 -17.07 4.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.882 -175.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 31.5 m -122.11 158.23 25.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.929 0.395 . . . . 0.0 110.113 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -91.16 -7.01 52.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.307 -174.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.7 t -147.72 140.98 25.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.096 0.474 . . . . 0.0 110.824 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 26.9 p -78.28 168.05 20.42 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.316 175.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 19.3 tp -74.11 105.42 5.32 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.641 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -79.82 -178.8 6.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.055 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.06 -7.1 57.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.973 -172.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -133.74 57.83 1.79 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.849 0.357 . . . . 0.0 111.736 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.407 ' H ' HG12 ' A' ' 230' ' ' VAL . 25.2 mmt -111.78 137.46 49.67 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -92.25 145.46 24.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.778 0.323 . . . . 0.0 111.047 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.413 HG21 HD22 ' A' ' 261' ' ' LEU . 19.3 t -118.69 118.2 57.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.866 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -134.73 135.75 42.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.99 0.424 . . . . 0.0 111.557 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.462 HD11 ' HG2' ' A' ' 267' ' ' MET . 21.1 mt -87.62 127.46 40.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.813 176.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.05 176.303 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.561 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 34.2 p . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 55.65 48.94 68.05 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.834 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.508 HG21 ' O ' ' A' ' 263' ' ' ALA . 57.2 mt -103.07 142.54 16.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 37.1 p -97.82 150.12 21.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.408 0.623 . . . . 0.0 112.261 -173.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.564 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.2 p -61.53 150.93 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.599 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 37.0 m -126.05 84.94 2.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.152 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 113.0 130.56 5.32 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.477 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -79.37 123.43 27.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -142.22 130.33 22.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.223 0.535 . . . . 0.0 111.474 -172.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.9 t -107.98 110.46 22.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.281 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.532 ' O ' HG13 ' A' ' 313' ' ' VAL . 62.4 m-85 -81.05 120.13 24.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.507 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -115.27 127.42 26.83 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.696 -175.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo . . . . . 0 N--CA 1.46 -0.464 0 C-N-CA 122.895 2.396 . . . . 0.0 111.265 173.563 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.442 ' CD2' ' HB ' ' A' ' 309' ' ' THR . 96.7 m-85 . . . . . 0 N--CA 1.456 -0.136 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -136.01 129.31 31.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.479 0.18 . . . . 0.0 110.785 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.5 m -97.88 107.64 20.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.05 0.452 . . . . 0.0 109.984 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.41 120.27 36.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.205 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 60.4 m -91.01 115.33 27.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.823 173.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 17.2 mt -132.24 168.86 17.31 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 5.3 p -60.52 -55.96 27.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.196 0.522 . . . . 0.0 110.136 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.508 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -136.75 136.81 39.26 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.146 177.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 15.8 p -132.11 32.75 3.97 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 6.9 m -82.47 149.25 27.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.308 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 93.51 13.37 55.64 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 62.7 mtt -114.02 148.0 37.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.367 -0.417 . . . . 0.0 110.141 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -134.41 156.33 48.73 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -54.15 121.96 9.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.074 0.464 . . . . 0.0 110.762 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 106.75 7.97 33.01 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.862 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.503 ' H ' HG12 ' A' ' 297' ' ' VAL . 80.1 m-20 -90.79 148.54 22.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.419 0.609 . . . . 0.0 110.16 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 4.6 tppp? -96.03 117.67 31.13 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.725 -177.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.435 HD11 HG21 ' A' ' 308' ' ' ILE . 38.5 pt -112.58 139.96 34.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 176.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 45.5 m -120.5 136.48 54.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.516 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -100.7 111.46 23.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.871 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -74.15 114.21 12.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.709 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.55 -34.39 5.17 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 86.0 t -90.95 111.71 24.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.85 170.07 13.82 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.406 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -75.95 171.73 13.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.644 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.105 177.881 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -59.18 100.33 0.07 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.882 -174.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.0 p -98.99 99.63 10.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.673 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.474 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 61.3 m-85 -118.23 142.8 47.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.09 0.472 . . . . 0.0 111.139 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.2 t -89.97 126.27 35.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.494 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 271' ' ' ASP . 11.5 p -69.12 135.13 28.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.122 0.487 . . . . 0.0 110.136 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.24 -32.93 4.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.684 -176.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.592 ' HD2' ' OE2' ' A' ' 307' ' ' GLU . 0.4 OUTLIER -167.85 137.07 2.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.255 -176.129 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 75.3 t -85.02 111.38 20.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 19.2 t -77.76 -53.9 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.646 -173.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -125.89 -11.63 6.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.81 0.338 . . . . 0.0 111.812 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 77.6 12.49 84.45 Favored Glycine 0 CA--C 1.516 0.145 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -170.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.0 p -149.9 22.17 0.88 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 174.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -174.04 112.63 0.18 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 113.378 -1.737 . . . . 0.0 107.991 -163.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.0 OUTLIER -119.43 164.05 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -174.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.592 ' OE2' ' HD2' ' A' ' 299' ' ' ARG . 11.4 pt-20 -125.01 127.01 46.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.218 0.532 . . . . 0.0 110.127 170.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.435 HG21 HD11 ' A' ' 273' ' ' ILE . 24.0 pt -120.42 175.79 4.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.884 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . 0.442 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 14.2 t -154.61 143.53 14.84 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.853 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.98 179.4 31.15 Favored 'Cis proline' 0 C--N 1.346 0.406 0 C-N-CA 123.709 -1.371 . . . . 0.0 112.512 -4.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' A' ' 257' ' ' ALA . 22.4 ttmm -76.94 121.68 85.16 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.504 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.09 108.54 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.217 1.944 . . . . 0.0 112.327 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 236' ' ' PHE . 0.1 OUTLIER -109.35 137.67 40.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.121 175.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -81.98 123.25 28.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.095 0.474 . . . . 0.0 110.513 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.5 -29.5 70.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.894 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.45 19.65 4.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.495 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -83.47 119.91 25.26 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.9 m -84.43 0.4 5.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -174.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 37.2 t -95.47 -28.16 15.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.566 0.222 . . . . 0.0 111.404 -174.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.425 ' CD1' ' HG2' ' A' ' 325' ' ' ARG . 0.9 OUTLIER -80.64 160.61 25.0 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.413 0.625 . . . . 0.0 112.41 -175.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.533 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 34.4 t -87.04 157.42 54.15 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.146 -178.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.533 ' HD2' ' OG ' ' A' ' 321' ' ' SER . 2.8 Cg_exo -35.61 -58.01 0.47 Allowed 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 124.764 3.643 . . . . 0.0 115.513 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.64 -25.08 64.65 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.376 -174.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 321' ' ' SER . 8.5 mm100 -61.15 -34.48 75.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.038 0.447 . . . . 0.0 110.116 174.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.425 ' HG2' ' CD1' ' A' ' 320' ' ' LEU . 31.1 mtm180 -64.77 -32.67 74.46 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.724 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -70.62 -24.94 62.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.087 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.77 -2.3 57.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.685 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.455 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -67.81 156.27 37.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.066 0.46 . . . . 0.0 111.022 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -138.42 -20.84 1.05 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.292 -173.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 23.4 m -125.28 160.17 31.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.946 0.403 . . . . 0.0 110.399 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -89.16 -17.14 29.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.527 -175.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 8.8 t -143.42 142.89 31.39 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 22.6 p -75.72 170.33 16.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.736 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.463 ' HG ' HG21 ' A' ' 230' ' ' VAL . 17.0 tp -72.34 103.3 3.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.564 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -81.99 -170.88 3.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.19 -176.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -80.32 -8.5 59.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.013 -175.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -137.42 66.97 1.44 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.0 0.429 . . . . 0.0 111.567 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.559 ' H ' HG12 ' A' ' 230' ' ' VAL . 23.1 mmt -119.86 132.48 55.58 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -91.25 137.16 32.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.839 0.352 . . . . 0.0 111.007 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 32.7 t -114.25 107.2 22.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.239 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . 0.561 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 64.5 t30 -126.35 145.62 50.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.922 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 22.8 mt -89.56 132.37 34.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 177.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 80.8 mt . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.542 176.566 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 120.343 0.116 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.56 39.77 95.46 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.006 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.6 HG21 ' O ' ' A' ' 263' ' ' ALA . 55.7 mt -103.05 145.28 12.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 36.0 p -99.22 160.79 14.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.417 0.627 . . . . 0.0 112.248 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.678 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.7 p -68.88 152.04 9.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.495 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.1 m -122.08 86.77 2.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.949 0.404 . . . . 0.0 110.7 173.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 102.56 137.2 9.47 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.337 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.54 130.27 42.69 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -132.9 127.14 33.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.165 0.507 . . . . 0.0 111.31 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.8 t -117.26 103.12 9.85 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -80.8 129.1 34.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.319 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -117.19 125.75 27.96 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.052 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 N--CA 1.461 -0.438 0 C-N-CA 123.111 2.541 . . . . 0.0 111.639 176.472 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 . . . . . 0 N--CA 1.45 -0.467 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -109.26 124.03 50.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.951 176.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.7 m -97.47 107.14 19.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.225 0.536 . . . . 0.0 110.275 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -89.0 124.86 42.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.603 -170.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 55.6 m -95.18 114.59 26.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.799 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.556 HD13 HG21 ' A' ' 340' ' ' VAL . 17.4 mt -129.87 170.52 13.8 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -176.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 16.8 m -57.31 -56.93 15.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.389 0.614 . . . . 0.0 109.599 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.6 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -138.52 141.02 39.34 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.776 175.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 11.2 p -130.8 26.49 4.98 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.7 m -80.49 147.5 30.86 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.526 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 95.24 -28.11 12.98 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -177.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 62.1 mtt -71.42 153.47 42.25 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -135.53 151.02 49.92 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.807 0.337 . . . . 0.0 110.58 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -56.39 131.8 49.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.204 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.77 19.14 32.53 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.352 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.488 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.8 t70 -103.28 -167.51 1.39 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 117.555 0.677 . . . . 0.0 110.159 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.441 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 3.9 tppp? -129.76 115.7 17.67 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.593 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.442 HD11 HG21 ' A' ' 308' ' ' ILE . 20.0 pt -115.06 142.76 26.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.134 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.516 ' HB3' HG22 ' A' ' 294' ' ' THR . 73.5 p -128.85 143.69 50.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.149 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -105.2 114.02 27.95 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.044 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.82 115.98 3.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.828 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.94 -31.15 6.95 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.105 -177.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 292' ' ' ASP . 48.5 t -84.54 136.08 23.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.525 ' NZ ' ' HB3' ' A' ' 279' ' ' LYS . 0.1 OUTLIER -160.76 156.33 25.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.112 0.482 . . . . 0.0 111.413 -177.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 329' ' ' ASN . 63.0 m-85 -76.58 148.63 36.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.372 -170.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.495 HD11 ' HB2' ' A' ' 315' ' ' LEU . 59.5 mt . . . . . 0 CA--C 1.519 -0.214 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.461 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 60.3 m-20 . . . . . 0 CA--C 1.518 -0.26 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -57.07 116.07 3.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.636 -174.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 274' ' ' SER . 28.1 p -97.81 129.17 44.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.866 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -130.63 143.14 50.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.783 0.325 . . . . 0.0 110.699 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 62.5 m -78.72 126.96 31.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.101 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.515 ' HA ' HG22 ' A' ' 308' ' ' ILE . 13.5 p -84.06 126.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.262 0.553 . . . . 0.0 110.018 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 44.7 t -84.01 -40.85 16.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.379 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -163.29 142.26 8.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.405 ' CG1' ' HA2' ' A' ' 303' ' ' GLY . 89.6 t -82.59 106.95 13.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 26.7 t -72.82 -58.7 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.945 -170.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -119.59 0.48 11.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.94 0.4 . . . . 0.0 111.331 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . 0.405 ' HA2' ' CG1' ' A' ' 300' ' ' VAL . . . 70.81 12.73 71.25 Favored Glycine 0 C--O 1.23 -0.143 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -173.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 19.4 p -149.31 19.72 0.95 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 174.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.551 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.9 t-160 -170.89 115.46 0.44 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 113.737 -1.574 . . . . 0.0 107.976 -164.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.73 165.04 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.494 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -123.86 122.1 37.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.051 0.453 . . . . 0.0 110.264 172.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.515 HG22 ' HA ' ' A' ' 297' ' ' VAL . 28.2 pt -124.03 168.55 16.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.102 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 310' ' ' PRO . 15.1 t -154.57 145.18 16.05 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.4 ' HA ' ' OG1' ' A' ' 309' ' ' THR . 10.2 Cg_exo -72.29 178.13 32.23 Favored 'Cis proline' 0 C--N 1.344 0.337 0 C-N-CA 124.013 -1.245 . . . . 0.0 112.556 0.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -87.39 123.37 69.83 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.743 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.448 ' HA ' ' OD1' ' A' ' 329' ' ' ASN . 48.7 Cg_endo -71.41 108.94 2.49 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.37 2.046 . . . . 0.0 112.091 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.56 132.0 57.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.713 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 317' ' ' ASP . . . -83.09 121.92 27.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.081 0.467 . . . . 0.0 110.448 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.495 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.0 tm? -62.99 -30.2 71.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.725 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -86.39 5.12 36.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.393 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 10.6 t70 -89.91 111.68 22.8 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 17.9 m -83.61 2.4 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 9.4 t -92.95 29.09 1.91 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.027 0.441 . . . . 0.0 110.832 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 2.5 pp -129.06 171.32 12.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.879 0.371 . . . . 0.0 111.467 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 41.7 t -85.96 149.14 49.85 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.105 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.655 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 1.4 Cg_endo -42.27 -47.29 7.19 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.84 3.027 . . . . 0.0 113.885 -177.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.443 ' O ' ' HD1' ' A' ' 327' ' ' TYR . 58.6 mm-40 -63.16 -23.38 67.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.98 0.419 . . . . 0.0 111.456 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -81.27 -24.34 37.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.784 -174.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 5.3 ptp180 -78.28 -22.31 48.43 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.096 0.474 . . . . 0.0 110.04 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -69.15 -36.03 76.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.183 174.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . 0.443 ' HD1' ' O ' ' A' ' 323' ' ' GLU . 77.8 m-85 -90.05 3.05 54.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.839 178.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -70.26 123.94 22.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.03 0.443 . . . . 0.0 110.022 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 312' ' ' PRO . 26.7 p-10 -109.28 -17.92 13.71 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.506 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.3 m -118.85 159.4 19.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.188 0.518 . . . . 0.0 110.798 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -96.84 -12.04 24.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.164 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.4 t -141.02 148.63 40.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.435 -176.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 7.6 p -85.04 166.27 16.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.694 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.611 HD12 ' SD ' ' A' ' 338' ' ' MET . 21.2 tp -67.74 104.4 1.64 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.678 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -84.04 156.82 22.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.772 -175.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.59 58.08 2.15 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.252 0.549 . . . . 0.0 111.942 -173.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -176.04 27.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.494 172.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.611 ' SD ' HD12 ' A' ' 334' ' ' LEU . 54.4 mtt -100.06 131.83 45.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -176.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -87.64 140.22 29.74 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.924 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.556 HG21 HD13 ' A' ' 261' ' ' LEU . 9.0 t -99.83 113.5 35.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.537 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -122.56 133.4 54.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.404 -175.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.438 ' CG1' HG22 ' A' ' 273' ' ' ILE . 14.6 mt -99.23 130.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.066 0.46 . . . . 0.0 110.798 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 46.3 mt . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.763 -178.82 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.674 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 41.6 p . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 120.394 0.14 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 58.05 43.11 95.26 Favored Glycine 0 C--N 1.329 0.165 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.24 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.479 HG21 ' O ' ' A' ' 263' ' ' ALA . 68.6 mt -90.66 149.46 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 2.3 p -96.8 157.58 15.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.572 0.701 . . . . 0.0 112.428 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.552 HG11 ' O ' ' A' ' 335' ' ' ALA . 6.8 p -76.16 151.35 6.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.499 -176.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 65.0 m -109.63 83.22 1.72 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.025 0.441 . . . . 0.0 110.385 174.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.7 154.75 28.94 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.341 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -73.05 124.91 26.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.966 0.412 . . . . 0.0 111.008 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -113.25 128.56 56.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.059 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 12.8 t -131.16 119.83 22.45 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.414 ' O ' ' HD3' ' A' ' 237' ' ' LYS . 88.2 m-85 -104.08 143.06 33.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.743 -175.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 236' ' ' PHE . 44.7 mmtm -129.41 138.66 33.65 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.631 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.443 ' HD3' HG21 ' A' ' 313' ' ' VAL . 82.9 Cg_endo . . . . . 0 N--CA 1.455 -0.764 0 C-N-CA 123.035 2.49 . . . . 0.0 112.166 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.457 ' CD1' ' HB ' ' A' ' 309' ' ' THR . 75.1 m-85 . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 120.935 0.398 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.448 ' HB2' ' HG3' ' A' ' 311' ' ' LYS . . . -114.59 121.89 44.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.618 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -89.43 106.38 18.41 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.748 177.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -86.04 118.13 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.402 -172.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 23.2 m -89.32 105.92 18.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.895 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 20.4 mt -122.07 172.08 8.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.735 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 42.2 m -64.57 -53.42 48.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.108 0.48 . . . . 0.0 109.783 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.57 142.93 41.32 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 18.2 p -134.07 30.0 3.68 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.3 m -81.26 134.63 35.63 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.956 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.7 -26.25 14.87 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -176.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . 0.468 ' HG3' HD11 ' A' ' 342' ' ' ILE . 1.9 mpt? -70.67 151.3 45.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -136.38 164.33 28.38 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -64.44 144.66 57.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.694 0.283 . . . . 0.0 110.676 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 77.8 19.02 76.29 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.742 173.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.519 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 1.7 t70 -100.68 -167.1 1.39 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 117.779 0.79 . . . . 0.0 109.907 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.462 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 13.1 tppt? -125.04 115.16 20.09 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.502 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.526 HD11 HG21 ' A' ' 308' ' ' ILE . 32.0 pt -116.93 139.31 44.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.677 177.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 50.1 p -118.9 138.4 52.78 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.559 -178.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -103.23 111.56 24.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.519 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.63 132.37 53.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.688 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 93.45 -34.71 4.46 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 56.4 t -86.0 146.04 6.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.502 ' NZ ' ' HB3' ' A' ' 279' ' ' LYS . 0.0 OUTLIER -162.22 162.21 28.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.75 0.31 . . . . 0.0 111.059 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 96.2 m-85 -73.59 170.3 15.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.63 -174.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.483 178.725 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.451 ' HA ' ' NZ ' ' A' ' 279' ' ' LYS . 64.7 m-20 . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.788 0.328 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -70.46 104.27 2.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.649 -174.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 14.0 p -92.14 103.29 15.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.033 177.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.404 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 61.6 m-85 -102.72 154.83 18.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.149 0.5 . . . . 0.0 111.277 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.4 m -89.99 120.89 31.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.088 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.519 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 14.2 p -84.19 139.45 17.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.466 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.2 t -105.76 -42.18 6.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.241 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -156.51 133.74 10.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.027 0.442 . . . . 0.0 111.659 -175.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 87.2 t -81.85 99.47 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 169.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.7 t -70.65 -58.47 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.917 -171.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -120.26 -0.66 10.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.719 0.295 . . . . 0.0 111.576 -174.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 69.31 12.58 66.32 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -172.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 26.6 p -147.4 19.99 1.2 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 7.1 t-160 -172.74 115.82 0.3 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.194 -164.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.52 166.75 13.62 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -176.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -123.86 126.56 46.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.084 0.469 . . . . 0.0 109.994 169.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.526 HG21 HD11 ' A' ' 273' ' ' ILE . 30.3 pt -123.12 170.04 13.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.997 -177.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . 0.457 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 13.5 t -154.52 145.12 16.03 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.433 ' HA ' ' OG1' ' A' ' 309' ' ' THR . 58.4 Cg_endo -70.2 176.08 35.36 Favored 'Cis proline' 0 C--N 1.347 0.48 0 C-N-CA 123.835 -1.319 . . . . 0.0 112.879 1.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.448 ' HG3' ' HB2' ' A' ' 257' ' ' ALA . 40.5 tttt -77.14 119.88 79.33 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.807 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 257' ' ' ALA . 27.1 Cg_exo -62.14 107.13 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.157 1.905 . . . . 0.0 111.676 177.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 328' ' ' ALA . 55.5 t -121.29 119.81 60.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.037 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.644 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -85.86 128.53 34.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.073 0.463 . . . . 0.0 111.101 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.3 tm? -70.16 -30.39 67.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.246 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -89.0 23.19 2.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.0 0.429 . . . . 0.0 111.25 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 14.6 t70 -100.52 137.49 38.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 30.1 m -84.29 -15.56 11.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 13.1 m -91.03 34.89 0.91 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.016 0.436 . . . . 0.0 111.485 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.497 ' HA ' ' NE2' ' A' ' 324' ' ' GLN . 1.9 pp -126.95 164.18 22.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.092 0.472 . . . . 0.0 111.449 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 65.4 p -99.89 168.59 9.25 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.768 176.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.502 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 86.8 Cg_exo -49.35 -36.07 37.14 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.306 2.004 . . . . 0.0 111.818 172.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.82 -46.3 65.96 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.818 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.497 ' NE2' ' HA ' ' A' ' 320' ' ' LEU . 26.5 mt-30 -69.65 -28.51 65.94 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -175.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.502 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 30.2 ptt180 -72.05 -21.69 61.49 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.324 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -73.4 -27.84 61.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.202 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -94.24 7.97 43.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.82 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.548 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -57.92 142.11 47.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.825 176.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -124.22 -30.02 3.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.2 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 27.7 m -122.4 160.11 24.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.871 0.367 . . . . 0.0 110.293 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -89.04 -20.89 23.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.071 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.1 t -141.6 141.88 33.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.994 0.426 . . . . 0.0 110.481 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 34.8 p -70.27 161.65 29.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.87 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.447 ' HG ' HG21 ' A' ' 230' ' ' VAL . 48.0 tp -69.47 103.41 2.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.552 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -82.93 170.42 14.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.841 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . 0.413 ' HA ' ' CG1' ' A' ' 230' ' ' VAL . 29.1 t70 -72.26 151.86 42.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.496 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 68.18 39.75 2.3 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.998 0.811 . . . . 0.0 111.608 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.411 ' H ' HG12 ' A' ' 230' ' ' VAL . 19.9 mmt -110.19 144.42 38.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 176.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.19 138.3 33.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.031 0.443 . . . . 0.0 111.316 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 23.9 t -113.73 110.73 33.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.444 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . 0.674 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 60.5 t30 -130.49 145.16 51.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.936 0.398 . . . . 0.0 111.484 -175.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.468 HD11 ' HG3' ' A' ' 267' ' ' MET . 61.0 mt -88.06 116.41 29.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.057 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 63.9 mt . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.182 -176.75 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 C--O 1.234 0.27 0 CA-C-O 120.362 0.125 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 63.25 53.1 42.1 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.283 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.511 HD12 ' O ' ' A' ' 263' ' ' ALA . 29.1 mm -102.21 143.02 15.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 20.7 p -131.49 170.21 15.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.087 0.47 . . . . 0.0 110.305 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.61 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.2 p -78.98 150.39 5.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.56 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.7 t -107.03 75.15 1.02 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.193 0.52 . . . . 0.0 109.654 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.83 155.06 29.57 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.042 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -78.01 141.6 38.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.925 0.393 . . . . 0.0 111.208 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -149.54 137.14 20.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.41 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.5 t -110.08 142.04 42.1 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 312' ' ' PRO . 92.5 m-85 -102.64 156.79 17.39 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . 46.9 mmtm -138.34 130.36 15.92 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.657 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.49 ' HD3' HG11 ' A' ' 313' ' ' VAL . 22.2 Cg_exo . . . . . 0 C--N 1.344 0.325 0 C-N-CA 122.677 2.252 . . . . 0.0 111.335 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 308' ' ' ILE . 60.5 m-85 . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.746 0.308 . . . . 0.0 110.653 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -120.34 134.37 55.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.735 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -93.91 105.21 17.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.283 0.564 . . . . 0.0 111.231 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.6 t -88.39 122.04 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.056 -175.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 11.9 m -96.51 106.04 18.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.254 0.55 . . . . 0.0 110.053 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.518 HD22 HG21 ' A' ' 340' ' ' VAL . 22.5 mt -122.18 167.26 13.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.574 -173.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 26.3 p -60.14 -52.42 65.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.529 0.68 . . . . 0.0 109.71 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.511 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.28 132.59 35.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.316 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 261' ' ' LEU . 7.7 p -128.9 15.29 6.36 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.214 174.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 25.2 m -83.4 144.78 29.39 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.742 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.74 0.73 57.62 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 71.9 mtm -123.22 153.3 40.31 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -142.07 178.99 7.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -63.43 142.22 58.47 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 123.201 0.313 . . . . 0.0 110.545 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 93.52 19.8 34.0 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.688 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.504 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 7.4 m-20 -116.85 164.78 14.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.546 0.673 . . . . 0.0 111.288 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -106.24 115.94 31.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.336 -177.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.484 HD11 HG21 ' A' ' 308' ' ' ILE . 15.6 pt -115.31 140.28 37.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.476 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 54.1 p -128.15 141.06 51.59 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.373 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -100.21 112.64 24.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.051 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.415 ' HA ' ' OD1' ' A' ' 292' ' ' ASP . . . -61.32 120.05 9.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.472 -175.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.49 -35.84 4.75 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.597 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 49.7 t -77.84 124.68 36.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -142.97 161.5 37.94 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.791 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -84.93 142.02 29.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.378 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 79.7 mt . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.112 176.505 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.415 ' OD1' ' HA ' ' A' ' 276' ' ' ALA . 56.6 m-20 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -60.01 98.86 0.06 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.527 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 38.6 p -79.98 124.03 28.34 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.626 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -124.54 146.78 48.81 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.234 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.8 m -86.19 118.29 25.55 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.151 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.504 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 11.7 p -73.8 123.44 28.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.414 0.626 . . . . 0.0 110.095 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.4 t -94.29 -38.22 9.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.599 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -164.81 133.6 3.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.499 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 79.9 t -90.14 100.89 11.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 167.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.63 -59.4 3.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.737 -172.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -98.67 -12.72 20.76 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.633 -170.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 74.13 13.1 81.4 Favored Glycine 0 CA--C 1.517 0.196 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.08 23.35 0.5 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 171.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.521 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 3.7 t-160 -170.67 115.33 0.46 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 113.813 -1.539 . . . . 0.0 107.533 -171.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.7 155.68 20.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -173.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.1 pt-20 -112.02 121.72 45.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.321 0.581 . . . . 0.0 110.128 172.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 256' ' ' PHE . 29.8 pt -118.19 169.37 8.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.968 -177.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.1 t -145.48 140.47 15.92 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.63 -179.24 26.53 Favored 'Cis proline' 0 C--N 1.345 0.374 0 C-N-CA 123.684 -1.382 . . . . 0.0 112.753 -2.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 23.8 ttmm -75.29 124.12 89.03 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.786 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 14.1 Cg_exo -68.52 108.24 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.408 2.072 . . . . 0.0 111.99 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.809 HG23 ' HA ' ' A' ' 328' ' ' ALA . 1.2 m -128.21 132.95 67.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.355 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.517 ' O ' HD21 ' A' ' 320' ' ' LEU . . . -95.22 135.71 36.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.906 -172.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.9 tm? -74.19 -24.1 59.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.547 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -82.25 -2.04 51.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.151 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -77.84 113.31 15.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.6 m -82.98 2.59 3.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.972 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 40.1 m -95.2 -27.61 15.44 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -175.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.517 HD21 ' O ' ' A' ' 314' ' ' ALA . 1.3 pp -79.1 152.74 30.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.56 0.695 . . . . 0.0 111.764 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.494 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.3 m -81.33 167.42 31.9 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.74 -173.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.541 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 78.2 Cg_exo -44.81 -52.26 6.4 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.528 2.819 . . . . 0.0 114.183 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -67.22 -30.98 71.05 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.897 -0.502 . . . . 0.0 111.003 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -71.36 -33.78 69.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.433 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.541 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 18.0 ptp180 -77.37 -14.98 59.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.214 0.53 . . . . 0.0 110.6 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -72.41 -30.8 64.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.122 171.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -85.93 -7.97 58.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.553 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.809 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -65.09 115.37 5.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.047 0.451 . . . . 0.0 110.908 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -104.13 -28.17 11.63 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.49 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 30.2 m -108.32 165.33 4.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.027 0.441 . . . . 0.0 111.355 -175.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -83.54 -40.08 19.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.438 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.8 t -128.79 144.98 51.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.169 0.509 . . . . 0.0 111.007 -176.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 13.5 p -77.76 173.96 11.52 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.428 174.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 14.5 tp -76.71 105.06 7.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.103 0.478 . . . . 0.0 110.179 -175.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.61 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.35 -178.6 6.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.413 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -82.54 -1.13 49.67 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -171.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -139.78 64.95 1.44 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.141 0.496 . . . . 0.0 111.281 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.45 ' H ' HG12 ' A' ' 230' ' ' VAL . 23.9 mmt -116.12 130.74 56.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.538 175.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -84.02 144.16 29.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.997 0.427 . . . . 0.0 111.016 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.518 HG21 HD22 ' A' ' 261' ' ' LEU . 21.5 t -113.86 115.4 49.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.481 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -131.58 138.99 49.09 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.799 -176.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 26.7 mt -87.62 125.22 41.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.653 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 49.1 mt . . . . . 0 C--N 1.322 -0.599 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.335 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 25.6 p . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 111.397 0.147 . . . . 0.0 111.397 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 61.96 35.27 91.15 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.506 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.521 HG21 ' O ' ' A' ' 263' ' ' ALA . 53.7 mt -79.88 153.05 4.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 19.6 p -97.2 143.97 27.48 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.612 0.72 . . . . 0.0 112.495 -173.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.623 HG11 ' O ' ' A' ' 335' ' ' ALA . 4.4 p -61.02 151.9 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.024 177.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 7.6 t -110.52 74.56 0.88 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 0.0 110.001 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 98.39 165.22 30.88 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.052 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -87.98 125.79 34.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.802 0.334 . . . . 0.0 110.442 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -120.39 127.04 51.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.04 0.448 . . . . 0.0 111.01 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 38.4 m -104.86 120.78 42.25 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.635 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.454 ' O ' HG13 ' A' ' 313' ' ' VAL . 93.3 m-85 -100.21 122.38 42.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.657 -176.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.439 ' HE2' HD23 ' A' ' 320' ' ' LEU . 32.4 mmtp -124.85 128.28 24.92 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.208 -178.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo . . . . . 0 N--CA 1.463 -0.296 0 C-N-CA 123.091 2.527 . . . . 0.0 111.855 177.503 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.408 ' CD1' ' HB ' ' A' ' 309' ' ' THR . 97.8 m-85 . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 121.073 0.463 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.438 ' HB2' ' HA ' ' A' ' 311' ' ' LYS . . . -146.19 113.79 6.38 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.065 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.3 m -86.4 104.07 15.55 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.338 0.59 . . . . 0.0 110.208 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.1 t -82.83 118.17 30.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.358 -172.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 21.8 m -86.97 105.24 16.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.212 0.529 . . . . 0.0 110.239 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.583 HD23 HG23 ' A' ' 230' ' ' VAL . 19.5 mt -122.76 161.36 24.1 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.2 m -58.86 -50.5 73.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.255 0.55 . . . . 0.0 109.587 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.521 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.89 144.23 41.24 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.46 HG22 HD12 ' A' ' 261' ' ' LEU . 16.0 p -131.31 26.59 4.82 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.135 0.969 . . . . 0.0 108.514 174.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 24.9 m -74.57 135.88 42.09 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.972 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 103.34 -12.91 54.96 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -176.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 55.7 mtt -96.41 138.79 33.49 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.591 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 6.6 ptpp? -130.88 156.93 44.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -55.93 114.39 1.9 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.945 0.402 . . . . 0.0 110.623 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 110.83 18.57 8.29 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.487 -176.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.591 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 9.6 m-20 -105.14 158.36 16.63 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 117.039 0.419 . . . . 0.0 110.766 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 15.0 tppt? -103.7 116.32 32.11 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.647 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 30.3 pt -112.74 139.56 37.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.189 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 4.1 m -124.45 130.57 52.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.445 -176.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -94.53 111.88 23.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.447 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.84 116.71 9.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.838 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 107.76 -11.78 38.45 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 39.2 t -111.81 128.9 68.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -135.99 157.97 45.55 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.43 ' HE1' ' CZ ' ' A' ' 295' ' ' PHE . 50.0 m-85 -73.45 165.02 25.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.775 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 C--N 1.327 -0.399 0 CA-C-O 121.221 0.534 . . . . 0.0 110.127 178.286 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 . . . . . 0 C--O 1.233 0.185 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -69.29 76.23 0.37 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.158 0.504 . . . . 0.0 111.117 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.421 HG22 ' OG ' ' A' ' 274' ' ' SER . 65.6 p -86.78 105.18 16.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.411 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 312' ' ' PRO . 61.8 m-85 -115.46 143.72 44.89 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.023 0.439 . . . . 0.0 111.035 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.7 m -86.8 124.58 33.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.957 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 271' ' ' ASP . 8.3 p -83.1 136.06 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.038 0.447 . . . . 0.0 110.239 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 37.8 t -101.61 -29.5 3.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.948 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -163.81 142.04 7.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.582 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 78.8 t -98.14 117.62 43.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 38.9 t -77.89 -58.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.92 -172.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -121.21 2.29 10.33 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -173.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 70.45 13.34 70.88 Favored Glycine 0 CA--C 1.518 0.25 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.9 p -146.41 18.04 1.34 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.439 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.8 t-160 -171.07 113.99 0.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.778 -169.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.35 161.97 16.83 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -173.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -120.78 121.24 37.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.36 0.6 . . . . 0.0 110.739 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.444 HG22 ' HA ' ' A' ' 297' ' ' VAL . 23.3 pt -112.76 174.57 2.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.415 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . 0.408 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 13.2 t -152.13 141.27 14.13 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.99 -179.79 26.24 Favored 'Cis proline' 0 C--N 1.345 0.349 0 C-N-CA 123.681 -1.383 . . . . 0.0 112.411 0.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.443 ' CG ' ' HB3' ' A' ' 236' ' ' PHE . 23.3 ttmm -74.56 123.12 88.87 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.286 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 295' ' ' PHE . 56.9 Cg_endo -74.46 108.42 2.68 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.115 1.876 . . . . 0.0 112.045 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.556 ' HB ' ' HA ' ' A' ' 328' ' ' ALA . 0.2 OUTLIER -106.54 132.71 53.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.216 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -78.95 116.84 19.52 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 123.53 0.519 . . . . 0.0 110.827 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.0 tm? -64.71 -29.67 70.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.31 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -91.77 15.53 12.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.854 -177.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -90.57 127.26 36.2 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 9.6 p -82.98 -12.53 12.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.989 0.423 . . . . 0.0 111.376 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 5.3 m -93.13 33.71 1.17 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.118 0.485 . . . . 0.0 111.32 -173.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.439 HD23 ' HE2' ' A' ' 237' ' ' LYS . 2.0 pp -132.78 170.91 14.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.745 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 23.3 m -106.23 159.61 29.11 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.341 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -39.97 -48.24 3.79 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.581 2.854 . . . . 0.0 113.913 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -56.28 -41.05 75.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.094 0.473 . . . . 0.0 111.343 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -72.1 -37.67 69.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.777 -175.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -77.05 -16.09 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.936 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -69.22 -30.75 68.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.478 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -96.16 -0.88 49.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.153 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.556 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -61.75 151.24 34.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.19 0.519 . . . . 0.0 111.546 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -138.43 -28.01 0.85 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.141 -171.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 23.4 m -113.89 162.16 12.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -92.51 -14.21 28.72 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.279 -176.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 11.9 t -147.62 148.5 31.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.768 0.318 . . . . 0.0 110.324 -177.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 46.0 m -77.78 158.63 29.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.575 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.429 ' HG ' HG21 ' A' ' 230' ' ' VAL . 41.1 tp -71.31 103.21 2.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.623 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -85.55 -179.24 6.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.407 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . 0.462 ' HA ' ' CG1' ' A' ' 230' ' ' VAL . 33.2 t70 -77.83 159.79 28.74 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.14 -0.224 . . . . 0.0 110.409 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 65.1 40.9 4.82 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.91 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.558 ' H ' HG12 ' A' ' 230' ' ' VAL . 25.2 mmt -110.28 140.32 44.56 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 176.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -92.21 135.25 34.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.989 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.435 HG21 HD22 ' A' ' 261' ' ' LEU . 14.0 t -114.26 105.01 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.902 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . 0.452 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 64.1 t30 -118.77 150.31 40.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.705 0.288 . . . . 0.0 111.003 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 69.3 mt -95.91 123.67 48.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.643 177.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 60.2 mt . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.394 176.314 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -85.09 57.47 4.99 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 339' ' ' ALA . 31.9 mm -85.78 142.93 12.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 122.282 0.233 . . . . 0.0 110.808 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 12.3 p -118.84 143.22 47.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.089 0.471 . . . . 0.0 110.467 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.632 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.9 p -59.5 149.39 6.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.75 -178.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 25.9 t -113.07 77.91 1.09 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 177.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 90.37 141.71 9.25 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.993 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.68 140.9 55.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.764 0.316 . . . . 0.0 110.927 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -144.76 132.87 21.54 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.544 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.1 t -116.92 114.12 23.4 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 175.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.479 ' O ' HG22 ' A' ' 313' ' ' VAL . 71.5 m-85 -81.15 133.0 35.39 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.343 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -124.09 134.99 25.84 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.436 ' HD3' HG21 ' A' ' 313' ' ' VAL . 84.9 Cg_endo . . . . . 0 N--CA 1.459 -0.519 0 C-N-CA 122.757 2.305 . . . . 0.0 111.831 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 C--O 1.225 -0.236 0 CA-C-O 120.827 0.346 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -146.18 123.37 11.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.677 0.275 . . . . 0.0 110.74 177.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.1 m -94.55 101.45 13.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.892 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.416 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.7 t -86.18 120.46 36.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.234 -173.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 30.3 m -92.9 109.73 21.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.917 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 19.2 mt -126.49 171.0 11.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.023 -175.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 16.6 p -62.07 -55.59 27.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.412 0.625 . . . . 0.0 109.77 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -136.85 139.05 41.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.785 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.4 p -131.38 27.55 4.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.793 0.806 . . . . 0.0 109.138 175.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 48.8 m -76.88 140.46 40.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.639 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 101.77 -2.25 52.49 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -173.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 63.3 mtt -108.03 137.27 46.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.813 -0.694 . . . . 0.0 109.299 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -155.0 141.69 18.95 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.581 ' HA ' HG13 ' A' ' 297' ' ' VAL . 29.1 ptt180 -39.34 119.24 0.9 Allowed 'General case' 0 N--CA 1.469 0.51 0 O-C-N 124.01 0.819 . . . . 0.0 112.694 -173.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 116.0 -9.26 18.47 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.564 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.47 ' H ' HG12 ' A' ' 297' ' ' VAL . 2.1 p30 -87.17 -174.82 5.06 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 117.523 0.662 . . . . 0.0 111.307 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 296' ' ' SER . 4.2 tmmm? -140.99 118.45 11.49 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.11 -177.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.42 HG22 HG13 ' A' ' 342' ' ' ILE . 34.3 pt -110.55 140.77 28.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.149 0.5 . . . . 0.0 110.095 -177.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 15.0 m -126.35 132.38 51.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.365 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -94.5 111.19 22.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.431 -176.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.7 116.75 7.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.722 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.38 -34.15 5.31 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 98.1 t -94.24 118.82 41.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.75 171.91 13.78 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.389 -178.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 95.5 m-85 -74.66 172.92 11.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.189 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.191 179.939 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.638 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -54.41 98.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.918 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.4 p -91.48 99.1 12.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.052 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.638 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 43.1 m-85 -118.61 138.63 52.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.919 0.39 . . . . 0.0 110.925 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 272' ' ' LYS . 28.1 t -85.4 138.43 32.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.898 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.581 HG13 ' HA ' ' A' ' 269' ' ' ARG . 4.3 p -71.67 137.27 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.966 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.25 -42.18 9.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.939 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 307' ' ' GLU . 28.2 tpt180 -165.1 142.14 5.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.773 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 99.0 t -103.13 119.16 51.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 171.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.07 -58.71 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.01 -174.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -121.6 -9.41 8.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.337 0.589 . . . . 0.0 111.651 -173.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.62 13.98 76.94 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.309 -172.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 55.2 p -140.06 12.14 2.42 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 171.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -163.03 116.05 1.59 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.457 -167.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.41 165.01 15.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 121.194 -0.202 . . . . 0.0 110.577 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 8.0 pt-20 -128.09 123.09 33.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.076 0.465 . . . . 0.0 109.77 170.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.429 HG22 ' HA ' ' A' ' 297' ' ' VAL . 26.6 pt -121.67 176.86 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.314 -175.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.5 t -154.11 144.22 15.59 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.018 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.73 179.37 31.15 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 123.414 -1.494 . . . . 0.0 112.606 -4.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -77.39 121.1 83.94 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.873 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.443 ' HG2' ' CD2' ' A' ' 236' ' ' PHE . 30.5 Cg_endo -68.83 108.38 1.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.067 1.845 . . . . 0.0 111.934 174.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.565 ' HB ' ' HA ' ' A' ' 328' ' ' ALA . 85.8 t -118.02 130.65 72.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.317 178.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.673 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -90.42 131.9 35.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.194 0.521 . . . . 0.0 111.459 -176.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.3 tm? -69.46 -29.08 66.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.719 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -97.63 15.17 24.23 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -83.8 128.3 34.43 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.82 0.21 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 18.0 m -105.49 30.84 5.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.224 -0.298 . . . . 0.0 111.757 -174.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 320' ' ' LEU . 1.7 pp -128.34 159.57 34.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.271 0.557 . . . . 0.0 111.879 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.412 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 2.7 t -91.53 152.75 43.82 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.854 175.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.554 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 50.1 Cg_exo -38.44 -47.99 2.48 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.978 3.118 . . . . 0.0 114.943 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -64.38 -33.58 76.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.828 0.347 . . . . 0.0 111.922 -176.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -68.06 -36.5 79.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.875 0.369 . . . . 0.0 111.243 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 7.4 ptm180 -78.76 -11.16 59.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.315 0.579 . . . . 0.0 110.366 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -74.73 -22.77 58.63 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.617 171.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -99.89 6.19 45.3 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.525 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.565 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -53.61 144.52 17.35 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.648 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -128.63 -34.69 1.98 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.032 -177.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.9 m -113.82 155.27 15.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.364 -178.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -90.97 -8.34 49.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.24 0.543 . . . . 0.0 110.809 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.4 t -148.3 141.28 24.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.881 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 24.1 m -75.38 166.18 24.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.898 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.437 ' HG ' HG21 ' A' ' 230' ' ' VAL . 26.2 tp -71.16 102.97 2.63 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.632 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -93.19 -172.9 3.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -74.35 160.83 30.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.776 0.322 . . . . 0.0 110.427 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 61.18 32.84 19.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.44 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.406 ' H ' HG12 ' A' ' 230' ' ' VAL . 25.5 mmt -102.48 126.89 49.67 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 228' ' ' ILE . . . -84.47 129.91 34.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.096 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 16.1 t -104.18 108.42 24.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -134.11 142.19 47.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.818 0.342 . . . . 0.0 111.908 -171.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.42 HG13 HG22 ' A' ' 273' ' ' ILE . 58.5 mt -87.96 127.0 41.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.76 175.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 57.8 mt . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.902 177.489 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 38.9 p . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 110.652 -0.129 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 54.4 56.75 20.28 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.247 -0.502 . . . . 0.0 112.832 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.483 HG21 ' O ' ' A' ' 263' ' ' ALA . 51.1 mt -103.24 150.05 6.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 14.6 p -97.58 153.7 18.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.535 0.683 . . . . 0.0 112.082 -177.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.613 HG12 ' H ' ' A' ' 338' ' ' MET . 7.8 p -65.93 150.4 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.025 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . 0.401 ' HB2' ' C ' ' A' ' 261' ' ' LEU . 10.2 t -102.32 66.89 1.01 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.76 158.37 31.87 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.211 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.22 132.54 53.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.017 0.437 . . . . 0.0 111.681 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.58 ' NE2' ' HB ' ' A' ' 260' ' ' THR . 83.6 mm-40 -120.66 127.37 52.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.293 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 11.2 p -129.86 144.77 51.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.14 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -133.81 158.98 41.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.47 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . 46.1 mmtm -139.81 126.91 12.61 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.886 178.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.466 ' HD3' HG11 ' A' ' 313' ' ' VAL . 2.8 Cg_endo . . . . . 0 N--CA 1.461 -0.419 0 C-N-CA 122.877 2.385 . . . . 0.0 111.641 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 308' ' ' ILE . 52.0 m-85 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.998 0.428 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -106.49 120.72 42.65 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.171 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.8 m -87.35 97.45 10.81 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.128 0.489 . . . . 0.0 110.899 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.5 t -83.91 125.39 40.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.546 -173.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . 0.58 ' HB ' ' NE2' ' A' ' 234' ' ' GLN . 13.3 m -97.53 106.97 19.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.187 0.518 . . . . 0.0 109.853 175.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.521 ' HB2' HG22 ' A' ' 264' ' ' THR . 17.4 mt -121.2 163.02 19.15 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -177.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.1 t -56.75 -51.88 67.16 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.483 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.88 136.95 37.59 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.521 HG22 ' HB2' ' A' ' 261' ' ' LEU . 17.5 p -125.25 24.13 7.47 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 122.005 0.907 . . . . 0.0 108.922 175.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 10.4 m -77.71 145.4 36.6 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.301 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 96.83 -15.9 61.88 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -174.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . 0.534 ' O ' HG21 ' A' ' 300' ' ' VAL . 54.1 mtt -92.28 132.84 36.37 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -129.75 149.73 51.37 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -49.71 114.07 0.98 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.548 0.69 . . . . 0.0 110.851 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 107.64 11.15 25.58 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.56 -0.745 . . . . 0.0 113.024 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.449 ' H ' HG12 ' A' ' 297' ' ' VAL . 6.4 m-20 -98.25 147.6 24.46 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 117.757 0.778 . . . . 0.0 110.991 176.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -94.63 117.53 30.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.334 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 22.7 pt -112.41 139.58 36.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.003 0.43 . . . . 0.0 110.238 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.464 ' HB3' HG22 ' A' ' 294' ' ' THR . 77.9 p -112.61 137.95 50.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.306 -177.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -105.89 119.95 40.49 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.368 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -63.3 136.27 57.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.892 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 81.95 -35.36 2.54 Favored Glycine 0 N--CA 1.454 -0.109 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.667 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 52.3 t -82.36 105.15 11.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -128.88 165.02 21.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.968 0.413 . . . . 0.0 111.46 -176.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.558 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 70.8 m-85 -79.26 144.75 34.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.3 -176.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.523 175.846 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 47.7 m-20 . . . . . 0 CA--C 1.518 -0.275 0 CA-C-O 120.735 0.303 . . . . 0.0 110.335 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.572 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -67.62 97.7 0.63 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.57 -175.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.464 HG22 ' HB3' ' A' ' 274' ' ' SER . 30.3 p -100.38 105.0 16.46 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.285 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.572 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 68.2 m-85 -112.62 145.87 39.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.937 0.399 . . . . 0.0 110.95 -178.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 50.1 m -86.08 124.91 33.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.324 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.449 HG12 ' H ' ' A' ' 271' ' ' ASP . 11.2 p -69.85 132.61 32.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.062 178.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.74 -33.94 4.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.951 0.405 . . . . 0.0 110.419 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -157.99 133.46 8.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.071 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.534 HG21 ' O ' ' A' ' 267' ' ' MET . 96.7 t -91.48 101.35 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.6 t -73.77 -59.06 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.686 -171.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -109.39 -11.44 14.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.001 0.429 . . . . 0.0 111.691 -174.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.79 12.98 83.49 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -170.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 5.2 p -147.55 18.09 1.17 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 173.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.485 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.7 t-160 -169.64 114.7 0.54 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.207 -167.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.31 167.91 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -174.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -126.18 119.72 28.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.257 0.551 . . . . 0.0 109.958 169.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 256' ' ' PHE . 27.1 pt -113.99 171.21 4.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.705 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 12.6 t -153.52 145.51 16.93 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.84 179.29 30.99 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.498 -1.459 . . . . 0.0 112.933 -2.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -82.64 121.1 77.75 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.913 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.85 113.28 3.24 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.798 2.332 . . . . 0.0 112.912 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.473 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.1 OUTLIER -114.38 139.52 39.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.818 173.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -87.07 131.31 34.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.673 -177.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.7 tm? -65.91 -28.06 68.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.881 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.69 24.97 3.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.198 178.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -91.91 122.04 34.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 8.4 p -84.05 -0.99 5.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.246 0.546 . . . . 0.0 111.483 -175.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 33.3 t -93.93 -25.52 17.25 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.069 -0.394 . . . . 0.0 111.474 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.438 HD21 ' O ' ' A' ' 314' ' ' ALA . 1.3 pp -83.7 162.85 20.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.238 0.542 . . . . 0.0 111.533 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.472 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 7.1 m -100.57 167.4 10.93 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.504 -176.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 42.2 Cg_exo -41.13 -51.51 3.85 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.8 3.0 . . . . 0.0 114.787 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.71 -39.28 93.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.002 0.429 . . . . 0.0 111.076 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -64.43 -28.95 70.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.906 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 325' ' ' ARG . 43.3 mtp85 -63.99 -28.73 70.01 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.796 0.331 . . . . 0.0 110.844 175.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -74.88 -19.34 60.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.104 0.478 . . . . 0.0 110.658 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -96.17 -2.78 45.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.473 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -72.74 106.39 4.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.661 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -98.31 -17.83 18.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.314 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.8 m -116.47 156.68 17.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.175 0.512 . . . . 0.0 110.417 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -82.38 -32.47 29.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.418 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 12.0 t -139.98 154.08 47.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.572 -174.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.2 p -86.95 169.66 12.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.318 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.431 ' HG ' HG21 ' A' ' 230' ' ' VAL . 18.1 tp -71.15 115.5 10.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.192 -175.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.481 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.58 -178.92 6.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.32 -177.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -78.97 -9.83 59.64 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -138.7 72.56 1.41 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.924 0.392 . . . . 0.0 111.376 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.613 ' H ' HG12 ' A' ' 230' ' ' VAL . 21.0 mmt -125.11 146.37 49.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -93.81 139.5 30.78 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.735 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.462 HG21 HD22 ' A' ' 261' ' ' LEU . 40.9 t -121.81 119.36 58.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.965 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -135.83 143.9 45.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.967 -176.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 52.7 mt -85.73 121.64 37.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.948 173.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 63.9 mt . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.399 -179.638 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.493 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 19.5 p . . . . . 0 C--O 1.236 0.377 0 N-CA-C 111.459 0.17 . . . . 0.0 111.459 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 58.44 39.91 93.59 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.764 -177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.642 HG21 ' O ' ' A' ' 263' ' ' ALA . 62.2 mt -103.23 146.63 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 21.8 p -108.24 156.08 19.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.398 0.618 . . . . 0.0 111.405 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.73 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.5 p -63.0 151.63 8.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.825 176.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . 0.403 ' H ' ' HA ' ' A' ' 261' ' ' LEU . 18.7 t -105.02 83.73 2.03 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 84.12 165.24 38.68 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.177 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.88 129.81 40.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.792 0.33 . . . . 0.0 110.425 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -123.39 127.4 48.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.049 0.452 . . . . 0.0 110.853 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 21.4 p -127.14 131.58 50.73 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.206 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 312' ' ' PRO . 78.4 m-85 -111.91 142.77 43.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.88 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -133.71 132.75 21.82 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.04 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.537 ' HD3' HG21 ' A' ' 313' ' ' VAL . 90.3 Cg_endo . . . . . 0 N--CA 1.452 -0.96 0 C-N-CA 122.689 2.259 . . . . 0.0 111.388 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.993 0.425 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -146.9 132.67 18.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.897 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.651 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -92.03 104.93 17.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.131 0.491 . . . . 0.0 111.131 177.443 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.8 t -85.65 117.45 30.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.495 -174.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 19.4 m -87.22 105.83 17.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.171 0.51 . . . . 0.0 110.195 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.505 HD23 HG23 ' A' ' 230' ' ' VAL . 20.5 mt -122.17 164.92 16.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.652 -177.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.3 t -59.9 -51.8 68.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.171 0.51 . . . . 0.0 109.776 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.642 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.37 131.45 32.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.22 176.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.463 HG22 ' HB2' ' A' ' 261' ' ' LEU . 12.8 p -126.0 18.09 7.84 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.774 0.797 . . . . 0.0 109.029 175.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 26.5 m -82.62 148.11 28.17 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.857 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 95.51 -0.18 63.21 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 42.9 mtm -117.07 158.08 24.79 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.449 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 23.4 pttm -139.94 172.45 12.74 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -59.29 121.07 10.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.631 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 103.04 18.85 13.88 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.244 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.47 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 59.8 m-20 -100.62 152.64 20.19 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 117.433 0.616 . . . . 0.0 110.135 178.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.404 ' HA ' ' HE3' ' A' ' 272' ' ' LYS . 1.5 tpmt? -95.07 116.32 28.57 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.97 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.494 HD11 HG21 ' A' ' 308' ' ' ILE . 15.0 pt -115.84 138.92 44.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.237 176.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 4.5 m -123.92 131.47 53.58 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.832 -178.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -99.26 112.2 24.41 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.964 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.61 115.39 3.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.459 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.27 -34.86 4.95 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.937 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 45.2 t -81.66 142.13 14.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.513 ' NZ ' ' HB3' ' A' ' 279' ' ' LYS . 0.1 OUTLIER -162.13 152.19 16.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.916 0.389 . . . . 0.0 111.276 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -80.85 154.16 27.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.465 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.154 177.008 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.419 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -68.0 104.0 1.64 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.367 -175.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 30.3 p -90.88 106.69 18.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.511 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.419 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 88.4 m-85 -105.31 149.89 25.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.158 0.504 . . . . 0.0 111.105 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 12.8 m -96.7 119.87 35.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.777 176.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.47 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.5 p -78.71 130.45 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.163 0.506 . . . . 0.0 110.231 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 21.1 t -93.49 -28.09 4.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.392 -178.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -172.88 140.62 0.96 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.63 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 95.7 t -90.31 109.54 20.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 170.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 42.8 t -78.03 -59.0 3.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.294 -172.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -110.33 -10.05 14.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.046 0.45 . . . . 0.0 111.737 -174.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.56 11.95 84.05 Favored Glycine 0 C--N 1.32 -0.343 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 27.9 p -146.01 13.91 1.31 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.61 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 3.7 t-160 -165.16 116.51 1.14 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.357 -167.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.9 m -119.26 162.13 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -176.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.31 120.65 42.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.926 0.393 . . . . 0.0 110.0 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.494 HG21 HD11 ' A' ' 273' ' ' ILE . 39.8 pt -122.36 176.74 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.092 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.5 t -154.45 145.6 16.46 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.13 -179.99 26.64 Favored 'Cis proline' 0 C--N 1.346 0.428 0 C-N-CA 124.23 -1.154 . . . . 0.0 112.84 -0.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -78.88 113.64 37.12 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.96 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 23.5 Cg_exo -63.68 107.94 0.81 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.351 2.034 . . . . 0.0 112.365 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.537 HG21 ' HD3' ' A' ' 238' ' ' PRO . 97.5 t -124.39 126.3 71.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -83.54 137.44 33.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.569 0.699 . . . . 0.0 111.897 -173.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.0 tm? -77.74 -25.2 49.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.54 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.6 5.2 43.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.426 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 12.2 t70 -74.51 120.03 19.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.03 0.443 . . . . 0.0 110.186 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.9 p -84.79 -15.43 10.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.323 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 33.7 m -77.13 -23.93 51.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.498 -174.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 2.0 pp -85.75 164.41 17.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.456 0.646 . . . . 0.0 111.915 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 21.4 m -92.33 159.25 37.5 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.693 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 2.6 Cg_endo -41.34 -51.12 4.22 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 124.276 3.317 . . . . 0.0 114.311 -177.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -65.11 -29.03 69.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.853 0.359 . . . . 0.0 111.257 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 23.5 mt-30 -71.76 -38.52 70.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.089 -178.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.421 ' HE ' HD11 ' A' ' 320' ' ' LEU . 10.1 ptp180 -73.73 -19.88 60.67 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.489 176.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.23 -18.68 64.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.155 0.502 . . . . 0.0 110.023 172.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -112.15 12.03 20.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.084 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -60.54 152.62 25.54 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.927 0.394 . . . . 0.0 110.999 176.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -118.27 -29.73 5.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.663 -175.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.7 m -133.19 170.7 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 121.014 -0.275 . . . . 0.0 110.759 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -84.13 -51.44 7.06 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.594 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 11.4 t -107.27 146.3 31.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.03 0.443 . . . . 0.0 110.778 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.1 p -80.46 157.98 26.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.739 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.457 HD12 ' HG3' ' A' ' 338' ' ' MET . 15.9 tp -68.56 101.96 1.38 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.73 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -82.53 165.89 19.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.489 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -76.96 25.41 0.15 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -149.1 30.92 0.77 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.962 0.41 . . . . 0.0 110.842 176.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.457 ' HG3' HD12 ' A' ' 334' ' ' LEU . 23.8 mmt -88.64 137.82 31.97 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.33 141.45 28.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.742 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 12.4 t -110.07 116.89 53.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.079 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . 0.493 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 27.8 t-20 -127.44 139.8 52.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.162 -177.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 16.3 mt -98.58 131.33 45.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 121.045 0.45 . . . . 0.0 111.125 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 33.5 mt . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.482 176.491 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 54.8 p . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 69.97 31.27 69.71 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.056 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.615 HG21 ' O ' ' A' ' 263' ' ' ALA . 89.0 mt -99.88 144.4 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.451 0.167 . . . . 0.0 110.613 -174.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 21.6 p -105.97 167.28 9.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.042 0.449 . . . . 0.0 111.549 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.555 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.0 p -73.17 151.06 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.711 174.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 8.5 t -116.41 68.26 0.73 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.231 0.539 . . . . 0.0 109.909 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 103.94 141.83 11.41 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.856 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.8 127.6 33.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.919 0.39 . . . . 0.0 110.946 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -123.57 126.04 45.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.119 0.485 . . . . 0.0 110.427 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 5.4 p -111.08 103.36 11.8 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.197 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -81.65 151.76 27.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.337 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -145.03 127.7 8.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.257 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.4 ' HD3' HG11 ' A' ' 313' ' ' VAL . 94.6 Cg_endo . . . . . 0 N--CA 1.456 -0.677 0 C-N-CA 122.763 2.309 . . . . 0.0 110.45 169.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.414 ' CD1' ' HB ' ' A' ' 309' ' ' THR . 83.6 m-85 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.728 0.299 . . . . 0.0 110.669 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -110.19 135.32 51.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.249 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.3 OUTLIER -103.63 100.39 10.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.08 0.467 . . . . 0.0 110.58 -177.513 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.524 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.8 t -83.97 124.52 39.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.1 -170.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 21.8 m -93.74 106.21 18.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.259 0.552 . . . . 0.0 110.358 175.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.511 ' HB2' HG22 ' A' ' 264' ' ' THR . 21.8 mt -123.09 164.16 19.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.771 -176.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.7 m -57.48 -53.48 57.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.285 0.565 . . . . 0.0 109.987 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.615 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -136.85 133.53 35.94 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.257 177.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.511 HG22 ' HB2' ' A' ' 261' ' ' LEU . 4.3 p -127.96 17.48 6.73 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 11.4 m -80.32 150.49 29.92 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.772 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 91.72 -3.22 77.91 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.823 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 57.8 mtm -108.79 161.25 15.29 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.439 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 23.1 pttm -132.45 175.45 9.28 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -65.95 136.87 56.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.902 0.382 . . . . 0.0 110.338 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.99 7.6 62.4 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.213 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.439 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 44.3 m-20 -85.25 142.23 29.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.621 0.71 . . . . 0.0 109.903 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 1.3 tpmt? -87.71 115.32 25.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.776 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.541 HD11 HG21 ' A' ' 308' ' ' ILE . 6.8 pt -113.41 139.04 40.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.394 176.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 44.2 t -128.45 132.18 48.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.315 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -101.6 112.03 24.46 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.461 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.02 117.46 7.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.602 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.19 -11.19 26.68 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.458 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.2 133.55 58.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.444 ' NZ ' ' HB3' ' A' ' 279' ' ' LYS . 0.2 OUTLIER -159.16 162.89 36.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.963 0.411 . . . . 0.0 111.602 -178.193 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -81.11 156.66 25.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.266 -174.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.414 HD22 ' H ' ' A' ' 281' ' ' LEU . 1.4 mm? . . . . . 0 CA--C 1.518 -0.252 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.437 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -54.56 123.17 12.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.374 -171.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.419 ' CG2' HD12 ' A' ' 343' ' ' LEU . 14.0 p -99.4 127.0 45.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.888 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 312' ' ' PRO . 86.0 m-85 -127.74 150.4 49.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.598 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 24.1 t -97.4 122.65 40.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.102 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.443 ' HA ' HG22 ' A' ' 308' ' ' ILE . 11.1 p -74.8 134.91 28.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.08 0.467 . . . . 0.0 109.949 177.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.404 HG21 ' CE1' ' A' ' 256' ' ' PHE . 37.3 t -98.59 -35.21 4.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.725 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -164.63 136.72 4.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 0.0 110.761 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 88.9 t -83.84 109.78 17.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 171.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 42.5 t -74.43 -59.33 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.708 -173.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -120.65 -14.5 8.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.413 0.625 . . . . 0.0 111.101 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 84.08 13.91 73.3 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -169.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 31.9 p -140.92 13.57 2.27 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 171.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.423 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 3.6 t-160 -168.71 121.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.038 -170.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 258' ' ' THR . 2.0 m -119.71 162.97 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.654 -175.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -116.69 123.0 46.16 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 170.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.541 HG21 HD11 ' A' ' 273' ' ' ILE . 43.7 pt -122.44 170.69 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.38 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . 0.414 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 5.1 t -153.41 144.85 16.44 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 172.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.18 179.84 25.69 Favored 'Cis proline' 0 C--N 1.345 0.368 0 C-N-CA 124.061 -1.225 . . . . 0.0 112.817 -1.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -88.97 119.7 69.87 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.977 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 295' ' ' PHE . 38.2 Cg_endo -69.68 116.48 4.57 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.673 2.249 . . . . 0.0 112.527 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.56 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -124.67 131.79 72.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.524 176.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 317' ' ' ASP . . . -78.96 130.92 36.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.259 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.34 -28.28 66.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.935 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -98.9 25.72 6.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.294 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . 0.546 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 10.0 t70 -78.59 123.55 27.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.2 m -83.5 3.29 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 16.8 m -109.77 18.63 20.0 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.672 0.272 . . . . 0.0 111.287 -174.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.8 pp -127.91 168.58 15.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.083 0.468 . . . . 0.0 111.945 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.424 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 4.1 m -102.82 169.97 6.86 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.568 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 99.2 Cg_exo -47.35 -48.95 13.95 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.234 2.623 . . . . 0.0 113.915 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -65.45 -33.95 77.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.284 0.564 . . . . 0.0 110.554 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.51 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 13.0 mm100 -67.44 -42.47 83.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.148 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -71.82 -17.01 62.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.913 0.387 . . . . 0.0 111.167 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.2 -29.16 67.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.067 0.46 . . . . 0.0 110.098 173.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -86.4 -13.17 47.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.827 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.56 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -58.41 143.68 44.48 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.29 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -131.13 -8.95 3.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.049 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.5 174.22 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.046 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -84.88 -45.23 12.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.684 0.278 . . . . 0.0 111.115 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 6.2 t -129.57 144.43 51.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.366 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.502 ' N ' ' HB2' ' A' ' 314' ' ' ALA . 22.5 m -68.22 169.48 10.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.414 ' HG ' HG21 ' A' ' 230' ' ' VAL . 21.4 tp -70.16 102.22 2.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -176.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.555 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -90.75 -173.69 3.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.312 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -73.3 158.98 34.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.89 0.376 . . . . 0.0 110.826 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 60.6 39.1 18.26 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.207 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.457 ' H ' HG12 ' A' ' 230' ' ' VAL . 26.1 mmt -104.6 133.08 50.05 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -89.01 137.6 32.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.066 0.46 . . . . 0.0 111.354 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 12.5 t -103.21 124.35 57.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.565 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -138.24 134.34 34.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.557 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 70.7 mt -88.46 119.72 36.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.917 0.389 . . . . 0.0 110.088 176.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . 0.419 HD12 ' CG2' ' A' ' 294' ' ' THR . 40.8 mt . . . . . 0 C--N 1.32 -0.697 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.721 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 33.7 p . . . . . 0 N--CA 1.446 -0.637 0 CA-C-O 121.191 0.519 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -81.23 67.83 3.55 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 174.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 263' ' ' ALA . 40.0 mm -100.1 145.01 11.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.585 -0.308 . . . . 0.0 110.685 -174.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.2 p -128.16 159.97 33.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.291 0.567 . . . . 0.0 110.681 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.678 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.4 p -84.68 151.88 3.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.537 -175.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 67.8 m -109.14 82.23 1.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.841 0.353 . . . . 0.0 110.408 174.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 93.58 165.22 37.29 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.592 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 334' ' ' LEU . . . -84.22 114.15 21.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.874 0.368 . . . . 0.0 110.15 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -120.61 128.43 53.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.026 -175.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 333' ' ' SER . 26.9 p -145.84 102.08 3.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.4 0.619 . . . . 0.0 110.092 172.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.421 ' C ' ' HD3' ' A' ' 311' ' ' LYS . 79.3 m-85 -95.15 148.15 22.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.927 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 237' ' ' LYS . 12.9 mptt -110.01 146.0 33.25 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.974 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.456 -0.682 0 C-N-CA 122.494 2.129 . . . . 0.0 111.677 174.729 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.436 ' CD2' ' HB ' ' A' ' 309' ' ' THR . 97.2 m-85 . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.41 ' HB2' ' HG3' ' A' ' 311' ' ' LYS . . . -105.08 118.24 36.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.611 0.244 . . . . 0.0 111.424 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -87.06 103.48 15.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.177 0.513 . . . . 0.0 110.586 175.399 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -82.22 118.23 29.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.021 -173.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 23.5 m -84.93 105.64 15.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.013 176.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.429 HD22 HG21 ' A' ' 340' ' ' VAL . 31.3 mt -126.09 166.45 16.98 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.949 -177.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.4 t -64.59 -52.85 55.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.096 0.474 . . . . 0.0 109.798 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.527 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.69 127.31 27.04 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.802 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 10.6 p -125.22 32.37 5.39 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 173.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 1.4 m -81.31 145.99 30.61 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.163 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 90.28 -2.8 81.63 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.758 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 59.7 mtt -97.79 146.3 25.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -133.05 172.73 12.25 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -59.36 138.49 57.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.034 0.445 . . . . 0.0 111.069 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 88.12 11.83 66.65 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.257 176.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.445 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 53.1 m-20 -90.64 153.84 20.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.555 0.678 . . . . 0.0 110.49 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -103.8 117.67 34.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.824 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.471 HD11 HG21 ' A' ' 308' ' ' ILE . 40.4 pt -112.72 139.87 35.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.137 178.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.506 ' HB3' HG22 ' A' ' 294' ' ' THR . 77.3 p -120.27 133.63 55.43 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.766 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -95.04 110.43 22.35 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 339' ' ' ALA . . . -70.83 118.72 13.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.122 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 108.49 -22.7 26.06 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.62 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 41.2 t -101.32 133.76 43.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -144.25 156.82 44.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.706 0.288 . . . . 0.0 111.131 -174.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.547 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 82.4 m-85 -77.55 169.35 18.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.599 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.686 179.04 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.547 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -71.56 95.48 1.42 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.249 -177.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.506 HG22 ' HB3' ' A' ' 274' ' ' SER . 70.8 p -103.78 126.72 51.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.35 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.424 ' CE2' ' HG3' ' A' ' 312' ' ' PRO . 92.5 m-85 -131.59 155.98 46.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.888 0.375 . . . . 0.0 110.828 -179.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 5.6 m -100.86 129.5 46.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.153 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.445 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 11.9 p -83.17 135.93 23.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.143 0.497 . . . . 0.0 110.462 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 27.9 t -98.48 -28.91 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.704 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 307' ' ' GLU . 27.8 tpt180 -167.17 137.92 3.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.506 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 97.6 t -87.85 111.36 22.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 14.9 t -75.86 -56.43 8.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.869 -170.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -119.3 -6.06 10.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.902 0.382 . . . . 0.0 111.65 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.94 12.16 84.17 Favored Glycine 0 C--N 1.322 -0.202 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -170.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 6.6 p -148.03 19.85 1.11 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.444 ' NE2' ' HB ' ' A' ' 258' ' ' THR . 3.6 t-160 -167.08 116.93 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.052 -1.431 . . . . 0.0 107.965 -170.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -118.64 152.15 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -175.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 299' ' ' ARG . 9.9 pt-20 -110.37 118.07 35.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.079 0.466 . . . . 0.0 110.002 173.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.471 HG21 HD11 ' A' ' 273' ' ' ILE . 27.2 pt -120.57 171.06 9.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.531 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . 0.436 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 7.1 t -148.91 140.32 14.21 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.625 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.4 -179.91 28.49 Favored 'Cis proline' 0 C--N 1.344 0.31 0 C-N-CA 123.906 -1.289 . . . . 0.0 112.375 -2.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 236' ' ' PHE . 37.2 ttmt -85.47 125.28 70.0 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.954 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.424 ' HG3' ' CE2' ' A' ' 295' ' ' PHE . 16.1 Cg_exo -67.74 108.97 1.76 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.661 2.241 . . . . 0.0 112.755 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.59 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -120.92 131.23 73.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.744 173.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -91.62 141.06 29.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.334 0.588 . . . . 0.0 111.377 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.7 tm? -72.84 -22.89 60.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.567 177.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.4 17.38 14.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.409 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.07 115.26 22.28 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 9.4 p -83.11 -9.68 11.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.005 0.431 . . . . 0.0 111.29 -175.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 15.0 m -82.33 -29.75 30.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.347 -174.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 2.4 pp -84.65 162.62 19.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.4 0.619 . . . . 0.0 112.002 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.491 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 41.9 m -95.93 166.07 15.19 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.076 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 71.3 Cg_exo -43.68 -44.23 11.33 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.554 2.836 . . . . 0.0 114.666 -177.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.27 -33.91 75.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.254 0.55 . . . . 0.0 111.201 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 46.4 mt-30 -79.86 -36.93 35.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.675 -175.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.446 ' HB3' ' CD1' ' A' ' 320' ' ' LEU . 13.6 ptm180 -73.2 -20.19 60.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.053 0.454 . . . . 0.0 110.161 177.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.01 -29.89 69.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.994 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -101.19 11.37 39.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.378 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.59 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -59.67 149.74 29.65 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.88 0.372 . . . . 0.0 111.212 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -125.95 -36.29 2.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.711 -176.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 30.7 m -110.31 155.19 11.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.229 0.537 . . . . 0.0 111.182 -175.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -85.61 -17.04 37.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.428 -176.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.1 t -144.0 139.74 29.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.225 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 235' ' ' SER . 73.0 m -70.89 163.62 27.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.241 175.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.418 ' HG ' HG21 ' A' ' 230' ' ' VAL . 29.0 tp -69.05 104.26 2.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.678 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -78.98 170.23 17.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.699 -175.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -76.44 12.41 1.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -170.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -152.93 65.31 0.78 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.356 0.598 . . . . 0.0 110.347 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.513 ' H ' HG12 ' A' ' 230' ' ' VAL . 22.2 mmt -114.85 141.95 47.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.255 178.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 276' ' ' ALA . . . -90.77 129.62 36.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.528 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 19.2 t -104.19 117.27 49.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -131.57 138.72 48.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.747 0.308 . . . . 0.0 111.185 -174.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 3.3 mt -90.42 133.37 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.137 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 60.4 mt . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.31 178.427 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 53.8 p . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.344 0.592 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -123.39 48.12 0.97 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 175.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.573 HG21 ' O ' ' A' ' 263' ' ' ALA . 17.4 mt -87.26 150.46 3.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -175.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 6.1 p -107.86 166.02 11.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.309 0.576 . . . . 0.0 111.722 -178.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.636 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.7 p -72.82 150.32 8.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.971 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . 0.492 ' HB2' ' N ' ' A' ' 262' ' ' SER . 7.0 t -110.87 74.48 0.87 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.344 0.592 . . . . 0.0 109.72 177.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 92.8 144.3 14.3 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.996 -178.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.51 126.89 29.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.857 0.361 . . . . 0.0 110.808 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -125.33 126.35 44.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.134 -179.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.9 m -105.65 104.42 14.14 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.693 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.406 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 55.8 m-85 -80.52 113.64 18.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.977 -176.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -124.64 121.78 25.76 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.92 0.391 . . . . 0.0 111.763 -174.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo . . . . . 0 N--CA 1.453 -0.893 0 C-N-CA 122.782 2.321 . . . . 0.0 110.997 170.765 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 N--CA 1.454 -0.253 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -101.99 115.69 31.09 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.727 0.299 . . . . 0.0 110.408 178.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.7 OUTLIER -92.78 103.61 15.95 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.164 0.507 . . . . 0.0 109.995 179.639 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.1 t -82.84 117.0 28.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.466 -171.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 16.2 m -87.04 105.3 17.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.101 177.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.48 HD12 HG22 ' A' ' 264' ' ' THR . 29.0 mt -125.59 162.73 24.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.13 -176.163 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.492 ' N ' ' HB2' ' A' ' 231' ' ' SER . 14.0 m -62.21 -50.2 72.73 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.428 0.632 . . . . 0.0 109.697 179.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.573 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -138.13 142.06 40.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.269 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.48 HG22 HD12 ' A' ' 261' ' ' LEU . 19.1 p -129.39 26.86 5.36 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.087 0.946 . . . . 0.0 108.875 174.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 15.5 m -77.71 138.3 38.97 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.343 -1.298 . . . . 0.0 109.513 175.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 104.9 -7.1 44.45 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -172.224 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . 0.451 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 61.1 mtt -101.5 144.74 29.89 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -154.89 141.98 19.31 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.518 ' HA ' HG13 ' A' ' 297' ' ' VAL . 24.3 ptt180 -44.46 116.52 1.05 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.96 0.788 . . . . 0.0 112.582 -171.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.62 -6.63 20.44 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.426 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.549 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.6 p30 -85.15 -177.9 6.64 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.482 0.641 . . . . 0.0 111.534 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -124.65 117.11 23.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.897 -177.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.503 HD11 HG21 ' A' ' 308' ' ' ILE . 40.8 pt -112.72 139.88 35.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.108 0.48 . . . . 0.0 110.208 177.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.501 ' OG ' HG22 ' A' ' 294' ' ' THR . 4.9 m -127.98 149.28 50.42 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.822 -178.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -113.59 111.85 22.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.424 -178.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.52 115.71 6.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.823 -178.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.32 -25.62 12.2 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.708 -178.258 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 47.2 t -99.04 115.15 38.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -132.7 162.55 31.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.867 0.365 . . . . 0.0 111.896 -173.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.457 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 60.1 m-85 -80.46 154.16 27.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.86 -175.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 315' ' ' LEU . 40.2 mt . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.796 179.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 C--O 1.234 0.261 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.516 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -70.69 87.9 0.69 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.464 -176.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.501 HG22 ' OG ' ' A' ' 274' ' ' SER . 70.5 p -90.99 112.53 24.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.288 178.416 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.516 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 68.0 m-85 -123.07 145.43 48.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.931 0.396 . . . . 0.0 110.857 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 11.9 m -80.3 130.0 34.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.696 175.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.549 HG12 ' H ' ' A' ' 271' ' ' ASP . 5.2 p -67.75 132.72 32.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.255 0.55 . . . . 0.0 109.668 179.293 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.425 HG23 ' HA ' ' A' ' 308' ' ' ILE . 84.6 t -94.07 -45.34 13.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.105 178.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -167.51 139.08 3.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.126 178.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 93.7 t -88.11 108.79 18.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 171.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.0 t -78.54 -59.66 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.971 -173.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -111.91 -8.16 14.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.948 0.404 . . . . 0.0 111.529 -174.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.16 12.85 83.22 Favored Glycine 0 CA--C 1.517 0.193 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -170.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 20.4 p -146.05 16.25 1.37 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 174.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.44 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.2 t-160 -170.73 115.53 0.46 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.384 -168.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.58 161.92 18.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.537 -175.227 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -116.22 129.29 56.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.511 HG22 ' HA ' ' A' ' 297' ' ' VAL . 27.1 pt -132.07 169.83 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.031 0.443 . . . . 0.0 111.471 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 7.2 t -150.02 143.58 16.78 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.41 177.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -76.44 -179.95 29.0 Favored 'Cis proline' 0 C--N 1.345 0.378 0 C-N-CA 124.129 -1.196 . . . . 0.0 112.419 -3.113 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.406 ' HG3' ' HB3' ' A' ' 236' ' ' PHE . 35.9 ttmt -87.41 123.35 69.84 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.207 -178.016 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.15 109.29 2.9 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.593 2.196 . . . . 0.0 112.658 178.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.477 ' CG2' ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -107.06 133.92 50.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.62 175.745 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.447 ' HB2' ' N ' ' A' ' 333' ' ' SER . . . -82.84 126.06 32.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.11 0.481 . . . . 0.0 111.409 -178.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.546 ' HB2' HD11 ' A' ' 281' ' ' LEU . 2.7 tm? -68.64 -29.6 68.13 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.968 177.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -79.52 -0.81 34.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.751 -179.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -79.92 122.5 26.76 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.984 0.421 . . . . 0.0 110.622 -178.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 14.2 p -83.96 -16.64 10.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.237 -178.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 24.5 m -74.42 -35.82 63.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.721 -175.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.474 ' O ' HD12 ' A' ' 320' ' ' LEU . 1.7 pp -75.4 152.64 38.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.276 0.56 . . . . 0.0 110.884 178.423 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.508 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.8 m -91.09 170.84 9.06 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.259 -173.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 91.2 Cg_exo -46.98 -50.45 10.89 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 123.446 2.764 . . . . 0.0 114.517 -175.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.35 -28.85 69.98 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.149 -177.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 50.9 mt-30 -76.03 -39.65 55.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.631 0.253 . . . . 0.0 111.026 -178.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.445 ' HB3' ' CD1' ' A' ' 320' ' ' LEU . 13.0 ptp180 -73.37 -22.85 60.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.009 0.433 . . . . 0.0 110.538 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.87 -34.21 77.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.217 174.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -96.6 6.23 49.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.185 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.477 ' HA ' ' CG2' ' A' ' 313' ' ' VAL . . . -61.41 135.61 57.75 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.887 0.375 . . . . 0.0 110.753 178.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -108.89 -29.2 8.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.365 -176.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.8 171.53 9.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.946 0.403 . . . . 0.0 111.132 -175.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -88.55 -38.77 14.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.449 -178.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.1 t -128.3 143.17 50.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.909 0.385 . . . . 0.0 110.763 -176.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.447 ' N ' ' HB2' ' A' ' 314' ' ' ALA . 44.1 m -72.29 162.71 29.09 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 172.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.419 ' HG ' HG21 ' A' ' 230' ' ' VAL . 23.0 tp -68.66 102.42 1.5 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -177.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.636 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -95.72 -179.24 4.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.269 -178.337 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -67.57 150.45 48.79 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 65.45 45.62 2.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.819 179.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 26.4 mmt -112.0 131.07 55.63 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -87.07 133.6 33.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.604 -176.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.424 HG21 HD22 ' A' ' 261' ' ' LEU . 10.3 t -101.83 114.86 42.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.476 177.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -125.85 134.52 51.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.098 -174.035 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 19.5 mt -93.01 131.43 40.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 174.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 121.022 0.439 . . . . 0.0 110.586 179.758 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 121.222 0.534 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.43 68.1 3.39 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 174.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.541 ' HB ' ' O ' ' A' ' 340' ' ' VAL . 40.6 mm -100.17 143.45 13.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 122.339 0.256 . . . . 0.0 111.101 -173.356 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 74.4 p -121.89 149.41 43.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.195 0.521 . . . . 0.0 110.506 173.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.668 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.5 p -64.48 152.97 8.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.678 175.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 14.2 t -124.58 88.78 2.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.914 0.388 . . . . 0.0 110.017 175.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 103.4 165.34 25.51 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.038 -178.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -86.52 125.13 33.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.718 0.294 . . . . 0.0 110.428 179.145 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -120.58 129.51 53.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.929 0.395 . . . . 0.0 110.961 -176.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 25.5 t -153.89 103.04 2.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.899 177.404 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -114.26 141.65 47.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.892 -179.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 237' ' ' LYS . 2.9 mptp? -111.9 145.89 33.66 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.822 -175.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.459 -0.539 0 C-N-CA 122.261 1.974 . . . . 0.0 110.846 174.115 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.504 ' CE1' HG21 ' A' ' 298' ' ' VAL . 48.1 m-85 . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 120.744 0.307 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -145.36 118.44 8.85 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.861 176.33 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 3.8 m -83.22 113.01 20.37 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.076 0.465 . . . . 0.0 110.484 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.5 t -98.08 120.5 47.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.427 -173.542 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 79.5 m -89.64 108.2 19.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.04 0.448 . . . . 0.0 109.958 174.167 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.51 HD23 HG23 ' A' ' 230' ' ' VAL . 23.9 mt -125.04 168.32 13.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.732 -177.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.8 t -64.7 -52.84 55.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.532 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.68 127.24 26.94 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.328 179.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.419 ' CG2' ' HB2' ' A' ' 261' ' ' LEU . 11.5 p -125.23 25.5 7.15 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.885 174.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 24.1 m -82.01 145.29 30.32 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.156 175.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.93 -18.17 57.2 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -173.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 59.9 mtt -91.46 138.81 31.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.936 -0.632 . . . . 0.0 109.317 176.245 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -133.35 153.61 51.43 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.339 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.423 ' HA ' HG13 ' A' ' 297' ' ' VAL . 30.9 ptt180 -58.13 134.63 56.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.971 0.415 . . . . 0.0 111.366 -175.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 99.6 14.45 34.87 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.296 -177.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.528 ' H ' HG12 ' A' ' 297' ' ' VAL . 0.6 OUTLIER -109.45 175.59 5.39 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.8 0.3 . . . . 0.0 110.224 179.487 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.468 ' HE3' HD12 ' A' ' 343' ' ' LEU . 5.2 tmmm? -127.09 117.49 22.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.564 -174.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.439 HD11 HG21 ' A' ' 308' ' ' ILE . 31.0 pt -111.65 142.57 23.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.906 -177.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 14.8 m -124.55 138.55 54.32 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.507 -178.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -100.87 112.0 24.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.485 -178.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.96 116.56 9.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.97 -178.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.19 -34.22 5.3 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 60.2 t -89.06 122.09 39.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 175.145 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -139.88 158.38 44.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.043 0.449 . . . . 0.0 111.608 -176.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -73.48 145.41 45.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.155 -173.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 315' ' ' LEU . 77.2 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.359 176.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.584 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -60.39 102.56 0.18 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.526 -170.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.466 ' HB ' ' HD3' ' A' ' 272' ' ' LYS . 19.7 p -95.19 111.19 23.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.603 177.045 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.584 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 65.1 m-85 -123.68 150.53 44.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.859 0.362 . . . . 0.0 110.897 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 16.2 m -96.06 134.03 39.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.255 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 271' ' ' ASP . 9.5 p -86.98 135.53 24.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.964 0.411 . . . . 0.0 110.359 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.504 HG21 ' CE1' ' A' ' 256' ' ' PHE . 46.0 t -105.48 -31.5 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.274 -176.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -162.27 138.4 7.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.826 0.346 . . . . 0.0 110.593 -178.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 89.3 t -92.4 114.23 28.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.83 -59.29 3.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.842 -172.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.77 -2.47 10.91 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.873 0.368 . . . . 0.0 111.794 -174.129 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.08 11.71 83.84 Favored Glycine 0 N--CA 1.459 0.2 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -174.075 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 5.9 p -150.75 23.03 0.78 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 173.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.465 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.2 t-160 -167.78 112.75 0.68 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 113.594 -1.639 . . . . 0.0 107.896 -165.454 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.27 169.89 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.559 -174.174 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 10.9 pt-20 -128.22 121.74 30.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.215 0.531 . . . . 0.0 109.931 169.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 273' ' ' ILE . 22.7 pt -120.98 174.65 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.143 -177.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.7 t -155.19 147.06 17.18 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.121 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -69.23 179.94 19.86 Favored 'Cis proline' 0 C--N 1.349 0.567 0 C-N-CA 124.163 -1.182 . . . . 0.0 113.162 -2.403 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 24.1 ttmm -82.26 124.81 78.02 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.212 -177.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 13.3 Cg_exo -69.25 109.89 2.32 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.84 2.36 . . . . 0.0 112.606 177.106 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -126.04 130.69 72.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.905 174.161 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -95.32 143.7 26.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.272 0.558 . . . . 0.0 111.506 -175.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.527 ' HB2' HD11 ' A' ' 281' ' ' LEU . 2.6 tm? -76.43 -26.5 55.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.101 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -98.05 26.0 5.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.647 178.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . 0.51 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 20.3 t70 -86.14 131.3 34.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.528 -179.412 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 11.3 p -84.49 -18.53 9.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.946 -176.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 19.7 m -91.77 5.11 51.09 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -168.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' A' ' 325' ' ' ARG . 0.8 OUTLIER -115.67 157.53 24.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.365 0.602 . . . . 0.0 112.056 -179.378 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 16.9 m -86.55 158.47 54.28 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.552 177.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.574 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 61.9 Cg_exo -39.66 -49.78 3.27 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.434 3.423 . . . . 0.0 114.882 -176.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.9 -39.39 85.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.849 0.357 . . . . 0.0 111.68 -177.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -72.71 -29.57 63.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -172.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 9.7 ptm180 -76.14 -18.77 58.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.449 0.642 . . . . 0.0 109.862 178.43 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.79 -21.7 61.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.78 172.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -96.74 1.24 50.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.706 175.501 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.527 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -59.09 144.43 45.56 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.551 179.412 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -118.17 -27.28 6.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.436 -176.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.8 m -119.31 170.89 8.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.685 0.278 . . . . 0.0 111.218 -177.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -82.71 -53.97 5.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.922 -176.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.4 t -114.91 145.28 42.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.066 0.46 . . . . 0.0 110.876 -171.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.0 m -75.23 154.62 37.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.438 178.563 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.451 ' HG ' HG21 ' A' ' 230' ' ' VAL . 16.7 tp -70.1 103.34 2.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.668 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -95.76 162.33 13.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.958 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . 0.458 ' HA ' HG13 ' A' ' 230' ' ' VAL . 38.4 t70 -75.21 62.72 1.27 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.097 0.475 . . . . 0.0 112.1 -174.143 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -176.6 33.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.696 171.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.451 ' H ' HG12 ' A' ' 230' ' ' VAL . 23.9 mmt -104.54 130.7 52.48 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -83.63 135.1 34.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.607 178.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.541 ' O ' ' HB ' ' A' ' 228' ' ' ILE . 22.0 t -112.22 115.05 48.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.525 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -132.6 135.2 45.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.875 0.369 . . . . 0.0 111.6 -174.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.407 ' CG1' HG22 ' A' ' 273' ' ' ILE . 45.8 mt -84.29 123.59 39.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.855 174.072 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . 0.468 HD12 ' HE3' ' A' ' 272' ' ' LYS . 51.3 mt . . . . . 0 C--N 1.32 -0.705 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.846 178.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.433 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 16.3 p . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 111.383 0.142 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 60.45 36.98 92.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.7 -177.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 58.6 mt -91.17 144.04 9.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -176.151 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 13.4 p -96.65 153.26 17.96 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.555 0.693 . . . . 0.0 111.998 -172.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.654 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.6 p -67.06 151.09 10.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.052 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 71.5 m -113.75 82.0 1.62 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.919 0.39 . . . . 0.0 110.463 177.104 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 95.34 147.57 22.85 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.013 -179.375 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -82.59 139.07 34.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.839 0.352 . . . . 0.0 111.116 -177.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -141.38 135.18 30.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.251 0.548 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.9 p -139.87 103.07 4.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.245 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -115.38 153.95 30.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.352 -177.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 320' ' ' LEU . 13.4 mptt -108.63 138.76 20.35 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.077 177.316 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 N--CA 1.462 -0.348 0 C-N-CA 122.677 2.251 . . . . 0.0 112.112 -179.762 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 . . . . . 0 CA--C 1.52 -0.188 0 CA-C-O 120.833 0.349 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.55 124.87 46.7 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.343 178.269 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.3 m -93.37 101.41 13.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.302 0.572 . . . . 0.0 110.363 -179.374 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -82.97 122.92 38.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.146 -173.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 29.8 m -98.01 106.43 18.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.36 0.6 . . . . 0.0 110.299 179.179 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.443 HD23 HG23 ' A' ' 230' ' ' VAL . 16.5 mt -125.08 164.56 19.94 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.727 -174.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 51.1 m -58.54 -54.75 43.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.198 0.523 . . . . 0.0 109.927 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -136.78 130.66 32.25 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.258 178.304 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.402 ' CG2' ' HB2' ' A' ' 261' ' ' LEU . 10.5 p -126.37 25.94 6.49 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.7 m -79.68 143.13 34.88 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.69 -1.595 . . . . 0.0 109.819 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 99.29 -19.76 52.64 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -175.204 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 85.2 mtp -75.72 152.56 37.44 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.131 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -154.83 147.26 24.03 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -178.232 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.478 ' HA ' HG13 ' A' ' 297' ' ' VAL . 32.1 ptt180 -51.9 114.43 1.3 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.366 0.603 . . . . 0.0 111.15 -176.066 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 116.33 6.13 15.94 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.557 -174.078 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -88.7 179.84 6.16 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 117.094 0.447 . . . . 0.0 110.928 176.067 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 0.2 OUTLIER -141.45 117.18 10.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.647 -178.115 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 308' ' ' ILE . 21.9 pt -113.22 139.95 35.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.026 0.441 . . . . 0.0 110.876 -178.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 69.9 p -120.88 133.99 55.3 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.706 176.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.471 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 95.5 m-85 -94.11 111.46 23.18 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.179 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.481 ' HA ' ' OD1' ' A' ' 292' ' ' ASP . . . -66.0 111.53 3.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.02 -177.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.22 -35.3 4.73 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.7 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 83.9 t -82.62 129.69 37.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 173.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -148.35 160.23 43.21 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.26 -175.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -77.08 150.94 35.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.931 -178.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.765 177.93 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.481 ' OD1' ' HA ' ' A' ' 276' ' ' ALA . 57.3 m-20 . . . . . 0 C--O 1.232 0.166 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -58.66 108.97 0.71 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.607 -175.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.3 p -91.49 118.17 30.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.164 -178.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.67 148.25 48.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.225 177.473 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 25.4 m -98.67 136.73 38.32 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.603 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' A' ' 269' ' ' ARG . 8.7 p -67.56 142.56 16.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.449 178.566 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.2 t -105.74 -45.03 8.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.742 173.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -154.94 139.36 16.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.637 179.589 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 77.3 t -86.05 109.23 18.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 171.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 31.9 t -76.45 -58.26 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.821 -172.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -122.58 -2.7 8.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.866 0.365 . . . . 0.0 111.318 -176.085 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 72.18 12.88 76.37 Favored Glycine 0 CA--C 1.518 0.268 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -172.056 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 4.4 p -149.11 21.75 0.97 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.176 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.468 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.9 t-160 -173.41 115.73 0.25 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 113.833 -1.531 . . . . 0.0 107.667 -167.326 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.64 162.67 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -173.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 10.1 pt-20 -123.19 126.11 46.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.113 0.482 . . . . 0.0 110.189 171.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.42 HG21 HD11 ' A' ' 273' ' ' ILE . 25.5 pt -125.24 168.8 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.38 -176.031 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 6.0 t -140.59 138.47 18.68 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.802 176.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.04 179.45 25.95 Favored 'Cis proline' 0 C--N 1.344 0.318 0 C-N-CA 123.364 -1.515 . . . . 0.0 112.411 -1.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 3.0 ttmp? -80.12 123.57 83.31 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.384 177.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 15.0 Cg_exo -67.85 113.36 2.97 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.821 2.348 . . . . 0.0 112.647 178.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.602 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -117.32 128.96 74.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.125 174.817 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -81.19 130.62 35.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.261 0.553 . . . . 0.0 111.201 -178.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.0 tm? -65.18 -27.06 68.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.052 177.325 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.43 10.94 27.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.567 -178.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . 0.404 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 12.9 t70 -74.68 128.96 36.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.789 0.328 . . . . 0.0 110.133 178.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.1 p -83.92 -17.89 10.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.93 0.395 . . . . 0.0 111.58 -175.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 12.3 m -79.06 -36.33 41.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.489 -173.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.557 HD13 ' HB3' ' A' ' 325' ' ' ARG . 1.5 pp -72.25 162.53 29.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.448 0.642 . . . . 0.0 112.141 -178.522 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.518 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 12.5 m -108.26 173.87 2.78 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.697 -179.009 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 72.8 Cg_exo -44.19 -53.17 4.98 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 123.429 2.753 . . . . 0.0 114.987 -173.172 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -62.96 -39.12 93.72 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.071 -176.425 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -65.38 -41.37 93.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.452 -179.006 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.557 ' HB3' HD13 ' A' ' 320' ' ' LEU . 5.4 ppt_? -74.68 -19.0 60.44 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.972 179.132 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.78 -18.39 62.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.202 173.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -103.21 -0.61 30.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.485 176.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.602 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -62.27 127.33 30.84 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.774 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -106.5 -26.61 11.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.493 -176.001 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 27.0 m -116.29 161.45 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.0 110.858 -177.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -89.18 -16.75 30.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.109 -177.493 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.3 t -143.01 139.46 30.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.967 0.413 . . . . 0.0 111.002 -178.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.425 ' N ' ' HB2' ' A' ' 314' ' ' ALA . 20.2 m -74.56 174.56 8.83 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.431 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 19.1 tp -78.05 102.89 7.66 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.654 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -84.04 169.29 15.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.147 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -81.36 32.26 0.34 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -171.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.94 48.57 0.39 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.059 0.457 . . . . 0.0 110.841 174.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.455 ' H ' HG12 ' A' ' 230' ' ' VAL . 26.2 mmt -110.68 137.66 48.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.243 179.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.48 132.58 40.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.946 0.403 . . . . 0.0 110.874 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 31.8 t -102.83 114.36 42.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.897 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . 0.433 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 8.4 t30 -126.07 124.46 40.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.398 -176.32 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 32.3 mt -77.65 128.54 38.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.921 172.004 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 74.9 mt . . . . . 0 C--N 1.322 -0.62 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.743 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 63.07 33.66 87.86 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.769 -176.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.45 HG21 ' O ' ' A' ' 263' ' ' ALA . 51.4 mt -102.99 149.96 6.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -175.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.88 148.07 32.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.812 0.339 . . . . 0.0 110.487 177.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.58 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.9 p -53.97 151.75 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.589 178.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . 0.45 ' HB2' ' N ' ' A' ' 262' ' ' SER . 9.4 t -100.79 69.57 1.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.068 0.461 . . . . 0.0 110.026 178.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 89.52 166.16 41.57 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.013 -178.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.11 117.49 10.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.995 0.426 . . . . 0.0 110.756 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -114.77 126.43 54.83 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.967 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 57.2 p -125.27 149.57 47.9 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.152 -178.058 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -125.75 154.87 41.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.631 -178.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -143.02 138.42 15.77 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.159 177.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.5 ' HD2' ' OE1' ' A' ' 324' ' ' GLN . 5.5 Cg_endo . . . . . 0 N--CA 1.448 -1.166 0 C-N-CA 121.766 1.644 . . . . 0.0 110.602 171.55 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.429 ' CD2' ' HB ' ' A' ' 309' ' ' THR . 78.8 m-85 . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -136.33 132.79 36.11 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.702 0.286 . . . . 0.0 110.771 178.194 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.7 m -98.94 103.05 14.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.109 0.481 . . . . 0.0 110.069 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.51 125.81 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.744 -171.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 23.5 m -93.4 106.15 18.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.193 175.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.451 ' HB2' HG22 ' A' ' 264' ' ' THR . 19.6 mt -126.0 160.62 29.56 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -177.388 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.459 ' O ' HG22 ' A' ' 304' ' ' THR . 15.9 p -61.57 -48.09 82.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.147 0.499 . . . . 0.0 110.127 -178.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.45 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -136.72 138.33 40.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.294 175.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.451 HG22 ' HB2' ' A' ' 261' ' ' LEU . 9.4 p -134.61 28.45 3.62 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.503 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.6 m -78.07 145.02 36.07 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.486 -178.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 97.08 -4.12 62.55 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.428 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 62.0 mtt -93.58 158.57 15.63 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 178.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.444 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 25.1 pttm -150.08 163.8 37.24 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -56.07 123.99 16.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.068 0.461 . . . . 0.0 110.791 -178.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 98.72 18.25 25.89 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.418 178.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.451 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 0.3 OUTLIER -99.1 160.22 14.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.634 0.717 . . . . 0.0 110.127 179.056 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -108.96 117.07 33.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.834 -175.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 308' ' ' ILE . 36.8 pt -117.91 140.7 40.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.234 0.54 . . . . 0.0 110.407 177.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.436 ' HB2' HG22 ' A' ' 294' ' ' THR . 39.0 t -126.97 153.81 45.38 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.371 179.29 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -117.46 111.69 19.63 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.08 117.73 5.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.234 -177.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.03 -34.7 5.06 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 96.3 t -88.37 114.44 26.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -137.12 157.15 47.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.962 0.411 . . . . 0.0 111.035 -175.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.421 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 63.0 m-85 -76.6 135.9 39.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.029 -176.239 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 68.9 mt . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.974 175.026 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.646 0.26 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.421 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -49.61 110.07 0.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.621 -175.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.515 HG21 HD11 ' A' ' 343' ' ' LEU . 4.9 p -100.49 120.5 40.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.08 -178.249 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -122.44 151.28 41.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.629 -178.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.8 m -98.32 130.59 45.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.211 178.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.451 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 14.1 p -80.83 132.08 32.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.322 0.582 . . . . 0.0 110.629 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 37.3 t -91.53 -33.9 5.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.317 -178.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -166.37 139.9 4.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.418 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 57.5 t -88.32 107.36 17.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 169.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 39.9 t -68.59 -54.79 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.874 -172.048 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -128.5 -6.42 5.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.154 0.502 . . . . 0.0 111.514 -174.156 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.04 12.67 80.69 Favored Glycine 0 N--CA 1.457 0.095 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -176.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 262' ' ' SER . 0.7 OUTLIER -150.65 20.84 0.81 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.229 1.014 . . . . 0.0 108.304 175.03 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -172.02 115.07 0.34 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.35 -171.325 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.89 162.59 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.514 -172.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -119.79 120.04 35.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.052 0.453 . . . . 0.0 110.014 171.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.459 HG21 HD11 ' A' ' 273' ' ' ILE . 27.6 pt -119.87 171.59 8.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.047 -177.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . 0.429 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 12.7 t -150.05 142.2 15.51 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.235 175.342 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.18 -179.53 27.42 Favored 'Cis proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.764 -1.348 . . . . 0.0 113.135 -1.563 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 31.0 ttmt -78.85 121.39 83.39 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.161 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 16.2 Cg_exo -67.25 109.5 1.78 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.697 2.265 . . . . 0.0 111.902 175.373 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.7 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.3 OUTLIER -130.2 127.3 62.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.58 178.161 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -77.26 129.2 35.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.195 -177.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 44.6 tp -73.86 -26.4 60.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.664 178.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -86.25 3.97 40.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.266 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -65.61 125.09 24.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.119 177.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 31.3 m -84.46 -6.42 10.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 17.3 m -91.49 -29.25 17.11 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.61 0.243 . . . . 0.0 111.248 -173.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 1.7 pp -73.4 167.38 21.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.405 0.622 . . . . 0.0 111.79 -179.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.43 ' H ' ' NE2' ' A' ' 324' ' ' GLN . 5.8 m -99.23 160.96 26.25 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.198 -177.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.459 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 46.5 Cg_exo -39.97 -52.94 2.61 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.578 2.852 . . . . 0.0 114.165 178.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -61.37 -34.02 74.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.05 0.453 . . . . 0.0 111.187 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.5 ' OE1' ' HD2' ' A' ' 238' ' ' PRO . 45.7 mt-30 -67.45 -25.07 65.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.025 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.459 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 44.8 mtm180 -63.31 -36.05 82.39 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.06 0.457 . . . . 0.0 110.042 175.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -63.54 -31.06 72.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.067 179.25 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -87.51 -10.53 51.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.392 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.7 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -69.79 146.99 51.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.699 0.285 . . . . 0.0 111.267 -177.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . 0.447 ' OD1' HG13 ' A' ' 330' ' ' VAL . 3.3 p30 -134.39 -36.6 0.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -174.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.447 HG13 ' OD1' ' A' ' 329' ' ' ASN . 34.5 m -101.75 170.1 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.935 -178.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -82.89 -47.4 11.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.886 0.374 . . . . 0.0 110.83 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 72.1 p -124.72 141.48 52.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.768 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 34.9 m -70.66 171.81 9.75 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.091 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 20.5 tp -71.72 103.12 2.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.093 0.473 . . . . 0.0 110.065 -175.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.58 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -91.51 -177.89 4.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.331 179.303 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -73.53 151.02 41.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.937 0.399 . . . . 0.0 110.867 -178.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 66.15 29.01 10.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.198 179.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.7 mmt -88.67 127.02 35.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -82.7 130.68 35.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.989 0.423 . . . . 0.0 111.323 -176.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 13.8 t -92.36 120.08 40.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.427 178.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -125.96 128.4 47.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.119 -175.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 9.6 mt -93.6 134.1 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 172.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . 0.515 HD11 HG21 ' A' ' 294' ' ' THR . 69.8 mt . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.145 179.032 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 60.55 54.98 32.6 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.897 -178.253 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.455 HG21 ' O ' ' A' ' 263' ' ' ALA . 55.9 mt -102.11 146.26 10.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 7.7 p -97.7 147.35 24.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.536 0.684 . . . . 0.0 111.903 -177.424 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.642 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.7 p -59.81 150.94 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.708 -178.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.9 t -97.96 74.63 2.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 79.99 158.69 16.89 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.596 179.617 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.51 146.58 53.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.709 0.29 . . . . 0.0 110.431 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -155.93 136.3 13.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.155 0.503 . . . . 0.0 110.721 -179.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.1 p -118.97 122.1 41.45 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.805 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.58 ' O ' HG12 ' A' ' 313' ' ' VAL . 54.3 m-85 -88.74 147.59 24.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.394 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 320' ' ' LEU . 34.4 mmtp -127.28 139.85 36.3 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.023 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.514 ' HD3' HG11 ' A' ' 313' ' ' VAL . 74.3 Cg_endo . . . . . 0 N--CA 1.453 -0.902 0 C-N-CA 122.922 2.415 . . . . 0.0 110.993 173.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.812 0.339 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -140.08 131.63 27.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.192 175.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.3 OUTLIER -101.02 102.6 13.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.093 0.473 . . . . 0.0 110.226 179.862 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.441 ' O ' ' HD2' ' A' ' 305' ' ' HIS . 3.3 t -82.48 120.87 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.059 -172.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 9.6 m -91.2 105.51 17.85 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.197 -179.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.439 HD22 HG21 ' A' ' 340' ' ' VAL . 19.3 mt -126.61 163.71 22.85 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -175.571 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 10.4 t -63.18 -49.17 75.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.191 0.52 . . . . 0.0 109.704 -178.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.455 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.08 138.22 40.14 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.41 HG22 ' HB2' ' A' ' 261' ' ' LEU . 15.8 p -130.51 25.22 5.11 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.84 0.828 . . . . 0.0 109.087 175.626 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.2 m -76.64 147.48 37.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.295 175.134 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.0 -18.82 56.57 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -175.021 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 56.8 mtt -87.03 139.58 30.43 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 11.5 ptmm? -143.75 145.46 32.41 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.035 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -46.34 122.6 4.14 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.921 0.763 . . . . 0.0 112.891 -170.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 98.36 18.85 24.99 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.689 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.575 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.1 t70 -100.08 -176.92 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.926 0.393 . . . . 0.0 110.749 -176.513 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.486 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 3.7 tppp? -122.69 116.27 23.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.225 -175.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.483 HD11 HG21 ' A' ' 308' ' ' ILE . 17.9 pt -120.21 139.9 46.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 120.916 0.389 . . . . 0.0 110.326 175.652 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 54.8 p -124.1 141.06 52.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.008 179.188 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -107.47 111.06 23.18 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.874 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.47 119.24 10.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.605 -178.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.26 -34.1 5.35 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.137 -0.554 . . . . 0.0 111.794 -178.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 70.6 t -90.93 137.15 22.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 177.044 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 279' ' ' LYS . 8.3 ptpt -159.97 160.79 33.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.076 0.465 . . . . 0.0 111.548 178.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -78.37 154.25 30.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.729 -172.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 315' ' ' LEU . 65.8 mt . . . . . 0 C--N 1.325 -0.496 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.456 179.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 . . . . . 0 C--O 1.233 0.218 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -59.14 111.19 1.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.048 -172.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.486 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 0.8 OUTLIER -94.3 123.39 37.67 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.795 176.32 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -121.39 148.57 44.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.407 178.153 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.6 m -91.62 122.22 33.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.722 178.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 271' ' ' ASP . 11.3 p -73.21 121.5 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.388 0.613 . . . . 0.0 110.112 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.2 t -84.53 -41.59 16.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.447 -178.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.532 ' HD2' ' OE2' ' A' ' 307' ' ' GLU . 0.9 OUTLIER -165.55 136.22 3.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.825 -175.749 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 84.4 t -90.17 111.77 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.416 175.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 14.9 t -78.09 -58.94 3.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.78 -173.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -116.87 -3.39 11.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.904 0.383 . . . . 0.0 111.8 -172.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 69.3 12.86 66.75 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -170.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.8 p -145.6 16.79 1.47 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 174.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.441 ' HD2' ' O ' ' A' ' 259' ' ' VAL . 5.6 t-160 -170.89 118.32 0.49 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.631 -1.168 . . . . 0.0 107.865 -170.316 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -118.73 156.97 20.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -173.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.532 ' OE2' ' HD2' ' A' ' 299' ' ' ARG . 10.8 pt-20 -114.26 122.14 45.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.126 0.488 . . . . 0.0 109.864 171.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.483 HG21 HD11 ' A' ' 273' ' ' ILE . 33.6 pt -118.88 175.01 4.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.232 -177.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 15.1 t -154.23 138.34 11.06 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.071 174.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.61 -178.94 25.51 Favored 'Cis proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.909 -1.288 . . . . 0.0 112.806 -1.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 22.0 ttmm -80.24 131.28 62.83 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.044 -179.146 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 3.7 Cg_exo -75.73 108.44 2.69 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.249 1.966 . . . . 0.0 111.496 173.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.684 HG23 ' HA ' ' A' ' 328' ' ' ALA . 1.0 OUTLIER -126.02 136.58 60.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.106 177.557 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -91.95 138.03 31.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.348 0.594 . . . . 0.0 112.292 -170.188 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.422 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.3 tm? -80.77 -31.73 35.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.185 178.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -85.38 8.18 19.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.265 -177.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . 0.507 ' OD2' ' HG ' ' A' ' 320' ' ' LEU . 23.5 t70 -83.22 129.52 35.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.203 179.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 11.9 p -84.8 -19.62 8.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.804 0.335 . . . . 0.0 111.268 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 36.8 t -69.66 -42.97 73.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.36 -172.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.557 HD13 ' HG2' ' A' ' 325' ' ' ARG . 0.4 OUTLIER -76.92 152.08 35.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.485 0.659 . . . . 0.0 111.165 176.426 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.479 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 18.1 m -86.1 163.18 44.02 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.151 -173.526 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 41.6 Cg_exo -37.59 -54.37 1.25 Allowed 'Trans proline' 0 C--N 1.356 0.974 0 C-N-CA 124.306 3.337 . . . . 0.0 114.889 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -64.96 -34.04 77.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.945 0.402 . . . . 0.0 111.235 -176.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 53.8 mt-30 -69.18 -32.74 72.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.032 0.444 . . . . 0.0 109.906 177.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.557 ' HG2' HD13 ' A' ' 320' ' ' LEU . 98.2 mtt180 -65.7 -26.71 67.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.744 175.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -72.64 -20.19 61.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.143 0.496 . . . . 0.0 110.609 176.399 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -97.56 -0.36 45.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.738 176.086 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.684 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -65.8 132.7 49.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.005 0.431 . . . . 0.0 111.078 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -108.29 -32.17 7.58 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.901 -172.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.59 172.83 6.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.668 -177.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -86.23 -48.68 8.33 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.647 0.26 . . . . 0.0 111.452 -178.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.7 t -118.32 149.72 40.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.038 0.447 . . . . 0.0 110.875 -175.784 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 28.7 p -79.75 174.21 11.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.815 176.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.44 HD12 ' HG3' ' A' ' 338' ' ' MET . 15.9 tp -78.27 103.7 8.37 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -176.216 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.642 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.52 174.69 11.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.743 -178.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -81.55 10.41 5.96 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.178 0.806 . . . . 0.0 113.178 -168.254 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -141.01 33.58 1.75 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.915 0.388 . . . . 0.0 111.318 177.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.44 ' HG3' HD12 ' A' ' 334' ' ' LEU . 14.3 mmt -86.19 131.75 34.17 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -86.18 130.87 34.38 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.774 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.439 HG21 HD22 ' A' ' 261' ' ' LEU . 18.1 t -104.75 111.64 35.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.829 178.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -126.04 136.65 53.2 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.67 -177.226 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 17.7 mt -85.25 121.15 36.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.924 0.393 . . . . 0.0 110.64 175.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 41.1 mt . . . . . 0 C--N 1.323 -0.575 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.788 175.772 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 29.8 p . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 119.918 -0.087 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 52.76 53.23 34.03 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.644 176.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 263' ' ' ALA . 42.6 mm -102.85 140.22 21.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -177.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.3 p -121.5 159.34 26.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.957 0.408 . . . . 0.0 110.808 175.18 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.614 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.0 p -80.78 150.4 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.236 177.372 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 75.1 m -116.1 86.26 2.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.219 0.533 . . . . 0.0 110.423 176.004 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 94.51 138.55 9.38 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.398 179.592 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.29 132.09 46.5 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.002 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -141.6 127.36 19.2 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.425 0.631 . . . . 0.0 111.067 -175.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.9 p -117.87 114.61 23.5 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.129 179.095 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -81.1 164.02 22.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.075 -178.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . 44.8 mmtm -135.78 130.76 18.84 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.85 0.357 . . . . 0.0 111.348 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.551 ' HD3' HG11 ' A' ' 313' ' ' VAL . 71.7 Cg_endo . . . . . 0 N--CA 1.449 -1.126 0 C-N-CA 122.885 2.39 . . . . 0.0 111.685 177.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.514 ' CE1' HG21 ' A' ' 298' ' ' VAL . 56.7 m-85 . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.004 0.431 . . . . 0.0 110.716 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.17 137.21 38.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.597 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.0 OUTLIER -97.69 107.15 19.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.268 0.556 . . . . 0.0 110.671 -177.889 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.47 ' HB ' HG22 ' A' ' 306' ' ' VAL . 3.1 t -89.41 124.22 42.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.408 -172.765 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 37.5 m -93.63 107.4 19.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.162 177.596 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.427 HD23 HG23 ' A' ' 230' ' ' VAL . 27.9 mt -124.64 172.12 9.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.422 -174.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.3 m -64.83 -53.69 42.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.37 0.605 . . . . 0.0 109.871 179.396 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.562 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -135.95 130.56 33.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.391 179.038 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.449 ' HB ' ' CG1' ' A' ' 306' ' ' VAL . 6.9 p -129.59 22.66 5.48 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.867 0.841 . . . . 0.0 108.817 174.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 15.5 m -80.59 145.37 31.77 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.564 176.17 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.99 -9.91 61.81 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -175.672 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . 0.461 ' HG2' HD11 ' A' ' 342' ' ' ILE . 57.9 mtt -93.88 151.8 19.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.007 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.52 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 1.9 ptpp? -147.34 157.15 43.47 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.396 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -52.36 117.23 2.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.152 0.501 . . . . 0.0 110.832 -178.074 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 106.28 18.43 11.17 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.741 -177.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.52 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 7.4 m-20 -99.78 159.16 15.27 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 117.236 0.518 . . . . 0.0 110.167 176.721 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -111.62 116.75 31.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.986 -178.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.535 HD11 HG21 ' A' ' 308' ' ' ILE . 34.6 pt -113.19 140.67 32.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.217 178.609 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.448 ' HB3' HG22 ' A' ' 294' ' ' THR . 22.0 p -123.14 139.98 53.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.22 178.822 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.437 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 93.1 m-85 -103.57 111.34 23.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.037 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.2 113.03 4.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.146 -176.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.34 -24.98 12.97 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.641 -178.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 90.6 t -97.5 128.18 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 177.296 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 292' ' ' ASP . 15.0 ptpt -160.46 179.73 8.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.2 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -68.56 174.89 3.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.183 -172.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 75.7 mt . . . . . 0 C--N 1.326 -0.429 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -171.438 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 279' ' ' LYS . 14.9 m-20 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -64.54 105.19 0.91 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.294 -175.19 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 274' ' ' SER . 15.8 p -90.93 132.66 35.81 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.597 177.007 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.408 ' CG ' HD12 ' A' ' 308' ' ' ILE . 97.7 m-85 -129.79 150.78 50.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.427 179.305 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 20.1 m -96.65 125.06 40.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.122 178.56 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 271' ' ' ASP . 12.4 p -80.82 138.07 20.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.161 0.505 . . . . 0.0 110.61 -179.484 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.514 HG21 ' CE1' ' A' ' 256' ' ' PHE . 45.3 t -104.75 -29.53 2.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.021 -178.822 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -164.1 137.2 5.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.017 0.437 . . . . 0.0 111.171 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 87.5 t -95.75 112.19 27.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 45.1 t -75.8 -58.79 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.909 -172.251 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -123.35 -3.06 8.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.298 0.57 . . . . 0.0 111.215 -175.753 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 78.37 13.87 82.8 Favored Glycine 0 C--N 1.322 -0.24 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -173.225 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 27.1 p -142.18 14.57 2.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.273 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.452 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.3 t-160 -164.02 117.45 1.44 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.491 -169.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.6 m -118.46 164.67 14.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -175.459 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.2 pt-20 -125.46 123.32 38.98 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 169.478 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.535 HG21 HD11 ' A' ' 273' ' ' ILE . 23.4 pt -124.44 164.3 23.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.045 -173.092 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . 0.432 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 8.2 t -135.57 140.19 33.28 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.637 174.693 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.8 179.55 30.17 Favored 'Cis proline' 0 CA--C 1.531 0.355 0 C-N-CA 123.187 -1.589 . . . . 0.0 112.655 -1.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.462 ' HG2' HG13 ' A' ' 313' ' ' VAL . 31.1 ttmt -70.81 119.53 73.59 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.742 177.575 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.466 ' HD2' ' CB ' ' A' ' 257' ' ' ALA . 38.1 Cg_endo -69.5 108.94 2.14 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.436 2.091 . . . . 0.0 111.65 175.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.714 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.2 OUTLIER -135.43 135.31 51.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.825 -178.497 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -83.4 129.76 35.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.251 -176.516 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.1 tm? -68.86 -26.07 64.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.45 178.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -99.31 18.3 17.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.103 -179.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . 0.441 ' HB3' ' CD2' ' A' ' 320' ' ' LEU . 9.9 t0 -65.47 130.85 44.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.726 178.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 30.4 m -83.16 1.98 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -173.194 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 14.2 t -125.78 28.34 6.2 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.064 -0.654 . . . . 0.0 112.441 -176.086 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.638 HD13 ' HG2' ' A' ' 325' ' ' ARG . 0.7 OUTLIER -123.54 164.76 18.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.131 0.491 . . . . 0.0 111.551 175.43 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.44 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.3 m -101.92 164.92 14.88 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.678 -179.284 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 86.4 Cg_exo -44.19 -50.18 7.96 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.641 2.894 . . . . 0.0 114.537 -176.623 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -66.34 -27.7 68.09 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -177.383 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 49.8 mt-30 -71.6 -28.9 64.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.005 0.431 . . . . 0.0 109.976 177.785 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.638 ' HG2' HD13 ' A' ' 320' ' ' LEU . 55.8 mtp180 -70.82 -18.93 62.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.434 178.019 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -74.52 -32.7 62.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.288 176.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -85.51 -4.25 59.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.742 177.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.714 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -63.3 159.62 17.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.06 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -138.65 -49.15 0.52 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.831 0.348 . . . . 0.0 111.244 -175.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.2 m -105.72 161.67 5.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.647 -175.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -91.78 -5.46 53.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.01 -176.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 8.0 t -147.73 136.3 21.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.527 -176.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.1 p -80.11 163.56 24.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.365 178.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 19.2 tp -70.57 106.09 3.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.968 0.413 . . . . 0.0 110.724 -173.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.614 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -79.53 173.53 12.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.81 -178.449 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -81.05 4.04 21.16 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -166.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -143.62 45.7 1.49 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.064 0.459 . . . . 0.0 111.421 176.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.444 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 22.8 mmt -92.17 143.56 26.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.214 178.018 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.42 138.45 33.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.422 179.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.544 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 19.1 t -112.9 116.96 54.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.14 0.495 . . . . 0.0 109.91 -178.603 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -125.41 138.9 54.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.891 -175.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.461 HD11 ' HG2' ' A' ' 267' ' ' MET . 21.7 mt -96.65 132.68 40.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.68 0.276 . . . . 0.0 110.452 174.637 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 54.9 mt . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.193 176.563 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 33.9 p . . . . . 0 N--CA 1.447 -0.58 0 CA-C-O 121.084 0.468 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.0 61.24 0.43 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 177.054 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.658 HG21 ' O ' ' A' ' 263' ' ' ALA . 23.7 mt -102.87 154.24 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.583 0.23 . . . . 0.0 110.841 -174.065 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 18.9 p -114.75 171.25 7.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.142 0.496 . . . . 0.0 111.571 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.533 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.1 p -87.35 150.15 3.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.87 -178.227 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 62.2 m -114.98 91.44 3.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.827 0.346 . . . . 0.0 110.393 175.638 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 90.46 161.41 37.41 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.143 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -83.27 117.73 23.17 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.934 0.397 . . . . 0.0 110.15 178.651 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -109.07 126.37 53.09 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.097 0.475 . . . . 0.0 109.958 179.672 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 10.2 p -121.29 125.63 47.52 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.618 -178.318 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.584 ' HB2' ' O ' ' A' ' 312' ' ' PRO . 86.2 m-85 -109.08 145.43 35.66 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.899 -179.118 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -133.4 144.27 51.61 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.984 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.45 ' HD2' HE21 ' A' ' 324' ' ' GLN . 59.9 Cg_endo . . . . . 0 N--CA 1.456 -0.713 0 C-N-CA 122.169 1.912 . . . . 0.0 110.863 173.18 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 . . . . . 0 CA--C 1.521 -0.147 0 CA-C-O 120.726 0.298 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -107.59 117.29 33.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.57 178.044 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 4.1 m -89.68 109.19 20.18 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.034 0.445 . . . . 0.0 110.314 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.0 t -92.73 122.27 44.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.593 -172.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 25.2 m -91.33 115.05 27.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.948 175.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 26.0 mt -132.78 172.41 12.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.273 -175.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 14.9 m -62.95 -56.48 16.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.476 0.655 . . . . 0.0 109.503 177.547 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.658 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -136.93 140.99 42.66 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.8 177.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 10.9 p -131.39 23.15 4.77 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.283 1.04 . . . . 0.0 108.205 173.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 7.6 m -77.93 142.64 38.26 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.859 -1.519 . . . . 0.0 109.649 176.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 97.96 -15.16 62.01 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -175.692 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 61.7 mtt -89.15 151.07 22.4 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -135.44 164.24 28.22 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -62.62 140.24 58.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.867 179.237 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.93 19.04 62.03 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.829 173.059 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.498 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 1.2 t70 -105.74 -166.73 1.24 Allowed 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 118.038 0.919 . . . . 0.0 110.458 -178.293 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -125.54 116.28 21.52 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.702 -178.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.466 HD11 HG21 ' A' ' 308' ' ' ILE . 19.6 pt -113.69 139.69 37.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.49 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.491 ' OG ' HG22 ' A' ' 294' ' ' THR . 2.9 m -122.19 140.39 52.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.486 -175.117 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -105.97 111.41 24.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.334 178.273 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -71.5 117.93 13.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.27 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.79 -17.55 22.76 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.611 -176.254 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.53 124.24 71.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -138.86 165.23 27.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.917 0.389 . . . . 0.0 111.757 -176.042 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -82.57 148.39 28.07 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.323 -176.226 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.714 -176.775 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.771 0.319 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.623 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -66.77 81.84 0.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.316 -177.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.491 HG22 ' OG ' ' A' ' 274' ' ' SER . 12.6 p -85.07 89.69 7.68 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.309 177.485 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.623 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 51.1 m-85 -96.03 149.24 21.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.279 0.561 . . . . 0.0 111.364 -176.171 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.9 m -91.51 126.76 36.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.969 -179.458 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.498 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 8.7 p -87.77 141.52 14.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.184 -178.346 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 13.3 p -104.78 -26.01 3.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.714 179.339 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -170.34 146.82 2.94 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.931 0.396 . . . . 0.0 111.086 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.69 121.0 41.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 169.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.22 -58.03 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.932 -172.544 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -129.02 -5.23 5.01 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.285 0.564 . . . . 0.0 111.631 -175.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.27 12.01 81.33 Favored Glycine 0 CA--C 1.518 0.247 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -175.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 22.2 p -145.05 16.24 1.55 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 171.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.9 t-160 -169.29 117.92 0.65 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.092 -1.413 . . . . 0.0 107.59 -167.264 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.6 m -119.58 168.57 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 117.706 0.23 . . . . 0.0 110.736 -174.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -126.18 118.18 24.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.259 0.552 . . . . 0.0 110.026 171.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.466 HG21 HD11 ' A' ' 273' ' ' ILE . 35.1 pt -119.84 174.28 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.341 -176.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.2 t -154.65 143.07 14.5 Favored Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.461 176.407 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -76.18 -179.12 25.96 Favored 'Cis proline' 0 C--N 1.345 0.344 0 C-N-CA 124.105 -1.206 . . . . 0.0 112.909 -3.076 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.454 ' HD3' ' HB3' ' A' ' 236' ' ' PHE . 2.5 ttmp? -75.09 132.1 77.46 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.12 -178.093 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.584 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 9.3 Cg_exo -71.82 108.15 2.37 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.326 2.017 . . . . 0.0 111.192 173.381 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 329' ' ' ASN . 4.4 m -130.11 128.01 64.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.788 -177.709 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -87.66 141.56 28.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.307 0.575 . . . . 0.0 112.238 -172.728 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -81.0 -28.8 35.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.996 -179.305 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -100.31 20.66 14.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.671 -176.336 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 11.6 t70 -83.38 124.08 30.3 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.277 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 9.3 p -82.96 -11.96 12.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.874 0.369 . . . . 0.0 111.608 -175.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 15.7 m -86.66 0.74 53.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.693 -172.708 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 1.5 pp -106.77 169.83 8.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.829 0.347 . . . . 0.0 111.312 179.508 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 28.2 t -85.88 148.03 47.29 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.539 175.383 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -42.72 -43.99 8.79 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.112 2.541 . . . . 0.0 113.662 -177.683 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -61.01 -29.99 70.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.958 0.408 . . . . 0.0 111.465 -178.139 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.45 HE21 ' HD2' ' A' ' 238' ' ' PRO . 18.8 mt-30 -71.16 -25.55 62.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.509 -178.582 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -62.67 -34.99 78.24 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.214 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.37 -24.06 65.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.948 178.296 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -103.21 11.82 36.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 177.823 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -73.89 164.87 26.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.865 178.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . 0.424 ' N ' HG23 ' A' ' 313' ' ' VAL . 50.4 t30 -139.99 -43.53 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.606 -172.655 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.6 m -111.21 175.33 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.698 0.285 . . . . 0.0 111.02 -178.663 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -80.48 -50.22 10.35 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.699 0.285 . . . . 0.0 111.454 -177.112 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.7 t -130.91 151.83 50.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.413 -177.983 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 49.0 m -71.4 167.47 19.51 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 174.004 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 27.8 tp -70.91 103.71 2.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 110.147 -176.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.533 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -89.76 -170.92 2.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.194 178.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -76.86 162.48 27.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.855 0.36 . . . . 0.0 110.705 -179.336 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 58.31 45.97 16.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.089 178.409 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.511 ' H ' HG12 ' A' ' 230' ' ' VAL . 24.8 mmt -114.61 131.04 56.84 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.339 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -85.53 138.98 31.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.008 -179.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 14.2 t -113.12 114.47 47.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.649 178.386 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -132.22 138.49 47.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.808 0.337 . . . . 0.0 111.813 -173.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.432 ' CG1' HG22 ' A' ' 273' ' ' ILE . 21.4 mt -91.6 123.29 43.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.846 174.537 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 59.2 mt . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.282 178.809 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 38.9 p . . . . . 0 N--CA 1.45 -0.435 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.82 50.92 62.45 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.359 178.3 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.496 ' HB ' ' HB ' ' A' ' 340' ' ' VAL . 48.0 mm -89.29 144.35 9.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -178.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 23.2 p -122.39 156.66 33.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.297 0.57 . . . . 0.0 111.262 176.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.61 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.1 p -73.84 151.16 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.043 179.395 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.3 t -115.37 64.62 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.208 0.528 . . . . 0.0 109.983 178.124 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 106.11 149.67 17.59 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.323 -179.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -59.37 125.49 23.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.904 0.383 . . . . 0.0 111.127 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 334' ' ' LEU . 26.3 mm-40 -113.24 126.6 55.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.961 0.41 . . . . 0.0 110.269 179.133 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 p -122.97 105.04 9.63 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.131 177.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -89.55 146.78 24.35 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.168 -173.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -144.08 121.12 6.54 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.776 178.719 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo . . . . . 0 N--CA 1.453 -0.893 0 C-N-CA 122.777 2.318 . . . . 0.0 110.694 168.144 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.48 122.57 43.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.556 0.217 . . . . 0.0 111.135 -177.724 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.4 m -96.31 107.38 19.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.044 0.45 . . . . 0.0 110.104 -179.526 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.5 t -92.91 119.32 40.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.767 -171.107 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 18.5 m -89.74 106.19 18.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.18 0.514 . . . . 0.0 109.983 174.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.45 ' HB2' ' CG2' ' A' ' 264' ' ' THR . 30.1 mt -121.29 169.37 10.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.058 -176.142 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 30.2 p -67.53 -48.26 67.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.334 0.588 . . . . 0.0 109.881 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.492 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -135.77 130.3 33.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.472 178.279 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.45 ' CG2' ' HB2' ' A' ' 261' ' ' LEU . 4.8 p -132.47 17.93 4.38 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.314 173.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 39.4 m -84.2 147.26 27.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.31 174.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 92.96 -5.48 75.98 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -171.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 70.9 mtp -108.67 138.66 44.63 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -137.7 154.33 49.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.779 0.323 . . . . 0.0 110.547 -178.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.455 ' HA ' HG13 ' A' ' 297' ' ' VAL . 26.2 ptt180 -59.61 135.32 57.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.64 -174.503 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 102.86 18.32 15.96 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.728 -0.749 . . . . 0.0 113.027 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.539 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 2.7 t0 -113.82 -169.57 1.54 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 117.369 0.585 . . . . 0.0 109.814 177.314 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.484 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 4.7 tppp? -124.18 116.56 22.91 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.592 -178.125 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.542 HD11 HG21 ' A' ' 308' ' ' ILE . 15.6 pt -117.19 140.48 39.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 120.131 -0.627 . . . . 0.0 109.965 179.106 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 44.2 p -126.21 150.87 48.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.145 -178.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.481 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 89.0 m-85 -111.83 111.32 22.2 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.065 -178.862 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.01 111.98 3.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 -178.032 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 113.67 -35.52 4.48 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -178.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 97.6 t -87.06 110.83 20.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -137.14 179.48 6.36 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.328 -174.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -69.08 172.81 6.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.109 -177.389 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 73.6 mt . . . . . 0 C--N 1.326 -0.446 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -175.001 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 120.747 0.308 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.458 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -61.31 107.3 0.74 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.006 -177.392 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.484 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 61.2 p -95.01 125.35 39.61 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.572 -179.491 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.48 ' CE2' ' HG3' ' A' ' 312' ' ' PRO . 88.1 m-85 -128.18 152.92 47.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.103 0.478 . . . . 0.0 111.132 -179.316 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 41.9 m -92.1 125.79 36.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.312 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.539 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.0 p -76.98 127.74 37.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.085 0.469 . . . . 0.0 110.415 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 23.4 t -100.59 -35.72 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.202 -175.594 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 299' ' ' ARG . 6.8 tpt180 -164.32 142.57 7.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 111.124 -179.107 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 94.5 t -102.69 117.84 48.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 170.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 46.0 t -77.19 -55.7 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.122 -172.369 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -128.49 -1.27 5.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.057 0.456 . . . . 0.0 111.604 -175.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 83.25 14.31 74.68 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.216 -176.501 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 1.8 p -145.97 19.93 1.44 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 171.449 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.413 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.7 t-160 -165.71 115.75 1.03 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.476 -171.584 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.2 m -119.05 164.89 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 110.235 -0.284 . . . . 0.0 110.235 -174.585 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 10.9 pt-20 -125.48 132.02 52.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.118 0.485 . . . . 0.0 109.9 169.673 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.542 HG21 HD11 ' A' ' 273' ' ' ILE . 21.5 pt -125.38 164.32 24.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.363 -176.347 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.4 t -141.86 141.16 21.26 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.714 175.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.75 -179.61 27.04 Favored 'Cis proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.964 -1.265 . . . . 0.0 112.532 -3.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 31.4 ttmt -86.31 126.25 65.32 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.48 ' HG3' ' CE2' ' A' ' 295' ' ' PHE . 8.7 Cg_exo -70.07 112.14 3.05 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.875 2.384 . . . . 0.0 112.712 178.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.622 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -119.39 128.94 75.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.789 172.661 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.692 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -88.02 138.72 31.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.906 -176.12 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 325' ' ' ARG . 3.0 tm? -68.53 -28.63 67.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.689 178.679 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -92.44 10.03 31.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.755 -179.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 9.9 t70 -72.57 122.22 21.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.996 0.426 . . . . 0.0 109.909 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.2 m -84.49 2.32 4.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.225 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.7 p -119.84 29.17 7.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -174.343 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 2.0 pp -128.74 161.22 30.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.061 0.458 . . . . 0.0 111.633 176.418 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 19.7 m -85.24 162.03 50.16 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.323 -177.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.49 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 96.0 Cg_exo -46.0 -46.3 16.21 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.32 2.68 . . . . 0.0 113.927 -177.649 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.23 -33.07 75.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.679 0.276 . . . . 0.0 111.267 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.497 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 50.9 mt-30 -69.32 -35.95 76.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.235 -177.052 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 8.0 ptp180 -74.8 -23.54 58.5 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.089 0.471 . . . . 0.0 110.206 178.91 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -72.03 -18.65 61.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.129 175.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -109.21 11.15 25.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.505 175.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.622 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -67.36 142.44 56.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.514 177.06 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . 0.413 ' OD1' HG13 ' A' ' 330' ' ' VAL . 5.6 p30 -125.39 -20.55 4.76 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -175.424 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.1 m -115.45 155.09 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.728 179.426 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -91.98 -2.48 56.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.781 -174.18 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 14.7 t -162.4 152.79 16.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.803 0.335 . . . . 0.0 110.254 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.0 p -86.88 165.56 15.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.114 179.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 234' ' ' GLN . 18.0 tp -68.27 108.0 3.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -177.483 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.61 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.35 -177.92 6.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.286 -177.122 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.48 1.49 29.13 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -172.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -147.87 54.94 1.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.224 0.535 . . . . 0.0 111.395 177.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.441 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 22.8 mmt -101.33 142.52 32.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.799 176.102 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.64 140.55 30.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.467 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 22.0 t -114.66 120.11 63.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.312 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -136.78 144.26 43.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.85 0.357 . . . . 0.0 111.147 -175.436 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 31.3 mt -93.86 128.47 45.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.71 178.093 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.566 -179.809 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 29.0 p . . . . . 0 N--CA 1.446 -0.652 0 CA-C-O 121.489 0.661 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -109.8 52.15 0.66 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 173.281 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.555 HG21 ' O ' ' A' ' 263' ' ' ALA . 22.7 mt -93.66 159.07 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.273 -0.463 . . . . 0.0 110.275 -173.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 13.3 p -118.23 153.42 33.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.281 0.563 . . . . 0.0 111.332 179.048 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.673 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.3 p -66.74 152.58 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.83 177.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.5 t -114.99 78.92 1.21 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.13 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 101.58 151.07 24.23 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.699 179.574 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -85.63 141.54 29.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.463 0.173 . . . . 0.0 110.609 179.579 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -157.62 150.47 23.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.159 0.504 . . . . 0.0 111.771 -177.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 38.4 p -153.39 102.33 2.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.994 172.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -80.61 143.9 32.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.775 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -107.51 134.46 19.98 Favored Pre-proline 0 C--N 1.323 -0.577 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.264 -177.228 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 N--CA 1.449 -1.113 0 C-N-CA 122.747 2.298 . . . . 0.0 110.647 169.065 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.824 0.345 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.27 132.91 53.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 177.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.4 m -94.85 114.27 26.12 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.041 0.448 . . . . 0.0 110.368 178.52 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.9 t -93.76 122.27 45.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.282 -173.882 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 3.0 m -94.0 106.7 18.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.049 179.527 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.551 HD23 HG23 ' A' ' 230' ' ' VAL . 23.1 mt -126.35 168.14 14.56 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.412 -174.026 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.6 t -63.25 -54.87 30.5 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.555 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.09 136.84 38.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.266 178.543 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.437 HG22 HD12 ' A' ' 261' ' ' LEU . 15.9 p -129.7 25.27 5.36 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.028 0.918 . . . . 0.0 108.558 175.23 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 17.4 m -82.96 153.44 25.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.284 -1.326 . . . . 0.0 109.712 176.885 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 90.7 -6.44 82.05 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -174.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . 0.415 ' HG2' HD11 ' A' ' 342' ' ' ILE . 47.8 mtt -104.3 147.45 27.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.828 -0.686 . . . . 0.0 109.314 178.524 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 0.0 OUTLIER -139.62 158.05 44.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.307 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -54.47 132.65 45.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.182 0.515 . . . . 0.0 111.437 -176.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 95.11 19.03 31.98 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.099 -177.271 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.574 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.1 t0 -103.46 169.01 8.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.7 0.286 . . . . 0.0 110.289 -178.284 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -118.5 115.46 24.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.996 -178.137 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.488 HD11 HG21 ' A' ' 308' ' ' ILE . 30.0 pt -112.78 139.74 36.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.039 0.447 . . . . 0.0 110.061 179.52 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.41 ' OG ' HG22 ' A' ' 294' ' ' THR . 7.1 m -124.48 133.47 53.34 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.871 -179.188 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -100.0 111.42 23.72 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.206 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 339' ' ' ALA . . . -66.51 120.54 13.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.342 -179.2 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.95 -25.95 12.2 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -176.591 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.559 ' HA ' ' OG1' ' A' ' 332' ' ' THR . 47.0 t -100.28 119.74 48.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.772 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -136.34 157.48 46.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.035 0.445 . . . . 0.0 111.436 -173.585 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -72.94 118.87 16.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.245 179.714 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 331' ' ' ASN . 1.5 pt? . . . . . 0 C--N 1.323 -0.544 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 276' ' ' ALA . 49.4 m-20 . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -65.81 101.14 0.61 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.037 -178.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.41 HG22 ' OG ' ' A' ' 274' ' ' SER . 45.4 p -84.05 117.16 23.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.959 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -120.64 148.31 44.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.921 0.391 . . . . 0.0 110.624 177.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 8.5 m -94.88 127.75 41.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.257 -178.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 271' ' ' ASP . 7.4 p -79.9 134.02 28.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.271 0.558 . . . . 0.0 110.286 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.428 ' HB ' ' HG3' ' A' ' 307' ' ' GLU . 61.0 t -95.13 -38.7 9.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.859 -178.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -166.82 139.88 3.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.752 0.311 . . . . 0.0 110.235 -179.199 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 86.8 t -83.88 103.75 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.622 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 18.4 t -72.58 -58.21 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.024 -171.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -116.69 -9.98 11.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.98 0.419 . . . . 0.0 111.817 -174.828 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 78.03 11.39 85.43 Favored Glycine 0 CA--C 1.516 0.136 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -173.378 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 20.3 p -148.98 18.53 0.98 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 173.43 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.8 t-160 -169.43 113.59 0.53 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.006 -165.079 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.5 m -119.06 163.17 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 121.206 -0.198 . . . . 0.0 110.57 -173.413 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.428 ' HG3' ' HB ' ' A' ' 298' ' ' VAL . 11.5 pt-20 -116.92 128.5 55.29 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 171.255 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.488 HG21 HD11 ' A' ' 273' ' ' ILE . 29.8 pt -126.61 168.15 20.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.123 0.487 . . . . 0.0 111.938 -176.104 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.3 t -146.92 138.57 13.38 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.049 174.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.36 -179.66 27.75 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.815 -1.327 . . . . 0.0 112.721 -1.599 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 38.6 ttmt -79.51 124.07 84.03 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.258 -178.479 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 13.4 Cg_exo -68.86 113.44 3.22 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.972 2.448 . . . . 0.0 112.384 177.416 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.513 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -123.96 129.28 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.355 176.229 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 317' ' ' ASP . . . -86.53 129.34 34.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.876 -177.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.83 -27.49 68.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.719 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -95.75 15.19 20.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 10.2 t70 -81.96 127.66 33.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.291 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.2 m -84.17 -3.48 7.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -174.027 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 14.7 m -96.82 1.38 50.62 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -174.676 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.0 OUTLIER -111.18 156.37 21.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.211 0.529 . . . . 0.0 111.403 178.515 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 16.0 m -94.07 165.7 17.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.11 -175.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 66.6 Cg_exo -42.96 -49.0 7.23 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 123.697 2.932 . . . . 0.0 114.253 -178.627 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -62.53 -39.51 93.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 0.0 110.949 -179.101 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 47.5 mt-30 -67.56 -33.25 74.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.309 179.592 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.458 ' HG2' HD13 ' A' ' 320' ' ' LEU . 83.2 mtt180 -60.86 -32.6 72.02 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.859 175.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -69.02 -25.11 64.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.677 179.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -95.52 -0.74 51.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 178.51 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.513 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -73.76 107.4 5.98 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.237 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . 0.504 ' ND2' HG13 ' A' ' 330' ' ' VAL . 5.6 p-10 -92.3 -5.38 52.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.157 -176.004 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.504 HG13 ' ND2' ' A' ' 329' ' ' ASN . 28.1 m -133.21 155.92 41.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.562 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.43 ' HB3' ' HB3' ' A' ' 281' ' ' LEU . 24.9 p-10 -93.99 -26.53 16.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.764 -178.669 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . 0.559 ' OG1' ' HA ' ' A' ' 278' ' ' VAL . 43.2 p -109.21 139.48 44.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.165 0.507 . . . . 0.0 111.311 -179.033 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 46.9 p -86.57 169.56 12.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.328 176.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.9 tp -74.91 102.22 4.69 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.673 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -82.3 165.86 20.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.961 -179.886 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -78.99 26.27 0.26 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -172.498 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -154.49 41.13 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.01 0.433 . . . . 0.0 110.911 176.111 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.463 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 23.4 mmt -99.32 149.66 22.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 177.786 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 276' ' ' ALA . . . -99.99 143.88 29.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.949 -179.111 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.5 t -110.91 115.8 50.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.143 -178.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -132.7 137.55 46.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.861 -177.273 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.415 HD11 ' HG2' ' A' ' 267' ' ' MET . 24.2 mt -97.9 129.5 48.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.718 178.375 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 59.8 mt . . . . . 0 C--N 1.325 -0.484 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.321 178.123 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 46.4 p . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 120.471 0.177 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -73.67 69.45 1.48 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.758 -177.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.502 HG21 ' O ' ' A' ' 263' ' ' ALA . 38.4 mt -102.33 152.6 5.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.477 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -99.86 169.6 9.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.392 0.615 . . . . 0.0 112.315 -177.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.632 HG11 ' O ' ' A' ' 335' ' ' ALA . 10.4 p -81.61 152.08 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.752 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.3 t -104.55 80.77 1.71 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 91.02 165.38 40.07 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.177 -179.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -96.33 136.88 36.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.603 0.239 . . . . 0.0 110.44 179.206 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -149.27 127.16 11.85 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.36 0.6 . . . . 0.0 111.327 179.602 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.513 ' HA ' ' HB3' ' A' ' 333' ' ' SER . 11.6 p -98.14 120.65 38.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.267 177.347 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.86 157.99 25.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.935 -175.435 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.408 ' HD2' ' HB3' ' A' ' 320' ' ' LEU . 46.6 mmtm -141.87 132.15 12.77 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.351 -179.498 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.612 ' HD3' HG11 ' A' ' 313' ' ' VAL . 70.6 Cg_endo . . . . . 0 N--CA 1.455 -0.762 0 C-N-CA 122.528 2.152 . . . . 0.0 112.063 178.438 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -113.88 114.36 26.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.307 177.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -84.16 103.02 13.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.432 0.634 . . . . 0.0 111.306 179.012 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.8 t -83.24 124.62 39.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.351 -177.273 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 6.1 m -97.82 105.77 17.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.912 178.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.473 ' HB2' HG22 ' A' ' 264' ' ' THR . 17.4 mt -123.04 165.76 16.26 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.998 -174.537 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.7 m -57.06 -56.71 18.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.434 0.635 . . . . 0.0 109.649 179.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.502 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -138.12 134.63 34.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.874 177.154 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 264' ' ' THR . . . . . 0.473 HG22 ' HB2' ' A' ' 261' ' ' LEU . 6.7 p -123.99 24.71 8.17 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.938 0.875 . . . . 0.0 108.723 175.132 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 44.9 m -75.4 131.79 40.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.16 173.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 110.48 -26.5 13.06 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -171.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -76.53 140.75 41.26 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 172.674 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -154.35 146.11 23.37 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.183 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.505 ' HA ' HG13 ' A' ' 297' ' ' VAL . 29.9 ptt180 -41.9 119.66 1.36 Allowed 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.149 0.906 . . . . 0.0 112.609 -173.334 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 110.33 -9.16 30.9 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.44 176.683 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.459 ' H ' HG12 ' A' ' 297' ' ' VAL . 2.4 p30 -77.06 -178.12 4.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.372 0.606 . . . . 0.0 111.943 -177.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.52 117.08 18.28 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.628 -178.598 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.435 HD11 HG21 ' A' ' 308' ' ' ILE . 35.5 pt -112.63 140.23 33.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.156 0.503 . . . . 0.0 110.763 179.342 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 22.7 t -121.32 145.29 48.03 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.559 178.49 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -112.33 111.46 22.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.023 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.65 120.24 15.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.591 -178.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.96 -34.24 5.19 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -178.068 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 96.1 t -90.29 115.68 30.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 173.235 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -131.46 151.41 51.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.033 0.444 . . . . 0.0 111.739 -173.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.533 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 77.5 m-85 -70.18 115.45 9.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.462 176.332 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 281' ' ' LEU . 2.3 pt? . . . . . 0 C--N 1.322 -0.611 0 CA-C-O 120.717 0.294 . . . . 0.0 111.114 -175.311 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 . . . . . 0 C--O 1.235 0.311 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.533 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -60.47 127.28 30.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.606 -174.531 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 29.3 p -120.03 122.95 42.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.591 -179.387 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.453 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 75.2 m-85 -133.78 152.28 51.83 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 11.9 t -96.28 134.8 38.94 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.41 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.505 HG13 ' HA ' ' A' ' 269' ' ' ARG . 4.7 p -69.79 139.98 19.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.145 178.733 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 50.2 t -104.67 -38.4 4.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.151 175.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -163.06 140.74 7.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.615 179.555 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.4 109.18 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.074 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.15 -59.61 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.017 -174.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -111.03 -13.62 14.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.291 0.567 . . . . 0.0 111.57 -175.026 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.22 13.99 77.74 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.255 -174.033 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 40.0 p -136.67 9.86 3.12 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 169.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.496 ' NE2' ' HB ' ' A' ' 258' ' ' THR . 2.2 t-160 -158.18 114.15 2.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.343 -1.299 . . . . 0.0 108.279 -168.749 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.2 m -118.69 150.98 20.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -177.011 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -111.06 117.05 32.24 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.182 0.515 . . . . 0.0 110.092 173.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.483 HG22 ' HA ' ' A' ' 297' ' ' VAL . 24.6 pt -116.67 172.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.069 -179.229 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.9 t -154.53 141.86 13.68 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.324 176.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.98 179.71 29.68 Favored 'Cis proline' 0 CA--C 1.531 0.337 0 C-N-CA 123.487 -1.464 . . . . 0.0 112.838 -3.06 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -83.87 128.03 64.83 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.58 -177.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.97 108.93 2.56 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.379 2.053 . . . . 0.0 111.727 174.459 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.697 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.8 OUTLIER -123.99 136.79 59.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.028 -179.063 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -86.88 138.27 31.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.54 0.686 . . . . 0.0 112.285 -173.041 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 315' ' ' LEU . . . . . 0.48 HD22 ' HB2' ' A' ' 325' ' ' ARG . 3.0 tm? -76.58 -33.67 58.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.253 178.594 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -89.2 13.99 11.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.256 -177.305 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . 0.454 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 11.3 t70 -73.13 123.27 23.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.034 179.266 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 11.8 p -83.75 -16.55 10.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.768 -175.825 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 14.4 m -80.61 -33.78 35.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.441 -172.086 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.5 pp -82.93 159.27 22.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.445 0.641 . . . . 0.0 112.084 -177.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.442 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 18.8 m -81.07 163.97 52.75 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.428 -178.5 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 67.2 Cg_exo -43.39 -52.86 4.69 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.503 2.802 . . . . 0.0 114.35 179.763 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.93 -28.54 70.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.09 0.471 . . . . 0.0 111.135 -177.15 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . 0.494 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 11.7 mm100 -69.22 -45.98 68.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.72 -179.008 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 325' ' ' ARG . . . . . 0.48 ' HB2' HD22 ' A' ' 315' ' ' LEU . 2.7 ptp180 -70.47 -21.15 62.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.857 0.361 . . . . 0.0 110.677 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -65.18 -28.4 69.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.983 0.421 . . . . 0.0 110.265 173.394 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -94.66 -0.2 54.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.002 179.575 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.697 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -60.85 149.87 34.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.422 178.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -124.75 -19.45 5.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.643 -176.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.0 m -127.99 163.61 31.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 331' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 281' ' ' LEU . 20.6 p-10 -83.77 -34.14 24.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.636 0.255 . . . . 0.0 111.337 -176.258 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 12.1 t -132.83 146.92 52.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.199 -178.589 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.513 ' HB3' ' HA ' ' A' ' 235' ' ' SER . 30.6 m -82.2 -175.86 5.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.749 -179.416 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.1 tp -75.99 103.81 6.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.134 -176.549 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . 0.632 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -82.01 169.45 16.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.479 179.697 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -79.44 23.25 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -171.277 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -155.42 46.46 0.5 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.96 0.41 . . . . 0.0 110.805 177.323 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.0 mmt -100.07 132.23 45.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.18 178.3 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -88.5 129.31 35.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.817 179.133 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 10.3 t -97.45 147.6 6.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -160.52 138.01 9.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.496 0.189 . . . . 0.0 110.798 176.212 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 47.3 mt -88.76 121.66 39.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.052 0.453 . . . . 0.0 110.672 176.365 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 61.5 mt . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.714 179.195 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 11.7 t 61.99 31.67 17.95 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.321 0.581 . . . . 0.0 110.41 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 13.9 m -113.67 -32.76 6.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.153 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -77.35 138.11 39.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.396 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.464 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 23.7 p -108.39 -62.61 1.43 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.075 -178.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 61.3 52.13 53.63 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.302 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.442 HG21 ' O ' ' A' ' 263' ' ' ALA . 58.7 mt -103.37 148.39 8.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 34.5 p -97.2 150.58 20.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.603 0.716 . . . . 0.0 111.992 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.62 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.8 p -63.92 151.45 8.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.025 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.9 t -115.34 81.68 1.62 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.899 0.381 . . . . 0.0 110.006 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 102.48 165.09 26.37 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.838 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -101.88 136.44 41.71 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.473 ' OE1' ' HA ' ' A' ' 259' ' ' VAL . 3.9 pt20 -144.14 139.46 28.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.247 0.546 . . . . 0.0 111.475 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 28.1 t -145.98 103.39 3.74 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.384 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -102.39 150.63 23.15 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 320' ' ' LEU . 45.9 mmtm -119.68 131.91 24.22 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.223 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.92 148.77 25.36 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.603 2.202 . . . . 0.0 111.863 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.17 124.64 29.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.228 0.537 . . . . 0.0 109.704 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -87.83 -177.7 5.86 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.397 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -67.4 -40.83 85.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.235 0.541 . . . . 0.0 109.788 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -97.42 103.01 14.91 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.047 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 7.5 mp -83.44 59.07 4.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.283 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -85.83 -55.02 4.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.148 -177.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -73.48 -55.29 6.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.927 0.394 . . . . 0.0 110.339 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -112.74 112.3 23.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.586 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -100.0 44.52 1.62 Allowed Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.028 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -58.45 121.1 10.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.94 0.4 . . . . 0.0 110.426 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -80.94 -37.05 30.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.548 -174.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 34.2 m -79.4 145.76 8.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.933 0.397 . . . . 0.0 110.654 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -105.91 95.67 5.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.025 0.441 . . . . 0.0 109.961 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.76 139.39 16.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.382 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 10.3 t70 57.76 40.97 25.79 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.605 0.717 . . . . 0.0 109.98 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -93.78 -53.65 3.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.332 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -100.15 -23.3 14.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.975 0.416 . . . . 0.0 110.542 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -95.7 144.77 25.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.216 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -117.27 115.83 26.05 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.082 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.2 m -87.36 100.3 12.62 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.107 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.473 ' HA ' ' OE1' ' A' ' 234' ' ' GLN . 2.5 t -83.1 122.27 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.414 -172.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 25.0 m -96.13 105.81 17.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.834 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.534 HD23 HG23 ' A' ' 230' ' ' VAL . 21.0 mt -123.7 165.95 16.37 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.968 -175.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.9 t -60.11 -54.66 43.27 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.442 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.27 139.44 40.95 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.166 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 11.6 p -132.48 24.55 4.43 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.98 0.895 . . . . 0.0 108.867 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 3.4 m -78.23 139.26 38.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.865 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.77 -9.02 55.12 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -175.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 61.6 mtt -94.13 148.97 21.66 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 24.8 pttm -139.11 163.56 32.1 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -57.52 135.95 56.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.86 0.362 . . . . 0.0 110.935 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 82.71 19.03 64.46 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.801 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.52 ' HB2' ' O ' ' A' ' 268' ' ' LYS . 0.6 OUTLIER -94.21 174.2 7.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.791 0.329 . . . . 0.0 110.178 -178.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 0.1 OUTLIER -114.8 116.72 29.07 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.69 -178.269 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.455 HD11 HG21 ' A' ' 308' ' ' ILE . 17.1 pt -122.31 139.93 47.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.898 0.38 . . . . 0.0 110.238 175.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 72.9 p -119.75 145.05 46.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.011 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.4 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 94.0 m-85 -107.0 111.4 23.87 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.19 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.415 ' HA ' ' OD1' ' A' ' 292' ' ' ASP . . . -66.18 113.3 4.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.071 -176.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.26 -34.25 5.4 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 96.6 t -87.9 118.81 34.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.416 ' HB2' ' OE1' ' A' ' 283' ' ' GLN . 14.6 ptpt -149.44 172.07 15.55 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.214 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -83.47 150.29 26.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.611 0.719 . . . . 0.0 112.364 -169.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' A' ' 315' ' ' LEU . 40.3 mt -67.29 124.76 24.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.965 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 112.91 -27.79 9.38 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.176 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.416 ' OE1' ' HB2' ' A' ' 279' ' ' LYS . 97.3 mt-30 -63.85 -48.87 75.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.701 0.286 . . . . 0.0 110.975 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 55.6 mtm -68.96 -20.12 64.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.675 -173.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -71.8 -15.28 62.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.485 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -131.05 -52.06 1.04 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.995 0.426 . . . . 0.0 110.598 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -83.72 107.03 15.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.095 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.14 -41.21 91.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.351 0.596 . . . . 0.0 109.888 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 87.0 mt -97.25 55.51 1.29 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.208 174.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.43 131.9 49.69 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.254 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.27 155.58 34.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.252 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.415 ' OD1' ' HA ' ' A' ' 276' ' ' ALA . 31.8 m-20 -81.41 166.52 20.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.491 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.433 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -57.97 113.32 1.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.291 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 9.5 p -96.77 105.39 17.5 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.052 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.433 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 68.6 m-85 -116.93 147.83 41.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.741 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.8 t -94.94 124.48 39.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.747 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.499 HG12 ' H ' ' A' ' 271' ' ' ASP . 12.9 p -75.15 140.98 16.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.323 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 37.9 t -103.33 -38.04 5.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.861 0.363 . . . . 0.0 110.83 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -158.82 136.75 10.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 0.0 111.026 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.25 106.58 17.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.53 -59.3 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.912 -171.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -112.9 -3.7 14.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.852 0.358 . . . . 0.0 111.445 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 71.24 12.46 72.38 Favored Glycine 0 CA--C 1.517 0.216 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -172.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 16.7 p -147.92 19.49 1.13 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.444 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.4 t-160 -169.98 113.15 0.48 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.056 -167.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.0 166.11 13.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -175.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.95 119.05 28.44 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.232 0.539 . . . . 0.0 109.996 171.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.455 HG21 HD11 ' A' ' 273' ' ' ILE . 36.6 pt -113.61 171.1 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.572 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 10.3 t -155.08 144.94 15.57 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -71.75 -179.91 24.16 Favored 'Cis proline' 0 CA--C 1.532 0.382 0 C-N-CA 124.215 -1.16 . . . . 0.0 113.048 -1.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -87.1 126.9 61.29 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.675 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.93 121.8 8.45 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.586 2.191 . . . . 0.0 112.328 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.696 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.9 OUTLIER -130.78 128.55 63.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.741 178.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -85.95 139.1 31.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.158 -174.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.565 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.0 tm? -80.73 -27.05 36.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.986 177.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -77.7 -10.48 59.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.443 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -83.02 116.02 22.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.037 0.446 . . . . 0.0 110.335 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.3 m -82.68 0.22 4.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.643 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 13.8 m -71.1 -19.18 62.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.609 0.242 . . . . 0.0 111.437 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 0.8 OUTLIER -94.94 168.77 10.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.147 0.498 . . . . 0.0 111.858 -177.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.405 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 15.2 t -87.45 152.28 52.01 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.906 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.405 ' HD2' ' OG ' ' A' ' 321' ' ' SER . 60.7 Cg_exo -40.73 -45.3 4.76 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.381 2.721 . . . . 0.0 113.781 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 323' ' ' GLU . 3.0 mp0 -51.33 -45.68 62.36 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.225 0.536 . . . . 0.0 110.855 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 13.7 mm100 -64.76 -25.23 67.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.28 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -65.33 -31.09 72.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.93 0.395 . . . . 0.0 110.53 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.45 74.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.373 175.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -85.53 -10.28 56.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.15 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.696 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -63.08 135.08 57.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.638 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -119.51 -30.24 4.9 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 34.3 m -112.91 165.69 7.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.044 0.45 . . . . 0.0 111.399 -177.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -78.71 -44.89 22.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.528 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.3 t -130.9 145.91 52.16 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.126 0.489 . . . . 0.0 110.97 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 38.4 m -74.18 169.02 18.42 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.727 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.8 tp -75.86 102.98 5.73 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.62 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -91.66 166.19 12.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.994 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.42 62.19 4.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.09 0.472 . . . . 0.0 111.778 -173.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -176.94 30.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.491 171.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.2 mmt -101.47 134.38 44.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.342 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -90.15 132.85 35.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.009 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 22.8 t -108.3 108.56 25.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.717 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . 0.464 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 64.1 t30 -123.6 132.5 53.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.074 -175.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 47.6 mt -76.59 129.94 36.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.125 0.488 . . . . 0.0 110.295 173.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 45.4 mt -82.8 135.57 34.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.803 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -90.91 113.13 25.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.495 0.664 . . . . 0.0 110.607 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.252 1.193 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.827 179.936 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 112.349 -0.3 . . . . 0.0 112.349 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.3 t -152.8 129.83 11.08 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.666 ' HA ' ' ND2' ' A' ' 344' ' ' ASN . 3.2 p -95.5 -8.45 35.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.091 0.472 . . . . 0.0 110.843 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -155.66 98.91 1.97 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.093 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.613 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 19.4 p -80.92 -56.06 4.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.061 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.64 49.66 76.16 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.754 177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.493 HG21 ' O ' ' A' ' 263' ' ' ALA . 57.7 mt -102.75 141.76 18.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 29.7 p -97.44 153.13 18.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.532 0.682 . . . . 0.0 111.839 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.611 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.7 p -58.92 151.5 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.289 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 10.2 t -105.33 73.51 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.992 0.425 . . . . 0.0 110.095 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 97.19 158.58 31.06 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.093 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -72.61 116.96 13.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.731 0.3 . . . . 0.0 110.401 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 334' ' ' LEU . 6.2 tp-100 -129.37 127.09 40.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.148 0.499 . . . . 0.0 110.589 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.2 p -118.5 125.38 49.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.105 0.478 . . . . 0.0 109.819 177.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.477 ' CD2' ' HG2' ' A' ' 312' ' ' PRO . 70.1 m-85 -81.23 131.86 35.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.602 -174.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -129.52 111.11 17.71 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -175.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -91.28 119.47 0.59 Allowed 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.67 2.247 . . . . 0.0 111.024 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.5 p -70.6 111.84 4.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.304 0.574 . . . . 0.0 109.966 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -132.88 133.91 43.9 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.787 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 81.2 m95 56.11 41.3 29.7 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.919 0.762 . . . . 0.0 111.354 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -142.94 145.13 32.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.915 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 91.5 mt 68.14 -174.72 0.19 Allowed 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.795 0.684 . . . . 0.0 111.107 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -96.47 -157.93 0.62 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.449 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -60.53 -32.19 71.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.135 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -91.12 111.49 22.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.115 0.483 . . . . 0.0 110.868 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -136.32 -154.05 6.72 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.567 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -71.18 106.86 3.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.791 0.329 . . . . 0.0 110.425 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -118.02 -7.67 10.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.199 -176.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 55.5 t -81.61 -39.45 17.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.71 0.766 . . . . 0.0 110.585 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . 0.445 ' ND2' ' HB2' ' A' ' 253' ' ' ASP . 31.4 p-10 -95.7 161.56 13.98 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.209 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 3.5 t -115.62 45.28 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 122.025 0.916 . . . . 0.0 109.433 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.445 ' HB2' ' ND2' ' A' ' 251' ' ' ASN . 3.0 m-20 -103.18 10.36 37.83 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.15 -178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -79.88 -52.33 8.02 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -90.71 -64.29 1.15 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.609 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -78.7 153.14 31.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.733 -176.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -106.5 117.19 33.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.071 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -92.1 101.82 14.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.107 0.48 . . . . 0.0 110.542 -178.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.471 ' HB ' HG22 ' A' ' 306' ' ' VAL . 3.3 t -83.2 118.99 31.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.517 -172.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 20.5 m -90.78 108.54 19.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.186 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.424 ' HB2' HG22 ' A' ' 264' ' ' THR . 20.7 mt -127.11 165.06 20.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.065 -175.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 20.8 m -58.59 -55.68 31.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.398 0.618 . . . . 0.0 109.543 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.493 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -138.2 141.16 40.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.527 ' HB ' ' SD ' ' A' ' 267' ' ' MET . 9.3 p -126.42 24.69 6.69 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.057 0.932 . . . . 0.0 108.766 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 17.0 m -71.59 138.8 49.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.372 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 105.76 -11.26 45.76 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . 0.53 ' SD ' HG11 ' A' ' 306' ' ' VAL . 63.3 mtt -95.18 142.83 27.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -154.17 140.36 18.5 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.523 ' HA ' HG13 ' A' ' 297' ' ' VAL . 30.0 ptt180 -44.17 118.01 1.38 Allowed 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.977 0.798 . . . . 0.0 112.607 -171.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.47 -10.63 19.4 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.467 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.497 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.5 p30 -82.84 -177.2 6.66 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.552 0.692 . . . . 0.0 112.175 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -124.97 117.73 24.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.973 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.534 HD11 HG21 ' A' ' 308' ' ' ILE . 37.5 pt -111.12 139.3 35.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.038 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.504 ' OG ' HG22 ' A' ' 294' ' ' THR . 3.0 m -125.34 129.51 50.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.508 -174.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -97.27 110.92 23.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.303 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.12 121.42 20.19 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.011 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.36 -27.93 9.58 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.77 131.28 50.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.438 ' HG3' ' SD ' ' A' ' 284' ' ' MET . 16.2 ptpt -141.84 157.73 44.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.786 0.327 . . . . 0.0 110.902 -175.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.401 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 43.3 m-85 -83.97 149.33 26.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.082 -174.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 315' ' ' LEU . 96.4 mt -79.06 179.01 7.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.391 176.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 82.67 -40.35 2.76 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.426 ' HB2' ' HB1' ' A' ' 290' ' ' ALA . 13.4 mm100 -90.67 -9.07 48.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.097 0.475 . . . . 0.0 109.937 176.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.438 ' SD ' ' HG3' ' A' ' 279' ' ' LYS . 86.0 mtp -98.42 31.62 2.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.185 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -66.28 -46.96 75.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.203 0.525 . . . . 0.0 109.894 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -138.16 -19.48 1.12 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.167 174.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -86.95 123.58 32.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.501 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.06 -30.51 7.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.798 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.443 ' H ' ' HG ' ' A' ' 289' ' ' LEU . 1.0 OUTLIER -84.39 46.1 1.19 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.056 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 283' ' ' GLN . . . -68.6 167.63 14.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.128 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -60.36 125.44 23.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.149 0.5 . . . . 0.0 111.021 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -62.17 158.73 16.22 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.295 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.401 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -71.29 85.87 0.79 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.9 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.504 HG22 ' OG ' ' A' ' 274' ' ' SER . 22.2 p -96.79 122.18 39.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.233 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.4 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 90.7 m-85 -124.11 153.65 41.15 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.97 0.414 . . . . 0.0 110.796 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.5 m -90.61 125.83 35.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.579 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 269' ' ' ARG . 4.8 p -67.03 134.45 30.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.034 0.445 . . . . 0.0 109.86 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 99.7 t -101.39 -53.05 7.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.744 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 301' ' ' VAL . 2.7 tmt_? -157.1 131.11 8.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.032 0.444 . . . . 0.0 110.843 -177.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 99.2 t -84.63 114.44 24.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.478 174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 299' ' ' ARG . 46.1 t -76.54 -59.15 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.644 -174.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -128.26 -7.72 5.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.445 0.64 . . . . 0.0 110.989 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.4 14.15 76.98 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 23.7 p -137.3 6.91 2.83 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 172.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.428 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.7 t-160 -164.14 119.64 1.55 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.456 -169.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.83 161.83 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -176.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -119.8 128.85 54.09 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 172.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.534 HG21 HD11 ' A' ' 273' ' ' ILE . 26.8 pt -133.94 171.64 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.102 0.477 . . . . 0.0 111.848 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 8.5 t -152.35 143.35 15.71 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.191 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.38 -179.96 27.88 Favored 'Cis proline' 0 CA--C 1.53 0.302 0 C-N-CA 123.752 -1.353 . . . . 0.0 112.939 -0.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -92.26 123.67 61.8 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.167 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.477 ' HG2' ' CD2' ' A' ' 236' ' ' PHE . 38.2 Cg_endo -70.48 109.46 2.45 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.49 2.127 . . . . 0.0 112.404 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 46.7 t -117.42 129.65 73.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.893 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -87.12 132.73 33.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.27 0.557 . . . . 0.0 111.473 -175.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.428 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.0 tm? -68.96 -26.99 65.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.205 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -98.27 19.48 14.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.719 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . 0.489 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 11.2 t70 -72.96 130.22 39.87 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.17 -16.61 10.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -174.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 18.9 t -90.76 -36.07 14.5 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -169.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.489 ' HG ' ' OD1' ' A' ' 317' ' ' ASP . 0.5 OUTLIER -71.15 175.92 4.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.526 0.679 . . . . 0.0 112.783 -175.3 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 13.5 m -103.13 158.53 31.58 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.21 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -39.7 -52.39 2.63 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.087 3.192 . . . . 0.0 114.756 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -58.54 -34.28 70.83 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -71.63 -26.46 62.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.788 0.328 . . . . 0.0 110.658 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -69.23 -22.97 63.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.975 0.416 . . . . 0.0 110.611 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -70.9 -34.3 71.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.29 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -86.24 -0.25 55.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.171 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -64.7 144.02 57.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.072 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -137.03 -9.26 1.78 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 32.5 m -123.4 155.25 29.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -84.88 -25.57 27.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 6.8 t -134.11 140.76 46.82 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.078 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 14.6 p -79.36 173.49 12.52 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 234' ' ' GLN . 19.1 tp -73.95 102.22 4.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.611 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -90.82 164.15 14.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.254 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . 0.427 ' HA ' ' CG1' ' A' ' 230' ' ' VAL . 23.8 t0 -77.89 60.57 2.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.181 0.515 . . . . 0.0 111.693 -173.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -178.23 29.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.473 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.5 mmt -98.17 134.37 41.32 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.228 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -94.48 131.14 40.5 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.79 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.404 HG21 HD22 ' A' ' 261' ' ' LEU . 9.0 t -104.75 114.05 43.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.048 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . 0.613 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 63.2 t30 -130.83 150.86 51.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.4 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 27.6 mt -102.84 130.73 52.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.115 0.483 . . . . 0.0 111.419 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 46.3 mt -86.41 116.18 24.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.192 173.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . 0.666 ' ND2' ' HA ' ' A' ' 224' ' ' THR . 40.3 m-80 -101.08 146.88 26.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.932 0.396 . . . . 0.0 111.412 -176.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 89.1 t . . . . . 0 C--O 1.246 0.907 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.048 177.747 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.576 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 43.3 t -91.79 133.17 35.87 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 3.4 p -82.86 -21.36 34.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.911 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 47.23 70.61 0.39 Allowed 'General case' 0 C--O 1.235 0.317 0 O-C-N 123.76 0.662 . . . . 0.0 112.452 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 33.8 p -106.36 -79.0 0.57 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.231 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.13 48.39 86.16 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.644 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 263' ' ' ALA . 27.3 mm -100.87 143.75 13.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.836 -0.182 . . . . 0.0 110.733 -174.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 18.9 p -119.79 167.76 11.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.181 0.515 . . . . 0.0 111.417 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.57 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.9 p -85.38 150.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.835 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.3 t -107.11 60.04 0.62 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.155 0.503 . . . . 0.0 110.37 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 102.67 159.71 25.78 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.591 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 334' ' ' LEU . . . -70.81 131.12 43.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.929 0.395 . . . . 0.0 110.649 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -133.96 126.35 30.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.106 -175.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 27.1 p -110.07 142.64 41.25 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.786 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.586 ' O ' HG12 ' A' ' 313' ' ' VAL . 98.7 m-85 -124.97 130.6 52.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.241 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -129.61 139.27 35.17 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.05 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.517 ' HA ' ' OD1' ' A' ' 254' ' ' ASN . 94.8 Cg_endo -88.84 160.52 6.14 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.763 2.309 . . . . 0.0 112.151 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 47.8 t -79.91 84.94 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.225 0.536 . . . . 0.0 110.212 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -103.61 104.75 14.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.054 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -133.83 134.0 42.29 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.768 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -62.01 124.19 20.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.528 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.09 58.23 1.96 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.528 0.68 . . . . 0.0 111.772 -177.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -72.67 -50.5 24.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.098 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -70.39 -48.62 55.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.329 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -175.34 -44.13 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.229 0.538 . . . . 0.0 110.418 175.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 149.62 144.54 3.96 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.214 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -95.6 75.24 3.25 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.27 0.557 . . . . 0.0 110.533 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -83.14 72.03 10.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.815 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.0 m -80.7 124.08 38.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.116 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -76.56 86.16 3.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.374 0.607 . . . . 0.0 110.633 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 14.6 p -147.25 150.71 14.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.293 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -76.64 60.03 1.61 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.38 0.61 . . . . 0.0 111.092 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.517 ' OD1' ' HA ' ' A' ' 238' ' ' PRO . 28.6 t-20 -87.77 -22.0 24.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.056 -177.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -76.95 -8.78 58.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.634 0.73 . . . . 0.0 109.692 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -110.6 159.33 17.66 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.127 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.441 ' HB2' ' HD2' ' A' ' 312' ' ' PRO . . . -121.24 114.97 22.14 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.664 0.269 . . . . 0.0 110.773 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.653 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -87.09 97.59 10.82 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.236 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -85.17 126.81 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.333 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 40.4 m -96.53 109.15 21.79 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 173.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.4 HD22 HG21 ' A' ' 340' ' ' VAL . 22.2 mt -122.43 172.52 8.28 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.7 m -58.87 -57.4 13.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.241 0.543 . . . . 0.0 109.754 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.479 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -137.2 135.98 37.76 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.956 178.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 8.2 p -130.79 23.88 5.01 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.544 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 89.7 m -82.89 137.05 34.39 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.87 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 112.54 -29.5 8.2 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -171.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -69.66 155.42 40.53 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 170.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -154.43 143.43 21.06 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.48 ' HA ' HG13 ' A' ' 297' ' ' VAL . 37.4 ptt180 -52.32 114.21 1.28 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.23 0.538 . . . . 0.0 111.06 -174.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 113.78 -2.7 24.51 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.903 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.426 ' H ' HG12 ' A' ' 297' ' ' VAL . 0.6 OUTLIER -83.6 175.1 9.99 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 117.1 0.45 . . . . 0.0 111.052 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -126.47 117.39 22.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.245 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.413 HG23 ' OD1' ' A' ' 271' ' ' ASP . 40.8 pt -112.13 140.28 32.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.188 0.518 . . . . 0.0 110.356 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.486 ' OG ' HG22 ' A' ' 294' ' ' THR . 2.7 m -120.5 137.48 54.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.987 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -101.24 111.35 23.54 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.68 116.34 9.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.023 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.27 -36.19 4.27 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 85.2 t -86.47 114.54 26.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 172.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -136.25 158.17 45.05 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.633 -172.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.481 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 66.7 m-85 -76.18 133.93 40.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.344 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.401 ' CD1' ' HB3' ' A' ' 315' ' ' LEU . 96.3 mt -76.17 154.74 35.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.663 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 102.17 -31.38 8.77 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 287' ' ' ASN . 84.6 mm-40 -74.81 -18.49 60.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.472 0.177 . . . . 0.0 111.067 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 74.0 mtm -91.6 10.24 28.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.656 0.265 . . . . 0.0 110.947 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -69.06 -27.75 65.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.058 0.456 . . . . 0.0 110.297 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -148.94 -41.6 0.15 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.739 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 283' ' ' GLN . 91.6 m-20 -70.95 108.25 4.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.973 0.416 . . . . 0.0 110.888 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 39.6 t -70.68 -32.09 48.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.596 0.713 . . . . 0.0 109.323 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.09 51.08 2.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.882 175.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -57.78 127.0 29.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.401 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -61.12 138.09 58.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.081 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -77.42 167.06 22.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.958 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.481 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -73.6 106.96 5.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.982 -176.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.498 HG21 HD11 ' A' ' 343' ' ' LEU . 67.0 p -97.34 133.62 41.71 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.97 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -131.33 148.89 52.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.941 0.401 . . . . 0.0 110.579 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.1 m -92.29 129.95 38.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.087 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.55 ' HA ' HG22 ' A' ' 308' ' ' ILE . 4.0 p -72.4 143.72 13.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.795 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 62.0 t -105.41 -38.95 4.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.682 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -162.66 136.35 6.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.654 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 58.7 t -86.53 110.45 20.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 169.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 24.3 t -77.32 -56.83 6.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.732 -171.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -127.49 13.92 7.06 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.618 -173.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 59.55 13.84 25.39 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-O 121.438 0.466 . . . . 0.0 112.055 -174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.3 p -150.27 19.49 0.85 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.476 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.3 t-160 -169.03 115.84 0.62 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.817 -1.538 . . . . 0.0 108.074 -166.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.5 m -119.43 163.42 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.313 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.1 pt-20 -124.44 116.38 22.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.143 0.496 . . . . 0.0 109.674 169.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.55 HG22 ' HA ' ' A' ' 297' ' ' VAL . 24.2 pt -115.87 169.83 6.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.104 -177.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.409 ' OG1' ' HA ' ' A' ' 310' ' ' PRO . 6.3 t -154.32 145.21 16.22 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.409 ' HA ' ' OG1' ' A' ' 309' ' ' THR . 59.4 Cg_endo -70.24 179.7 22.57 Favored 'Cis proline' 0 C--N 1.346 0.403 0 C-N-CA 124.038 -1.234 . . . . 0.0 113.238 1.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.46 ' HE3' ' HB3' ' A' ' 236' ' ' PHE . 31.7 tttp -83.53 119.11 73.28 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.255 -177.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 19.9 Cg_endo -62.29 109.11 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.51 2.14 . . . . 0.0 112.091 178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.791 HG23 ' HA ' ' A' ' 328' ' ' ALA . 8.9 m -127.81 128.33 69.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.324 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -87.34 136.16 33.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.953 -173.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.401 ' HB3' ' CD1' ' A' ' 281' ' ' LEU . 43.9 tp -80.62 -28.81 36.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.512 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -85.91 13.53 7.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.334 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -76.02 117.78 18.1 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 29.5 m -82.87 1.17 3.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.743 -175.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 16.1 m -94.51 -27.95 15.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.69 0.281 . . . . 0.0 111.107 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.6 pp -79.38 174.27 11.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.061 0.457 . . . . 0.0 111.291 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.533 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.6 m -116.36 168.37 8.79 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.16 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 29.3 Cg_exo -39.62 -49.1 3.38 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.793 2.995 . . . . 0.0 114.925 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -61.53 -36.94 82.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.039 0.447 . . . . 0.0 111.297 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 15.5 mm-40 -68.84 -30.4 68.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.603 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -62.86 -25.58 68.35 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.216 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.78 -34.05 69.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.128 0.489 . . . . 0.0 110.298 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -76.05 -30.67 58.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.297 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.791 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -59.26 139.69 56.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.08 -175.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -135.13 -33.36 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.822 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 27.6 m -101.35 171.24 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.969 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -75.33 -57.18 4.05 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.739 -176.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.8 t -139.41 164.1 30.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.666 0.269 . . . . 0.0 110.358 -175.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.6 p -73.91 164.48 26.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.743 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.504 ' HG ' HG21 ' A' ' 230' ' ' VAL . 25.6 tp -67.43 104.27 1.5 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.254 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.57 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -87.07 -174.35 4.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.598 -178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -80.99 157.31 25.55 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.579 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 59.33 39.08 22.75 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.864 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.9 mmt -103.78 130.17 51.27 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -81.69 137.81 35.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.214 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.431 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 22.0 t -111.18 110.06 30.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -123.29 144.21 49.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.638 -173.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 55.6 mt -96.84 127.56 48.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.31 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.498 HD11 HG21 ' A' ' 294' ' ' THR . 84.0 mt -69.6 140.67 53.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.415 -178.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -82.7 77.48 9.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.458 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.36 178.498 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.3 m 60.53 41.75 15.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.161 0.505 . . . . 0.0 111.053 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 86.1 m -68.3 -49.73 58.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.965 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 57.36 75.46 0.37 Allowed 'General case' 0 C--O 1.234 0.256 0 O-C-N 123.489 0.493 . . . . 0.0 110.875 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 32.2 p -73.16 40.32 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.306 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -82.14 76.06 2.26 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.083 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 40.1 mt -95.82 153.51 3.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 3.2 p -96.6 151.69 19.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.485 0.659 . . . . 0.0 112.211 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.548 HG11 ' O ' ' A' ' 335' ' ' ALA . 4.2 p -64.5 151.01 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.638 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.1 t -105.52 76.77 1.23 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.61 165.16 40.73 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.059 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.44 122.8 18.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.953 0.406 . . . . 0.0 110.596 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.448 ' NE2' ' HB ' ' A' ' 260' ' ' THR . 86.1 mm-40 -110.0 126.91 54.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.235 0.54 . . . . 0.0 110.496 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.4 p -137.21 112.17 8.97 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.76 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 234' ' ' GLN . 40.9 m-85 -116.95 132.41 56.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.86 0.362 . . . . 0.0 110.926 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -115.94 131.55 23.67 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.367 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 254' ' ' ASN . 72.9 Cg_endo -79.65 132.07 9.65 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.381 2.054 . . . . 0.0 111.512 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 24.1 t -82.71 83.73 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.242 0.544 . . . . 0.0 109.773 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -100.82 93.51 5.58 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.802 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.418 ' HA ' ' OD1' ' A' ' 244' ' ' ASP . 91.4 m95 67.09 -174.03 0.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.535 -177.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 68.47 122.85 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.121 0.568 . . . . 0.0 110.729 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 6.4 mp 58.37 42.68 21.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.388 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' A' ' 241' ' ' TRP . 30.3 m-20 -74.18 -19.27 60.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.782 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -88.05 -53.15 4.87 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.39 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -103.76 -20.45 13.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -173.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -81.73 163.42 44.06 Favored Glycine 0 C--N 1.321 -0.266 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.23 -174.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 55.53 58.05 4.86 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.511 0.724 . . . . 0.0 110.967 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -77.84 -42.73 32.63 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.78 177.38 4.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.166 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 8.3 t30 63.49 81.33 0.21 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.474 0.654 . . . . 0.0 110.109 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 12.3 t -81.86 62.91 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.8 0.809 . . . . 0.0 110.083 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.53 42.26 3.0 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.537 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 238' ' ' PRO . 6.0 p30 -72.63 -51.54 19.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.706 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -86.78 -47.27 9.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.817 0.341 . . . . 0.0 110.929 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -78.93 139.08 38.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.505 -176.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.454 ' HB2' ' HG3' ' A' ' 311' ' ' LYS . . . -100.41 115.97 31.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.616 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -85.83 97.78 10.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.978 179.459 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.0 t -81.98 114.18 22.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.977 -173.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.448 ' HB ' ' NE2' ' A' ' 234' ' ' GLN . 17.5 m -86.42 107.19 17.93 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.985 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.453 HD12 HG22 ' A' ' 264' ' ' THR . 21.0 mt -122.12 167.12 13.53 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -177.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.8 m -55.86 -54.6 42.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.372 0.606 . . . . 0.0 109.65 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -138.4 146.83 42.68 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.453 HG22 HD12 ' A' ' 261' ' ' LEU . 24.3 p -133.6 31.38 3.7 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.889 0.852 . . . . 0.0 108.904 174.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.9 m -80.24 152.7 28.95 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.65 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 90.36 -28.73 7.19 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 52.7 mtt -78.2 135.62 37.65 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.512 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 3.2 ptpp? -134.36 163.53 29.46 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -52.85 126.58 20.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.941 0.4 . . . . 0.0 111.147 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 95.21 18.82 32.43 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.098 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.512 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 66.5 m-20 -100.77 161.39 13.63 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 117.349 0.574 . . . . 0.0 110.892 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.489 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 12.0 tppt? -106.53 117.53 34.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.782 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.475 HD11 HG21 ' A' ' 308' ' ' ILE . 36.5 pt -112.25 139.74 35.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.128 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.416 ' HB3' HG22 ' A' ' 294' ' ' THR . 32.6 p -113.06 134.35 54.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.317 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -100.06 111.55 23.84 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.932 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.96 130.73 46.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.837 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 89.43 -35.51 3.7 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.082 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.6 124.23 35.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.504 ' HD2' ' SD ' ' A' ' 284' ' ' MET . 8.6 ptpp? -143.01 159.91 41.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.879 0.371 . . . . 0.0 111.183 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.435 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 80.7 m-85 -78.66 156.3 29.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.478 -173.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.11 143.3 57.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.291 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 107.03 -15.94 39.57 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.417 HE21 ' HB1' ' A' ' 290' ' ' ALA . 20.9 mt-30 -91.26 175.16 7.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.504 ' SD ' ' HD2' ' A' ' 279' ' ' LYS . 48.9 mtm 70.76 12.76 7.22 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.425 0.453 . . . . 0.0 111.422 176.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -83.7 -43.16 15.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.313 0.578 . . . . 0.0 109.501 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -166.21 54.19 0.09 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.555 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -153.69 119.47 5.3 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.702 0.763 . . . . 0.0 110.992 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 23.0 t -87.13 -20.92 7.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.181 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 83.9 mt -87.43 42.72 1.06 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.031 175.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.417 ' HB1' HE21 ' A' ' 283' ' ' GLN . . . -63.88 132.14 49.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.823 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -79.09 150.76 31.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.346 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -87.3 158.19 19.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.913 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.435 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -65.17 108.93 2.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.123 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.489 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 4.4 p -103.54 110.99 23.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.142 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -115.79 157.68 24.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.158 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 27.8 t -96.89 127.24 42.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.471 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.468 HG12 ' H ' ' A' ' 271' ' ' ASP . 12.1 p -82.85 131.23 34.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.169 0.509 . . . . 0.0 110.228 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 39.2 t -92.21 -36.08 7.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.193 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.408 ' O ' ' HG2' ' A' ' 307' ' ' GLU . 11.1 tpt180 -162.67 144.1 10.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.228 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.464 HG12 ' H ' ' A' ' 303' ' ' GLY . 93.1 t -91.24 114.71 28.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 16.8 t -77.83 -52.29 16.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.976 -172.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -125.11 3.16 7.93 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -172.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . 0.464 ' H ' HG12 ' A' ' 300' ' ' VAL . . . 65.22 13.98 58.73 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.295 -171.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 3.7 p -151.9 20.57 0.69 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.561 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.0 t-160 -171.43 114.94 0.39 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 113.821 -1.536 . . . . 0.0 108.296 -164.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.6 m -118.84 160.66 18.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -176.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 299' ' ' ARG . 12.2 pt-20 -118.03 120.5 37.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.081 0.467 . . . . 0.0 109.984 173.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 273' ' ' ILE . 31.0 pt -118.56 164.47 14.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.273 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.405 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 8.8 t -154.11 140.91 13.15 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.141 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.405 ' C ' ' HA ' ' A' ' 309' ' ' THR . 15.5 Cg_exo -69.02 177.2 27.69 Favored 'Cis proline' 0 C--N 1.347 0.492 0 C-N-CA 123.932 -1.278 . . . . 0.0 112.567 -0.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.454 ' HG3' ' HB2' ' A' ' 257' ' ' ALA . 39.3 ttmt -90.42 124.88 61.62 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.731 -178.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.06 109.38 2.16 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.789 2.326 . . . . 0.0 112.467 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.49 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -112.69 130.83 65.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.897 176.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -81.93 126.97 32.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.173 0.511 . . . . 0.0 111.133 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.2 -31.58 70.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.61 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -82.55 3.61 27.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.588 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . 0.461 ' OD2' ' HG ' ' A' ' 320' ' ' LEU . 20.2 t70 -72.96 123.11 22.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.888 0.375 . . . . 0.0 110.119 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.51 2.11 4.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 29.1 t -93.93 -31.27 14.36 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -173.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.604 HD13 ' HG2' ' A' ' 325' ' ' ARG . 0.4 OUTLIER -84.09 155.17 22.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.595 0.712 . . . . 0.0 112.492 -177.163 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.485 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 47.1 t -80.12 154.92 75.02 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.919 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.485 ' HD2' ' OG ' ' A' ' 321' ' ' SER . 41.3 Cg_exo -36.13 -52.65 1.05 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 124.087 3.191 . . . . 0.0 114.291 177.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.28 -38.84 84.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.815 0.34 . . . . 0.0 111.122 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 15.3 mm100 -64.65 -26.72 68.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.637 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.604 ' HG2' HD13 ' A' ' 320' ' ' LEU . 88.2 mtt180 -73.33 -19.23 61.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.912 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -78.83 -25.42 44.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.987 175.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -88.69 -11.63 44.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.536 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.49 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -66.76 121.65 15.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.782 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . 0.483 ' OD1' HG13 ' A' ' 330' ' ' VAL . 3.2 p30 -102.35 -27.45 12.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.823 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.483 HG13 ' OD1' ' A' ' 329' ' ' ASN . 36.0 m -113.85 168.08 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.998 0.427 . . . . 0.0 110.995 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -88.48 -41.43 12.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.328 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.5 t -123.64 145.36 49.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.252 0.548 . . . . 0.0 110.853 -174.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 7.5 p -73.0 162.57 29.33 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.339 172.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.451 ' HG ' HG21 ' A' ' 230' ' ' VAL . 40.6 tp -71.57 104.16 3.22 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.548 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.01 178.0 8.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.639 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -81.01 153.45 27.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.551 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 66.41 34.51 6.21 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 124.083 0.864 . . . . 0.0 111.897 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.515 ' H ' HG12 ' A' ' 230' ' ' VAL . 78.5 mmm -106.55 149.8 26.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -94.32 140.25 30.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.031 0.443 . . . . 0.0 111.588 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 41.7 t -125.28 120.35 57.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -138.51 148.21 44.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.711 0.291 . . . . 0.0 111.218 -174.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 60.5 mt -87.92 122.57 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.005 0.431 . . . . 0.0 110.585 174.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 47.8 mt -86.35 112.19 21.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.281 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -99.53 89.15 4.06 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.528 -0.749 . . . . 0.0 110.678 -178.538 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.912 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.7 p -86.33 71.57 10.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.191 0.52 . . . . 0.0 111.177 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 16.5 p -100.11 27.04 5.87 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.125 0.488 . . . . 0.0 111.158 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.08 96.43 5.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.785 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.554 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 22.2 p -72.68 -60.57 2.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.033 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.99 48.01 88.18 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.569 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.408 HG21 ' O ' ' A' ' 263' ' ' ALA . 71.3 mt -102.25 143.7 14.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 17.5 p -96.84 150.21 20.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.703 0.763 . . . . 0.0 112.243 -173.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.709 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.9 p -62.77 151.26 8.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.469 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 70.9 m -102.2 72.52 1.3 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.95 0.405 . . . . 0.0 110.724 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 99.09 164.86 29.95 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.377 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -88.93 138.53 31.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.618 0.246 . . . . 0.0 110.436 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' A' ' 234' ' ' GLN . 3.1 pt20 -153.58 147.32 25.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.143 0.497 . . . . 0.0 110.849 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 50.7 p -119.06 124.23 46.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.224 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -81.36 146.91 30.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.129 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.408 ' HB3' HE22 ' A' ' 324' ' ' GLN . 48.0 mmtm -141.76 116.57 6.9 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.112 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -92.08 119.33 0.49 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.476 2.117 . . . . 0.0 110.436 166.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.458 ' CG2' ' HB2' ' A' ' 242' ' ' GLN . 7.7 p -88.61 133.99 29.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.101 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -116.35 104.17 11.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.431 -175.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 85.8 m95 69.36 30.63 4.12 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.292 0.637 . . . . 0.0 111.598 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.458 ' HB2' ' CG2' ' A' ' 239' ' ' VAL . 26.7 mt-30 -138.89 124.26 19.3 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 91.9 mt 61.53 21.48 12.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.107 0.48 . . . . 0.0 110.696 -175.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.406 ' HA ' ' HB2' ' A' ' 248' ' ' ASN . 2.6 m-20 -82.52 -36.96 25.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.364 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -65.06 -46.15 82.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.478 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -137.11 105.76 5.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.063 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 144.09 -58.6 0.53 Allowed Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.549 -0.621 . . . . 0.0 111.549 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . 0.406 ' HB2' ' HA ' ' A' ' 244' ' ' ASP . 35.7 m-80 -100.61 73.18 1.6 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.188 0.518 . . . . 0.0 109.711 175.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -90.17 -50.29 6.07 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.681 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.1 m -112.66 161.23 11.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.766 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 69.96 126.56 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.993 0.808 . . . . 0.0 111.202 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 3.8 m -84.98 62.27 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.773 0.797 . . . . 0.0 110.797 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -66.36 -17.31 64.69 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.995 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -75.94 -17.13 59.86 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.728 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -111.73 -32.87 6.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.154 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.555 ' O ' ' HE3' ' A' ' 311' ' ' LYS . 40.9 m-85 -115.01 164.96 13.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.455 -176.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -130.98 138.52 49.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.662 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 4.0 m -101.54 114.41 28.42 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.434 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.7 t -95.42 125.02 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.234 -174.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 28.3 m -98.74 111.55 23.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.022 177.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 340' ' ' VAL . 14.7 mt -130.59 169.34 15.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.455 -174.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.5 m -62.5 -55.38 28.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.492 0.663 . . . . 0.0 109.829 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.408 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.6 135.04 36.24 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.194 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 3.4 p -127.45 26.64 5.95 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 172.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 37.8 m -74.5 140.67 44.69 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.129 -1.851 . . . . 0.0 110.548 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 94.32 -11.93 69.68 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 66.0 mtt -86.09 145.2 27.15 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 25.2 pttm -136.22 155.23 50.42 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -57.34 128.48 37.22 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.92 18.47 34.38 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.447 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.548 ' H ' HG12 ' A' ' 297' ' ' VAL . 0.6 OUTLIER -101.28 178.02 4.77 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.5 ' HD3' ' HB ' ' A' ' 294' ' ' THR . 2.3 tmmm? -130.75 116.21 17.69 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.172 -177.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 308' ' ' ILE . 37.7 pt -112.48 151.42 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.936 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.411 ' OG ' HG22 ' A' ' 294' ' ' THR . 18.5 m -140.41 144.07 35.97 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.395 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.486 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 88.7 m-85 -102.77 111.97 24.54 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.593 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.86 113.02 5.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.431 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.44 -18.19 23.11 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.712 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 59.4 t -110.32 114.08 46.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.591 ' HD3' ' HB3' ' A' ' 290' ' ' ALA . 0.6 OUTLIER -131.05 159.4 37.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.814 0.34 . . . . 0.0 111.472 -176.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -69.86 161.46 29.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.045 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 315' ' ' LEU . 87.2 mt -77.21 -177.94 4.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.916 177.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 72.05 16.71 76.78 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.726 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.441 ' OE1' ' HG2' ' A' ' 291' ' ' GLN . 37.2 mt-30 -135.14 -161.78 1.19 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 69.5 mtp 75.93 -45.84 0.54 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.83 0.706 . . . . 0.0 111.723 173.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.23 -36.46 84.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.463 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -128.34 -43.71 1.44 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.998 0.428 . . . . 0.0 110.337 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -75.45 104.0 5.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.193 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 48.6 t -74.4 -48.55 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.265 0.555 . . . . 0.0 109.645 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 93.0 mt -83.97 55.0 3.11 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.591 ' HB3' ' HD3' ' A' ' 279' ' ' LYS . . . -66.11 125.61 26.04 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.135 -176.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . 0.441 ' HG2' ' OE1' ' A' ' 283' ' ' GLN . 10.7 pt20 -55.58 129.8 40.45 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 123.939 0.774 . . . . 0.0 111.255 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -74.78 168.26 20.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.393 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.659 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -64.21 86.09 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.734 -176.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.5 ' HB ' ' HD3' ' A' ' 272' ' ' LYS . 43.7 p -87.93 110.37 20.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.526 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.659 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 64.7 m-85 -119.45 147.49 44.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.037 0.446 . . . . 0.0 111.381 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.7 m -91.89 127.82 37.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.689 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 271' ' ' ASP . 7.5 p -83.29 130.82 35.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.16 0.505 . . . . 0.0 110.289 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 307' ' ' GLU . 12.8 p -95.06 -30.05 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.498 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -163.38 139.84 7.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.11 0.481 . . . . 0.0 111.253 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 72.7 t -97.36 119.51 45.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.88 -59.88 2.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.838 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -129.23 -3.69 4.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.375 0.607 . . . . 0.0 111.091 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.6 14.44 75.91 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.413 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 14.4 p -143.0 16.09 1.92 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 174.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -171.54 116.28 0.4 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.807 -168.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.54 163.55 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.632 -174.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.439 ' O ' HG12 ' A' ' 298' ' ' VAL . 6.7 pt-20 -124.85 123.36 39.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.105 0.478 . . . . 0.0 109.943 172.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 297' ' ' VAL . 28.4 pt -129.17 175.05 11.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.284 -174.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.413 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 11.6 t -154.17 145.39 16.46 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 176.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.79 179.36 29.52 Favored 'Cis proline' 0 C--N 1.345 0.393 0 C-N-CA 124.002 -1.249 . . . . 0.0 112.65 -2.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.555 ' HE3' ' O ' ' A' ' 256' ' ' PHE . 30.1 ttmt -84.42 128.84 60.1 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.854 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.497 ' HG3' ' CE2' ' A' ' 295' ' ' PHE . 7.6 Cg_exo -71.28 108.87 2.45 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.448 2.099 . . . . 0.0 112.283 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.613 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -123.33 129.99 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.546 175.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -85.59 131.03 34.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.796 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.405 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.2 tm? -62.29 -32.69 73.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.716 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -92.83 24.83 3.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.351 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.27 128.55 34.31 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 29.3 m -84.48 -1.89 6.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -173.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 33.7 t -110.13 -14.34 14.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -173.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.95 167.9 21.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.6 0.714 . . . . 0.0 112.312 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.4 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 7.9 t -99.98 154.03 37.45 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.15 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.49 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 67.0 Cg_exo -41.86 -47.81 6.27 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.158 2.572 . . . . 0.0 113.549 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 323' ' ' GLU . 1.6 mp0 -53.76 -39.94 65.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.186 0.517 . . . . 0.0 110.933 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.408 HE22 ' HB3' ' A' ' 237' ' ' LYS . 40.5 mt-30 -72.76 -23.88 60.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.823 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.49 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 29.6 mtm180 -66.36 -27.46 67.89 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.942 0.401 . . . . 0.0 110.297 176.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.82 63.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.222 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -96.06 7.57 46.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.939 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.613 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -58.9 140.09 55.81 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.898 0.38 . . . . 0.0 110.527 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -123.17 -33.43 3.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.412 -170.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 27.5 m -125.47 169.01 17.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.862 0.363 . . . . 0.0 110.16 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -94.07 -16.87 23.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.809 0.338 . . . . 0.0 110.916 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.0 t -144.62 141.33 29.31 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.894 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 50.1 m -80.18 171.99 14.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.2 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 17.7 tp -68.25 103.89 1.7 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.187 0.518 . . . . 0.0 110.364 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.709 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -81.02 170.82 15.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.917 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -79.31 11.56 2.85 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.373 -171.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -142.85 40.99 1.54 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.025 0.44 . . . . 0.0 110.979 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 21.6 mmt -98.99 133.07 43.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.355 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -94.33 130.6 40.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.822 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.469 HG21 HD13 ' A' ' 261' ' ' LEU . 12.2 t -99.78 113.17 34.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.613 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . 0.554 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 57.9 t30 -130.65 139.61 50.36 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.032 -177.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.6 mt -86.93 122.82 39.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.939 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 38.0 mt -86.03 118.28 25.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.747 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -95.87 102.48 14.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.715 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.068 -0.967 . . . . 0.0 110.657 -178.947 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.674 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.6 p -76.04 -19.51 58.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.711 0.291 . . . . 0.0 111.464 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 28.4 m -71.27 -30.3 66.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.263 0.554 . . . . 0.0 110.323 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.31 63.03 6.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.499 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 341' ' ' ASN . 31.0 p -130.72 66.02 1.53 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.329 0.585 . . . . 0.0 111.189 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -113.94 56.43 0.49 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.573 HG21 ' O ' ' A' ' 263' ' ' ALA . 10.9 mt -92.51 161.2 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.22 -0.49 . . . . 0.0 110.342 -172.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 37.0 p -113.22 157.99 21.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.305 0.574 . . . . 0.0 111.369 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.697 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.2 p -72.07 151.63 8.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.454 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 39.8 t -106.24 95.43 5.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.921 174.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 83.42 165.04 37.42 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.92 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -92.99 126.08 37.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -142.0 129.53 21.39 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.249 0.547 . . . . 0.0 111.357 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 15.5 t -106.42 121.9 45.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.551 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.46 ' O ' HG13 ' A' ' 313' ' ' VAL . 91.2 m-85 -83.89 113.53 21.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.862 0.363 . . . . 0.0 110.596 -176.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.419 ' HE2' HD23 ' A' ' 320' ' ' LEU . 33.3 mmtp -124.04 118.48 26.8 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.528 -176.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.39 134.97 16.11 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.516 2.144 . . . . 0.0 111.774 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 5.9 p -71.76 95.33 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.804 0.811 . . . . 0.0 110.965 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -125.31 80.8 1.91 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.376 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -141.39 97.46 3.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.148 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -70.07 103.99 2.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.831 0.348 . . . . 0.0 110.209 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 79.7 mt -74.04 -58.11 3.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.91 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -107.93 -92.52 0.41 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.132 174.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -88.6 -40.87 13.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.528 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.528 ' CG ' ' HD2' ' A' ' 249' ' ' LYS . 3.7 p30 -132.93 179.23 6.3 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.093 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -138.09 76.53 0.35 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.442 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 19.2 m120 59.43 52.76 5.6 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 122.746 0.418 . . . . 0.0 110.827 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.528 ' HD2' ' CG ' ' A' ' 246' ' ' ASP . 0.1 OUTLIER -77.56 -18.91 56.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.811 -175.262 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 40.4 t -80.7 -19.93 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.714 0.768 . . . . 0.0 109.571 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -86.28 84.52 7.45 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.265 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 28.1 m -90.37 25.22 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 122.018 0.913 . . . . 0.0 110.392 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -77.62 -15.45 59.2 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.538 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.413 ' O ' ' HE2' ' A' ' 311' ' ' LYS . 53.5 m-80 -71.96 -7.69 50.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.292 -178.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.504 ' NE ' ' HA ' ' A' ' 255' ' ' ARG . 3.3 mmp_? -75.8 -15.48 60.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.152 0.501 . . . . 0.0 109.744 174.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -108.68 165.62 11.41 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.353 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.417 ' HB2' ' HA ' ' A' ' 311' ' ' LYS . . . -140.04 120.48 14.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.47 177.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.0 OUTLIER -90.27 104.24 16.84 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.991 0.424 . . . . 0.0 110.338 -179.466 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.456 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.6 t -88.94 117.9 33.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 -173.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 60.6 m -89.59 107.69 19.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.018 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.423 HD12 HG22 ' A' ' 264' ' ' THR . 18.6 mt -123.6 164.11 19.68 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.68 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 17.2 m -57.52 -52.93 63.38 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.432 0.634 . . . . 0.0 109.681 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.573 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.47 146.13 43.9 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 175.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.423 HG22 HD12 ' A' ' 261' ' ' LEU . 16.0 p -132.0 29.93 4.34 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.102 0.953 . . . . 0.0 108.569 174.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 18.3 m -73.74 138.97 44.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.291 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 100.15 -1.06 56.15 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.312 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . 0.402 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 54.9 mtt -102.04 142.86 32.65 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 62.0 pttt -143.33 148.18 35.87 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -50.18 122.32 6.68 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.601 0.563 . . . . 0.0 111.876 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 97.45 18.35 28.59 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.678 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.523 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.4 t70 -98.06 -171.02 2.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.98 0.39 . . . . 0.0 110.168 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -135.12 117.06 15.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.872 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.498 HD11 HG21 ' A' ' 308' ' ' ILE . 29.6 pt -112.64 140.37 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.421 -0.512 . . . . 0.0 109.974 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 6.8 m -120.86 137.03 54.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.233 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -103.18 111.55 23.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.3 119.03 12.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.365 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.03 -32.14 6.53 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -176.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.49 ' HA ' ' CG2' ' A' ' 332' ' ' THR . 43.7 t -96.73 122.37 48.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 279' ' ' LYS . 11.2 ptpt -140.12 170.1 16.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.878 0.37 . . . . 0.0 111.379 -176.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -81.18 173.41 12.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.753 -174.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 71.9 mt -80.1 71.28 6.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.257 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 143.84 -163.67 27.61 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.97 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 60.86 30.88 19.93 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.053 0.454 . . . . 0.0 110.85 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 65.4 mtm -123.1 -15.87 7.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.916 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.79 -55.9 14.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.239 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -113.95 -24.51 9.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.138 0.494 . . . . 0.0 110.299 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -82.48 105.04 13.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.301 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 19.7 t -74.52 -34.3 35.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.354 0.597 . . . . 0.0 109.454 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 94.9 mt -89.66 61.27 5.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.311 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -61.89 124.51 20.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.407 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -63.5 127.3 30.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.179 0.514 . . . . 0.0 110.264 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -76.0 166.91 22.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.463 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.578 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -52.91 104.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.513 0.508 . . . . 0.0 111.199 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.05 106.48 16.73 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.037 -176.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.519 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 50.2 m-85 -122.96 154.82 37.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.949 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 31.6 t -91.69 134.84 34.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.303 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 271' ' ' ASP . 11.9 p -87.15 126.74 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.218 0.533 . . . . 0.0 110.171 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.6 t -92.59 -38.77 10.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.581 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -159.13 133.89 8.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 50.3 t -93.8 110.28 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 39.5 t -70.16 -58.28 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.887 -171.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -124.34 -8.92 7.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.257 0.551 . . . . 0.0 111.151 -176.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.9 13.86 76.67 Favored Glycine 0 C--N 1.32 -0.309 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -172.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 29.6 p -138.71 13.2 2.72 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 172.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -166.35 120.65 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.519 -170.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.6 159.81 20.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 -176.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -122.77 115.48 22.11 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.284 0.564 . . . . 0.0 109.724 168.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.498 HG21 HD11 ' A' ' 273' ' ' ILE . 30.1 pt -111.83 178.35 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.102 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 15.0 t -153.73 142.73 14.67 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.428 ' HD2' ' CD1' ' A' ' 295' ' ' PHE . 4.8 Cg_exo -82.13 -179.87 25.15 Favored 'Cis proline' 0 C--N 1.344 0.317 0 C-N-CA 124.282 -1.133 . . . . 0.0 112.522 -2.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 257' ' ' ALA . 24.4 ttmm -77.27 124.42 87.04 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.491 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.507 ' HA ' ' OD1' ' A' ' 329' ' ' ASN . 64.3 Cg_endo -77.94 108.6 2.56 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.374 2.05 . . . . 0.0 112.365 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 236' ' ' PHE . 0.2 OUTLIER -109.49 136.17 46.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' A' ' 317' ' ' ASP . . . -81.47 115.8 20.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.057 0.456 . . . . 0.0 111.106 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.96 -26.54 66.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.528 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.09 12.54 21.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.864 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . 0.43 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 21.4 t70 -85.66 118.63 25.29 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.88 -14.34 11.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.004 0.43 . . . . 0.0 111.221 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.5 t -77.7 -28.28 50.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.47 -174.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.419 HD23 ' HE2' ' A' ' 237' ' ' LYS . 1.8 pp -71.07 172.92 8.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.31 0.576 . . . . 0.0 112.009 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.436 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 23.5 m -102.65 162.98 18.53 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.483 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.438 ' O ' ' HG3' ' A' ' 325' ' ' ARG . 85.3 Cg_exo -44.62 -52.21 6.31 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.004 3.136 . . . . 0.0 115.39 -172.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -73.42 -18.13 61.18 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.771 -0.581 . . . . 0.0 111.743 -172.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -73.92 -39.7 63.65 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.224 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 322' ' ' PRO . 0.0 OUTLIER -75.07 -16.29 60.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.121 0.486 . . . . 0.0 110.785 178.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -66.71 -35.48 80.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.551 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -95.43 -0.62 52.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.138 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.447 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -66.19 128.45 36.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.15 0.5 . . . . 0.0 111.266 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . 0.507 ' OD1' ' HA ' ' A' ' 312' ' ' PRO . 10.2 p30 -110.85 -26.85 9.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.699 -176.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 29.2 m -108.54 164.07 5.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.017 0.437 . . . . 0.0 110.834 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -98.86 -5.66 30.54 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.49 ' CG2' ' HA ' ' A' ' 278' ' ' VAL . 8.9 t -146.05 148.11 32.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.059 0.457 . . . . 0.0 110.882 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 59.5 m -81.26 167.33 19.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.492 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.43 ' HG ' HG21 ' A' ' 230' ' ' VAL . 18.7 tp -76.02 102.92 5.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.697 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.58 167.63 19.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.297 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -80.68 28.7 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -171.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -153.09 32.23 0.48 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.874 0.368 . . . . 0.0 110.838 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.6 mmt -94.22 129.99 40.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.871 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -85.15 140.69 30.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.618 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.4 HG21 HD13 ' A' ' 261' ' ' LEU . 11.2 t -109.46 108.11 24.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.919 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . 0.515 ' HA ' ' O ' ' A' ' 226' ' ' THR . 6.8 t30 -119.6 132.11 55.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.15 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 4.0 mt -92.72 129.57 43.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.02 0.438 . . . . 0.0 110.591 175.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 50.8 mt -76.17 111.1 11.23 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -123.77 144.91 49.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.97 0.414 . . . . 0.0 110.75 -174.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.248 1.015 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.986 -177.317 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.708 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 48.8 m -124.66 165.93 17.03 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 14.9 t -160.06 160.21 32.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.946 0.403 . . . . 0.0 110.366 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -132.05 -172.56 2.91 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 20.1 p -66.81 -77.24 0.07 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.275 176.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 50.96 37.73 36.76 Favored Glycine 0 C--N 1.332 0.361 0 O-C-N 123.331 0.394 . . . . 0.0 113.056 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.406 HG21 ' O ' ' A' ' 263' ' ' ALA . 44.2 mt -82.5 141.7 14.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -176.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 5.4 p -95.29 147.14 23.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.724 0.773 . . . . 0.0 112.131 -171.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.67 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.6 p -57.54 151.37 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.089 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 33.1 t -101.93 47.7 0.89 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.084 0.469 . . . . 0.0 110.427 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 122.57 163.94 12.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.407 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -79.34 123.26 27.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.797 0.332 . . . . 0.0 110.417 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.437 HE22 ' CB ' ' A' ' 260' ' ' THR . 95.1 mt-30 -132.88 131.55 41.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.228 0.537 . . . . 0.0 111.217 -177.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 32.1 t -131.34 101.93 5.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.571 ' O ' HG13 ' A' ' 313' ' ' VAL . 64.8 m-85 -94.68 137.45 33.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.219 -176.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.69 ' HB3' ' NE2' ' A' ' 324' ' ' GLN . 3.3 mptp? -109.85 146.56 34.36 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.681 -177.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.553 ' HA ' ' OD1' ' A' ' 254' ' ' ASN . 73.5 Cg_endo -80.25 137.24 11.87 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.571 2.181 . . . . 0.0 111.029 170.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.67 109.22 7.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.431 0.634 . . . . 0.0 110.539 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -136.41 129.77 31.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.538 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 28.2 t90 71.74 -53.21 0.69 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.022 0.826 . . . . 0.0 111.492 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -74.8 153.38 38.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.449 ' HG ' ' H ' ' A' ' 247' ' ' GLY . 39.3 tp 58.53 51.37 8.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.403 0.62 . . . . 0.0 110.012 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -75.67 -9.08 58.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.458 -175.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -80.4 -25.91 38.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.881 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -124.47 -59.87 1.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.434 -173.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.449 ' H ' ' HG ' ' A' ' 243' ' ' LEU . . . 60.67 -142.58 48.18 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.961 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -105.12 12.88 31.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.351 0.596 . . . . 0.0 109.772 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -79.08 -33.48 44.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.809 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.09 179.9 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.692 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 62.54 -154.7 0.34 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.45 138.44 22.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 171.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -77.13 110.41 11.78 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.553 ' OD1' ' HA ' ' A' ' 238' ' ' PRO . 20.1 t-20 -71.79 -7.63 49.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.108 -174.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -67.42 -17.19 64.62 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.705 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -107.4 135.58 48.65 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.652 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -100.55 122.9 44.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.475 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -90.68 101.26 14.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.016 0.436 . . . . 0.0 111.089 179.002 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.6 t -83.15 121.48 36.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.977 -175.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.437 ' CB ' HE22 ' A' ' 234' ' ' GLN . 29.0 m -94.28 107.02 18.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.312 0.577 . . . . 0.0 109.985 176.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.481 ' HB2' HG22 ' A' ' 264' ' ' THR . 17.8 mt -121.04 163.19 18.71 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.634 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 26.2 m -55.03 -54.0 48.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.172 0.51 . . . . 0.0 109.958 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.406 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.47 135.45 36.84 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.481 HG22 ' HB2' ' A' ' 261' ' ' LEU . 7.9 p -126.37 29.25 5.82 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.5 m -82.21 139.51 34.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.023 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 96.05 18.48 31.53 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 65.4 mtt -121.45 147.26 45.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.022 -0.589 . . . . 0.0 109.722 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -139.14 169.5 17.66 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.527 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 298' ' ' VAL . 47.6 mtt180 -56.48 128.56 36.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.777 0.323 . . . . 0.0 111.371 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.02 18.57 42.89 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.354 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.488 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 92.0 m-20 -93.78 156.12 16.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.169 0.484 . . . . 0.0 110.302 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -102.9 116.6 32.87 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.423 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.478 HD11 HG21 ' A' ' 308' ' ' ILE . 28.5 pt -113.51 138.69 42.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.095 176.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 10.5 t -120.19 132.25 55.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.461 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.453 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 92.5 m-85 -94.43 110.33 22.12 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.97 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.44 111.37 8.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.374 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.63 -19.95 20.98 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.577 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 74.7 t -104.44 128.7 57.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 174.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -147.11 159.7 43.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.956 0.407 . . . . 0.0 111.106 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 76.9 m-85 -73.66 166.08 23.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.277 -175.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 89.6 mt -61.32 136.86 58.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.489 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 99.23 -22.35 41.23 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.028 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -75.78 128.74 35.8 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 287' ' ' ASN . 86.1 mtp 69.48 17.54 8.0 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.599 -176.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.38 -36.99 60.83 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -151.85 24.02 0.67 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.772 -1.103 . . . . 0.0 108.923 171.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 284' ' ' MET . 9.6 m120 -130.85 96.16 4.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.026 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 83.7 t -62.99 -49.41 83.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.175 0.512 . . . . 0.0 110.219 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 80.5 mt -87.59 61.11 6.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.864 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -82.78 173.44 11.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.973 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -102.27 137.73 40.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.438 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -76.41 166.74 23.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.465 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -68.99 129.99 41.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.762 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 9.3 p -119.74 110.6 16.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.847 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -116.95 151.75 36.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.057 0.455 . . . . 0.0 110.95 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.3 m -98.56 131.08 45.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.713 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.488 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.3 p -79.09 131.33 34.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.263 0.554 . . . . 0.0 110.8 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.554 ' O ' ' HG2' ' A' ' 269' ' ' ARG . 25.6 t -94.61 -24.55 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.532 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.445 ' HB3' ' CD ' ' A' ' 307' ' ' GLU . 12.4 tpt180 -176.85 139.33 0.29 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.369 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 75.6 t -90.59 111.02 22.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 36.9 t -73.27 -55.59 12.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.047 -171.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -128.96 -4.26 5.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.191 0.519 . . . . 0.0 111.463 -176.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 80.55 13.32 81.79 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.46 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.3 p -143.51 16.42 1.83 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.1 t-160 -165.47 118.25 1.16 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.269 -170.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.5 m -118.95 157.54 20.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -176.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.445 ' CD ' ' HB3' ' A' ' 299' ' ' ARG . 8.8 pt-20 -115.39 121.72 43.66 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 173.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.478 HG21 HD11 ' A' ' 273' ' ' ILE . 30.0 pt -122.45 163.75 20.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.184 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.9 t -149.21 142.28 15.85 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.447 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.05 179.63 28.93 Favored 'Cis proline' 0 C--N 1.345 0.35 0 C-N-CA 123.463 -1.474 . . . . 0.0 112.696 -0.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -83.14 124.45 76.33 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.053 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -72.78 109.2 2.74 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.835 2.357 . . . . 0.0 112.225 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 236' ' ' PHE . 0.0 OUTLIER -118.82 137.3 53.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.642 176.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -81.46 131.15 35.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.285 0.564 . . . . 0.0 110.459 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -73.79 -29.35 62.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.111 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -93.9 24.79 3.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.346 0.593 . . . . 0.0 110.498 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . 0.646 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 14.8 t70 -82.05 121.4 26.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.198 177.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 13.1 p -84.32 -19.09 9.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.986 0.422 . . . . 0.0 110.996 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 34.2 t -71.72 -46.61 58.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.51 -174.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.646 ' HG ' ' OD1' ' A' ' 317' ' ' ASP . 0.3 OUTLIER -74.82 170.15 16.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.739 0.781 . . . . 0.0 113.066 -175.167 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 41.2 t -83.77 151.59 61.49 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.624 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.45 ' HA ' ' HD2' ' A' ' 325' ' ' ARG . 99.9 Cg_exo -45.84 -40.3 19.6 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.183 2.588 . . . . 0.0 113.414 176.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -60.44 -41.53 94.24 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.444 0.64 . . . . 0.0 110.914 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.69 ' NE2' ' HB3' ' A' ' 237' ' ' LYS . 39.2 mt-30 -70.21 -24.44 63.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.037 -177.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.45 ' HD2' ' HA ' ' A' ' 322' ' ' PRO . 90.6 mtt180 -70.34 -26.51 63.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.585 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.5 -29.07 68.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.236 0.541 . . . . 0.0 110.17 176.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -97.38 6.36 48.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.342 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.423 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -71.79 150.13 44.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 0.0 110.884 177.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -126.97 -32.25 2.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.915 0.388 . . . . 0.0 111.387 -174.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.9 m -112.46 155.14 13.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.24 -176.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -83.76 -22.1 32.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.252 0.548 . . . . 0.0 109.99 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 278' ' ' VAL . 1.4 t -129.46 131.44 46.71 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.606 -176.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 8.7 p -75.39 168.13 20.58 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.682 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 20.5 tp -70.22 103.73 2.44 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.67 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.49 173.14 12.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.294 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.31 10.37 3.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.858 -173.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -143.0 57.85 1.41 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.234 0.54 . . . . 0.0 110.786 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.8 mmt -117.11 136.14 53.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.282 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -96.38 131.93 42.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.903 0.382 . . . . 0.0 110.823 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.408 HG22 ' CD1' ' A' ' 275' ' ' PHE . 38.5 t -103.51 108.2 23.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.669 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -123.11 129.55 51.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.337 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 42.9 mt -80.17 125.14 38.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.525 175.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 78.5 mt -72.75 112.29 8.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.853 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -88.71 77.94 7.79 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.873 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.34 177.784 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.858 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.1 m -75.46 -42.19 53.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.702 0.287 . . . . 0.0 110.675 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 13.4 t -70.75 149.62 46.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -130.37 112.71 13.54 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.223 0.535 . . . . 0.0 111.066 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 28.6 p -96.18 82.65 3.49 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.972 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.79 63.96 3.06 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.742 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 263' ' ' ALA . 45.5 mm -98.66 139.58 20.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.583 0.23 . . . . 0.0 111.112 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.3 p -121.72 160.24 24.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.949 0.404 . . . . 0.0 110.581 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.629 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.8 p -78.5 151.04 5.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.345 177.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.8 t -116.73 78.81 1.24 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.234 0.54 . . . . 0.0 109.755 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 110.68 166.33 19.1 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.46 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -97.35 110.12 22.74 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -97.51 127.36 43.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.36 0.6 . . . . 0.0 111.604 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.6 m -127.33 101.2 6.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.101 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.419 ' HB3' ' HE2' ' A' ' 311' ' ' LYS . 94.1 m-85 -85.49 167.92 15.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.497 -174.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . 42.7 mmtm -137.65 136.63 20.4 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.496 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.542 ' HD3' HG11 ' A' ' 313' ' ' VAL . 71.6 Cg_endo -89.86 127.97 1.59 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.638 2.226 . . . . 0.0 111.686 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 8.0 p -61.77 125.37 17.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.058 0.456 . . . . 0.0 110.359 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -73.58 114.36 11.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.304 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 74.7 m95 72.51 155.62 0.16 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.05 0.844 . . . . 0.0 111.444 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -79.17 133.72 36.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.171 -175.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 87.3 mt -97.03 167.93 10.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.963 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -119.16 -151.29 0.48 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -60.86 -39.74 90.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.253 0.549 . . . . 0.0 110.079 174.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -102.59 179.17 4.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.548 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 116.4 -90.76 0.53 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.772 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -100.85 171.95 7.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.546 0.212 . . . . 0.0 110.61 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -80.19 -39.25 29.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.051 0.453 . . . . 0.0 110.169 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.6 m -73.51 113.89 12.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.431 0.634 . . . . 0.0 110.706 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -103.75 22.26 14.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.575 0.703 . . . . 0.0 110.489 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.0 p -99.18 148.63 6.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.328 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -59.94 118.64 6.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.842 0.353 . . . . 0.0 110.25 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -93.52 2.14 56.53 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.843 -175.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -85.93 -32.71 21.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.134 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -79.45 127.91 32.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.963 173.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.75 122.67 43.76 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.825 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -90.96 104.3 16.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.501 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.6 t -86.33 121.96 38.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.441 -173.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 63.3 m -91.12 105.35 17.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.218 0.533 . . . . 0.0 110.202 175.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.496 HD23 HG23 ' A' ' 230' ' ' VAL . 21.7 mt -122.02 162.85 20.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.623 -177.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 8.0 m -59.79 -52.05 67.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.169 0.509 . . . . 0.0 109.875 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.533 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.08 125.09 24.29 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.667 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.54 ' HB ' ' SD ' ' A' ' 267' ' ' MET . 6.7 p -124.92 27.07 6.86 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.138 0.971 . . . . 0.0 108.589 174.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 8.3 m -82.89 138.05 34.02 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.585 177.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 101.7 -14.31 57.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -175.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . 0.54 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 64.5 mtt -82.82 153.73 25.04 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -153.67 142.61 21.17 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.549 ' HA ' HG13 ' A' ' 297' ' ' VAL . 34.6 ptt180 -50.87 114.03 1.06 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.624 0.578 . . . . 0.0 111.401 -173.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.16 -2.43 22.49 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.74 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.489 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.4 p30 -81.67 -179.25 7.3 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 117.258 0.529 . . . . 0.0 111.243 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -131.93 116.51 17.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.845 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.402 HD11 HG21 ' A' ' 308' ' ' ILE . 22.3 pt -114.14 138.9 42.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.148 0.499 . . . . 0.0 110.769 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 13.3 t -118.51 137.07 53.45 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.615 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -103.69 111.36 23.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.037 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.54 118.82 13.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.688 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.99 -13.74 26.56 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.682 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.02 147.94 15.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.605 ' HG3' ' SD ' ' A' ' 284' ' ' MET . 11.6 ptpt -161.24 156.55 24.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.912 0.387 . . . . 0.0 111.48 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -81.15 153.46 27.24 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.465 -171.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.46 HD11 ' HB2' ' A' ' 315' ' ' LEU . 83.7 mt -72.07 143.02 49.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.213 175.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 100.22 -39.8 2.63 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.45 ' O ' ' HB3' ' A' ' 287' ' ' ASN . 6.3 tp-100 -76.69 -20.11 56.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.238 0.542 . . . . 0.0 109.649 178.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.605 ' SD ' ' HG3' ' A' ' 279' ' ' LYS . 88.2 mtp -98.03 17.19 18.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.703 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -80.57 -56.06 4.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.805 0.336 . . . . 0.0 110.94 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -121.59 -29.95 4.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.589 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 283' ' ' GLN . 3.0 t-20 -75.42 108.95 8.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.036 0.446 . . . . 0.0 109.954 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.04 -31.26 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.241 0.543 . . . . 0.0 109.872 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 73.5 mt -91.56 53.93 2.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.509 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.408 ' HB3' ' HD3' ' A' ' 279' ' ' LYS . . . -65.52 124.87 23.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.05 -177.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -59.74 141.86 54.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.096 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -66.02 148.23 52.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.357 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -57.71 117.76 4.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.085 -172.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 37.9 p -105.01 113.75 27.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.565 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -110.94 148.44 32.5 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.992 0.425 . . . . 0.0 110.735 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 16.0 m -96.23 127.92 42.67 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.001 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.58 ' HA ' HG22 ' A' ' 308' ' ' ILE . 2.5 p -73.95 140.62 17.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.7 t -104.09 -31.85 2.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.055 0.455 . . . . 0.0 109.88 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.552 ' HD2' ' OE2' ' A' ' 307' ' ' GLU . 1.2 tmt_? -173.47 138.41 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.0 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 79.4 t -90.64 116.8 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 22.2 t -78.01 -58.8 3.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.042 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -116.71 -10.62 11.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.918 0.389 . . . . 0.0 111.864 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 78.53 12.22 84.48 Favored Glycine 0 CA--C 1.517 0.204 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -171.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.8 p -149.92 22.3 0.88 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.473 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 8.5 t-160 -174.08 115.59 0.21 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 113.561 -1.654 . . . . 0.0 107.999 -166.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.23 166.51 13.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.552 ' OE2' ' HD2' ' A' ' 299' ' ' ARG . 10.5 pt-20 -123.79 122.34 37.8 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 169.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.58 HG22 ' HA ' ' A' ' 297' ' ' VAL . 30.0 pt -121.2 170.74 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.51 -174.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.408 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 11.8 t -152.01 139.93 13.07 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.969 172.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.408 ' C ' ' HA ' ' A' ' 309' ' ' THR . 61.6 Cg_endo -71.14 179.4 25.39 Favored 'Cis proline' 0 C--N 1.345 0.368 0 C-N-CA 123.846 -1.314 . . . . 0.0 113.209 2.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.509 ' HG2' HG13 ' A' ' 313' ' ' VAL . 19.6 ttmt -84.95 126.37 68.17 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.669 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 19.9 Cg_exo -65.9 108.11 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.316 2.011 . . . . 0.0 111.84 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.542 HG11 ' HD3' ' A' ' 238' ' ' PRO . 1.3 m -130.87 129.54 63.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.151 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -93.06 141.5 28.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.433 -173.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.46 ' HB2' HD11 ' A' ' 281' ' ' LEU . 2.8 tm? -75.07 -26.16 59.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.483 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -94.83 26.0 3.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.644 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -83.49 136.56 34.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 27.8 m -83.81 -9.77 11.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 9.6 t -120.22 23.33 11.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.938 0.399 . . . . 0.0 111.626 -171.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.23 168.67 10.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.077 0.465 . . . . 0.0 111.026 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 51.9 m -112.49 165.25 13.43 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.358 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.462 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 85.5 Cg_exo -45.25 -49.45 10.16 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.517 2.812 . . . . 0.0 114.737 -175.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.2 -28.94 61.51 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.807 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -67.99 -41.13 82.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.663 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.462 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 28.8 ptt180 -69.12 -23.43 63.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.145 0.498 . . . . 0.0 110.17 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -80.68 -10.25 59.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.628 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -118.41 16.52 13.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.783 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.413 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -65.1 151.27 46.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.223 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . 0.413 ' H ' HG23 ' A' ' 313' ' ' VAL . 83.3 m-20 -115.21 -39.64 3.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.796 -175.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 30.7 m -118.26 168.28 10.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.22 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -82.31 -49.63 9.83 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.874 0.368 . . . . 0.0 110.798 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 13.5 t -117.79 149.82 40.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.202 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 22.6 p -80.8 171.23 15.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.009 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 20.1 tp -73.75 111.27 8.74 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.629 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -82.0 170.68 15.29 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.137 0.494 . . . . 0.0 111.435 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.07 -8.92 57.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.506 -169.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -138.33 55.36 1.75 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.04 0.448 . . . . 0.0 111.578 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.52 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 14.5 mmt -102.33 147.57 26.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.162 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -96.14 143.56 27.16 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.68 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.463 ' O ' ' HB ' ' A' ' 228' ' ' ILE . 17.7 t -115.52 126.89 73.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -133.35 136.35 45.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.177 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 25.2 mt -90.1 124.38 42.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.919 0.39 . . . . 0.0 110.324 174.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 45.2 mt -75.16 113.16 12.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.212 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -75.96 88.59 2.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 175.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.247 0.94 0 CA-C-O 117.642 -1.17 . . . . 0.0 110.409 -178.102 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.63 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 35.4 m -108.09 104.46 13.9 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.769 0.319 . . . . 0.0 110.357 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.44 ' OG1' ' HB2' ' A' ' 344' ' ' ASN . 13.5 p -91.56 1.76 56.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.84 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -76.64 69.9 3.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.203 0.525 . . . . 0.0 110.716 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.531 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 23.2 p -66.95 -59.6 3.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.693 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 60.67 39.3 96.41 Favored Glycine 0 CA--C 1.516 0.144 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.313 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.553 HG21 ' O ' ' A' ' 263' ' ' ALA . 71.9 mt -102.95 143.86 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 7.0 p -111.3 151.43 28.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.079 0.466 . . . . 0.0 111.246 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.644 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.5 p -60.75 150.48 6.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.807 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 8.8 t -112.3 82.21 1.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.115 0.484 . . . . 0.0 109.747 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 92.66 149.61 24.99 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.858 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.56 121.75 17.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.837 0.351 . . . . 0.0 110.552 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -113.25 126.96 55.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.203 0.525 . . . . 0.0 110.238 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 20.3 p -127.9 104.0 7.57 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.171 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -81.51 161.51 23.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.789 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -142.02 133.74 13.38 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.601 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.57 ' HD3' HG11 ' A' ' 313' ' ' VAL . 84.7 Cg_endo -87.76 174.51 4.77 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.853 2.368 . . . . 0.0 111.435 176.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 46.3 t -108.7 96.79 4.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.913 0.387 . . . . 0.0 110.012 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.415 ' HB1' ' HB3' ' A' ' 323' ' ' GLU . . . -95.43 -164.39 1.16 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.64 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -79.21 -52.39 8.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.707 0.289 . . . . 0.0 110.753 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.573 ' HB2' ' OE1' ' A' ' 323' ' ' GLU . 26.8 mt-30 -105.89 139.01 41.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.821 0.343 . . . . 0.0 110.62 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.8 35.51 1.6 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.809 -175.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 59.9 -108.67 0.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.465 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -88.63 -47.31 8.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.921 0.391 . . . . 0.0 110.983 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -161.67 155.7 22.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.601 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -146.33 -69.47 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.111 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -83.52 65.5 8.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.469 0.652 . . . . 0.0 111.403 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -74.25 -57.19 4.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.991 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.468 HG23 HG13 ' A' ' 252' ' ' VAL . 17.4 m -86.11 162.79 2.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.083 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -80.15 96.3 6.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.129 0.49 . . . . 0.0 110.966 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.468 HG13 HG23 ' A' ' 250' ' ' VAL . 18.1 m -116.4 154.42 17.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.5 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -86.66 129.09 35.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.71 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -67.73 -33.42 74.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.657 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 44.0 mtm-85 -95.2 -49.22 5.59 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -174.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -79.19 147.66 32.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.991 0.424 . . . . 0.0 111.019 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -119.86 126.98 52.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.524 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.5 m -93.96 99.19 11.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.01 0.433 . . . . 0.0 110.62 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.456 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.7 t -83.66 120.16 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.168 -174.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 19.3 m -91.55 105.75 17.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.835 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.428 ' HB2' HG22 ' A' ' 264' ' ' THR . 19.9 mt -121.63 169.41 10.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.257 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 6.6 m -63.05 -55.19 27.68 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.553 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -136.62 131.15 33.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.696 178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.438 ' HB ' ' SD ' ' A' ' 267' ' ' MET . 3.2 p -129.51 27.49 5.27 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 174.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 18.4 m -82.69 141.88 32.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.096 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.03 -3.95 60.62 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -174.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . 0.438 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 89.5 mtp -86.9 152.85 22.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -154.84 140.85 18.34 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.22 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.655 ' HA ' HG13 ' A' ' 297' ' ' VAL . 35.9 ptt180 -52.45 117.82 3.14 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.374 0.606 . . . . 0.0 111.089 -175.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.47 1.12 21.8 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.378 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -84.06 179.68 7.45 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.132 0.466 . . . . 0.0 110.507 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.485 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 5.1 tppp? -137.67 115.94 11.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.827 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 308' ' ' ILE . 35.7 pt -112.99 140.0 35.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.206 0.527 . . . . 0.0 110.389 178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 17.9 m -131.39 138.73 49.24 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.663 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -100.29 113.5 26.25 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.096 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.94 113.56 2.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.499 -176.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.77 -34.34 5.16 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.932 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.7 t -81.14 127.85 39.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -149.12 161.75 41.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.708 0.289 . . . . 0.0 110.896 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 91.8 m-85 -83.67 158.42 21.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.053 -175.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 315' ' ' LEU . 95.5 mt -81.65 44.35 0.81 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.305 0.574 . . . . 0.0 111.26 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -144.08 25.8 2.05 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.471 HE21 ' HB1' ' A' ' 290' ' ' ALA . 12.3 mt-30 -130.42 170.86 13.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.272 -0.464 . . . . 0.0 109.815 -175.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 19.1 mmt 62.54 26.54 15.77 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.499 0.499 . . . . 0.0 111.11 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -78.41 -32.62 48.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.205 0.526 . . . . 0.0 109.955 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -155.23 -41.39 0.08 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.441 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -72.6 125.49 27.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.475 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 22.4 t -85.94 -22.09 7.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.186 0.517 . . . . 0.0 109.924 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 86.0 mt -81.42 59.62 4.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.718 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.471 ' HB1' HE21 ' A' ' 283' ' ' GLN . . . -80.14 133.64 36.08 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.136 -176.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -69.56 167.51 16.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.397 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -95.3 166.85 11.69 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 172.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -59.78 106.76 0.52 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.957 0.408 . . . . 0.0 111.334 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.485 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 21.3 p -88.59 115.6 26.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.501 -177.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -121.31 144.31 48.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.367 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 68.4 m -101.32 132.39 46.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.749 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.655 HG13 ' HA ' ' A' ' 269' ' ' ARG . 9.3 p -67.49 140.35 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.126 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.63 -42.65 7.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.111 175.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.417 ' HB3' ' CD ' ' A' ' 307' ' ' GLU . 23.5 tpt180 -157.33 128.06 6.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.85 -178.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 97.8 t -86.3 97.8 6.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 172.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 25.4 t -65.9 -58.74 5.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.691 -173.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -126.66 -8.31 6.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.141 0.496 . . . . 0.0 111.472 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.15 13.81 78.27 Favored Glycine 0 C--N 1.321 -0.252 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.677 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 21.6 p -138.95 10.31 2.6 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 170.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -162.74 116.6 1.71 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.453 -1.249 . . . . 0.0 107.894 -169.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.99 160.29 18.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.674 -172.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.0 pt-20 -121.28 122.58 40.22 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 168.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.52 HG21 HD11 ' A' ' 273' ' ' ILE . 23.4 pt -123.49 169.39 14.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.228 0.537 . . . . 0.0 112.309 -174.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.0 t -145.38 138.83 14.38 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.788 172.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.33 -179.75 24.62 Favored 'Cis proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.759 -1.35 . . . . 0.0 113.313 -1.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.449 ' HG3' ' HB2' ' A' ' 257' ' ' ALA . 3.3 ttmp? -87.42 125.53 65.29 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.558 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 14.4 Cg_exo -68.61 108.85 1.94 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.369 2.046 . . . . 0.0 111.861 175.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 328' ' ' ALA . 1.5 m -136.3 120.86 25.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -82.49 134.43 35.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.838 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.9 tm? -75.69 -25.05 56.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.618 176.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -85.9 6.02 30.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.14 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -77.2 126.8 31.53 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.2 m -83.94 2.35 3.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 7.7 m -103.5 23.22 12.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.703 0.287 . . . . 0.0 111.77 -172.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.472 HD13 ' HG2' ' A' ' 325' ' ' ARG . 1.0 OUTLIER -126.18 157.2 38.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.44 0.638 . . . . 0.0 112.25 -179.29 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.497 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 2.8 m -92.25 166.81 16.35 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.554 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 2.3 Cg_endo -42.18 -58.08 1.34 Allowed 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.759 2.973 . . . . 0.0 113.864 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.573 ' OE1' ' HB2' ' A' ' 242' ' ' GLN . 15.8 mp0 -60.4 -36.88 79.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.137 0.494 . . . . 0.0 111.084 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 9.2 mm100 -63.4 -30.5 71.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.664 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.472 ' HG2' HD13 ' A' ' 320' ' ' LEU . 34.2 mtp85 -61.28 -39.31 89.93 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.226 176.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.04 -26.15 68.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.066 0.46 . . . . 0.0 110.922 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -87.11 -12.88 45.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.232 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.605 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -72.3 151.63 42.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.515 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -137.18 -35.72 0.68 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -173.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.3 m -101.93 167.62 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.852 0.358 . . . . 0.0 111.092 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -83.63 -39.3 20.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.919 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.1 t -126.69 139.54 53.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.673 -177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.461 ' N ' ' HB2' ' A' ' 314' ' ' ALA . 46.3 m -70.42 171.92 9.24 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.411 ' HG ' HG21 ' A' ' 230' ' ' VAL . 20.3 tp -71.24 103.91 2.96 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.644 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -79.62 172.12 14.22 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.878 -175.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.51 -11.61 60.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.129 -171.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -132.49 71.27 1.47 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.016 0.436 . . . . 0.0 111.223 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.477 ' H ' HG12 ' A' ' 230' ' ' VAL . 23.5 mmt -121.84 133.84 54.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.666 175.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -85.38 136.54 33.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.906 0.384 . . . . 0.0 111.301 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 17.4 t -101.4 112.82 35.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.703 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . 0.531 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 5.7 t-20 -129.91 138.8 51.1 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.815 0.34 . . . . 0.0 111.382 -177.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 62.3 mt -92.1 125.92 44.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 172.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 40.4 mt -75.75 124.7 27.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.97 0.414 . . . . 0.0 111.012 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . 0.44 ' HB2' ' OG1' ' A' ' 224' ' ' THR . 46.2 t-20 -86.86 81.56 8.11 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.505 -0.759 . . . . 0.0 110.3 -177.7 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.815 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.6 m -75.12 144.77 42.68 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 12.2 m 59.16 69.13 0.74 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.307 0.575 . . . . 0.0 110.213 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.21 106.41 2.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.57 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 3.8 p -129.84 97.92 4.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.27 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -116.52 37.53 3.35 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.505 HG21 ' O ' ' A' ' 263' ' ' ALA . 37.9 mt -82.28 152.44 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.277 -0.461 . . . . 0.0 109.883 -173.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 22.0 p -114.64 162.59 16.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.454 0.645 . . . . 0.0 111.808 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.641 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.8 p -62.7 151.75 7.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.897 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 16.5 t -116.82 78.9 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.195 0.521 . . . . 0.0 109.615 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 100.82 145.79 17.89 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.904 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.83 111.74 5.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.844 0.354 . . . . 0.0 110.304 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -109.15 127.8 54.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.264 0.554 . . . . 0.0 110.834 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 16.7 p -115.95 143.12 45.88 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.639 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -115.99 154.45 29.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.791 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -143.45 135.56 13.2 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.501 ' HD3' HG11 ' A' ' 313' ' ' VAL . 10.9 Cg_endo -91.24 121.0 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.892 2.395 . . . . 0.0 110.66 169.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.468 HG12 ' OD1' ' A' ' 254' ' ' ASN . 8.9 p -62.43 132.21 28.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 121.359 0.6 . . . . 0.0 111.171 -176.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -100.32 -169.34 1.71 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.992 -177.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 98.9 m95 72.87 127.09 0.04 OUTLIER 'General case' 0 C--O 1.234 0.274 0 O-C-N 124.013 0.82 . . . . 0.0 111.358 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -68.76 154.89 41.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.491 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 246' ' ' ASP . 1.4 pp -113.14 34.39 4.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.077 0.465 . . . . 0.0 111.488 -173.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -73.66 -54.06 9.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.474 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -87.78 -52.01 5.54 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 243' ' ' LEU . 3.6 p-10 -147.8 159.28 43.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.15 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 179.14 -166.17 35.52 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.998 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -92.35 78.83 5.04 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.042 0.448 . . . . 0.0 110.669 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -81.21 59.41 3.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.455 0.645 . . . . 0.0 110.108 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.4 m -136.65 -169.21 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.959 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . 0.411 HD22 ' N ' ' A' ' 251' ' ' ASN . 0.9 OUTLIER -73.84 72.47 1.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.133 0.492 . . . . 0.0 110.156 176.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.418 ' HB ' ' OD1' ' A' ' 254' ' ' ASN . 15.8 m -77.92 129.46 37.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.698 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -93.76 53.02 1.76 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.343 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.468 ' OD1' HG12 ' A' ' 239' ' ' VAL . 4.0 m-20 -68.28 -49.62 59.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.165 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.443 ' NE ' ' HA ' ' A' ' 255' ' ' ARG . 5.7 tpm_? -79.44 -33.34 42.56 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.48 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 308' ' ' ILE . 51.7 m-85 -99.91 176.95 5.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.171 -172.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -153.57 125.23 7.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.677 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -90.18 104.13 16.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.246 0.546 . . . . 0.0 111.147 178.004 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.8 t -86.61 121.09 37.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.998 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 30.5 m -92.84 109.54 20.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.992 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.413 HD22 HG21 ' A' ' 340' ' ' VAL . 17.4 mt -124.54 176.03 6.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.918 -176.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 35.0 t -64.56 -59.66 4.03 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.505 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.58 138.7 39.83 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 7.6 p -126.97 28.09 5.86 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.004 0.906 . . . . 0.0 108.914 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 1.3 m -78.81 151.28 32.02 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.981 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 93.11 -22.44 34.57 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . 0.462 ' HG2' HD11 ' A' ' 342' ' ' ILE . 53.8 mtt -79.6 144.67 33.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.574 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 0.3 OUTLIER -137.31 152.48 49.8 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -50.82 126.03 14.87 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.568 0.542 . . . . 0.0 111.474 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.95 19.23 37.35 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.567 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.574 ' HB2' ' O ' ' A' ' 268' ' ' LYS . 0.8 OUTLIER -98.81 177.39 5.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.973 0.416 . . . . 0.0 110.673 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -122.02 116.34 24.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.908 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.504 HD11 HG21 ' A' ' 308' ' ' ILE . 40.3 pt -113.19 140.28 34.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.215 177.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -118.24 133.47 55.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.215 -176.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -99.63 110.99 23.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.894 0.378 . . . . 0.0 110.028 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.09 117.81 15.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.531 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.79 -24.41 15.09 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 42.4 t -99.99 133.85 41.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -151.1 160.63 43.77 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 120.993 0.425 . . . . 0.0 111.066 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -78.19 154.33 31.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.369 -169.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.463 HD11 ' HB2' ' A' ' 315' ' ' LEU . 84.4 mt -71.32 141.01 50.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.388 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 94.69 -29.34 9.26 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.54 ' O ' ' HB2' ' A' ' 287' ' ' ASN . 28.6 mm-40 -84.4 8.13 17.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.995 0.426 . . . . 0.0 110.746 -177.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 90.5 mtp -122.77 8.92 9.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.955 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -83.82 -32.77 25.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.144 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -160.26 31.62 0.17 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.419 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.54 ' HB2' ' O ' ' A' ' 283' ' ' GLN . 17.0 m120 -128.35 103.16 7.0 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.455 -175.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 50.6 t -70.73 -31.36 45.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.341 0.591 . . . . 0.0 109.658 176.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 93.8 mt -89.49 55.58 3.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.032 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.97 112.74 7.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.677 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . 0.423 ' CD ' ' H ' ' A' ' 291' ' ' GLN . 1.0 OUTLIER -68.57 144.82 54.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.617 -178.086 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -69.63 154.32 42.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.52 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.484 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -60.33 102.05 0.16 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.26 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 1.2 p -103.44 117.84 35.38 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.245 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.484 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 85.1 m-85 -124.36 152.59 42.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.13 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.7 m -92.2 125.5 36.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.198 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 271' ' ' ASP . 10.9 p -81.48 130.17 36.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.301 0.572 . . . . 0.0 110.521 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 58.6 t -90.53 -38.7 11.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.548 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -160.41 141.47 12.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.202 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 90.4 t -94.38 107.56 19.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 27.3 t -77.41 -59.17 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.873 -172.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -120.21 -7.58 9.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.384 0.611 . . . . 0.0 111.116 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 79.27 14.18 81.93 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.316 -174.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 25.6 p -137.18 7.55 2.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.155 0.979 . . . . 0.0 108.525 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.568 ' NE2' ' HB ' ' A' ' 258' ' ' THR . 3.5 t-160 -160.88 118.96 2.45 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.392 -170.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -118.73 155.49 20.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -115.04 115.01 26.14 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.504 HG21 HD11 ' A' ' 273' ' ' ILE . 25.4 pt -114.2 176.72 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.711 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 5.2 t -154.17 141.53 13.59 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.674 174.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.09 -179.9 28.35 Favored 'Cis proline' 0 C--N 1.346 0.4 0 C-N-CA 123.818 -1.326 . . . . 0.0 112.568 -4.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -81.18 126.11 77.75 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.857 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.49 109.13 2.78 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.43 2.087 . . . . 0.0 111.887 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.755 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.4 OUTLIER -126.56 134.16 66.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.694 178.425 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -91.85 135.29 34.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.72 -173.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.463 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.3 tm? -70.55 -30.24 66.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.834 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -86.2 11.13 12.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.186 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.52 121.91 25.19 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 31.1 m -83.54 1.81 3.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -174.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.2 t -102.56 -6.5 22.76 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.424 -174.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.4 pp -102.82 153.77 19.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.49 0.662 . . . . 0.0 111.684 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 14.8 m -87.51 160.95 46.78 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.004 -177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -39.14 -50.49 2.72 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.923 3.082 . . . . 0.0 114.612 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -58.09 -41.17 82.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.255 0.55 . . . . 0.0 111.333 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 47.9 mt-30 -70.48 -26.31 63.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.711 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.421 ' HG2' ' CD1' ' A' ' 320' ' ' LEU . 76.6 mtt180 -61.04 -35.43 76.89 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 121.018 0.437 . . . . 0.0 110.445 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.89 -28.88 67.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.431 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . 0.455 ' CD2' ' HA ' ' A' ' 324' ' ' GLN . 12.0 m-85 -81.71 -11.05 59.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.824 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.755 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -65.59 139.01 58.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.991 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -127.62 -17.07 4.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.882 -175.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 31.5 m -122.11 158.23 25.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.929 0.395 . . . . 0.0 110.113 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -91.16 -7.01 52.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.307 -174.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.7 t -147.72 140.98 25.16 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.096 0.474 . . . . 0.0 110.824 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 26.9 p -78.28 168.05 20.42 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.316 175.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 19.3 tp -74.11 105.42 5.32 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.641 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -79.82 -178.8 6.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.055 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.06 -7.1 57.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.973 -172.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -133.74 57.83 1.79 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.849 0.357 . . . . 0.0 111.736 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.407 ' H ' HG12 ' A' ' 230' ' ' VAL . 25.2 mmt -111.78 137.46 49.67 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -92.25 145.46 24.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.778 0.323 . . . . 0.0 111.047 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.413 HG21 HD22 ' A' ' 261' ' ' LEU . 19.3 t -118.69 118.2 57.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.866 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -134.73 135.75 42.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.99 0.424 . . . . 0.0 111.557 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.462 HD11 ' HG2' ' A' ' 267' ' ' MET . 21.1 mt -87.62 127.46 40.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.813 176.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 65.3 mt -75.13 111.19 10.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.05 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -81.52 146.1 30.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.981 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 34.0 t . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.348 -0.834 . . . . 0.0 110.789 -177.376 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.617 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 34.8 t -79.64 -37.33 36.27 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.922 0.391 . . . . 0.0 110.144 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 20.8 p -82.31 -83.45 0.13 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.865 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 47.73 69.08 0.56 Allowed 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.711 0.632 . . . . 0.0 110.953 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.561 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 34.2 p -75.55 -64.95 0.96 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.441 -174.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 55.65 48.94 68.05 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.834 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.508 HG21 ' O ' ' A' ' 263' ' ' ALA . 57.2 mt -103.07 142.54 16.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 37.1 p -97.82 150.12 21.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.408 0.623 . . . . 0.0 112.261 -173.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.564 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.2 p -61.53 150.93 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.599 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 37.0 m -126.05 84.94 2.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.152 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 113.0 130.56 5.32 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.477 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -79.37 123.43 27.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -142.22 130.33 22.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.223 0.535 . . . . 0.0 111.474 -172.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.9 t -107.98 110.46 22.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.281 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.532 ' O ' HG13 ' A' ' 313' ' ' VAL . 62.4 m-85 -81.05 120.13 24.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.507 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -115.27 127.42 26.83 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.696 -175.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -83.69 -178.02 3.42 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.895 2.396 . . . . 0.0 111.265 173.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.427 HG12 ' HB3' ' A' ' 254' ' ' ASN . 7.7 p -112.94 110.56 32.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.263 0.554 . . . . 0.0 110.574 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.18 133.06 49.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.539 174.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -73.78 102.59 4.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.191 0.519 . . . . 0.0 110.281 -175.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -119.5 103.09 9.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.826 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 29.7 tp -84.51 68.95 10.49 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.392 0.615 . . . . 0.0 110.118 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -134.73 -63.36 0.71 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.544 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -87.57 -55.85 3.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.145 0.497 . . . . 0.0 110.404 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -123.95 150.26 44.98 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.94 -6.12 87.13 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.569 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . 0.528 ' HA ' ' OD1' ' A' ' 251' ' ' ASN . 13.1 m120 59.18 39.29 23.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.279 0.562 . . . . 0.0 111.203 176.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -68.52 -63.1 1.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.558 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 5.0 m -132.23 106.23 10.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.309 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . 0.528 ' OD1' ' HA ' ' A' ' 248' ' ' ASN . 11.9 m120 -137.56 52.81 1.88 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.283 -175.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 251' ' ' ASN . 96.1 t 74.13 143.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.351 0 O-C-N 123.683 0.614 . . . . 0.0 110.535 -178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -59.05 104.26 0.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.363 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.427 ' HB3' HG12 ' A' ' 239' ' ' VAL . 9.2 p30 -93.85 -16.06 24.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.291 -174.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 310' ' ' PRO . 23.9 mmt180 -91.69 -6.66 51.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.156 0.503 . . . . 0.0 110.402 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.442 ' CD2' ' HB ' ' A' ' 309' ' ' THR . 96.7 m-85 -120.14 160.98 21.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.017 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -136.01 129.31 31.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.479 0.18 . . . . 0.0 110.785 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.5 m -97.88 107.64 20.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.05 0.452 . . . . 0.0 109.984 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.41 120.27 36.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.205 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 60.4 m -91.01 115.33 27.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.823 173.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 17.2 mt -132.24 168.86 17.31 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 5.3 p -60.52 -55.96 27.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.196 0.522 . . . . 0.0 110.136 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.508 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -136.75 136.81 39.26 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.146 177.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 15.8 p -132.11 32.75 3.97 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 6.9 m -82.47 149.25 27.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.308 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 93.51 13.37 55.64 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 62.7 mtt -114.02 148.0 37.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.367 -0.417 . . . . 0.0 110.141 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -134.41 156.33 48.73 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -54.15 121.96 9.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.074 0.464 . . . . 0.0 110.762 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 106.75 7.97 33.01 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.862 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.503 ' H ' HG12 ' A' ' 297' ' ' VAL . 80.1 m-20 -90.79 148.54 22.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.419 0.609 . . . . 0.0 110.16 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 4.6 tppp? -96.03 117.67 31.13 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.725 -177.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.435 HD11 HG21 ' A' ' 308' ' ' ILE . 38.5 pt -112.58 139.96 34.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 176.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 45.5 m -120.5 136.48 54.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.516 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -100.7 111.46 23.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.871 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -74.15 114.21 12.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.709 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.55 -34.39 5.17 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 86.0 t -90.95 111.71 24.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.418 ' HD2' ' SD ' ' A' ' 284' ' ' MET . 0.5 OUTLIER -128.85 170.07 13.82 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.406 -177.109 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -75.95 171.73 13.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.644 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 89.0 mt -83.33 81.51 8.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.105 177.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 179.89 165.54 33.97 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.405 ' OE1' ' HG2' ' A' ' 291' ' ' GLN . 51.1 mt-30 61.97 -153.95 0.35 Allowed 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.792 0.348 . . . . 0.0 110.354 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.418 ' SD ' ' HD2' ' A' ' 279' ' ' LYS . 89.8 mtp 73.67 6.99 5.03 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.203 0.601 . . . . 0.0 111.545 175.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -82.64 -54.19 5.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.11 0.481 . . . . 0.0 110.143 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -133.73 -35.2 0.99 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.851 176.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -70.05 133.33 47.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.788 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.62 -21.64 6.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.491 0.662 . . . . 0.0 110.195 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 94.9 mt -83.85 56.84 3.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.686 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -77.86 111.28 13.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.073 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . 0.405 ' HG2' ' OE1' ' A' ' 283' ' ' GLN . 10.2 pt20 -50.58 124.61 11.14 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.777 0.673 . . . . 0.0 112.268 -173.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -76.21 166.39 23.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.844 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -59.18 100.33 0.07 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.882 -174.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.0 p -98.99 99.63 10.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.673 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.474 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 61.3 m-85 -118.23 142.8 47.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.09 0.472 . . . . 0.0 111.139 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 23.2 t -89.97 126.27 35.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.494 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 271' ' ' ASP . 11.5 p -69.12 135.13 28.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.122 0.487 . . . . 0.0 110.136 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.24 -32.93 4.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.684 -176.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.592 ' HD2' ' OE2' ' A' ' 307' ' ' GLU . 0.4 OUTLIER -167.85 137.07 2.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.255 -176.129 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 75.3 t -85.02 111.38 20.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 19.2 t -77.76 -53.9 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.646 -173.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -125.89 -11.63 6.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.81 0.338 . . . . 0.0 111.812 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 77.6 12.49 84.45 Favored Glycine 0 CA--C 1.516 0.145 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -170.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.0 p -149.9 22.17 0.88 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 174.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -174.04 112.63 0.18 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 113.378 -1.737 . . . . 0.0 107.991 -163.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.0 OUTLIER -119.43 164.05 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -174.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.592 ' OE2' ' HD2' ' A' ' 299' ' ' ARG . 11.4 pt-20 -125.01 127.01 46.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.218 0.532 . . . . 0.0 110.127 170.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.435 HG21 HD11 ' A' ' 273' ' ' ILE . 24.0 pt -120.42 175.79 4.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.884 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.442 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 14.2 t -154.61 143.53 14.84 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.853 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 255' ' ' ARG . 74.1 Cg_endo -75.98 179.4 31.15 Favored 'Cis proline' 0 C--N 1.346 0.406 0 C-N-CA 123.709 -1.371 . . . . 0.0 112.512 -4.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' A' ' 257' ' ' ALA . 22.4 ttmm -76.94 121.68 85.16 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.504 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.09 108.54 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.217 1.944 . . . . 0.0 112.327 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 236' ' ' PHE . 0.1 OUTLIER -109.35 137.67 40.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.121 175.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -81.98 123.25 28.72 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.095 0.474 . . . . 0.0 110.513 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.5 -29.5 70.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.894 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.45 19.65 4.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.495 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -83.47 119.91 25.26 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.9 m -84.43 0.4 5.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -174.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 37.2 t -95.47 -28.16 15.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.566 0.222 . . . . 0.0 111.404 -174.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.425 ' CD1' ' HG2' ' A' ' 325' ' ' ARG . 0.9 OUTLIER -80.64 160.61 25.0 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.413 0.625 . . . . 0.0 112.41 -175.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.533 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 34.4 t -87.04 157.42 54.15 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.146 -178.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.533 ' HD2' ' OG ' ' A' ' 321' ' ' SER . 2.8 Cg_exo -35.61 -58.01 0.47 Allowed 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 124.764 3.643 . . . . 0.0 115.513 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.64 -25.08 64.65 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.376 -174.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 321' ' ' SER . 8.5 mm100 -61.15 -34.48 75.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.038 0.447 . . . . 0.0 110.116 174.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.425 ' HG2' ' CD1' ' A' ' 320' ' ' LEU . 31.1 mtm180 -64.77 -32.67 74.46 Favored 'General case' 0 C--N 1.335 -0.063 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.724 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -70.62 -24.94 62.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.087 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.77 -2.3 57.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.685 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.455 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -67.81 156.27 37.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.066 0.46 . . . . 0.0 111.022 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -138.42 -20.84 1.05 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.292 -173.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 23.4 m -125.28 160.17 31.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.946 0.403 . . . . 0.0 110.399 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -89.16 -17.14 29.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.527 -175.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 8.8 t -143.42 142.89 31.39 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 22.6 p -75.72 170.33 16.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.736 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.463 ' HG ' HG21 ' A' ' 230' ' ' VAL . 17.0 tp -72.34 103.3 3.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.564 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -81.99 -170.88 3.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.19 -176.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -80.32 -8.5 59.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.013 -175.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -137.42 66.97 1.44 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.0 0.429 . . . . 0.0 111.567 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.559 ' H ' HG12 ' A' ' 230' ' ' VAL . 23.1 mmt -119.86 132.48 55.58 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -91.25 137.16 32.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.839 0.352 . . . . 0.0 111.007 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 32.7 t -114.25 107.2 22.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.239 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . 0.561 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 64.5 t30 -126.35 145.62 50.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.922 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 22.8 mt -89.56 132.37 34.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 177.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 80.8 mt -76.14 118.97 19.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.542 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -125.87 149.41 48.7 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 28.9 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.824 -179.671 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.53 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 42.2 p 49.55 44.77 24.35 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.178 0.591 . . . . 0.0 111.571 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.9 t -159.82 157.72 29.75 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.444 -178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 52.4 64.79 1.72 Allowed 'General case' 0 C--O 1.234 0.287 0 O-C-N 123.575 0.547 . . . . 0.0 111.482 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 24.2 p -72.37 -72.05 0.26 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.172 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.56 39.77 95.46 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.006 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.6 HG21 ' O ' ' A' ' 263' ' ' ALA . 55.7 mt -103.05 145.28 12.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 36.0 p -99.22 160.79 14.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.417 0.627 . . . . 0.0 112.248 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.678 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.7 p -68.88 152.04 9.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.495 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.1 m -122.08 86.77 2.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.949 0.404 . . . . 0.0 110.7 173.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 102.56 137.2 9.47 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.337 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.54 130.27 42.69 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -132.9 127.14 33.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.165 0.507 . . . . 0.0 111.31 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.8 t -117.26 103.12 9.85 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -80.8 129.1 34.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.319 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -117.19 125.75 27.96 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.052 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.545 ' HA ' ' OD1' ' A' ' 254' ' ' ASN . 95.2 Cg_endo -80.32 172.91 13.09 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.111 2.541 . . . . 0.0 111.639 176.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.11 127.14 40.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.092 0.472 . . . . 0.0 110.477 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -73.97 107.21 6.05 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 30.0 m-90 -63.32 -18.85 64.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.067 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -99.97 103.57 15.13 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.0 mp -107.11 -159.4 0.69 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.623 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -78.21 -155.66 0.08 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.433 HD22 ' N ' ' A' ' 245' ' ' ASN . 0.9 OUTLIER -63.67 -32.1 73.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.775 0.322 . . . . 0.0 111.041 -178.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -106.28 107.06 17.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.421 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.67 -173.82 45.59 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.56 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -88.45 129.4 35.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.106 0.479 . . . . 0.0 110.179 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -103.11 -20.83 14.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.25 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 36.0 m -78.62 155.84 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.726 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -89.06 85.26 6.65 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 254' ' ' ASN . 8.1 p -83.67 131.81 32.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.216 -174.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -80.83 40.56 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.551 0.691 . . . . 0.0 110.501 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.545 ' OD1' ' HA ' ' A' ' 238' ' ' PRO . 11.9 t-20 -77.55 -12.35 59.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.208 -175.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -70.67 -12.15 61.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.766 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -114.47 148.54 37.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.919 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -109.26 124.03 50.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.951 176.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.7 m -97.47 107.14 19.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.225 0.536 . . . . 0.0 110.275 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -89.0 124.86 42.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.603 -170.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 55.6 m -95.18 114.59 26.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.799 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.556 HD13 HG21 ' A' ' 340' ' ' VAL . 17.4 mt -129.87 170.52 13.8 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -176.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 16.8 m -57.31 -56.93 15.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.389 0.614 . . . . 0.0 109.599 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.6 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -138.52 141.02 39.34 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.776 175.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 11.2 p -130.8 26.49 4.98 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.7 m -80.49 147.5 30.86 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.526 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 95.24 -28.11 12.98 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -177.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 62.1 mtt -71.42 153.47 42.25 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -135.53 151.02 49.92 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.807 0.337 . . . . 0.0 110.58 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -56.39 131.8 49.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.204 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.77 19.14 32.53 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.352 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.488 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.8 t70 -103.28 -167.51 1.39 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 117.555 0.677 . . . . 0.0 110.159 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.441 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 3.9 tppp? -129.76 115.7 17.67 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.593 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.442 HD11 HG21 ' A' ' 308' ' ' ILE . 20.0 pt -115.06 142.76 26.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.134 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.516 ' HB3' HG22 ' A' ' 294' ' ' THR . 73.5 p -128.85 143.69 50.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.149 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -105.2 114.02 27.95 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.044 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.82 115.98 3.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.828 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.94 -31.15 6.95 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.105 -177.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 292' ' ' ASP . 48.5 t -84.54 136.08 23.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.525 ' NZ ' ' HB3' ' A' ' 279' ' ' LYS . 0.1 OUTLIER -160.76 156.33 25.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.112 0.482 . . . . 0.0 111.413 -177.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 329' ' ' ASN . 63.0 m-85 -76.58 148.63 36.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.372 -170.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.495 HD11 ' HB2' ' A' ' 315' ' ' LEU . 59.5 mt -63.34 -34.7 78.28 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.461 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -64.65 -19.1 64.62 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.788 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -112.22 4.48 17.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.661 0.267 . . . . 0.0 110.861 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 90.5 mmm -121.47 22.88 10.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.96 0.41 . . . . 0.0 110.724 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -81.35 -52.05 7.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.176 0.512 . . . . 0.0 110.211 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -130.67 -7.34 4.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.946 175.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -102.7 149.15 24.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.042 178.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.41 -15.56 10.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.726 0.774 . . . . 0.0 109.505 178.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 92.5 mt -88.47 50.71 2.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.973 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.446 ' HB3' ' HD3' ' A' ' 279' ' ' LYS . . . -84.58 124.14 31.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.364 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -60.41 146.14 45.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.083 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 278' ' ' VAL . 60.3 m-20 -60.05 139.8 57.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.212 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -57.07 116.07 3.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.636 -174.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 274' ' ' SER . 28.1 p -97.81 129.17 44.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.866 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -130.63 143.14 50.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.783 0.325 . . . . 0.0 110.699 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 62.5 m -78.72 126.96 31.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.101 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.515 ' HA ' HG22 ' A' ' 308' ' ' ILE . 13.5 p -84.06 126.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.262 0.553 . . . . 0.0 110.018 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 44.7 t -84.01 -40.85 16.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.379 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -163.29 142.26 8.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.405 ' CG1' ' HA2' ' A' ' 303' ' ' GLY . 89.6 t -82.59 106.95 13.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 26.7 t -72.82 -58.7 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.945 -170.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -119.59 0.48 11.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.94 0.4 . . . . 0.0 111.331 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . 0.405 ' HA2' ' CG1' ' A' ' 300' ' ' VAL . . . 70.81 12.73 71.25 Favored Glycine 0 C--O 1.23 -0.143 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -173.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 19.4 p -149.31 19.72 0.95 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 174.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.551 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.9 t-160 -170.89 115.46 0.44 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 113.737 -1.574 . . . . 0.0 107.976 -164.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.73 165.04 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.494 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -123.86 122.1 37.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.051 0.453 . . . . 0.0 110.264 172.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.515 HG22 ' HA ' ' A' ' 297' ' ' VAL . 28.2 pt -124.03 168.55 16.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.102 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 310' ' ' PRO . 15.1 t -154.57 145.18 16.05 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.4 ' HA ' ' OG1' ' A' ' 309' ' ' THR . 10.2 Cg_exo -72.29 178.13 32.23 Favored 'Cis proline' 0 C--N 1.344 0.337 0 C-N-CA 124.013 -1.245 . . . . 0.0 112.556 0.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -87.39 123.37 69.83 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.743 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.448 ' HA ' ' OD1' ' A' ' 329' ' ' ASN . 48.7 Cg_endo -71.41 108.94 2.49 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.37 2.046 . . . . 0.0 112.091 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.56 132.0 57.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.713 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 317' ' ' ASP . . . -83.09 121.92 27.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.081 0.467 . . . . 0.0 110.448 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.495 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.0 tm? -62.99 -30.2 71.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.725 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -86.39 5.12 36.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.393 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 10.6 t70 -89.91 111.68 22.8 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 17.9 m -83.61 2.4 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 9.4 t -92.95 29.09 1.91 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.027 0.441 . . . . 0.0 110.832 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 2.5 pp -129.06 171.32 12.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.879 0.371 . . . . 0.0 111.467 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 41.7 t -85.96 149.14 49.85 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.105 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.655 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 1.4 Cg_endo -42.27 -47.29 7.19 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.84 3.027 . . . . 0.0 113.885 -177.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.443 ' O ' ' HD1' ' A' ' 327' ' ' TYR . 58.6 mm-40 -63.16 -23.38 67.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.98 0.419 . . . . 0.0 111.456 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -81.27 -24.34 37.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.784 -174.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 5.3 ptp180 -78.28 -22.31 48.43 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.096 0.474 . . . . 0.0 110.04 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -69.15 -36.03 76.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.183 174.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . 0.443 ' HD1' ' O ' ' A' ' 323' ' ' GLU . 77.8 m-85 -90.05 3.05 54.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.839 178.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -70.26 123.94 22.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.03 0.443 . . . . 0.0 110.022 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 312' ' ' PRO . 26.7 p-10 -109.28 -17.92 13.71 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.506 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.3 m -118.85 159.4 19.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.188 0.518 . . . . 0.0 110.798 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -96.84 -12.04 24.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.164 -174.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.4 t -141.02 148.63 40.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.435 -176.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 7.6 p -85.04 166.27 16.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.694 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.611 HD12 ' SD ' ' A' ' 338' ' ' MET . 21.2 tp -67.74 104.4 1.64 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.678 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -84.04 156.82 22.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.772 -175.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.59 58.08 2.15 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.252 0.549 . . . . 0.0 111.942 -173.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -176.04 27.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.494 172.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.611 ' SD ' HD12 ' A' ' 334' ' ' LEU . 54.4 mtt -100.06 131.83 45.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -176.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -87.64 140.22 29.74 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.924 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.556 HG21 HD13 ' A' ' 261' ' ' LEU . 9.0 t -99.83 113.5 35.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.537 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -122.56 133.4 54.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.404 -175.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.438 ' CG1' HG22 ' A' ' 273' ' ' ILE . 14.6 mt -99.23 130.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.066 0.46 . . . . 0.0 110.798 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 46.3 mt -82.7 115.95 21.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.763 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -80.43 100.69 8.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.408 177.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 C--O 1.246 0.878 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.31 -177.518 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 112.174 -0.371 . . . . 0.0 112.174 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.458 ' N ' ' HB2' ' A' ' 344' ' ' ASN . 15.7 m -73.68 -61.58 1.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.875 0.369 . . . . 0.0 111.185 -176.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.417 ' HB ' HG23 ' A' ' 226' ' ' THR . 7.7 m -85.46 -18.6 33.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.856 -177.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 58.32 60.11 2.76 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.532 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.674 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 41.6 p -82.38 -69.9 0.59 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.967 -176.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 58.05 43.11 95.26 Favored Glycine 0 C--N 1.329 0.165 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.24 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.479 HG21 ' O ' ' A' ' 263' ' ' ALA . 68.6 mt -90.66 149.46 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 2.3 p -96.8 157.58 15.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.572 0.701 . . . . 0.0 112.428 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.552 HG11 ' O ' ' A' ' 335' ' ' ALA . 6.8 p -76.16 151.35 6.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.499 -176.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 65.0 m -109.63 83.22 1.72 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.025 0.441 . . . . 0.0 110.385 174.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.7 154.75 28.94 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.341 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -73.05 124.91 26.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.966 0.412 . . . . 0.0 111.008 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -113.25 128.56 56.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.059 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 12.8 t -131.16 119.83 22.45 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.414 ' O ' ' HD3' ' A' ' 237' ' ' LYS . 88.2 m-85 -104.08 143.06 33.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.743 -175.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 236' ' ' PHE . 44.7 mmtm -129.41 138.66 33.65 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.631 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.443 ' HD3' HG21 ' A' ' 313' ' ' VAL . 82.9 Cg_endo -89.69 135.75 2.52 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.035 2.49 . . . . 0.0 112.166 177.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 84.3 t -73.01 98.21 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.136 0.493 . . . . 0.0 110.788 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -92.97 89.91 6.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.295 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -147.4 -76.72 0.18 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.468 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.4 ' OE1' ' HD2' ' A' ' 249' ' ' LYS . 51.7 tp60 58.94 102.69 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.781 0.675 . . . . 0.0 111.177 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 62.2 tp -109.55 -51.55 2.86 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.3 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -143.21 -178.06 5.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.657 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -52.79 -42.61 65.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.239 0.543 . . . . 0.0 110.164 175.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -106.75 146.08 31.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.949 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 158.85 -138.51 5.73 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.069 -1.062 . . . . 0.0 112.975 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -78.8 45.17 0.58 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.4 ' HD2' ' OE1' ' A' ' 242' ' ' GLN . 27.7 mtpp -119.79 4.08 11.05 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.126 0.489 . . . . 0.0 110.394 174.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 30.0 m -103.87 155.28 5.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.637 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 65.38 107.57 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.777 0.673 . . . . 0.0 110.66 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 96.1 t 70.8 112.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.779 -175.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.439 ' CB ' ' HB2' ' A' ' 256' ' ' PHE . 60.7 m-20 -60.54 139.97 57.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.152 -173.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.541 ' O ' ' HD2' ' A' ' 311' ' ' LYS . 9.9 m120 -82.61 -46.39 13.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.375 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -91.9 -12.73 32.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.872 -174.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.457 ' CD1' ' HB ' ' A' ' 309' ' ' THR . 75.1 m-85 -115.56 144.68 43.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.393 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.448 ' HB2' ' HG3' ' A' ' 311' ' ' LYS . . . -114.59 121.89 44.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.618 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -89.43 106.38 18.41 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.748 177.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -86.04 118.13 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.402 -172.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 23.2 m -89.32 105.92 18.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.895 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 20.4 mt -122.07 172.08 8.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.735 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 42.2 m -64.57 -53.42 48.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.108 0.48 . . . . 0.0 109.783 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.57 142.93 41.32 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 18.2 p -134.07 30.0 3.68 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 4.3 m -81.26 134.63 35.63 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.956 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.7 -26.25 14.87 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -176.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . 0.468 ' HG3' HD11 ' A' ' 342' ' ' ILE . 1.9 mpt? -70.67 151.3 45.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -136.38 164.33 28.38 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -64.44 144.66 57.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.694 0.283 . . . . 0.0 110.676 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 77.8 19.02 76.29 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.742 173.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.519 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 1.7 t70 -100.68 -167.1 1.39 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 117.779 0.79 . . . . 0.0 109.907 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.462 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 13.1 tppt? -125.04 115.16 20.09 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.502 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.526 HD11 HG21 ' A' ' 308' ' ' ILE . 32.0 pt -116.93 139.31 44.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.677 177.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 50.1 p -118.9 138.4 52.78 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.559 -178.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -103.23 111.56 24.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.519 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.63 132.37 53.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.688 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 93.45 -34.71 4.46 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 56.4 t -86.0 146.04 6.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.578 ' HD2' ' SD ' ' A' ' 284' ' ' MET . 0.0 OUTLIER -162.22 162.21 28.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.75 0.31 . . . . 0.0 111.059 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 96.2 m-85 -73.59 170.3 15.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.63 -174.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.99 141.38 56.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.483 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 102.8 -26.36 24.31 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -173.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -78.14 146.97 34.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.578 ' SD ' ' HD2' ' A' ' 279' ' ' LYS . 94.0 mtp 66.76 20.44 10.65 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.797 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -96.11 -31.73 12.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.543 0.687 . . . . 0.0 109.649 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -161.87 39.94 0.13 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -124.02 100.17 6.61 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.726 -171.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 42.6 t -68.75 -41.54 82.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.02 -0.734 . . . . 0.0 109.02 173.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 74.0 mt -105.68 79.62 1.46 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.655 175.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -90.9 123.49 34.46 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.998 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -68.34 165.8 17.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.695 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.451 ' HA ' ' NZ ' ' A' ' 279' ' ' LYS . 64.7 m-20 -94.72 164.01 13.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.683 -178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -70.46 104.27 2.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.649 -174.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 14.0 p -92.14 103.29 15.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.033 177.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.404 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 61.6 m-85 -102.72 154.83 18.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.149 0.5 . . . . 0.0 111.277 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.4 m -89.99 120.89 31.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.088 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.519 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 14.2 p -84.19 139.45 17.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.466 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.2 t -105.76 -42.18 6.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.241 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -156.51 133.74 10.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.027 0.442 . . . . 0.0 111.659 -175.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 87.2 t -81.85 99.47 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 169.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 32.7 t -70.65 -58.47 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.917 -171.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -120.26 -0.66 10.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.719 0.295 . . . . 0.0 111.576 -174.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 69.31 12.58 66.32 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -172.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 26.6 p -147.4 19.99 1.2 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 7.1 t-160 -172.74 115.82 0.3 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 113.695 -1.593 . . . . 0.0 108.194 -164.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.52 166.75 13.62 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -176.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -123.86 126.56 46.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.084 0.469 . . . . 0.0 109.994 169.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.526 HG21 HD11 ' A' ' 273' ' ' ILE . 30.3 pt -123.12 170.04 13.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.997 -177.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.457 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 13.5 t -154.52 145.12 16.03 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.433 ' HA ' ' OG1' ' A' ' 309' ' ' THR . 58.4 Cg_endo -70.2 176.08 35.36 Favored 'Cis proline' 0 C--N 1.347 0.48 0 C-N-CA 123.835 -1.319 . . . . 0.0 112.879 1.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.541 ' HD2' ' O ' ' A' ' 254' ' ' ASN . 40.5 tttt -77.14 119.88 79.33 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.807 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 257' ' ' ALA . 27.1 Cg_exo -62.14 107.13 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.157 1.905 . . . . 0.0 111.676 177.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 328' ' ' ALA . 55.5 t -121.29 119.81 60.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.037 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.644 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -85.86 128.53 34.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.073 0.463 . . . . 0.0 111.101 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.3 tm? -70.16 -30.39 67.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.246 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -89.0 23.19 2.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.0 0.429 . . . . 0.0 111.25 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 14.6 t70 -100.52 137.49 38.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 30.1 m -84.29 -15.56 11.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 13.1 m -91.03 34.89 0.91 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.016 0.436 . . . . 0.0 111.485 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.497 ' HA ' ' NE2' ' A' ' 324' ' ' GLN . 1.9 pp -126.95 164.18 22.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.092 0.472 . . . . 0.0 111.449 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 65.4 p -99.89 168.59 9.25 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.768 176.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.502 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 86.8 Cg_exo -49.35 -36.07 37.14 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.306 2.004 . . . . 0.0 111.818 172.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.82 -46.3 65.96 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.818 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.497 ' NE2' ' HA ' ' A' ' 320' ' ' LEU . 26.5 mt-30 -69.65 -28.51 65.94 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -175.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.502 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 30.2 ptt180 -72.05 -21.69 61.49 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.324 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -73.4 -27.84 61.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.202 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -94.24 7.97 43.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.82 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.548 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -57.92 142.11 47.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.825 176.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -124.22 -30.02 3.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.2 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 27.7 m -122.4 160.11 24.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.871 0.367 . . . . 0.0 110.293 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -89.04 -20.89 23.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.071 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.1 t -141.6 141.88 33.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.994 0.426 . . . . 0.0 110.481 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 34.8 p -70.27 161.65 29.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.87 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.447 ' HG ' HG21 ' A' ' 230' ' ' VAL . 48.0 tp -69.47 103.41 2.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.552 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -82.93 170.42 14.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.841 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . 0.413 ' HA ' ' CG1' ' A' ' 230' ' ' VAL . 29.1 t70 -72.26 151.86 42.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.496 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 68.18 39.75 2.3 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.998 0.811 . . . . 0.0 111.608 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.411 ' H ' HG12 ' A' ' 230' ' ' VAL . 19.9 mmt -110.19 144.42 38.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 176.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.19 138.3 33.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.031 0.443 . . . . 0.0 111.316 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 23.9 t -113.73 110.73 33.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.444 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . 0.674 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 60.5 t30 -130.49 145.16 51.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.936 0.398 . . . . 0.0 111.484 -175.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.468 HD11 ' HG3' ' A' ' 267' ' ' MET . 61.0 mt -88.06 116.41 29.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.057 174.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 63.9 mt -78.13 154.17 31.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.182 -176.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . 0.458 ' HB2' ' N ' ' A' ' 223' ' ' SER . 7.5 t30 -123.35 128.95 50.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.755 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.55 -0.738 . . . . 0.0 109.939 179.259 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.773 0 N-CA-C 111.956 -0.458 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.4 m 61.51 60.03 1.75 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.41 0.624 . . . . 0.0 111.195 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 11.8 t -156.58 141.82 17.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.384 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 56.3 48.26 17.52 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.233 0.539 . . . . 0.0 110.285 -174.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 20.0 p -69.38 -56.79 6.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.186 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 63.25 53.1 42.1 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.283 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.511 HD12 ' O ' ' A' ' 263' ' ' ALA . 29.1 mm -102.21 143.02 15.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 20.7 p -131.49 170.21 15.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.087 0.47 . . . . 0.0 110.305 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.61 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.2 p -78.98 150.39 5.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.56 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.7 t -107.03 75.15 1.02 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.193 0.52 . . . . 0.0 109.654 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.83 155.06 29.57 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.042 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -78.01 141.6 38.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.925 0.393 . . . . 0.0 111.208 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -149.54 137.14 20.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.41 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.5 t -110.08 142.04 42.1 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 312' ' ' PRO . 92.5 m-85 -102.64 156.79 17.39 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . 46.9 mmtm -138.34 130.36 15.92 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.657 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.49 ' HD3' HG11 ' A' ' 313' ' ' VAL . 22.2 Cg_exo -65.16 121.04 8.38 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.677 2.252 . . . . 0.0 111.335 177.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 254' ' ' ASN . 23.3 t -78.17 84.88 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.418 -176.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -82.44 82.17 7.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.602 176.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 70.03 -60.64 0.48 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 124.046 0.841 . . . . 0.0 110.748 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.614 ' O ' ' HA2' ' A' ' 247' ' ' GLY . 7.5 tp60 61.5 101.62 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.506 0.722 . . . . 0.0 110.9 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 83.6 mt -99.41 77.34 2.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.774 -176.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -79.67 -86.85 0.07 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.618 177.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -89.56 -55.84 3.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.229 0.537 . . . . 0.0 110.047 172.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -127.62 -31.32 2.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.563 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 242' ' ' GLN . . . 137.04 150.5 5.79 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.411 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -108.54 47.49 0.9 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.134 0.493 . . . . 0.0 109.906 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -80.53 -35.8 33.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.534 -174.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.0 t -87.89 -6.9 10.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 122.059 0.933 . . . . 0.0 109.818 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -74.55 113.01 11.3 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.27 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.463 ' O ' ' HD2' ' A' ' 256' ' ' PHE . 28.7 m -88.16 36.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.519 0.676 . . . . 0.0 111.716 -176.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -99.01 15.22 26.49 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.331 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.571 ' O ' ' HE2' ' A' ' 311' ' ' LYS . 58.6 t30 -94.03 -50.43 5.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.943 176.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -68.96 -25.63 64.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.887 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 308' ' ' ILE . 60.5 m-85 -114.66 143.9 44.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.653 -177.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -120.34 134.37 55.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.735 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -93.91 105.21 17.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.283 0.564 . . . . 0.0 111.231 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.6 t -88.39 122.04 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.056 -175.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 11.9 m -96.51 106.04 18.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.254 0.55 . . . . 0.0 110.053 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.518 HD22 HG21 ' A' ' 340' ' ' VAL . 22.5 mt -122.18 167.26 13.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.574 -173.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 26.3 p -60.14 -52.42 65.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.529 0.68 . . . . 0.0 109.71 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.511 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.28 132.59 35.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.316 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 261' ' ' LEU . 7.7 p -128.9 15.29 6.36 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.214 174.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 25.2 m -83.4 144.78 29.39 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.742 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.74 0.73 57.62 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 71.9 mtm -123.22 153.3 40.31 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -142.07 178.99 7.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -63.43 142.22 58.47 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 123.201 0.313 . . . . 0.0 110.545 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 93.52 19.8 34.0 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.688 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.504 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 7.4 m-20 -116.85 164.78 14.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.546 0.673 . . . . 0.0 111.288 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -106.24 115.94 31.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.336 -177.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.484 HD11 HG21 ' A' ' 308' ' ' ILE . 15.6 pt -115.31 140.28 37.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.476 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 54.1 p -128.15 141.06 51.59 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.373 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -100.21 112.64 24.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.051 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.415 ' HA ' ' OD1' ' A' ' 292' ' ' ASP . . . -61.32 120.05 9.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.472 -175.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.49 -35.84 4.75 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.597 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 49.7 t -77.84 124.68 36.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -142.97 161.5 37.94 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.791 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -84.93 142.02 29.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.378 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.475 HD23 ' SD ' ' A' ' 284' ' ' MET . 79.7 mt -75.56 164.17 26.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.112 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 100.42 -40.85 2.3 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.965 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -99.43 -7.96 25.39 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.766 -0.255 . . . . 0.0 111.205 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.475 ' SD ' HD23 ' A' ' 281' ' ' LEU . 81.6 mtp -72.14 -26.5 62.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -63.6 -45.19 91.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.846 0.355 . . . . 0.0 111.322 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -95.63 -42.24 8.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.964 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -92.38 91.07 7.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.93 0.395 . . . . 0.0 110.66 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.76 -31.83 55.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.411 ' HG ' ' H ' ' A' ' 289' ' ' LEU . 0.9 OUTLIER -86.56 38.23 0.78 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.423 174.379 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -56.55 139.35 49.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.381 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -61.23 148.42 41.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.556 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.415 ' OD1' ' HA ' ' A' ' 276' ' ' ALA . 56.6 m-20 -69.55 149.58 48.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -60.01 98.86 0.06 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.527 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 38.6 p -79.98 124.03 28.34 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.626 177.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -124.54 146.78 48.81 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.234 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.8 m -86.19 118.29 25.55 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.151 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.504 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 11.7 p -73.8 123.44 28.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.414 0.626 . . . . 0.0 110.095 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.4 t -94.29 -38.22 9.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.599 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -164.81 133.6 3.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.499 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 79.9 t -90.14 100.89 11.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 167.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.63 -59.4 3.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.737 -172.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -98.67 -12.72 20.76 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.633 -170.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 74.13 13.1 81.4 Favored Glycine 0 CA--C 1.517 0.196 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.08 23.35 0.5 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 171.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.521 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 3.7 t-160 -170.67 115.33 0.46 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 113.813 -1.539 . . . . 0.0 107.533 -171.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.7 155.68 20.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -173.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.1 pt-20 -112.02 121.72 45.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.321 0.581 . . . . 0.0 110.128 172.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 256' ' ' PHE . 29.8 pt -118.19 169.37 8.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.968 -177.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.1 t -145.48 140.47 15.92 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.63 -179.24 26.53 Favored 'Cis proline' 0 C--N 1.345 0.374 0 C-N-CA 123.684 -1.382 . . . . 0.0 112.753 -2.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.571 ' HE2' ' O ' ' A' ' 254' ' ' ASN . 23.8 ttmm -75.29 124.12 89.03 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.786 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 14.1 Cg_exo -68.52 108.24 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.408 2.072 . . . . 0.0 111.99 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.809 HG23 ' HA ' ' A' ' 328' ' ' ALA . 1.2 m -128.21 132.95 67.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.355 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.517 ' O ' HD21 ' A' ' 320' ' ' LEU . . . -95.22 135.71 36.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.906 -172.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.9 tm? -74.19 -24.1 59.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.547 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -82.25 -2.04 51.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.151 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -77.84 113.31 15.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.6 m -82.98 2.59 3.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.972 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 40.1 m -95.2 -27.61 15.44 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -175.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.517 HD21 ' O ' ' A' ' 314' ' ' ALA . 1.3 pp -79.1 152.74 30.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.56 0.695 . . . . 0.0 111.764 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.494 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.3 m -81.33 167.42 31.9 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.74 -173.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.541 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 78.2 Cg_exo -44.81 -52.26 6.4 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.528 2.819 . . . . 0.0 114.183 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -67.22 -30.98 71.05 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.897 -0.502 . . . . 0.0 111.003 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -71.36 -33.78 69.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.433 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.541 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 18.0 ptp180 -77.37 -14.98 59.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.214 0.53 . . . . 0.0 110.6 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -72.41 -30.8 64.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.122 171.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -85.93 -7.97 58.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.553 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.809 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -65.09 115.37 5.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.047 0.451 . . . . 0.0 110.908 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -104.13 -28.17 11.63 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.49 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 30.2 m -108.32 165.33 4.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.027 0.441 . . . . 0.0 111.355 -175.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -83.54 -40.08 19.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.438 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.8 t -128.79 144.98 51.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.169 0.509 . . . . 0.0 111.007 -176.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 13.5 p -77.76 173.96 11.52 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.428 174.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 14.5 tp -76.71 105.06 7.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.103 0.478 . . . . 0.0 110.179 -175.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.61 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.35 -178.6 6.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.413 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -82.54 -1.13 49.67 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -171.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -139.78 64.95 1.44 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.141 0.496 . . . . 0.0 111.281 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.45 ' H ' HG12 ' A' ' 230' ' ' VAL . 23.9 mmt -116.12 130.74 56.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.538 175.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -84.02 144.16 29.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.997 0.427 . . . . 0.0 111.016 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.518 HG21 HD22 ' A' ' 261' ' ' LEU . 21.5 t -113.86 115.4 49.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.481 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -131.58 138.99 49.09 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.799 -176.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 26.7 mt -87.62 125.22 41.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.653 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 49.1 mt -85.02 123.06 30.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -74.9 92.1 2.53 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.95 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 6.8 m . . . . . 0 C--O 1.249 1.049 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.924 -179.764 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 25.6 m -106.0 -179.05 3.83 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 15.7 m 65.85 66.98 0.49 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.474 0.654 . . . . 0.0 111.341 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.46 113.09 24.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.577 174.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 25.6 p -71.8 -71.88 0.25 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.397 -176.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 61.96 35.27 91.15 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.506 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.521 HG21 ' O ' ' A' ' 263' ' ' ALA . 53.7 mt -79.88 153.05 4.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 19.6 p -97.2 143.97 27.48 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.612 0.72 . . . . 0.0 112.495 -173.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.623 HG11 ' O ' ' A' ' 335' ' ' ALA . 4.4 p -61.02 151.9 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.024 177.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 7.6 t -110.52 74.56 0.88 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 0.0 110.001 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 98.39 165.22 30.88 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.052 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -87.98 125.79 34.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.802 0.334 . . . . 0.0 110.442 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -120.39 127.04 51.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.04 0.448 . . . . 0.0 111.01 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 38.4 m -104.86 120.78 42.25 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.635 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.454 ' O ' HG13 ' A' ' 313' ' ' VAL . 93.3 m-85 -100.21 122.38 42.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.657 -176.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.439 ' HE2' HD23 ' A' ' 320' ' ' LEU . 32.4 mmtp -124.85 128.28 24.92 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.208 -178.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.77 177.12 8.76 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 123.091 2.527 . . . . 0.0 111.855 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 12.6 p -81.67 129.38 37.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.153 0.501 . . . . 0.0 110.693 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -89.97 125.8 35.51 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.895 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -74.28 91.7 2.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.864 0.364 . . . . 0.0 110.128 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.503 ' O ' ' HA2' ' A' ' 247' ' ' GLY . 1.6 pp0? -152.0 146.0 25.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.005 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.7 pp -133.25 13.33 4.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.817 173.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -84.31 -41.0 17.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.672 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -87.81 -50.07 6.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.089 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -155.51 -68.72 0.12 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.114 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 242' ' ' GLN . . . 154.65 -153.48 24.83 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.929 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -103.88 130.36 51.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.117 0.484 . . . . 0.0 110.563 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -114.16 -46.04 3.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.745 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 24.9 m -69.58 110.96 3.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.678 0.751 . . . . 0.0 111.098 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -129.41 148.67 51.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.192 -176.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.6 t 54.09 53.64 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.991 0.901 . . . . 0.0 109.713 -175.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -165.32 -35.89 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.606 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -77.64 -1.02 28.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -168.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -99.27 -8.38 25.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.978 0.418 . . . . 0.0 110.368 173.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.408 ' CD1' ' HB ' ' A' ' 309' ' ' THR . 97.8 m-85 -134.85 -176.11 4.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.073 0.463 . . . . 0.0 110.448 -177.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.438 ' HB2' ' HA ' ' A' ' 311' ' ' LYS . . . -146.19 113.79 6.38 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.065 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.3 m -86.4 104.07 15.55 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.338 0.59 . . . . 0.0 110.208 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.1 t -82.83 118.17 30.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.358 -172.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 21.8 m -86.97 105.24 16.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.212 0.529 . . . . 0.0 110.239 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.583 HD23 HG23 ' A' ' 230' ' ' VAL . 19.5 mt -122.76 161.36 24.1 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.2 m -58.86 -50.5 73.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.255 0.55 . . . . 0.0 109.587 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.521 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.89 144.23 41.24 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.46 HG22 HD12 ' A' ' 261' ' ' LEU . 16.0 p -131.31 26.59 4.82 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.135 0.969 . . . . 0.0 108.514 174.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 24.9 m -74.57 135.88 42.09 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.972 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 103.34 -12.91 54.96 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -176.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 55.7 mtt -96.41 138.79 33.49 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.591 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 6.6 ptpp? -130.88 156.93 44.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -55.93 114.39 1.9 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.945 0.402 . . . . 0.0 110.623 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 110.83 18.57 8.29 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.487 -176.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.591 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 9.6 m-20 -105.14 158.36 16.63 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 117.039 0.419 . . . . 0.0 110.766 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 15.0 tppt? -103.7 116.32 32.11 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.647 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 30.3 pt -112.74 139.56 37.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.189 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 4.1 m -124.45 130.57 52.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.445 -176.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -94.53 111.88 23.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.447 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.84 116.71 9.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.838 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 107.76 -11.78 38.45 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 39.2 t -111.81 128.9 68.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -135.99 157.97 45.55 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.43 ' HE1' ' CZ ' ' A' ' 295' ' ' PHE . 50.0 m-85 -73.45 165.02 25.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.775 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 82.8 mt -67.21 -39.17 86.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.221 0.534 . . . . 0.0 110.127 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -70.11 148.48 46.08 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.718 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.543 ' O ' ' HB2' ' A' ' 287' ' ' ASN . 83.4 mm-40 72.86 23.0 2.94 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.048 0.539 . . . . 0.0 110.703 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 73.2 mtp -113.33 25.45 11.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.018 0.437 . . . . 0.0 110.528 175.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -94.98 -56.29 2.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.929 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -143.93 37.0 1.28 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.182 0.515 . . . . 0.0 109.918 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.543 ' HB2' ' O ' ' A' ' 283' ' ' GLN . 15.5 m120 -125.12 109.21 12.62 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.517 -175.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 43.1 t -76.27 -35.05 26.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.332 0.587 . . . . 0.0 109.71 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 89.7 mt -91.35 51.85 1.98 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.401 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -61.67 150.33 36.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.361 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -63.63 118.62 8.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.08 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -65.66 166.43 10.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.633 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -69.29 76.23 0.37 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.158 0.504 . . . . 0.0 111.117 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.421 HG22 ' OG ' ' A' ' 274' ' ' SER . 65.6 p -86.78 105.18 16.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.411 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 312' ' ' PRO . 61.8 m-85 -115.46 143.72 44.89 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.023 0.439 . . . . 0.0 111.035 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.7 m -86.8 124.58 33.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.957 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 271' ' ' ASP . 8.3 p -83.1 136.06 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.038 0.447 . . . . 0.0 110.239 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 37.8 t -101.61 -29.5 3.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.948 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -163.81 142.04 7.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.582 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 78.8 t -98.14 117.62 43.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 38.9 t -77.89 -58.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.92 -172.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -121.21 2.29 10.33 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -173.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 70.45 13.34 70.88 Favored Glycine 0 CA--C 1.518 0.25 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.9 p -146.41 18.04 1.34 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.439 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.8 t-160 -171.07 113.99 0.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.338 -1.301 . . . . 0.0 107.778 -169.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.35 161.97 16.83 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -173.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -120.78 121.24 37.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.36 0.6 . . . . 0.0 110.739 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.444 HG22 ' HA ' ' A' ' 297' ' ' VAL . 23.3 pt -112.76 174.57 2.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.415 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.408 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 13.2 t -152.13 141.27 14.13 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.99 -179.79 26.24 Favored 'Cis proline' 0 C--N 1.345 0.349 0 C-N-CA 123.681 -1.383 . . . . 0.0 112.411 0.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.443 ' CG ' ' HB3' ' A' ' 236' ' ' PHE . 23.3 ttmm -74.56 123.12 88.87 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.286 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 295' ' ' PHE . 56.9 Cg_endo -74.46 108.42 2.68 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.115 1.876 . . . . 0.0 112.045 177.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.556 ' HB ' ' HA ' ' A' ' 328' ' ' ALA . 0.2 OUTLIER -106.54 132.71 53.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.216 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -78.95 116.84 19.52 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 123.53 0.519 . . . . 0.0 110.827 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.0 tm? -64.71 -29.67 70.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.31 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -91.77 15.53 12.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.854 -177.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -90.57 127.26 36.2 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 9.6 p -82.98 -12.53 12.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.989 0.423 . . . . 0.0 111.376 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 5.3 m -93.13 33.71 1.17 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.118 0.485 . . . . 0.0 111.32 -173.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.439 HD23 ' HE2' ' A' ' 237' ' ' LYS . 2.0 pp -132.78 170.91 14.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.745 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 23.3 m -106.23 159.61 29.11 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.341 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -39.97 -48.24 3.79 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.581 2.854 . . . . 0.0 113.913 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -56.28 -41.05 75.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.094 0.473 . . . . 0.0 111.343 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -72.1 -37.67 69.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.777 -175.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -77.05 -16.09 59.38 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.936 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -69.22 -30.75 68.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.478 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -96.16 -0.88 49.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.153 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.556 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -61.75 151.24 34.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.19 0.519 . . . . 0.0 111.546 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -138.43 -28.01 0.85 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.141 -171.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 23.4 m -113.89 162.16 12.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -92.51 -14.21 28.72 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.279 -176.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 11.9 t -147.62 148.5 31.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.768 0.318 . . . . 0.0 110.324 -177.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 46.0 m -77.78 158.63 29.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.575 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.429 ' HG ' HG21 ' A' ' 230' ' ' VAL . 41.1 tp -71.31 103.21 2.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.623 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -85.55 -179.24 6.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.407 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . 0.462 ' HA ' ' CG1' ' A' ' 230' ' ' VAL . 33.2 t70 -77.83 159.79 28.74 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.14 -0.224 . . . . 0.0 110.409 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 65.1 40.9 4.82 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.91 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.558 ' H ' HG12 ' A' ' 230' ' ' VAL . 25.2 mmt -110.28 140.32 44.56 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 176.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -92.21 135.25 34.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.989 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.435 HG21 HD22 ' A' ' 261' ' ' LEU . 14.0 t -114.26 105.01 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.902 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . 0.452 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 64.1 t30 -118.77 150.31 40.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.705 0.288 . . . . 0.0 111.003 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 69.3 mt -95.91 123.67 48.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.643 177.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 60.2 mt -84.26 147.78 27.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.394 176.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -82.86 95.82 8.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.008 0.433 . . . . 0.0 110.181 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.55 -0.738 . . . . 0.0 109.763 179.179 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.536 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 23.3 t -87.42 102.57 14.67 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.161 0.505 . . . . 0.0 110.566 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 9.8 t -116.04 43.66 2.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.092 0.949 . . . . 0.0 109.247 175.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -65.88 104.0 1.02 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.551 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 17.4 p -74.72 73.2 2.03 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.536 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -85.09 57.47 4.99 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 339' ' ' ALA . 31.9 mm -85.78 142.93 12.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 122.282 0.233 . . . . 0.0 110.808 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 12.3 p -118.84 143.22 47.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.089 0.471 . . . . 0.0 110.467 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.632 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.9 p -59.5 149.39 6.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.75 -178.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 25.9 t -113.07 77.91 1.09 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 177.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 90.37 141.71 9.25 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.993 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.68 140.9 55.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.764 0.316 . . . . 0.0 110.927 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -144.76 132.87 21.54 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.544 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.1 t -116.92 114.12 23.4 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 175.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.479 ' O ' HG22 ' A' ' 313' ' ' VAL . 71.5 m-85 -81.15 133.0 35.39 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.343 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -124.09 134.99 25.84 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.436 ' HD3' HG21 ' A' ' 313' ' ' VAL . 84.9 Cg_endo -86.19 152.88 9.49 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.757 2.305 . . . . 0.0 111.831 178.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.08 83.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.151 0.5 . . . . 0.0 110.407 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -131.28 81.87 2.01 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.789 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -129.86 -51.94 1.14 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.696 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -151.47 159.77 44.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.07 177.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 79.0 mt -112.76 117.43 32.19 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.94 0.4 . . . . 0.0 110.714 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -77.59 163.23 26.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.017 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -55.85 -40.0 72.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.73 0.3 . . . . 0.0 111.166 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -97.96 17.55 18.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.14 0.495 . . . . 0.0 110.146 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 82.04 -62.12 4.59 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.676 -0.57 . . . . 0.0 111.676 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -164.92 174.15 10.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 249' ' ' LYS . 52.8 tttp -135.44 32.33 3.09 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.682 0.753 . . . . 0.0 109.564 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 28.5 m -134.58 176.6 8.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.624 -176.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -80.41 74.3 7.28 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 254' ' ' ASN . 7.4 p -64.14 114.22 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.669 0.747 . . . . 0.0 111.406 -174.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -101.69 31.64 3.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.616 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.4 ' H ' HG22 ' A' ' 252' ' ' VAL . 28.2 p-10 -62.35 -21.89 65.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.925 -175.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.507 ' NE ' ' HA ' ' A' ' 255' ' ' ARG . 4.9 mmp_? -104.79 -3.45 23.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.516 0.198 . . . . 0.0 111.366 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -122.21 169.94 10.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.827 0.346 . . . . 0.0 110.883 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -146.18 123.37 11.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.677 0.275 . . . . 0.0 110.74 177.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.1 m -94.55 101.45 13.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.892 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.416 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.7 t -86.18 120.46 36.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.234 -173.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 30.3 m -92.9 109.73 21.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.917 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 19.2 mt -126.49 171.0 11.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.023 -175.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 16.6 p -62.07 -55.59 27.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.412 0.625 . . . . 0.0 109.77 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -136.85 139.05 41.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.785 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 14.4 p -131.38 27.55 4.74 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.793 0.806 . . . . 0.0 109.138 175.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 48.8 m -76.88 140.46 40.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.639 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 101.77 -2.25 52.49 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -173.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 63.3 mtt -108.03 137.27 46.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.813 -0.694 . . . . 0.0 109.299 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -155.0 141.69 18.95 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.581 ' HA ' HG13 ' A' ' 297' ' ' VAL . 29.1 ptt180 -39.34 119.24 0.9 Allowed 'General case' 0 N--CA 1.469 0.51 0 O-C-N 124.01 0.819 . . . . 0.0 112.694 -173.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 116.0 -9.26 18.47 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.564 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.47 ' H ' HG12 ' A' ' 297' ' ' VAL . 2.1 p30 -87.17 -174.82 5.06 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 117.523 0.662 . . . . 0.0 111.307 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 296' ' ' SER . 4.2 tmmm? -140.99 118.45 11.49 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.11 -177.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.42 HG22 HG13 ' A' ' 342' ' ' ILE . 34.3 pt -110.55 140.77 28.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.149 0.5 . . . . 0.0 110.095 -177.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 15.0 m -126.35 132.38 51.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.365 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -94.5 111.19 22.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.431 -176.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.7 116.75 7.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.722 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.38 -34.15 5.31 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 98.1 t -94.24 118.82 41.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.75 171.91 13.78 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.389 -178.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 95.5 m-85 -74.66 172.92 11.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.189 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 94.0 mt -75.92 92.74 3.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.191 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 135.95 171.53 12.36 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.724 173.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.517 ' HB3' HD22 ' A' ' 287' ' ' ASN . 76.7 mt-30 59.4 45.54 13.65 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 122.816 0.446 . . . . 0.0 111.298 177.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 58.4 mtm -128.78 -6.36 5.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.301 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -70.75 -55.41 8.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.024 0.44 . . . . 0.0 110.607 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -114.84 -28.42 7.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.772 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.517 HD22 ' HB3' ' A' ' 283' ' ' GLN . 50.0 t30 -74.68 109.81 8.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.103 -176.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 31.4 t -82.43 -33.35 11.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.579 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 94.0 mt -82.87 48.53 1.36 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.375 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -77.91 111.26 13.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.397 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . 0.431 ' CD ' ' H ' ' A' ' 291' ' ' GLN . 4.5 pm0 -51.34 129.71 25.46 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 123.71 0.631 . . . . 0.0 111.37 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -74.88 168.49 19.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.381 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.638 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -54.41 98.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.918 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.4 p -91.48 99.1 12.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.052 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.638 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 43.1 m-85 -118.61 138.63 52.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.919 0.39 . . . . 0.0 110.925 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 272' ' ' LYS . 28.1 t -85.4 138.43 32.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.898 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.581 HG13 ' HA ' ' A' ' 269' ' ' ARG . 4.3 p -71.67 137.27 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.966 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.25 -42.18 9.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.939 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 307' ' ' GLU . 28.2 tpt180 -165.1 142.14 5.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.773 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 99.0 t -103.13 119.16 51.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 171.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.07 -58.71 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.01 -174.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -121.6 -9.41 8.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.337 0.589 . . . . 0.0 111.651 -173.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.62 13.98 76.94 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.309 -172.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 55.2 p -140.06 12.14 2.42 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 171.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -163.03 116.05 1.59 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.457 -167.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.41 165.01 15.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 121.194 -0.202 . . . . 0.0 110.577 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 8.0 pt-20 -128.09 123.09 33.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.076 0.465 . . . . 0.0 109.77 170.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.429 HG22 ' HA ' ' A' ' 297' ' ' VAL . 26.6 pt -121.67 176.86 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.314 -175.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.5 t -154.11 144.22 15.59 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.018 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.73 179.37 31.15 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 123.414 -1.494 . . . . 0.0 112.606 -4.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -77.39 121.1 83.94 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.873 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.443 ' HG2' ' CD2' ' A' ' 236' ' ' PHE . 30.5 Cg_endo -68.83 108.38 1.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.067 1.845 . . . . 0.0 111.934 174.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.565 ' HB ' ' HA ' ' A' ' 328' ' ' ALA . 85.8 t -118.02 130.65 72.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.317 178.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.673 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -90.42 131.9 35.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.194 0.521 . . . . 0.0 111.459 -176.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.3 tm? -69.46 -29.08 66.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.719 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -97.63 15.17 24.23 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -83.8 128.3 34.43 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.82 0.21 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 18.0 m -105.49 30.84 5.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.224 -0.298 . . . . 0.0 111.757 -174.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 320' ' ' LEU . 1.7 pp -128.34 159.57 34.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.271 0.557 . . . . 0.0 111.879 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.412 ' OG ' ' HD2' ' A' ' 322' ' ' PRO . 2.7 t -91.53 152.75 43.82 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.854 175.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.554 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 50.1 Cg_exo -38.44 -47.99 2.48 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.978 3.118 . . . . 0.0 114.943 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -64.38 -33.58 76.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.828 0.347 . . . . 0.0 111.922 -176.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -68.06 -36.5 79.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.875 0.369 . . . . 0.0 111.243 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 7.4 ptm180 -78.76 -11.16 59.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.315 0.579 . . . . 0.0 110.366 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -74.73 -22.77 58.63 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.617 171.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -99.89 6.19 45.3 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.525 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.565 ' HA ' ' HB ' ' A' ' 313' ' ' VAL . . . -53.61 144.52 17.35 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.648 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -128.63 -34.69 1.98 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.032 -177.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.9 m -113.82 155.27 15.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.364 -178.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -90.97 -8.34 49.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.24 0.543 . . . . 0.0 110.809 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.4 t -148.3 141.28 24.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.881 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 24.1 m -75.38 166.18 24.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.898 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.437 ' HG ' HG21 ' A' ' 230' ' ' VAL . 26.2 tp -71.16 102.97 2.63 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.632 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -93.19 -172.9 3.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -74.35 160.83 30.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.776 0.322 . . . . 0.0 110.427 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 61.18 32.84 19.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.44 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.406 ' H ' HG12 ' A' ' 230' ' ' VAL . 25.5 mmt -102.48 126.89 49.67 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 228' ' ' ILE . . . -84.47 129.91 34.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.096 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 16.1 t -104.18 108.42 24.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -134.11 142.19 47.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.818 0.342 . . . . 0.0 111.908 -171.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.42 HG13 HG22 ' A' ' 273' ' ' ILE . 58.5 mt -87.96 127.0 41.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.76 175.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 57.8 mt -80.48 111.69 17.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.902 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -102.85 83.64 2.27 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.167 0.508 . . . . 0.0 110.629 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.248 0.977 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.133 176.074 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.851 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 17.9 m -119.57 31.94 6.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.007 0.432 . . . . 0.0 111.059 -176.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 20.4 m -131.92 116.96 17.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.204 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 56.09 70.63 0.62 Allowed 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.568 0.543 . . . . 0.0 110.989 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 38.9 p -81.51 -49.8 10.16 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.652 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 54.4 56.75 20.28 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.247 -0.502 . . . . 0.0 112.832 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.483 HG21 ' O ' ' A' ' 263' ' ' ALA . 51.1 mt -103.24 150.05 6.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 14.6 p -97.58 153.7 18.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.535 0.683 . . . . 0.0 112.082 -177.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.613 HG12 ' H ' ' A' ' 338' ' ' MET . 7.8 p -65.93 150.4 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.025 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.401 ' HB2' ' C ' ' A' ' 261' ' ' LEU . 10.2 t -102.32 66.89 1.01 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.76 158.37 31.87 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.211 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.22 132.54 53.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.017 0.437 . . . . 0.0 111.681 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.58 ' NE2' ' HB ' ' A' ' 260' ' ' THR . 83.6 mm-40 -120.66 127.37 52.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.293 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 11.2 p -129.86 144.77 51.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.14 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -133.81 158.98 41.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.47 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . 46.1 mmtm -139.81 126.91 12.61 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.886 178.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.466 ' HD3' HG11 ' A' ' 313' ' ' VAL . 2.8 Cg_endo -79.73 143.08 16.44 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.877 2.385 . . . . 0.0 111.641 175.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 59.6 t -81.38 123.61 38.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.77 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -81.92 152.13 26.92 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 18.8 t90 67.43 91.51 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.743 0.652 . . . . 0.0 109.508 -174.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -113.03 167.64 10.36 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.501 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -82.97 -75.94 0.29 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.967 0.413 . . . . 0.0 110.091 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -137.02 -70.41 0.45 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.865 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -82.99 -39.72 20.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.237 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 254' ' ' ASN . 4.3 t0 -146.21 -174.31 4.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.127 -174.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -150.47 124.07 1.67 Allowed Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 20.3 m120 64.88 57.19 1.03 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.067 0.46 . . . . 0.0 110.755 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -72.46 -11.7 60.78 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.099 -175.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 51.3 t -84.34 -14.29 11.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 122.063 0.935 . . . . 0.0 109.796 176.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -92.45 -179.02 5.08 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.236 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 4.7 p -49.4 133.39 7.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-O 120.692 0.282 . . . . 0.0 110.356 175.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -48.46 121.8 4.83 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.569 -173.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.422 ' HB3' ' OD1' ' A' ' 246' ' ' ASP . 18.4 t30 -83.2 -51.16 7.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.312 -176.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.476 ' NE ' ' HA ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -79.15 -21.53 46.35 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.607 -177.429 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 308' ' ' ILE . 52.0 m-85 -111.63 140.89 45.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.808 -176.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -106.49 120.72 42.65 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.171 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.8 m -87.35 97.45 10.81 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.128 0.489 . . . . 0.0 110.899 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.5 t -83.91 125.39 40.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.546 -173.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.58 ' HB ' ' NE2' ' A' ' 234' ' ' GLN . 13.3 m -97.53 106.97 19.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.187 0.518 . . . . 0.0 109.853 175.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.521 ' HB2' HG22 ' A' ' 264' ' ' THR . 17.4 mt -121.2 163.02 19.15 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -177.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.1 t -56.75 -51.88 67.16 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.483 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.88 136.95 37.59 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.521 HG22 ' HB2' ' A' ' 261' ' ' LEU . 17.5 p -125.25 24.13 7.47 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 122.005 0.907 . . . . 0.0 108.922 175.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 10.4 m -77.71 145.4 36.6 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.301 174.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 96.83 -15.9 61.88 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -174.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . 0.534 ' O ' HG21 ' A' ' 300' ' ' VAL . 54.1 mtt -92.28 132.84 36.37 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -129.75 149.73 51.37 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -49.71 114.07 0.98 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.548 0.69 . . . . 0.0 110.851 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 107.64 11.15 25.58 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.56 -0.745 . . . . 0.0 113.024 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.449 ' H ' HG12 ' A' ' 297' ' ' VAL . 6.4 m-20 -98.25 147.6 24.46 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 117.757 0.778 . . . . 0.0 110.991 176.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -94.63 117.53 30.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.334 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 22.7 pt -112.41 139.58 36.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.003 0.43 . . . . 0.0 110.238 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.464 ' HB3' HG22 ' A' ' 294' ' ' THR . 77.9 p -112.61 137.95 50.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.306 -177.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -105.89 119.95 40.49 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.368 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -63.3 136.27 57.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.892 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 81.95 -35.36 2.54 Favored Glycine 0 N--CA 1.454 -0.109 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.667 177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 52.3 t -82.36 105.15 11.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -128.88 165.02 21.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.968 0.413 . . . . 0.0 111.46 -176.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.558 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 70.8 m-85 -79.26 144.75 34.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.3 -176.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 82.5 mt -78.88 172.67 13.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.523 175.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 97.85 -21.29 46.87 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.605 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -115.88 -7.42 12.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.781 0.324 . . . . 0.0 111.055 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 83.4 mtp -87.79 49.8 1.87 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.231 0.539 . . . . 0.0 111.445 -174.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -102.06 -51.6 3.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.721 174.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.32 24.49 0.36 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.485 175.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -106.11 110.1 22.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.517 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.96 -29.73 34.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.237 0.541 . . . . 0.0 110.009 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 87.8 mt -89.06 33.89 0.79 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.671 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.401 ' HB3' ' HD3' ' A' ' 279' ' ' LYS . . . -62.77 120.7 11.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.877 175.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -57.31 130.63 47.07 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.958 -173.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 47.7 m-20 -75.78 161.88 28.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.335 178.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.572 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -67.62 97.7 0.63 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.57 -175.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.464 HG22 ' HB3' ' A' ' 274' ' ' SER . 30.3 p -100.38 105.0 16.46 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.285 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.572 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 68.2 m-85 -112.62 145.87 39.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.937 0.399 . . . . 0.0 110.95 -178.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 50.1 m -86.08 124.91 33.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.324 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.449 HG12 ' H ' ' A' ' 271' ' ' ASP . 11.2 p -69.85 132.61 32.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.062 178.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.74 -33.94 4.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.951 0.405 . . . . 0.0 110.419 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -157.99 133.46 8.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.071 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.534 HG21 ' O ' ' A' ' 267' ' ' MET . 96.7 t -91.48 101.35 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.6 t -73.77 -59.06 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.686 -171.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -109.39 -11.44 14.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.001 0.429 . . . . 0.0 111.691 -174.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.79 12.98 83.49 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -170.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 5.2 p -147.55 18.09 1.17 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 173.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.485 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.7 t-160 -169.64 114.7 0.54 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.207 -167.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.31 167.91 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -174.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -126.18 119.72 28.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.257 0.551 . . . . 0.0 109.958 169.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 256' ' ' PHE . 27.1 pt -113.99 171.21 4.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.705 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 12.6 t -153.52 145.51 16.93 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.84 179.29 30.99 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.498 -1.459 . . . . 0.0 112.933 -2.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -82.64 121.1 77.75 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.913 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.85 113.28 3.24 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.798 2.332 . . . . 0.0 112.912 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.473 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.1 OUTLIER -114.38 139.52 39.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.818 173.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -87.07 131.31 34.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.673 -177.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.7 tm? -65.91 -28.06 68.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.881 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.69 24.97 3.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.198 178.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -91.91 122.04 34.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 8.4 p -84.05 -0.99 5.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.246 0.546 . . . . 0.0 111.483 -175.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 33.3 t -93.93 -25.52 17.25 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.069 -0.394 . . . . 0.0 111.474 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.438 HD21 ' O ' ' A' ' 314' ' ' ALA . 1.3 pp -83.7 162.85 20.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.238 0.542 . . . . 0.0 111.533 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.472 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 7.1 m -100.57 167.4 10.93 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.504 -176.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 42.2 Cg_exo -41.13 -51.51 3.85 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.8 3.0 . . . . 0.0 114.787 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.71 -39.28 93.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.002 0.429 . . . . 0.0 111.076 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -64.43 -28.95 70.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.906 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 325' ' ' ARG . 43.3 mtp85 -63.99 -28.73 70.01 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.796 0.331 . . . . 0.0 110.844 175.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -74.88 -19.34 60.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.104 0.478 . . . . 0.0 110.658 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -96.17 -2.78 45.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.473 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -72.74 106.39 4.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.661 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -98.31 -17.83 18.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.314 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.8 m -116.47 156.68 17.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.175 0.512 . . . . 0.0 110.417 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -82.38 -32.47 29.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.418 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 12.0 t -139.98 154.08 47.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.572 -174.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.2 p -86.95 169.66 12.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.318 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.431 ' HG ' HG21 ' A' ' 230' ' ' VAL . 18.1 tp -71.15 115.5 10.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.192 -175.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.481 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.58 -178.92 6.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.32 -177.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -78.97 -9.83 59.64 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -138.7 72.56 1.41 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.924 0.392 . . . . 0.0 111.376 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.613 ' H ' HG12 ' A' ' 230' ' ' VAL . 21.0 mmt -125.11 146.37 49.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -93.81 139.5 30.78 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.735 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.462 HG21 HD22 ' A' ' 261' ' ' LEU . 40.9 t -121.81 119.36 58.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.965 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -135.83 143.9 45.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.967 -176.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 52.7 mt -85.73 121.64 37.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.948 173.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 63.9 mt -78.85 127.06 31.54 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.399 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -81.38 87.67 6.16 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 0 C--O 1.248 0.983 0 CA-C-N 115.278 -0.873 . . . . 0.0 112.085 -174.756 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.902 0 CA-C-O 120.094 -0.281 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.0 m 63.8 -80.16 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.965 0.506 . . . . 0.0 111.02 -176.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 20.6 p -122.0 -66.51 1.03 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -128.28 163.58 24.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.806 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.493 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 19.5 p -61.13 -65.09 0.75 Allowed 'General case' 0 C--N 1.322 -0.589 0 O-C-N 122.982 0.176 . . . . 0.0 111.459 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 58.44 39.91 93.59 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.764 -177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.642 HG21 ' O ' ' A' ' 263' ' ' ALA . 62.2 mt -103.23 146.63 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 21.8 p -108.24 156.08 19.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.398 0.618 . . . . 0.0 111.405 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.73 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.5 p -63.0 151.63 8.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.825 176.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.403 ' H ' ' HA ' ' A' ' 261' ' ' LEU . 18.7 t -105.02 83.73 2.03 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 84.12 165.24 38.68 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.177 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.88 129.81 40.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.792 0.33 . . . . 0.0 110.425 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -123.39 127.4 48.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.049 0.452 . . . . 0.0 110.853 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 21.4 p -127.14 131.58 50.73 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.206 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 312' ' ' PRO . 78.4 m-85 -111.91 142.77 43.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.88 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -133.71 132.75 21.82 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.04 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.537 ' HD3' HG21 ' A' ' 313' ' ' VAL . 90.3 Cg_endo -88.36 151.38 6.61 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.689 2.259 . . . . 0.0 111.388 174.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 239' ' ' VAL . 6.3 p -85.33 83.57 2.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 122.114 0.959 . . . . 0.0 109.261 175.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -99.64 80.24 2.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.202 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -141.87 156.13 45.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.498 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -85.2 101.98 12.94 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -95.83 76.26 3.18 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.063 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -90.15 -46.04 8.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.654 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -87.87 -37.78 16.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.088 0.47 . . . . 0.0 110.196 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -107.8 -173.65 2.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.636 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -149.57 -176.0 22.36 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -133.16 130.27 38.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 117.115 0.458 . . . . 0.0 110.228 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -125.31 -9.68 6.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 30.5 m -73.02 162.88 4.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.88 0.371 . . . . 0.0 110.81 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -73.64 86.11 1.62 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.093 -177.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 252' ' ' VAL . 7.6 p -147.35 65.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 122.341 1.067 . . . . 0.0 109.781 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -79.45 146.56 32.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.951 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -94.55 4.56 53.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.08 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -96.87 -52.86 3.73 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -170.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -110.11 171.89 7.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.993 0.425 . . . . 0.0 111.173 -172.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -146.9 132.67 18.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.897 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.651 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -92.03 104.93 17.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.131 0.491 . . . . 0.0 111.131 177.443 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.8 t -85.65 117.45 30.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.495 -174.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 19.4 m -87.22 105.83 17.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.171 0.51 . . . . 0.0 110.195 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.505 HD23 HG23 ' A' ' 230' ' ' VAL . 20.5 mt -122.17 164.92 16.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.652 -177.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.3 t -59.9 -51.8 68.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.171 0.51 . . . . 0.0 109.776 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.642 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.37 131.45 32.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.22 176.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.463 HG22 ' HB2' ' A' ' 261' ' ' LEU . 12.8 p -126.0 18.09 7.84 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.774 0.797 . . . . 0.0 109.029 175.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 26.5 m -82.62 148.11 28.17 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.857 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 95.51 -0.18 63.21 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 42.9 mtm -117.07 158.08 24.79 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.449 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 23.4 pttm -139.94 172.45 12.74 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -59.29 121.07 10.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.631 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 103.04 18.85 13.88 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.244 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.47 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 59.8 m-20 -100.62 152.64 20.19 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 117.433 0.616 . . . . 0.0 110.135 178.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.404 ' HA ' ' HE3' ' A' ' 272' ' ' LYS . 1.5 tpmt? -95.07 116.32 28.57 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.97 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.494 HD11 HG21 ' A' ' 308' ' ' ILE . 15.0 pt -115.84 138.92 44.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.237 176.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 4.5 m -123.92 131.47 53.58 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.832 -178.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -99.26 112.2 24.41 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.964 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.61 115.39 3.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.459 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.27 -34.86 4.95 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.937 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 45.2 t -81.66 142.13 14.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.513 ' NZ ' ' HB3' ' A' ' 279' ' ' LYS . 0.1 OUTLIER -162.13 152.19 16.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.916 0.389 . . . . 0.0 111.276 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -80.85 154.16 27.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.465 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.63 156.12 39.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.154 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.18 -39.14 3.1 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.671 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -80.75 2.98 23.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.986 0.422 . . . . 0.0 110.565 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.459 ' SD ' ' HG3' ' A' ' 279' ' ' LYS . 65.8 mtm -123.19 17.37 9.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.66 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -57.79 -54.65 44.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.011 0.434 . . . . 0.0 110.738 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -141.44 47.37 1.68 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -122.03 107.87 12.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.937 -176.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 45.6 t -80.89 -29.61 11.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 173.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 64.2 mt -100.6 54.96 0.87 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.826 177.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -78.88 145.05 34.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.747 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -76.18 173.65 11.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.271 0.558 . . . . 0.0 110.984 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -93.33 163.26 13.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.625 173.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.419 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -68.0 104.0 1.64 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.367 -175.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 30.3 p -90.88 106.69 18.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.511 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.419 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 88.4 m-85 -105.31 149.89 25.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.158 0.504 . . . . 0.0 111.105 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 12.8 m -96.7 119.87 35.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.777 176.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.47 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.5 p -78.71 130.45 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.163 0.506 . . . . 0.0 110.231 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 21.1 t -93.49 -28.09 4.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.392 -178.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -172.88 140.62 0.96 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.63 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 95.7 t -90.31 109.54 20.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 170.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 42.8 t -78.03 -59.0 3.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.294 -172.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -110.33 -10.05 14.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.046 0.45 . . . . 0.0 111.737 -174.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.56 11.95 84.05 Favored Glycine 0 C--N 1.32 -0.343 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 27.9 p -146.01 13.91 1.31 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.61 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 3.7 t-160 -165.16 116.51 1.14 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.357 -167.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.9 m -119.26 162.13 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -176.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.31 120.65 42.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.926 0.393 . . . . 0.0 110.0 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.494 HG21 HD11 ' A' ' 273' ' ' ILE . 39.8 pt -122.36 176.74 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.092 -179.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.5 t -154.45 145.6 16.46 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.13 -179.99 26.64 Favored 'Cis proline' 0 C--N 1.346 0.428 0 C-N-CA 124.23 -1.154 . . . . 0.0 112.84 -0.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -78.88 113.64 37.12 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.96 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 23.5 Cg_exo -63.68 107.94 0.81 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.351 2.034 . . . . 0.0 112.365 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.537 HG21 ' HD3' ' A' ' 238' ' ' PRO . 97.5 t -124.39 126.3 71.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -83.54 137.44 33.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.569 0.699 . . . . 0.0 111.897 -173.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.0 tm? -77.74 -25.2 49.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.54 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.6 5.2 43.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.426 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 12.2 t70 -74.51 120.03 19.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.03 0.443 . . . . 0.0 110.186 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.9 p -84.79 -15.43 10.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.323 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 33.7 m -77.13 -23.93 51.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.498 -174.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 2.0 pp -85.75 164.41 17.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.456 0.646 . . . . 0.0 111.915 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 21.4 m -92.33 159.25 37.5 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.693 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 2.6 Cg_endo -41.34 -51.12 4.22 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 124.276 3.317 . . . . 0.0 114.311 -177.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -65.11 -29.03 69.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.853 0.359 . . . . 0.0 111.257 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 23.5 mt-30 -71.76 -38.52 70.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.089 -178.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.421 ' HE ' HD11 ' A' ' 320' ' ' LEU . 10.1 ptp180 -73.73 -19.88 60.67 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.489 176.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.23 -18.68 64.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.155 0.502 . . . . 0.0 110.023 172.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -112.15 12.03 20.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.084 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -60.54 152.62 25.54 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.927 0.394 . . . . 0.0 110.999 176.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -118.27 -29.73 5.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.663 -175.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.7 m -133.19 170.7 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 121.014 -0.275 . . . . 0.0 110.759 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -84.13 -51.44 7.06 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.594 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 11.4 t -107.27 146.3 31.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.03 0.443 . . . . 0.0 110.778 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.1 p -80.46 157.98 26.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.739 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.457 HD12 ' HG3' ' A' ' 338' ' ' MET . 15.9 tp -68.56 101.96 1.38 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.73 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -82.53 165.89 19.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.489 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -76.96 25.41 0.15 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -149.1 30.92 0.77 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.962 0.41 . . . . 0.0 110.842 176.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.457 ' HG3' HD12 ' A' ' 334' ' ' LEU . 23.8 mmt -88.64 137.82 31.97 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.33 141.45 28.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.742 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 12.4 t -110.07 116.89 53.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.079 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . 0.493 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 27.8 t-20 -127.44 139.8 52.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.162 -177.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 16.3 mt -98.58 131.33 45.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 121.045 0.45 . . . . 0.0 111.125 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 33.5 mt -97.11 146.34 25.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.482 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -100.43 106.64 18.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.774 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 43.9 t . . . . . 0 C--O 1.252 1.234 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.635 -177.737 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.859 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 44.2 m -87.22 -46.47 9.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.847 0.324 . . . . 0.0 110.629 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 342' ' ' ILE . 32.4 p -80.72 -29.9 36.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.287 0.565 . . . . 0.0 110.345 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -79.99 76.57 6.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.342 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 54.8 p -67.72 -31.72 71.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.055 -174.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 69.97 31.27 69.71 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.056 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.615 HG21 ' O ' ' A' ' 263' ' ' ALA . 89.0 mt -99.88 144.4 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.451 0.167 . . . . 0.0 110.613 -174.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 21.6 p -105.97 167.28 9.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.042 0.449 . . . . 0.0 111.549 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.555 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.0 p -73.17 151.06 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.711 174.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 8.5 t -116.41 68.26 0.73 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.231 0.539 . . . . 0.0 109.909 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 103.94 141.83 11.41 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.856 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.8 127.6 33.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.919 0.39 . . . . 0.0 110.946 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -123.57 126.04 45.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.119 0.485 . . . . 0.0 110.427 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 5.4 p -111.08 103.36 11.8 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.197 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -81.65 151.76 27.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.337 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -145.03 127.7 8.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.257 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.4 ' HD3' HG11 ' A' ' 313' ' ' VAL . 94.6 Cg_endo -86.6 176.48 4.73 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.763 2.309 . . . . 0.0 110.45 169.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.62 123.22 70.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.198 0.523 . . . . 0.0 111.104 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -72.0 148.2 46.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.295 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -81.5 92.28 6.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.283 0.563 . . . . 0.0 109.912 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -148.19 114.99 6.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.746 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 77.1 mt 69.34 94.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 O-C-N 124.151 0.907 . . . . 0.0 110.819 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -70.02 -21.55 63.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.817 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -74.93 -29.08 60.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.603 0.239 . . . . 0.0 111.033 -177.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -152.41 95.01 1.98 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.905 0.383 . . . . 0.0 110.193 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -161.51 86.42 0.11 Allowed Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 8.8 t30 58.54 73.59 0.47 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.358 0.599 . . . . 0.0 109.888 -176.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -81.7 -26.1 34.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.733 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 25.6 m -63.82 152.34 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.087 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -81.27 104.81 11.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.308 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 7.4 p -159.69 124.84 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.689 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -68.22 125.28 25.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.562 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -92.84 -15.25 26.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.394 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -82.14 -15.26 53.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.068 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.414 ' CD1' ' HB ' ' A' ' 309' ' ' THR . 83.6 m-85 -114.0 140.44 48.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.669 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -110.19 135.32 51.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.249 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.3 OUTLIER -103.63 100.39 10.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.08 0.467 . . . . 0.0 110.58 -177.513 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.524 ' HB ' HG22 ' A' ' 306' ' ' VAL . 2.8 t -83.97 124.52 39.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.1 -170.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 21.8 m -93.74 106.21 18.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.259 0.552 . . . . 0.0 110.358 175.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.511 ' HB2' HG22 ' A' ' 264' ' ' THR . 21.8 mt -123.09 164.16 19.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.771 -176.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.7 m -57.48 -53.48 57.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.285 0.565 . . . . 0.0 109.987 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.615 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -136.85 133.53 35.94 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.257 177.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.511 HG22 ' HB2' ' A' ' 261' ' ' LEU . 4.3 p -127.96 17.48 6.73 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 11.4 m -80.32 150.49 29.92 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.772 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 91.72 -3.22 77.91 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.823 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 57.8 mtm -108.79 161.25 15.29 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.439 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 23.1 pttm -132.45 175.45 9.28 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -65.95 136.87 56.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.902 0.382 . . . . 0.0 110.338 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.99 7.6 62.4 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.213 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.439 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 44.3 m-20 -85.25 142.23 29.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.621 0.71 . . . . 0.0 109.903 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 1.3 tpmt? -87.71 115.32 25.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.776 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.541 HD11 HG21 ' A' ' 308' ' ' ILE . 6.8 pt -113.41 139.04 40.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.394 176.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 44.2 t -128.45 132.18 48.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.315 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -101.6 112.03 24.46 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.461 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.02 117.46 7.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.602 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.19 -11.19 26.68 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.458 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.2 133.55 58.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.444 ' NZ ' ' HB3' ' A' ' 279' ' ' LYS . 0.2 OUTLIER -159.16 162.89 36.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.963 0.411 . . . . 0.0 111.602 -178.193 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -81.11 156.66 25.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.266 -174.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.414 HD22 ' H ' ' A' ' 281' ' ' LEU . 1.4 mm? -81.68 152.14 27.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.437 -177.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.83 -56.46 0.47 Allowed Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.431 176.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -68.62 -19.84 64.45 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -174.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 71.0 mtm -75.45 -11.29 60.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.154 -177.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.24 -36.72 61.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.744 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -122.25 -39.9 2.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.724 0.297 . . . . 0.0 111.584 -177.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -82.59 119.18 23.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.086 0.47 . . . . 0.0 110.721 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.65 -28.03 12.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 73.8 mt -86.34 61.92 7.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.343 175.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -82.16 114.17 20.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.725 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.74 163.98 13.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.186 -177.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -95.6 143.88 26.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.695 177.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -54.56 123.17 12.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.374 -171.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.419 ' CG2' HD12 ' A' ' 343' ' ' LEU . 14.0 p -99.4 127.0 45.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.888 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 312' ' ' PRO . 86.0 m-85 -127.74 150.4 49.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.598 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 24.1 t -97.4 122.65 40.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.102 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.443 ' HA ' HG22 ' A' ' 308' ' ' ILE . 11.1 p -74.8 134.91 28.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.08 0.467 . . . . 0.0 109.949 177.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.404 HG21 ' CE1' ' A' ' 256' ' ' PHE . 37.3 t -98.59 -35.21 4.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.725 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -164.63 136.72 4.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 0.0 110.761 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 88.9 t -83.84 109.78 17.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 171.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 42.5 t -74.43 -59.33 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.708 -173.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -120.65 -14.5 8.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.413 0.625 . . . . 0.0 111.101 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 84.08 13.91 73.3 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -169.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 31.9 p -140.92 13.57 2.27 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 171.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.423 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 3.6 t-160 -168.71 121.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.038 -170.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 258' ' ' THR . 2.0 m -119.71 162.97 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.654 -175.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -116.69 123.0 46.16 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 170.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.541 HG21 HD11 ' A' ' 273' ' ' ILE . 43.7 pt -122.44 170.69 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.38 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.414 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 5.1 t -153.41 144.85 16.44 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 172.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.18 179.84 25.69 Favored 'Cis proline' 0 C--N 1.345 0.368 0 C-N-CA 124.061 -1.225 . . . . 0.0 112.817 -1.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -88.97 119.7 69.87 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.977 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 295' ' ' PHE . 38.2 Cg_endo -69.68 116.48 4.57 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.673 2.249 . . . . 0.0 112.527 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.56 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -124.67 131.79 72.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.524 176.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 317' ' ' ASP . . . -78.96 130.92 36.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.259 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.34 -28.28 66.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.935 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -98.9 25.72 6.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.294 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . 0.546 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 10.0 t70 -78.59 123.55 27.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.2 m -83.5 3.29 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 16.8 m -109.77 18.63 20.0 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.672 0.272 . . . . 0.0 111.287 -174.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.8 pp -127.91 168.58 15.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.083 0.468 . . . . 0.0 111.945 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.424 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 4.1 m -102.82 169.97 6.86 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.568 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 99.2 Cg_exo -47.35 -48.95 13.95 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.234 2.623 . . . . 0.0 113.915 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -65.45 -33.95 77.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.284 0.564 . . . . 0.0 110.554 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.51 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 13.0 mm100 -67.44 -42.47 83.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.148 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -71.82 -17.01 62.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.913 0.387 . . . . 0.0 111.167 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.2 -29.16 67.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.067 0.46 . . . . 0.0 110.098 173.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -86.4 -13.17 47.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.827 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.56 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -58.41 143.68 44.48 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.29 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -131.13 -8.95 3.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.049 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.5 174.22 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.046 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -84.88 -45.23 12.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.684 0.278 . . . . 0.0 111.115 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 6.2 t -129.57 144.43 51.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.366 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.502 ' N ' ' HB2' ' A' ' 314' ' ' ALA . 22.5 m -68.22 169.48 10.34 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.414 ' HG ' HG21 ' A' ' 230' ' ' VAL . 21.4 tp -70.16 102.22 2.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -176.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.555 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -90.75 -173.69 3.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.312 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -73.3 158.98 34.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.89 0.376 . . . . 0.0 110.826 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 60.6 39.1 18.26 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.207 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.457 ' H ' HG12 ' A' ' 230' ' ' VAL . 26.1 mmt -104.6 133.08 50.05 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -89.01 137.6 32.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.066 0.46 . . . . 0.0 111.354 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 12.5 t -103.21 124.35 57.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.565 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -138.24 134.34 34.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.557 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.571 ' O ' ' HB ' ' A' ' 224' ' ' THR . 70.7 mt -88.46 119.72 36.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.917 0.389 . . . . 0.0 110.088 176.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.419 HD12 ' CG2' ' A' ' 294' ' ' THR . 40.8 mt -86.23 138.61 31.74 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.721 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -139.76 150.2 44.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.991 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.25 1.105 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.053 -177.238 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.724 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.0 m -132.13 22.19 4.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.091 0.472 . . . . 0.0 110.671 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 1.7 p -101.71 -32.15 10.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.936 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -76.31 96.28 3.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.395 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 33.7 p -81.36 80.5 7.75 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.194 -178.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -81.23 67.83 3.55 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 174.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 263' ' ' ALA . 40.0 mm -100.1 145.01 11.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.585 -0.308 . . . . 0.0 110.685 -174.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.2 p -128.16 159.97 33.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.291 0.567 . . . . 0.0 110.681 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.678 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.4 p -84.68 151.88 3.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.537 -175.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 67.8 m -109.14 82.23 1.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.841 0.353 . . . . 0.0 110.408 174.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 93.58 165.22 37.29 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.592 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 334' ' ' LEU . . . -84.22 114.15 21.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.874 0.368 . . . . 0.0 110.15 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -120.61 128.43 53.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.026 -175.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 333' ' ' SER . 26.9 p -145.84 102.08 3.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.4 0.619 . . . . 0.0 110.092 172.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.421 ' C ' ' HD3' ' A' ' 311' ' ' LYS . 79.3 m-85 -95.15 148.15 22.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.927 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 237' ' ' LYS . 12.9 mptt -110.01 146.0 33.25 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.974 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 254' ' ' ASN . 71.6 Cg_endo -82.57 130.36 6.02 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.494 2.129 . . . . 0.0 111.677 174.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 44.3 t -81.75 94.54 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.255 0.55 . . . . 0.0 110.561 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -90.33 161.07 15.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.383 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 93.6 m95 70.95 126.19 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 O-C-N 124.017 0.823 . . . . 0.0 111.332 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -99.28 112.25 24.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.057 178.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -109.33 -78.65 0.59 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -138.61 144.12 39.61 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -67.9 -10.52 53.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.161 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -77.78 -29.56 50.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.266 175.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -95.01 -64.33 0.99 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.713 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -86.66 70.84 10.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.627 0.727 . . . . 0.0 110.237 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -61.74 125.23 23.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.141 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.34 -13.51 11.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.516 0.674 . . . . 0.0 111.245 -174.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -82.62 68.76 9.2 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.318 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 7.8 p -177.29 156.82 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.612 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -76.93 75.28 3.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.131 0.491 . . . . 0.0 109.783 177.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 238' ' ' PRO . 23.1 p30 -91.56 -26.04 18.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.398 -177.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -93.96 -50.86 5.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.0 0.429 . . . . 0.0 110.021 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.436 ' CD2' ' HB ' ' A' ' 309' ' ' THR . 97.2 m-85 -85.72 152.02 23.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.531 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.41 ' HB2' ' HG3' ' A' ' 311' ' ' LYS . . . -105.08 118.24 36.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.611 0.244 . . . . 0.0 111.424 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.0 OUTLIER -87.06 103.48 15.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.177 0.513 . . . . 0.0 110.586 175.399 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -82.22 118.23 29.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.021 -173.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 23.5 m -84.93 105.64 15.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.013 176.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.429 HD22 HG21 ' A' ' 340' ' ' VAL . 31.3 mt -126.09 166.45 16.98 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.949 -177.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.4 t -64.59 -52.85 55.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.096 0.474 . . . . 0.0 109.798 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.527 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.69 127.31 27.04 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.802 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 10.6 p -125.22 32.37 5.39 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 173.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 1.4 m -81.31 145.99 30.61 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.163 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 90.28 -2.8 81.63 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.758 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 59.7 mtt -97.79 146.3 25.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -133.05 172.73 12.25 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -59.36 138.49 57.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.034 0.445 . . . . 0.0 111.069 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 88.12 11.83 66.65 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.257 176.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.445 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 53.1 m-20 -90.64 153.84 20.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.555 0.678 . . . . 0.0 110.49 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -103.8 117.67 34.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.824 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.471 HD11 HG21 ' A' ' 308' ' ' ILE . 40.4 pt -112.72 139.87 35.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.137 178.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.506 ' HB3' HG22 ' A' ' 294' ' ' THR . 77.3 p -120.27 133.63 55.43 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.766 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -95.04 110.43 22.35 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 339' ' ' ALA . . . -70.83 118.72 13.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.122 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 108.49 -22.7 26.06 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.62 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 41.2 t -101.32 133.76 43.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -144.25 156.82 44.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.706 0.288 . . . . 0.0 111.131 -174.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.547 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 82.4 m-85 -77.55 169.35 18.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.599 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 86.1 mt -77.39 68.68 3.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.686 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -162.16 138.96 5.67 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.486 ' O ' ' HB3' ' A' ' 287' ' ' ASN . 23.8 mt-30 64.02 36.64 9.78 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.76 0.424 . . . . 0.0 110.575 -178.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 89.0 mmm -119.12 37.25 4.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.077 0.465 . . . . 0.0 111.182 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -98.25 -54.81 2.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.975 174.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -138.88 13.01 2.68 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.395 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 283' ' ' GLN . 39.5 t-20 -113.51 136.96 52.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.358 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 30.6 t -102.1 -26.92 3.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.294 0.569 . . . . 0.0 110.087 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 97.2 mt -85.0 48.85 1.63 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.685 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.28 170.67 11.27 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.393 177.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -67.83 118.23 10.79 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.943 0.401 . . . . 0.0 110.516 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -65.57 153.49 41.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.023 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.547 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -71.56 95.48 1.42 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.249 -177.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.506 HG22 ' HB3' ' A' ' 274' ' ' SER . 70.8 p -103.78 126.72 51.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.35 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.424 ' CE2' ' HG3' ' A' ' 312' ' ' PRO . 92.5 m-85 -131.59 155.98 46.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.888 0.375 . . . . 0.0 110.828 -179.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 5.6 m -100.86 129.5 46.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.153 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.445 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 11.9 p -83.17 135.93 23.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.143 0.497 . . . . 0.0 110.462 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 27.9 t -98.48 -28.91 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.704 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 307' ' ' GLU . 27.8 tpt180 -167.17 137.92 3.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.506 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 97.6 t -87.85 111.36 22.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 172.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 14.9 t -75.86 -56.43 8.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.869 -170.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -119.3 -6.06 10.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.902 0.382 . . . . 0.0 111.65 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.94 12.16 84.17 Favored Glycine 0 C--N 1.322 -0.202 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -170.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 6.6 p -148.03 19.85 1.11 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.444 ' NE2' ' HB ' ' A' ' 258' ' ' THR . 3.6 t-160 -167.08 116.93 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.052 -1.431 . . . . 0.0 107.965 -170.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -118.64 152.15 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -175.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 299' ' ' ARG . 9.9 pt-20 -110.37 118.07 35.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.079 0.466 . . . . 0.0 110.002 173.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.471 HG21 HD11 ' A' ' 273' ' ' ILE . 27.2 pt -120.57 171.06 9.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.531 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.436 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 7.1 t -148.91 140.32 14.21 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.625 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.4 -179.91 28.49 Favored 'Cis proline' 0 C--N 1.344 0.31 0 C-N-CA 123.906 -1.289 . . . . 0.0 112.375 -2.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 236' ' ' PHE . 37.2 ttmt -85.47 125.28 70.0 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.954 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.424 ' HG3' ' CE2' ' A' ' 295' ' ' PHE . 16.1 Cg_exo -67.74 108.97 1.76 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.661 2.241 . . . . 0.0 112.755 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.59 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -120.92 131.23 73.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.744 173.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -91.62 141.06 29.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.334 0.588 . . . . 0.0 111.377 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 315' ' ' LEU . 2.7 tm? -72.84 -22.89 60.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.567 177.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.4 17.38 14.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.409 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.07 115.26 22.28 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 9.4 p -83.11 -9.68 11.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.005 0.431 . . . . 0.0 111.29 -175.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 15.0 m -82.33 -29.75 30.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.347 -174.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 2.4 pp -84.65 162.62 19.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.4 0.619 . . . . 0.0 112.002 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.491 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 41.9 m -95.93 166.07 15.19 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.076 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 71.3 Cg_exo -43.68 -44.23 11.33 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.554 2.836 . . . . 0.0 114.666 -177.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.27 -33.91 75.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.254 0.55 . . . . 0.0 111.201 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 46.4 mt-30 -79.86 -36.93 35.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.675 -175.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.446 ' HB3' ' CD1' ' A' ' 320' ' ' LEU . 13.6 ptm180 -73.2 -20.19 60.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.053 0.454 . . . . 0.0 110.161 177.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.01 -29.89 69.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.994 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -101.19 11.37 39.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.378 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.59 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -59.67 149.74 29.65 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.88 0.372 . . . . 0.0 111.212 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -125.95 -36.29 2.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.711 -176.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 30.7 m -110.31 155.19 11.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.229 0.537 . . . . 0.0 111.182 -175.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -85.61 -17.04 37.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.428 -176.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.1 t -144.0 139.74 29.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.225 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.476 ' HB3' ' HB3' ' A' ' 235' ' ' SER . 73.0 m -70.89 163.62 27.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.241 175.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.418 ' HG ' HG21 ' A' ' 230' ' ' VAL . 29.0 tp -69.05 104.26 2.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.678 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -78.98 170.23 17.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.699 -175.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -76.44 12.41 1.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -170.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -152.93 65.31 0.78 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.356 0.598 . . . . 0.0 110.347 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.513 ' H ' HG12 ' A' ' 230' ' ' VAL . 22.2 mmt -114.85 141.95 47.22 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.255 178.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 276' ' ' ALA . . . -90.77 129.62 36.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.528 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 19.2 t -104.19 117.27 49.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -131.57 138.72 48.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.747 0.308 . . . . 0.0 111.185 -174.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 3.3 mt -90.42 133.37 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.137 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 60.4 mt -80.96 147.4 30.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.31 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -95.84 99.87 11.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.277 -175.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.569 175.429 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.658 0 N-CA-C 111.865 -0.494 . . . . 0.0 111.865 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 13.3 m 60.77 37.14 19.02 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.749 0.42 . . . . 0.0 111.427 178.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 7.0 p -104.49 -43.41 5.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.038 0.447 . . . . 0.0 111.106 -179.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -92.02 74.61 5.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.571 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 53.8 p -107.37 89.4 2.99 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.344 0.592 . . . . 0.0 110.811 179.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -123.39 48.12 0.97 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 175.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.573 HG21 ' O ' ' A' ' 263' ' ' ALA . 17.4 mt -87.26 150.46 3.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -175.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 6.1 p -107.86 166.02 11.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.309 0.576 . . . . 0.0 111.722 -178.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.636 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.7 p -72.82 150.32 8.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.971 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.492 ' HB2' ' N ' ' A' ' 262' ' ' SER . 7.0 t -110.87 74.48 0.87 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.344 0.592 . . . . 0.0 109.72 177.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 92.8 144.3 14.3 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.996 -178.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.51 126.89 29.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.857 0.361 . . . . 0.0 110.808 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -125.33 126.35 44.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.134 -179.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.9 m -105.65 104.42 14.14 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.693 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.406 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 55.8 m-85 -80.52 113.64 18.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.977 -176.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -124.64 121.78 25.76 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.92 0.391 . . . . 0.0 111.763 -174.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.481 ' HA ' ' OD1' ' A' ' 254' ' ' ASN . 76.2 Cg_endo -86.01 128.55 3.24 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.782 2.321 . . . . 0.0 110.997 170.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 5.4 p -86.57 108.9 18.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.599 0.714 . . . . 0.0 110.859 -177.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -81.35 81.18 7.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.054 178.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -128.99 75.73 1.67 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.91 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -142.3 101.88 3.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.979 177.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 53.4 mt -105.74 -13.13 15.64 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 176.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -166.48 -171.4 1.89 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.029 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.508 ' O ' ' HE2' ' A' ' 249' ' ' LYS . 4.1 p-10 -65.16 -30.7 71.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 117.639 0.199 . . . . 0.0 111.321 -178.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -89.51 40.99 1.02 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.932 0.396 . . . . 0.0 111.394 -178.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -95.17 -126.84 4.97 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 176.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -88.14 66.06 8.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.289 0.566 . . . . 0.0 109.609 174.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.508 ' HE2' ' O ' ' A' ' 245' ' ' ASN . 21.8 ttmm -85.14 -57.93 2.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.113 -177.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 251' ' ' ASN . 14.4 m -79.96 99.32 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.661 0.743 . . . . 0.0 111.469 -177.203 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 250' ' ' VAL . 26.4 t-20 168.79 119.29 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.841 -178.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.4 m -119.4 36.07 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.549 0.69 . . . . 0.0 110.333 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -120.31 -47.9 2.34 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.966 -178.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' A' ' 238' ' ' PRO . 19.7 t-20 -68.73 -14.35 62.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.349 -174.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -82.7 -6.58 59.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.09 177.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.83 154.86 39.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.807 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -101.99 115.69 31.09 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.727 0.299 . . . . 0.0 110.408 178.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.7 OUTLIER -92.78 103.61 15.95 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.164 0.507 . . . . 0.0 109.995 179.639 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.1 t -82.84 117.0 28.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.466 -171.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 16.2 m -87.04 105.3 17.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.101 177.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.48 HD12 HG22 ' A' ' 264' ' ' THR . 29.0 mt -125.59 162.73 24.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.13 -176.163 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.492 ' N ' ' HB2' ' A' ' 231' ' ' SER . 14.0 m -62.21 -50.2 72.73 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.428 0.632 . . . . 0.0 109.697 179.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.573 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -138.13 142.06 40.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.269 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.48 HG22 HD12 ' A' ' 261' ' ' LEU . 19.1 p -129.39 26.86 5.36 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.087 0.946 . . . . 0.0 108.875 174.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 15.5 m -77.71 138.3 38.97 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.343 -1.298 . . . . 0.0 109.513 175.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 104.9 -7.1 44.45 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -172.224 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . 0.451 ' SD ' ' HB ' ' A' ' 264' ' ' THR . 61.1 mtt -101.5 144.74 29.89 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -154.89 141.98 19.31 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.518 ' HA ' HG13 ' A' ' 297' ' ' VAL . 24.3 ptt180 -44.46 116.52 1.05 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.96 0.788 . . . . 0.0 112.582 -171.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 115.62 -6.63 20.44 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.426 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.549 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.6 p30 -85.15 -177.9 6.64 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.482 0.641 . . . . 0.0 111.534 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -124.65 117.11 23.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.897 -177.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.503 HD11 HG21 ' A' ' 308' ' ' ILE . 40.8 pt -112.72 139.88 35.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.108 0.48 . . . . 0.0 110.208 177.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.501 ' OG ' HG22 ' A' ' 294' ' ' THR . 4.9 m -127.98 149.28 50.42 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.822 -178.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -113.59 111.85 22.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.424 -178.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.52 115.71 6.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.823 -178.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.32 -25.62 12.2 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.708 -178.258 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 47.2 t -99.04 115.15 38.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.437 ' HD3' ' HB3' ' A' ' 290' ' ' ALA . 15.9 ptpt -132.7 162.55 31.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.867 0.365 . . . . 0.0 111.896 -173.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.457 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 60.1 m-85 -80.46 154.16 27.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.86 -175.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 315' ' ' LEU . 40.2 mt -81.94 161.34 23.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.796 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 102.11 -3.56 51.68 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.492 175.027 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.414 ' OE1' ' HG2' ' A' ' 291' ' ' GLN . 89.5 mt-30 -123.74 -16.48 6.67 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 70.1 mtm -79.67 14.3 1.74 Allowed 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.084 -0.385 . . . . 0.0 111.923 -173.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -95.63 -21.5 18.18 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.926 0.393 . . . . 0.0 110.729 178.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -154.25 -46.6 0.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.564 -178.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -75.84 95.04 3.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.394 -178.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.55 -32.12 55.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.16 -176.169 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 85.2 mt -84.17 49.51 1.67 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.152 0.501 . . . . 0.0 110.005 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.437 ' HB3' ' HD3' ' A' ' 279' ' ' LYS . . . -57.89 128.79 38.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.112 -178.377 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . 0.414 ' HG2' ' OE1' ' A' ' 283' ' ' GLN . 23.7 pt20 -60.98 132.96 55.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.443 -176.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -72.48 166.13 23.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.942 177.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.516 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -70.69 87.9 0.69 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.464 -176.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.501 HG22 ' OG ' ' A' ' 274' ' ' SER . 70.5 p -90.99 112.53 24.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.288 178.416 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.516 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 68.0 m-85 -123.07 145.43 48.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.931 0.396 . . . . 0.0 110.857 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 11.9 m -80.3 130.0 34.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.696 175.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.549 HG12 ' H ' ' A' ' 271' ' ' ASP . 5.2 p -67.75 132.72 32.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.255 0.55 . . . . 0.0 109.668 179.293 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.425 HG23 ' HA ' ' A' ' 308' ' ' ILE . 84.6 t -94.07 -45.34 13.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.105 178.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -167.51 139.08 3.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.126 178.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 93.7 t -88.11 108.79 18.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 171.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.0 t -78.54 -59.66 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.971 -173.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -111.91 -8.16 14.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.948 0.404 . . . . 0.0 111.529 -174.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.16 12.85 83.22 Favored Glycine 0 CA--C 1.517 0.193 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -170.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 20.4 p -146.05 16.25 1.37 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 174.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.44 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.2 t-160 -170.73 115.53 0.46 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.384 -168.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.58 161.92 18.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.537 -175.227 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -116.22 129.29 56.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.511 HG22 ' HA ' ' A' ' 297' ' ' VAL . 27.1 pt -132.07 169.83 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.031 0.443 . . . . 0.0 111.471 -179.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 7.2 t -150.02 143.58 16.78 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.41 177.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -76.44 -179.95 29.0 Favored 'Cis proline' 0 C--N 1.345 0.378 0 C-N-CA 124.129 -1.196 . . . . 0.0 112.419 -3.113 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.406 ' HG3' ' HB3' ' A' ' 236' ' ' PHE . 35.9 ttmt -87.41 123.35 69.84 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.207 -178.016 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.15 109.29 2.9 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.593 2.196 . . . . 0.0 112.658 178.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.477 ' CG2' ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -107.06 133.92 50.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.62 175.745 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.447 ' HB2' ' N ' ' A' ' 333' ' ' SER . . . -82.84 126.06 32.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.11 0.481 . . . . 0.0 111.409 -178.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.546 ' HB2' HD11 ' A' ' 281' ' ' LEU . 2.7 tm? -68.64 -29.6 68.13 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.968 177.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -79.52 -0.81 34.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.751 -179.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -79.92 122.5 26.76 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.984 0.421 . . . . 0.0 110.622 -178.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 14.2 p -83.96 -16.64 10.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.237 -178.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 24.5 m -74.42 -35.82 63.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.721 -175.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.474 ' O ' HD12 ' A' ' 320' ' ' LEU . 1.7 pp -75.4 152.64 38.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.276 0.56 . . . . 0.0 110.884 178.423 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.508 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.8 m -91.09 170.84 9.06 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.259 -173.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 91.2 Cg_exo -46.98 -50.45 10.89 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 123.446 2.764 . . . . 0.0 114.517 -175.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.35 -28.85 69.98 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.149 -177.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 50.9 mt-30 -76.03 -39.65 55.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.631 0.253 . . . . 0.0 111.026 -178.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.445 ' HB3' ' CD1' ' A' ' 320' ' ' LEU . 13.0 ptp180 -73.37 -22.85 60.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.009 0.433 . . . . 0.0 110.538 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.87 -34.21 77.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.217 174.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -96.6 6.23 49.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.185 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.477 ' HA ' ' CG2' ' A' ' 313' ' ' VAL . . . -61.41 135.61 57.75 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.887 0.375 . . . . 0.0 110.753 178.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -108.89 -29.2 8.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.365 -176.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.8 171.53 9.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.946 0.403 . . . . 0.0 111.132 -175.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -88.55 -38.77 14.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.449 -178.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.1 t -128.3 143.17 50.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.909 0.385 . . . . 0.0 110.763 -176.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.447 ' N ' ' HB2' ' A' ' 314' ' ' ALA . 44.1 m -72.29 162.71 29.09 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 172.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.419 ' HG ' HG21 ' A' ' 230' ' ' VAL . 23.0 tp -68.66 102.42 1.5 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -177.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.636 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -95.72 -179.24 4.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.269 -178.337 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -67.57 150.45 48.79 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 65.45 45.62 2.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.819 179.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 26.4 mmt -112.0 131.07 55.63 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -87.07 133.6 33.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.604 -176.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.424 HG21 HD22 ' A' ' 261' ' ' LEU . 10.3 t -101.83 114.86 42.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.476 177.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -125.85 134.52 51.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.098 -174.035 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 19.5 mt -93.01 131.43 40.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 174.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 68.0 mt -74.18 111.34 9.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.022 0.439 . . . . 0.0 110.586 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -94.67 82.74 3.97 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.517 178.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.733 -178.719 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.781 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.8 m -87.87 -42.75 12.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.853 0.359 . . . . 0.0 110.696 -179.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 18.4 m -111.35 70.56 0.72 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.492 0.663 . . . . 0.0 110.257 178.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -130.17 123.54 30.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.26 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 23.1 p -77.84 79.06 4.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.222 0.534 . . . . 0.0 111.501 -177.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.43 68.1 3.39 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 174.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.541 ' HB ' ' O ' ' A' ' 340' ' ' VAL . 40.6 mm -100.17 143.45 13.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 122.339 0.256 . . . . 0.0 111.101 -173.356 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 74.4 p -121.89 149.41 43.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.195 0.521 . . . . 0.0 110.506 173.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.668 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.5 p -64.48 152.97 8.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.678 175.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 14.2 t -124.58 88.78 2.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.914 0.388 . . . . 0.0 110.017 175.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 103.4 165.34 25.51 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.038 -178.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -86.52 125.13 33.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.718 0.294 . . . . 0.0 110.428 179.145 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -120.58 129.51 53.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.929 0.395 . . . . 0.0 110.961 -176.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 25.5 t -153.89 103.04 2.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.899 177.404 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -114.26 141.65 47.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.892 -179.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 237' ' ' LYS . 2.9 mptp? -111.9 145.89 33.66 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.822 -175.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.25 128.37 12.86 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.261 1.974 . . . . 0.0 110.846 174.115 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.467 HG13 ' HB3' ' A' ' 242' ' ' GLN . 13.5 t -78.05 84.93 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.333 0.587 . . . . 0.0 110.382 -175.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -89.41 86.04 6.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.575 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 11.5 t90 56.08 68.78 0.81 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.604 0.716 . . . . 0.0 110.206 -177.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.467 ' HB3' HG13 ' A' ' 239' ' ' VAL . 7.7 tt0 -138.3 105.91 5.59 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.634 -178.015 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 82.7 mt 70.47 4.61 5.01 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.651 -177.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 60.83 -171.07 0.15 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.966 -177.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -82.58 -15.34 52.6 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.292 0.567 . . . . 0.0 109.689 175.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -80.17 -43.09 22.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.212 -177.376 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.72 -22.95 78.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.785 -176.625 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -83.88 90.31 7.35 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.139 0.495 . . . . 0.0 110.205 178.195 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -77.75 -33.85 52.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.066 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 252' ' ' VAL . 27.5 m -78.16 152.71 5.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.113 176.18 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -92.87 85.66 5.24 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.051 0.453 . . . . 0.0 110.949 -176.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 250' ' ' VAL . 38.8 t -87.79 127.91 40.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.697 176.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.583 ' OD2' ' HA ' ' A' ' 257' ' ' ALA . 0.8 OUTLIER -58.51 116.08 3.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.17 0.51 . . . . 0.0 110.231 176.365 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -90.79 -50.8 5.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.836 -176.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -88.74 -30.22 19.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.112 -176.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.504 ' CE1' HG21 ' A' ' 298' ' ' VAL . 48.1 m-85 -102.64 -175.09 2.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.306 -179.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.583 ' HA ' ' OD2' ' A' ' 253' ' ' ASP . . . -145.36 118.44 8.85 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.861 176.33 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 3.8 m -83.22 113.01 20.37 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.076 0.465 . . . . 0.0 110.484 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.5 t -98.08 120.5 47.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.427 -173.542 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 79.5 m -89.64 108.2 19.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.04 0.448 . . . . 0.0 109.958 174.167 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.51 HD23 HG23 ' A' ' 230' ' ' VAL . 23.9 mt -125.04 168.32 13.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.732 -177.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.8 t -64.7 -52.84 55.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.532 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -136.68 127.24 26.94 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.328 179.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.419 ' CG2' ' HB2' ' A' ' 261' ' ' LEU . 11.5 p -125.23 25.5 7.15 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.885 174.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 24.1 m -82.01 145.29 30.32 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.156 175.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.93 -18.17 57.2 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -173.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 59.9 mtt -91.46 138.81 31.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.936 -0.632 . . . . 0.0 109.317 176.245 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -133.35 153.61 51.43 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.339 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.423 ' HA ' HG13 ' A' ' 297' ' ' VAL . 30.9 ptt180 -58.13 134.63 56.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.971 0.415 . . . . 0.0 111.366 -175.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 99.6 14.45 34.87 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.296 -177.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.528 ' H ' HG12 ' A' ' 297' ' ' VAL . 0.6 OUTLIER -109.45 175.59 5.39 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.8 0.3 . . . . 0.0 110.224 179.487 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.468 ' HE3' HD12 ' A' ' 343' ' ' LEU . 5.2 tmmm? -127.09 117.49 22.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.564 -174.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.439 HD11 HG21 ' A' ' 308' ' ' ILE . 31.0 pt -111.65 142.57 23.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.906 -177.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 14.8 m -124.55 138.55 54.32 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.507 -178.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -100.87 112.0 24.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.485 -178.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.96 116.56 9.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.97 -178.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.19 -34.22 5.3 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 60.2 t -89.06 122.09 39.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 175.145 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -139.88 158.38 44.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.043 0.449 . . . . 0.0 111.608 -176.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -73.48 145.41 45.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.155 -173.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 315' ' ' LEU . 77.2 mt -69.77 141.32 53.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.359 176.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.46 -22.59 15.59 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.344 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.604 ' O ' ' HA ' ' A' ' 290' ' ' ALA . 11.8 mm100 -91.2 25.96 2.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.678 0.275 . . . . 0.0 111.109 -176.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 54.9 mtt -108.26 -22.51 12.32 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 172.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -88.53 -55.65 3.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.307 177.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -64.86 -59.87 3.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.567 177.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 283' ' ' GLN . 14.4 m120 -81.01 101.57 9.63 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 171.486 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 64.1 t -61.81 -33.77 59.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.994 -177.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 74.0 mt -92.9 -2.58 55.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.806 177.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 283' ' ' GLN . . . 63.65 168.56 0.15 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.41 -178.381 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -130.69 126.33 36.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.395 176.036 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.2 157.61 37.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.056 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.584 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -60.39 102.56 0.18 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.526 -170.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.466 ' HB ' ' HD3' ' A' ' 272' ' ' LYS . 19.7 p -95.19 111.19 23.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.603 177.045 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.584 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 65.1 m-85 -123.68 150.53 44.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.859 0.362 . . . . 0.0 110.897 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 16.2 m -96.06 134.03 39.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.255 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 271' ' ' ASP . 9.5 p -86.98 135.53 24.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.964 0.411 . . . . 0.0 110.359 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.504 HG21 ' CE1' ' A' ' 256' ' ' PHE . 46.0 t -105.48 -31.5 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.274 -176.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -162.27 138.4 7.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.826 0.346 . . . . 0.0 110.593 -178.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 89.3 t -92.4 114.23 28.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.83 -59.29 3.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.842 -172.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.77 -2.47 10.91 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.873 0.368 . . . . 0.0 111.794 -174.129 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 75.08 11.71 83.84 Favored Glycine 0 N--CA 1.459 0.2 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -174.075 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 5.9 p -150.75 23.03 0.78 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 173.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.465 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.2 t-160 -167.78 112.75 0.68 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 113.594 -1.639 . . . . 0.0 107.896 -165.454 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -119.27 169.89 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.559 -174.174 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 10.9 pt-20 -128.22 121.74 30.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.215 0.531 . . . . 0.0 109.931 169.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 273' ' ' ILE . 22.7 pt -120.98 174.65 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.143 -177.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.7 t -155.19 147.06 17.18 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.121 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -69.23 179.94 19.86 Favored 'Cis proline' 0 C--N 1.349 0.567 0 C-N-CA 124.163 -1.182 . . . . 0.0 113.162 -2.403 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 24.1 ttmm -82.26 124.81 78.02 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.212 -177.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 13.3 Cg_exo -69.25 109.89 2.32 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.84 2.36 . . . . 0.0 112.606 177.106 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -126.04 130.69 72.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.905 174.161 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -95.32 143.7 26.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.272 0.558 . . . . 0.0 111.506 -175.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.527 ' HB2' HD11 ' A' ' 281' ' ' LEU . 2.6 tm? -76.43 -26.5 55.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.101 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -98.05 26.0 5.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.647 178.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . 0.51 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 20.3 t70 -86.14 131.3 34.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.528 -179.412 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 11.3 p -84.49 -18.53 9.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.946 -176.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 19.7 m -91.77 5.11 51.09 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -168.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' A' ' 325' ' ' ARG . 0.8 OUTLIER -115.67 157.53 24.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.365 0.602 . . . . 0.0 112.056 -179.378 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 16.9 m -86.55 158.47 54.28 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.552 177.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.574 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 61.9 Cg_exo -39.66 -49.78 3.27 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.434 3.423 . . . . 0.0 114.882 -176.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.9 -39.39 85.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.849 0.357 . . . . 0.0 111.68 -177.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -72.71 -29.57 63.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -172.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 9.7 ptm180 -76.14 -18.77 58.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.449 0.642 . . . . 0.0 109.862 178.43 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.79 -21.7 61.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.78 172.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -96.74 1.24 50.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.706 175.501 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.527 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -59.09 144.43 45.56 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.551 179.412 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -118.17 -27.28 6.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.436 -176.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.8 m -119.31 170.89 8.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.685 0.278 . . . . 0.0 111.218 -177.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -82.71 -53.97 5.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.922 -176.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 10.4 t -114.91 145.28 42.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.066 0.46 . . . . 0.0 110.876 -171.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.0 m -75.23 154.62 37.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.438 178.563 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.451 ' HG ' HG21 ' A' ' 230' ' ' VAL . 16.7 tp -70.1 103.34 2.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.668 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -95.76 162.33 13.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.958 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . 0.458 ' HA ' HG13 ' A' ' 230' ' ' VAL . 38.4 t70 -75.21 62.72 1.27 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.097 0.475 . . . . 0.0 112.1 -174.143 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -176.6 33.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.696 171.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.451 ' H ' HG12 ' A' ' 230' ' ' VAL . 23.9 mmt -104.54 130.7 52.48 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -83.63 135.1 34.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.607 178.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.541 ' O ' ' HB ' ' A' ' 228' ' ' ILE . 22.0 t -112.22 115.05 48.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.525 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -132.6 135.2 45.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.875 0.369 . . . . 0.0 111.6 -174.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.407 ' CG1' HG22 ' A' ' 273' ' ' ILE . 45.8 mt -84.29 123.59 39.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.855 174.072 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.468 HD12 ' HE3' ' A' ' 272' ' ' LYS . 51.3 mt -80.04 112.31 17.22 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.846 178.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -86.25 146.52 26.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.526 -178.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 51.4 t . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.537 -0.744 . . . . 0.0 110.289 -178.727 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 14.3 p -93.75 38.92 1.06 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.052 0.453 . . . . 0.0 110.963 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.6 m -80.76 60.73 4.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.426 0.631 . . . . 0.0 110.293 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -118.27 129.6 55.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.217 -179.316 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.433 ' OG1' ' HA ' ' A' ' 341' ' ' ASN . 16.3 p -121.67 -92.37 0.54 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.383 -178.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 60.45 36.98 92.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.7 -177.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 58.6 mt -91.17 144.04 9.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -176.151 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 13.4 p -96.65 153.26 17.96 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.555 0.693 . . . . 0.0 111.998 -172.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.654 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.6 p -67.06 151.09 10.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.052 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 71.5 m -113.75 82.0 1.62 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.919 0.39 . . . . 0.0 110.463 177.104 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 95.34 147.57 22.85 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.013 -179.375 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -82.59 139.07 34.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.839 0.352 . . . . 0.0 111.116 -177.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -141.38 135.18 30.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.251 0.548 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 9.9 p -139.87 103.07 4.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.245 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -115.38 153.95 30.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.352 -177.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 320' ' ' LEU . 13.4 mptt -108.63 138.76 20.35 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.077 177.316 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.03 147.23 38.18 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.677 2.251 . . . . 0.0 112.112 -179.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.411 ' CG1' ' HB2' ' A' ' 254' ' ' ASN . 4.3 p -67.82 101.08 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.552 0.691 . . . . 0.0 110.829 179.309 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.34 152.69 45.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.631 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -92.58 96.33 10.14 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.556 -178.006 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -81.26 -153.29 0.1 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.504 174.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.0 177.56 8.77 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.418 177.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.39 -61.0 2.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.947 0.403 . . . . 0.0 110.338 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -70.86 -41.49 71.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.21 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -105.44 75.96 1.18 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.291 176.226 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -168.68 -125.22 0.77 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.041 -179.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -147.35 119.71 8.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.401 0.62 . . . . 0.0 111.05 179.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -105.06 69.93 0.88 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.555 176.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.9 m -101.1 150.46 5.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.402 -174.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -105.72 24.12 12.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.424 0.63 . . . . 0.0 110.305 178.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 25.1 m -120.27 144.01 30.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.092 178.438 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.37 82.7 5.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.351 0.596 . . . . 0.0 111.492 -177.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.411 ' HB2' ' CG1' ' A' ' 239' ' ' VAL . 14.2 m120 -77.5 4.95 9.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.71 176.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.546 ' HD2' ' H ' ' A' ' 255' ' ' ARG . 1.8 mpt_? -74.36 -40.08 62.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.353 -178.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -78.83 147.53 33.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.725 -175.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.55 124.87 46.7 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.343 178.269 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.3 m -93.37 101.41 13.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.302 0.572 . . . . 0.0 110.363 -179.374 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.7 t -82.97 122.92 38.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.146 -173.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 29.8 m -98.01 106.43 18.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.36 0.6 . . . . 0.0 110.299 179.179 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.443 HD23 HG23 ' A' ' 230' ' ' VAL . 16.5 mt -125.08 164.56 19.94 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.727 -174.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 51.1 m -58.54 -54.75 43.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.198 0.523 . . . . 0.0 109.927 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -136.78 130.66 32.25 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.258 178.304 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.402 ' CG2' ' HB2' ' A' ' 261' ' ' LEU . 10.5 p -126.37 25.94 6.49 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.7 m -79.68 143.13 34.88 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.69 -1.595 . . . . 0.0 109.819 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 99.29 -19.76 52.64 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -175.204 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 85.2 mtp -75.72 152.56 37.44 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.131 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -154.83 147.26 24.03 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -178.232 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.478 ' HA ' HG13 ' A' ' 297' ' ' VAL . 32.1 ptt180 -51.9 114.43 1.3 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.366 0.603 . . . . 0.0 111.15 -176.066 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 116.33 6.13 15.94 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.557 -174.078 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -88.7 179.84 6.16 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 117.094 0.447 . . . . 0.0 110.928 176.067 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 342' ' ' ILE . 0.2 OUTLIER -141.45 117.18 10.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.647 -178.115 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 308' ' ' ILE . 21.9 pt -113.22 139.95 35.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.026 0.441 . . . . 0.0 110.876 -178.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 69.9 p -120.88 133.99 55.3 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.706 176.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.471 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 95.5 m-85 -94.11 111.46 23.18 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.179 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.481 ' HA ' ' OD1' ' A' ' 292' ' ' ASP . . . -66.0 111.53 3.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.02 -177.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.22 -35.3 4.73 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.7 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 83.9 t -82.62 129.69 37.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 173.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.412 ' HD2' ' SD ' ' A' ' 284' ' ' MET . 10.0 ptpp? -148.35 160.23 43.21 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.26 -175.542 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -77.08 150.94 35.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.931 -178.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.0 130.58 47.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.765 177.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 124.39 -5.32 8.74 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 -177.464 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -110.03 164.06 12.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.587 -0.306 . . . . 0.0 110.224 178.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.412 ' SD ' ' HD2' ' A' ' 279' ' ' LYS . 90.7 mtp 71.76 -31.33 0.22 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.574 0.75 . . . . 0.0 112.766 176.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -58.51 -40.49 83.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.074 0.464 . . . . 0.0 110.84 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -142.91 -36.29 0.39 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.07 176.596 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -79.89 113.95 18.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.713 179.58 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 23.1 t -77.69 -32.05 17.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.231 0.539 . . . . 0.0 109.641 177.636 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 86.1 mt -75.69 92.87 3.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.817 176.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -108.9 123.69 49.48 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.516 -171.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -87.04 127.9 35.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.426 -179.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.481 ' OD1' ' HA ' ' A' ' 276' ' ' ALA . 57.3 m-20 -62.9 146.93 51.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.182 -178.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 274' ' ' SER . . . -58.66 108.97 0.71 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.607 -175.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 23.3 p -91.49 118.17 30.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.164 -178.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.67 148.25 48.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.225 177.473 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 25.4 m -98.67 136.73 38.32 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.603 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' A' ' 269' ' ' ARG . 8.7 p -67.56 142.56 16.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.449 178.566 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.2 t -105.74 -45.03 8.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.742 173.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -154.94 139.36 16.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.637 179.589 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 77.3 t -86.05 109.23 18.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 171.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 31.9 t -76.45 -58.26 4.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.821 -172.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -122.58 -2.7 8.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.866 0.365 . . . . 0.0 111.318 -176.085 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 72.18 12.88 76.37 Favored Glycine 0 CA--C 1.518 0.268 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -172.056 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 4.4 p -149.11 21.75 0.97 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.176 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.468 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.9 t-160 -173.41 115.73 0.25 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 113.833 -1.531 . . . . 0.0 107.667 -167.326 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -119.64 162.67 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -173.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 10.1 pt-20 -123.19 126.11 46.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.113 0.482 . . . . 0.0 110.189 171.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.42 HG21 HD11 ' A' ' 273' ' ' ILE . 25.5 pt -125.24 168.8 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.38 -176.031 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 6.0 t -140.59 138.47 18.68 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.802 176.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.04 179.45 25.95 Favored 'Cis proline' 0 C--N 1.344 0.318 0 C-N-CA 123.364 -1.515 . . . . 0.0 112.411 -1.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 3.0 ttmp? -80.12 123.57 83.31 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.384 177.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 15.0 Cg_exo -67.85 113.36 2.97 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.821 2.348 . . . . 0.0 112.647 178.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.602 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -117.32 128.96 74.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.125 174.817 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -81.19 130.62 35.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.261 0.553 . . . . 0.0 111.201 -178.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.0 tm? -65.18 -27.06 68.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.052 177.325 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.43 10.94 27.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.567 -178.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . 0.404 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 12.9 t70 -74.68 128.96 36.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.789 0.328 . . . . 0.0 110.133 178.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.1 p -83.92 -17.89 10.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.93 0.395 . . . . 0.0 111.58 -175.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 12.3 m -79.06 -36.33 41.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.489 -173.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.557 HD13 ' HB3' ' A' ' 325' ' ' ARG . 1.5 pp -72.25 162.53 29.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.448 0.642 . . . . 0.0 112.141 -178.522 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.518 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 12.5 m -108.26 173.87 2.78 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.697 -179.009 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 72.8 Cg_exo -44.19 -53.17 4.98 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 123.429 2.753 . . . . 0.0 114.987 -173.172 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -62.96 -39.12 93.72 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.071 -176.425 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -65.38 -41.37 93.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.452 -179.006 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.557 ' HB3' HD13 ' A' ' 320' ' ' LEU . 5.4 ppt_? -74.68 -19.0 60.44 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.972 179.132 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.78 -18.39 62.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.202 173.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -103.21 -0.61 30.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.485 176.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.602 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -62.27 127.33 30.84 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.774 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -106.5 -26.61 11.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.493 -176.001 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 27.0 m -116.29 161.45 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.0 110.858 -177.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -89.18 -16.75 30.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.109 -177.493 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 5.3 t -143.01 139.46 30.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.967 0.413 . . . . 0.0 111.002 -178.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.425 ' N ' ' HB2' ' A' ' 314' ' ' ALA . 20.2 m -74.56 174.56 8.83 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.431 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 19.1 tp -78.05 102.89 7.66 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.654 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -84.04 169.29 15.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.147 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -81.36 32.26 0.34 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -171.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.94 48.57 0.39 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.059 0.457 . . . . 0.0 110.841 174.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.455 ' H ' HG12 ' A' ' 230' ' ' VAL . 26.2 mmt -110.68 137.66 48.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.243 179.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.48 132.58 40.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.946 0.403 . . . . 0.0 110.874 179.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 31.8 t -102.83 114.36 42.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.897 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . 0.433 ' HA ' ' OG1' ' A' ' 226' ' ' THR . 8.4 t30 -126.07 124.46 40.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.398 -176.32 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 272' ' ' LYS . 32.3 mt -77.65 128.54 38.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.921 172.004 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 74.9 mt -71.32 111.31 6.55 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -102.03 77.9 1.74 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.909 -177.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 36.6 t . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.725 178.864 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.86 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.555 ' HB2' ' O ' ' A' ' 266' ' ' GLY . 20.6 p -89.61 50.93 1.98 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.189 0.518 . . . . 0.0 111.438 -175.389 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 12.5 t -131.12 17.03 5.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.505 0.669 . . . . 0.0 109.879 176.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -125.92 102.46 7.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.921 179.013 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 11.7 p -90.01 -77.58 0.39 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.011 -176.378 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 63.07 33.66 87.86 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.769 -176.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.45 HG21 ' O ' ' A' ' 263' ' ' ALA . 51.4 mt -102.99 149.96 6.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -175.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.88 148.07 32.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.812 0.339 . . . . 0.0 110.487 177.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.58 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.9 p -53.97 151.75 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.589 178.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.45 ' HB2' ' N ' ' A' ' 262' ' ' SER . 9.4 t -100.79 69.57 1.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.068 0.461 . . . . 0.0 110.026 178.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 89.52 166.16 41.57 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.013 -178.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.11 117.49 10.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.995 0.426 . . . . 0.0 110.756 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -114.77 126.43 54.83 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.967 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 57.2 p -125.27 149.57 47.9 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.152 -178.058 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -125.75 154.87 41.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.631 -178.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -143.02 138.42 15.77 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.159 177.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.5 ' HD2' ' OE1' ' A' ' 324' ' ' GLN . 5.5 Cg_endo -84.91 118.02 2.01 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 121.766 1.644 . . . . 0.0 110.602 171.55 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.45 83.27 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.388 0.613 . . . . 0.0 109.8 -178.276 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -114.5 135.66 53.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.134 176.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -88.79 36.69 0.81 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.367 0.603 . . . . 0.0 110.581 -177.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 63.77 -168.55 0.2 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.373 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 94.4 mt 70.49 -73.14 0.1 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.789 0.681 . . . . 0.0 111.577 178.529 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -147.08 168.36 21.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.918 0.39 . . . . 0.0 111.043 -174.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -69.72 -16.26 63.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.104 176.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -93.97 23.99 4.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.248 175.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.85 -34.5 15.24 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.729 177.316 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -97.84 124.13 42.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.226 0.536 . . . . 0.0 110.403 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -80.2 -13.22 59.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.784 -175.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.6 m -67.21 125.74 25.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.136 0.494 . . . . 0.0 110.513 176.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -112.51 139.15 48.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.241 -173.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 20.6 t 59.0 75.38 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.535 176.475 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -169.21 -46.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.036 176.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -76.74 -22.98 53.07 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -174.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -81.53 -2.3 49.39 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.123 0.487 . . . . 0.0 110.11 175.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.429 ' CD2' ' HB ' ' A' ' 309' ' ' THR . 78.8 m-85 -121.26 160.21 24.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.814 -179.244 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -136.33 132.79 36.11 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.702 0.286 . . . . 0.0 110.771 178.194 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 2.7 m -98.94 103.05 14.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.109 0.481 . . . . 0.0 110.069 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.51 125.81 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.744 -171.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 23.5 m -93.4 106.15 18.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.193 175.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.451 ' HB2' HG22 ' A' ' 264' ' ' THR . 19.6 mt -126.0 160.62 29.56 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -177.388 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.459 ' O ' HG22 ' A' ' 304' ' ' THR . 15.9 p -61.57 -48.09 82.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.147 0.499 . . . . 0.0 110.127 -178.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.45 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -136.72 138.33 40.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.294 175.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.451 HG22 ' HB2' ' A' ' 261' ' ' LEU . 9.4 p -134.61 28.45 3.62 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.503 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 2.6 m -78.07 145.02 36.07 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.486 -178.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . 0.555 ' O ' ' HB2' ' A' ' 223' ' ' SER . . . 97.08 -4.12 62.55 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.428 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 62.0 mtt -93.58 158.57 15.63 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 178.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.444 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 25.1 pttm -150.08 163.8 37.24 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -56.07 123.99 16.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.068 0.461 . . . . 0.0 110.791 -178.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 98.72 18.25 25.89 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.418 178.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.451 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 0.3 OUTLIER -99.1 160.22 14.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.634 0.717 . . . . 0.0 110.127 179.056 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -108.96 117.07 33.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.834 -175.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 308' ' ' ILE . 36.8 pt -117.91 140.7 40.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.234 0.54 . . . . 0.0 110.407 177.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.436 ' HB2' HG22 ' A' ' 294' ' ' THR . 39.0 t -126.97 153.81 45.38 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.371 179.29 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -117.46 111.69 19.63 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.08 117.73 5.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.234 -177.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.03 -34.7 5.06 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 96.3 t -88.37 114.44 26.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.431 ' HD2' ' SD ' ' A' ' 284' ' ' MET . 9.0 ptpp? -137.12 157.15 47.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.962 0.411 . . . . 0.0 111.035 -175.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.421 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 63.0 m-85 -76.6 135.9 39.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.029 -176.239 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 68.9 mt -65.73 133.48 51.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.974 175.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 121.89 -16.21 8.87 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -171.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.415 ' OE1' ' HB2' ' A' ' 279' ' ' LYS . 98.0 mt-30 -92.23 -169.08 2.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.921 -0.639 . . . . 0.0 109.698 174.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.431 ' SD ' ' HD2' ' A' ' 279' ' ' LYS . 75.9 mtm 63.63 17.58 10.51 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.735 176.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -101.99 -51.04 3.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.3 0.572 . . . . 0.0 109.57 174.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -130.33 32.05 4.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.281 176.104 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -114.97 108.75 17.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.604 -175.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 43.4 t -67.78 -62.29 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.162 -176.123 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 82.2 mt -93.64 -32.56 14.03 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 176.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . 61.24 107.19 0.02 OUTLIER 'General case' 0 C--O 1.236 0.37 0 O-C-N 124.169 0.918 . . . . 0.0 112.218 178.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -65.46 122.44 17.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.396 0.617 . . . . 0.0 109.749 176.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -66.71 167.91 10.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.265 -175.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.421 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -49.61 110.07 0.34 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.621 -175.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.515 HG21 HD11 ' A' ' 343' ' ' LEU . 4.9 p -100.49 120.5 40.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.08 -178.249 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -122.44 151.28 41.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.629 -178.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.8 m -98.32 130.59 45.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.211 178.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.451 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 14.1 p -80.83 132.08 32.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.322 0.582 . . . . 0.0 110.629 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 37.3 t -91.53 -33.9 5.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.317 -178.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -166.37 139.9 4.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.418 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 57.5 t -88.32 107.36 17.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 169.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 39.9 t -68.59 -54.79 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.874 -172.048 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -128.5 -6.42 5.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.154 0.502 . . . . 0.0 111.514 -174.156 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.04 12.67 80.69 Favored Glycine 0 N--CA 1.457 0.095 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -176.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 262' ' ' SER . 0.7 OUTLIER -150.65 20.84 0.81 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.229 1.014 . . . . 0.0 108.304 175.03 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -172.02 115.07 0.34 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.35 -171.325 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.3 m -118.89 162.59 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.514 -172.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -119.79 120.04 35.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.052 0.453 . . . . 0.0 110.014 171.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.459 HG21 HD11 ' A' ' 273' ' ' ILE . 27.6 pt -119.87 171.59 8.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.047 -177.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.429 ' HB ' ' CD2' ' A' ' 256' ' ' PHE . 12.7 t -150.05 142.2 15.51 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.235 175.342 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.18 -179.53 27.42 Favored 'Cis proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.764 -1.348 . . . . 0.0 113.135 -1.563 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 31.0 ttmt -78.85 121.39 83.39 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.161 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 16.2 Cg_exo -67.25 109.5 1.78 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.697 2.265 . . . . 0.0 111.902 175.373 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.7 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.3 OUTLIER -130.2 127.3 62.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.58 178.161 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -77.26 129.2 35.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.195 -177.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 44.6 tp -73.86 -26.4 60.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.664 178.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -86.25 3.97 40.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.266 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -65.61 125.09 24.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.119 177.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 31.3 m -84.46 -6.42 10.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 17.3 m -91.49 -29.25 17.11 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.61 0.243 . . . . 0.0 111.248 -173.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 1.7 pp -73.4 167.38 21.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.405 0.622 . . . . 0.0 111.79 -179.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.43 ' H ' ' NE2' ' A' ' 324' ' ' GLN . 5.8 m -99.23 160.96 26.25 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.198 -177.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.459 ' HA ' ' NE ' ' A' ' 325' ' ' ARG . 46.5 Cg_exo -39.97 -52.94 2.61 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.578 2.852 . . . . 0.0 114.165 178.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -61.37 -34.02 74.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.05 0.453 . . . . 0.0 111.187 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.5 ' OE1' ' HD2' ' A' ' 238' ' ' PRO . 45.7 mt-30 -67.45 -25.07 65.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.025 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.459 ' NE ' ' HA ' ' A' ' 322' ' ' PRO . 44.8 mtm180 -63.31 -36.05 82.39 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.06 0.457 . . . . 0.0 110.042 175.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -63.54 -31.06 72.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.067 179.25 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -87.51 -10.53 51.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.392 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.7 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -69.79 146.99 51.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.699 0.285 . . . . 0.0 111.267 -177.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . 0.447 ' OD1' HG13 ' A' ' 330' ' ' VAL . 3.3 p30 -134.39 -36.6 0.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -174.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.447 HG13 ' OD1' ' A' ' 329' ' ' ASN . 34.5 m -101.75 170.1 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.935 -178.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -82.89 -47.4 11.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.886 0.374 . . . . 0.0 110.83 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 72.1 p -124.72 141.48 52.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.768 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 34.9 m -70.66 171.81 9.75 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.091 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 20.5 tp -71.72 103.12 2.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.093 0.473 . . . . 0.0 110.065 -175.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.58 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -91.51 -177.89 4.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.331 179.303 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -73.53 151.02 41.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.937 0.399 . . . . 0.0 110.867 -178.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 66.15 29.01 10.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.198 179.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.7 mmt -88.67 127.02 35.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -82.7 130.68 35.16 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.989 0.423 . . . . 0.0 111.323 -176.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 13.8 t -92.36 120.08 40.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.427 178.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -125.96 128.4 47.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.119 -175.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 9.6 mt -93.6 134.1 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 172.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . 0.515 HD11 HG21 ' A' ' 294' ' ' THR . 69.8 mt -72.49 122.38 21.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.145 179.032 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -76.65 77.58 3.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 -176.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 C--O 1.25 1.083 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.567 177.16 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.9 p -73.26 -20.02 60.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.029 0.414 . . . . 0.0 111.416 -177.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 22.5 p -87.61 -2.58 58.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.106 0.479 . . . . 0.0 110.594 176.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -99.7 136.65 39.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.433 176.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 20.0 p -91.78 -89.53 0.18 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.717 -177.305 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 60.55 54.98 32.6 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.897 -178.253 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.455 HG21 ' O ' ' A' ' 263' ' ' ALA . 55.9 mt -102.11 146.26 10.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 7.7 p -97.7 147.35 24.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.536 0.684 . . . . 0.0 111.903 -177.424 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.642 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.7 p -59.81 150.94 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.708 -178.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.9 t -97.96 74.63 2.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 79.99 158.69 16.89 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.596 179.617 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.51 146.58 53.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.709 0.29 . . . . 0.0 110.431 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -155.93 136.3 13.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.155 0.503 . . . . 0.0 110.721 -179.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.1 p -118.97 122.1 41.45 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.805 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.58 ' O ' HG12 ' A' ' 313' ' ' VAL . 54.3 m-85 -88.74 147.59 24.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.394 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 320' ' ' LEU . 34.4 mmtp -127.28 139.85 36.3 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.023 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.514 ' HD3' HG11 ' A' ' 313' ' ' VAL . 74.3 Cg_endo -91.04 163.64 3.85 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.922 2.415 . . . . 0.0 110.993 173.27 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.65 121.02 62.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.163 0.506 . . . . 0.0 110.192 177.562 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -125.29 79.73 1.83 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.215 178.381 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 43.0 t-105 175.59 135.3 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.782 -176.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -72.29 103.98 3.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.15 0.5 . . . . 0.0 110.03 176.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 16.3 tp -140.08 114.61 9.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.909 -175.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -141.87 -36.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.84 0.353 . . . . 0.0 111.59 -176.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -67.81 -55.02 14.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.835 0.35 . . . . 0.0 110.969 -178.136 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -134.64 162.04 33.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.078 -178.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.92 -60.23 4.82 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.4 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -137.2 136.43 38.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -120.04 -49.55 2.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.906 0.384 . . . . 0.0 110.223 178.071 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.8 m -96.87 115.73 37.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.265 0.555 . . . . 0.0 110.946 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -114.65 85.01 2.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.041 177.408 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 252' ' ' VAL . 12.4 p -138.08 28.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 122.906 1.336 . . . . 0.0 109.077 177.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -133.98 13.71 3.95 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.22 -177.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -92.92 -43.2 9.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.232 178.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -81.5 -11.97 59.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.801 177.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -114.76 160.36 19.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.455 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -140.08 131.63 27.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.192 175.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.3 OUTLIER -101.02 102.6 13.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.093 0.473 . . . . 0.0 110.226 179.862 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.441 ' O ' ' HD2' ' A' ' 305' ' ' HIS . 3.3 t -82.48 120.87 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.059 -172.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 9.6 m -91.2 105.51 17.85 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.197 -179.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.439 HD22 HG21 ' A' ' 340' ' ' VAL . 19.3 mt -126.61 163.71 22.85 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -175.571 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 10.4 t -63.18 -49.17 75.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.191 0.52 . . . . 0.0 109.704 -178.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.455 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.08 138.22 40.14 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.41 HG22 ' HB2' ' A' ' 261' ' ' LEU . 15.8 p -130.51 25.22 5.11 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.84 0.828 . . . . 0.0 109.087 175.626 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 5.2 m -76.64 147.48 37.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.295 175.134 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.0 -18.82 56.57 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -175.021 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 56.8 mtt -87.03 139.58 30.43 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 11.5 ptmm? -143.75 145.46 32.41 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.035 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -46.34 122.6 4.14 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.921 0.763 . . . . 0.0 112.891 -170.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 98.36 18.85 24.99 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.689 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.575 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.1 t70 -100.08 -176.92 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.926 0.393 . . . . 0.0 110.749 -176.513 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.486 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 3.7 tppp? -122.69 116.27 23.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.225 -175.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.483 HD11 HG21 ' A' ' 308' ' ' ILE . 17.9 pt -120.21 139.9 46.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 120.916 0.389 . . . . 0.0 110.326 175.652 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 54.8 p -124.1 141.06 52.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.008 179.188 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -107.47 111.06 23.18 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.874 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.47 119.24 10.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.605 -178.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.26 -34.1 5.35 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.137 -0.554 . . . . 0.0 111.794 -178.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 70.6 t -90.93 137.15 22.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 177.044 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 279' ' ' LYS . 8.3 ptpt -159.97 160.79 33.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.076 0.465 . . . . 0.0 111.548 178.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -78.37 154.25 30.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.729 -172.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 315' ' ' LEU . 65.8 mt -68.27 146.33 53.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.456 179.064 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.1 -19.89 36.22 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.138 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -78.39 -13.91 59.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.063 0.459 . . . . 0.0 110.455 -178.392 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 36.4 mtm -117.17 42.11 2.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.115 -179.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -69.56 -56.64 6.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.881 -177.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -132.03 -29.64 1.64 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.419 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -83.31 126.08 32.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.4 178.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 24.4 t -83.31 -24.04 8.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.443 178.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 90.2 mt -78.25 70.21 4.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.582 175.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -94.97 127.08 40.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.136 -176.177 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -60.52 134.34 56.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.695 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -71.14 153.18 42.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.131 -178.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -59.14 111.19 1.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.048 -172.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.486 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 0.8 OUTLIER -94.3 123.39 37.67 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.795 176.32 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -121.39 148.57 44.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.407 178.153 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.6 m -91.62 122.22 33.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.722 178.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 271' ' ' ASP . 11.3 p -73.21 121.5 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.388 0.613 . . . . 0.0 110.112 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 61.2 t -84.53 -41.59 16.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.447 -178.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.532 ' HD2' ' OE2' ' A' ' 307' ' ' GLU . 0.9 OUTLIER -165.55 136.22 3.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.825 -175.749 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 84.4 t -90.17 111.77 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.416 175.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 14.9 t -78.09 -58.94 3.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.78 -173.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -116.87 -3.39 11.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.904 0.383 . . . . 0.0 111.8 -172.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 69.3 12.86 66.75 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -170.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.8 p -145.6 16.79 1.47 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 174.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.441 ' HD2' ' O ' ' A' ' 259' ' ' VAL . 5.6 t-160 -170.89 118.32 0.49 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.631 -1.168 . . . . 0.0 107.865 -170.316 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.4 m -118.73 156.97 20.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -173.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.532 ' OE2' ' HD2' ' A' ' 299' ' ' ARG . 10.8 pt-20 -114.26 122.14 45.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.126 0.488 . . . . 0.0 109.864 171.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.483 HG21 HD11 ' A' ' 273' ' ' ILE . 33.6 pt -118.88 175.01 4.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.232 -177.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 15.1 t -154.23 138.34 11.06 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.071 174.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.61 -178.94 25.51 Favored 'Cis proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.909 -1.288 . . . . 0.0 112.806 -1.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 22.0 ttmm -80.24 131.28 62.83 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.044 -179.146 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 3.7 Cg_exo -75.73 108.44 2.69 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.249 1.966 . . . . 0.0 111.496 173.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.684 HG23 ' HA ' ' A' ' 328' ' ' ALA . 1.0 OUTLIER -126.02 136.58 60.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.106 177.557 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -91.95 138.03 31.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.348 0.594 . . . . 0.0 112.292 -170.188 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.422 ' HB2' HD11 ' A' ' 281' ' ' LEU . 3.3 tm? -80.77 -31.73 35.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.185 178.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -85.38 8.18 19.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.265 -177.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . 0.507 ' OD2' ' HG ' ' A' ' 320' ' ' LEU . 23.5 t70 -83.22 129.52 35.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.203 179.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 11.9 p -84.8 -19.62 8.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.804 0.335 . . . . 0.0 111.268 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 36.8 t -69.66 -42.97 73.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.36 -172.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.557 HD13 ' HG2' ' A' ' 325' ' ' ARG . 0.4 OUTLIER -76.92 152.08 35.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.485 0.659 . . . . 0.0 111.165 176.426 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.479 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 18.1 m -86.1 163.18 44.02 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.151 -173.526 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 41.6 Cg_exo -37.59 -54.37 1.25 Allowed 'Trans proline' 0 C--N 1.356 0.974 0 C-N-CA 124.306 3.337 . . . . 0.0 114.889 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -64.96 -34.04 77.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.945 0.402 . . . . 0.0 111.235 -176.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 53.8 mt-30 -69.18 -32.74 72.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.032 0.444 . . . . 0.0 109.906 177.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.557 ' HG2' HD13 ' A' ' 320' ' ' LEU . 98.2 mtt180 -65.7 -26.71 67.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.744 175.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -72.64 -20.19 61.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.143 0.496 . . . . 0.0 110.609 176.399 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -97.56 -0.36 45.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.738 176.086 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.684 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -65.8 132.7 49.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.005 0.431 . . . . 0.0 111.078 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -108.29 -32.17 7.58 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.901 -172.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.59 172.83 6.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.668 -177.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -86.23 -48.68 8.33 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.647 0.26 . . . . 0.0 111.452 -178.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.7 t -118.32 149.72 40.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.038 0.447 . . . . 0.0 110.875 -175.784 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 28.7 p -79.75 174.21 11.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.815 176.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.44 HD12 ' HG3' ' A' ' 338' ' ' MET . 15.9 tp -78.27 103.7 8.37 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -176.216 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.642 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.52 174.69 11.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.743 -178.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -81.55 10.41 5.96 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.178 0.806 . . . . 0.0 113.178 -168.254 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -141.01 33.58 1.75 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.915 0.388 . . . . 0.0 111.318 177.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.44 ' HG3' HD12 ' A' ' 334' ' ' LEU . 14.3 mmt -86.19 131.75 34.17 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -86.18 130.87 34.38 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.774 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.439 HG21 HD22 ' A' ' 261' ' ' LEU . 18.1 t -104.75 111.64 35.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.829 178.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -126.04 136.65 53.2 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.67 -177.226 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.401 HG22 HD22 ' A' ' 344' ' ' ASN . 17.7 mt -85.25 121.15 36.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.924 0.393 . . . . 0.0 110.64 175.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 41.1 mt -91.53 120.94 32.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.788 175.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . 0.401 HD22 HG22 ' A' ' 342' ' ' ILE . 7.5 p30 -138.93 127.29 22.88 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.131 -178.792 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.421 -0.799 . . . . 0.0 109.722 178.932 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.824 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 34.1 p -153.26 -49.78 0.1 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.968 0.413 . . . . 0.0 110.397 -178.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 16.8 p -109.34 126.32 53.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.001 178.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 59.35 57.61 3.31 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.142 178.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 29.8 p -67.35 -35.82 80.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.124 179.375 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 52.76 53.23 34.03 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.644 176.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 263' ' ' ALA . 42.6 mm -102.85 140.22 21.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -177.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 24.3 p -121.5 159.34 26.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.957 0.408 . . . . 0.0 110.808 175.18 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.614 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.0 p -80.78 150.4 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.236 177.372 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 75.1 m -116.1 86.26 2.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.219 0.533 . . . . 0.0 110.423 176.004 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 94.51 138.55 9.38 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.398 179.592 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.29 132.09 46.5 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.002 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -141.6 127.36 19.2 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.425 0.631 . . . . 0.0 111.067 -175.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.9 p -117.87 114.61 23.5 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.129 179.095 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -81.1 164.02 22.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.075 -178.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . 44.8 mmtm -135.78 130.76 18.84 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.85 0.357 . . . . 0.0 111.348 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.551 ' HD3' HG11 ' A' ' 313' ' ' VAL . 71.7 Cg_endo -90.69 127.88 1.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.885 2.39 . . . . 0.0 111.685 177.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 14.1 p -80.39 140.9 16.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 120.901 0.381 . . . . 0.0 110.45 -179.057 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -96.4 167.27 11.27 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.19 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -77.26 -34.61 55.72 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -67.53 102.53 1.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.182 173.026 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 37.8 tp -176.12 82.98 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.049 -175.059 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -94.13 -12.91 27.43 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.859 -176.658 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -87.84 -17.44 31.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.302 -179.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -144.49 152.17 40.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.879 0.371 . . . . 0.0 110.831 -174.762 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -109.9 49.95 0.81 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.609 -178.028 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -83.93 25.45 0.81 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.615 0.721 . . . . 0.0 110.077 178.773 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -83.85 -58.2 2.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.223 -178.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.31 -5.3 10.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.897 0.856 . . . . 0.0 109.948 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -109.86 139.22 45.18 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.884 -179.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 89.4 t 65.1 99.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.358 0 O-C-N 123.755 0.659 . . . . 0.0 110.248 -175.007 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -53.12 129.35 30.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.172 -174.61 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.482 ' OD1' ' HA ' ' A' ' 238' ' ' PRO . 63.4 t30 -93.4 -23.46 18.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.201 -174.689 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -89.85 -42.09 11.45 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.761 -174.39 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.514 ' CE1' HG21 ' A' ' 298' ' ' VAL . 56.7 m-85 -103.34 121.33 42.54 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.716 -176.519 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.17 137.21 38.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.597 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.0 OUTLIER -97.69 107.15 19.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.268 0.556 . . . . 0.0 110.671 -177.889 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.47 ' HB ' HG22 ' A' ' 306' ' ' VAL . 3.1 t -89.41 124.22 42.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.408 -172.765 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 37.5 m -93.63 107.4 19.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.162 177.596 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.427 HD23 HG23 ' A' ' 230' ' ' VAL . 27.9 mt -124.64 172.12 9.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.422 -174.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.3 m -64.83 -53.69 42.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.37 0.605 . . . . 0.0 109.871 179.396 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.562 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -135.95 130.56 33.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.391 179.038 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.449 ' HB ' ' CG1' ' A' ' 306' ' ' VAL . 6.9 p -129.59 22.66 5.48 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.867 0.841 . . . . 0.0 108.817 174.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 15.5 m -80.59 145.37 31.77 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.564 176.17 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 98.99 -9.91 61.81 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -175.672 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . 0.461 ' HG2' HD11 ' A' ' 342' ' ' ILE . 57.9 mtt -93.88 151.8 19.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.007 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.52 ' HG2' ' OD2' ' A' ' 271' ' ' ASP . 1.9 ptpp? -147.34 157.15 43.47 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.396 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -52.36 117.23 2.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.152 0.501 . . . . 0.0 110.832 -178.074 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 106.28 18.43 11.17 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.741 -177.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.52 ' OD2' ' HG2' ' A' ' 268' ' ' LYS . 7.4 m-20 -99.78 159.16 15.27 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 117.236 0.518 . . . . 0.0 110.167 176.721 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -111.62 116.75 31.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.986 -178.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.535 HD11 HG21 ' A' ' 308' ' ' ILE . 34.6 pt -113.19 140.67 32.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.217 178.609 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.448 ' HB3' HG22 ' A' ' 294' ' ' THR . 22.0 p -123.14 139.98 53.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.22 178.822 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.437 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 93.1 m-85 -103.57 111.34 23.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.037 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.2 113.03 4.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.146 -176.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.34 -24.98 12.97 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.641 -178.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 90.6 t -97.5 128.18 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 177.296 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 292' ' ' ASP . 15.0 ptpt -160.46 179.73 8.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.2 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -68.56 174.89 3.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.183 -172.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 75.7 mt -71.96 -85.74 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -171.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -87.9 31.11 4.77 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.247 -0.501 . . . . 0.0 112.747 -172.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.458 ' O ' ' HB3' ' A' ' 287' ' ' ASN . 5.4 tt0 -89.36 -4.51 58.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.099 0.476 . . . . 0.0 110.022 -179.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 77.2 mtp -109.82 8.97 24.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.018 -174.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -62.69 -52.08 64.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.096 -177.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -130.75 -20.71 2.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.806 178.207 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 283' ' ' GLN . 49.5 t30 -81.11 96.33 7.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.125 0.488 . . . . 0.0 109.96 178.642 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 26.3 t -69.3 -32.64 54.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.93 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 96.1 mt -86.77 43.94 1.12 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.323 177.44 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.0 113.39 3.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.836 -179.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -57.49 143.26 41.29 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.771 -179.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 279' ' ' LYS . 14.9 m-20 -73.55 161.23 30.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.779 179.284 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -64.54 105.19 0.91 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.294 -175.19 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 274' ' ' SER . 15.8 p -90.93 132.66 35.81 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.597 177.007 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.408 ' CG ' HD12 ' A' ' 308' ' ' ILE . 97.7 m-85 -129.79 150.78 50.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.427 179.305 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 20.1 m -96.65 125.06 40.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.122 178.56 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 271' ' ' ASP . 12.4 p -80.82 138.07 20.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.161 0.505 . . . . 0.0 110.61 -179.484 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.514 HG21 ' CE1' ' A' ' 256' ' ' PHE . 45.3 t -104.75 -29.53 2.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.021 -178.822 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -164.1 137.2 5.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.017 0.437 . . . . 0.0 111.171 -179.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 87.5 t -95.75 112.19 27.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 45.1 t -75.8 -58.79 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.909 -172.251 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -123.35 -3.06 8.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.298 0.57 . . . . 0.0 111.215 -175.753 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 78.37 13.87 82.8 Favored Glycine 0 C--N 1.322 -0.24 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -173.225 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 27.1 p -142.18 14.57 2.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.273 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.452 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 5.3 t-160 -164.02 117.45 1.44 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.491 -169.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.6 m -118.46 164.67 14.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -175.459 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 9.2 pt-20 -125.46 123.32 38.98 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 169.478 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.535 HG21 HD11 ' A' ' 273' ' ' ILE . 23.4 pt -124.44 164.3 23.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.045 -173.092 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.432 ' HB ' ' CD1' ' A' ' 256' ' ' PHE . 8.2 t -135.57 140.19 33.28 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.637 174.693 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.8 179.55 30.17 Favored 'Cis proline' 0 CA--C 1.531 0.355 0 C-N-CA 123.187 -1.589 . . . . 0.0 112.655 -1.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.462 ' HG2' HG13 ' A' ' 313' ' ' VAL . 31.1 ttmt -70.81 119.53 73.59 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.742 177.575 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.466 ' HD2' ' CB ' ' A' ' 257' ' ' ALA . 38.1 Cg_endo -69.5 108.94 2.14 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.436 2.091 . . . . 0.0 111.65 175.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.714 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.2 OUTLIER -135.43 135.31 51.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.825 -178.497 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -83.4 129.76 35.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.251 -176.516 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 315' ' ' LEU . 3.1 tm? -68.86 -26.07 64.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.45 178.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -99.31 18.3 17.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.103 -179.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . 0.441 ' HB3' ' CD2' ' A' ' 320' ' ' LEU . 9.9 t0 -65.47 130.85 44.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.726 178.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 30.4 m -83.16 1.98 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -173.194 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 14.2 t -125.78 28.34 6.2 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.064 -0.654 . . . . 0.0 112.441 -176.086 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.638 HD13 ' HG2' ' A' ' 325' ' ' ARG . 0.7 OUTLIER -123.54 164.76 18.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.131 0.491 . . . . 0.0 111.551 175.43 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.44 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 19.3 m -101.92 164.92 14.88 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.678 -179.284 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 86.4 Cg_exo -44.19 -50.18 7.96 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.641 2.894 . . . . 0.0 114.537 -176.623 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -66.34 -27.7 68.09 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -177.383 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 49.8 mt-30 -71.6 -28.9 64.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.005 0.431 . . . . 0.0 109.976 177.785 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.638 ' HG2' HD13 ' A' ' 320' ' ' LEU . 55.8 mtp180 -70.82 -18.93 62.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.434 178.019 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -74.52 -32.7 62.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.288 176.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -85.51 -4.25 59.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.742 177.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.714 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -63.3 159.62 17.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.06 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -138.65 -49.15 0.52 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.831 0.348 . . . . 0.0 111.244 -175.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.2 m -105.72 161.67 5.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.647 -175.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -91.78 -5.46 53.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.01 -176.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 8.0 t -147.73 136.3 21.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.527 -176.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.1 p -80.11 163.56 24.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.365 178.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 19.2 tp -70.57 106.09 3.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.968 0.413 . . . . 0.0 110.724 -173.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.614 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -79.53 173.53 12.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.81 -178.449 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -81.05 4.04 21.16 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -166.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -143.62 45.7 1.49 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.064 0.459 . . . . 0.0 111.421 176.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.444 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 22.8 mmt -92.17 143.56 26.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.214 178.018 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.42 138.45 33.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.422 179.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.544 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 19.1 t -112.9 116.96 54.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.14 0.495 . . . . 0.0 109.91 -178.603 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -125.41 138.9 54.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.891 -175.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.461 HD11 ' HG2' ' A' ' 267' ' ' MET . 21.7 mt -96.65 132.68 40.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.68 0.276 . . . . 0.0 110.452 174.637 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 54.9 mt -84.26 115.62 22.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.193 176.563 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -92.15 110.32 21.7 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.986 -0.531 . . . . 0.0 110.567 179.697 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.7 p -86.91 49.83 1.89 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.27 0.557 . . . . 0.0 110.422 178.834 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.5 m -77.81 75.99 4.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.457 -177.433 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.52 102.88 1.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.734 179.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 33.9 p -114.66 92.11 3.84 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.626 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.0 61.24 0.43 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 177.054 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.658 HG21 ' O ' ' A' ' 263' ' ' ALA . 23.7 mt -102.87 154.24 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.583 0.23 . . . . 0.0 110.841 -174.065 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 18.9 p -114.75 171.25 7.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.142 0.496 . . . . 0.0 111.571 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.533 HG11 ' O ' ' A' ' 335' ' ' ALA . 8.1 p -87.35 150.15 3.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.87 -178.227 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 62.2 m -114.98 91.44 3.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.827 0.346 . . . . 0.0 110.393 175.638 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 90.46 161.41 37.41 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.143 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -83.27 117.73 23.17 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.934 0.397 . . . . 0.0 110.15 178.651 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -109.07 126.37 53.09 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.097 0.475 . . . . 0.0 109.958 179.672 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 10.2 p -121.29 125.63 47.52 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.618 -178.318 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.584 ' HB2' ' O ' ' A' ' 312' ' ' PRO . 86.2 m-85 -109.08 145.43 35.66 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.899 -179.118 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -133.4 144.27 51.61 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.984 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.45 ' HD2' HE21 ' A' ' 324' ' ' GLN . 59.9 Cg_endo -80.4 120.82 4.12 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.169 1.912 . . . . 0.0 110.863 173.18 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.16 130.44 36.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.334 0.587 . . . . 0.0 110.631 -177.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -106.15 -173.77 2.38 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.169 179.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 26.9 m-90 -94.99 -19.86 19.85 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.913 0.387 . . . . 0.0 110.436 178.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -79.66 102.8 9.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 173.207 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 74.1 mt -109.85 73.13 0.83 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.235 -172.455 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -111.84 -3.44 14.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.145 177.825 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -73.87 -51.35 16.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.05 -178.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -159.84 -40.91 0.05 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.532 -178.533 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 134.55 165.26 10.83 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.672 175.115 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -157.63 74.99 0.77 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.409 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -97.93 6.41 47.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.418 -179.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 26.7 m -118.4 173.78 4.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.462 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -84.91 144.44 28.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.094 178.111 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.33 135.36 27.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.94 0.4 . . . . 0.0 110.923 -178.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -74.0 93.22 2.21 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 174.339 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -89.48 -15.74 32.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.093 -172.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -96.63 -4.45 41.02 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.966 179.71 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -126.22 133.18 51.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.532 -179.307 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -107.59 117.29 33.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.57 178.044 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 4.1 m -89.68 109.19 20.18 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.034 0.445 . . . . 0.0 110.314 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 3.0 t -92.73 122.27 44.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.593 -172.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 25.2 m -91.33 115.05 27.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.948 175.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 26.0 mt -132.78 172.41 12.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.273 -175.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 14.9 m -62.95 -56.48 16.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.476 0.655 . . . . 0.0 109.503 177.547 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.658 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -136.93 140.99 42.66 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.8 177.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . . . . . . . . . 10.9 p -131.39 23.15 4.77 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.283 1.04 . . . . 0.0 108.205 173.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 7.6 m -77.93 142.64 38.26 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.859 -1.519 . . . . 0.0 109.649 176.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 97.96 -15.16 62.01 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -175.692 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 61.7 mtt -89.15 151.07 22.4 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -135.44 164.24 28.22 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -62.62 140.24 58.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.867 179.237 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.93 19.04 62.03 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.829 173.059 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.498 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 1.2 t70 -105.74 -166.73 1.24 Allowed 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 118.038 0.919 . . . . 0.0 110.458 -178.293 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -125.54 116.28 21.52 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.702 -178.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.466 HD11 HG21 ' A' ' 308' ' ' ILE . 19.6 pt -113.69 139.69 37.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.49 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.491 ' OG ' HG22 ' A' ' 294' ' ' THR . 2.9 m -122.19 140.39 52.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.486 -175.117 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -105.97 111.41 24.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.334 178.273 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -71.5 117.93 13.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.27 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.79 -17.55 22.76 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.611 -176.254 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.53 124.24 71.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.486 ' HD3' ' HB3' ' A' ' 290' ' ' ALA . 1.0 OUTLIER -138.86 165.23 27.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.917 0.389 . . . . 0.0 111.757 -176.042 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -82.57 148.39 28.07 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.323 -176.226 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 284' ' ' MET . 97.3 mt -80.84 -19.7 44.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.714 -176.775 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -63.09 -18.9 60.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.95 -178.23 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 287' ' ' ASN . 28.6 tt0 -121.08 13.3 11.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.132 0.491 . . . . 0.0 110.218 179.303 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.448 ' HB2' ' HA ' ' A' ' 281' ' ' LEU . 66.7 mmm -105.45 33.89 3.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.252 -178.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -92.34 -27.54 17.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.8 0.333 . . . . 0.0 110.524 178.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -161.8 -25.03 0.05 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.8 179.808 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 283' ' ' GLN . 16.3 m120 -68.97 123.13 20.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.164 0.506 . . . . 0.0 110.754 178.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.49 -34.39 15.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.728 178.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 70.6 mt -91.42 47.03 1.34 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.674 177.702 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 279' ' ' LYS . . . -65.4 134.68 54.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.215 -177.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -53.05 131.27 36.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.819 -178.458 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -74.01 167.93 20.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.483 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.623 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -66.77 81.84 0.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.316 -177.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.491 HG22 ' OG ' ' A' ' 274' ' ' SER . 12.6 p -85.07 89.69 7.68 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.309 177.485 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.623 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 51.1 m-85 -96.03 149.24 21.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.279 0.561 . . . . 0.0 111.364 -176.171 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.9 m -91.51 126.76 36.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.969 -179.458 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.498 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 8.7 p -87.77 141.52 14.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.184 -178.346 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 13.3 p -104.78 -26.01 3.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.714 179.339 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -170.34 146.82 2.94 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.931 0.396 . . . . 0.0 111.086 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.69 121.0 41.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 169.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.22 -58.03 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.932 -172.544 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -129.02 -5.23 5.01 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.285 0.564 . . . . 0.0 111.631 -175.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.27 12.01 81.33 Favored Glycine 0 CA--C 1.518 0.247 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -175.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 22.2 p -145.05 16.24 1.55 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 171.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.9 t-160 -169.29 117.92 0.65 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.092 -1.413 . . . . 0.0 107.59 -167.264 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.6 m -119.58 168.57 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 117.706 0.23 . . . . 0.0 110.736 -174.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -126.18 118.18 24.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.259 0.552 . . . . 0.0 110.026 171.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.466 HG21 HD11 ' A' ' 273' ' ' ILE . 35.1 pt -119.84 174.28 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.341 -176.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.2 t -154.65 143.07 14.5 Favored Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.461 176.407 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -76.18 -179.12 25.96 Favored 'Cis proline' 0 C--N 1.345 0.344 0 C-N-CA 124.105 -1.206 . . . . 0.0 112.909 -3.076 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.454 ' HD3' ' HB3' ' A' ' 236' ' ' PHE . 2.5 ttmp? -75.09 132.1 77.46 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.12 -178.093 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.584 ' O ' ' HB2' ' A' ' 236' ' ' PHE . 9.3 Cg_exo -71.82 108.15 2.37 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.326 2.017 . . . . 0.0 111.192 173.381 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 329' ' ' ASN . 4.4 m -130.11 128.01 64.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.788 -177.709 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -87.66 141.56 28.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.307 0.575 . . . . 0.0 112.238 -172.728 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -81.0 -28.8 35.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.996 -179.305 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -100.31 20.66 14.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.671 -176.336 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 11.6 t70 -83.38 124.08 30.3 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.277 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 9.3 p -82.96 -11.96 12.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.874 0.369 . . . . 0.0 111.608 -175.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 15.7 m -86.66 0.74 53.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.693 -172.708 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 1.5 pp -106.77 169.83 8.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.829 0.347 . . . . 0.0 111.312 179.508 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 28.2 t -85.88 148.03 47.29 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.539 175.383 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -42.72 -43.99 8.79 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.112 2.541 . . . . 0.0 113.662 -177.683 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -61.01 -29.99 70.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.958 0.408 . . . . 0.0 111.465 -178.139 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.45 HE21 ' HD2' ' A' ' 238' ' ' PRO . 18.8 mt-30 -71.16 -25.55 62.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.509 -178.582 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -62.67 -34.99 78.24 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.214 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.37 -24.06 65.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.948 178.296 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -103.21 11.82 36.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 177.823 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -73.89 164.87 26.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.865 178.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . 0.424 ' N ' HG23 ' A' ' 313' ' ' VAL . 50.4 t30 -139.99 -43.53 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.606 -172.655 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.6 m -111.21 175.33 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.698 0.285 . . . . 0.0 111.02 -178.663 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -80.48 -50.22 10.35 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.699 0.285 . . . . 0.0 111.454 -177.112 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 9.7 t -130.91 151.83 50.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.413 -177.983 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 49.0 m -71.4 167.47 19.51 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 174.004 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 27.8 tp -70.91 103.71 2.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 110.147 -176.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.533 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -89.76 -170.92 2.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.194 178.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -76.86 162.48 27.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.855 0.36 . . . . 0.0 110.705 -179.336 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . 58.31 45.97 16.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.089 178.409 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.511 ' H ' HG12 ' A' ' 230' ' ' VAL . 24.8 mmt -114.61 131.04 56.84 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.339 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -85.53 138.98 31.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.008 -179.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 14.2 t -113.12 114.47 47.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.649 178.386 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -132.22 138.49 47.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.808 0.337 . . . . 0.0 111.813 -173.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.432 ' CG1' HG22 ' A' ' 273' ' ' ILE . 21.4 mt -91.6 123.29 43.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.846 174.537 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 59.2 mt -79.16 139.1 38.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.282 178.809 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -71.22 110.59 5.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.849 -179.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 51.4 t . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.544 -0.741 . . . . 0.0 109.527 178.144 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.8 t -73.27 -41.1 64.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.858 0.361 . . . . 0.0 110.301 -179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 16.6 p -89.42 51.37 2.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.403 0.62 . . . . 0.0 110.744 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -86.41 98.72 11.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.778 -178.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 38.9 p -74.76 -59.09 2.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.341 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 59.82 50.92 62.45 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.359 178.3 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.496 ' HB ' ' HB ' ' A' ' 340' ' ' VAL . 48.0 mm -89.29 144.35 9.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -178.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 23.2 p -122.39 156.66 33.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.297 0.57 . . . . 0.0 111.262 176.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.61 HG11 ' O ' ' A' ' 335' ' ' ALA . 7.1 p -73.84 151.16 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.043 179.395 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.3 t -115.37 64.62 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.208 0.528 . . . . 0.0 109.983 178.124 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 106.11 149.67 17.59 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.323 -179.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -59.37 125.49 23.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.904 0.383 . . . . 0.0 111.127 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 334' ' ' LEU . 26.3 mm-40 -113.24 126.6 55.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.961 0.41 . . . . 0.0 110.269 179.133 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 p -122.97 105.04 9.63 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.131 177.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -89.55 146.78 24.35 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.168 -173.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -144.08 121.12 6.54 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.776 178.719 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -91.38 143.08 3.02 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.777 2.318 . . . . 0.0 110.694 168.144 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 239' ' ' VAL . 7.3 p -78.4 84.93 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 122.255 1.026 . . . . 0.0 110.465 -179.41 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -82.26 80.87 8.35 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.571 178.121 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 15.0 t-105 -163.7 -69.96 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.148 -177.264 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 60.24 101.94 0.02 OUTLIER 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.049 179.078 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.81 157.56 32.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.666 179.594 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -56.14 -58.78 6.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.703 0.287 . . . . 0.0 110.855 -177.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -80.33 -55.08 5.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.755 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -89.14 71.93 8.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.206 0.527 . . . . 0.0 111.166 -178.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -98.73 139.83 14.67 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.277 176.153 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -78.51 83.38 4.71 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -96.51 -39.21 9.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.457 -173.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 25.7 m -115.06 152.08 16.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 57.9 t30 54.33 64.87 1.67 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.739 0.78 . . . . 0.0 109.48 -174.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 23.4 m -87.65 50.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.454 -173.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -62.11 -16.85 55.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.151 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -69.21 -18.78 63.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.804 178.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -89.29 -15.24 33.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.095 0.474 . . . . 0.0 109.971 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -99.26 142.91 30.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.639 178.008 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' A' ' 307' ' ' GLU . . . -100.48 122.57 43.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.556 0.217 . . . . 0.0 111.135 -177.724 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.4 m -96.31 107.38 19.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.044 0.45 . . . . 0.0 110.104 -179.526 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.5 t -92.91 119.32 40.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.767 -171.107 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 18.5 m -89.74 106.19 18.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.18 0.514 . . . . 0.0 109.983 174.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.45 ' HB2' ' CG2' ' A' ' 264' ' ' THR . 30.1 mt -121.29 169.37 10.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.058 -176.142 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 30.2 p -67.53 -48.26 67.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.334 0.588 . . . . 0.0 109.881 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.492 ' O ' HD12 ' A' ' 228' ' ' ILE . . . -135.77 130.3 33.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.472 178.279 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.45 ' CG2' ' HB2' ' A' ' 261' ' ' LEU . 4.8 p -132.47 17.93 4.38 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.314 173.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 39.4 m -84.2 147.26 27.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.31 174.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 92.96 -5.48 75.98 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -171.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 70.9 mtp -108.67 138.66 44.63 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -137.7 154.33 49.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.779 0.323 . . . . 0.0 110.547 -178.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.455 ' HA ' HG13 ' A' ' 297' ' ' VAL . 26.2 ptt180 -59.61 135.32 57.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.64 -174.503 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 102.86 18.32 15.96 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.728 -0.749 . . . . 0.0 113.027 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.539 ' H ' ' CG1' ' A' ' 297' ' ' VAL . 2.7 t0 -113.82 -169.57 1.54 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 117.369 0.585 . . . . 0.0 109.814 177.314 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.484 ' HD2' ' HB ' ' A' ' 294' ' ' THR . 4.7 tppp? -124.18 116.56 22.91 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.592 -178.125 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.542 HD11 HG21 ' A' ' 308' ' ' ILE . 15.6 pt -117.19 140.48 39.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 120.131 -0.627 . . . . 0.0 109.965 179.106 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 44.2 p -126.21 150.87 48.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.145 -178.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.481 ' HB2' ' HB ' ' A' ' 278' ' ' VAL . 89.0 m-85 -111.83 111.32 22.2 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.065 -178.862 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.01 111.98 3.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 -178.032 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 113.67 -35.52 4.48 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -178.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 275' ' ' PHE . 97.6 t -87.06 110.83 20.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -137.14 179.48 6.36 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.328 -174.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -69.08 172.81 6.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.109 -177.389 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 73.6 mt -64.91 -62.02 1.81 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -175.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -100.6 51.17 1.01 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.21 -177.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.473 ' HG3' ' HB1' ' A' ' 290' ' ' ALA . 6.1 tp-100 -92.42 -41.5 10.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.843 0.354 . . . . 0.0 110.749 -176.587 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 58.9 mtm -97.37 30.21 2.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.053 0.454 . . . . 0.0 110.253 177.162 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -77.37 -32.42 54.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.165 179.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -153.6 -42.24 0.09 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.653 179.219 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -62.4 127.98 33.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.291 0.567 . . . . 0.0 111.282 -177.764 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 44.6 t -86.07 -28.88 6.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.331 177.127 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 88.1 mt -87.82 54.59 3.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.149 174.29 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.473 ' HB1' ' HG3' ' A' ' 283' ' ' GLN . . . -66.61 116.39 7.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.103 -177.059 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -82.11 132.62 35.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.291 177.384 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -76.19 167.94 20.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.374 -178.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.458 ' HB1' ' CE2' ' A' ' 295' ' ' PHE . . . -61.31 107.3 0.74 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.006 -177.392 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.484 ' HB ' ' HD2' ' A' ' 272' ' ' LYS . 61.2 p -95.01 125.35 39.61 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.572 -179.491 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.48 ' CE2' ' HG3' ' A' ' 312' ' ' PRO . 88.1 m-85 -128.18 152.92 47.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.103 0.478 . . . . 0.0 111.132 -179.316 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 41.9 m -92.1 125.79 36.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.312 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.539 ' CG1' ' H ' ' A' ' 271' ' ' ASP . 12.0 p -76.98 127.74 37.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.085 0.469 . . . . 0.0 110.415 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 23.4 t -100.59 -35.72 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.202 -175.594 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 299' ' ' ARG . 6.8 tpt180 -164.32 142.57 7.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 111.124 -179.107 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 94.5 t -102.69 117.84 48.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 170.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 46.0 t -77.19 -55.7 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.122 -172.369 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -128.49 -1.27 5.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.057 0.456 . . . . 0.0 111.604 -175.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 83.25 14.31 74.68 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.216 -176.501 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 1.8 p -145.97 19.93 1.44 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 171.449 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.413 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.7 t-160 -165.71 115.75 1.03 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.476 -171.584 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.2 m -119.05 164.89 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 110.235 -0.284 . . . . 0.0 110.235 -174.585 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 257' ' ' ALA . 10.9 pt-20 -125.48 132.02 52.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.118 0.485 . . . . 0.0 109.9 169.673 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.542 HG21 HD11 ' A' ' 273' ' ' ILE . 21.5 pt -125.38 164.32 24.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.363 -176.347 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.4 t -141.86 141.16 21.26 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.714 175.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.75 -179.61 27.04 Favored 'Cis proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.964 -1.265 . . . . 0.0 112.532 -3.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 31.4 ttmt -86.31 126.25 65.32 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.48 ' HG3' ' CE2' ' A' ' 295' ' ' PHE . 8.7 Cg_exo -70.07 112.14 3.05 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.875 2.384 . . . . 0.0 112.712 178.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.622 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -119.39 128.94 75.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.789 172.661 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.692 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -88.02 138.72 31.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.906 -176.12 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 325' ' ' ARG . 3.0 tm? -68.53 -28.63 67.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.689 178.679 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -92.44 10.03 31.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.755 -179.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 9.9 t70 -72.57 122.22 21.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.996 0.426 . . . . 0.0 109.909 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.2 m -84.49 2.32 4.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.225 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 23.7 p -119.84 29.17 7.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -174.343 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 2.0 pp -128.74 161.22 30.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.061 0.458 . . . . 0.0 111.633 176.418 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 19.7 m -85.24 162.03 50.16 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.323 -177.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.49 ' O ' ' HG2' ' A' ' 325' ' ' ARG . 96.0 Cg_exo -46.0 -46.3 16.21 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.32 2.68 . . . . 0.0 113.927 -177.649 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.23 -33.07 75.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.679 0.276 . . . . 0.0 111.267 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.497 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 50.9 mt-30 -69.32 -35.95 76.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.235 -177.052 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 322' ' ' PRO . 8.0 ptp180 -74.8 -23.54 58.5 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.089 0.471 . . . . 0.0 110.206 178.91 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -72.03 -18.65 61.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.129 175.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -109.21 11.15 25.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.505 175.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.622 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -67.36 142.44 56.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.514 177.06 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . 0.413 ' OD1' HG13 ' A' ' 330' ' ' VAL . 5.6 p30 -125.39 -20.55 4.76 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -175.424 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 28.1 m -115.45 155.09 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.728 179.426 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -91.98 -2.48 56.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.781 -174.18 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 14.7 t -162.4 152.79 16.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.803 0.335 . . . . 0.0 110.254 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.0 p -86.88 165.56 15.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.114 179.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 234' ' ' GLN . 18.0 tp -68.27 108.0 3.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -177.483 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.61 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -80.35 -177.92 6.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.286 -177.122 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.48 1.49 29.13 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -172.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -147.87 54.94 1.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.224 0.535 . . . . 0.0 111.395 177.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.441 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 22.8 mmt -101.33 142.52 32.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.799 176.102 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -95.64 140.55 30.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.467 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 228' ' ' ILE . 22.0 t -114.66 120.11 63.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.312 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -136.78 144.26 43.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.85 0.357 . . . . 0.0 111.147 -175.436 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 31.3 mt -93.86 128.47 45.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.71 178.093 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 39.4 mt -88.13 111.96 22.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.566 -179.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -90.21 125.93 35.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.334 178.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.593 -0.718 . . . . 0.0 110.222 178.478 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.8 m -92.13 -49.25 6.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.02 0.438 . . . . 0.0 110.551 -179.748 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 23.0 p -126.66 28.93 5.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.309 0.576 . . . . 0.0 109.981 177.745 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -78.3 91.02 4.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.111 -175.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 29.0 p -79.13 72.97 5.71 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.489 0.661 . . . . 0.0 111.057 177.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -109.8 52.15 0.66 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 173.281 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.555 HG21 ' O ' ' A' ' 263' ' ' ALA . 22.7 mt -93.66 159.07 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.273 -0.463 . . . . 0.0 110.275 -173.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 13.3 p -118.23 153.42 33.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.281 0.563 . . . . 0.0 111.332 179.048 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.673 HG11 ' O ' ' A' ' 335' ' ' ALA . 9.3 p -66.74 152.58 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.83 177.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 18.5 t -114.99 78.92 1.21 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.13 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 101.58 151.07 24.23 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.699 179.574 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -85.63 141.54 29.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.463 0.173 . . . . 0.0 110.609 179.579 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -157.62 150.47 23.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.159 0.504 . . . . 0.0 111.771 -177.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 38.4 p -153.39 102.33 2.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.994 172.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -80.61 143.9 32.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.775 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -107.51 134.46 19.98 Favored Pre-proline 0 C--N 1.323 -0.577 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.264 -177.228 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.502 ' HA ' ' OD1' ' A' ' 254' ' ' ASN . 74.5 Cg_endo -90.01 120.69 0.9 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.747 2.298 . . . . 0.0 110.647 169.065 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.598 ' O ' HD11 ' A' ' 243' ' ' LEU . 49.2 t -82.1 105.57 12.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 120.837 0.351 . . . . 0.0 110.165 -177.313 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -78.96 81.83 5.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.794 -176.825 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -132.31 -72.86 0.52 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.863 178.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -161.96 108.17 1.31 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.324 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.598 HD11 ' O ' ' A' ' 239' ' ' VAL . 4.7 mp -128.43 71.77 1.41 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.994 -176.436 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -128.31 -77.67 0.56 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.437 176.064 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -74.32 -54.93 6.66 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -118.54 132.35 56.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.119 172.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -121.73 148.79 17.24 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.497 178.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . 0.401 ' OD1' HG21 ' A' ' 239' ' ' VAL . 3.5 t-20 -69.79 132.14 45.6 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.525 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 65.34 66.79 0.53 Allowed 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.744 0.652 . . . . 0.0 110.734 -178.35 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.8 t 72.11 147.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.875 176.506 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -88.94 131.14 35.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.26 -178.578 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.9 t 54.81 57.45 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.994 0.902 . . . . 0.0 110.109 -178.276 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -151.81 -42.85 0.11 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.032 -179.176 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 238' ' ' PRO . 19.4 t-20 -63.78 -18.32 63.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.619 0.724 . . . . 0.0 109.717 177.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -68.64 -21.84 64.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.756 175.208 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -115.77 160.93 19.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.837 -174.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.27 132.91 53.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 177.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 1.4 m -94.85 114.27 26.12 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.041 0.448 . . . . 0.0 110.368 178.52 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.9 t -93.76 122.27 45.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.282 -173.882 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 3.0 m -94.0 106.7 18.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.049 179.527 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.551 HD23 HG23 ' A' ' 230' ' ' VAL . 23.1 mt -126.35 168.14 14.56 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.412 -174.026 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.6 t -63.25 -54.87 30.5 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.555 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -137.09 136.84 38.69 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.266 178.543 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.437 HG22 HD12 ' A' ' 261' ' ' LEU . 15.9 p -129.7 25.27 5.36 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.028 0.918 . . . . 0.0 108.558 175.23 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 17.4 m -82.96 153.44 25.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.284 -1.326 . . . . 0.0 109.712 176.885 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 90.7 -6.44 82.05 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -174.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . 0.415 ' HG2' HD11 ' A' ' 342' ' ' ILE . 47.8 mtt -104.3 147.45 27.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.828 -0.686 . . . . 0.0 109.314 178.524 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 271' ' ' ASP . 0.0 OUTLIER -139.62 158.05 44.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.307 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -54.47 132.65 45.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.182 0.515 . . . . 0.0 111.437 -176.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 95.11 19.03 31.98 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.099 -177.271 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.574 ' H ' HG12 ' A' ' 297' ' ' VAL . 1.1 t0 -103.46 169.01 8.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.7 0.286 . . . . 0.0 110.289 -178.284 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -118.5 115.46 24.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.996 -178.137 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.488 HD11 HG21 ' A' ' 308' ' ' ILE . 30.0 pt -112.78 139.74 36.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.039 0.447 . . . . 0.0 110.061 179.52 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.41 ' OG ' HG22 ' A' ' 294' ' ' THR . 7.1 m -124.48 133.47 53.34 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.871 -179.188 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -100.0 111.42 23.72 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.206 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 339' ' ' ALA . . . -66.51 120.54 13.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.342 -179.2 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 111.95 -25.95 12.2 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -176.591 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.559 ' HA ' ' OG1' ' A' ' 332' ' ' THR . 47.0 t -100.28 119.74 48.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.772 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -136.34 157.48 46.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.035 0.445 . . . . 0.0 111.436 -173.585 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -72.94 118.87 16.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.245 179.714 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 331' ' ' ASN . 1.5 pt? -76.06 171.42 14.5 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.33 -45.78 3.52 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 -174.312 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -64.2 -28.48 69.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 110.491 177.276 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 82.7 mtp -72.11 -10.51 59.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.357 -175.716 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.32 -14.16 60.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.924 0.392 . . . . 0.0 111.245 -179.249 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -138.93 -38.83 0.5 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.913 0.387 . . . . 0.0 110.812 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -86.33 124.23 32.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.399 -178.349 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 40.8 t -88.73 -33.44 6.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 176.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 88.7 mt -92.24 54.11 2.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.763 177.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.24 130.24 42.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.368 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -77.62 161.85 27.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.626 -177.394 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 276' ' ' ALA . 49.4 m-20 -72.99 158.91 34.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.876 177.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -65.81 101.14 0.61 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.037 -178.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.41 HG22 ' OG ' ' A' ' 274' ' ' SER . 45.4 p -84.05 117.16 23.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.959 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -120.64 148.31 44.08 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.921 0.391 . . . . 0.0 110.624 177.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 8.5 m -94.88 127.75 41.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.257 -178.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 271' ' ' ASP . 7.4 p -79.9 134.02 28.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.271 0.558 . . . . 0.0 110.286 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.428 ' HB ' ' HG3' ' A' ' 307' ' ' GLU . 61.0 t -95.13 -38.7 9.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.859 -178.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -166.82 139.88 3.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.752 0.311 . . . . 0.0 110.235 -179.199 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 86.8 t -83.88 103.75 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.622 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 18.4 t -72.58 -58.21 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.024 -171.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -116.69 -9.98 11.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.98 0.419 . . . . 0.0 111.817 -174.828 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 78.03 11.39 85.43 Favored Glycine 0 CA--C 1.516 0.136 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -173.378 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 20.3 p -148.98 18.53 0.98 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 173.43 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 4.8 t-160 -169.43 113.59 0.53 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.006 -165.079 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.5 m -119.06 163.17 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 121.206 -0.198 . . . . 0.0 110.57 -173.413 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.428 ' HG3' ' HB ' ' A' ' 298' ' ' VAL . 11.5 pt-20 -116.92 128.5 55.29 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 171.255 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.488 HG21 HD11 ' A' ' 273' ' ' ILE . 29.8 pt -126.61 168.15 20.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.123 0.487 . . . . 0.0 111.938 -176.104 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.3 t -146.92 138.57 13.38 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.049 174.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.36 -179.66 27.75 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.815 -1.327 . . . . 0.0 112.721 -1.599 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 312' ' ' PRO . 38.6 ttmt -79.51 124.07 84.03 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.258 -178.479 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 311' ' ' LYS . 13.4 Cg_exo -68.86 113.44 3.22 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.972 2.448 . . . . 0.0 112.384 177.416 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.513 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.0 OUTLIER -123.96 129.28 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.355 176.229 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 317' ' ' ASP . . . -86.53 129.34 34.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.876 -177.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.83 -27.49 68.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.719 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -95.75 15.19 20.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 314' ' ' ALA . 10.2 t70 -81.96 127.66 33.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.291 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 28.2 m -84.17 -3.48 7.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -174.027 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 14.7 m -96.82 1.38 50.62 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -174.676 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.0 OUTLIER -111.18 156.37 21.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.211 0.529 . . . . 0.0 111.403 178.515 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 16.0 m -94.07 165.7 17.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.11 -175.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 66.6 Cg_exo -42.96 -49.0 7.23 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 123.697 2.932 . . . . 0.0 114.253 -178.627 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -62.53 -39.51 93.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 0.0 110.949 -179.101 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 47.5 mt-30 -67.56 -33.25 74.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.309 179.592 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.458 ' HG2' HD13 ' A' ' 320' ' ' LEU . 83.2 mtt180 -60.86 -32.6 72.02 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.859 175.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -69.02 -25.11 64.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.677 179.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -95.52 -0.74 51.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 178.51 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.513 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -73.76 107.4 5.98 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.237 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . 0.504 ' ND2' HG13 ' A' ' 330' ' ' VAL . 5.6 p-10 -92.3 -5.38 52.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.157 -176.004 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.504 HG13 ' ND2' ' A' ' 329' ' ' ASN . 28.1 m -133.21 155.92 41.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.562 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.43 ' HB3' ' HB3' ' A' ' 281' ' ' LEU . 24.9 p-10 -93.99 -26.53 16.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.764 -178.669 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.559 ' OG1' ' HA ' ' A' ' 278' ' ' VAL . 43.2 p -109.21 139.48 44.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.165 0.507 . . . . 0.0 111.311 -179.033 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 46.9 p -86.57 169.56 12.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.328 176.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.9 tp -74.91 102.22 4.69 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.673 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -82.3 165.86 20.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.961 -179.886 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -78.99 26.27 0.26 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -172.498 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -154.49 41.13 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.01 0.433 . . . . 0.0 110.911 176.111 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.463 ' H ' ' CG1' ' A' ' 230' ' ' VAL . 23.4 mmt -99.32 149.66 22.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 177.786 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 276' ' ' ALA . . . -99.99 143.88 29.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.949 -179.111 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.5 t -110.91 115.8 50.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.143 -178.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -132.7 137.55 46.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.861 -177.273 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.415 HD11 ' HG2' ' A' ' 267' ' ' MET . 24.2 mt -97.9 129.5 48.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.718 178.375 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 59.8 mt -84.93 143.58 28.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.321 178.123 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -124.87 99.21 6.04 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.906 0.384 . . . . 0.0 110.197 179.504 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.518 179.939 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.666 0 N-CA-C 112.204 -0.358 . . . . 0.0 112.204 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 13.8 p -79.76 -11.68 59.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.775 0.321 . . . . 0.0 111.112 -177.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 342' ' ' ILE . 20.8 p -74.65 -8.8 57.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.492 179.253 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -75.97 60.37 1.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.303 0.573 . . . . 0.0 110.651 179.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 46.4 p -83.98 73.86 10.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.912 -178.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -73.67 69.45 1.48 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.758 -177.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.502 HG21 ' O ' ' A' ' 263' ' ' ALA . 38.4 mt -102.33 152.6 5.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.477 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 25.6 p -99.86 169.6 9.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.392 0.615 . . . . 0.0 112.315 -177.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.632 HG11 ' O ' ' A' ' 335' ' ' ALA . 10.4 p -81.61 152.08 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.752 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.3 t -104.55 80.77 1.71 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 91.02 165.38 40.07 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.177 -179.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -96.33 136.88 36.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.603 0.239 . . . . 0.0 110.44 179.206 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -149.27 127.16 11.85 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.36 0.6 . . . . 0.0 111.327 179.602 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.513 ' HA ' ' HB3' ' A' ' 333' ' ' SER . 11.6 p -98.14 120.65 38.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.267 177.347 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.86 157.99 25.49 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.935 -175.435 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.408 ' HD2' ' HB3' ' A' ' 320' ' ' LEU . 46.6 mmtm -141.87 132.15 12.77 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.351 -179.498 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.612 ' HD3' HG11 ' A' ' 313' ' ' VAL . 70.6 Cg_endo -87.61 145.69 6.9 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.528 2.152 . . . . 0.0 112.063 178.438 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.44 126.93 38.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.337 0.589 . . . . 0.0 110.622 177.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -131.37 -160.79 1.07 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.627 179.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -74.76 81.17 2.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.221 0.534 . . . . 0.0 110.374 178.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -172.29 173.81 4.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.549 177.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.428 ' N ' HD23 ' A' ' 243' ' ' LEU . 1.8 pt? -144.46 30.08 1.25 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.701 176.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.45 ' HB3' ' H ' ' A' ' 245' ' ' ASN . 3.7 m-20 60.09 -154.58 0.37 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.055 -178.761 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.45 ' H ' ' HB3' ' A' ' 244' ' ' ASP . 16.5 m120 -71.5 -55.21 8.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.599 0.238 . . . . 0.0 111.545 -175.384 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -100.04 -59.35 1.73 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.915 0.388 . . . . 0.0 110.96 -176.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 173.79 163.67 27.68 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.773 -178.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -125.95 122.08 34.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.99 0.424 . . . . 0.0 110.58 -178.835 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -86.7 -25.03 24.98 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.6 m -60.3 115.54 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.572 -179.577 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 251' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -141.7 143.69 33.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.353 178.402 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 17.8 t 56.8 65.73 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.741 0.782 . . . . 0.0 109.936 -176.056 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -165.59 -44.23 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.113 -179.318 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -67.4 -13.81 62.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.784 -177.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -60.4 -24.8 65.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.35 0.595 . . . . 0.0 110.114 174.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -116.01 163.52 15.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.599 177.214 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -113.88 114.36 26.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.307 177.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 306' ' ' VAL . 0.2 OUTLIER -84.16 103.02 13.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.432 0.634 . . . . 0.0 111.306 179.012 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 305' ' ' HIS . 2.8 t -83.24 124.62 39.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.351 -177.273 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 6.1 m -97.82 105.77 17.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.912 178.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.473 ' HB2' HG22 ' A' ' 264' ' ' THR . 17.4 mt -123.04 165.76 16.26 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.998 -174.537 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.7 m -57.06 -56.71 18.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.434 0.635 . . . . 0.0 109.649 179.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.502 ' O ' HG21 ' A' ' 228' ' ' ILE . . . -138.12 134.63 34.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.874 177.154 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 264' ' ' THR . . . . . 0.473 HG22 ' HB2' ' A' ' 261' ' ' LEU . 6.7 p -123.99 24.71 8.17 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.938 0.875 . . . . 0.0 108.723 175.132 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 44.9 m -75.4 131.79 40.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.16 173.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 110.48 -26.5 13.06 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -171.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -76.53 140.75 41.26 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 172.674 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -154.35 146.11 23.37 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.183 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.505 ' HA ' HG13 ' A' ' 297' ' ' VAL . 29.9 ptt180 -41.9 119.66 1.36 Allowed 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.149 0.906 . . . . 0.0 112.609 -173.334 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 110.33 -9.16 30.9 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.44 176.683 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.459 ' H ' HG12 ' A' ' 297' ' ' VAL . 2.4 p30 -77.06 -178.12 4.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.372 0.606 . . . . 0.0 111.943 -177.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.52 117.08 18.28 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.628 -178.598 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.435 HD11 HG21 ' A' ' 308' ' ' ILE . 35.5 pt -112.63 140.23 33.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.156 0.503 . . . . 0.0 110.763 179.342 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 293' ' ' ALA . 22.7 t -121.32 145.29 48.03 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.559 178.49 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -112.33 111.46 22.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.023 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.65 120.24 15.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.591 -178.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 112.96 -34.24 5.19 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -178.068 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 96.1 t -90.29 115.68 30.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 173.235 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -131.46 151.41 51.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.033 0.444 . . . . 0.0 111.739 -173.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.533 ' CE2' ' HA ' ' A' ' 293' ' ' ALA . 77.5 m-85 -70.18 115.45 9.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.462 176.332 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 281' ' ' LEU . 2.3 pt? -74.95 -18.28 60.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.717 0.294 . . . . 0.0 111.114 -175.311 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -70.17 -20.73 76.77 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 175.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -71.54 -17.69 62.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.984 0.421 . . . . 0.0 110.091 177.719 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 58.1 mtt -78.89 2.52 19.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.053 -178.31 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -58.1 -38.43 76.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.328 -178.407 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -145.27 -32.17 0.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.052 0.454 . . . . 0.0 110.761 178.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -85.34 118.25 24.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.002 0.429 . . . . 0.0 110.57 178.538 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 45.2 t -76.4 -30.12 19.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.26 -179.342 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 87.4 mt -89.12 61.9 6.0 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -178.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -60.24 123.2 16.49 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.784 -174.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 291' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -60.9 145.48 50.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.231 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -71.42 154.04 41.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.382 176.499 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.533 ' HA ' ' CE2' ' A' ' 280' ' ' PHE . . . -60.47 127.28 30.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.606 -174.531 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 29.3 p -120.03 122.95 42.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.591 -179.387 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.453 ' CE2' ' HB1' ' A' ' 293' ' ' ALA . 75.2 m-85 -133.78 152.28 51.83 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 11.9 t -96.28 134.8 38.94 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.41 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.505 HG13 ' HA ' ' A' ' 269' ' ' ARG . 4.7 p -69.79 139.98 19.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.145 178.733 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 50.2 t -104.67 -38.4 4.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.151 175.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -163.06 140.74 7.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.615 179.555 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.4 109.18 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.074 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.15 -59.61 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.017 -174.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -111.03 -13.62 14.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.291 0.567 . . . . 0.0 111.57 -175.026 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . 82.22 13.99 77.74 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.255 -174.033 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 40.0 p -136.67 9.86 3.12 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 169.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.496 ' NE2' ' HB ' ' A' ' 258' ' ' THR . 2.2 t-160 -158.18 114.15 2.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.343 -1.299 . . . . 0.0 108.279 -168.749 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 258' ' ' THR . 1.2 m -118.69 150.98 20.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -177.011 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -111.06 117.05 32.24 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.182 0.515 . . . . 0.0 110.092 173.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.483 HG22 ' HA ' ' A' ' 297' ' ' VAL . 24.6 pt -116.67 172.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.069 -179.229 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 9.9 t -154.53 141.86 13.68 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.324 176.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.98 179.71 29.68 Favored 'Cis proline' 0 CA--C 1.531 0.337 0 C-N-CA 123.487 -1.464 . . . . 0.0 112.838 -3.06 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.419 ' HZ3' ' HB2' ' A' ' 311' ' ' LYS . 3.7 ttmp? -83.87 128.03 64.83 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.58 -177.774 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 312' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.97 108.93 2.56 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.379 2.053 . . . . 0.0 111.727 174.459 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.697 HG23 ' HA ' ' A' ' 328' ' ' ALA . 0.8 OUTLIER -123.99 136.79 59.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.028 -179.063 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 330' ' ' VAL . . . -86.88 138.27 31.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.54 0.686 . . . . 0.0 112.285 -173.041 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . 0.48 HD22 ' HB2' ' A' ' 325' ' ' ARG . 3.0 tm? -76.58 -33.67 58.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.253 178.594 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -89.2 13.99 11.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.256 -177.305 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . 0.454 ' OD1' ' HG ' ' A' ' 320' ' ' LEU . 11.3 t70 -73.13 123.27 23.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.034 179.266 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 11.8 p -83.75 -16.55 10.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.768 -175.825 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 14.4 m -80.61 -33.78 35.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.441 -172.086 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 324' ' ' GLN . 1.5 pp -82.93 159.27 22.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.445 0.641 . . . . 0.0 112.084 -177.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.442 ' HB3' ' HD2' ' A' ' 322' ' ' PRO . 18.8 m -81.07 163.97 52.75 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.428 -178.5 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 321' ' ' SER . 67.2 Cg_exo -43.39 -52.86 4.69 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.503 2.802 . . . . 0.0 114.35 179.763 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.93 -28.54 70.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.09 0.471 . . . . 0.0 111.135 -177.15 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.494 ' HB2' ' HB2' ' A' ' 320' ' ' LEU . 11.7 mm100 -69.22 -45.98 68.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.72 -179.008 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 325' ' ' ARG . . . . . 0.48 ' HB2' HD22 ' A' ' 315' ' ' LEU . 2.7 ptp180 -70.47 -21.15 62.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.857 0.361 . . . . 0.0 110.677 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -65.18 -28.4 69.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.983 0.421 . . . . 0.0 110.265 173.394 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 327' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -94.66 -0.2 54.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.002 179.575 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.697 ' HA ' HG23 ' A' ' 313' ' ' VAL . . . -60.85 149.87 34.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.422 178.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 329' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -124.75 -19.45 5.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.643 -176.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 314' ' ' ALA . 35.0 m -127.99 163.61 31.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 281' ' ' LEU . 20.6 p-10 -83.77 -34.14 24.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.636 0.255 . . . . 0.0 111.337 -176.258 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 12.1 t -132.83 146.92 52.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.199 -178.589 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.513 ' HB3' ' HA ' ' A' ' 235' ' ' SER . 30.6 m -82.2 -175.86 5.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.749 -179.416 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 15.1 tp -75.99 103.81 6.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.134 -176.549 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.632 ' O ' HG11 ' A' ' 230' ' ' VAL . . . -82.01 169.45 16.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.479 179.697 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -79.44 23.25 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -171.277 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -155.42 46.46 0.5 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.96 0.41 . . . . 0.0 110.805 177.323 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.0 mmt -100.07 132.23 45.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.18 178.3 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -88.5 129.31 35.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.817 179.133 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 10.3 t -97.45 147.6 6.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -160.52 138.01 9.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.496 0.189 . . . . 0.0 110.798 176.212 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.404 ' O ' ' HB ' ' A' ' 224' ' ' THR . 47.3 mt -88.76 121.66 39.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.052 0.453 . . . . 0.0 110.672 176.365 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 343' ' ' LEU . . . . . . . . . . . . . 61.5 mt -81.98 143.6 31.48 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.714 179.195 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -123.55 138.52 54.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.468 -178.039 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 45.8 t . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.35 176.466 . . . . . . . . 0 0 . 1 stop_ save_